PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J				Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J			Economic evaluation of nurse led intermediate care versus standard acute care for post-acute medical patients: cost minimisation analysis of data from a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							INPATIENT UNIT	Objective To undertake an economic evaluation of nurse led intermediate care compared with standard hospital care for post-acute medical patients. Design Cost minimisation analysis from an NHS perspective, comprising secondary care, primary care, and community care, using data from a pragmatic randomised controlled trial. Setting Nurse led unit and acute general medical wards in large, urban, UK teaching hospital. Participants 238 patients. Outcome measure Costs to acute hospital trusts and to the NHS over six months. Results On an intention to treat basis, nurse led care was associated with higher costs during the initial admission period (nurse led care 7892 pound ($14 970; E11 503), standard care 4810 pound, difference 3082 pound (95% confidence interval 1161 pound to 5002 pound)) pound. During the readmission period, costs were similar (nurse led care 1444 pound, standard care 1879 pound, difference - 435 pound, - 1406 pound to 536 pound) pound. Total costs at six months were significantly higher (nurse led care 10 529 pound, standard care 7819 pound, difference 2710 pound, 518 pound to 4903 pound). Sensitivity analyses suggested that the trend for nurse led care to be more expensive was maintained even with substantial cost reductions, although differences were no longer significant. Conclusion Acute hospitals may not be cost effective settings for nurse led intermediate care. Both inpatient and total costs were significantly higher for nurse led care than for standard care of post-acute medical patients, suggesting that this model of care should not be pursued unless clinical or organisational benefits justify the increased investment.	Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England; Univ Southampton, Dept Geriatr Med, Southampton SO9 5NH, Hants, England; Southampton Gen Hosp, Med Stat Grp, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Dept Geriatr Med, Elderly Care Res Unit, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton	Walsh, B (corresponding author), Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England.	b.m.walsh@soton.ac.uk		Walsh, Bronagh/0000-0003-1008-0545				Coast J, 1998, BRIT MED J, V316, P1802, DOI 10.1136/bmj.316.7147.1802; *DEP HLTH, 2001, HLTH SERV CIRC 2001; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2000, SHAP FUT NHS LONG TE; Griffiths P, 2001, AGE AGEING, V30, P483, DOI 10.1093/ageing/30.6.483; Griffiths P, 2000, INT J NURS STUD, V37, P153, DOI 10.1016/S0020-7489(99)00061-9; GRIFFITHS P, 1995, EVALUATING NURSE LED; NETTEN A, 1999, UNIT COSTS COMMUNITY; PEARSON A, 1992, NURSING BEDS EVALUAT; Stein RL, 2004, J PALESTINE STUD, V33, P5, DOI 10.1525/jps.2004.33.4.005; Steiner A, 2001, AGE AGEING, V30, P433, DOI 10.1093/ageing/30.6.433; Steiner A, 2001, BRIT MED J, V322, P453, DOI 10.1136/bmj.322.7284.453; Walsh B, 2003, INT J NURS STUD, V40, P307, DOI 10.1016/S0020-7489(02)00091-3; Wiles R, 2001, J ADV NURS, V34, P813, DOI 10.1046/j.1365-2648.2001.01812.x	15	24	24	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					699	702		10.1136/bmj.38397.633588.8F	http://dx.doi.org/10.1136/bmj.38397.633588.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912IT	15757959	Green Published, Bronze			2022-12-28	WOS:000228071900015
J	Sabatine, MS; Cannon, CP; Gibson, CM; Lopez-Sendon, JL; Montalescot, G; Theroux, P; Claeys, MJ; Cools, F; Hill, KA; Skene, AM; McCabe, CH; Braunwald, E; Braunwald, E; Cannon, C; Sabatine, M; McCabe, C; McCagg, A; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Delaet, I; Townes, L; Anhalt, D; van Holder, K; Skene, A; Hill, K; Braunwald, E; Cannon, C; Sabatine, M; McCabe, C; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Delaet, I; Townes, L; Skene, A; Ardissino, D; Aylward, P; Bertrand, M; Bode, C; Budaj, A; Claeys, M; Dellborg, M; Ferreira, R; Gershlick, A; Huber, K; Keltai, M; Kleiman, N; Lewis, B; Lopez-Sendon, J; Marx, J; Montalescot, G; Nicolau, J; Ongen, Z; Paolasso, E; Pons, JL; Ruda, M; Theroux, P; Van de Werf, F; Verheugt, F; Wilcox, R; Zeymer, U; Braunwald, E; Cannon, C; Sabatine, M; Gibson, M; McCabe, C; McCagg, A; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Froehlich, J; Delaet, I; Townes, L; Anhalt, D; van Holder, K; Pieters, A; Skene, A; Hill, K; Charlesworth, A; Goulder, M; Stead, S; Wiviott, S; Aroesty, J; Berger, C; Garcia, L; Greer, D; Leeman, D; Lyle, H; Philippides, G; Schwamm, L; Gibson, M; Marble, S; Aroesty, J; Buros, J; Ciaglo, L; Kirtane, A; Shui, A; Wilson, A; Scirica, B; Morrow, D; Giugliano, R; Wiviott, S; Morrow, D; Ridker, P; Rifai, N; Sabatine, M; Kucherlapati, R; Kwiatkowski, D; Stone, P; Maccallum, G; Lucier, M; Garriga, A; Anderson, J; Fox, K; Kelsey, S; Batalla, A; Areses, ELD; Fiol, M; Bethencourt, A; Lozano, I; Figueras, J; Cortes, JG; Jimenez, AG; Fernandez, AR; Montero, IF; Casasnovas, J; Aso, FO; de Blas, RC; Audicana, J; Errazti, IE; Montero, JS; Rohlfs, I; Pinero, C; Rodriguez, MM; Alvarez, LV; Belras, AC; Barros, S; Fernandez, JD; Tobaruela, A; Bonneau, A; Soulat, L; Lambert, Y; Caussanel, J; Livareck, B; Ramaut, C; Ricome, J; Lapostolle, F; Beruben, A; Thieleux, F; Martelli, J; Martelet, M; Mouallem, J; Ahmed, F; Galley, D; Alhabaj, S; Doucos, D; Bearez, E; Spetebroodt, S; Gully, C; Dujardin, J; Averland, B; Emmonot, B; Pollet, D; Vallet, P; Mossaz, R; Marquand, A; Kermarrec, A; Le Lay, C; Douillet, R; Olliver, L; Matas, O; Kassam, S; Halperin, F; Parsons, P; Bovak, B; Hart, B; Sussex, B; Newman, S; Gosselin, G; David, M; Sidhar, K; Wiseman, D; Lefkowitz, C; Thornley, M; Bhargava, R; McCullum, A; Grandmond, D; Carignan, D; Kouz, S; Roy, M; Polasek, P; Stedham, V; Lai, K; Paquette, B; Raco, D; Sayles, M; Sridhar, K; Wiseman, D; Tremblay, B; Darveau, C; Sussex, B; Newman, S; Senaratne, M; Holland, M; Bata, I; Hulan, M; Constance, C; Pouliot, S; Gossard, D; Day, L; Glanz, A; Vilag, C; Hui, W; Kvill, L; Dion, D; Morisette, A; Sandrin, F; Mitges, S; Cools, F; Vanhagendoren, S; De Meester, A; Marcovitch, O; Allaf, E; Gits, F; Verrostte, J; Thoeng, J; Quinonez, M; Appeltants, H; D'Hooghe, G; Eycken, M; Swennen, I; Hollanders, G; Michael, E; Decroly, P; Rombaut, E; Carlaire, D; Vermander, D; Marenne, SF; Gavray, C; Michel, P; Poth, A; Paquay, J; Lutasu, S; Dirk, D; Vermeulen, J; Govaerts, E; Boldueva, S; Sherenkov, A; Ruda, M; Kostenko, V; Tereschenko, S; Zalevsky, G; Boyarkin, M; Tankhilevitch, B; Glezer, M; Gratsiansky, N; Shlyakhto, E; Sidorenko, B; Zadiontchenko, V; Perepech, N; Gruzdev, A; Chernov, S; Pollock, B; Andresen, D; Hoffmann, S; Andresen, D; Arntz, H; Klein, H; Neuss, H; Wilhelms, E; Henzgen, R; Kuckuck, H; Darius, H; Hausdorf, C; Ochs, H; Olbrich, H; Willenbrock, R; Hepp, A; Wucherpfennig, P; Wiechmann, H; Schmidtendorf, H; Kohler, B; Sehnert, W; Ueberreiter, A; Uebis, R; Stockmann, M; Rommele, U; Meissner, A; Schneider, L; Adgey, J; McAllister, T; McEneaney, D; Mackin, A; Sulke, N; Dixon, R; Wilcox, R; Congreave, S; Flapan, A; Flint, L; Purvis, J; McCorkell, G; Stubbs, P; Steer, C; McKkee, P; Senior, R; Chester, L; Levy, T; Kennard, S; Bishop, A; Hlaing, S; de Belder, M; Cunningham, N; Gilbert, T; Young, J; Henderson, R; Falcon-Lang, D; Gershlick, A; Fairbrother, K; Rosenfeld, T; Atar, S; Lewis, B; Yuval, R; Meisel, S; Alony, I; Rozenman, Y; Logrineuko, S; Goldhammer, E; Harel, S; David, D; Erez, N; Jafari, J; Tubul, O; Marmor, A; Pritulo, L; Caspi, A; Roitberg, N; Kaluski, E; Amar, R; Tzivoni, D; Rojanski, A; Yedid-Am, S; Keren, A; Datiashvily, L; Saraiva, JK; Garcia, CT; Markman, M; Chaves, A; Vaz, RC; Dutra, O; Coelho, OR; Sciampaglia, R; da Cunha, CP; de Brito, MR; Lotufo, P; Ribeiro, E; Cicogna, A; Michalaros, YL; Ornellas, CE; Santos, SCD; Rosatelli, P; Pimentel, W; Grudzinski, M; Guimaraes, F; Gustavo, C; Moreira, M; Gosmao, J; Hertzberger, D; Schut, A; van der Zwaan, C; Havenaar, H; van Wijngaarden, J; Verheij, H; Wajon, E; Bosschaart, M; Oomen, A; Daniels, M; Coppes, A; Vergeught, F; Dieker, H; Jochemsen, D; Fijlstra, I; Leenders, C; Gelder, T; Janicke, D; Bass, J; Hamroff, G; Keeler, K; Chandra, M; Van Hoose, B; Minor, S; Mock, P; Chandra, M; Olliges, M; Unwala, A; Fisher, C; French, W; Barillas, O; Chandna, H; Holly, D; Chandna, H; Holly, D; Grewal, G; Gurnsey, L; Mehta, P; Cruse, A; Perlman, R; Palazzo, D; Puma, J; Payne, C; Torres, J; Patten, L; Lefkovic, L; Viswanathan, N; Rees, A; Yoches, A; Rodriguez-Ospina, L; Santos, J; Chohan, A; Kemp, A; Perlman, R; Palazzo, D; Weiss, R; Brennan, B; Aude, Y; Harrison, P; Brogan, G; Ayan, J; Cragg, D; Murawka, A; Garg, M; McKelvy, J; Hulyalkar, A; Kuchenrither, C; Jackson, S; Whitaker, J; Richardson, J; Vicari, R; Howard, M; Aude, Y; Harrison, P; Chadow, H; Hauptman, R; Gelormini, J; Giambra, T; Lakkis, N; Jiang, S; Hernandez, I; Vazquez, A; Rosas, EL; Lawrenz, JC; Bustamante, F; Martinez, CA; Alcocer, MA; Hernandez, EG; Dogre, CW; Bustillos, MDB; Alvarado, R; Ramirez, MC; Hinojosa, P; Rivera, OO; Pons, JL; Carrillo, J; Velasco, JA; Quintana, F; Petersen, F; Palomera, R; Ibarra, M; Sanchez, CJ; Delgado, L; Bayram, E; Machado, GM; Berli, MA; Vinuela, JC; Allall, O; Fuentealba, V; Reguero, M; Covelli, G; San Martin, E; Francia, E; Gadaleta, F; Haehnel, M; Iglesias, R; Blumberg, S; de Lima, AA; Henquin, R; Estrada, JN; de Arenaza, D; Fernandez, R; Abud, M; Becker, C; Milesi, R; Schamuck, R; Doyharzabal, JM; Caime, DG; Teresa, LC; Kuschnir, E; Sgammini, H; Sgammini, J; David, J; Sosa, CH; Redcozub, E; Avalos, V; Nul, D; Ramos, S; Castro, PT; Rodriguez, A; Sosa, C; Lopez, JG; Novo, F; Diez, F; Piraino, R; Godoy, G; Weller, C; Pomposiello, J; Sanchez, A; Karlsson, J; Collberg, K; Malmqvist, K; Cedergren, E; Dellborg, M; Coops, G; Kallryd, A; Laudon, P; Bandh, S; Andersson, C; Soome, S; Classon, H; Lugnegard, J; Ahlmark, H; Risenfors, M; Ortgren, L; Fjelstad, B; Osberg, S; Frisell, J; Sandstrom, M; Silvestri, O; Sasso, A; Rolli, A; Paoli, G; Chiarella, F; Olivotte, L; Doronzo, B; Coppolino, A; Pivoccari, G; Pesaresi, A; Ambrosio, G; Del Pinto, M; De Luca, I; Laico, M; De Ferrari, G; Baldini, E; Guiducci, U; Tortorella, G; Romano, M; Villani, R; Casazza, F; Capozi, A; Moretti, L; Del Pinto, M; Perelli, S; Sinagra, G; Maras, P; Porcu, M; Scorcu, G; Proietti, F; Severi, S; Gessek, J; Pawlowicz, L; Szelemej, R; Gorski, M; Janion, M; Sielski, J; Kleinrok, A; Rodzik, J; Hiczkiewicz, J; Pasler, MM; Soltsiak, M; Gorny, J; Huber, K; Jordanova, N; Heigert, M; Kopp, K; Frank, H; Laggner, A; Schreiber, W; Weihs, W; Drexel, MH; Doubell, A; Burgess, L; Bennett, J; Snyders, F; Ebrahim, I; Bobak, C; Marx, J; deBeer, M; Schmidt, S; Cyster, H; van der Berg, P; Groenewald, W; Herbst, L; Britz, A; Snyman, M; Schonken, M; Badenhorst, J; Blomerus, P; Mpe, M; Bobak, C; Mynhardt, J; Groenewald, C; van Dyk, C; Meiring, J; Steingo, L; Glaeser, L; Whelan, A; Tulloch, G; Gunalingham, B; Conway, B; Soward, A; Hales, S; Lefkovits, J; Sallaberger, M; Owesby, D; Kesby, J; Amerena, J; Fogarty, K; Chew, D; Austin, M; Kovaricek, S; Banham, N; Tulloch, G; Jobbagy, L; Dinnyes, J; Lippai, J; Oze, B; Szakal, I; Bartal, G; Foldi, A; Foley, D; McGrath, F; Meany, B; Geraghty, M; Daly, K; Henessey, S; Mulvihill, N; Schilling, C; Kearney, P; Kelly, P; Kearney, P; Kelly, P; Ongen, Z; Vura, A; Kozan, O; Ozaydin, E; Kultursay, H; Kayikcioglu, M; Degertekin, M; Mutlu, B; Monteiro, F; Ferreira, D; Carrageta, M				Sabatine, MS; Cannon, CP; Gibson, CM; Lopez-Sendon, JL; Montalescot, G; Theroux, P; Claeys, MJ; Cools, F; Hill, KA; Skene, AM; McCabe, CH; Braunwald, E; Braunwald, E; Cannon, C; Sabatine, M; McCabe, C; McCagg, A; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Delaet, I; Townes, L; Anhalt, D; van Holder, K; Skene, A; Hill, K; Braunwald, E; Cannon, C; Sabatine, M; McCabe, C; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Delaet, I; Townes, L; Skene, A; Ardissino, D; Aylward, P; Bertrand, M; Bode, C; Budaj, A; Claeys, M; Dellborg, M; Ferreira, R; Gershlick, A; Huber, K; Keltai, M; Kleiman, N; Lewis, B; Lopez-Sendon, J; Marx, J; Montalescot, G; Nicolau, J; Ongen, Z; Paolasso, E; Pons, JL; Ruda, M; Theroux, P; Van de Werf, F; Verheugt, F; Wilcox, R; Zeymer, U; Braunwald, E; Cannon, C; Sabatine, M; Gibson, M; McCabe, C; McCagg, A; Job, B; Gaudin, C; Thizon-de Gaulle, I; Blumenthal, M; Saini, R; Froehlich, J; Delaet, I; Townes, L; Anhalt, D; van Holder, K; Pieters, A; Skene, A; Hill, K; Charlesworth, A; Goulder, M; Stead, S; Wiviott, S; Aroesty, J; Berger, C; Garcia, L; Greer, D; Leeman, D; Lyle, H; Philippides, G; Schwamm, L; Gibson, M; Marble, S; Aroesty, J; Buros, J; Ciaglo, L; Kirtane, A; Shui, A; Wilson, A; Scirica, B; Morrow, D; Giugliano, R; Wiviott, S; Morrow, D; Ridker, P; Rifai, N; Sabatine, M; Kucherlapati, R; Kwiatkowski, D; Stone, P; Maccallum, G; Lucier, M; Garriga, A; Anderson, J; Fox, K; Kelsey, S; Batalla, A; Areses, ELD; Fiol, M; Bethencourt, A; Lozano, I; Figueras, J; Cortes, JG; Jimenez, AG; Fernandez, AR; Montero, IF; Casasnovas, J; Aso, FO; de Blas, RC; Audicana, J; Errazti, IE; Montero, JS; Rohlfs, I; Pinero, C; Rodriguez, MM; Alvarez, LV; Belras, AC; Barros, S; Fernandez, JD; Tobaruela, A; Bonneau, A; Soulat, L; Lambert, Y; Caussanel, J; Livareck, B; Ramaut, C; Ricome, J; Lapostolle, F; Beruben, A; Thieleux, F; Martelli, J; Martelet, M; Mouallem, J; Ahmed, F; Galley, D; Alhabaj, S; Doucos, D; Bearez, E; Spetebroodt, S; Gully, C; Dujardin, J; Averland, B; Emmonot, B; Pollet, D; Vallet, P; Mossaz, R; Marquand, A; Kermarrec, A; Le Lay, C; Douillet, R; Olliver, L; Matas, O; Kassam, S; Halperin, F; Parsons, P; Bovak, B; Hart, B; Sussex, B; Newman, S; Gosselin, G; David, M; Sidhar, K; Wiseman, D; Lefkowitz, C; Thornley, M; Bhargava, R; McCullum, A; Grandmond, D; Carignan, D; Kouz, S; Roy, M; Polasek, P; Stedham, V; Lai, K; Paquette, B; Raco, D; Sayles, M; Sridhar, K; Wiseman, D; Tremblay, B; Darveau, C; Sussex, B; Newman, S; Senaratne, M; Holland, M; Bata, I; Hulan, M; Constance, C; Pouliot, S; Gossard, D; Day, L; Glanz, A; Vilag, C; Hui, W; Kvill, L; Dion, D; Morisette, A; Sandrin, F; Mitges, S; Cools, F; Vanhagendoren, S; De Meester, A; Marcovitch, O; Allaf, E; Gits, F; Verrostte, J; Thoeng, J; Quinonez, M; Appeltants, H; D'Hooghe, G; Eycken, M; Swennen, I; Hollanders, G; Michael, E; Decroly, P; Rombaut, E; Carlaire, D; Vermander, D; Marenne, SF; Gavray, C; Michel, P; Poth, A; Paquay, J; Lutasu, S; Dirk, D; Vermeulen, J; Govaerts, E; Boldueva, S; Sherenkov, A; Ruda, M; Kostenko, V; Tereschenko, S; Zalevsky, G; Boyarkin, M; Tankhilevitch, B; Glezer, M; Gratsiansky, N; Shlyakhto, E; Sidorenko, B; Zadiontchenko, V; Perepech, N; Gruzdev, A; Chernov, S; Pollock, B; Andresen, D; Hoffmann, S; Andresen, D; Arntz, H; Klein, H; Neuss, H; Wilhelms, E; Henzgen, R; Kuckuck, H; Darius, H; Hausdorf, C; Ochs, H; Olbrich, H; Willenbrock, R; Hepp, A; Wucherpfennig, P; Wiechmann, H; Schmidtendorf, H; Kohler, B; Sehnert, W; Ueberreiter, A; Uebis, R; Stockmann, M; Rommele, U; Meissner, A; Schneider, L; Adgey, J; McAllister, T; McEneaney, D; Mackin, A; Sulke, N; Dixon, R; Wilcox, R; Congreave, S; Flapan, A; Flint, L; Purvis, J; McCorkell, G; Stubbs, P; Steer, C; McKkee, P; Senior, R; Chester, L; Levy, T; Kennard, S; Bishop, A; Hlaing, S; de Belder, M; Cunningham, N; Gilbert, T; Young, J; Henderson, R; Falcon-Lang, D; Gershlick, A; Fairbrother, K; Rosenfeld, T; Atar, S; Lewis, B; Yuval, R; Meisel, S; Alony, I; Rozenman, Y; Logrineuko, S; Goldhammer, E; Harel, S; David, D; Erez, N; Jafari, J; Tubul, O; Marmor, A; Pritulo, L; Caspi, A; Roitberg, N; Kaluski, E; Amar, R; Tzivoni, D; Rojanski, A; Yedid-Am, S; Keren, A; Datiashvily, L; Saraiva, JK; Garcia, CT; Markman, M; Chaves, A; Vaz, RC; Dutra, O; Coelho, OR; Sciampaglia, R; da Cunha, CP; de Brito, MR; Lotufo, P; Ribeiro, E; Cicogna, A; Michalaros, YL; Ornellas, CE; Santos, SCD; Rosatelli, P; Pimentel, W; Grudzinski, M; Guimaraes, F; Gustavo, C; Moreira, M; Gosmao, J; Hertzberger, D; Schut, A; van der Zwaan, C; Havenaar, H; van Wijngaarden, J; Verheij, H; Wajon, E; Bosschaart, M; Oomen, A; Daniels, M; Coppes, A; Vergeught, F; Dieker, H; Jochemsen, D; Fijlstra, I; Leenders, C; Gelder, T; Janicke, D; Bass, J; Hamroff, G; Keeler, K; Chandra, M; Van Hoose, B; Minor, S; Mock, P; Chandra, M; Olliges, M; Unwala, A; Fisher, C; French, W; Barillas, O; Chandna, H; Holly, D; Chandna, H; Holly, D; Grewal, G; Gurnsey, L; Mehta, P; Cruse, A; Perlman, R; Palazzo, D; Puma, J; Payne, C; Torres, J; Patten, L; Lefkovic, L; Viswanathan, N; Rees, A; Yoches, A; Rodriguez-Ospina, L; Santos, J; Chohan, A; Kemp, A; Perlman, R; Palazzo, D; Weiss, R; Brennan, B; Aude, Y; Harrison, P; Brogan, G; Ayan, J; Cragg, D; Murawka, A; Garg, M; McKelvy, J; Hulyalkar, A; Kuchenrither, C; Jackson, S; Whitaker, J; Richardson, J; Vicari, R; Howard, M; Aude, Y; Harrison, P; Chadow, H; Hauptman, R; Gelormini, J; Giambra, T; Lakkis, N; Jiang, S; Hernandez, I; Vazquez, A; Rosas, EL; Lawrenz, JC; Bustamante, F; Martinez, CA; Alcocer, MA; Hernandez, EG; Dogre, CW; Bustillos, MDB; Alvarado, R; Ramirez, MC; Hinojosa, P; Rivera, OO; Pons, JL; Carrillo, J; Velasco, JA; Quintana, F; Petersen, F; Palomera, R; Ibarra, M; Sanchez, CJ; Delgado, L; Bayram, E; Machado, GM; Berli, MA; Vinuela, JC; Allall, O; Fuentealba, V; Reguero, M; Covelli, G; San Martin, E; Francia, E; Gadaleta, F; Haehnel, M; Iglesias, R; Blumberg, S; de Lima, AA; Henquin, R; Estrada, JN; de Arenaza, D; Fernandez, R; Abud, M; Becker, C; Milesi, R; Schamuck, R; Doyharzabal, JM; Caime, DG; Teresa, LC; Kuschnir, E; Sgammini, H; Sgammini, J; David, J; Sosa, CH; Redcozub, E; Avalos, V; Nul, D; Ramos, S; Castro, PT; Rodriguez, A; Sosa, C; Lopez, JG; Novo, F; Diez, F; Piraino, R; Godoy, G; Weller, C; Pomposiello, J; Sanchez, A; Karlsson, J; Collberg, K; Malmqvist, K; Cedergren, E; Dellborg, M; Coops, G; Kallryd, A; Laudon, P; Bandh, S; Andersson, C; Soome, S; Classon, H; Lugnegard, J; Ahlmark, H; Risenfors, M; Ortgren, L; Fjelstad, B; Osberg, S; Frisell, J; Sandstrom, M; Silvestri, O; Sasso, A; Rolli, A; Paoli, G; Chiarella, F; Olivotte, L; Doronzo, B; Coppolino, A; Pivoccari, G; Pesaresi, A; Ambrosio, G; Del Pinto, M; De Luca, I; Laico, M; De Ferrari, G; Baldini, E; Guiducci, U; Tortorella, G; Romano, M; Villani, R; Casazza, F; Capozi, A; Moretti, L; Del Pinto, M; Perelli, S; Sinagra, G; Maras, P; Porcu, M; Scorcu, G; Proietti, F; Severi, S; Gessek, J; Pawlowicz, L; Szelemej, R; Gorski, M; Janion, M; Sielski, J; Kleinrok, A; Rodzik, J; Hiczkiewicz, J; Pasler, MM; Soltsiak, M; Gorny, J; Huber, K; Jordanova, N; Heigert, M; Kopp, K; Frank, H; Laggner, A; Schreiber, W; Weihs, W; Drexel, MH; Doubell, A; Burgess, L; Bennett, J; Snyders, F; Ebrahim, I; Bobak, C; Marx, J; deBeer, M; Schmidt, S; Cyster, H; van der Berg, P; Groenewald, W; Herbst, L; Britz, A; Snyman, M; Schonken, M; Badenhorst, J; Blomerus, P; Mpe, M; Bobak, C; Mynhardt, J; Groenewald, C; van Dyk, C; Meiring, J; Steingo, L; Glaeser, L; Whelan, A; Tulloch, G; Gunalingham, B; Conway, B; Soward, A; Hales, S; Lefkovits, J; Sallaberger, M; Owesby, D; Kesby, J; Amerena, J; Fogarty, K; Chew, D; Austin, M; Kovaricek, S; Banham, N; Tulloch, G; Jobbagy, L; Dinnyes, J; Lippai, J; Oze, B; Szakal, I; Bartal, G; Foldi, A; Foley, D; McGrath, F; Meany, B; Geraghty, M; Daly, K; Henessey, S; Mulvihill, N; Schilling, C; Kearney, P; Kelly, P; Kearney, P; Kelly, P; Ongen, Z; Vura, A; Kozan, O; Ozaydin, E; Kultursay, H; Kayikcioglu, M; Degertekin, M; Mutlu, B; Monteiro, F; Ferreira, D; Carrageta, M		CLARITY-TIMI 28 Investigators	Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REPERFUSION THERAPY; PLASMINOGEN-ACTIVATOR; FOLLOW-UP; THROMBOLYSIS; TIMI; HEPARIN; REOCCLUSION; RATIONALE; DESIGN	BACKGROUND: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death. METHODS: We enrolled 3491 patients, 18 to 75 years of age, who presented within 12 hours after the onset of an ST-elevation myocardial infarction and randomly assigned them to receive clopidogrel (300-mg loading dose, followed by 75 mg once daily) or placebo. Patients received a fibrinolytic agent, aspirin, and when appropriate, heparin (dispensed according to body weight) and were scheduled to undergo angiography 48 to 192 hours after the start of study medication. The primary efficacy end point was a composite of an occluded infarct-related artery (defined by a Thrombolysis in Myocardial Infarction flow grade of 0 or 1) on angiography or death or recurrent myocardial infarction before angiography. RESULTS: The rates of the primary efficacy end point were 21.7 percent in the placebo group and 15.0 percent in the clopidogrel group, representing an absolute reduction of 6.7 percentage points in the rate and a 36 percent reduction in the odds of the end point with clopidogrel therapy (95 percent confidence interval, 24 to 47 percent; P<0.001). By 30 days, clopidogrel therapy reduced the odds of the composite end point of death from cardiovascular causes, recurrent myocardial infarction, or recurrent ischemia leading to the need for urgent revascularization by 20 percent (from 14.1 to 11.6 percent, P=0.03). The rates of major bleeding and intracranial hemorrhage were similar in the two groups. CONCLUSIONS: In patients 75 years of age or younger who have myocardial infarction with ST-segment elevation and who receive aspirin and a standard fibrinolytic regimen, the addition of clopidogrel improves the patency rate of the infarct-related artery and reduces ischemic complications.	Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Hosp Univ Gregorio Maranon, Madrid, Spain; Hop La Pitie Salpetriere, Inst Cardiol, Paris, France; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Univ Antwerp Hosp, Dept Cardiol, Edegem, Belgium; Acad Ziekenhuis Klina, Brasschaat, Belgium; Nottingham Clin Res Grp, Nottingham, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; General University Gregorio Maranon Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montreal; University of Antwerp	Sabatine, MS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	msabatine@partners.org	Lopez de Sa, Esteban/AAY-2627-2021; Nicolau, Jose C/E-1487-2012; Wiviott, Stephen/HIK-2534-2022; Fiol, Miguel/F-6793-2016; Claeys, Marc/ABH-8781-2020; Lenguas, José Antonio Casasnovas/F-4038-2010; Meisel, Simcha/AAH-8985-2021; Gibson, C. Michael/AAE-8212-2019; Ambrosio, Giuseppe/C-6596-2013; Kucherlapati, Raju/ABC-8807-2021; Ongen, Zeki/AAD-1179-2021; Lotufo, Paulo/A-9843-2008; KAYIKCIOGLU, Meral/AAH-6687-2020; Sinagra, Gianfranco/AAE-3943-2020; Sabatine, Marc/AAJ-6751-2020; Cannon, Christopher P/AAY-7644-2020; Kaluski, Edo/Q-1972-2019; Verheugt, F.W.A./H-8105-2014; Lima, Thaísa/AAG-6483-2021; saini, renu/GRR-2088-2022; Ardissino, Diego/AAC-4041-2022; Boldueva, Svetlana/AAH-3862-2019	Lopez de Sa, Esteban/0000-0002-3504-6901; Nicolau, Jose C/0000-0002-9680-3689; Fiol, Miguel/0000-0002-5370-1391; Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Ambrosio, Giuseppe/0000-0002-9677-980X; Lotufo, Paulo/0000-0002-4856-8450; Sabatine, Marc/0000-0002-0691-3359; Cannon, Christopher P/0000-0003-4596-2791; Kaluski, Edo/0000-0002-1400-3988; Boldueva, Svetlana/0000-0002-1898-084X; Chew, Derek/0000-0003-3593-296X; MELCHOR, LORENZO/0000-0002-8685-268X; Aylward, Philip/0000-0002-5358-8552; Claeys, Marc/0000-0002-6628-9543; Budaj, Andrzej/0000-0002-6395-2098	NHLBI NIH HHS [R01 HL072879] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072879] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2005, AM HEART J, V149, P217, DOI 10.1016/j.ahj.2004.08.038; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; Cannon CP, 1997, AM J CARDIOL, V80, P696, DOI 10.1016/S0002-9149(97)00497-9; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; DALEN JE, 1988, AM J CARDIOL, V62, P179, DOI 10.1016/0002-9149(88)90208-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Giugliano RP, 2001, AM HEART J, V141, P742, DOI 10.1067/mhj.2001.114975; Herbert JM, 1998, THROMB HAEMOSTASIS, V80, P512; Liu LS, 2000, J CARDIOVASC RISK, V7, P435; MEIJER A, 1993, CIRCULATION, V87, P1524, DOI 10.1161/01.CIR.87.5.1524; MUELLER HS, 1995, J AM COLL CARDIOL, V26, P900, DOI 10.1016/0735-1097(95)00270-1; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; Quinn MJ, 1999, CIRCULATION, V100, P1667, DOI 10.1161/01.CIR.100.15.1667; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; The GUSTO Angiographic Investigators, 1994, NEW ENGL J MED, V330, P516; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2001, LANCET, V357, P1905; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 2001, LANCET, V358, P605; YASUDA T, 1990, J AM COLL CARDIOL, V16, P1728, DOI 10.1016/0735-1097(90)90327-L; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	1357	1492	0	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1179	1189		10.1056/NEJMoa050522	http://dx.doi.org/10.1056/NEJMoa050522			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15758000				2022-12-28	WOS:000227832300004
J	Marmot, M				Marmot, M			Social determinants of health inequalities	LANCET			English	Article							MORTALITY	The gross inequalities in health that we see within and between countries present a challenge to the world. That there should be a spread of life expectancy of 48 years among countries and 20 years or more within countries is not inevitable. A burgeoning volume of research identifies social factors at the root of much of these inequalities in health. Social determinants are relevant to communicable and non-communicable disease alike. Health status, therefore, should be of concern to policy makers in every sector, not solely those involved in health policy. As a response to this global challenge, WHO is launching a Commission on Social Determinants of Health, which will review the evidence, raise societal debate, and recommend policies with the goal of improving health of the world's most vulnerable people. A major thrust of the Commission is turning public-health knowledge into political action.	UCL, Int Ctr Hlth & Soc, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Int Ctr Hlth & Soc, 1-19 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Medical Research Council [G8802774, G0100222, G19/35] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Acheson D., 1998, INEQUALITIES HLTH RE; [Anonymous], 1999, DEV FREEDOM; [Anonymous], 2002, WORLD HLTH REPORT 20; Attanasio O., 2004, EWP0406 IFS; Beaglehole R., 2003, WORLD HLTH REPORT 20; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; CROMBIE IK, 2004, CLOSING HLTH INEQUAL; *DEP HLTH, 2003, TACKL HLTH IN PROGR; Donkin A, 2002, HLTH STAT Q, V15, P5; Doyal L., 1991, THEORY HUMAN NEED, DOI DOI 10.1007/978-1-349-21500-3; Farmer P., 2003, PATHOLOGIES POWER HL; Farmer P., 1999, INFECT INEQUALITIES; Fogel RW, 2000, 4 GREAT AWAKENING FU; HOGSTEDT H, 2004, SCAN J PUBLIC HL S64, V32, P1; Hurt LS, 2004, J EPIDEMIOL COMMUN H, V58, P315, DOI 10.1136/jech.2003.007351; Kim J. Y., 2000, DYING GROWTH GLOBAL; KINSELLA K, 2001, US CENS BUR AG WORLD; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Marmot M, 2004, STATUS SYNDROME; MURRAY CJL, 1998, US PATTERNS MORTALIT; *OAB TORR STRAIT C, STAT HUM RIGHTS EQ O; Plavinski SL, 2003, BRIT MED J, V326, P1240, DOI 10.1136/bmj.326.7401.1240; Rose G., 1992, STRATEGY PREVENTIVE; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1995, MORTALITY INDICATOR; STIGLITZ JE, 2002, GLOBALIZATION ITS DI; *UN, 2004, HUM DEV REP 2004; *UN DEV PROGR, 2003, HUM DEV REP; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Whitehead M, 1990, CONCEPTS PRINCIPLES; *WHO, 2003, TREAT 3 MILL 2005 MA; Wilkinson R, 2005, IMPACT INEQUALITY MA; WILKISNON R, 2003, SOLID FACTS; World Health Organization, 2004, WORLD HLTH REP 2004	35	2544	2608	12	539	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1099	1104		10.1016/S0140-6736(05)71146-6	http://dx.doi.org/10.1016/S0140-6736(05)71146-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781105	Green Submitted			2022-12-28	WOS:000227731800034
J	Kemp, M				Kemp, M			From science in art to the art of science	NATURE			English	Article									Univ Oxford, Oxford OX1 2JD, England; Wallace Kemp Artakt, London, England	University of Oxford	Kemp, M (corresponding author), Univ Oxford, Oxford OX1 2JD, England.							KEMP M, 2002, NATURE, V416, P265; KEMP M, 2000, VISUALIZATIONS NATUR, P144; KEMP M, 2000, NATURE, V404, P546; KEMP M, 2002, NATURE, V419, P882; KEMP M, 2001, NATURE, V413, P778; KEMP M, 2000, VISUALIZATIONS NATUR, P1; KEMP M, 2004, NATURE, V430, P969; KEMP M, 2003, NATURE, V424, P181; KEMP M, 2004, NATURE, V428, P803	9	19	19	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					308	309		10.1038/434308a	http://dx.doi.org/10.1038/434308a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772646				2022-12-28	WOS:000227715100035
J	Lightman, A				Lightman, A			A tale of two loves	NATURE			English	Article									MIT, Boston, MA USA	Massachusetts Institute of Technology (MIT)	Lightman, A (corresponding author), MIT, Boston, MA USA.								0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					299	300		10.1038/434299a	http://dx.doi.org/10.1038/434299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772644				2022-12-28	WOS:000227715100033
J	Escobar-Morreale, HF; Botella-Carretero, JI; Gomez-Bueno, M; Galan, JM; Barrios, V; Sancho, J				Escobar-Morreale, HF; Botella-Carretero, JI; Gomez-Bueno, M; Galan, JM; Barrios, V; Sancho, J			Thyroid hormone replacement therapy in primary hypothyroidism: A Randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone	ANNALS OF INTERNAL MEDICINE			English	Article							NOTTINGHAM HEALTH PROFILE; QUALITY-OF-LIFE; SPANISH VERSION; THYROIDECTOMIZED RATS; TRIIODOTHYRONINE; LEVOTHYROXINE; BIOAVAILABILITY; QUESTIONNAIRE; EUTHYROIDISM; CARCINOMA	Background: Substituting part of the dose of L-thyroxine with small but supraphysiologic doses of liothyronine in hypothyroid patients has yielded conflicting results. Objective: To evaluate combinations of L-thyroxine plus liothyronine in hypothyroid patients that match the proportions present in normal secretions of the human thyroid gland. Design: Randomized, double-blind, crossover trial. Setting: Academic research hospital. Participants: 28 women with overt primary hypothyroidism. Intervention: Crossover trial comparing treatment with L-thyroxine, 100 mu g/d (standard treatment), versus treatment with L-thyroxine, 75 mu g/d, plus liothyronine, 5 mu g/d (combination treatment), for 8-week periods. All patients also received L-thyroxine, 87.5 mu g/d, plus liothyronine, 7.5 mu g/d (add-on combination treatment), for a final 8-week add-on period. Measurements: Primary outcomes included serum thyroid hormone levels, results of quality-of-life and psychometric tests, and patients' preference. Multiple biological thyroid hormone end points were studied as secondary outcomes. Results: Compared with standard treatment, combination treatment led to lower free thyroxine levels (decrease, 3.9 pmol/L [95% CI, 2.5 to 5.3 pmol/L]), slightly higher serum levels of thyroid-stimulating hormone (increase, 0.62 mU/L [CI, 0.01 to 1.23 mU/L]), and unchanged free triiodothyronine levels. No improvement was observed in the other primary and secondary end points after combination treatment, with the exception of the Digit Span Test, in which the mean backward score and the mean total score increased slightly (0.6 digit [CI, 0.1 to 1.0 digit] and 0.8 digit [CI, 0.2 to 1.4 digits], respectively). The add-on combination treatment resulted in overreplacement. Levels of thyroidstimulating hormone decreased by 0.85 mU/L (CI, 0.27 to 1.43 mU/L and serum free triiodothyronine levels increased by 0.8 pmol/L (CI, 0.1 to 1.5 pmol/L compared with standard treatment; 10 patients had levels of thyroid-stimulating hormone that were below the normal range. Twelve patients preferred combination treatment, 6 patients preferred the add-on combination treatment, 2 patients preferred standard treatment, and 6 patients had no preference (P = 0.015). Limitations: Treatment with L-thyroxine, 87.5 mu g/d, plus liothyronine, 7.5 mu g/d, was an add-on regimen and was not randomized. Conclusions: Physiologic combinations of L-thyroxine plus liothyronine do not offer any objective advantage over L-thyroxine alone, yet patients prefer combination treatment.	Hosp Ramon & Cajal, Dept Endocrinol, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Escobar-Morreale, HF (corresponding author), Hosp Ramon & Cajal, Dept Endocrinol, Carretera Colmenar Km 91, E-28034 Madrid, Spain.	hescobarm.hrc@salud.madrid.org	Botella-Carretero, Jose I./DGQ-8720-2022; Escobar-Morreale, Héctor F/G-5468-2010; Sancho, Juan J/H-1771-2013; SANCHO-INSENSER, JUAN-JOSE/AAH-8777-2021	Escobar-Morreale, Héctor F/0000-0002-6890-1644; Gomez-Bueno, Manuel/0000-0002-9764-7518; Botella-Carretero, Jose I./0000-0002-6425-2747				Alonso J, 1998, MED CLIN-BARCELONA, V111, P410; ALONSO J, 1990, AM J PUBLIC HEALTH, V80, P704, DOI 10.2105/AJPH.80.6.704; ALONSO J, 1994, QUAL LIFE RES, V3, P385, DOI 10.1007/BF00435390; Botella-Carretero JI, 2004, ENDOCR-RELAT CANCER, V11, P345, DOI 10.1677/erc.0.0110345; Botella-Carretero JI, 2003, ENDOCR-RELAT CANCER, V10, P601, DOI 10.1677/erc.0.0100601; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Bunevicius R, 2000, INT J NEUROPSYCHOPH, V3, P167, DOI 10.1017/S1461145700001826; Bunevicius R, 2002, ENDOCRINE, V18, P129, DOI 10.1385/ENDO:18:2:129; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Celesia G G, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P53; Clyde PW, 2003, JAMA-J AM MED ASSOC, V290, P2952, DOI 10.1001/jama.290.22.2952; Cooper DS, 2003, JAMA-J AM MED ASSOC, V290, P3002, DOI 10.1001/jama.290.22.3002; DEESCOBAR GM, 1976, REGULATION THYROID F, V1, P109; Escobar-Morreale HF, 1999, BIOCHIMIE, V81, P453, DOI 10.1016/S0300-9084(99)80095-9; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; EscobarMorreale HF, 1995, J CLIN INVEST, V96, P2828, DOI 10.1172/JCI118353; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; FLEISS JL, 1986, CROSSOVER STUDY, P263; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Hennemann G, 2004, THYROID, V14, P271, DOI 10.1089/105072504323030924; KAPLAN E, 1991, WAIS R NI NEUROPSYCH; Kaplan MM, 2003, J CLIN ENDOCR METAB, V88, P4540, DOI 10.1210/jc.2003-031436; Ladenson PW, 2002, CLIN ENDOCRINOL, V57, P575, DOI 10.1046/j.1365-2265.2002.01682.x; LEBOFF MS, 1982, METABOLISM, V31, P900, DOI 10.1016/0026-0495(82)90179-2; McNair D.M., 1992, POMS MANUAL PROFILE; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; PILO A, 1990, AM J PHYSIOL, V258, pE715, DOI 10.1152/ajpendo.1990.258.4.E715; Pratt H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P69; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P4551, DOI 10.1210/jc.2003-030139; Siegmund W, 2004, CLIN ENDOCRINOL, V60, P750, DOI 10.1111/j.1365-2265.2004.02050.x; SMITH RN, 1970, BRIT MED J, V4, P145, DOI 10.1136/bmj.4.5728.145; Toft AD, 1999, NEW ENGL J MED, V340, P469, DOI 10.1056/NEJM199902113400611; Tudor G, 1994, Stat Methods Med Res, V3, P345, DOI 10.1177/096228029400300404; Utiger RD, 1995, ENDOCRINOLOGY, P752; Walsh JP, 2003, J CLIN ENDOCR METAB, V88, P4543, DOI 10.1210/jc.2003-030249; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wechsler D, 2003, WAIS 3 ESCALA INTELI; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	40	110	115	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					412	424		10.7326/0003-4819-142-6-200503150-00007	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767619				2022-12-28	WOS:000227621100003
J	Walther, P; Resch, KJ; Rudolph, T; Schenck, E; Weinfurter, H; Vedral, V; Aspelmeyer, M; Zeilinger, A				Walther, P; Resch, KJ; Rudolph, T; Schenck, E; Weinfurter, H; Vedral, V; Aspelmeyer, M; Zeilinger, A			Experimental one-way quantum computing	NATURE			English	Article							COMPUTATION; ENTANGLEMENT; INFORMATION; SEPARABILITY; STATES	Standard quantum computation is based on sequences of unitary quantum logic gates that process qubits. The one-way quantum computer proposed by Raussendorf and Briegel is entirely different. It has changed our understanding of the requirements for quantum computation and more generally how we think about quantum physics. This new model requires qubits to be initialized in a highly entangled cluster state. From this point, the quantum computation proceeds by a sequence of single-qubit measurements with classical feedforward of their outcomes. Because of the essential role of measurement, a one-way quantum computer is irreversible. In the one-way quantum computer, the order and choices of measurements determine the algorithm computed. We have experimentally realized four-qubit cluster states encoded into the polarization state of four photons. We characterize the quantum state fully by implementing experimental four-qubit quantum state tomography. Using this cluster state, we demonstrate the feasibility of one-way quantum computing through a universal set of one-and two-qubit operations. Finally, our implementation of Grover's search algorithm demonstrates that one-way quantum computation is ideally suited for such tasks.	Univ Vienna, Inst Expt Phys, A-1090 Vienna, Austria; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, QOLS, London SW7 2BW, England; Univ Munich, Dept Phys, D-80799 Munich, Germany; Max Planck Inst Quantum Opt, D-85741 Garching, Germany; Erwin Schrodinger Inst Math Phys, A-1090 Vienna, Austria; Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; Austrian Acad Sci, IQOQI, A-1090 Vienna, Austria; Ecole Normale Super, F-75005 Paris, France	University of Vienna; Imperial College London; University of Munich; Max Planck Society; University of Leeds; Austrian Academy of Sciences; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Walther, P (corresponding author), Univ Vienna, Inst Expt Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	pwalther@quantum.at; zeilinger-office@quantum.at	Walther, Philip/O-2993-2019; Weinfurter, Harald/F-8225-2015; Aspelmeyer, Markus/C-4098-2017; vedral, vlatko/P-1712-2014; Zeilinger, Anton/A-1170-2011; Vedral, Vlatko/L-3270-2016; Walther, Philip/D-6346-2018; Rudolph, Terence/B-2300-2008	Walther, Philip/0000-0002-4964-817X; Weinfurter, Harald/0000-0001-6882-3909; Aspelmeyer, Markus/0000-0003-4499-7335; Vedral, Vlatko/0000-0002-8588-2940; Walther, Philip/0000-0002-4964-817X; Rudolph, Terence/0000-0002-1678-3893	Engineering and Physical Sciences Research Council [GR/S51226/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahn J, 2000, SCIENCE, V287, P463, DOI 10.1126/science.287.5452.463; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bhattacharya N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137901; Biham E, 2004, THEOR COMPUT SCI, V320, P15, DOI 10.1016/j.tcs.2004.03.041; Braunstein S, 2000, FORTSCHR PHYS, V48, P767; BROWN DE, 2004, EFFICIENT LINEAR OPT; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; Coffman V, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.052306; Deutsch D, 1998, PHYS WORLD, V11, P47; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Dur W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.180403; Ekert A, 1998, PHILOS T R SOC A, V356, P1769, DOI 10.1098/rsta.1998.0248; Gasparoni S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020504; Greenberger D. M., 1989, BELLS THEOREM QUANTU; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Horodecki M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047902; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; HORODECKI R, 1995, PHYS LETT A, V200, P340, DOI 10.1016/0375-9601(95)00214-N; Hradil Z, 1997, PHYS REV A, V55, pR1561, DOI 10.1103/PhysRevA.55.R1561; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Jones JA, 1998, NATURE, V393, P344, DOI 10.1038/30687; Josza R., 2003, P ROY SOC LOND A MAT, V459, P2011; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Linden N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047901; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; NIELSEN M. A., 2004, FAULT TOLERANT QUANT; Nielsen MA, 2003, PHYS LETT A, V308, P96, DOI 10.1016/S0375-9601(02)01803-0; Nielsen MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040503; O'Brien JL, 2003, NATURE, V426, P264, DOI 10.1038/nature02054; Peres A, 1996, PHYS REV LETT, V77, P1413, DOI 10.1103/PhysRevLett.77.1413; Pittman TB, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.032316; Raussendorf R, 2002, QUANTUM INFORM COMPU, V2, P443; Raussendorf R, 2002, J MOD OPTIC, V49, P1299, DOI 10.1080/09500340110107487; Raussendorf R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022312; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Sanaka K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017902; SCHUMACHER B, 1995, PHYS REV A, V51, P2738, DOI 10.1103/PhysRevA.51.2738; SHOR PW, 1994, AN S FDN CO, P124; TOTH G, 2004, DETECTING GENUINE MU; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552; Weinstein YS, 2004, J CHEM PHYS, V121, P6117, DOI 10.1063/1.1785151; Zeilinger A., 1992, NASA C PUBLICATION, V3135	50	879	912	6	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					169	176		10.1038/nature03347	http://dx.doi.org/10.1038/nature03347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758991	Green Submitted			2022-12-28	WOS:000227494500035
J	Weiss, G; Goodnough, LT				Weiss, G; Goodnough, LT			Medical progress: Anemia of chronic disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RECOMBINANT-HUMAN-ERYTHROPOIETIN; NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; SERUM TRANSFERRIN RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; SQUAMOUS-CELL CARCINOMA; BODY IRON STORES; INTRAVENOUS IRON; CANCER-PATIENTS; HEMODIALYSIS-PATIENTS		Med Univ Innsbruck, Dept Gen Internal Med Clin Immunol & Infect Dis, A-6020 Innsbruck, Austria; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA	Medical University of Innsbruck; Stanford University; Stanford University	Weiss, G (corresponding author), Med Univ Innsbruck, Dept Gen Internal Med Clin Immunol & Infect Dis, Anichstr 35, A-6020 Innsbruck, Austria.	guenter.weiss@uibk.ac.at	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Weiss, Guenter/0000-0003-0709-2158				Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Acs G, 2001, CANCER RES, V61, P3561; Adamson JW, 1998, NEW ENGL J MED, V339, P625, DOI 10.1056/NEJM199808273390910; Aguilera Abelardo, 2002, Adv Perit Dial, V18, P200; ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; Arcasoy MO, 2002, LAB INVEST, V82, P911, DOI 10.1097/01.LAB.0000020415.72863.40; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; BAROSI G, 1994, ANN HEMATOL, V68, P215, DOI 10.1007/BF01737420; BEGUIN Y, 1993, BLOOD, V81, P1067; Bennett CL, 2004, NEW ENGL J MED, V351, P1403, DOI 10.1056/NEJMoa040528; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; Cazzola M, 1996, BLOOD, V87, P4824, DOI 10.1182/blood.V87.11.4824.bloodjournal87114824; Cella D, 2003, ANN ONCOL, V14, P511, DOI 10.1093/annonc/mdg167; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; Cooper AC, 2003, J AM SOC NEPHROL, V14, P1776, DOI 10.1097/01.ASN.0000071514.36428.61; DENZ H, 1992, EUR J HAEMATOL, V48, P244; Dunn A, 2003, J PAIN SYMPTOM MANAG, V26, P1132, DOI 10.1016/j.jpainsymman.2003.04.001; Eschbach JW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016440.52271.F7; FROST AE, 1993, TRANSPLANTATION, V56, P1008; Gasche C, 2001, AM J GASTROENTEROL, V96, P2382; Glaser CM, 2001, INT J RADIAT ONCOL, V50, P705, DOI 10.1016/S0360-3016(01)01488-2; Goodnough LT, 2003, ARCH INTERN MED, V163, P1820; Goodnough LT, 2001, NEW ENGL J MED, V345, P1272, DOI 10.1056/NEJM200110253451711; Goodnough LT, 2000, BLOOD, V96, P823, DOI 10.1182/blood.V96.3.823.015k49_823_833; Gordeuk VR, 2001, J CLIN VIROL, V20, P111, DOI 10.1016/S1386-6532(00)00134-7; Groopman, 2000, JNCI-J NATL CANCER I, V92, P497; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Harrison L, 2001, SEMIN ONCOL, V28, P54, DOI 10.1053/sonc.2001.25399; Heeschen, 2004, BLOOD, V103, P4388; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; HENRY D, 1995, BLOOD, V85, P1676, DOI 10.1182/blood.V85.6.1676.bloodjournal8561676; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kaltwasser JP, 2001, J RHEUMATOL, V28, P2430; Kletzmayr J, 2002, NEPHROL DIAL TRANSPL, V17, P962, DOI 10.1093/ndt/17.6.962; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; LIPSCHITZ DA, 1974, NEW ENGL J MED, V290, P1213, DOI 10.1056/NEJM197405302902201; Littlewood TJ, 2001, J CLIN ONCOL, V19, P2865, DOI 10.1200/JCO.2001.19.11.2865; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1666, DOI 10.1093/ndt/gfh314; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; LUDWIG H, 1994, BLOOD, V84, P1056, DOI 10.1182/blood.V84.4.1056.bloodjournal8441056; LUDWIG H, 1990, NEW ENGL J MED, V322, P1693, DOI 10.1056/NEJM199006143222402; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; MACIEJEWSKI JP, 1995, J CLIN INVEST, V96, P1085, DOI 10.1172/JCI118094; Maheshwari A, 2004, LIVER TRANSPLANT, V10, P165, DOI 10.1002/lt.20031; Mast AE, 1998, CLIN CHEM, V44, P45; MATZNER Y, 1979, GERONTOLOGY, V25, P113, DOI 10.1159/000212328; Maury CPJ, 2003, ARTHRITIS RHEUM-US, V48, P3068, DOI 10.1002/art.11294; Means Robert T Jr, 2003, Curr Hematol Rep, V2, P116; MEANS RT, 1991, BLOOD, V78, P2564; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; MOLDAWER LL, 1989, FASEB J, V3, P1637, DOI 10.1096/fasebj.3.5.2784116; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Moreno F, 2000, J AM SOC NEPHROL, V11, P335, DOI 10.1681/ASN.V112335; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Muller HM, 2001, CLIN TRANSPLANT, V15, P343, DOI 10.1034/j.1399-0012.2001.150507.x; Murphy ST, 2000, SEMIN NEPHROL, V20, P350; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nissenson AR, 2003, ARCH INTERN MED, V163, P1400, DOI 10.1001/archinte.163.12.1400; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pietrangelo A, 2002, AM J PHYSIOL-GASTR L, V282, pG403, DOI 10.1152/ajpgi.00404.2001; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Rizzo JD, 2002, J CLIN ONCOL, V20, P4083, DOI 10.1200/JCO.2002.07.177; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Salvarani C, 1996, RHEUMATOL INT, V16, P45, DOI 10.1007/BF01816434; Spivak JL, 2002, ONCOLOGY-NY, V16, P25; Stenvinkel P, 2001, NEPHROL DIAL TRANSPL, V16, P36, DOI 10.1093/ndt/16.suppl_7.36; STEVENS RG, 1988, NEW ENGL J MED, V319, P1047, DOI 10.1056/NEJM198810203191603; Sullivan JL, 1999, KIDNEY INT, V55, pS135, DOI 10.1046/j.1523-1755.1999.055Suppl.69135.x; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Taniguchi S, 1997, BLOOD, V90, P2244, DOI 10.1182/blood.V90.6.2244.2244_2244_2252; Teehan GS, 2004, CLIN INFECT DIS, V38, P1090, DOI 10.1086/382878; Thompson JA, 2000, BLOOD, V95, P1175, DOI 10.1182/blood.V95.4.1175.004k51_1175_1179; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; van Iperen CE, 2001, BRIT J HAEMATOL, V115, P739, DOI 10.1046/j.1365-2141.2001.03167.x; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; WANG CQ, 1995, J CELL PHYSIOL, V162, P134, DOI 10.1002/jcp.1041620116; Weinberg ED, 1999, EMERG INFECT DIS, V5, P346, DOI 10.3201/eid0503.990305; Weiss G, 2003, KIDNEY INT, V64, P572, DOI 10.1046/j.1523-1755.2003.00099.x; Weiss G, 2002, EUR J CLIN INVEST, V32, P70, DOI 10.1046/j.1365-2362.2002.0320s1070.x; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193; Westenfelder C, 2000, KIDNEY INT, V58, P647, DOI 10.1046/j.1523-1755.2000.00211.x; Wilson A, 2004, AM J MED, V116, P44, DOI 10.1016/j.amjmed.2003.12.011; Winn RJ, 2000, ONCOLOGY-NY, V14, P26; YAP GS, 1994, INFECT IMMUN, V62, P357, DOI 10.1128/IAI.62.2.357-362.1994; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yasuda Y, 2003, CARCINOGENESIS, V24, P1567, DOI 10.1093/carcin/bgg126; 2001, AM J KIDNEY DIS, V38, P442	102	2170	2335	4	154	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					1011	1023		10.1056/NEJMra041809	http://dx.doi.org/10.1056/NEJMra041809			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758012				2022-12-28	WOS:000227491200010
J	Hay, RJ				Hay, RJ			Mucormycosis: an infectious complication of traumatic injury	LANCET			English	Editorial Material							ZYGOMYCOSIS; COMBINATION; PATIENT		Queens Univ Belfast, Fac Med & Hlth Sci, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Hay, RJ (corresponding author), Queens Univ Belfast, Fac Med & Hlth Sci, Belfast BT9 7BL, Antrim, North Ireland.	r.hay@qub.ac.uk						Carter JE, 2003, CUTIS, V72, P221; Chakrabarti A, 2001, J INFECTION, V42, P261, DOI 10.1053/jinf.2001.0831; Chaney S, 2004, SOUTH MED J, V97, P683, DOI 10.1097/00007611-200407000-00014; COCANOUR CS, 1992, J TRAUMA, V32, P12, DOI 10.1097/00005373-199201000-00003; Dannaoui E, 2002, ANTIMICROB AGENTS CH, V46, P2708, DOI 10.1128/AAC.46.8.2708-2711.2002; Gleissner B, 2004, LEUKEMIA LYMPHOMA, V45, P1351, DOI 10.1080/10428190310001653691; Lithander J, 2001, BRIT J OPHTHALMOL, V85, P374, DOI 10.1136/bjo.85.3.371d; Maravi-Poma E, 2004, INTENS CARE MED, V30, P724, DOI 10.1007/s00134-003-2132-1; PATINO JF, 1991, WORLD J SURG, V15, P240, DOI 10.1007/BF01659059; Rickerts V, 2001, EUR J CLIN MICROBIOL, V20, P744, DOI 10.1007/s100960100599; Verma A, 2004, BONE MARROW TRANSPL, V33, P1065, DOI 10.1038/sj.bmt.1704485	11	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					830	831		10.1016/S0140-6736(05)71020-5	http://dx.doi.org/10.1016/S0140-6736(05)71020-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752513				2022-12-28	WOS:000227444600008
J	Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G				Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G			Life at depth: Photobacterium profundum genome sequence and expression analysis	SCIENCE			English	Article							VIBRIO-CHOLERAE; PRESSURE; CHROMOSOMES; PATHOGEN; BACTERIA; DISTINCT; STRESS; GROWTH	Deep-sea life requires adaptation to high pressure, an extreme yet common condition given that oceans cover 70% of Earth's surface and have an average depth of 3800 meters. Survival at such depths requires specific adaptation but, compared with other extreme conditions, high pressure has received little attention. Recently, Photobacterium profundum strain SS9 has been adopted as a model for piezophily. Here we report its genome sequence (6.4 megabase pairs) and transcriptome analysis. The results provide a first glimpse into the. molecular basis for life in the largest portion of the biosphere, revealing high metabolic versatility.	Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Padua; University of Padua; University of California System; University of California San Diego; Scripps Institution of Oceanography	Valle, G (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Via Bassi 58-B, I-35131 Padua, Italy.	giorgio.valle@unipd.it	VEZZI, ALESSANDRO/AAB-7686-2022; Romualdi, Chiara/K-1132-2016; Campanaro, Stefano/I-5657-2019; Vitulo, Nicola/GVT-2319-2022; Lauro, Federico/X-2420-2019	VEZZI, ALESSANDRO/0000-0002-8629-6644; Romualdi, Chiara/0000-0003-4792-9047; Lauro, Federico/0000-0002-8373-1014; simionati, barbara/0000-0002-0522-0737; Vitulo, Nicola/0000-0002-9571-0747; CAMPANARO, STEFANO/0000-0002-9431-1648; Cestaro, Alessandro/0000-0003-1439-5165; VALLE, GIORGIO/0000-0003-4377-5685				Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Egan ES, 2003, CELL, V114, P521, DOI 10.1016/S0092-8674(03)00611-1; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawano H, 2003, BIOSCI BIOTECH BIOCH, V67, P1983, DOI 10.1271/bbb.67.1983; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Pruss BM, 1999, J BACTERIOL, V181, P2624; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Varela C, 2003, APPL MICROBIOL BIOT, V60, P547, DOI 10.1007/s00253-002-1120-7; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; YAYANOS AA, 1986, P NATL ACAD SCI USA, V83, P9542, DOI 10.1073/pnas.83.24.9542	18	204	824	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1459	1461		10.1126/science.1103341	http://dx.doi.org/10.1126/science.1103341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746425				2022-12-28	WOS:000227503100044
J	Flannigan, DJ; Suslick, KS				Flannigan, DJ; Suslick, KS			Plasma formation and temperature measurement during single-bubble cavitation	NATURE			English	Article							SONOLUMINESCING BUBBLE; EMISSION; ARGON	Single-bubble sonoluminescence (SBSL1-5) results from the extreme temperatures and pressures achieved during bubble compression; calculations have predicted(6,7) the existence of a hot, optically opaque plasma core(8) with consequent bremsstrahlung radiation(9,10). Recent controversial reports(11,12) claim the observation of neutrons from deuterium - deuterium fusion during acoustic cavitation(11,12.) However, there has been previously no strong experimental evidence for the existence of a plasma during single- or multi-bubble sonoluminescence. SBSL typically produces featureless emission spectra(13) that reveal little about the intra-cavity physical conditions or chemical processes. Here we report observations of atomic (Ar) emission and extensive molecular (SO) and ionic (O-2(+)) progressions in SBSL spectra from concentrated aqueous H2SO4 solutions. Both the Ar and SO emission permit spectroscopic temperature determinations, as accomplished for multi-bubble sonoluminescence with other emitters(14-16). The emissive excited states observed from both Ar and O-2(+) are inconsistent with any thermal process. The Ar excited states involved are extremely high in energy (> 13 eV) and cannot be thermally populated at the measured Ar emission temperatures (4,000 - 15,000 K); the ionization energy of O-2 is more than twice its bond dissociation energy, so O-2(+) likewise cannot be thermally produced. We therefore conclude that these emitting species must originate from collisions with high-energy electrons, ions or particles from a hot plasma core.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Suslick, KS (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	ksuslick@uiuc.edu	Suslick, Kenneth S/A-1841-2010; Flannigan, David/E-4449-2014	Suslick, Kenneth S/0000-0001-5422-0701; Flannigan, David/0000-0002-1829-1868				Ajello JM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000122; BARBER BP, 1992, PHYS REV LETT, V69, P3839, DOI 10.1103/PhysRevLett.69.3839; Brenner MP, 2002, REV MOD PHYS, V74, P425, DOI 10.1103/RevModPhys.74.425; Burnett PDS, 2001, J QUANT SPECTROSC RA, V71, P215, DOI 10.1016/S0022-4073(01)00069-3; Camara C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.124301; COOPER R, 1977, J PHYS CHEM-US, V81, P2215, DOI 10.1021/j100539a001; Didenko YT, 2000, PHYS REV LETT, V84, P777, DOI 10.1103/PhysRevLett.84.777; Didenko YT, 2002, NATURE, V418, P394, DOI 10.1038/nature00895; Didenko YT, 2000, NATURE, V407, P877, DOI 10.1038/35038020; FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397; GAITAN DF, 1992, J ACOUST SOC AM, V91, P3166, DOI 10.1121/1.402855; Gompf B, 1997, PHYS REV LETT, V79, P1405, DOI 10.1103/PhysRevLett.79.1405; GREENEWALT CH, 1925, J IND ENG CHEM, V17, P522; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; HILLER R, 1994, SCIENCE, V266, P248, DOI 10.1126/science.266.5183.248; Lohse D, 1997, PHYS REV LETT, V78, P1359, DOI 10.1103/PhysRevLett.78.1359; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398; Moss WC, 1999, PHYS REV E, V59, P2986, DOI 10.1103/PhysRevE.59.2986; SCHAPPE RS, 1988, PHYS REV A, V38, P4537, DOI 10.1103/PhysRevA.38.4537; Taleyarkhan RP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036109; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; Toegel R, 2003, J CHEM PHYS, V118, P1863, DOI 10.1063/1.1531610; TOURIN R, 1966, SPECTROSCOPIC GAS TE; Troia A., 2003, WORLD C ULTR, P1041; Vazquez G, 2001, OPT LETT, V26, P575, DOI 10.1364/OL.26.000575; WIESE WL, 1989, PHYS REV A, V39, P2461, DOI 10.1103/PhysRevA.39.2461; Yasui K, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.035301; Yasui K, 1999, PHYS REV E, V60, P1754, DOI 10.1103/PhysRevE.60.1754; Zeldovich Ya.B, 1966, PHYS SHOCK WAVES HIG, VI	30	468	486	6	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					52	55		10.1038/nature03361	http://dx.doi.org/10.1038/nature03361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744295	Green Published			2022-12-28	WOS:000227334600039
J	Kesselheim, AS; Brennan, TA				Kesselheim, AS; Brennan, TA			Overbilling vs. downcoding - The battle between physicians and insurers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				*OFF INSP GEN, 1992, FRAGM PHYS CLAIMS	1	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					855	857		10.1056/NEJMp058011	http://dx.doi.org/10.1056/NEJMp058011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745973				2022-12-28	WOS:000227310700001
J	Muss, HB; Woolf, S; Berry, D; Cirrincione, C; Weiss, RB; Budman, D; Wood, WC; Henderson, IC; Hudis, C; Winer, E; Cohen, H; Wheeler, J; Norton, L				Muss, HB; Woolf, S; Berry, D; Cirrincione, C; Weiss, RB; Budman, D; Wood, WC; Henderson, IC; Hudis, C; Winer, E; Cohen, H; Wheeler, J; Norton, L		Canc Leukemia Grp B	Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED-TRIAL; ELDERLY-PATIENTS; DOSE-INTENSITY; CYCLOPHOSPHAMIDE; METHOTREXATE; TOXICITY; AGE; FLUOROURACIL; THERAPY; COMORBIDITY	Context Adjuvant chemotherapy improves survival for patients with local-regional breast cancer, but healthy older patients at high risk of recurrence are frequently not offered adjuvant chemotherapy, and the benefit of adjuvant chemotherapy in older patients is uncertain. Objective To compare the benefits and toxic effects of adjuvant chemotherapy among breast cancer patients in age groups of 50 years or younger, 51 to 64 years, and 65 years or older. Design and Setting Retrospective review of data from 4 randomized trials that accrued patients from academic and community medical centers between 1975 and 1999. Median follow-up for all patients was 9.6 years. All trials randomized patients to different regimens, doses, schedules, and durations of chemotherapy and all had a treatment arm with doses or schedules that were regarded to be "high" and potentially more toxic. Patients A total of 6487 women with lymph node-positive breast cancer; 542 (8%) patients were 65 years or older and 159 (2 %) were 70 years or older. Main Outcome Measure Comparison of disease-free survival, overall survival, and treatment-related mortality among different age groups. Results Multivariate analysis showed that smaller tumor size, fewer positive lymph nodes, more chemotherapy, and tamoxifen use were all significantly (P<.001) related to longer disease-free and overall survival. There was no association between age and disease-free survival. Overall survival was significantly (P<.001) worse for patients aged 65 or older because of death from causes other than breast cancer. Thirty-three deaths (0.5% of all patients) were attributed to treatment, and older women had higher treatment-related mortality. Older women and younger women derived Similar reductions in breast cancer mortality and recurrence from regimens containing more chemotherapy. Conclusion Age alone should not be a contraindication to the use of optimal chemotherapy regimens in older women who are in good general health.	Univ Vermont, Vermont Canc Ctr, Fletcher Allen Hlth Care, Burlington, VT 05401 USA; Canc & Leukemia Grp B Stat Ctr, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; Vet Adm Med Ctr, Durham, NC USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; NYU, N Shore Univ Hosp, Manhasset, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Emory Univ, Sch Med, Atlanta, GA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Vermont; University of Vermont Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; UTMD Anderson Cancer Center; Georgetown University; New York University; Northwell Health; North Shore University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Emory University; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center	Muss, HB (corresponding author), Univ Vermont, Vermont Canc Ctr, Fletcher Allen Hlth Care, UHC Campus,St Joseph 3400,1 S Prospect St, Burlington, VT 05401 USA.	hyman.muss@uvm.edu	Hudis, Clifford/AAW-9482-2021	Hudis, Clifford/0000-0001-7144-8791; Norton, Larry/0000-0003-3701-9250	NATIONAL CANCER INSTITUTE [U10CA060247, U10CA060138, U10CA016450, U10CA047555, U10CA045389, U10CA037135, U10CA008025, U10CA047559, U10CA074811, U10CA004326, U10CA047577, U10CA035279, U10CA035421, U10CA011028, U10CA007968, U10CA031946, U10CA045564, U10CA045808, U10CA077597, U10CA077298, U10CA026806, U10CA011789, U10CA031983, U10CA031809, U10CA025224, U10CA045374, U10CA033601, U10CA012046, U10CA021060, U10CA052784, U10CA041287, U10CA003927, U10CA054697, U10CA012011, U10CA077406, U10CA012449, U10CA035091, U10CA077651, U10CA032291, U10CA032102, U10CA002599, U10CA047642, U10CA004457, U10CA047545, U10CA021115, U10CA045418] Funding Source: NIH RePORTER; NCI NIH HHS [CA02599, CA03927, CA04326, CA04457, CA07968, CA08025, CA11028, CA11789, CA12011, CA12046, CA12449, CA16450, CA21060, CA21115, CA25224, CA26806, CA31809, CA31946, CA31983, CA32102, CA32291, CA33601, CA35091, CA35279, CA35421, CA37135, CA41287, CA45374, CA45389, CA45418, CA45564, CA45808, CA47515, CA47545, CA47555, CA47559, CA47577, CA47642, CA52784, CA54697, CA60138, CA60247, CA71323, CA74811, CA77298, CA77406, CA77440, CA77597, CA77651] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 1998, LANCET, V352, P930; *AM JOINT COMM CAN, 1997, CANC STAG MAN; BEGG CB, 1980, CANCER CLIN TRIALS, V3, P369; BONNETERRE JM, 2002, P AN M AM SOC CLIN, V21, pA39; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; CHRISTMAN K, 1992, JAMA-J AM MED ASSOC, V268, P57, DOI 10.1001/jama.268.1.57; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clarke M, 1998, LANCET, V351, P1451; Crivellari D, 2000, J CLIN ONCOL, V18, P1412, DOI 10.1200/JCO.2000.18.7.1412; Dees EC, 2000, CANCER INVEST, V18, P521, DOI 10.3109/07357900009012191; DESCH CE, 1993, J CLIN ONCOL, V11, P777, DOI 10.1200/JCO.1993.11.4.777; Du XLL, 2003, ANN INTERN MED, V138, P90, DOI 10.7326/0003-4819-138-2-200301210-00009; Du XLL, 2002, J CLIN ONCOL, V20, P4636, DOI 10.1200/JCO.2002.05.088; Extermann M, 2000, J CLIN ONCOL, V18, P1709, DOI 10.1200/JCO.2000.18.8.1709; GELMAN RS, 1984, J CLIN ONCOL, V2, P1404, DOI 10.1200/JCO.1984.2.12.1404; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Holmes CE, 2003, CA-CANCER J CLIN, V53, P227, DOI 10.3322/canjclin.53.4.227; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Ibrahim NK, 1996, ARCH INTERN MED, V156, P882, DOI 10.1001/archinte.156.8.882; Kemeny MM, 2003, J CLIN ONCOL, V21, P2268, DOI 10.1200/JCO.2003.09.124; Kimmick GG, 2001, ONCOLOGY-NY, V15, P280; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; Lichtman SM, 2000, ONCOLOGY-NY, V14, P1743; Lyman GH, 2003, J CLIN ONCOL, V21, P4524, DOI 10.1200/JCO.2003.05.002; Perloff M, 1996, J CLIN ONCOL, V14, P1589, DOI 10.1200/JCO.1996.14.5.1589; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Sateren WB, 2002, J CLIN ONCOL, V20, P2109, DOI 10.1200/JCO.2002.08.056; Thor AD, 1998, JNCI-J NATL CANCER I, V90, P1346, DOI 10.1093/jnci/90.18.1346; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Yancik R, 2000, HEMATOL ONCOL CLIN N, V14, P17, DOI 10.1016/S0889-8588(05)70275-6; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	31	308	314	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1073	1081		10.1001/jama.293.9.1073	http://dx.doi.org/10.1001/jama.293.9.1073			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LY	15741529				2022-12-28	WOS:000227285200017
J	Sato, Y; Honda, Y; Iwamoto, J; Kanoko, T; Satoh, K				Sato, Y; Honda, Y; Iwamoto, J; Kanoko, T; Satoh, K			RETRACTED: Effect of folate and mecobalamin on hip fractures in patients with stroke - A randomized controlled trial (Retracted article. See vol. 315, pg. 2405, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Retracted Publication							ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; PLASMA HOMOCYSTEINE; VERTEBRAL FRACTURES; HEMIPLEGIC PATIENTS; ELDERLY-PEOPLE; BONE-DENSITY; RISK-FACTORS; FOLIC-ACID; WOMEN	Context Stroke increases the risk of subsequent hip fracture by 2 to 4 times. Hyperhomocysteinemia is a risk factor for both ischemic stroke and osteoporotic fractures in elderly men and women. Treatment with folate and mecobalamin (vitamin B-12) may improve hyperhomocysteinemia. Objective To investigate whether treatment with folate and vitamin B12 reduces the incidence of hip fractures in patients with hemiplegia following stroke. Design, Setting, and Patients A double-blind, randomized controlled study of 628 consecutive patients aged 65 years or older with residual hemiplegia at least 1 year following first ischemic stroke, who were recruited from a single Japanese hospital from April 1, 2000, to May 31, 2001. Patients were assigned to daily oral treatment with 5 mg of folate and 1500 mug of mecobalamin, or double placebo; 559 completed the 2-year follow-up. Main Outcome Measure Incidence of hip fractures in the 2 patient groups during the 2-year follow-up. Results At baseline, patients in both groups had high levels of plasma homocysteine and low levels of serum cobalamin and serum folate. After 2 years, plasma homocysteine levels decreased by 38% in the treatment group and increased by 31 % in the placebo group (P<.001). The number of hip fractures per 1000 patient-years was 10 and 43 for the treatment and placebo groups, respectively (P<.001). The adjusted relative risk, absolute risk reduction, and the number needed to treat for hip fractures in the treatment vs placebo groups were 0.20 (95% confidence interval [CI], 0.080.50), 7.1 % (95% Cl, 3.6%-10.8%), and 14 (95% Cl, 9-28), respectively. No significant adverse effects were reported. Conclusion In this Japanese population with a high baseline fracture risk, combined treatment with folate and vitamin 131, is safe and effective in reducing the risk of a hip fracture in elderly patients following stroke.	Mitate Hosp, Dept Neurol, Tagawa 8260041, Japan; Keio Univ, Sch Med, Dept Sports Med, Tokyo, Japan; Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Rehabil Med, Hirosaki, Aomori 036, Japan; Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan	Keio University; Hirosaki University; Hirosaki University	Sato, Y (corresponding author), Mitate Hosp, Dept Neurol, 3237 Yugeta, Tagawa 8260041, Japan.	y-sato@ktarn.or.jp						ARAKI A, 1989, ATHEROSCLEROSIS, V79, P139, DOI 10.1016/0021-9150(89)90118-4; ASPLUND K, 1985, STROKE, V16, P885; Bainbridge KE, 2004, OSTEOPOROSIS INT, V15, P439, DOI 10.1007/s00198-003-1562-5; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; BRATTSTROM L, 1992, EUR J CLIN INVEST, V22, P214, DOI 10.1111/j.1365-2362.1992.tb01829.x; BROWNER WS, 1991, LANCET, V338, P1470, DOI 10.1016/0140-6736(91)92782-W; CHIU KY, 1992, INJURY, V23, P297, DOI 10.1016/0020-1383(92)90171-N; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; El Kossi MMH, 2000, STROKE, V31, P1889, DOI 10.1161/01.STR.31.8.1889; GRIECO AJ, 1977, AM J MED SCI, V273, P120, DOI 10.1097/00000441-197703000-00001; Henderson LB, 2000, GENET MED, V2, P222, DOI 10.1097/00125817-200007000-00004; HOOPER G, 1979, INJURY, V10, P281, DOI 10.1016/0020-1383(79)90044-5; JACKSON SH, 1973, CLIN CHIM ACTA, V45, P215, DOI 10.1016/0009-8981(73)90429-4; JOOSTEN E, 1993, AM J CLIN NUTR, V58, P468, DOI 10.1093/ajcn/58.4.468; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsui T, 2001, STROKE, V32, P1116, DOI 10.1161/01.STR.32.5.1116; MATSUMOTO C, 1994, CALCIFIED TISSUE INT, V55, P324, DOI 10.1007/BF00299308; McKusick V. A., 1966, HERITABLE DISORDERS, P155; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; MORREELS CL, 1968, RADIOLOGY, V90, P1150, DOI 10.1148/90.6.1150; MUDD SH, 1985, AM J HUM GENET, V37, P1; MULLEY G, 1979, POSTGRAD MED J, V55, P264, DOI 10.1136/pgmj.55.642.264; Nurmi I, 2003, ARCH ORTHOP TRAUM SU, V123, P551, DOI 10.1007/s00402-003-0583-z; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; POPLINGHER AR, 1985, ACTA ORTHOP SCAND, V56, P226; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Sato Y, 2001, STROKE, V32, P1673, DOI 10.1161/01.STR.32.7.1673; Sato Y, 2000, J BONE MINER RES, V15, P2487, DOI 10.1359/jbmr.2000.15.12.2487; Sato Y, 2003, NEUROLOGY, V61, P338, DOI 10.1212/01.WNL.0000078892.24356.90; Sato Y, 2002, J NEUROL SCI, V202, P65, DOI 10.1016/S0022-510X(02)00210-1; Sato Y, 1996, EUR NEUROL, V36, P278, DOI 10.1159/000117272; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; UELAND PM, 1993, CLIN CHEM, V39, P1764; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924	41	213	224	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1082	1088		10.1001/jama.293.9.1082	http://dx.doi.org/10.1001/jama.293.9.1082			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LY	15741530	Bronze			2022-12-28	WOS:000227285200018
J	Gandhi, TK				Gandhi, TK			Fumbled handoffs: One dropped ball after another	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; CRITICAL-VALUES; CARE; COMMUNICATION; ERRORS; TRIAL; WOMEN	Missed follow-up of abnormal test results and resultant delays in diagnosis is a safety issue that is gaining increasing attention. Despite increases in the numbers and types of available diagnostic tests, current systems in health care do not reliably ensure that test results are received and acted upon by ordering physicians. This article examines the case of a patient whose diagnosis of tuberculosis was substantially delayed because of systems problems, including poor continuity (with multiple-provider involvement), lack of communication of test results and other clinical information, and several handoffs. Strategies to ensure adequate communication of critical information and follow-up of test results are discussed, such as explicit criteria for communication of abnormal results, test-tracking systems for ordering providers, and use of information technologies.	Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gandhi, TK (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	tgandhi@partners.org						Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; ASTION M, 2004, RESULT STOPPED HERE; Berlin L, 2002, AM J ROENTGENOL, V178, P809, DOI 10.2214/ajr.178.4.1780809; Boohaker EA, 1996, ARCH INTERN MED, V156, P327, DOI 10.1001/archinte.156.3.327; Haas JS, 2000, J GEN INTERN MED, V15, P321, DOI 10.1046/j.1525-1497.2000.08030.x; Howanitz PJ, 2002, ARCH PATHOL LAB MED, V126, P663; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LEVINSON W, 1994, JAMA-J AM MED ASSOC, V272, P1619, DOI 10.1001/jama.272.20.1619; MARCUS AC, 1992, MED CARE, V30, P216, DOI 10.1097/00005650-199203000-00004; MURFF HJ, 2001, MAKING HLTH CARE SAF; Pereira TC, 2004, AM J CLIN PATHOL, V122, P201, DOI 10.1309/7NRW7G684VEPWPMR; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; *PHYS INS ASS AM, 1997, PHYS INS ASS AM AM C; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Poon EG, 2004, J GEN INTERN MED, V19, P316, DOI 10.1111/j.1525-1497.2004.30357.x; Poon EG, 2003, J BIOMED INFORM, V36, P80, DOI 10.1016/S1532-0464(03)00061-3; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Stiell A, 2003, CAN MED ASSOC J, V169, P1023	21	173	173	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					352	358		10.7326/0003-4819-142-5-200503010-00010	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738454				2022-12-28	WOS:000227325100005
J	Scherder, E; Oosterman, J; Swaab, D; Herr, K; Ooms, M; Ribbe, M; Sergeant, J; Pickering, G; Benedetti, F				Scherder, E; Oosterman, J; Swaab, D; Herr, K; Ooms, M; Ribbe, M; Sergeant, J; Pickering, G; Benedetti, F			Recent developments in pain in dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; OLDER-ADULTS; MEDIAL PAIN; SCALES; EPIDEMIOLOGY; DISCOMFORT; MANAGEMENT; SYSTEM		Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands; Free Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; Netherlands Inst Brain Res, NL-1105 AZ Amsterdam, Netherlands; Univ Iowa, Coll Nursing, Iowa City, IA 52333 USA; Vrije Univ Amsterdam Med Ctr, Dept Nursing Home Med, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, EMGO Inst, NL-1081 BT Amsterdam, Netherlands; Univ Hosp, Clin Pharmacol Ctr, F-63000 Clermont Ferrand, France; Univ Turin, Sch Med, Dept Neurosci, I-10125 Turin, Italy	University of Groningen; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Iowa; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; CHU Clermont Ferrand; University of Turin	Scherder, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	eja.scherder@psy.vu.nl	Oosterman, Joukje/D-6125-2012; Herr, Keela/AAO-2146-2020	Oosterman, Joukje/0000-0003-0549-8832; Herr, Keela/0000-0003-4588-0235; Swaab, Dick/0000-0002-9665-7845				[Anonymous], ANN LONGTERM CARE; Benedetti F, 2004, PAIN, V111, P22, DOI 10.1016/j.pain.2004.05.015; Benedetti F, 1999, PAIN, V80, P377, DOI 10.1016/S0304-3959(98)00228-0; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; BLENNOW K, 1993, ACTA NEUROL SCAND, V88, P221; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; Caligiuri MP, 2001, INT J GERIATR PSYCH, V16, P907, DOI 10.1002/gps.443; Chibnall JT, 2001, PAIN, V92, P173, DOI 10.1016/S0304-3959(00)00485-1; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; Creac'h C, 2000, AM J NEURORADIOL, V21, P1402; Dickson DW, 2001, CLIN GERIATR MED, V17, P209, DOI 10.1016/S0749-0690(05)70066-5; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Ferrell BA, 1995, J PAIN SYMPTOM MANAG, V10, P591, DOI 10.1016/0885-3924(95)00121-2; Fuchs-Lacelle S, 2004, PAIN MANAG NURS, V5, P37, DOI 10.1016/j.pmn.2003.10.001; Gibson S J, 2001, Pain Res Manag, V6, P126; Hadjistavropoulos T, 2002, EUR J PAIN, V6, P179, DOI 10.1053/eujp.2001.0327; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Horgas AL, 2004, NURS CLIN N AM, V39, P593, DOI 10.1016/j.cnur.2004.02.013; HURLEY AC, 1992, RES NURS HEALTH, V15, P369, DOI 10.1002/nur.4770150506; KAKIGI R, 1992, J NEUROL SCI, V107, P205, DOI 10.1016/0022-510X(92)90290-2; Kovach CR, 1999, J PAIN SYMPTOM MANAG, V18, P412, DOI 10.1016/S0885-3924(99)00094-9; Lefebvre-Chapiro L., 2001, EJPC, V8, P191, DOI DOI 10.1186/1471-2318-7-29; Lindeboom J, 2004, EUR J PHARMACOL, V490, P83, DOI 10.1016/j.ejphar.2004.02.046; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainero I, 2000, EUR J PAIN-LONDON, V4, P267, DOI 10.1053/eujp.2000.0185; Rub U, 2002, J CHEM NEUROANAT, V23, P279, DOI 10.1016/S0891-0618(02)00007-8; Scherder EJA, 2003, LANCET NEUROL, V2, P677, DOI 10.1016/S1474-4422(03)00556-8; Scherder EJA, 2000, GERONTOLOGY, V46, P47, DOI 10.1159/000022133; SEMLA TP, 1993, J AM GERIATR SOC, V41, P408, DOI 10.1111/j.1532-5415.1993.tb06949.x; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Skoog I, 2004, ACTA PSYCHIAT SCAND, V109, P4, DOI 10.1046/j.1600-0447.2003.00260.x; SNIDER SR, 1976, NEUROLOGY, V34, P957; Snow AL, 2004, DEMENT GERIATR COGN, V17, P240, DOI 10.1159/000076446; Svendsen KB, 2003, ARCH NEUROL-CHICAGO, V60, P1089, DOI 10.1001/archneur.60.8.1089; Waseem S, 2001, POSTGRAD MED, V110, P33, DOI 10.3810/pgm.2001.12.1063; Yamamoto M, 1996, J NEUROL SCI, V137, P117, DOI 10.1016/0022-510X(95)00327-X	38	136	138	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2005	330	7489					461	464A		10.1136/bmj.330.7489.461	http://dx.doi.org/10.1136/bmj.330.7489.461			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731144	Green Submitted, Green Published			2022-12-28	WOS:000227315400023
J	Cleland, JGF; Daubert, J; Erdmann, E; Freemantle, N; Gras, D; Kappenberger, L; Tavazzi, L; Cleland, JGF; Daubert, JC; Erdmann, E; Gras, D; Kappenberger, L; Klein, W; Tavazzi, L; Poole-Wilson, PA; Ryden, L; Wedel, H; Wellens, HJJ; Uretsky, B; Thygesen, K; Bocker, D; Marijianowski, MMH; Freemantle, N; Calvert, MJ; Christ, G; Fruhwald, F; Hofmann, R; Krypta, A; Leisch, F; Pacher, R; Rauscha, F; Tavernier, R; Thomsen, PEB; Boesgaard, S; Eiskjaer, H; Esperen, GT; Haarbo, J; Hagemann, A; Korup, E; Moller, M; Mortensen, P; Sogaard, P; Vesterlund, T; Huikuri, H; Niemela, KI; Toivonen, L; Bauer, F; Cohen-Solal, A; Crocq, C; Djiane, P; Dubois-Rande, JL; de Groote, P; Juilliere, Y; Kirkorian, G; Komajda, M; Laperche, T; Le Marec, H; Leclercq, C; Tribouilloy, C; Er, F; Fleck, E; Hoppe, UC; Kleber, FX; Maisch, B; Neuzner, J; Reithmann, C; Remp, T; Schmitt, C; Stahl, C; Strasser, RH; Albanese, MC; Bartoloni, A; Bocchiardo, M; Capucci, A; Carboni, A; Circo, A; Disertori, M; del Medico, R; Forzani, T; Frigerio, M; Gavazzi, A; Landolina, M; Lunati, M; Mangiameli, S; Piacenti, M; Piti, A; Ravazzi, PA; Raviele, A; Santini, M; Serio, A; Trevi, GP; Volterrani, M; Zardini, M; Bracke, FALE; de Cock, CC; Meijer, A; Tukkie, R; Mediavilla, JC; Concha, M; Delgado, JF; Gonzalez-Garcia, A; Munoz-Aguilera, R; Ferrer, JM; Ridocci, F; Andren, B; Brandt, J; Blomstrom, P; Edner, M; Hellstrom, K; Jensen, S; Kristensson, B; Maru, F; Moller, SJ; Ronn, F; Smedgard, P; Wikstrom, G; Fuhrer, J; Girod, G; Broomes, GH; Chalil, S; Dargie, H; Davies, W; Delaney, A; Elliott, P; Goode, GK; Haywood, G; Kaye, GC; Kurbaan, AS; Lane, R; Levy, T; Leyva, F; Marshall, H; Muhyaldeen, S; Nitikin, N; Roberts, MJD; Skehan, JD; Toff, WD; Wright, DJ; Bassi, C; Ghio, S; Ghizzardi, E; Magrini, G; Pasotti, M; Pierota, V; Tellaroli, E; Serio, A; Scelsi, L; Fahrleitner, A; Leb, G; Wenisch, H; Bennett, A; Cooklin, M; Ghosh, J; Hurren, S; Kaye, GC; Khan, NK				Cleland, JGF; Daubert, J; Erdmann, E; Freemantle, N; Gras, D; Kappenberger, L; Tavazzi, L; Cleland, JGF; Daubert, JC; Erdmann, E; Gras, D; Kappenberger, L; Klein, W; Tavazzi, L; Poole-Wilson, PA; Ryden, L; Wedel, H; Wellens, HJJ; Uretsky, B; Thygesen, K; Bocker, D; Marijianowski, MMH; Freemantle, N; Calvert, MJ; Christ, G; Fruhwald, F; Hofmann, R; Krypta, A; Leisch, F; Pacher, R; Rauscha, F; Tavernier, R; Thomsen, PEB; Boesgaard, S; Eiskjaer, H; Esperen, GT; Haarbo, J; Hagemann, A; Korup, E; Moller, M; Mortensen, P; Sogaard, P; Vesterlund, T; Huikuri, H; Niemela, KI; Toivonen, L; Bauer, F; Cohen-Solal, A; Crocq, C; Djiane, P; Dubois-Rande, JL; de Groote, P; Juilliere, Y; Kirkorian, G; Komajda, M; Laperche, T; Le Marec, H; Leclercq, C; Tribouilloy, C; Er, F; Fleck, E; Hoppe, UC; Kleber, FX; Maisch, B; Neuzner, J; Reithmann, C; Remp, T; Schmitt, C; Stahl, C; Strasser, RH; Albanese, MC; Bartoloni, A; Bocchiardo, M; Capucci, A; Carboni, A; Circo, A; Disertori, M; del Medico, R; Forzani, T; Frigerio, M; Gavazzi, A; Landolina, M; Lunati, M; Mangiameli, S; Piacenti, M; Piti, A; Ravazzi, PA; Raviele, A; Santini, M; Serio, A; Trevi, GP; Volterrani, M; Zardini, M; Bracke, FALE; de Cock, CC; Meijer, A; Tukkie, R; Mediavilla, JC; Concha, M; Delgado, JF; Gonzalez-Garcia, A; Munoz-Aguilera, R; Ferrer, JM; Ridocci, F; Andren, B; Brandt, J; Blomstrom, P; Edner, M; Hellstrom, K; Jensen, S; Kristensson, B; Maru, F; Moller, SJ; Ronn, F; Smedgard, P; Wikstrom, G; Fuhrer, J; Girod, G; Broomes, GH; Chalil, S; Dargie, H; Davies, W; Delaney, A; Elliott, P; Goode, GK; Haywood, G; Kaye, GC; Kurbaan, AS; Lane, R; Levy, T; Leyva, F; Marshall, H; Muhyaldeen, S; Nitikin, N; Roberts, MJD; Skehan, JD; Toff, WD; Wright, DJ; Bassi, C; Ghio, S; Ghizzardi, E; Magrini, G; Pasotti, M; Pierota, V; Tellaroli, E; Serio, A; Scelsi, L; Fahrleitner, A; Leb, G; Wenisch, H; Bennett, A; Cooklin, M; Ghosh, J; Hurren, S; Kaye, GC; Khan, NK		CARE-HF Study Investigators	The effect of cardiac resynchronization on morbidity and mortality in heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; THERAPY; RESYNCHRONISATION; DEFIBRILLATOR; SURVIVAL	Background Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony. We evaluated its effects on morbidity and mortality. Methods Patients with New York Heart Association class III or IV heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony who were receiving standard pharmacologic therapy were randomly assigned to receive medical therapy alone or with cardiac resynchronization. The primary end point was the time to death from any cause or an unplanned hospitalization for a major cardiovascular event. The principal secondary end point was death from any cause. Results A total of 813 patients were enrolled and followed for a mean of 29.4 months. The primary end point was reached by 159 patients in the cardiac-resynchronization group, as compared with 224 patients in the medical-therapy group (39 percent vs. 55 percent; hazard ratio, 0.63; 95 percent confidence interval, 0.51 to 0.77; P<0.001). There were 82 deaths in the cardiac-resynchronization group, as compared with 120 in the medical-therapy group (20 percent vs. 30 percent; hazard ratio 0.64; 95 percent confidence interval, 0.48 to 0.85; P<0.002). As compared with medical therapy, cardiac resynchronization reduced the interventricular mechanical delay, the end-systolic volume index, and the area of the mitral regurgitant jet; increased the left ventricular ejection fraction; and improved symptoms and the quality of life (P<0.01 for all comparisons). Conclusions In patients with heart failure and cardiac dyssynchrony, cardiac resynchronization improves symptoms and the quality of life and reduces complications and the risk of death. These benefits are in addition to those afforded by standard pharmacologic therapy. The implantation of a cardiac-resynchronization device should routinely be considered in such patients.	Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull, Yorks, England; Hop Pontchaillou, Dept Cardiol, Rennes, France; Univ Cologne, Innere Med Klin 3, Cologne, Germany; Univ Birmingham, Edgbaston, England; Nouvelles Clin Nantaises, Nantes, France; CHU Vaudois, Div Cardiol, Lausanne, Switzerland; Policlin San Matteo, Ist Ric & Cura Carattere Sci, I-27100 Pavia, Italy	University of Hull; CHU Rennes; University of Cologne; University of Birmingham; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Fondazione San Matteo	Cleland, JGF (corresponding author), Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull, Yorks, England.	j.g.cleland@hull.ac.uk	Maisch, Bernhard/AAH-9198-2020; Scelsi, Laura/AAB-9729-2019; Kaye, Gerald/T-8056-2019; Bracke, Frank/AAI-9237-2021; Ghio, Stefano/ABH-1151-2021; Landolina, Maurizio Eugenio/AAL-1218-2020; Cleland, John G./AAZ-4185-2020; Kaye, Gerald/F-6182-2012; Le Marec, Hervé/D-2718-2015; Tavazzi, Luigi/ABD-5119-2020; Delgado, Juan F./G-1066-2017; Calvert, Melanie/F-7055-2011; Juillière, Yves/AAG-1038-2020	Scelsi, Laura/0000-0001-9409-691X; Bracke, Frank/0000-0002-2726-4327; Ghio, Stefano/0000-0002-1858-1152; Landolina, Maurizio Eugenio/0000-0002-2790-4195; Cleland, John G./0000-0002-1471-7016; Kaye, Gerald/0000-0002-0702-3681; Le Marec, Hervé/0000-0002-8288-8693; Tavazzi, Luigi/0000-0003-0336-8356; Delgado, Juan F./0000-0002-5401-8324; Calvert, Melanie/0000-0002-1856-837X; Juillière, Yves/0000-0002-6101-7530; Freemantle, Nick/0000-0001-5807-5740				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Calvert M, 2005, ANN INTERN MED, V142, P305, DOI 10.7326/0003-4819-142-4-200502150-00017; Calvert MJ, 2005, EUR J HEART FAIL, V7, P243, DOI 10.1016/j.ejheart.2005.01.012; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGE, 2004, EUR J HEART FAIL, V6, P501, DOI 10.1016/j.ejheart.2004.04.014; Cleland JGF, 2005, EUR J HEART FAIL, V7, P205, DOI 10.1016/j.ejheart.2005.01.010; Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3; Cleland JGF, 2003, J AM COLL CARDIOL, V42, P1234, DOI 10.1016/S0735-1097(03)00948-3; Collett D, 1994, MODELLING SURVIVAL D; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Khand A, 2000, J AM COLL CARDIOL, V36, P2284, DOI 10.1016/S0735-1097(00)00995-5; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lechat P, 1999, LANCET, V353, P9; McAlister FA, 2005, ANN INTERN MED, V142, P311; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; Rogers JG, 2004, NEW ENGL J MED, V350, P2193, DOI 10.1056/NEJMe048067; Shih JH, 1995, CONTROL CLIN TRIALS, V16, P395, DOI 10.1016/S0197-2456(95)00132-8; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	28	4359	4601	0	165	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1539	1549		10.1056/NEJMoa050496	http://dx.doi.org/10.1056/NEJMoa050496			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15753115	Green Accepted			2022-12-28	WOS:000228324200006
J	Sabin, CA; Hill, T; Lampe, F; Matthias, R; Bhagani, S; Gilson, R; Youle, MS; Johnson, MA; Fisher, M; Scullard, G; Easterbrook, P; Gazzard, B; Phillips, AN				Sabin, CA; Hill, T; Lampe, F; Matthias, R; Bhagani, S; Gilson, R; Youle, MS; Johnson, MA; Fisher, M; Scullard, G; Easterbrook, P; Gazzard, B; Phillips, AN		UK CHIC Study Grp	Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGIMENS; AIDS	Objectives To investigate whether there is evidence that an increasing proportion of HIV infected patients is starting to experience increases in viral load and decreases in CD4 cell count that are consistent with exhaustion of available treatment options. Design Multicentre cohort study. Setting Six large HIV treatment centres in southeast England. Participants All individuals seen for care between. I January 1996 and 31 December 2002. Main outcome measures Exposure to individual antiretroviral drugs and drug classes, CD4 count, plasma HIV RNA burden. Results Information is available on 16 593 individuals (13 378 (80.6%) male patients, 10 340 (62.3%) infected via homosexual or bisexual sex, 4426 (26.7%) infected via heterosexual sex, median age 34 years). Overall, 10 207 of the 16 593 patients (61.5%) have been exposed to any antiretroviral therapy. This proportion increased from 41.2% of patients under follow up at the end of 1996 to 71.3% of those under follow up in 2002. The median CD4 count and HIV RNA burden of patients under follow up in each year changed from 270 cells/mm(3) and 4.34 log(10) copies/ml in 1996 to 408 cells/mm(3) and 1.89 log(10) copies/ml, respectively, in 2002. By 2002, 3060 (38%) of patients who had ever been treated with antiretroviral therapy had experienced all three main classes. Of these, around one quarter had evidence of "viral load failure" with all these three classes. Patients with three class failure were more likely to have an HIV RNA burden > 2.7 log(10) copies/ml and a CD4 count < 200 cells/mm(3). Conclusions The proportion of individuals with HfV infection in the United Kingdom who have been treated has increased gradually over time. A substantial proportion of these patients seem to be in danger of exhausting their options for antiretroviral treatment. New drugs with low toxicity, which are not associated with cross resistance to existing drugs, are urgently needed for such patients.	Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Royal Free & UC Med Sch, UK CHIC Study, London NW3 2PF, England; MRC, Clin Trials Unit, UK CHIC Study, London NW1 2DA, England; Royal Free Hosp, Royal Free Ctr HIV Med, London NW3 2QG, England; Royal Free & UC Med Sch, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England; Brighton & Sussex Univ Hosp Trust, Dept HIV Med, Lawson Unit, Brighton BN2 5BE, E Sussex, England; St Marys NHS Trust, Dept GU Med & Communicable Dis, London W2 1NY, England; Guys Kings & St Thomas Sch Med, London SE5 9RT, England; Chelsea & Westminster Hosp, Kobler Ctr, London SW10 9NH, England	University of London; University College London; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; King's College London; Imperial College London	Sabin, CA (corresponding author), Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England.	c.sabin@pcps.ucl.ac.uk	Lampe, Fiona/I-5826-2019; Phillips, Andrew N/B-4427-2008; Easterbrook, Philippa J/A-3937-2009; Sabin, Caroline/C-2464-2008; Gilson, Richard J C/C-5123-2009	Lampe, Fiona/0000-0001-6851-5471; Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; Easterbrook, Philippa/0000-0002-2603-5418; Bhagani, Sanjay/0000-0003-2557-4337				Barry S M, 2002, HIV Med, V3, P129, DOI 10.1046/j.1468-1293.2002.00103.x; CHADBORN T, 2003, 9 ANN C BRIT HIV ASS; COLONNO R, 2003, 10 C RETR OPP INF BO; Easterbrook PJ, 2000, AIDS, V14, P561, DOI 10.1097/00002030-200003310-00012; Gulick RM, 2002, AIDS, V16, pS135, DOI 10.1097/00002030-200216004-00019; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; LALEZARI J, 2000, 13 INT C AIDS DURB 9; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paulsen D, 2002, AIDS RES HUM RETROV, V18, P1011, DOI 10.1089/08892220260235371; Phillips AN, 2002, J INFECT DIS, V186, P1086, DOI 10.1086/343801; *PUBL HLTH LAB SER, 2002, HIV AIDS UK 2001; Sabin C, 2004, HIV MED, V5, P115; SQUIRES KE, 2002, 42 INT C ANT AG CHEM; STASZEWSKI S, 2003, 10 C RETR OPP INF BO; *UK COLL GROUP HIV, IN PRESS AIDS	17	64	71	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2005	330	7493					695	698B		10.1136/bmj.38369.669850.8F	http://dx.doi.org/10.1136/bmj.38369.669850.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912IT	15749728	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000228071900014
J	Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L				Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L			Risk factors for relapse in health care professionals with substance use disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED PHYSICIANS; ABUSE; ANESTHESIOLOGISTS; PROGRAMS; PREVALENCE; EXPERIENCE; ADDICTION; MODEL	Context Substance use disorders among physicians are important and persistent problems. Considerable debate exists over whether,use of major opioids, especially among anesthesiologists, is associated with a higher relapse rate compared with alcohol and nonopioids. Moreover, the risk factors for relapse with current treatment and monitoring strategies are unknown. Objective To test the hypothesis that chemically dependent healthcare professionals using a major opioid (eg, fentanyl, sufentanil, morphine, meperidine) as drug of choice are at higher risk of relapse. Design, Setting, and Participants Retrospective cohort study of 292 health care professionals enrolled in the Washington Physicians Health Program, an independent posttreatment monitoring program, followed up between January 1, 1991, and December 31, 2001. Main Outcome Measure Factors associated with relapse, defined as the resumption of substance use after initial diagnosis and completion of primary treatment for chemical dependency. Results Twenty-five percent (74 of 292 individuals) had at least 1 relapse. A family history of a substance use disorder increased the risk of relapse (hazard ratio [HR], 2.29; 95% confidence interval [CI], 1.44-3.64). The use of a major opioid increased the risk of relapse significantly in the presence of a coexisting psychiatric disorder (HR, 5.79; 95% Cl, 2.89-11.42) but not in the absence of a coexisting psychiatric disorder (HR, 0.85; 95% Cl, 0.33-2.17). The presence of all 3 factors major opioid use, dual diagnosis, and family history-markedly increased the risk of relapse (HR, 13.25; 95% Cl, 5.22-33.59). The risk of subsequent relapses increased after the first relapse (HR, 1.69; 95% Cl, 1.13-2.53). Conclusions The risk of relapse with substance use was increased in health care professionals who used a major opioid or had a coexisting psychiatric illness or a family history of a substance use disorder. The presence of more than 1 of these risk factors and previous relapse further increased the likelihood of relapse. These observations should be considered in monitoring the recovery of health care professionals.	Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Whisper Light Stat Consulting, Seattle, WA USA; Washington Phys Hlth Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Domino, KB (corresponding author), Univ Washington, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.	kdomino@u.washington.edu						Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008; Angres D. H., 1998, HEALING HEALER ADDIC, P34; Bohigian G M, 1994, Mo Med, V91, P275; Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; Gallegos K V, 1988, QRB Qual Rev Bull, V14, P116; Gallegos K V, 1992, Md Med J, V41, P315; HANKES L, 1992, SUBSTANCE ABUSE COMP, P897; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Leshner AI, 1999, JAMA-J AM MED ASSOC, V282, P1314, DOI 10.1001/jama.282.14.1314; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LINK CL, 1984, BIOMETRICS, V40, P601, DOI 10.2307/2530904; MENK EJ, 1990, JAMA-J AM MED ASSOC, V263, P3060, DOI 10.1001/jama.263.22.3060; MORSE RM, 1984, JAMA-J AM MED ASSOC, V251, P743, DOI 10.1001/jama.251.6.743; Paris RT, 1999, J ADDICT DIS, V18, P1, DOI 10.1300/J069v18n01_01; PELTON C, 1991, J PSYCHOACTIVE DRUGS, V23, P427, DOI 10.1080/02791072.1991.10471613; Reading E G, 1992, Md Med J, V41, P325; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; SHORE JH, 1987, JAMA-J AM MED ASSOC, V257, P2931; SPIEGELMAN WG, 1984, ANESTHESIOLOGY, V60, P335, DOI 10.1097/00000542-198404000-00009; TALBOTT GD, 1987, JAMA-J AM MED ASSOC, V257, P2927, DOI 10.1001/jama.257.21.2927; TALBOTT GD, 2003, PRINCIPLES ADDICTION, P1009; Zacny JP, 1999, ANESTHESIOLOGY, V90, P269, DOI 10.1097/00000542-199901000-00033	23	132	139	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1453	1460		10.1001/jama.293.12.1453	http://dx.doi.org/10.1001/jama.293.12.1453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784868				2022-12-28	WOS:000227784700024
J	Danishevski, K; McKee, M				Danishevski, K; McKee, M			Reforming the Russian health-care system	LANCET			English	Editorial Material									Open Hlth Inst, Moscow 129010, Russia; London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Danishevski, K (corresponding author), Open Hlth Inst, Moscow 129010, Russia.	kdanishevski@ohi.ru	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Onischenko G. G., 2003, Voprosy Pitaniya, V72, P3; *PRIM TASS EC NEWS, 2004, SPEECH OP GOV SESS 2; Service R., 2002, RUSSIA EXPT PEOPLE	4	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1012	1014						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781084				2022-12-28	WOS:000227731800009
J	De Serres, G; Duval, B				De Serres, G; Duval, B			Pertussis vaccination beyond childhood	LANCET			English	Editorial Material							COMPUTER-SIMULATIONS; STRATEGIES; INFANCY		Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada; Univ Laval, Quebec City, PQ, Canada	Laval University	De Serres, G (corresponding author), Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada.	gaston.deserres@ssss.gouv.qc.ca						*CDC, 1999, PERC PERS AG 18 YEAR; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; Forsyth KD, 2004, CLIN INFECT DIS, V39, P1802, DOI 10.1086/426020; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; SALISBURY D M, 2004, VACCINES, P1387; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Skowronski DM, 2004, VACCINE, V23, P353, DOI 10.1016/j.vaccine.2004.05.033; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012	11	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1015	1016						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781085				2022-12-28	WOS:000227731800010
J	Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA				Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA			Type VII collagen is required for Ras-driven human epidermal tumorigenesis	SCIENCE			English	Article							SQUAMOUS-CELL CARCINOMAS; EPIDERMOLYSIS-BULLOSA; ANCHORING FIBRILS; NC1 DOMAIN; LAMININ-5; BINDS; SKIN	Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers. To study the role of collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1) were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII-null epidermis in a non-cell-autonomous fashion. Fibronectin-like sequences within NC1 (FNC1) promoted tumor cell invasion in a laminin 5-dependent manner and were required for tumorigenesis. Tumor-stroma interactions mediated by collagen VII thus promote neoplasia, and retention of NC1 sequences in a subset of RDEB patients may contribute to their increased susceptibility to squamous cell carcinoma.	VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Oregon Health & Science University	Khavari, PA (corresponding author), VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@cmgm.stanford.edu			NIAMS NIH HHS [AR43799, AR44012] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR043799, R01AR043799, P01AR044012] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; HESSLE H, 1984, DIFFERENTIATION, V26, P49, DOI 10.1111/j.1432-0436.1984.tb01372.x; Kainulainen T, 1997, BRIT J DERMATOL, V136, P331, DOI 10.1046/j.1365-2133.1997.5581514.x; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; Mallipeddi R, 2002, CLIN EXP DERMATOL, V27, P616, DOI 10.1046/j.1365-2230.2002.01130.x; MARINKOVICH MP, 2003, DERMATOLOGY GEN MED, V1, P596; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; WETZELS RHW, 1991, AM J PATHOL, V139, P451	18	101	104	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1773	1776		10.1126/science.1106209	http://dx.doi.org/10.1126/science.1106209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774758				2022-12-28	WOS:000227883900044
J	Wigley, TML				Wigley, TML			The climate change commitment	SCIENCE			English	Article							SENSITIVITY; SIMULATIONS; PROJECTIONS; SYSTEM; MODEL; CO2	Even if atmospheric composition were fixed today, global-mean temperature and sea level rise would continue due to oceanic thermal inertia. These constant-composition (CC) commitments and their uncertainties are quantified. Constant-emissions (CE) commitments are also considered. The CC warming commitment could exceed 1 degrees C. The CE warming commitment is 2 degrees to 6 degrees C by the year 2400. For sea level rise, the CC commitment is 10 centimeters per century (extreme range approximately 1 to 30 centimeters per century) and the CE commitment is 25 centimeters per century (7 to 50 centimeters per century). Avoiding these changes requires, eventually, a reduction in emissions to substantially below present levels. For sea level rise, a substantial long-term commitment may be impossible to avoid.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Wigley, TML (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	wigley@cgd.ucar.edu	Wigley, Tom M.L./B-4705-2008					Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016875; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; HANSEN J, 1985, SCIENCE, V229, P857, DOI 10.1126/science.229.4716.857; Hansen J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001143; HOFFERT ML, 1980, J GEOPHYS RES, V86, P6667; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Pielke RA, 2003, B AM METEOROL SOC, V84, P331, DOI 10.1175/BAMS-84-3-331; Raper S.C.B., 1996, SEA LEVEL RISE COAST, P11, DOI DOI 10.1007/978-94-015-8719-8_2; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Stouffer RJ, 1999, J CLIMATE, V12, P2224, DOI 10.1175/1520-0442(1999)012<2224:ROACOA>2.0.CO;2; Wetherald RT, 2001, GEOPHYS RES LETT, V28, P1535, DOI 10.1029/2000GL011786; Wigley T.M.L., 1984, CLIMAT MONITOR, V13, P133; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 2002, J CLIMATE, V15, P2945, DOI 10.1175/1520-0442(2002)015<2945:RFLWPI>2.0.CO;2; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604; WIGLEY TML, 1985, NATURE, V315, P649, DOI 10.1038/315649a0; Wigley TML, 1993, CLIMATE SEA LEVEL CH, P111; WIGLEY TML, IN PRESS GEOPHYS RES	20	232	238	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1766	1769		10.1126/science.1103934	http://dx.doi.org/10.1126/science.1103934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774756	Green Published			2022-12-28	WOS:000227883900042
J	Reenan, RA				Reenan, RA			Molecular determinants and guided evolution of species-specific RNA editing	NATURE			English	Article							PRE-MESSENGER-RNA; AP-2 BINDING; C2B DOMAIN; GLUR-B; SYNAPTOTAGMIN; DROSOPHILA; CONSERVATION; TRANSCRIPT; DEFICIENT; RECEPTORS	Most RNA editing systems are mechanistically diverse, informationally restorative, and scattershot in eukaryotic lineages(1). In contrast, genetic recoding by adenosine-to-inosine RNA editing seems common in animals; usually, altering highly conserved or invariant coding positions in proteins(2-4). Here I report striking variation between species in the recoding of synaptotagmin I (sytI). Fruitflies, mosquitoes and butterflies possess shared and species-specific sytI editing sites, all within a single exon. Honeybees, beetles and roaches do not edit sytI. The editing machinery is usually directed to modify particular adenosines by information stored in intron-mediated RNA structures(5-7). Combining comparative genomics of 34 species with mutational analysis reveals that complex, multi-domain, pre-mRNA structures solely determine species- appropriate RNA editing. One of these is a previously unreported long-range pseudoknot. I show that small changes to intronic sequences, far removed from an editing site, can transfer the species specificity of editing between RNA substrates. Taken together, these data support a phylogeny of sytI gene editing spanning more than 250 million years of hexapod evolution. The results also provide models for the genesis of RNA editing sites through the stepwise addition of structural domains, or by short walks through sequence space from ancestral structures.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Reenan, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	rreenan@neuron.uchc.edu						Aronoff R, 2004, J NEUROSCI, V24, P8135, DOI 10.1523/JNEUROSCI.2587-04.2004; Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bass BL, 2001, RNA EDITING; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Dawson TR, 2004, J BIOL CHEM, V279, P4941, DOI 10.1074/jbc.M310068200; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Grauso M, 2002, GENETICS, V160, P1519; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hanrahan CJ, 2000, GENETICS, V155, P1149; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kung SS, 2001, FEBS LETT, V509, P277, DOI 10.1016/S0014-5793(01)03183-0; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Nakhost A, 2004, J NEUROCHEM, V89, P354, DOI 10.1111/j.1471-4159.2004.02325.x; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	30	92	104	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					409	413		10.1038/nature03364	http://dx.doi.org/10.1038/nature03364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772668				2022-12-28	WOS:000227715100058
J	Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W				Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W			Ancient co-speciation of simian foamy viruses and primates	NATURE			English	Article							MOLECULAR EVOLUTION; DIVERGENCE TIMES; ABSOLUTE RATES; DNA EVIDENCE; PHYLOGENY; SEQUENCES; GENE; HOSTS; COSPECIATION; COEVOLUTION	Although parasite - host co-speciation is a long-held hypothesis, convincing evidence for long-term co-speciation remains elusive, largely because of small numbers of hosts and parasites studied and uncertainty over rates of evolutionary change(1-5). Cospeciation is especially rare in RNA viruses, in which cross-species transfer is the dominant mode of evolution(6-9). Simian foamy viruses (SFVs) are ubiquitous, non-pathogenic retroviruses that infect all primates(10,11). Here we test the co-speciation hypothesis in SFVs and their primate hosts by comparing the phylogenies of SFV polymerase and mitochondrial cytochrome oxidase subunit II from African and Asian monkeys and apes. The phylogenetic trees were remarkably congruent in both branching order and divergence times, strongly supporting cospeciation. Molecular clock calibrations revealed an extremely low rate of SFV evolution, 1.7 x 10(-8) substitutions per site per year, making it the slowest-evolving RNA virus documented so far. These results indicate that SFVs might have co-speciated with Old World primates for at least 30 million years, making them the oldest known vertebrate RNA viruses.	Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; So Res Inst, Frederick, MD 21701 USA; Univ Rennes 1, CNRS, Biol Stn, F-35380 Paimpont, France; Cercopan, Calabar, Cross River Sta, Nigeria; Emory Univ, Winship Canc Ctr, Dept Pathol, Atlanta, GA 30322 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Duke University; United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Emory University; University of Oxford	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd,MS G-19, Atlanta, GA 30333 USA.	bis3@cdc.gov	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; VALLET, Dominique/L-2309-2018	Holmes, Edward/0000-0001-9596-3552; VALLET, Dominique/0000-0002-8551-6019				ADKINS RM, 1994, J MOL EVOL, V38, P215; BROOKS DR, 1987, INT J PARASITOL, V17, P291, DOI 10.1016/0020-7519(87)90052-X; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; DISOTELL TR, 1992, MOL BIOL EVOL, V9, P1; Gojobori T, 2000, AIDS REV, V2, P39; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Groves C.P., 2001, PRIMATE TAXONOMY; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Lochelt M, 2003, CURR TOP MICROBIOL, V277, P27; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; PAGE RDM, 1990, SYST ZOOL, V39, P205, DOI 10.2307/2992182; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SHADAN FF, 1993, P NATL ACAD SCI USA, V90, P4117, DOI 10.1073/pnas.90.9.4117; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059	30	211	226	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					376	380		10.1038/nature03341	http://dx.doi.org/10.1038/nature03341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772660	Green Published			2022-12-28	WOS:000227715100050
J	Tripp, J; Viner, R				Tripp, J; Viner, R			ABC of adolescence - Sexual health, contraception., and teenage pregnancy	BRITISH MEDICAL JOURNAL			English	Review									Univ Exeter, Exeter EX4 4QJ, Devon, England; UCL Hosp NHS Fdn Trust, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of Exeter; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tripp, J (corresponding author), Univ Exeter, Exeter EX4 4QJ, Devon, England.	rviner@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247				Rogstad KE, 2002, INT J STD AIDS, V13, P420, DOI 10.1258/095646202760029868; *SOC EXCL UN, 1999, TEEN PREGN REP; Toumbourou J., 2000, EVIDENCE BASED HLTH; *TRUST STUD AD, 2003, KEY DAT AD	4	59	63	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2005	330	7491					590	593		10.1136/bmj.330.7491.590	http://dx.doi.org/10.1136/bmj.330.7491.590			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	906EC	15761001	Green Published			2022-12-28	WOS:000227622300022
J	Kiessling, AA				Kiessling, AA			Eggs alone - Human parthenotes: an ethical source of stem cells for therapies?	NATURE			English	Editorial Material									Harvard Inst Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kiessling, AA (corresponding author), Harvard Inst Med, 4 Blackfan Circle, Boston, MA 02115 USA.							Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; KIESSLING AA, 2003, HUMAN EMBRYONIC STEM; Kiessling Ann A, 2004, Conn Law Rev, V36, P1051; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402	4	18	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					145	145		10.1038/434145a	http://dx.doi.org/10.1038/434145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758976	Bronze			2022-12-28	WOS:000227494500022
J	de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C				de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C			Chromosomal instability in amniocytes from fetuses of mothers who smoke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOBACCO-SPECIFIC CARCINOGEN; SISTER-CHROMATID EXCHANGE; FRAGILE SITES; CIGARETTE-SMOKING; CHILDHOOD-CANCER; MATERNAL SMOKING; IN-UTERO; ABERRATION; WOMEN; REARRANGEMENTS	Context Tobacco increases the risk of systemic diseases, and it has adverse effects on pregnancy. However, only indirect data have been published on a possible genotoxic effect on pregnancy in humans. Objectives To determine whether maternal smoking has a genotoxic effect on amniotic cells, expressed as an increased chromosomal instability, and to analyze whether any chromosomal regions are especially affected by exposure to tobacco. Design, Setting, and Patients In this prospective study, amniocytes were obtained by routine amniocentesis for prenatal diagnosis from 25 controls and 25 women who smoke (greater than or equal to10 cigarettes/d for greater than or equal to10 years), who were asked to fill out a smoking questionnaire concerning their smoking habits. Chromosomal instability was analyzed in blinded fashion by 2 independent observers in routine chromosome spreads. Breakpoints implicated in chromosomal abnormalities were identified by G-banding. Main Outcome Measures Association between maternal smoking and increased chromosomal instability in amniotic fluid cells, expressed as chromosomal lesions (gaps and breaks) and structural chromosomal abnormalities. Results Comparison of cytogenetic data between smokers and nonsmokers (controls) showed important differences for the proportion of structural chromosomal abnormalities (smokers: 12.1 % [96/793]; controls: 3.5% [26/752]; P=.002) and to a lesser degree for the proportion of metaphases with chromosomal instability (smokers: 10.5% [262/2492]; controls: 8.0% [210/2637]; P=.04), and for the proportion of chromosomal lesions (smokers: 15.7% [391/2492]; controls: 10.1 % [267/2637]; P=.045). Statistical analysis of the 689 breakpoints detected showed that band 11q23, which is a band commonly implicated in hematopoietic malignancies, was the chromosomal region most affected by tobacco. Conclusions Our findings show that smoking 10 or more cigarettes per day for at least 10 years and during pregnancy is associated with increased chromosomal instability in amniocytes. Band 11q23, known to be involved in leukemogenesis, seems especially sensitive to genotoxic compounds contained in tobacco.	Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain; Ctr Patol Celular, Barcelona, Spain; Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Egozcue, J (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain.	joselp.egozcue@uab.es	Giraldo, Jesus/F-9881-2011	Giraldo, Jesus/0000-0001-7082-4695				Anderson D, 1997, ENVIRON MOL MUTAGEN, V30, P95, DOI 10.1002/(SICI)1098-2280(1997)30:2<95::AID-EM1>3.0.CO;2-B; BAN S, 1995, MUTAT RES-ENVIR MUTA, V334, P197, DOI 10.1016/0165-1161(95)90011-X; BOHM U, 1995, HUM GENET, V95, P249, DOI 10.1007/BF00225189; CAPOROSSI D, 1995, HUM GENET, V96, P269; CHEN CS, 1993, BLOOD, V81, P2386; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Glover TW, 1998, RECENT RES CANCER, V154, P185; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hall GW, 2001, BEST PRACT RES CL HA, V14, P573, DOI 10.1053/beha.2001.0155; JAFFE ES, 2001, WHO CLASSIFICATION T, P86; Jalili T, 1998, CANCER RES, V58, P2633; Jauniaux E, 1999, OBSTET GYNECOL, V93, P25, DOI 10.1016/S0029-7844(98)00318-4; KERBER S, 1993, PRENATAL DIAG, V13, P21, DOI 10.1002/pd.1970130105; Kolialexi A, 1998, ANTICANCER RES, V18, P2359; Lackmann GM, 1999, J NATL CANCER I, V91, P459, DOI 10.1093/jnci/91.5.459; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; MIGUEZ L, 1991, EARLY HUM DEV, V26, P93, DOI 10.1016/0378-3782(91)90013-S; Milunsky A, 2000, PRENATAL DIAG, V20, P307, DOI 10.1002/(SICI)1097-0223(200004)20:4<307::AID-PD797>3.0.CO;2-M; Musthapa MS, 2004, ENVIRON MOL MUTAGEN, V43, P243, DOI 10.1002/em.20018; Norppa Hannu, 2004, IARC Sci Publ, P179; Pluth JM, 2000, MUTAT RES-GEN TOX EN, V465, P101, DOI 10.1016/S1383-5718(99)00217-X; PRICE PJ, 1988, KARYOGRAM, V14, P10; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rowland RE, 1999, HEREDITAS, V131, P143, DOI 10.1111/j.1601-5223.1999.00143.x; SALONEN K, 1993, MUTAT RES, V298, P285, DOI 10.1016/0165-1218(93)90008-2; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; SHULMAN LP, 1991, AM J OBSTET GYNECOL, V165, P1877, DOI 10.1016/0002-9378(91)90049-W; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P1, DOI 10.1159/000133157; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Stein CK, 2002, GENE CHROMOSOME CANC, V34, P333, DOI 10.1002/gcc.10061; Stokes ME, 2000, CATEGORICAL DATA ANA; Vogler GP, 2002, JAMA-J AM MED ASSOC, V287, P241, DOI 10.1001/jama.287.2.241	35	55	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1212	1222		10.1001/jama.293.10.1212	http://dx.doi.org/10.1001/jama.293.10.1212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755944	Bronze			2022-12-28	WOS:000227498400022
J	Rona, RJ; Hyams, KC; Wessely, S				Rona, RJ; Hyams, KC; Wessely, S			Screening for psychological illness in military personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRITISH ARMED-FORCES; VETERANS; HEALTH; BARRIERS		Inst Psychiat, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England; Kings Coll London, Dept Publ Hlth Sci, London WC2R 2LS, England; Dept Vet Affairs, Off Occupat & Environm Hlth, Washington, DC USA	University of London; King's College London; University of London; King's College London	Wessely, S (corresponding author), Inst Psychiat, Kings Ctr Mil Hlth Res, Weston Educ Ctr, Cutcombe Rd, London SE5 9RJ, England.	s.wessely@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BLIESE P, RES REPORT 2004 001; *DEP DEF, 1997, 64903 DEP DEF; *DIR GEN DEF HLTH, 2003, HLTH B, V11; French C, 2004, J MED SCREEN, V11, P153, DOI 10.1258/0969141041732247; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Gilbody SM, 2001, BRIT MED J, V322, P406, DOI 10.1136/bmj.322.7283.406; GINZBERG E, 2003, J MED SCREEN, V10, P40; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jackson JL, 1999, ARCH FAM MED, V8, P135, DOI 10.1001/archfami.8.2.135; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; LAGUARDIA RL, 1983, AM J ORTHOPSYCHIAT, V53, P18, DOI 10.1111/j.1939-0025.1983.tb03345.x; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; Morrison AS, 1992, SCREENING CHRONIC DI; *NAT CTR PTSD, 2004, IR QAR CLIN GUID; Rona RJ, 2004, J MED SCREEN, V11, P158, DOI 10.1258/0969141041732210; Rona RJ, 2004, J MED SCREEN, V11, P148, DOI 10.1258/0969141041732193; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; VETERANS HEALTH ADMINISTRATION DEPARTMENT OF DEFENSE, CLIN PRACT GUID MAN; Wessely S, 2004, PSYCHIATRY, V67, P153, DOI 10.1521/psyc.67.2.153.35953; Wessely S, 2004, WAR SOC, V22, P89, DOI DOI 10.1179/072924704791202130; Wilson JMG, 1968, PRINCIPLES PRACTICE; Wright KM, 2002, MIL MED, V167, P853, DOI 10.1093/milmed/167.10.853; WRIGHT KM, IN PRESS MIL MED	28	58	59	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1257	1260		10.1001/jama.293.10.1257	http://dx.doi.org/10.1001/jama.293.10.1257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904LB	15755948				2022-12-28	WOS:000227498400026
J	Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM				Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM		Georgia Emerging Infections Progra	Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment	LANCET			English	Article							EFFLUX; PREVALENCE; MEF(A); GENES; MEFE	Background The prevalence of macrolide resistance in Streptococcus pneumoniae has risen in recent years after the introduction of new macrolides and their increased use. We assessed emergence of macrolide-resistant invasive S pneumoniae disease in Atlanta, CA, USA, before and after the licensing, in February 2000, of the heptavalent pneumococcal conjugate vaccine for young children. Methods Prospective population-based surveillance was used to obtain pneumococcal isolates and demographic data from patients with invasive pneumococcal disease. We calculated cumulative incidence rates for invasive pneumococcal disease for 1994-2002 using population estimates and census data from the US Census Bureau. Findings The incidence of invasive pneumococcal disease in Atlanta fell from 30.2 per 100 000 population (mean annual incidence 1994-99) to 13.1 per 100 000 in 2002 (p < 0.0001). Striking reductions were seen in children younger than 2 years (82% decrease) and in those 2-4 years (71% decrease), age-groups targeted to receive pneumococcal conjugate vaccine. Significant declines were also noted in adults aged 20-39 (54%), 40-64 (25%), and 65 years and older (39%). Macrolide resistance in invasive S pneumoniae disease in Atlanta, after increasing steadily from 4.5 per 100 000 in 1994 to 9.3 per 100 000 in 1999, fell to 2.9 per 100 000 by 2002. Reductions in disease caused by mefE-mediated and erm-mediated macrolide-resistant isolates of conjugate-vaccine serotypes 6B, 9V, 19F, and 23F, and the vaccine-associated serotype 6A were also recorded. Interpretation Vaccines can be a powerful strategy for reducing antibiotic resistance in a community.	Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; VA Med Ctr, Res Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA; Georgia Dept Human Resources, Div Publ Hlth, Atlanta, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Stephens, DS (corresponding author), Emory Univ Hosp, Dept Med, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dstep01@emory.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022; Stephens, David S/A-8788-2012	Zughaier, Susu/0000-0001-7487-8770; 				Angot P, 2000, EUR J CLIN MICROBIOL, V19, P755, DOI 10.1007/PL00011229; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arpin C, 1999, ANTIMICROB AGENTS CH, V43, P944, DOI 10.1128/AAC.43.4.944; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P658; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1140; Centers for Disease Control and Prevention (CDC), 2003, MMWR MORB MORTAL WKL, V52, P987; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; Del Grosso M, 2002, J CLIN MICROBIOL, V40, P774, DOI 10.1128/JCM.40.3.774-778.2002; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Gay K, 2001, J INFECT DIS, V184, P56, DOI 10.1086/321001; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Huebner RE, 2000, Int J Infect Dis, V4, P214, DOI 10.1016/S1201-9712(00)90112-7; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; KLUGMAN KP, 2002, EUR RESPIR J, V36, P3; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; *NAT COMM CLIN LAB, 1998, M100SB NCCLS; Nuermberger E, 2004, CLIN INFECT DIS, V38, P99, DOI 10.1086/380126; Okamoto Hiroki, 2002, Journal of Infection and Chemotherapy, V8, P28; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Smith PJ, 2001, AM J PREV MED, V20, P17, DOI 10.1016/S0749-3797(01)00285-9; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P2118, DOI 10.1128/AAC.44.8.2118-2125.2000; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	127	134	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					855	863		10.1016/S0140-6736(05)71043-6	http://dx.doi.org/10.1016/S0140-6736(05)71043-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752529				2022-12-28	WOS:000227444600027
J	Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P				Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P			How visual stimuli activate dopaminergic neurons at short latency	SCIENCE			English	Article							PRIMATE SUPERIOR COLLICULUS; MIDBRAIN DOPAMINE; SUBSTANTIA-NIGRA; RATS; INHIBITION; RECEPTORS; RESPONSES; RELEASE; EVENTS; SIGNAL	Unexpected, biologically salient stimuli elicit a short-latency, phasic response in midbrain dopaminergic (DA) neurons. Although this signal is, important for reinforcement learning the information it conveys to forebrain target structures remains uncertain. One way to decode the phasic DA signal would be to determine the perceptual properties of sensory inputs to DA neurons. After local disinhibition of the superior colliculus in anesthetized rats, DA neurons became visually responsive, whereas disinhibition of the visual cortex was ineffective. As the primary source of visual afferents, the limited processing capacities of the colliculus may constrain the visual information content of phasic DA responses.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	University of Sheffield; Macquarie University	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	P.Redgrave@sheffield.ac.uk	Coizet, Véronique/T-1601-2019	Coizet, Véronique/0000-0001-5192-6610; Overton, Paul/0000-0003-4334-261X; Dommett, Eleanor/0000-0002-6973-8762; Blaha, Charles/0000-0001-5155-1505				BINNS KE, 1995, VISUAL NEUROSCI, V12, P563, DOI 10.1017/S0952523800008452; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Katsuta H, 2003, NEUROSCI RES, V46, P73, DOI 10.1016/S0168-0102(03)00029-4; Michael DJ, 1999, J PHARMACEUT BIOMED, V19, P33, DOI 10.1016/S0731-7085(98)00145-9; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1981, PSYCHOPHARMACOLOGY, V75, P198, DOI 10.1007/BF00432187; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sefton Ann Jervie, 1995, P833; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; STEIN BE, 1991, ELECTROPHYSIOLOGY VI, P85; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	26	214	224	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1476	1479		10.1126/science.1107026	http://dx.doi.org/10.1126/science.1107026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746431				2022-12-28	WOS:000227503100050
J	Clarke, P; Glick, S; Reilly, BM				Clarke, P; Glick, S; Reilly, BM			Clinical problem-solving: On the threshold - A diagnosis of exclusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, 1900 W Polk St,1501-A, Chicago, IL 60612 USA.	breilly@cchil.org						[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; CALABRESE LH, 1992, CLEV CLIN J MED, V59, P293, DOI 10.3949/ccjm.59.3.293; CHITTURI S, 2003, SCHIFFS DIS LIVER, P1059; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HUMPHRIES M, 1992, THORAX, V47, P577, DOI 10.1136/thx.47.8.577; Kasik JE., 1999, TUBERCULOSIS NONTUBE, P175; KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; Nguyen LN, 1996, ARCH NEUROL-CHICAGO, V53, P771, DOI 10.1001/archneur.1996.00550080093017; OFFENBACHER H, 1991, J NEUROL, V238, P340, DOI 10.1007/BF00315335; Ozates M, 2000, ACTA RADIOL, V41, P13; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Zuger Abigail, 1997, P417	15	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					919	924		10.1056/NEJMcps040804	http://dx.doi.org/10.1056/NEJMcps040804			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745983				2022-12-28	WOS:000227310700012
J	Loog, M; Morgan, DO				Loog, M; Morgan, DO			Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates	NATURE			English	Article							B-TYPE CYCLINS; S-PHASE; SACCHAROMYCES-CEREVISIAE; RECOGNITION MOTIF; FISSION YEAST; BUDDING YEAST; CELL CYCLE; MITOSIS; REPLICATION; EXIT	Cell-cycle events are controlled by cyclin-dependent kinases (CDKs), whose periodic activation is driven by cyclins. Different cyclins promote distinct cell-cycle events, but the molecular basis for these differences remains unclear(1,2). Here we compare the specificity of two budding yeast cyclins, the S-phase cyclin Clb5 and the M-phase cyclin Clb2, in the phosphorylation of 150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5 - Cdk1 than Clb2 - Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, Orc6, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate ( the RXL or Cy motif). Phosphorylation of Clb5-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5 specificity in vivo. Although we did not identify any highly Clb2-specific substrates, we found that Clb2 - Cdk1 possessed higher intrinsic kinase activity than Clb5 - Cdk1, enabling efficient phosphorylation of a broad range of mitotic Cdk1 targets. Thus, Clb5 and Clb2 use distinct mechanisms to enhance the phosphorylation of S-phase and M-phase substrates.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	dmorgan@cgl.ucsf.edu		Morgan, David/0000-0001-8753-4416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1996, MOL CELL BIOL, V16, P6623; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Donaldson AD, 2000, EMBO REP, V1, P507; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Miller ME, 2001, J CELL SCI, V114, P1811; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Stern B, 1996, TRENDS GENET, V12, P345; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X	29	286	288	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					104	108		10.1038/nature03329	http://dx.doi.org/10.1038/nature03329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744308				2022-12-28	WOS:000227334600052
J	Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Balogh, A; Bertucci, C; Burton, ME; Cowley, SWH; Erdos, G; Giampieri, G; Glassmeier, KH; Khurana, KK; Leisner, J; Neubauer, FM; Russell, CT; Smith, EJ; Southwood, DJ; Tsurutani, BT				Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Balogh, A; Bertucci, C; Burton, ME; Cowley, SWH; Erdos, G; Giampieri, G; Glassmeier, KH; Khurana, KK; Leisner, J; Neubauer, FM; Russell, CT; Smith, EJ; Southwood, DJ; Tsurutani, BT			Cassini magnetometer observations during Saturn orbit insertion	SCIENCE			English	Article							INTERPLANETARY MAGNETIC-FIELD; SOLAR-WIND; BOW SHOCKS; MAGNETOSPHERE; MODEL; MAGNETOPAUSE; WAVES	Cassini's successful orbit insertion has provided the first examination of Saturn's magnetosphere in 23 years, revealing a dynamic plasma and magnetic environment on short and long time scales. There has been no noticeable change in the internal magnetic field, either in its strength or its near-alignment with the rotation axis. However, the external magnetic field is different compared with past spacecraft observations. The current sheet within the magnetosphere is thinner and more extended, and we observed small diamagnetic cavities and ion cyclotron waves of types that were not reported before.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; CESR, F-31028 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; European Space Agcy, F-75738 Paris, France	Imperial College London; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Leicester; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Braunschweig University of Technology; University of California System; University of California Los Angeles; University of Cologne; European Space Agency	Dougherty, MK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	m.dougherty@imperial.ac.uk	Arridge, Christopher S/A-2894-2009; Bertucci, Cesar/GOG-8941-2022; Russell, Christopher T/E-7745-2012; tsurutani, bruce/G-5835-2019; Achilleos, Nicholas/C-1647-2008	Arridge, Christopher S/0000-0002-0431-6526; Russell, Christopher T/0000-0003-1639-8298; tsurutani, bruce/0000-0001-7299-9835; Khurana, Krishan/0000-0002-2856-1171; Bertucci, Cesar/0000-0002-2540-5384; Achilleos, Nicholas/0000-0002-5886-3509; Cowley, Stanley/0000-0002-4041-0034				ACUNA MH, 1983, J GEOPHYS RES-SPACE, V88, P8771, DOI 10.1029/JA088iA11p08771; Bunce EJ, 2003, ANN GEOPHYS-GERMANY, V21, P1709, DOI 10.5194/angeo-21-1709-2003; CONNERNEY JEP, 1983, J GEOPHYS RES-SPACE, V88, P8779, DOI 10.1029/JA088iA11p08779; DAVIS L, 1990, J GEOPHYS RES-SPACE, V95, P15257, DOI 10.1029/JA095iA09p15257; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Giampieri G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020194; Jackman CM, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010614; NESS NF, 1981, SCIENCE, V212, P211, DOI 10.1126/science.212.4491.211; NESS NF, 1982, SCIENCE, V215, P558, DOI 10.1126/science.215.4532.558; RUSSELL CT, 1982, NATURE, V296, P45, DOI 10.1038/296045a0; Russell CT, 2000, ADV SPACE RES, V26, P1489, DOI 10.1016/S0273-1177(00)00083-1; SCHULZ M, 1987, GEOPHYS RES LETT, V14, P182, DOI 10.1029/GL014i003p00182; SLAVIN JA, 1985, J GEOPHYS RES-SPACE, V90, P6275, DOI 10.1029/JA090iA07p06275; SLAVIN JA, 1983, GEOPHYS RES LETT, V10, P9, DOI 10.1029/GL010i001p00009; SMITH EJ, 1980, J GEOPHYS RES-SPACE, V85, P5655, DOI 10.1029/JA085iA11p05655; SMITH EJ, 1983, J GEOPHYS RES-SPACE, V88, P7831, DOI 10.1029/JA088iA10p07831; Tsyganenko N.A., 2002, J GEOPHYS RES, V107; TSYGANENKO NA, 1995, J GEOPHYS RES-SPACE, V100, P5599, DOI 10.1029/94JA03193; TSYGANENKO NA, 1989, PLANET SPACE SCI, V37, P5, DOI 10.1016/0032-0633(89)90066-4	20	194	194	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1266	1270		10.1126/science.1106098	http://dx.doi.org/10.1126/science.1106098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731444				2022-12-28	WOS:000227313200046
J	Buttgereit, F; Burmester, GR; Lipworth, BJ				Buttgereit, F; Burmester, GR; Lipworth, BJ			Optimised glucocorticoid therapy: the sharpening of an old spear	LANCET			English	Review							SCINTIGRAPHIC DETECTION; TRANSACTIVATION; MECHANISMS; INFECTION; LIPOSOMES; EFFICACY; LEADS; MODEL	Context Glucocorticoids are frequently and successfully used drugs that mediate important immunosuppressive and anti-inflammatory effects. These drugs are also relatively inexpensive, but it is their broad range of adverse reactions that continuously stimulate efforts to optimise glucocorticoid treatment. Starting point Last year, Mary Leonard and colleagues studied 60 children and adolescents with nephrotic syndrome intermittently treated with high-dose glucocorticoids (N Engl J Med 2004; 351: 868-75). The patients received an average of 23 g glucocorticoids and were significantly shorter, had a significantly greater body-mass index, and the prevalence of obesity was significantly higher than in controls. The expected deficits in the bone-mineral content of the spine or whole body were not seen, although this finding could be attributed to the highly increased body-mass index of many of the patients. Where next Glucocorticoids are urgently needed to treat a wide range of diseases in children and adults. Therefore strategies such as preferred local application or fine-tuned dose regimens have been developed over the past five decades to improve the benefit-risk ratio. However, these efforts with conventional glucocorticoid drugs seem to have almost reached their limits. A further improvement needs qualitatively new drugs, which are currently in the development pipeline, with the most promising being the nitrosoglucocorticoids (nitrosteroids) and selective glucocorticoid-receptor agonists.	Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland; Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany	University of Dundee; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	b.j.lipworth@dundee.ac.uk	Burmester, Gerd R./AAY-7514-2020	Buttgereit, Frank/0000-0003-2534-550X				Bachrach LK, 2004, NEW ENGL J MED, V351, P924, DOI 10.1056/NEJMe048193; Buttgereit F, 2004, ARTHRITIS RHEUM-US, V50, P3408, DOI 10.1002/art.20583; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Dams ETM, 2000, J NUCL MED, V41, P622; Kirwan JR, 1999, RHEUMATOLOGY, V38, P100, DOI 10.1093/rheumatology/38.2.100; Laverman P, 1999, ADV DRUG DELIVER REV, V37, P225, DOI 10.1016/S0169-409X(98)00095-7; Leonard MB, 2004, NEW ENGL J MED, V351, P868, DOI 10.1056/NEJMoa040367; Lin CW, 2002, MOL PHARMACOL, V62, P297, DOI 10.1124/mol.62.2.297; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Miner JN, 2002, BIOCHEM PHARMACOL, V64, P355, DOI 10.1016/S0006-2952(02)01121-8; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Paul-Clark M, 2000, BRIT J PHARMACOL, V131, P1345, DOI 10.1038/sj.bjp.0703704; Paul-Clark MJ, 2003, J IMMUNOL, V171, P3245, DOI 10.4049/jimmunol.171.6.3245; Paul-Clark MJ, 2002, P NATL ACAD SCI USA, V99, P1677, DOI 10.1073/pnas.022641099; Perretti M, 2003, DIGEST LIVER DIS, V35, pS41, DOI 10.1016/S1590-8658(03)00051-3; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schmidt J, 2003, BRAIN, V126, P1895, DOI 10.1093/brain/awg176; Yoshiuchi I, 1998, J CLIN ENDOCR METAB, V83, P1016, DOI 10.1210/jc.83.3.1016	21	141	156	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					801	803						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733723				2022-12-28	WOS:000227285300029
J	Young, ED; Simon, JI; Galy, A; Russell, SS; Tonui, E; Lovera, O				Young, ED; Simon, JI; Galy, A; Russell, SS; Tonui, E; Lovera, O			Supra-canonical Al-26/Al-27 and the residence time of CAls in the solar protoplanetary disk	SCIENCE			English	Article							REFRACTORY INCLUSIONS; ALLENDE METEORITE; CHONDRULES; NEBULA; PARTICLES; SYSTEM; AL-26	The canonical initial Al-26/At-27 ratio of 4.5 x 10(-5) has been a fiducial marker for the beginning of the solar system. Laser ablation and whole-rock multiple-collector inductively coupled plasma-source mass spectrometry magnesium isotope analyses of calcium- and aluminum-rich inclusions (CAIs) from CV3 meteorites demonstrate that some CAIs had initial Al-26/Al-27 values at least 25% greater than canonical and that the canonical initial Al-26/Al-27 cannot mark the beginning of solar system formation. Using rates of Mg diffusion in minerals, we find that the canonical initial Al-26/Al-27 is instead the culmination of thousands of brief high-temperature events incurred by CAIs during a 10(5)-year residence time in the solar protoplanetary disk.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Nat Hist Museum, London SW7 5BD, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Cambridge; Natural History Museum London	Young, ED (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	eyoung@ess.ucla.edu	Galy, Albert/A-8518-2011; Simon, Justin/D-7015-2011; Galy, Albert/M-3101-2019	Galy, Albert/0000-0001-9978-4287; Galy, Albert/0000-0001-9978-4287; Young, Edward/0000-0002-1299-0801; Russell, Sara/0000-0001-5531-7847				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Bizzarro M, 2004, NATURE, V431, P275, DOI 10.1038/nature02882; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; GALY A, 2004, LUNAR PLANETARY SCI, V35; GREENWOOD JP, 2004, LUNAR PLANETARY SCI, V35; Keil K, 2000, PLANET SPACE SCI, V48, P887, DOI 10.1016/S0032-0633(00)00054-4; LaTourrette T, 1998, EARTH PLANET SC LETT, V158, P91, DOI 10.1016/S0012-821X(98)00048-X; LATOURRETTE T, 1999, LUNAR PLANETARY SCI, V30; Lee T, 1974, GEOPHYS RES LETT, V1, P225, DOI 10.1029/GL001i006p00225; LOVERA O, 1989, J GEOPHYS RES, V94, P17017; MACPHERSON GJ, 1993, GEOCHIM COSMOCHIM AC, V57, P231, DOI 10.1016/0016-7037(93)90481-B; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; Mahon K. I., 1996, IGRV, V38, P293, DOI [DOI 10.1080/00206819709465336, 10.1080/00206819709465336]; McSween H. Y., 2002, ASTEROIDS, P559; PODOSEK FA, 1991, GEOCHIM COSMOCHIM AC, V55, P1083, DOI 10.1016/0016-7037(91)90165-2; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2159, DOI 10.1016/0016-7037(82)90192-2; UREY HC, 1955, P NATL ACAD SCI USA, V41, P127, DOI 10.1073/pnas.41.3.127; Wadhwa M., 2000, PROTOSTARS PLANETS, P995; Weidenschilling SJ, 2003, ICARUS, V165, P438, DOI 10.1016/S0019-1035(03)00169-6; Wood JA, 1996, METORIT PLANET SCI, V31, P641, DOI 10.1111/j.1945-5100.1996.tb02037.x; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P683, DOI 10.1016/S0016-7037(01)00796-7	25	136	138	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					223	227		10.1126/science.1108140	http://dx.doi.org/10.1126/science.1108140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15746387				2022-12-28	WOS:000228273700044
J	Ridker, PM; Cook, NR; Lee, IM; Gordon, D; Gaziano, JM; Manson, JE; Hennekens, CH; Buring, JE				Ridker, PM; Cook, NR; Lee, IM; Gordon, D; Gaziano, JM; Manson, JE; Hennekens, CH; Buring, JE			A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHIBITION; CORONARY; UPDATE; STROKE; RISK; AGE	Background: Randomized trials have shown that low-dose aspirin decreases the risk of a first myocardial infarction in men, with little effect on the risk of ischemic stroke. There are few similar data in women. Methods: We randomly assigned 39,876 initially healthy women 45 years of age or older to receive 100 mg of aspirin on alternate days or placebo and then monitored them for 10 years for a first major cardiovascular event (i.e., nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes). Results: During follow-up, 477 major cardiovascular events were confirmed in the aspirin group, as compared with 522 in the placebo group, for a nonsignificant reduction in risk with aspirin of 9 percent (relative risk, 0.91; 95 percent confidence interval, 0.80 to 1.03; P=0.13). With regard to individual end points, there was a 17 percent reduction in the risk of stroke in the aspirin group, as compared with the placebo group (relative risk, 0.83; 95 percent confidence interval, 0.69 to 0.99; P=0.04), owing to a 24 percent reduction in the risk of ischemic stroke (relative risk, 0.76; 95 percent confidence interval, 0.63 to 0.93; P=0.009) and a nonsignificant increase in the risk of hemorrhagic stroke (relative risk, 1.24; 95 percent confidence interval, 0.82 to 1.87; P=0.31). As compared with placebo, aspirin had no significant effect on the risk of fatal or nonfatal myocardial infarction (relative risk, 1.02; 95 percent confidence interval, 0.84 to 1.25; P=0.83) or death from cardiovascular causes (relative risk, 0.95; 95 percent confidence interval, 0.74 to 1.22; P=0.68). Gastrointestinal bleeding requiring transfusion was more frequent in the aspirin group than in the placebo group (relative risk, 1.40; 95 percent confidence interval, 1.07 to 1.83; P=0.02). Subgroup analyses showed that aspirin significantly reduced the risk of major cardiovascular events, ischemic stroke, and myocardial infarction among women 65 years of age or older. Conclusions: In this large, primary-prevention trial among women, aspirin lowered the risk of stroke without affecting the risk of myocardial infarction or death from cardiovascular causes, leading to a nonsignificant finding with respect to the primary end point.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Univ Miami, Sch Med, Dept Med, Miami, FL USA; Univ Miami, Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL USA; Florida Atlantic Univ, Ctr Excellence, Dept Biomed Sci, Miami, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Miami; University of Miami; State University System of Florida; Florida Atlantic University	Buring, JE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	jburing@rics.bwh.harvard.edu	Lee, I-Min/ABD-5409-2021		NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; *COLL GROUP PRIM P, 2001, LANCET, V357, P1134; Eidelman RS, 2003, ARCH INTERN MED, V163, P2006, DOI 10.1001/archinte.163.17.2006; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kjeldsen SE, 2000, J HYPERTENS, V18, P629, DOI 10.1097/00004872-200018050-00017; Kurth T, 2003, CIRCULATION, V108, P1191, DOI 10.1161/01.CIR.0000087593.07533.9B; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Linfante A, 2004, CIRCULATION, V110, P664; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Meade TW, 1998, LANCET, V351, P233; MONTGOMERY PR, 1986, CLIN PHARMACOL THER, V39, P571, DOI 10.1038/clpt.1986.98; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pulcinelli FM, 2004, J AM COLL CARDIOL, V43, P979, DOI 10.1016/j.jacc.2003.08.062; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker P M, 1996, J Cardiovasc Risk, V3, P209, DOI 10.1097/00043798-199604000-00013; Rodondi N, 2004, AM J MED, V117, P528, DOI 10.1016/j.amjmed.2004.07.037; Sanderson S, 2005, ANN INTERN MED, V142, P370, DOI 10.7326/0003-4819-142-5-200503010-00012; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X	26	1460	1541	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1293	1304		10.1056/NEJMoa050613	http://dx.doi.org/10.1056/NEJMoa050613			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15753114				2022-12-28	WOS:000227998300006
J	Eccles, SA; Paon, L				Eccles, SA; Paon, L			Breast cancer metastasis: when, where, how?	LANCET			English	Editorial Material									Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK	Eccles, SA (corresponding author), Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England.	Sue.Eccles@icr.ac.uk						Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Brandt B, 1998, INT J CANCER, V76, P824, DOI 10.1002/(SICI)1097-0215(19980610)76:6<824::AID-IJC10>3.0.CO;2-2; EPSTEIN RJ, 2004, NAT REV CANCER, P1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Zeelenberg IS, 2003, CANCER RES, V63, P3833	8	14	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1006	1007		10.1016/S0140-6736(05)71116-8	http://dx.doi.org/10.1016/S0140-6736(05)71116-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781080				2022-12-28	WOS:000227731800005
J	MacMahon, S; Neal, B; Rodgers, A				MacMahon, S; Neal, B; Rodgers, A			Hypertension - time to move on	LANCET			English	Editorial Material							BLOOD-PRESSURE; DISEASE		Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	University of Sydney; University of Auckland	MacMahon, S (corresponding author), Royal Prince Alfred Hosp, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	smacmahon@thegeorgeinstitute.org		MacMahon, Stephen/0000-0003-2064-7699; Rodgers, Anthony/0000-0003-1282-1896; Neal, Bruce/0000-0002-0490-7465				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Fox KM, 2003, LANCET, V362, P782; HARINGTON M, 1959, BRIT MED J, V2, P969, DOI 10.1136/bmj.2.5158.969; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1994, HYPERTENS RES, V17, P23; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; *NZ GUID GROUP, 2003, GUID DET MAN CARD DI; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; *REUT BUS INS HEAL, 2003, CARD MARK OUTL 2008; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Turnbull F, 2003, LANCET, V362, P1527; WHO, 2002, RED RISKS PROM HLTH; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Yusuf S, 2000, NEW ENGL J MED, V342, P145	17	44	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1108	1109						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781107				2022-12-28	WOS:000227731800036
J	Marin, JM; Carrizo, SJ; Vicente, E; Agusti, AGN				Marin, JM; Carrizo, SJ; Vicente, E; Agusti, AGN			Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study	LANCET			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; CONTROLLED-TRIALS; CEREBRAL-INFARCTION; RISK-FACTORS; FOLLOW-UP; MORTALITY; POPULATION; HEALTH; HYPERTENSION	Background The effect of obstructive sleep apnoea-hypopnoea as a cardiovascular risk factor and the potential protective effect of its treatment with continuous positive airway pressure (CPAP) is unclear. We did an observational study to compare incidence of fatal and non-fatal cardiovascular events in simple snorers, patients with untreated obstructive sleep apnoea-hypopnoea, patients treated with CPAP, and healthy men recruited from the general population. Methods We recruited men with obstructive sleep apnoea-hypopnoea or simple snorers from a sleep clinic, and a population-based sample of healthy men, matched for age and body-mass index with the patients with untreated severe obstructive sleep apnoea-hypopnoea. The presence and severity of the disorder was determined with full polysonmography, and the apnoea-hypopnoea index (AHI) was calculated as the average number of apnoeas and hypopnoeas per hour of sleep. Participants were followed-up at least once per year for a mean of 10.1 years (SD 1.6) and CPAP compliance was checked with the built-in meter. Endpoints were fatal cardiovascular events (death from myocardial infarction or stroke) and non-fatal cardiovascular events (non-fatal myocardial infarction, non-fatal stroke, coronary artery bypass surgery, and percutaneous transluminal coronary angiography). Findings 264 healthy men, 377 simple snorers, 403 with untreated mild-moderate obstructive sleep apnoea-hypopnoea, 235 with untreated severe disease, and 372 with the disease and treated with CPAP were included in the analysis. Patients with untreated severe disease had a higher incidence of fatal cardiovascular events (1.06 per 100 person-years) and non-fatal cardiovascular events (2.13 per 100 person-years) than did untreated patients with mild-moderate disease (0.55, p=0.02 and 0.89, p<0.0001), simple snorers (0.34, p=0.0006 and 0.58, p<0.0001), patients treated with CPAP (0.35, p=0.0008 and 0.64, p<0.0001), and healthy participants (0.3, p=0.0012 and 0.45, p<0.0001). Multivariate analysis, adjusted for potential confounders, showed that untreated severe obstructive sleep apnoea-hypopnoea significantly increased the risk of fatal (odds ratio 2.87, 95%Cl 1.17-7.51) and non-fatal (3.17, 1.12-7.51) cardiovascular events compared with healthy participants. Interpretation In men, severe obstructive sleep apnoea-hypopnoea significantly increases the risk of fatal and non-fatal cardiovascular events. CPAP treatment reduces this risk.	Hosp Univ Miguel Servet, Resp Serv, Zaragoza, Spain; IUNICS, Hosp Univ Son Dureta, Resp Serv, Palma de Mallorca, Spain	Miguel Servet University Hospital; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears	Marin, JM (corresponding author), Hosp Univ Miguel Servet, Serv Neurol, Isabel la Catolica, Zaragoza 50006, Spain.	jmmarint@unizar.es	CARRIZO SIERRA, SANTIAGO/AAO-1780-2021; Lavu, Madhav/A-9409-2013; Garcia-Navarro, Alvar Agusti/F-4474-2015	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Marin Trigo, Jose Maria/0000-0001-9096-2294				AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; [Anonymous], 1983, PROP MULT MON TRENDS; Ballester E, 1999, AM J RESP CRIT CARE, V159, P495, DOI 10.1164/ajrccm.159.2.9804061; Barbe F, 1998, AM J RESP CRIT CARE, V158, P18, DOI 10.1164/ajrccm.158.1.9709135; Bassetti C, 1996, NEUROLOGY, V47, P1167, DOI 10.1212/WNL.47.5.1167; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BOBINSKY G, 1995, CHEST, V108, P625; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; COX DR, 1972, J R STAT SOC B, V34, P187; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; GONZALEZROTHI RJ, 1988, CHEST, V94, P531, DOI 10.1378/chest.94.3.531; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; HEDNER JA, 1992, AM REV RESPIR DIS, V146, P1240, DOI 10.1164/ajrccm/146.5_Pt_1.1240; Hu FB, 2000, J AM COLL CARDIOL, V35, P308, DOI 10.1016/S0735-1097(99)00540-9; Imadojemu VA, 2002, AM J RESP CRIT CARE, V165, P950, DOI 10.1164/ajrccm.165.7.2102003; Iranzo A, 2002, NEUROLOGY, V58, P911, DOI 10.1212/WNL.58.6.911; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JENNUM P, 1995, CHEST, V108, P138, DOI 10.1378/chest.108.1.138; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kannel WB, 1971, FRAMINGHAM STUDY EPI; Karlawish JHT, 2001, AM J RESP CRIT CARE, V163, P809, DOI 10.1164/ajrccm.163.4.ed0201d; Kato M, 2000, CIRCULATION, V102, P2607; KOSKENVUO M, 1987, BRIT MED J, V294, P16, DOI 10.1136/bmj.294.6563.16; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Lindberg E, 1998, THORAX, V53, P631, DOI 10.1136/thx.53.8.631; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; Marin JM, 1997, INT J EPIDEMIOL, V26, P381, DOI 10.1093/ije/26.2.381; Milleron O, 2004, EUR HEART J, V25, P728, DOI 10.1016/j.ehj.2004.02.008; Montserrat J M, 1998, Arch Bronconeumol, V34, P204; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; MOORE T, 2001, AM J RESP CRIT CARE, V164, P1910; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P717, DOI 10.1164/ajrccm.152.2.7633732; PALOMAKI H, 1991, STROKE, V22, P1021, DOI 10.1161/01.STR.22.8.1021; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; PARTINEN M, 1985, LANCET, V2, P1325; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; RECHTSCHAFEN A, 1968, MANUAL STANDADIZED T; Sanner BM, 2000, EUR RESPIR J, V16, P648, DOI 10.1034/j.1399-3003.2000.16d14.x; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; WALKER AE, 1981, STROKE S1, V12; WILKOX I, 1993, SLEEP, V16, P539; Wright J, 1998, THORAX, V53, P410, DOI 10.1136/thx.53.5.410; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	51	3180	3326	5	171	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1046	1053		10.1016/S0140-6736(05)71141-7	http://dx.doi.org/10.1016/S0140-6736(05)71141-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781100				2022-12-28	WOS:000227731800029
J	McCloskey, J; Nalbant, SS; Steacy, S				McCloskey, J; Nalbant, SS; Steacy, S			Indonesian earthqauake: Earthquake risk from co-seismic stress.	NATURE			English	Article							FAULT; SEA		Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, County Derry, North Ireland	Ulster University	McCloskey, J (corresponding author), Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, County Derry, North Ireland.	j.mccloskey@ulster.ac.uk	Steacy, Sandy/AAB-1173-2020	Steacy, Sandy/0000-0001-8606-3296; Nalbant, Suleyman Sami/0000-0002-7944-5912				Genrich JF, 2000, J GEOPHYS RES-SOL EA, V105, P28327, DOI 10.1029/2000JB900158; Hubert-Ferrari A, 2000, NATURE, V404, P269, DOI 10.1038/35005054; Nalbant SS, 1998, J GEOPHYS RES-SOL EA, V103, P24469, DOI 10.1029/98JB01491; NEWCOMB KR, 1987, J GEOPHYS RES-SOLID, V92, P421, DOI 10.1029/JB092iB01p00421; Pollitz FF, 1997, B SEISMOL SOC AM, V87, P1; Rydelek PA, 2003, EARTH PLANET SC LETT, V206, P289, DOI 10.1016/S0012-821X(02)01095-6; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; STEIN S, IN PRESS NATURE; Zachariasen J, 1999, J GEOPHYS RES-SOL EA, V104, P895, DOI 10.1029/1998JB900050	9	155	179	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					291	291		10.1038/434291a	http://dx.doi.org/10.1038/434291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772639	Bronze, Green Published			2022-12-28	WOS:000227715100028
J	Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G				Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G		HRSC Co-Investigator Team	Evidence from the Mars Express High Resolution Stereo Camera for a frozen sea close to Mars' equator	NATURE			English	Article							CERBERUS FOSSAE; WATER; PLAINS; FATE; GROUNDWATER; VOLCANISM; STABILITY; EVOLUTION; FLOODS; MODEL	It is thought that the Cerberus Fossae fissures on Mars were the source of both lava and water floods(1,2-4) two to ten million years ago(1,2,5). Evidence for the resulting lava plains has been identified in eastern Elysium(1,2,4,6 - 8), but seas and lakes from these fissures and previous water flooding events were presumed to have evaporated and sublimed away(9-11). Here we present High Resolution Stereo Camera images from the European Space Agency Mars Express spacecraft that indicate that such lakes may still exist. We infer that the evidence is consistent with a frozen body of water, with surface pack-ice, around 5 degrees north latitude and 150 degrees east longitude in southern Elysium. The frozen lake measures about 800 x 900 km in lateral extent and may be up to 45 metres deep - similar in size and depth to the North Sea. From crater counts, we determined its age to be 5 +/- 2 million years old. If our interpretation is confirmed, this is a place that might preserve evidence of primitive life, if it has ever developed on Mars.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; UCL, Dept Geomat Engn, London WC1E 6BT, England; Free Univ Berlin, Inst Geosci, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; European Space Agcy, Res & Sci Support Dept, ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands; Nat Hist Museum, Dept Mineral, London SW7 5PB, England; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England	Open University - UK; University of London; University College London; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Brown University; European Space Agency; Natural History Museum London; Lancaster University	Murray, JB (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	J.B.Murray@open.ac.uk	Hauber, Ernst/U-2521-2018; Werner, Stephanie C/A-6438-2012; Mitchell, Karl Leon/AGL-9516-2022; Muller, Jan-Peter/Q-8886-2019; Mitchell, Karl Leon/AAG-3821-2020; van Gasselt, Stephan/L-9762-2013	Hauber, Ernst/0000-0002-1375-304X; Werner, Stephanie C/0000-0001-5704-0909; Muller, Jan-Peter/0000-0002-5077-3736; Mitchell, Karl Leon/0000-0003-1093-8441; van Gasselt, Stephan/0000-0003-2130-6343				Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; Fuller ER, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001842; Garvin J.B., 2003, 6 INT C MARS; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017135; HUMPRHIS SE, 1995, AM GEOPHYS UNION MON, V91, P1; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; LANAGAN P, 2003, 6 INT C MARS; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LASKAR J, 2004, LUNAR PLANET SCI, V35; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Patrick MR, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002537; Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; RICE JW, 2002, LUNAR PLANET SCI, V33; Skinner B. J., 1966, GEOL SOC AM MEM, DOI [rg/10.1130/MEM97-p75, 10.1130/MEM97-p75]; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; WALLACE D, 1983, ICARUS, V39, P476; Werner SC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002020	28	135	138	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					352	356		10.1038/nature03379	http://dx.doi.org/10.1038/nature03379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772653				2022-12-28	WOS:000227715100043
J	Seaton, A; Donaldson, K				Seaton, A; Donaldson, K			Nanoscience, nanotoxicology, and the need to think small	LANCET			English	Editorial Material							PARTICULATE AIR-POLLUTION; TRANSLOCATION; PARTICLES		Inst Occupat Med, Edinburgh EH14 4AP, Midlothian, Scotland; Univ Edinburgh, Sch Med, Ctr Inflammat Res, ELEGI Colt Lab, Edinburgh, Midlothian, Scotland	University of Edinburgh	Seaton, A (corresponding author), Inst Occupat Med, Res Pk N, Edinburgh EH14 4AP, Midlothian, Scotland.	oem049@abdn.ac.uk						[Anonymous], 1986, ENGINES CREATION; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Donaldson K, 2004, MUTAT RES-FUND MOL M, V553, P5, DOI 10.1016/j.mrfmmm.2004.06.011; FEYNMAN RP, 1960, ENG SCI; Liao DP, 1999, ENVIRON HEALTH PERSP, V107, P521, DOI 10.2307/3434393; Nemmar A, 2004, TOXICOL LETT, V149, P243, DOI 10.1016/j.toxlet.2003.12.061; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Royal Society and the Royal Academy of Engineering, 2004, NAN NAN OPP UNC; Seaton A, 2003, THORAX, V58, P1012, DOI 10.1136/thorax.58.12.1012; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6	10	104	111	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					923	924		10.1016/S0140-6736(05)71061-8	http://dx.doi.org/10.1016/S0140-6736(05)71061-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766981				2022-12-28	WOS:000227559800009
J	Muttoni, G; Erba, E; Kent, DV; Bachtadse, V				Muttoni, G; Erba, E; Kent, DV; Bachtadse, V			Mesozoic Alpine facies deposition as a result of past latitudinal plate motion	NATURE			English	Article							POLARITY CHRONS; PALEOMAGNETISM; NORTHERN; PALEOGEOGRAPHY; RADIOLARITES; SWITZERLAND; COMPLEX; WANDER; CHERTS; MARGIN	The fragmentation of Pangaea as a consequence of the opening of the Atlantic Ocean is documented in the Alpine - Mediterranean region by the onset of widespread pelagic sedimentation(1). Shallow-water sediments were replaced by mainly pelagic limestones in the Early Jurassic period, radiolarian cherts in the Middle - Late Jurassic period, and again pelagic limestones in the Late Jurassic - Cretaceous period(1). During initial extension, basin subsidence below the carbonate compensation depth (CCD) is thought to have triggered the transition from Early Jurassic limestones to Middle - Late Jurassic radiolarites(1). It has been proposed that the transition from radiolarites to limestones in the Late Jurassic period was due to an increase in calcareous nannoplankton abundance when the CCD was depressed below the ocean floor(1). But in modern oceans, sediments below the CCD are not necessarily radiolaritic. Here we present palaeomagnetic samples from the Jurassic - Cretaceous pelagic succession exposed in the Lombardian basin, Italy. On the basis of an analysis of our palaeolatitudinal data in a broader palaeogeographic context, we propose an alternative explanation for the above facies tripartition. We suggest that the Lombardian basin drifted initially towards, and subsequently away from, a near-equatorial upwelling zone of high biosiliceous productivity. Our tectonic model for the genesis of radiolarites adds an essential horizontal plate motion component to explanations involving only vertical variations of CCD relative to the ocean floor. It may explain the deposition of radiolarites throughout the Mediterranean and Middle Eastern region during the Jurassic period.	Univ Milan, Dept Earth Sci, I-20133 Milan, Italy; ALP Alpine Lab Paleomagnetism, I-12016 Peveragno, CN, Italy; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Munich, Dept Geo & Umweltwissensch, D-80333 Munich, Germany	University of Milan; Rutgers State University New Brunswick; Columbia University; University of Munich	Muttoni, G (corresponding author), Univ Milan, Dept Earth Sci, Via Mangiagalli 34, I-20133 Milan, Italy.	giovanni.muttoni1@unimi.it	Bachtadse, Valerian/E-3457-2010	Bachtadse, Valerian/0000-0002-1226-2986; Allam, Sherif/0000-0002-5555-7928; Muttoni, Giovanni/0000-0001-7908-1664; Kent, Dennis/0000-0002-7677-2993				Aiello IW, 2001, GEOL SOC AM BULL, V113, P469, DOI 10.1130/0016-7606(2001)113<0469:PAPOJR>2.0.CO;2; [Anonymous], 1993, PALEOMAGNETISM ATLAN, DOI 10.1017/CBO9780511524936; [Anonymous], 2003, SPEC PAPERS GEOL SOC, DOI DOI 10.1130/0-8137-2373-6.93; Bartolini A, 1999, PALAEOGEOGR PALAEOCL, V145, P43, DOI 10.1016/S0031-0182(98)00097-2; BAUMGARTNER PO, 1987, ECLOGAE GEOL HELV, V80, P831; BAUMGARTNER PO, 1995, MEM GEOL LAUSANNE, V23, P737; Besse J, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002684; BULLARD E, 1965, PHILOS TR R SOC S-A, V258, P41, DOI 10.1098/rsta.1965.0020; CHANNELL JET, 1992, EARTH PLANET SC LETT, V108, P161, DOI 10.1016/0012-821X(92)90020-V; CHANNELL JET, 1995, EARTH PLANET SC LETT, V134, P125, DOI 10.1016/0012-821X(95)00111-O; CHANNELL JET, 1993, EARTH PLANET SC LETT, V118, P145, DOI 10.1016/0012-821X(93)90165-6; CHANNELL JET, 1996, PALAEOMAGNETISM TECT, P119; DEWEVER P, 1994, B CENT RECH EXPL, V18, P315; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; HAGSTRUM JT, 1993, GEOL SOC AM BULL, V105, P766, DOI 10.1130/0016-7606(1993)105<0766:DOFCCA>2.3.CO;2; Hargraves RB, 1999, GEOPHYS J INT, V136, P705, DOI 10.1046/j.1365-246x.1999.00760.x; HARGRAVES RB, 1989, J GEOPHYS RES-SOLID, V94, P1851, DOI 10.1029/JB094iB02p01851; HORNER F, 1983, GEOPHYS J ROY ASTR S, V73, P705, DOI 10.1111/j.1365-246X.1983.tb03341.x; Kennett J., 1982, MARINE GEOLOGY; Klitgord K. D., 1986, GEOLOGY N AM, P351, DOI DOI 10.1130/DNAG-GNA-M.351; Larson R. L., 1992, P ODP SCI RESULTS, V129, P615, DOI DOI 10.2973/0DP.PR0C.SR.129.144.1992; LOTTES A. I., 1990, MEMOIRS, V12, P383; MCFADDEN PL, 1981, GEOPHYS J ROY ASTR S, V67, P19, DOI 10.1111/j.1365-246X.1981.tb02729.x; Muttoni G, 2003, EARTH PLANET SC LETT, V215, P379, DOI 10.1016/S0012-821X(03)00452-7; RICHARDS DR, 1993, CAN J EARTH SCI, V30, P1898, DOI 10.1139/e93-168; SICHLER B, 1980, CAN J EARTH SCI, V17, P1546, DOI 10.1139/e80-162; VANFOSSEN MC, 1993, GEOPHYS J INT, V113, P175, DOI 10.1111/j.1365-246X.1993.tb02538.x; VANFOSSEN MC, 1992, J GEOPHYS RES-SOL EA, V97, P19651, DOI 10.1029/92JB01466; WINTERER EL, 1981, AAPG BULL, V65, P394	30	83	85	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					59	63		10.1038/nature03378	http://dx.doi.org/10.1038/nature03378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744297	Green Published			2022-12-28	WOS:000227334600041
J	Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE				Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE		Diabetes Prevention Program Res Gr	The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance	ANNALS OF INTERNAL MEDICINE			English	Article							MELLITUS; RISK; DISEASE; NIDDM; PREVALENCE; INFARCTION; DIAGNOSIS; THERAPY; OBESITY; STROKE	Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. Objective: To estimate the lifetime cost-utility of the DPP interventions. Design: Markov simulation model to estimate progression of disease, costs, and quality of life. Data Sources: The DPP and published reports. Target Population: Members of the DPP cohort 25 years of age or older with impaired glucose tolerance. Time Horizon: Lifetime. Perspectives: Health system and societal. Interventions: intensive lifestyle, metformin, and placebo interventions as implemented in the DPP. Outcome Measures: Cumulative incidence of diabetes, microvascular and neuropathic complications, cardiovascular complications, survival, direct medical and direct nonmedical costs, quality-adjusted life-years (QALYs), and cost per QALY. Results of Base-Case Analysis: Compared with the placebo intervention, the lifestyle and metformin interventions were estimated to delay the development of type 2 diabetes by 11 and 3 years, respectively, and to reduce the absolute incidence of diabetes by 20% and 8%, respectively. The cumulative incidence of microvascular, neuropathic, and cardiovascular complications were reduced and survival was improved by 0.5 and 0.2 years. Compared with the placebo intervention, the cost per QALY was approximately $1100 for the lifestyle intervention and $31300 for the metformin intervention. From a societal perspective, the interventions cost approximately $8800 and $29 900 per QALY, respectively. From both perspectives, the lifestyle intervention dominated the metformin intervention. Results of Sensitivity Analysis: Cost-effectiveness improved when the interventions were implemented as they might be in routine clinical practice. The lifestyle intervention was cost-effective in all age groups. The metformin intervention did not represent good use of resources for persons older than 65 years of age. Limitations: Simulation results depend on the accuracy of the underlying assumptions, including participant adherence. Conclusions: Health policy should promote diabetes prevention in high-risk individuals.	RTI Int, Res Triangle Pk, NC USA; Univ Michigan, Hlth Syst, Ann Arbor, MI USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Medstar Res Inst, Hyattsville, MD USA	Research Triangle Institute; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Indiana University System; Indiana University-Purdue University Indianapolis	Herman, WH (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Program Coordinating Ctr, 6100 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu		Hicks, Katherine/0000-0002-1058-3401; Hoerger, Thomas/0000-0003-4154-7806	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK048489, U01 DK048489-06] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Barzilay JI, 2001, DIABETES CARE, V24, P1233, DOI 10.2337/diacare.24.7.1233; Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; Bray GA, 1999, DIABETES CARE, V22, P623; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Gold MR, 1996, COST EFFECTIVENESS H; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2003, DIABETES CARE, V26, P3182, DOI 10.2337/diacare.26.11.3182; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Herman WH, 2003, DIABETES CARE, V26, P36; Herman WH, 1998, DIABETIC MED, V15, P1045, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L; *HLTH CAR FIN ADM, 1998, 1999 MED CLIN DIAGN; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; KINGSLEY RG, 1977, J CONSULT CLIN PSYCH, V45, P288, DOI 10.1037/0022-006X.45.2.288; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Qureshi AI, 1998, STROKE, V29, P1329, DOI 10.1161/01.STR.29.7.1329; REIBER GE, 1995, NIH PUBLICATION, P409; Renjilian DA, 2001, J CONSULT CLIN PSYCH, V69, P717, DOI 10.1037//0022-006X.69.4.717; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SCHEFFLER RM, 1992, AM J PUBLIC HEALTH, V82, P168, DOI 10.2105/AJPH.82.2.168; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Thompson TJ, 1996, DIABETIC MED, V13, P337, DOI 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637	41	477	487	0	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					323	332		10.7326/0003-4819-142-5-200503010-00007	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738451	Green Accepted			2022-12-28	WOS:000227325100002
J	Sanderson, S; Emery, J; Baglin, T; Kinmonth, AL				Sanderson, S; Emery, J; Baglin, T; Kinmonth, AL			Narrative review: Aspirin resistance and its clinical implications	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE CORONARY SYNDROMES; BOUND P-SELECTIN; MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; THROMBOXANE BIOSYNTHESIS; OXIDANT STRESS; HIGH-RISK; IN-VIVO; PREVALENCE; MECHANISMS	Aspirin is currently the most cost-effective drug for the secondary prevention of cardiovascular disease, but treatment failures are relatively common. Several factors have been linked to these recurrent vascular events in patients prescribed aspirin, including smoking, drug interactions, nonadherence, comorbid conditions, and aspirin resistance. The term aspirin resistance has been used to describe not only an absence of the expected pharmacologic effects of aspirin on platelets but also poor clinical outcomes, such as recurrent vascular events, in patients treated with aspirin. Aspirin resistance is perhaps more precisely understood as the phenomenon of measurable, persisting platelet activation that occurs in patients prescribed a therapeutic dose of aspirin and may underlie an unknown proportion of aspirin treatment failures. Key challenges for future research are to standardize a definition of aspirin resistance and to compare whether different measures of platelet activation, either alone or in combination, independently predict cardiovascular events. These challenges must be met before researchers conduct studies to assess the clinical utility of testing on patient outcomes and cost-effective prescribing.	Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England; Inst Publ Hlth, Cambridge, England; Univ Western Australia, Claremont, WA USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Western Australia	Sanderson, S (corresponding author), Univ Cambridge, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	simon.sanderson@srl.cam.ac.uk						ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Altman Raul, 2004, Thromb J, V2, P1, DOI 10.1186/1477-9560-2-1; Andersen K, 2002, THROMB RES, V108, P37, DOI 10.1016/S0049-3848(02)00405-X; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Blann AD, 1997, ATHEROSCLEROSIS, V128, P135, DOI 10.1016/S0021-9150(96)05980-1; Bruno A, 2002, STROKE, V33, P57, DOI 10.1161/hs0102.102010; Cambria-Kiely JA, 2002, J THROMB THROMBOLYS, V14, P51, DOI 10.1023/A:1022066305399; Cambria-Kiely JA, 2002, J THROMB THROMBOLYS, V13, P49, DOI 10.1023/A:1015324310374; Carlos Timothy M., 1994, Blood, V84, P2068; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cipollone F, 2000, CIRCULATION, V102, P1007, DOI 10.1161/01.CIR.102.9.1007; Cooke GE, 1998, LANCET, V351, P1253, DOI 10.1016/S0140-6736(05)79320-X; Curtis JP, 2003, BRIT MED J, V327, P1322, DOI 10.1136/bmj.327.7427.1322; Davi G, 1999, CIRCULATION, V99, P224; De Gaetano G, 2003, J THROMB HAEMOST, V1, P2048, DOI 10.1046/j.1538-7836.2003.00354.x; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FitzGerald GA, 2003, LANCET, V361, P542, DOI 10.1016/S0140-6736(03)12560-3; Friend M, 2003, BRIT MED J, V326, P82, DOI 10.1136/bmj.326.7380.82; GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J; Grundmann K, 2003, J NEUROL, V250, P63, DOI 10.1007/s00415-003-0954-y; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Gum PA, 2001, AM J CARDIOL, V88, P230, DOI 10.1016/S0002-9149(01)01631-9; Halushka MK, 2003, CLIN PHARMACOL THER, V73, P122, DOI 10.1067/mcp.2003.1; Hankey GJ, 2004, BMJ-BRIT MED J, V328, P477, DOI 10.1136/bmj.328.7438.477; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; HUNG J, 1995, CIRCULATION, V92, P2432, DOI 10.1161/01.CIR.92.9.2432; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Husain S, 1998, CIRCULATION, V97, P716, DOI 10.1161/01.CIR.97.8.716; Jilma B, 2001, AM J CARDIOL, V88, P1348; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; Kottke-Marchant K, 2002, ARCH PATHOL LAB MED, V126, P133; Kottke-Marchant K, 1999, CLIN APPL THROMB-HEM, V5, P122, DOI 10.1177/107602969900500209; Kurth T, 2003, CIRCULATION, V108, P1191, DOI 10.1161/01.CIR.0000087593.07533.9B; Lim E, 2003, BMJ-BRIT MED J, V327, P1309, DOI 10.1136/bmj.327.7427.1309; Maalej N, 1996, CIRCULATION, V93, P1201, DOI 10.1161/01.CIR.93.6.1201; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; McKee SA, 2002, THROMB HAEMOSTASIS, V88, P711, DOI 10.1055/s-0037-1613290; Mehta SR, 2003, J AM COLL CARDIOL, V41, p79S, DOI 10.1016/S0735-1097(02)02831-0; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Mueller MR, 1997, THROMB HAEMOSTASIS, V78, P1003; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Naber C, 2000, FEBS LETT, V484, P199, DOI 10.1016/S0014-5793(00)02158-X; O'Connor CM, 1999, AM J CARDIOL, V83, P1345, DOI 10.1016/S0002-9149(99)00098-3; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Perneby C, 1999, THROMB RES, V96, P427, DOI 10.1016/S0049-3848(99)00126-7; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Roller RE, 2002, BLOOD COAGUL FIBRIN, V13, P277, DOI 10.1097/00001721-200206000-00001; Rupprecht HJ, 1998, CIRCULATION, V97, P1046, DOI 10.1161/01.CIR.97.11.1046; Sane DC, 2002, AM J CARDIOL, V90, P893, DOI 10.1016/S0002-9149(02)02718-2; Santoso S, 2001, TRANSFUS CLIN BIOL, V8, P261, DOI 10.1016/S1246-7820(01)00123-9; Schafer AI, 2003, CIRCULATION, V108, P910, DOI 10.1161/01.CIR.0000088843.52678.8A; Serebruany VL, 1999, THROMB RES, V96, P51, DOI 10.1016/S0049-3848(99)00063-8; Smout J, 2002, BRIT J SURG, V89, P4, DOI 10.1046/j.0007-1323.2001.01971.x; Steer KA, 1997, HEART, V77, P333, DOI 10.1136/hrt.77.4.333; Tarjan Jeno, 1999, Orvosi Hetilap, V140, P2339; ten Berg JM, 2002, THROMB RES, V105, P385, DOI 10.1016/S0049-3848(02)00040-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Weber AA, 2000, PLATELETS, V11, P177; Weber BL, 2002, CANCER CELL, V1, P37, DOI 10.1016/S1535-6108(02)00026-0; Wu AHB, 2001, AM J CARDIOL, V87, P1361, DOI 10.1016/S0002-9149(01)01553-3; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zimmermann N, 2001, J THORAC CARDIOV SUR, V121, P982, DOI 10.1067/mtc.2001.111416	68	134	150	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					370	380		10.7326/0003-4819-142-5-200503010-00012	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738456				2022-12-28	WOS:000227325100007
J	McPherson, A				McPherson, A			ABC of adolescence - Adolescents in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GENERAL-PRACTICE; HEALTH					rviner@ich.ucl.ac.uk						Gregg R, 1998, BRIT J GEN PRACT, V48, P909; Jacobson LD, 2000, FAM PRACT, V17, P156, DOI 10.1093/fampra/17.2.156; Kari J, 1997, BRIT J GEN PRACT, V47, P109; McPherson A, 1996, BRIT J GEN PRACT, V46, P627; Sanci LA, 2000, BRIT MED J, V320, P224, DOI 10.1136/bmj.320.7229.224	5	39	39	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2005	330	7489					465	467		10.1136/bmj.330.7489.465	http://dx.doi.org/10.1136/bmj.330.7489.465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731145	Green Published			2022-12-28	WOS:000227315400024
J	Holman, MJ; Murray, NW				Holman, MJ; Murray, NW			The use of transit timing to detect terrestrial-mass extrasolar planets	SCIENCE			English	Article							GRAVITATIONAL LENSING EXPERIMENT; LUMINOSITY OBJECT TRANSITS; GALACTIC DISK; SEARCH; COMPANION; SYSTEM	Future surveys for transiting extrasolar planets are expected to detect hundreds of jovian-mass planets and tens of terrestria-mass planets. For many of these newly discovered planets, the intervals between successive transits will be measured with an accuracy of 0.1 to 100 minutes. We show that these timing measurements will allow for the detection of additional planets in the system (not necessarily transiting) by their gravitational interaction with the transiting planet. The transit-time variations depend on the mass of the additional planets and in some cases terrestrial-mass planets will produce a measurable effect. In systems where two planets are seen to transit, the density of both planets can be determined without radial-velocity observations.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Toronto	Holman, MJ (corresponding author), Harvard Smithsonian Ctr Astrophys, MS51,60 Garden St, Cambridge, MA 02138 USA.	mholman@cfa.harvard.edu		Murray, Norman/0000-0002-8659-3729				AGOL E, 2004, ASTROPH0412032; BACKER DC, 1993, NATURE, V365, P817, DOI 10.1038/365817a0; Bodenheimer P, 2003, ASTROPHYS J, V592, P555, DOI 10.1086/375565; Bond IA, 2004, ASTROPHYS J, V606, pL155, DOI 10.1086/420928; Borucki WJ, 2003, P SOC PHOTO-OPT INS, V4854, P129, DOI 10.1117/12.460266; Brown EW, 1936, MON NOT R ASTRON SOC, V97, P0056, DOI 10.1093/mnras/97.1.56; BUTLER P, 2004, ASTROPH0408587; CATALA C, 1995, ASTR SOC P, V76, P426; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; GILLILAND RL, 1993, ASTRON J, V106, P2441, DOI 10.1086/116814; HENRY GW, 2000, APJ, V529, P41; Laughlin G, 2001, ASTROPHYS J, V551, pL109, DOI 10.1086/319847; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; Miralda-Escude J, 2002, ASTROPHYS J, V564, P1019, DOI 10.1086/324279; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; NARAYAN R, 2004, ASTROPH0409766; Sasselov DD, 2003, ASTROPHYS J, V596, P1327, DOI 10.1086/378145; SODERHJELM S, 1975, ASTRON ASTROPHYS, V42, P229; Stoer J., 2013, INTRO NUMERICAL ANAL, VVolume 12, DOI [10.1007/978-0-387-21738-3, DOI 10.1007/978-0-387-21738-3]; Udalski A, 2003, ACTA ASTRONOM, V53, P133; Udalski A, 2002, ACTA ASTRONOM, V52, P1; Udalski A, 2002, ACTA ASTRONOM, V52, P115; WISDOM J, 1980, ASTRON J, V85, P1122, DOI 10.1086/112778; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	30	536	542	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1288	1291		10.1126/science.1107822	http://dx.doi.org/10.1126/science.1107822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731449				2022-12-28	WOS:000227313200052
J	Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD				Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD			State transitions and light adaptation require chloroplast thylakoid protein kinase STN7	NATURE			English	Article							COMPLEX-II LHCII; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; ENERGY-DISTRIBUTION; PHOSPHORYLATION; PHOTOSYNTHESIS; XANTHOPHYLL; FLUORESCENCE; CHLOROPHYLL; MUTANTS	Photosynthetic organisms are able to adjust to changing light conditions through state transitions, a process that involves the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI)(1,2). Balancing of the light absorption capacity of these two photosystems is achieved through the reversible association of the major antenna complex (LHCII) between PSII and PSI (ref. 3). Excess stimulation of PSII relative to PSI leads to the reduction of the plastoquinone pool and the activation of a kinase(4,5); the phosphorylation of LHCII; and the displacement of LHCII from PSII to PSI ( state 2). Oxidation of the plastoquinone pool by excess stimulation of PSI reverses this process ( state 1). The Chlamydomonas thylakoid-associated Ser-Thr kinase Stt7, which is required for state transitions, has an orthologue named STN7 in Arabidopsis(6). Here we show that loss of STN7 blocks state transitions and LHCII phosphorylation. In stn7 mutant plants the plastoquinone pool is more reduced and growth is impaired under changing light conditions, indicating that STN7, and probably state transitions, have an important role in response to environmental changes.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva, Switzerland; CEA Cadarache, DSV,DEVM, Lab Ecophysiol Photosynth, UMR 6191,CNRS CEA, F-3108 St Paul Les Durance, France	University of Geneva; University of Geneva; CEA	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	jean-david.rochaix@molbio.unige.ch	Bellafiore, stephane/J-4756-2014; BARNECHE, Fredy/AAB-5054-2019; Bellafiore, stephane/AFS-1835-2022; PELTIER, Gilles/ABD-4484-2021; Rochaix, Jean-David/ABC-5243-2020; Barneche, Fredy/M-4228-2015	Bellafiore, stephane/0000-0002-4394-0866; BARNECHE, Fredy/0000-0002-7014-7097; Bellafiore, stephane/0000-0002-4394-0866; PELTIER, Gilles/0000-0002-2226-3931; Barneche, Fredy/0000-0002-7014-7097				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Baroli I, 2000, PHILOS T R SOC B, V355, P1385, DOI 10.1098/rstb.2000.0700; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V935, P152, DOI 10.1016/0005-2728(88)90212-5; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; BENNETT J, 1979, EUR J BIOCHEM, V99, P133, DOI 10.1111/j.1432-1033.1979.tb13239.x; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Lunde C, 2003, PLANT CELL PHYSIOL, V44, P44, DOI 10.1093/pcp/pcg012; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Race HL, 1996, BIOCHEMISTRY-US, V35, P13006, DOI 10.1021/bi961809k; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; ROBINSON HH, 1980, BIOCHIM BIOPHYS ACTA, V590, P97, DOI 10.1016/0005-2728(80)90149-8; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; SOKOLENKO A, 1995, FEBS LETT, V371, P176, DOI 10.1016/0014-5793(95)00892-D; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vink M, 2004, BIOCHEMISTRY-US, V43, P7824, DOI 10.1021/bi030267l; WEIS E, 1985, PHOTOSYNTH RES, V6, P73, DOI 10.1007/BF00029047; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Zer H, 2003, BIOCHEMISTRY-US, V42, P728, DOI 10.1021/bi020451r; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	30	545	576	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					892	895		10.1038/nature03286	http://dx.doi.org/10.1038/nature03286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729347				2022-12-28	WOS:000227174600049
J	Dennis, M; Lewis, SC; Warlow, C				Dennis, M; Lewis, SC; Warlow, C		FOOD Trial Collaboration	Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial	LANCET			English	Article							UNDERNUTRITION	Background Undernutrition is common in hospital patients with stroke, can develop or worsen in hospital, and is associated with poor outcomes. We aimed to establish whether routine oral nutritional supplements improve outcome after stroke. Methods The FOOD trials are a family of three pragmatic, multicentre, randomised controlled trials. We measured the outcomes of stroke patients who could swallow and who were randomly allocated normal hospital diet or normal hospital diet plus oral nutritional supplements until hospital discharge. The primary outcome was death or poor outcome (modified Rankin scale [MRS] grade 3-5), 6 months after enrolment, measured unaware of treatment allocation. Analysis was by intention to treat. Findings Between Nov 1, 1996, and July 31, 2003, 4023 patients were enrolled by 125 hospitals in 15 countries. Only 314 (8%) patients were judged to be undernourished at baseline. Vital status and MRS at the end of the trial were known for 4012 and 4004 patients, respectively. Supplemented diet was associated with an absolute reduction in risk of death of 0 . 7% (95% Cl -1 . 4 to 2 . 7) and an increased risk of death or poor outcome of 0 . 7% (-2.3 to 3.8). Interpretation We could not confirm the anticipated 4% absolute benefit for death or poor outcome from routine oral nutritional supplements for mainly well nourished stroke patients in hospital. Our results would be compatible with a 1% or 2% absolute benefit or harm from oral supplements. These results do not support a policy of routine oral supplementation after stroke.	Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk	Lindley, Richard/B-8148-2013	Lindley, Richard/0000-0002-0104-5679; Cohen, David/0000-0001-7318-8567; dennis, martin/0000-0003-1148-8972; yalciner, betul/0000-0002-2946-1113	Department of Health [96/29/01] Funding Source: Medline; National Institute for Health Research [96/29/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Choi-Kwon S, 1998, ACTA NEUROL SCAND, V98, P187, DOI 10.1111/j.1600-0404.1998.tb07292.x; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; COUNSELL CE, 1998, THESIS U CAMBRIDGE C; Dennis M, 2003, STROKE, V34, P127, DOI 10.1161/01.STR.0000044165.41303.50; Dolan P, 1995, SOCIAL TARIFF EUROQO; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; *FOOD TRIAL COLL, 2003, STROKE, V34, P140; Gariballa SE, 1998, JPEN-PARENTER ENTER, V22, P315, DOI 10.1177/0148607198022005315; Mead GE, 1998, INT J CLIN PRACT, V52, P316; MILNE AC, 2004, COCHRANE LIB; Potter JM, 2001, CURR OPIN CLIN NUTR, V4, P21, DOI 10.1097/00075197-200101000-00005; Potter JM, 2001, JPEN-PARENTER ENTER, V25, P323, DOI 10.1177/0148607101025006323; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; UNOSSON M, 1994, STROKE, V25, P366, DOI 10.1161/01.STR.25.2.366; Weir NU, 2003, J NEUROL NEUROSUR PS, V74, P447, DOI 10.1136/jnnp.74.4.447	17	126	132	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					755	763						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733716				2022-12-28	WOS:000227285300022
J	Truog, RD; Waisel, DB; Burns, JP				Truog, RD; Waisel, DB; Burns, JP			Do-not-resuscitate orders in the surgical setting	LANCET			English	Editorial Material									Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Truog, RD (corresponding author), Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA.	Robert.Truog@childrens.harvard.edu	Burns, Jeffrey P/AAW-8474-2021	Waisel, David/0000-0002-5307-4092				*AM COLL SURG, 1994, ACS B           0929; *AM SOC AN, 2001, ETH GUID AN CAR PAT; [Anonymous], 1974, JAMA-J AM MED ASSOC, V227, P864; Burns JP, 2003, CRIT CARE MED, V31, P1543, DOI 10.1097/01.CCM.0000064743.44696.49; Fallat ME, 2004, PEDIATRICS, V114, P1686, DOI 10.1542/peds.2004-2119; Heffner JE, 1996, ARCH INTERN MED, V156, P793, DOI 10.1001/archinte.156.7.793; *MA GEN HOSP CLIN, 1976, NEW ENGL J MED, V295, P362; MITTELBERGER JA, 1993, ARCH INTERN MED, V153, P228, DOI 10.1001/archinte.153.2.228; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 1999, ANESTHESIOLOGY, V90, P289, DOI 10.1097/00000542-199901000-00034; Waisel DB, 2002, J CLIN ANESTH, V14, P467, DOI 10.1016/S0952-8180(02)00401-4	12	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					733	735						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733701				2022-12-28	WOS:000227285300006
J	Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA				Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA			Complement factor H polymorphism and age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; ASSOCIATION; MACULOPATHY; ACTIVATION; DISEASE; LINKAGE; GLOMERULONEPHRITIS	Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association (P = 4.95 x 10(-10)) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 --> histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.	Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Sequenom Inc, San Diego, CA 92121 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sequenom; Boston University; Boston University; Boston University; Boston University; Boston University	Edwards, AO (corresponding author), Inst Retina Res, 3215 Princess Lane, Dallas, TX 75229 USA.	albert-edwards@swbell.net	Farrer, Lindsay/AAS-1035-2020; Mohammed, Imran/J-8271-2012; Manning, Alisa Knodle/ABC-7711-2021	Mohammed, Imran/0000-0002-8412-0768; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Acosta J, 2004, CURR PHARM DESIGN, V10, P203, DOI 10.2174/1381612043453441; Backes JM, 2004, ANN PHARMACOTHER, V38, P110, DOI 10.1345/aph.1D203; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wener MH, 2000, J RHEUMATOL, V27, P2351; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636	28	1890	2043	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					421	424		10.1126/science.1110189	http://dx.doi.org/10.1126/science.1110189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761121				2022-12-28	WOS:000228492000056
J	Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S				Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S		HRSC Co-Investigator Team	Tropical to mid-latitude snow and ice accumulation, flow and glaciation on Mars	NATURE			English	Article							ROCK GLACIERS; EVOLUTION; FEATURES; DEBRIS	Images from the Mars Express HRSC (High-Resolution Stereo Camera) of debris aprons at the base of massifs in eastern Hellas reveal numerous concentrically ridged lobate and pitted features and related evidence of extremely ice-rich glacier-like viscous flow and sublimation. Together with new evidence for recent ice-rich rock glaciers at the base of the Olympus Mons scarp superposed on larger Late Amazonian debris-covered piedmont glaciers, we interpret these deposits as evidence for geologically recent and recurring glacial activity in tropical and mid-latitude regions of Mars during periods of increased spin-axis obliquity when polar ice was mobilized and redeposited in microenvironments at lower latitudes. The data indicate that abundant residual ice probably remains in these deposits and that these records of geologically recent climate changes are accessible to future automated and human surface exploration.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; US Geol Survey, Menlo Pk, CA 94025 USA; Orsay Terre, F-91405 Orsay, France; ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands	Brown University; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); United States Department of the Interior; United States Geological Survey; European Space Agency	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	james_head@brown.edu	Kreslavsky, Mikhail/J-3425-2013; Werner, Stephanie C/A-6438-2012; Hauber, Ernst/U-2521-2018; van Gasselt, Stephan/L-9762-2013; Jaumann, Ralf/N-1001-2018	Werner, Stephanie C/0000-0001-5704-0909; Hauber, Ernst/0000-0002-1375-304X; van Gasselt, Stephan/0000-0003-2130-6343; Jaumann, Ralf/0000-0002-9759-6597; Kreslavsky, Mikhail/0000-0002-1900-826X				BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baratoux D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013779; BENN DI, 1998, GLACIERS GLACIATION, P237; Boulton GS, 1971, TILL S, P41; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Eyles N., 1978, J GLACIOL, V20, P99, DOI [10.3189/S0022143000021249, DOI 10.1017/S0022143000021249]; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Grove JM, 1988, LITTLE ICE AGE; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HARTSHORN JH, 1952, GEOL SOC AM BULL, V63, P1259; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HEAD JW, 2003, 3 MARS POL C; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; JOHNSON PG, 1980, ARCTIC ALPINE RES, V12, P195, DOI 10.2307/1550516; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Mangold N, 2002, PLANET SPACE SCI, V50, P385, DOI 10.1016/S0032-0633(02)00005-3; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MARTIN HE, 1987, PROG PHYS GEOG, V11, P260; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MILKOVICH SM, 2003, 6 INT MARS C; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MORRIS EC, 1994, MISC INV SER US GEOL; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; POTTER N, 1984, J GEOL EDUC, V32, P226, DOI 10.5408/0022-1368-32.4.226; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; SHEAN DE, 2004, LUNAR PLANET SCI, V35; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WARREN CR, 1995, GEOGR REV, V8, P2	38	253	256	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					346	351		10.1038/nature03359	http://dx.doi.org/10.1038/nature03359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772652				2022-12-28	WOS:000227715100042
J	Sloan, PA; Palmer, RE				Sloan, PA; Palmer, RE			Two-electron dissociation of single molecules by atomic manipulation at room temperature	NATURE			English	Article							SCANNING TUNNELING MICROSCOPE; ELECTRON-ATTACHMENT; CHEMICAL-REACTION; CHLOROBENZENE; SURFACE; CHEMISORPTION; SELECTIVITY; EXCITATION; VIBRATION; DYNAMICS	Using the tip of a scanning tunnelling microscope (STM) to mechanically manipulate individual atoms and molecules on a surface is now a well established procedure(1,2). Similarly, selective vibrational excitation of adsorbed molecules with an STM tip to induce motion or dissociation has been widely demonstrated(3,4). Such experiments are usually performed on weakly bound atoms that need to be stabilized by operating at cryogenic temperatures. Analogous experiments at room temperature(5) are more difficult, because they require relatively strongly bound species that are not perturbed by random thermal fluctuations. But manipulation can still be achieved through electronic excitation of the atom or molecule by the electron current(6-11) tunnelling between STM tip and surface at relatively high bias voltages(10,11), typically 1 - 5V. Here we use this approach to selectively dissociate chlorine atoms from individual oriented chlorobenzene molecules adsorbed on a Si( 111)- 7 x 7 surface. We map out the final destination of the chlorine daughter atoms, finding that their radial and angular distributions depend on the tunnelling current and hence excitation rate. In our system, one tunnelling electron has nominally sufficient energy to induce dissociation, yet the process requires two electrons. We explain these observations by a two-electron mechanism that couples vibrational excitation and dissociative electron attachment steps.	Univ Birmingham, Sch Phys & Astron, Nanoscale Phys Res Lab, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Palmer, RE (corresponding author), Univ Birmingham, Sch Phys & Astron, Nanoscale Phys Res Lab, Birmingham B15 2TT, W Midlands, England.	r.e.palmer@bham.ac.uk	Brodholt, John P/B-7136-2011; Sloan, Peter/N-8818-2019; Palmer, Richard E/A-5366-2008	Brodholt, John P/0000-0001-7395-5834; Sloan, Peter/0000-0002-0810-8468; Palmer, Richard E/0000-0001-8728-8083	Engineering and Physical Sciences Research Council [GR/R89509/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alavi S, 2000, PHYS REV LETT, V85, P5372, DOI 10.1103/PhysRevLett.85.5372; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; BOLAND JJ, 1990, PHYS REV B, V41, P9865, DOI 10.1103/PhysRevB.41.9865; BRUNE H, 1992, PHYS REV LETT, V68, P624, DOI 10.1103/PhysRevLett.68.624; Cao Y, 2000, J CHEM PHYS, V112, P4759, DOI 10.1063/1.481032; DIXONWARREN SJ, 1991, PHYS REV LETT, V67, P2395, DOI 10.1103/PhysRevLett.67.2395; DRESSLER R, 1985, CHIMIA, V39, P385; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fishlock TW, 2000, NATURE, V404, P743, DOI 10.1038/35008030; Fontanesi C, 2001, J MOL STRUC-THEOCHEM, V548, P13, DOI 10.1016/S0166-1280(00)00863-0; GUYOTSIONNEST P, 1990, PHYS REV LETT, V64, P2156, DOI 10.1103/PhysRevLett.64.2156; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Jensen JA, 1996, PHYS REV LETT, V76, P1388, DOI 10.1103/PhysRevLett.76.1388; Jiang GP, 2003, SURF SCI, V544, P147, DOI 10.1016/j.susc.2003.07.004; Komeda T, 2004, J CHEM PHYS, V120, P5347, DOI 10.1063/1.1647044; Komeda T, 2002, SCIENCE, V295, P2055, DOI 10.1126/science.1069016; Lauhon LJ, 2000, PHYS REV LETT, V84, P1527, DOI 10.1103/PhysRevLett.84.1527; Li ZH, 2004, J PHYS CHEM B, V108, P14049, DOI 10.1021/jp047722n; Lu PH, 1999, J CHEM PHYS, V111, P9905, DOI 10.1063/1.480325; Martin F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068101; Modelli A, 2003, PHYS CHEM CHEM PHYS, V5, P2923, DOI 10.1039/b304083f; Nakamura Y, 2001, SURF SCI, V487, P127, DOI 10.1016/S0039-6028(01)01082-2; PALMER RE, 1992, PROG SURF SCI, V41, P51, DOI 10.1016/0079-6816(92)90010-F; PALMER RE, 1992, REV MOD PHYS, V64, P383, DOI 10.1103/RevModPhys.64.383; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; SALAM GP, 1994, PHYS REV B, V49, P10655, DOI 10.1103/PhysRevB.49.10655; Skalicky T, 2002, PHYS CHEM CHEM PHYS, V4, P3583, DOI 10.1039/b202494b; Sloan PA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118301; Soukiassian L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035303; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410	30	155	155	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					367	371		10.1038/nature03385	http://dx.doi.org/10.1038/nature03385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772657				2022-12-28	WOS:000227715100047
J	Weissman, JS; Annas, CL; Epstein, AM; Schneider, EC; Clarridge, B; Kirle, L; Gatsonis, C; Feibelmann, S; Ridley, N				Weissman, JS; Annas, CL; Epstein, AM; Schneider, EC; Clarridge, B; Kirle, L; Gatsonis, C; Feibelmann, S; Ridley, N			Error reporting and disclosure systems - Views from hospital leaders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; PREVENTABILITY	Context The Institute of Medicine has recommended establishing mandatory error reporting systems for hospitals and other health settings. Objective To examine the opinions and experiences of hospital leaders with state reporting systems. Design and Setting Survey of chief executive and chief operating officers (CEOs/ COOs) from randomly selected hospitals in 2 states with mandatory reporting and public disclosure, 2 states with mandatory reporting without public disclosure, and 2 states without mandatory systems in 2002-2003. Main Outcome Measures Perceptions of the effects of mandatory systems on error reporting, likelihood of lawsuits, and overall patient safety; attitudes regarding release of incident reports to the public; and likelihood of reporting incidents to the state or to the affected patient based on hypothetical clinical vignettes that varied the type and severity of patient injury. Results Responses were received from 203 of 320 hospitals (response rate =63%). Most CEOs/COOs thought that a mandatory, nonconfidential system would discourage reporting of patient safety incidents to their hospital's own internal reporting system (69%) and encourage lawsuits (79%) while having no effect or a negative effect on patient safety (73%). More than 80% felt that the names of both the hospital and the involved professionals should be kept confidential, although respondents from states with mandatory public disclosure systems were more willing than respondents from the other states to release the hospital name (22% vs 4%-6%, P=.005). Based on the vignettes, more than 90% of hospital leaders said their hospital would report incidents involving serious injury to the state, but far fewer would report moderate or minor injuries, even when the incident was of sufficient consequence that they would tell the affected patient or family. Conclusions Most hospital leaders expressed substantial concerns about the impact of mandatory, nonconfidential reporting systems on hospital internal reporting, lawsuits, and overall patient safety. While hospital leaders generally favor disclosure of patient safety incidents to involved patients, fewer would disclose incidents involving moderate or minor injury to state reporting systems.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; Massachusetts Hosp Assoc, Burlington, MA USA; Brown Univ, Ctr Stat Sci & Appl Math, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Boston; Brown University	Weissman, JS (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	jweissman@partners.org		Schneider, Eric/0000-0002-1132-5084	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011928] Funding Source: NIH RePORTER; AHRQ HHS [5 U18 HS11928] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HOSP ASS, 2001, AHA GUID; BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Bogner MS, 1994, HUMAN ERROR MED; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Cooksey JA, 1996, J PUBLIC HEALTH POL, V17, P261, DOI 10.2307/3343266; FLOWERS L, 2001, SATE BASED MANDATORY; *I MED, 2000, TO ERR IS HUM BUILD; *JOINT COMM ACCR H, 2003, HOSP ACCR STAND, P79; Leape LL, 1998, JAMA-J AM MED ASSOC, V280, P1444, DOI 10.1001/jama.280.16.1444; MCLANAHAN SS, 1980, J APPL BEHAV SCI, V16, P354, DOI 10.1177/002188638001600306; Mehmood I, 2003, THE J, V8, P75; Pressman J., 1973, IMPLEMENTATION; Rothschild JM, 2002, ARCH INTERN MED, V162, P2414, DOI 10.1001/archinte.162.21.2414; Shah BV, 1996, SUDAAN USERS MANUAL; Sharpe VA, 2003, HASTINGS CENT REP, V33, pS1, DOI 10.2307/3528637	17	78	78	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1359	1366		10.1001/jama.293.11.1359	http://dx.doi.org/10.1001/jama.293.11.1359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769969	Bronze			2022-12-28	WOS:000227698600024
J	Karsten, SL; Geschwind, DH				Karsten, SL; Geschwind, DH			Exercise your amyloid	CELL			English	Editorial Material							TRANSGENIC MICE; DEPOSITION	The interplay of genetics and the environment in the etiology of Alzheimer's disease (AD) is not well understood. Now, Lazarov and coworkers (Lazarov et al., 2005 [this issue of Cell]) show that a simple paradigm of environmental enrichment alleviates amyloid burden and alters disease-associated gene expression changes in a double transgenic mouse model of AD.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Karsten, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA.		Karsten, Stan/AAI-4076-2021	Karsten, Stanislav/0000-0001-7387-4874				Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Geschwind DH, 2003, LANCET NEUROL, V2, P275, DOI 10.1016/S1474-4422(03)00379-X; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368	10	9	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					572	574		10.1016/j.cell.2005.02.027	http://dx.doi.org/10.1016/j.cell.2005.02.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766520	Bronze			2022-12-28	WOS:000227771400003
J	Mosey, NJ; Muser, MH; Woo, TK				Mosey, NJ; Muser, MH; Woo, TK			Molecular mechanisms for the functionality of lubricant additives	SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; ANTIWEAR FILMS; NANOMECHANICAL PROPERTIES; WEAR INHIBITORS; ZINC DIALKYL; FRICTION; TRIBOFILMS; TRIBOLOGY; DYNAMICS; ORIGIN	Wear limits the life-span of many mechanical devices with moving parts. To reduce wear, lubricants are frequently enriched with additives, such as zinc phosphates, that form protective films on rubbing surfaces. Using first-principles molecular dynamics simulations of films derived from commercial, additives, we unraveled the molecular origin of how antiwear films can form, function, and dissipate energy. These effects originate from pressure-induced changes in the coordination number of atoms acting as cross-linking agents to form chemically connected networks. The proposed mechanism explains a diverse body of experiments and promises to prove useful in the rational design of antiwear additives that operate on a wider range of surface materials, with reduced environmental side effects.	Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada; Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Muser, MH (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.	mmuser@uwo.ca	Woo, Tom/D-7701-2011; Müser, Martin/ABH-4626-2020; Müser, Martin/B-7412-2008	Müser, Martin/0000-0003-0919-0843; 				Abdelmaksoud M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.176101; Aktary M, 2002, TRIBOL LETT, V12, P155, DOI 10.1023/A:1014755123184; Alfe D, 1999, NATURE, V401, P462, DOI 10.1038/46758; Bair S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058302; BARTZ WJ, 1993, ENGINES AUTOMOTIVE L; Bec S, 1999, P ROY SOC A-MATH PHY, V455, P4181, DOI 10.1098/rspa.1999.0497; BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; Bhushan B., 1996, TRIBOLOGY MECH MAGNE; Cavazzoni C, 1999, SCIENCE, V283, P44, DOI 10.1126/science.283.5398.44; CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209; FOCHER P, 1994, EUROPHYS LETT, V26, P345, DOI 10.1209/0295-5075/26/5/005; Fuller M, 1995, TRIBOL LETT, V1, P367; Fuller MLS, 1998, TRIBOL INT, V31, P627, DOI 10.1016/S0301-679X(98)00084-X; Graham JF, 1999, TRIBOL LETT, V6, P149, DOI 10.1023/A:1019124026402; Granick S, 1999, PHYS TODAY, V52, P26, DOI 10.1063/1.882747; HARRISON JA, 1994, J AM CHEM SOC, V116, P10399, DOI 10.1021/ja00102a006; He G, 1999, SCIENCE, V284, P1650, DOI 10.1126/science.284.5420.1650; Hutchings IM, 2003, FRICTION, LUBRICATION, AND WEAR OF ARTIFICIAL JOINTS, P1; HUTTER J, 1995, CPMD; Jiang SY, 1996, J PHYS CHEM-US, V100, P15760, DOI 10.1021/jp960649j; JOST HP, 1990, WEAR, V136, P1, DOI 10.1016/0043-1648(90)90068-L; Landman U, 1996, LANGMUIR, V12, P4514, DOI 10.1021/la950890+; Martin JM, 2001, TRIBOL INT, V34, P523, DOI 10.1016/S0301-679X(01)00029-9; Mosey NJ, 2003, J PHYS CHEM A, V107, P5058, DOI 10.1021/jp034085c; Muser MH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.224301; Nicholls MA, 2005, TRIBOL INT, V38, P15, DOI 10.1016/j.triboint.2004.05.009; Nicholls MA, 2004, TRIBOL LETT, V17, P205, DOI 10.1023/B:TRIL.0000032447.32442.6a; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1997, SOLID STATE COMMUN, V38, P115; Pawlak Z., 2003, TRIBOCHEMISTRY LUBRI; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Persson BNJ, 2001, J CHEM PHYS, V115, P3840, DOI 10.1063/1.1388626; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Sheasby JS, 1996, WEAR, V201, P209, DOI 10.1016/S0043-1648(96)07242-0; Spikes H, 2004, TRIBOL LETT, V17, P469, DOI 10.1023/B:TRIL.0000044495.26882.b5; Tutein AB, 2000, LANGMUIR, V16, P291, DOI 10.1021/1a991225u; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Wan Y, 2002, TRIBOLOGY S, V40, P155; WILLERMET PA, 1995, TRIBOL INT, V28, P177, DOI 10.1016/0301-679X(95)98965-G; Wimmer MA, 2003, WEAR, V255, P1007, DOI 10.1016/S0043-1648(03)00127-3; Wisniewski Z, 2003, SOLID STATE IONICS, V157, P275, DOI 10.1016/S0167-2738(02)00221-7	42	183	188	14	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1612	1615		10.1126/science.1107895	http://dx.doi.org/10.1126/science.1107895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761150				2022-12-28	WOS:000227622400044
J	Gagnon, K; Chadwell, CD; Norabuena, E				Gagnon, K; Chadwell, CD; Norabuena, E			Measuring the onset of locking in the Peru-Chile trench with GPS and acoustic measurements	NATURE			English	Article							NAZCA-SOUTH AMERICA; PLATE VELOCITIES; EARTHQUAKES; JAPAN; UPDIP; ZONE	The subduction zone off the west coast of South America marks the convergence of the oceanic Nazca plate and the continental South America plate. Nazca - South America convergence over the past 23 million years has created the 6-km-deep Peru - Chile trench, 150 km offshore. High pressure between the plates creates a locked zone, leading to deformation of the overriding plate. The surface area of this locked zone is thought to control the magnitude of co-seismic release and is limited by pressure, temperature, sediment type and fluid content(1). Here we present seafloor deformation data from the submerged South America plate obtained from a combination of Global Positioning System (GPS) receivers and acoustic transponders. We estimate that the measured horizontal surface motion perpendicular to the trench is consistent with a model having no slip along the thrust fault between 2 and 40 km depth. A tsunami in 1996, 200 km north of our site, was interpreted as being the result of an anomalously shallow interplate earthquake(2). Seismic coupling at shallow depths, such as we observe, may explain why co-seismic events in the Peruvian subduction zone create large tsunamis.	Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA; Univ Miami, Geodesy Dept, Miami, FL 33149 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami	Chadwell, CD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA.	cchadwell@ucsd.edu	Norabuena, Edmundo O/I-5486-2013; Norabuena, Edmundo O./M-8772-2019	Norabuena, Edmundo/0000-0002-1865-8922				ALTIMINI A, 2002, J GEOPHYS RES, V107, P2214, DOI DOI 10.1029/2001JB000561; Angermann D, 1999, EARTH PLANET SC LETT, V171, P329, DOI 10.1016/S0012-821X(99)00173-9; Bevis M, 1999, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000011; CAHILL T, 1992, J GEOPHYS RES-SOL EA, V97, P17503, DOI 10.1029/92JB00493; Chadwell CD, 2003, OCEAN ENG, V30, P1467, DOI 10.1016/S0029-8018(02)00141-5; Chadwell CD, 2001, GEOPHYS RES LETT, V28, P3701, DOI 10.1029/2001GL013280; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; GOMBERG J, 1994, J GEOPHYS RES-SOL EA, V99, P20299, DOI 10.1029/94JB00039; Gutscher MA, 2002, J S AM EARTH SCI, V15, P3, DOI 10.1016/S0895-9811(02)00002-0; Hampel A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002593; Krabbenhoft A, 2004, GEOPHYS J INT, V159, P749, DOI 10.1111/j.1365-246X.2004.02425.x; Larson KM, 1997, J GEOPHYS RES-SOL EA, V102, P9961, DOI 10.1029/97JB00514; Moore JC, 2001, GEOLOGY, V29, P183, DOI 10.1130/0091-7613(2001)029<0183:ULOTSZ>2.0.CO;2; Newman AV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015409; Norabuena E, 1998, SCIENCE, V279, P358, DOI 10.1126/science.279.5349.358; Norabuena EO, 1999, GEOPHYS RES LETT, V26, P3405, DOI 10.1029/1999GL005394; Oleskevich DA, 1999, J GEOPHYS RES-SOL EA, V104, P14965, DOI 10.1029/1999JB900060; Satake K, 1999, PURE APPL GEOPHYS, V154, P467, DOI 10.1007/s000240050240; SCHWELLER WJ, 1981, GEOL SOC AM MEM, V154, P323; Sella GF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000033; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Spiess FN, 1998, PHYS EARTH PLANET IN, V108, P101, DOI 10.1016/S0031-9201(98)00089-2; TICHELAAR BW, 1991, J GEOPHYS RES-SOLID, V96, P11997, DOI 10.1029/91JB00200; TICHELAAR BW, 1993, J GEOPHYS RES-SOL EA, V98, P2017, DOI 10.1029/92JB02045; Wang K., 2004, EOS T AM GEOPHYS UN, V85, P180, DOI [DOI 10.1029/2004EO180005, 10.1029/2004eo180005]; WEBB FH, 1997, INTRO GIPSY OASIS, V2	26	138	148	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					205	208		10.1038/nature03412	http://dx.doi.org/10.1038/nature03412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758997				2022-12-28	WOS:000227494500042
J	Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM				Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM			Musical imagery - Sound of silence activates auditory cortex	NATURE			English	Editorial Material							VISUAL-CORTEX; EVENT		Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Dartmouth College; University of Aberdeen	Kraemer, DJM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Macrae, Neil/C-4761-2008					FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hughes HC, 2001, NEUROIMAGE, V13, P1073, DOI 10.1006/nimg.2001.0766; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013	9	179	182	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					158	158		10.1038/434158a	http://dx.doi.org/10.1038/434158a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758989	Bronze			2022-12-28	WOS:000227494500033
J	Melosh, HJ; Collins, GS				Melosh, HJ; Collins, GS			Meteor Crater formed by low-velocity impact - The paucity of melted rock in this crater may be due to the striking projectile's speed	NATURE			English	Editorial Material							EARTHS ATMOSPHERE; DISRUPTION		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Melosh, HJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	jmelosh@lpl.arizona.edu		Collins, Gareth/0000-0002-6087-6149	Natural Environment Research Council [NE/B501871/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bland PA, 2003, NATURE, V424, P288, DOI 10.1038/nature01757; Bryan J.B, 1978, P 9 LUN PLAN SCI C, P3931; KIEFFER SW, 1980, REV GEOPHYS, V18, P143, DOI 10.1029/RG018i001p00143; Nininger H.H., 1956, ARIZONAS METEORITE C; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; Shoemaker E. M., 1963, MOON METEOR COMET, P301	9	40	40	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					157	157		10.1038/434157a	http://dx.doi.org/10.1038/434157a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758988	Bronze			2022-12-28	WOS:000227494500032
J	Smith, RJH; Bale, JF; White, KR				Smith, RJH; Bale, JF; White, KR			Sensorineural hearing loss in children	LANCET			English	Review							CONNEXIN 26 GENE; CONGENITAL CYTOMEGALOVIRUS-INFECTION; SCREENING DEMONSTRATION PROJECT; NUTRITION EXAMINATION SURVEY; COCHLEAR HAIR-CELLS; 3RD NATIONAL-HEALTH; BACTERIAL-MENINGITIS; UNITED-STATES; INTERVENTION PROGRAMS; RECESSIVE DEAFNESS	During the past three to four decades, the incidence of acquired sensorineural hearing loss (SNHL) in children living in more developed countries has fallen, as a result of improved neonatal care and the widespread implementation of immunisation programmes. The overall decrease has been accompanied by a relative increase in the proportion of inherited forms of SNHL. The contribution made by one gene in particular, GJB2, to the genetic load of SNHL has strongly affected the assessment and care of children with hearing loss. These changes in the incidence of SNHL have not been seen in children living in less developed countries, where the prevalence of consanguinity is high in many areas, and both genetic and acquired forms of SNHL are more common, particularly among children who live in poverty. Focused genetic counselling and health education might lead to a decrease in the prevalence of inherited SNHL in these countries. Establishment of vaccination programmes for several vaccine-preventable infectious diseases would reduce rates of acquired SNHL. Although the primary purpose of such programmes is the prevention of serious and in many cases fatal infections, a secondary benefit would be a reduction in disease-related complications such as SNHL that cause permanent disability in survivors.	Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA USA; Univ Utah, Sch Med, Primary Childrens Med Ctr, Dept Pediat, Salt Lake City, UT USA; Utah State Univ, Natl Ctr Hearing Assessment & Management, Logan, UT 84322 USA	University of Iowa; Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	Smith, RJH (corresponding author), Univ Iowa Hosp & Clin, Dept Otolaryngol, 200 Hawkins Dr,21151-PFP, Iowa City, IA 52242 USA.	Richard-smith@uiowa.edu		Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842, R01DC003544] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03544, DC02842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; ARAB SB, 2004, GENET EPIDEMIOL, V27, P74; Arts HA, 2002, OTOLARYNG CLIN N AM, V35, P925, DOI 10.1016/S0030-6665(02)00059-2; Azaiez H, 2004, HUM MUTAT, V24, P305, DOI 10.1002/humu.20084; Bale JF, 2002, NEUROL CLIN, V20, P1039, DOI 10.1016/S0733-8619(02)00014-2; BALE JF, 1989, HDB CLIN NEUROLOGY, V12, P263; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; BarskyFirkser L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e4; Bauer PW, 2003, LARYNGOSCOPE, V113, P2135, DOI 10.1097/00005537-200312000-00015; Bayazit YA, 2003, INT J PEDIATR OTORHI, V67, P1331, DOI 10.1016/j.ijporl.2003.08.003; Ben Arab S, 2000, CLIN GENET, V57, P439, DOI 10.1034/j.1399-0004.2000.570607.x; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BESS FH, 1994, PEDIATRICS, V93, P330; BOOY R, 1991, ARCH DIS CHILD, V66, P1251, DOI 10.1136/adc.66.10.1251; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Boyle C A, 1996, MMWR CDC Surveill Summ, V45, P1; Britt W J, 1996, VIROLOGY, V3, P2493; Burns W, 1970, Ciba Found Symp, P177; CANTRELLE P, 1960, POPULATION, V15, P665, DOI 10.2307/1526131; Carvill S, 2001, J INTELL DISABIL RES, V45, P467, DOI 10.1046/j.1365-2788.2001.00366.x; CHALBI N, 1998, FAMILLE POPULATION, V1, P39; Cheng AK, 1999, ANN OTO RHINOL LARYN, V108, P124; Cherukupally SR, 2004, OTOLARYNG HEAD NECK, V130, P339, DOI 10.1016/j.otohns.2003.11.017; CLAYTON EW, 1992, PEDIATRICS, V90, P641; Cohn ES, 1999, AM J MED GENET, V89, P130, DOI 10.1002/(SICI)1096-8628(19990924)89:3<130::AID-AJMG3>3.0.CO;2-M; Cone-Wesson Barbara, 2002, J Am Acad Audiol, V13, P173; Conyn-van Spaendonck M A, 2000, Ned Tijdschr Geneeskd, V144, P1069; Cremers C WRJ, 2002, GENETIC HEARING IMPA; CROCKETT R, 2004, 17 ANN WORKSH HEAR S; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; Dahl E, 1996, J BIOL CHEM, V271, P17903, DOI 10.1074/jbc.271.30.17903; Dahle A J, 2000, J Am Acad Audiol, V11, P283; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; DAVIS A, 1992, British Journal of Audiology, V26, P77, DOI 10.3109/03005369209077875; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; DesGeorges J, 2003, MENT RETARD DEV D R, V9, P89, DOI 10.1002/mrdd.10064; DODGE PR, 1984, NEW ENGL J MED, V311, P869, DOI 10.1056/NEJM198410043111401; DRONAMRAJU KR, 1964, POPULATION PARIS, V19, P291; ELSSMANN SF, 1987, HEAR J, V40, P13; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; FELDMAN W, 1990, Journal of General Internal Medicine, V5, pS50, DOI 10.1007/BF02600842; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Firszt JB, 2004, ARCH OTOLARYNGOL, V130, P536, DOI 10.1001/archotol.130.5.536; Fischel-Ghodsian N, 1999, ANN NY ACAD SCI, V884, P99, DOI 10.1111/j.1749-6632.1999.tb08639.x; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; FORTNUM H, 1993, BRIT J AUDIOL, V27, P43, DOI 10.3109/03005369309077889; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Garrod AE, 1902, LANCET, V2, P1616; Gates GA, 2003, NEW ENGL J MED, V349, P421, DOI 10.1056/NEJMp038107; HAAPANIEMI J, 1995, EUR ARCH OTO-RHINO-L, V252, P391; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Harrison M, 1996, EAR HEARING, V17, P55, DOI 10.1097/00003446-199602000-00007; Hetu R, 1995, J Am Acad Audiol, V6, P378; ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665; Johnson J L, 1997, Hawaii Med J, V56, P352; Karikoski JO, 1995, SCAND AUDIOL, V24, P237, DOI 10.3109/01050399509047542; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kennedy C, 2000, LANCET, V356, P1903, DOI 10.1016/S0140-6736(00)03267-0; Kennedy CR, 1998, LANCET, V352, P1957; Keren R, 2002, PEDIATRICS, V110, P855, DOI 10.1542/peds.110.5.855; KHLAT M, 1991, EPIDEMIOL REV, V13, P28, DOI 10.1093/oxfordjournals.epirev.a036072; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kileny PR, 2001, OTOL NEUROTOL, V22, P42, DOI 10.1097/00129492-200101000-00008; KIMBERLING WJ, GENEREVIEWS GENETEST; Koomen I, 2003, PEDIATRICS, V112, P1049, DOI 10.1542/peds.112.5.1049; KRUPPA B, 1995, HNO, V43, P31; LEES REM, 1985, CAN J PUBLIC HEALTH, V76, P171; LEONARD DR, 1999, EPIDEMIOLOGIC REPORT, V99, P4; Li YL, 2003, ARCH PEDIAT ADOL MED, V157, P162, DOI 10.1001/archpedi.157.2.162; Lin HC, 2002, INT J PEDIATR OTORHI, V63, P209; Liu YH, 2002, J HUM GENET, V47, P688, DOI 10.1007/s100380200106; Lucotte G, 2001, GENET TEST, V5, P149, DOI 10.1089/109065701753145646; LYON M, 1986, CAN J PUBLIC HEALTH, V77, P221; MACE AL, 1991, EAR HEARING, V12, P287, DOI 10.1097/00003446-199108000-00008; Maisoun AM, 2003, SAUDI MED J, V24, P55; Maki-Torkko EM, 1998, SCAND AUDIOL, V27, P95, DOI 10.1080/010503998420333; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; MAXON AB, 1993, BRIT J AUDIOL, V27, P149, DOI 10.3109/03005369309077906; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Minoda R, 2004, NEUROREPORT, V15, P1089, DOI 10.1097/00001756-200405190-00001; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Mostafapour SP, 1998, LARYNGOSCOPE, V108, P1832, DOI 10.1097/00005537-199812000-00013; Nabili V, 1999, LARYNGOSCOPE, V109, P931, DOI 10.1097/00005537-199906000-00017; Najmabadi H, 2005, AM J MED GENET A, V133A, P132, DOI 10.1002/ajmg.a.30576; Niskar AS, 1998, JAMA-J AM MED ASSOC, V279, P1071, DOI 10.1001/jama.279.14.1071; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; ORCHIK DJ, 1995, CLIN PEDIATR, V34, P278, DOI 10.1177/000992289503400511; OZDAMAR O, 1983, ARCH OTOLARYNGOL, V109, P13; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Paradise JL, 1999, PEDIATRICS, V103, P670, DOI 10.1542/peds.103.3.670; Parving A, 1999, ACTA PAEDIATR, V88, P69, DOI 10.1080/080352599750029439; PARVING A, 1998, J AUDIOL MED, V7, P100; Pass Robert F, 2002, Semin Pediatr Infect Dis, V13, P196, DOI 10.1053/spid.2002.125863; PECKHAM CS, 1989, J ANTIMICROB CHEMOTH, V23, P17, DOI 10.1093/jac/23.suppl_E.17; Peltola H, 1998, PEDIATR INFECT DIS J, V17, pS126, DOI 10.1097/00006454-199809001-00007; Prieve BA, 2000, EAR HEARING, V21, P85, DOI 10.1097/00003446-200004000-00003; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.3.CO;2-9; RIORDAN A, 1993, BRIT J AUDIOL, V27, P375, DOI 10.3109/03005369309076713; Rivera LB, 2002, PEDIATRICS, V110, P762, DOI 10.1542/peds.110.4.762; ROOS KL, 1990, CLIN THER, V12, P290; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; SHAPIRO SM, 1994, AM J OTOLARYNG, V15, P129, DOI 10.1016/0196-0709(94)90062-0; Shou JY, 2003, MOL CELL NEUROSCI, V23, P169, DOI 10.1016/S1044-7431(03)00066-6; Smith R., GENEREVIEWS GENETEST; SORENSON JR, 1984, PEDIATRICS, V73, P183; Stein L, 1995, AUDIOLOGY TODAY, V7, P10; Stein LK, 1999, PEDIATR CLIN N AM, V46, P95, DOI 10.1016/S0031-3955(05)70084-5; STEIN LK, 1990, EAR HEARING, V11, P201, DOI 10.1097/00003446-199006000-00006; Stierman L., 1994, BIRTH DEFECTS CALIFO; Stuart A, 2000, Am J Audiol, V9, P135, DOI 10.1044/1059-0889(2000/016); Sutton GJ, 1997, BRIT J AUDIOL, V31, P39, DOI 10.3109/03005364000000007; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; TLUCZEK A, 1992, J DEV BEHAV PEDIATR, V13, P181; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; Vega Cuadri A, 2001, ACTA OTORRINOLARINGO, V52, P273; VIENNY H, 1984, PEDIATRICS, V73, P579; Vohr B R, 2001, J Perinatol, V21, P15, DOI 10.1038/sj.jp.7200475; Vohr BR, 1998, J PEDIATR-US, V133, P353, DOI 10.1016/S0022-3476(98)70268-9; Weichbold V, 2001, PEDIATRICS, V108, P1111, DOI 10.1542/peds.108.5.1111; Wellman MB, 2003, OTOL NEUROTOL, V24, P907, DOI 10.1097/00129492-200311000-00015; White KR, 2004, AM J MED GENET A, V130A, P29, DOI 10.1002/ajmg.a.30048; White KR, 2003, MENT RETARD DEV D R, V9, P79, DOI 10.1002/mrdd.10063; WHITE KR, 2002, TXB AUDIOLOGICAL MED, P339; *WHO, 1998, TECHN REV GROUP M GL; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; 1993, INT J PEDIAT OTORHIN, V27, P215; 1981, FED REG 3, P37773	136	472	515	1	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					879	890		10.1016/S0140-6736(05)71047-3	http://dx.doi.org/10.1016/S0140-6736(05)71047-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752533				2022-12-28	WOS:000227444600031
J	Lallement, R; Quemerais, E; Bertaux, JL; Ferron, S; Koutroumpa, D; Pellinen, R				Lallement, R; Quemerais, E; Bertaux, JL; Ferron, S; Koutroumpa, D; Pellinen, R			Deflection of the interstellar neutral hydrogen flow across the heliospheric interface	SCIENCE			English	Article							LYMAN-ALPHA GLOW; SOLAR-WIND; OUTER HELIOSPHERE; MAGNETIC-FIELDS; CLOUD; HELIUM; ANISOTROPIES; INFERENCES; PARTICLES; VOYAGER-1	Using an absorption cell, we measured the Doppler shifts of the interstellar hydrogen resonance glow to show the direction of the neutral hydrogen flow as it enters the inner heliosphere. The neutral hydrogen flow is found to be deflected relative to the helium flow by about 4degrees. The most likely explanation of this deflection is a distortion of the heliosphere under the action of an ambient interstellar magnetic field. in this case, the helium flow vector and the hydrogen flow vector constrain the direction of the magnetic field and act as an interstellar magnetic compass.	CNRS, Serv Aeron, Inst Pierre Simon Laplace, F-91371 Verrieres Le Buisson, France; Finnish Meteorol Inst, FIN-00101 Helsinki, Finland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Finnish Meteorological Institute	Lallement, R (corresponding author), CNRS, Serv Aeron, Inst Pierre Simon Laplace, Boite Postale 3, F-91371 Verrieres Le Buisson, France.	rosine.lallement@aerov.jussieu.fr		Koutroumpa, Dimitra/0000-0002-5716-3412				BARANOV VB, 1993, J GEOPHYS RES-SPACE, V98, P15157, DOI 10.1029/93JA01171; BERTAUX JL, 1971, ASTRON ASTROPHYS, V11, P200; Bertaux JL, 1995, SOL PHYS, V162, P403, DOI 10.1007/BF00733435; BERTIN P, 1993, J GEOPHYS RES-SPACE, V98, P15193, DOI 10.1029/93JA01179; Burlaga LF, 2003, ASTROPHYS J, V582, P540, DOI 10.1086/344571; Costa J, 1999, ASTRON ASTROPHYS, V349, P660; Gloeckler G, 2004, ASTRON ASTROPHYS, V426, P845, DOI 10.1051/0004-6361:20035768; HOLZER TE, 1977, REV GEOPHYS, V15, P467, DOI 10.1029/RG015i004p00467; Izmodenov VV, 1999, J GEOPHYS RES-SPACE, V104, P4731, DOI 10.1029/1998JA900122; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; Lallement R, 1999, AIP CONF PROC, V471, P205, DOI 10.1063/1.58795; LALLEMENT R, 1993, SCIENCE, V260, P1095, DOI 10.1126/science.260.5111.1095; Lallement R, 1997, ASTRON ASTROPHYS, V324, P1105; LALLEMENT R, 1995, ASTRON ASTROPHYS, V304, P461; LALLEMENT R, 1992, ASTRON ASTROPHYS, V266, P479; Lemaire P, 2002, ESA SPEC PUBL, V508, P219; Linde TJ, 1998, J GEOPHYS RES-SPACE, V103, P1889, DOI 10.1029/97JA02144; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; McNutt RL, 1999, AIP CONF PROC, V471, P823, DOI 10.1063/1.58735; Pogorelov NV, 2004, ASTROPHYS J, V614, P1007, DOI 10.1086/423798; Quemerais E, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009871; Quemerais E, 1999, J GEOPHYS RES-SPACE, V104, P12585, DOI 10.1029/1998JA900101; Quemerais E, 2002, ASTRON ASTROPHYS, V396, P269, DOI 10.1051/0004-6361:20021396; Ratkiewicz R, 2002, ADV SPACE RES, V29, P433, DOI 10.1016/S0273-1177(01)00608-1; Redfield S, 2000, ASTROPHYS J, V534, P825, DOI 10.1086/308769; STONE EC, IN PRESS ADV SPACE R; Vallerga J, 2004, ASTRON ASTROPHYS, V426, P855, DOI 10.1051/0004-6361:20035887; WALLIS MK, 1975, NATURE, V254, P202, DOI 10.1038/254202a0; Witte M, 2004, ASTRON ASTROPHYS, V426, P835, DOI 10.1051/0004-6361:20035956; Woods TN, 2000, J GEOPHYS RES-SPACE, V105, P27195, DOI 10.1029/2000JA000051; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277	32	296	297	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1447	1449		10.1126/science.1107953	http://dx.doi.org/10.1126/science.1107953			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746421				2022-12-28	WOS:000227503100040
J	Lusi, EA; Guarascio, P				Lusi, EA; Guarascio, P			A target rash	LANCET			English	Editorial Material									Azienda Osped San Camillo Forlanini, I-00152 Rome, Italy	Azienda Ospedaliera San Camillo-Forlanini	Lusi, EA (corresponding author), Azienda Osped San Camillo Forlanini, I-00152 Rome, Italy.	alusi@katamail.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					784	784						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733720				2022-12-28	WOS:000227285300026
J	Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA				Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA			The controlled evolution of a polymer single crystal	SCIENCE			English	Article							DIP-PEN NANOLITHOGRAPHY; ATOMIC-FORCE MICROSCOPY; X-RAY-DIFFRACTION; ELECTROCHEMICAL NUCLEATION; GROWTH; MONOLAYERS; CRYSTALLIZATION; SURFACES; PARALLEL; PROBE	We present a method for controlling the initiation and kinetics of polymer crystal growth using dip-pen nanolithography and an atomic force microscope tip coated with poly-DL-lysine hydrobromide. Triangular prisms of the polymer epitaxially grow on freshly cleaved mica substrates, and their in-plane and out-of-plane growth rates can be controlled by raster scanning the coated tip across the substrate. Atomic force microscope images were concomitantly recorded, providing a set of photographic images of the process as it spans the nanometer-to micrometer-length scales as a function of environmental conditions.	Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, Nanoscale Sci & Engn Ctr, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu	Bedzyk, Michael J/K-6903-2013; LIU, XIAOGANG/A-8038-2011; salaita, khalid/C-4414-2008; Goswami, Dipak Kumar/AAR-4656-2021; Goswami, Dipak K/E-8186-2011; Bedzyk, Michael J/B-7503-2009; Mirkin, Chad A/E-3911-2010	LIU, XIAOGANG/0000-0003-2517-5790; Goswami, Dipak Kumar/0000-0002-5891-6172; Goswami, Dipak K/0000-0002-5891-6172; Mirkin, Chad/0000-0002-6634-7627	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062109] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62109-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal G, 2003, J AM CHEM SOC, V125, P580, DOI 10.1021/ja020471g; Barsotti RJ, 2004, LANGMUIR, V20, P4795, DOI 10.1021/la049763g; Bullen D, 2004, APPL PHYS LETT, V84, P789, DOI 10.1063/1.1644317; Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i; Empedocles SA, 1997, SCIENCE, V278, P2114, DOI 10.1126/science.278.5346.2114; Fransaer JL, 1999, J PHYS CHEM B, V103, P7643, DOI 10.1021/jp990622a; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Hobbs JK, 2001, MACROMOLECULES, V34, P353, DOI 10.1021/ma001697b; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hooks DE, 1998, J PHYS CHEM B, V102, P9958, DOI 10.1021/jp982851n; Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410; JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278; KERN R, 1989, NATO ADV SCI I B-PHY, P143; LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774; LANDAU EM, 1985, NATURE, V318, P353, DOI 10.1038/318353a0; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Maynor BW, 2004, J AM CHEM SOC, V126, P6409, DOI 10.1021/ja0317832; McCrone WC., 1965, PHYSICS CHEM ORGANIC, P726; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Pluth JJ, 1997, P NATL ACAD SCI USA, V94, P12263, DOI 10.1073/pnas.94.23.12263; RATNER B, 1998, ACS S SERIES; Sanz N, 2004, LANGMUIR, V20, P5989, DOI 10.1021/la036385r; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Walko DA, 2004, AIP CONF PROC, V705, P1166, DOI 10.1063/1.1758007; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	27	92	95	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1763	1766		10.1126/science.1109487	http://dx.doi.org/10.1126/science.1109487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774755				2022-12-28	WOS:000227883900041
J	Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH				Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH			Involvement of MicroRNA in AU-rich element-mediated mRNA instability	CELL			English	Article							BINDING-PROTEIN; INTERFERENCE; SEQUENCE; CLONING; EXOSOME; HUR; TRISTETRAPROLIN; IDENTIFICATION; DEADENYLATION; TRANSLATION	AU-rich elements (AREs) in the 3' untranslated region (UTR) of unstable mRNAs dictate their degradation. An RNAi-based screen performed in Drosophila S2 cells has revealed that Dicer1, Argonaute1 (Ago1) and Ago2, components involved in microRNA (miRNA) processing and function, are required for the rapid decay of mRNA containing AREs of tumor necrosis factor-a. The requirement for Dicer in the instability of ARE-containing mRNA (ARE-RNA) was confirmed in HeLa cells. We further observed that miR16, a human miRNA containing an UAAAUAUU sequence that is complementary to the ARE sequence, is required for ARE-RNA turnover. The role of miR16 in ARE-RNA decay is sequence-specific and requires the ARE binding protein tristetraprolin (TTP). TTP does not directly bind to miR16 but interacts through association with Ago/eiF2C family members to complex with miR16 and assists in the targeting of ARE. miRNA targeting of ARE, therefore, appears to be an essential step in ARE-mediated mRNA degradation.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Scripps Research Institute; Novartis; Hong Kong University of Science & Technology	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jhan@scripps.edu	Lin, SC/G-4666-2010; Jing, Qing/F-6752-2016; Han, J/G-4671-2010; Motoyama, Andrea/AAB-9362-2019	Jing, Qing/0000-0001-9834-1214; Guth-Gundel, Sabine/0000-0001-9115-1397	NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054796, R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER; NCI NIH HHS [CA93926] Funding Source: Medline; NIAID NIH HHS [AI054796, AI41637] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	45	673	740	4	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					623	634		10.1016/j.cell.2004.12.038	http://dx.doi.org/10.1016/j.cell.2004.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766526	Bronze			2022-12-28	WOS:000227771400009
J	Boetius, A				Boetius, A			Lost city life	SCIENCE			English	Editorial Material							MID-ATLANTIC RIDGE; VENT FIELD; METHANE; ARCHAEA		Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Max Planck Society	Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	aboetius@mpi-bremen.de	Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176				Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; CHARLOU JL, 1993, J GEOPHYS RES-SOL EA, V98, P9625, DOI 10.1029/92JB02047; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x	12	23	27	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2005	307	5714					1420	1422		10.1126/science.1109849	http://dx.doi.org/10.1126/science.1109849			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746415				2022-12-28	WOS:000227503100031
J	Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M				Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M			Requirement for caspase-8 in NF-kappa B activation by antigen receptor	SCIENCE			English	Article							MALT1; BCL10; THETA	Caspase-8, a proapoptotic protease, has an essential role in lymphocyte activation and protective immunity. We show that caspase-8 deficiency (CED) in humans and mice specifically abolishes activation of the transcription factor nuclear factor kappaB (NF-kappaB) after stimulation through antigen receptors, Fc receptors, or Toll-like receptor 4 in T, B, and natural killer cells. Caspase-8 also causes the up complex of the inhibitor of NF-kappaB kinase (IKK) to associate with the upstream Bcl10-MALT1 (mucosa-associated lymphatic tissue) adapter complex. Recruitment of the IKKalpha,beta complex, its activation, and the nuclear translocation of NF-kappaB require enzyme activity of full-length caspase-8. These findings thus explain the paradoxical association of defective apoptosis and combined immunodeficiency in human CED.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lenardo, M (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Bidère, Nicolas/K-8887-2015; Su, Helen C/H-9541-2015; sakai, Keiko/F-5807-2013	Bidère, Nicolas/0000-0001-9177-0008; Su, Helen C/0000-0002-5582-9110; Hakem, Razqallah/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, Z01AI000732, Z01AI000565, ZIAAI000732, ZIAAI000565, ZIAAI000769] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yu L, 2003, SCIENCE, V302, P1515, DOI 10.1126/science.1092951; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	21	338	363	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1465	1468		10.1126/science.1104765	http://dx.doi.org/10.1126/science.1104765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746428	Green Published			2022-12-28	WOS:000227503100047
J	Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE				Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE			Family-based association between Alzheimer's disease and variants in UBQLN1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; LINKAGE; PROTEIN; ALLELE; TESTS; ONSET; UBIQUILIN; AGE; UBIQUITINATION; ACCUMULATION	BACKGROUND Recent analyses suggest that the known Alzheimer's disease genes account for less than half the genetic variance in this disease. The gene encoding ubiquilin 1 (UBQLN1) is one of several candidate genes for Alzheimer's disease located near a well-established linkage peak on chromosome 9q22. METHODS We evaluated 19 single-nucleotide polymorphisms in three genes within the chromosome 9q linkage region in 437 multiplex families with Alzheimer's disease from the National Institute of Mental Health (NIMH) sample (1439 subjects). We then tested the single-nucleotide polymorphisms showing a positive result in an independently identified set of 217 sibships discordant for Alzheimer's disease (Consortium on Alzheimer's Genetics [CAG] sample; 489 subjects) and assessed the functional effect of an implicated single-nucleotide polymorphism in brain tissue from 25 patients with Alzheimer's disease and 17 controls. RESULTS In the NIMH sample, we observed a significant association between Alzheimer's disease and various single-nucleotide polymorphisms in UBQLN1. We confirmed these associations in the CAG sample. The risk-conferring haplotype in both samples was defined by a single intronic single-nucleotide polymorphism located downstream of exon 8. The risk allele was associated with a dose-dependent increase in an alternatively spliced UBQLN1 (lacking exon 8) transcript in RNA extracted from brain samples of patients with Alzheimer's disease. CONCLUSIONS Our findings suggest that genetic variants in UBQLN1 on chromosome 9q22 substantially increase the risk of Alzheimer's disease, possibly by influencing alternative splicing of this gene in the brain.	Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimer Dis Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Charlestown, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Neurogenetics, La Jolla, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Tanzi, RE (corresponding author), MGH E, MIND, Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Elliott, Kathryn/0000-0002-4926-1215				Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; BLACKER D, 1994, ARCH NEUROL-CHICAGO, V51, P1198, DOI 10.1001/archneur.1994.00540240042014; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MARTIN ER, 2003, J BIOINFORM COMPUT B, V1, P1; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Wollmer MA, 2003, NEUROBIOL AGING, V24, P421, DOI 10.1016/S0197-4580(02)00094-5; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1	30	196	204	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					884	894		10.1056/NEJMoa042765	http://dx.doi.org/10.1056/NEJMoa042765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745979				2022-12-28	WOS:000227310700007
J	Cooper, DS				Cooper, DS			Drug therapy: Antithyroid drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; COLONY-STIMULATING FACTOR; THYROID FOLLICULAR CELLS; SHORT-TERM TREATMENT; GRAVES-DISEASE; INDUCED AGRANULOCYTOSIS; PROPYLTHIOURACIL THERAPY; INTELLECTUAL-DEVELOPMENT; RADIOIODINE TREATMENT; SERUM CONCENTRATIONS		Johns Hopkins Univ, Sch Med, Sinai Hosp Baltimore, Div Endocrinol, Baltimore, MD 21215 USA	Johns Hopkins University; Sinai Hospital of Baltimore	Cooper, DS (corresponding author), Johns Hopkins Univ, Sch Med, Sinai Hosp Baltimore, Div Endocrinol, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	dcooper@lifebridgehealth.org						ABRAHAM P, 2004, COCHRANE DB SYST REV, V2; Akamizu T, 2002, CLIN EXP IMMUNOL, V127, P92, DOI 10.1046/j.1365-2249.2002.01720.x; ALLANNIC H, 1990, J CLIN ENDOCR METAB, V70, P675, DOI 10.1210/jcem-70-3-675; American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; AMINO N, 1982, J CLIN ENDOCR METAB, V55, P108, DOI 10.1210/jcem-55-1-108; Andrade VA, 2001, J CLIN ENDOCR METAB, V86, P3488, DOI 10.1210/jc.86.8.3488; Andres E, 2001, QJM-MON J ASSOC PHYS, V94, P423, DOI 10.1093/qjmed/94.8.423; ARAB DM, 1995, J CLIN ENDOCR METAB, V80, P1083, DOI 10.1210/jc.80.4.1083; Azizi F, 2003, J PEDIATR ENDOCR MET, V16, P1239; Azizi F, 2002, J ENDOCRINOL INVEST, V25, P493, DOI 10.1007/BF03345489; BARNES HV, 1972, J CLIN ENDOCR METAB, V35, P250, DOI 10.1210/jcem-35-2-250; Benker G, 1998, CLIN ENDOCRINOL, V49, P451, DOI 10.1046/j.1365-2265.1998.00554.x; BERGLUND J, 1991, J INTERN MED, V229, P435, DOI 10.1111/j.1365-2796.1991.tb00371.x; BERKMAN EM, 1983, TRANSFUSION, V23, P135, DOI 10.1046/j.1537-2995.1983.23283172851.x; Bonnema SJ, 2004, J CLIN ENDOCR METAB, V89, P4439, DOI 10.1210/jc.2004-0247; Braga M, 2002, THYROID, V12, P135, DOI 10.1089/105072502753522365; CHERON RG, 1981, NEW ENGL J MED, V304, P525, DOI 10.1056/NEJM198102263040907; CHO BY, 1992, CLIN ENDOCRINOL, V36, P585, DOI 10.1111/j.1365-2265.1992.tb02269.x; Cooper DS, 1998, ENDOCRIN METAB CLIN, V27, P225, DOI 10.1016/S0889-8529(05)70308-X; COOPER DS, 1987, ARCH INTERN MED, V147, P785, DOI 10.1001/archinte.147.4.785; Cooper DS, 2003, J CLIN ENDOCR METAB, V88, P3474, DOI 10.1210/jc.2003-030185; Cooper DS, 1999, ENDOCRINOLOGIST, V9, P457, DOI 10.1097/00019616-199911000-00008; COOPER DS, 1984, NEW ENGL J MED, V311, P1353, DOI 10.1056/NEJM198411223112106; COOPER DS, 1982, J CLIN ENDOCR METAB, V54, P101, DOI 10.1210/jcem-54-1-101; COOPER DS, 1984, J CLIN ENDOCR METAB, V58, P473, DOI 10.1210/jcem-58-3-473; Corrales JJ, 1997, J ENDOCRINOL, V155, P491, DOI 10.1677/joe.0.1550491; DAVIDSON B, 1978, ENDOCRINOLOGY, V103, P871, DOI 10.1210/endo-103-3-871; DAVIES TF, 1984, J CLIN INVEST, V73, P397, DOI 10.1172/JCI111225; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; DUCORNET B, 1988, ANN MED INTERNE, V139, P410; EISENSTEIN Z, 1992, EUR J PEDIATR, V151, P558, DOI 10.1007/BF01957719; FELDTRASMUSSEN U, 1994, J CLIN ENDOCR METAB, V78, P98, DOI 10.1210/jc.78.1.98; FIBBE WE, 1986, BRIT J HAEMATOL, V64, P363, DOI 10.1111/j.1365-2141.1986.tb04130.x; Fukao A, 2003, CLIN ENDOCRINOL, V58, P550, DOI 10.1046/j.1365-2265.2003.01625.x; Fukata S, 1999, THYROID, V9, P29, DOI 10.1089/thy.1999.9.29; GARCIAMAYOR RVG, 1992, J ENDOCRINOL INVEST, V15, P815, DOI 10.1007/BF03348811; GARDNER DF, 1986, J CLIN ENDOCR METAB, V62, P217, DOI 10.1210/jcem-62-1-217; GILES HG, 1982, J PHARM PHARMACOL, V34, P62, DOI 10.1111/j.2042-7158.1982.tb04684.x; Grebe SKG, 1998, CLIN ENDOCRINOL, V48, P585, DOI 10.1046/j.1365-2265.1998.00446.x; Guma M, 2003, J CLIN ENDOCR METAB, V88, P2141, DOI 10.1210/jc.2002-021383; Gunton JE, 1999, J CLIN ENDOCR METAB, V84, P13, DOI 10.1210/jc.84.1.13; Gurlek A, 1997, J CLIN GASTROENTEROL, V24, P180, DOI 10.1097/00004836-199704000-00013; HAMBURGER JI, 1992, THYROID, V2, P219, DOI 10.1089/thy.1992.2.219; Harper L, 2004, CLIN ENDOCRINOL, V60, P671, DOI 10.1111/j.1365-2265.2004.02029.x; HASHIZUME K, 1991, NEW ENGL J MED, V324, P947, DOI 10.1056/NEJM199104043241403; He CT, 2004, CLIN ENDOCRINOL, V60, P676, DOI 10.1111/j.1365-2265.2004.02032.x; HEDLEY AJ, 1989, CLIN ENDOCRINOL, V31, P209, DOI 10.1111/j.1365-2265.1989.tb01244.x; HEGEDUS L, 1984, ACTA ENDOCRINOL-COP, V107, P482, DOI 10.1530/acta.0.1070482; Helfgott SM, 2002, NEW ENGL J MED, V347, P122, DOI 10.1056/NEJMcpc020104; HOFFMAN WH, 1988, DEV PHARMACOL THERAP, V11, P73, DOI 10.1159/000457669; Homsanit M, 2001, CLIN ENDOCRINOL, V54, P385, DOI 10.1046/j.1365-2265.2001.01239.x; HORTON RC, 1989, LANCET, V2, P568; IKEDA S, 1982, CAN ANAESTH SOC J, V29, P477, DOI 10.1007/BF03009412; JANSSON R, 1985, CLIN PHARMACOKINET, V10, P443, DOI 10.2165/00003088-198510050-00006; JANSSON R, 1983, J CLIN ENDOCR METAB, V57, P129, DOI 10.1210/jcem-57-1-129; Jongjaroenprasert W, 2002, THYROID, V12, P627, DOI 10.1089/105072502320288500; JORDE R, 1995, J INTERN MED, V238, P161, DOI 10.1111/j.1365-2796.1995.tb00914.x; JULIA A, 1991, BRIT J HAEMATOL, V79, P366, DOI 10.1111/j.1365-2141.1991.tb08042.x; Junik R, 1989, Endokrynol Pol, V40, P307; Kallner G, 1996, J INTERN MED, V239, P525, DOI 10.1046/j.1365-2796.1996.489827000.x; KAMPMANN JP, 1979, ACTA MED SCAND, P93; LIAW YF, 1993, ANN INTERN MED, V118, P424, DOI 10.7326/0003-4819-118-6-199303150-00005; Ljunggren JG, 1998, THYROID, V8, P653, DOI 10.1089/thy.1998.8.653; MANDEL SJ, 1994, THYROID, V4, P129, DOI 10.1089/thy.1994.4.129; Mandel SR, 2001, J CLIN ENDOCR METAB, V86, P2354, DOI 10.1210/jc.86.6.2354; MARCHANT B, 1971, METABOLISM, V20, P989, DOI 10.1016/0026-0495(71)90021-7; MASHIO Y, 1988, ACTA ENDOCRINOL-COP, V119, P139, DOI 10.1530/acta.0.1190139; Maugendre D, 1999, CLIN ENDOCRINOL, V50, P127, DOI 10.1046/j.1365-2265.1999.00629.x; MCCRUDEN DC, 1987, CLIN ENDOCRINOL, V26, P33, DOI 10.1111/j.1365-2265.1987.tb03636.x; MCGREGOR AM, 1980, NEW ENGL J MED, V303, P302, DOI 10.1056/NEJM198008073030603; McIver B, 1996, NEW ENGL J MED, V334, P220, DOI 10.1056/NEJM199601253340403; MESSER PM, 1990, ACTA ENDOCRINOL-COP, V123, P311, DOI 10.1530/acta.0.1230311; MEYERGESSNER M, 1989, DEUT MED WOCHENSCHR, V114, P166, DOI 10.1055/s-2008-1066570; Michelangeli V, 1998, THYROID, V8, P119, DOI 10.1089/thy.1998.8.119; Mitsiades N, 2000, THYROID, V10, P527, DOI 10.1089/thy.2000.10.527; MOMOTANI N, 1984, CLIN ENDOCRINOL, V20, P695, DOI 10.1111/j.1365-2265.1984.tb00119.x; MOMOTANI N, 1986, NEW ENGL J MED, V315, P24, DOI 10.1056/NEJM198607033150104; Momotani N, 1997, J CLIN ENDOCR METAB, V82, P3633, DOI 10.1210/jc.82.11.3633; Momotani N, 2000, CLIN ENDOCRINOL, V53, P177, DOI 10.1046/j.1365-2265.2000.01078.x; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; NABIL N, 1982, J CLIN ENDOCR METAB, V54, P180, DOI 10.1210/jcem-54-1-180; Nakazato N, 1999, THYROID, V9, P775, DOI 10.1089/thy.1999.9.775; Nedrebo BG, 2002, EUR J ENDOCRINOL, V147, P583, DOI 10.1530/eje.0.1470583; NICHOLAS WC, 1995, SOUTH MED J, V88, P973, DOI 10.1097/00007611-199509000-00018; Page SR, 1996, CLIN ENDOCRINOL, V45, P511, DOI 10.1046/j.1365-2265.1996.00800.x; Page SR, 1997, CLIN ENDOCRINOL, V46, P240; PARKER W A, 1982, Clinical Pharmacy, V1, P471; PASCHKE R, 1995, J CLIN ENDOCR METAB, V80, P2470, DOI 10.1210/jc.80.8.2470; Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x; Pfeilschifter J, 1997, EUR J ENDOCRINOL, V136, P81, DOI 10.1530/eje.0.1360081; REINHARDT W, 1989, J ENDOCRINOL INVEST, V12, P559, DOI 10.1007/BF03350760; REINWEIN D, 1993, J CLIN ENDOCR METAB, V76, P1516; Rittmaster RS, 1996, J CLIN ENDOCR METAB, V81, P3283, DOI 10.1210/jc.81.9.3283; Ruiz JK, 2003, ANN PHARMACOTHER, V37, P224; Russo MW, 2004, LIVER TRANSPLANT, V10, P1018, DOI 10.1002/lt.20204; Salvi M, 1996, J CLIN ENDOCR METAB, V81, P2976, DOI 10.1210/jc.81.8.2976; Santos RB, 2004, THYROID, V14, P525, DOI 10.1089/1050725041517093; Sato H, 2000, J CLIN ENDOCR METAB, V85, P4270, DOI 10.1210/jc.85.11.4270; SCHLEUSENER H, 1989, ACTA ENDOCRINOL-COP, V121, P304, DOI 10.1530/acta.0.1210304; Schott M, 2004, HORM METAB RES, V36, P92, DOI 10.1055/s-2004-814217; Sera N, 2000, THYROID, V10, P595, DOI 10.1089/thy.2000.10.595; SHABTAI R, 1984, ARTHRITIS RHEUM, V27, P227, DOI 10.1002/art.1780270216; Sheng WH, 1999, QJM-INT J MED, V92, P455, DOI 10.1093/qjmed/92.8.455; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; SLINGERLAND DW, 1979, JAMA-J AM MED ASSOC, V242, P2408, DOI 10.1001/jama.242.22.2408; SOLOMON B, 1990, J CLIN ENDOCR METAB, V70, P1518, DOI 10.1210/jcem-70-6-1518; Sonnet E, 1999, J ENDOCRINOL INVEST, V22, P430, DOI 10.1007/BF03343586; Taguchi M, 1999, CLIN ENDOCRINOL, V51, P667, DOI 10.1046/j.1365-2265.1999.00888.x; Tajiri J, 2004, THYROID, V14, P459, DOI 10.1089/105072504323150787; TAJIRI J, 1993, ARCH INTERN MED, V153, P509, DOI 10.1001/archinte.153.4.509; Tajiri J, 1997, THYROID, V7, P575, DOI 10.1089/thy.1997.7.575; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; Taurog Alvin, 1996, P47; TENG CS, 1980, J CLIN ENDOCR METAB, V50, P144, DOI 10.1210/jcem-50-1-144; Torring O, 1996, J CLIN ENDOCR METAB, V81, P2986, DOI 10.1210/jc.81.8.2986; TOTH EL, 1988, AM J MED, V85, P725; TOTTERMAN TH, 1987, NEW ENGL J MED, V316, P15, DOI 10.1056/NEJM198701013160104; Tsatsoulis A, 1996, EUR J CLIN INVEST, V26, P341; TSATSOULIS A, 1995, EUR J CLIN INVEST, V25, P654, DOI 10.1111/j.1365-2362.1995.tb01981.x; UCHIGATA Y, 1994, DIABETES RES CLIN PR, V22, P89, DOI 10.1016/0168-8227(94)90040-X; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; Vitti P, 1997, THYROID, V7, P369, DOI 10.1089/thy.1997.7.369; Volpe R, 2001, CURR PHARM DESIGN, V7, P451, DOI 10.2174/1381612013397898; WALDHAUSER L, 1991, DRUG METAB DISPOS, V19, P354; WANG PW, 1988, CLIN ENDOCRINOL, V28, P205, DOI 10.1111/j.1365-2265.1988.tb03657.x; Wartofsky L, 1991, Thyroid, V1, P129, DOI 10.1089/thy.1991.1.129; Werner R S, 1991, Thyroid, V1, P293; Williams KV, 1997, J CLIN ENDOCR METAB, V82, P1727, DOI 10.1210/jc.82.6.1727; Wilson R, 1996, QJM-INT J MED, V89, P381; WILSON R, 1988, CLIN EXP IMMUNOL, V73, P312; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; WOOD LC, 1979, J CLIN INVEST, V64, P1429, DOI 10.1172/JCI109601; Zantut-Wittmann DE, 2001, THYROID, V11, P575, DOI 10.1089/105072501750302886; 2005, DESTINATIONRX HOME P	134	722	782	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					905	917		10.1056/NEJMra042972	http://dx.doi.org/10.1056/NEJMra042972			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745981				2022-12-28	WOS:000227310700009
J	Knill, E				Knill, E			Quantum computing with realistically noisy devices	NATURE			English	Article							TELEPORTATION; COMPUTATION; ALGORITHMS; TIME	In theory, quantum computers offer a means of solving problems that would be intractable on conventional computers. Assuming that a quantum computer could be constructed, it would in practice be required to function with noisy devices called 'gates'. These gates cause decoherence of the fragile quantum states that are central to the computer's operation. The goal of so-called 'fault-tolerant quantum computing' is therefore to compute accurately even when the error probability per gate (EPG) is high. Here we report a simple architecture for fault-tolerant quantum computing, providing evidence that accurate quantum computing is possible for EPGs as high as three per cent. Such EPGs have been experimentally demonstrated, but to avoid excessive resource overheads required by the necessary architecture, lower EPGs are needed. Assuming the availability of quantum resources comparable to the digital resources available in today's computers, we show that non-trivial quantum computations at EPGs of as high as one per cent could be implemented.	Natl Inst Stand & Technol, Math & Computat Sci Div, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Knill, E (corresponding author), Natl Inst Stand & Technol, Math & Computat Sci Div, Boulder, CO 80305 USA.	knill@boulder.nist.gov						ABRAMS DS, 1999, FAST QUANTUM ALGORIT; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; BOLLINGER JJ, 1991, IEEE T INSTRUM MEAS, V40, P126, DOI 10.1109/TIM.1990.1032897; BRAVYI S, 2004, UNIVERSAL QUANTUM CO; Childs AM, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012314; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; DiVincenzo DP, 1998, PHYS REV A, V57, P830, DOI 10.1103/PhysRevA.57.830; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; GOTTESMAN D, 1997, THESIS CALTECH PASAD; *INT COOP, 2004, MICR QUICK REF GUID; KNIL E, 2004, FAULT TOLERANT POSTS; Knill E, 1998, P ROY SOC A-MATH PHY, V454, P365, DOI 10.1098/rspa.1998.0166; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; KNILL E, 2004, QUANTUM COMPUTING VE; Knill E., 2004, FAULT TOLERANT POSTS; KNILL E, 2003, SCALABLE QUANTUM COM; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; NIELSEN MA, 2001, QUANTUM COMPUTATION; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; REICHARDT BW, 2004, IMPROVED ANCILLA PRE; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Steane AM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042322; Steane AM, 2002, QUANTUM INF COMPUT, V2, P297; Steane AM, 1998, FORTSCHR PHYS, V46, P443, DOI 10.1002/(SICI)1521-3978(199806)46:4/5<443::AID-PROP443>3.0.CO;2-8; SVORE KM, 2004, LOCAL FAULT TOLERANT; Zhou XL, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052316; [No title captured]	34	686	717	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					39	44		10.1038/nature03350	http://dx.doi.org/10.1038/nature03350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744292	Green Submitted			2022-12-28	WOS:000227334600036
J	Mauer, M; Fioretto, P				Mauer, M; Fioretto, P			Preventing microalbuminuria in type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Univ Minnesota, Minneapolis, MN 55455 USA; Univ Padua, I-35126 Padua, Italy	University of Minnesota System; University of Minnesota Twin Cities; University of Padua	Mauer, M (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	mauer002@umn.edu	Mauer, Michael/ABD-5415-2020; fioretto, paola/AHD-4415-2022	FIORETTO, PAOLA/0000-0003-3445-0387				MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835	2	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					833	834						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15736290				2022-12-28	WOS:000227147500018
J	Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA				Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA			Crystal structure of the malaria vaccine candidate apical membrane antigen 1	SCIENCE			English	Article							PLASMODIUM-KNOWLESI; ERYTHROCYTE INVASION; APPLE DOMAINS; PAN MODULE; PROTEIN; IMMUNIZATION; MEROZOITES; EXPRESSION; HOMOLOG; PROGRAM	Apical membrane antigen 1 from Plasmodium is a leading malaria vaccine candidate. The protein is essential for host-cell invasion, but its molecular function is unknown. The crystal structure of the three domains comprising the ectoplasmic region of the antigen from P. vivax, solved at 1.8 angstrom resolution, shows that domains I and II belong to the PAN motif, which defines a superfamily of protein folds implicated in receptor binding. We also mapped the epitope of an invasion-inhibitory monoclonal antibody specific for the P. falciparum ortholog and modeled this to the structure. The location of the epitope and current knowledge on structure-function correlations for PAN domains together suggest a receptor-binding role during invasion in which domain II plays a critical part. These results are likely to aid vaccine and drug design.	Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, F-75724 Paris, France; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC National Institute for Medical Research	Bentley, GA (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, 25 Rue Docteur Roux, F-75724 Paris, France.	bentley@pasteur.fr	Remarque, Edmond J/B-2217-2010; Remarque, Ed/AAE-8643-2020; Bentley, Graham/B-3623-2011	Marie-Laure, Chesne-Seck/0000-0002-0963-2181; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	Medical Research Council [MC_U117532063] Funding Source: Medline; MRC [MC_U117532063] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2001, ACTA CRYSTALLOGR D, V57, P1071, DOI 10.1107/S0907444901007405; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vulliez-Le Normand B, 2004, ACTA CRYSTALLOGR D, V60, P2040, DOI 10.1107/S090744490402116X; WATERS AP, 1990, J BIOL CHEM, V265, P17974	27	157	166	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					408	411		10.1126/science.1107449	http://dx.doi.org/10.1126/science.1107449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15731407				2022-12-28	WOS:000228492000051
J	Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ				Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ			Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis	LANCET			English	Article							NKT CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T(H)2 BIAS; EXPRESSION; ACTIVATION; PREVENTS; IL-12; LYMPHOCYTES	Background Sarcoidosis is a multisystem disorder that predominantly involves the lungs, characterised by a T-helper-1 (Th1) biased CD4-positive T-cell response and granuloma formation, for which the explanation is unknown. A newly identified subset of T cells with immunoregulatory functions, CD1d-restricted natural-killer T (NKT) cells, has been shown to protect against disorders with increased CD4-positive Th1 responses in animals. We explored whether abnormalities in these cells are implicated in the pathogenesis of sarcoidosis. Methods We generated fluorescence-labelled CD1d-tetrameric complexes and used them, with monoclonal antibodies to V alpha 24 and V beta 11 T-cell receptor, to assess the frequency of CD1d-restricted NKT cells in the peripheral blood of 60 patients with histologically proven sarcoidosis (16 with Lofgren's syndrome) and 60 healthy controls. Lung lymphocytes were also analysed in 16 of the patients with sarcoidosis. Findings CD1d-restricted NKT cells were absent or greatly reduced in peripheral blood from all patients with sarcoidosis, except those with Lofgren's syndrome (median proportion of lymphocytes 0.01% [IQR 0-0.03] vs 0.06% [0.03-0.12] in controls; p=0.0004). The deficiency was found in both acute and resolved disease and was unrelated to systemic corticosteroid therapy. There was no difference in the proportion of CD1d-restricted NKT cells between peripheral blood and lungs in patients, suggesting that the peripheral-blood deficiency is not due to sequestration of these cells in the lungs. The NKT cells were not observed in mediastinal lymph nodes or granulomatous lesions. CD1d expression on antigen-presenting cells of patients was normal, thus the deficiency of CD1d-restricted NKT cells is not explained by abnormal CD1d expression. Interpretation Loss of immunoregulation by CD1d-restricted NKT cells could explain the amplified and persistent T-cell activity that characterises sarcoidosis. Relevance to practice Our findings give new insight into the pathogenesis of sarcoidosis and draw attention to a potential target for therapeutic modulation in sarcoidosis.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England; Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; Univ Birmingham, Dept Med Sci, Lung Injury & Fibrosis Treatment Programme, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Birmingham	Ho, LP (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England.		Urban, Britta/W-6087-2018; Ho, Ling-Pei/AAL-4776-2021; thickett, david/I-4770-2012	Urban, Britta/0000-0002-4197-8393; thickett, david/0000-0002-5456-6080; Ho, Ling Pei/0000-0001-8319-301X				Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Carnaud C, 1999, J IMMUNOL, V163, P4647; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Ho LP, 2002, CHEST, V121, P1421, DOI 10.1378/chest.121.5.1421; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hosoda Y, 1997, CLIN CHEST MED, V18, P681, DOI 10.1016/S0272-5231(05)70412-3; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KONISHI K, 1988, J CLIN INVEST, V82, P775, DOI 10.1172/JCI113678; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moller DR, 1996, J IMMUNOL, V156, P4952; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; SILTZBACH LE, 1967, MED CLIN N AM, V51, P483, DOI 10.1016/S0025-7125(16)33069-3; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Spagnolo P, 2003, AM J RESP CRIT CARE, V168, P1162, DOI 10.1164/rccm.200303-456OC; Taha RA, 1999, AM J RESP CRIT CARE, V160, P1119, DOI 10.1164/ajrccm.160.4.9807120; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756	34	68	70	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1062	1072		10.1016/S0140-6736(05)71143-0	http://dx.doi.org/10.1016/S0140-6736(05)71143-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781102				2022-12-28	WOS:000227731800031
J	Ruggenenti, P; Perna, A; Loriga, G; Ganeva, M; Ene-Iordache, B; Turturro, M; Lesti, M; Perticucci, E; Chakarski, IN; Leonardis, D; Garini, G; Sessa, A; Basile, C; Alpa, M; Scanziani, R; Sorba, G; Zoccali, C; Remuzzi, G				Ruggenenti, P; Perna, A; Loriga, G; Ganeva, M; Ene-Iordache, B; Turturro, M; Lesti, M; Perticucci, E; Chakarski, IN; Leonardis, D; Garini, G; Sessa, A; Basile, C; Alpa, M; Scanziani, R; Sorba, G; Zoccali, C; Remuzzi, G		REIN-2 Study Grp	Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial	LANCET			English	Article							CONVERTING ENZYME-INHIBITION; CHRONIC KIDNEY-DISEASE; ACE-INHIBITION; CALCIUM-ANTAGONISTS; PROGRESSION; NEPHROPATHIES; HYPERTENSION; PROTEINURIA; RAMIPRIL; BENEFITS	Background In chronic nephropathies, inhibition of angiotensin-converting enzyme (ACE) is renoprotective, but can further renoprotection be achieved by reduction of blood pressure to lower than usual targets? We aimed to assess the effect of intensified versus conventional blood-pressure control on progression to end-stage renal disease. Methods We undertook a multicentre, randomised controlled trial of patients with non-diabetic proteinuric nephropathies receiving background treatment with the ACE inhibitor ramipril (2.5-5 mg/day). We randomly assigned participants either conventional (diastolic <90 mm Hg; n=169) or intensified (systolic/diastolic <130/80 mm Hg; n=169) blood-pressure control. To achieve the intensified blood-pressure level, patients received add-on therapy with the dilrydropyridine calcium-channel blocker felodipine (5-10 mg/day). The primary outcome measure was time to end-stage renal disease over 36 months' follow-up, and analysis was by intention to treat. Findings Of 338 patients who were randomised, three (two assigned intensified and one allocated conventional blood-pressure control) never took study drugs and they were excluded. over a median follow-up of 19 months (IQR 12-35), 38/167.(23%) patients assigned to intensified blood-pressure control and 34/168 (20%) allocated conventional control progressed to end-stage renal disease (hazard ratio 1.00 [95% CI 0.61-1.64]; p=0.99). Interpretation In patients with non-diabetic proteinuric nephropathies receiving background ACE-inhibitor therapy, no additional benefit from further blood-pressure reduction by felodipine could be shown.	Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, Clin Res Ctr Rare Dis Aldo e Cele Dacco, I-24125 Bergamo, Italy; Osped Riuniti Bergamo, Azienda Osped, Nephrol Unit, I-24100 Bergamo, Italy; Univ Hosp St George, Dept Med Informat Serv, Plovdiv, Bulgaria; Thracian Univ, Fac Med, Stara Zagora, Bulgaria; Osped Riuniti Reggio Calabria, Azienda Osped, CNR, IBIM, Reggio Di Calabria, Italy; Azienda Osped Univ, Dipartimento Clin Med Nefrol & Sci Prevenz, Parma, Italy; Osped Civile, Azienda Osped, Vimercate, Italy; Osped Civile Martina Franca, Azienda Osped, Taranto, Italy; Osped G Bosco, Ctr Immunopathol & Rare Dis, Turin, Italy; Osped Civile, Azienda Osped, Milan, Italy; Osped SS Annunziata, Azienda Osped, Sassari, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; Trakia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Parma; University Hospital of Parma; Ospedale di Vimercate; Ospedale di Vimercate	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, Clin Res Ctr Rare Dis Aldo e Cele Dacco, Via Gavazzeni 11,Villa Camozzi, I-24125 Bergamo, Italy.	manuelap@marionegri.it	Zoccali, Carmine/B-9445-2009; Lesti, Mariadomenica/ABH-7380-2020; Ene-Iordache, Bogdan/C-6824-2018; Perna, Annalisa/AAC-1323-2020; Remuzzi, Giuseppe/V-9766-2017	Lesti, Mariadomenica/0000-0001-5338-5926; Ene-Iordache, Bogdan/0000-0002-4011-9343; Perna, Annalisa/0000-0002-9257-0283; Remuzzi, Giuseppe/0000-0002-6194-3446; Zoccali, Carmine/0000-0002-6616-1996				Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; ANDERSON S, 1992, KIDNEY INT, V41, P891, DOI 10.1038/ki.1992.136; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; [Anonymous], 1991, J NEPHROL, V3, P193; Bakris GL, 2003, AM J MED, V115, P49, DOI 10.1016/j.amjmed.2003.08.013; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buckalew V, 2002, DIABETES, V51, pA38; Buter H, 1998, NEPHROL DIAL TRANSPL, V13, P1682, DOI 10.1093/ndt/13.7.1682; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Gashti CN, 2004, CURR OPIN NEPHROL HY, V13, P155, DOI 10.1097/00041552-200403000-00003; GASPARI F, 1995, J AM SOC NEPHROL, V6, P1; HASHIMOTO K, 1975, 1ST INT NIF AD S, P11; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Herlitz H, 2001, NEPHROL DIAL TRANSPL, V16, P2158, DOI 10.1093/ndt/16.11.2158; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kloke HJ, 1998, KIDNEY INT, V53, P1559, DOI 10.1046/j.1523-1755.1998.00912.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lewis JB, 1999, AM J KIDNEY DIS, V34, P809, DOI 10.1016/S0272-6386(99)70036-3; MIMRAN A, 1994, AM J HYPERTENS, V7, pS73, DOI 10.1093/ajh/7.9.73S; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Roberts C, 1998, BRIT MED J, V317, P1301, DOI 10.1136/bmj.317.7168.1301; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2096; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; TODD PA, 1992, DRUGS, V44, P251, DOI 10.2165/00003495-199244020-00008; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	36	454	480	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					939	946		10.1016/S0140-6736(05)71082-5	http://dx.doi.org/10.1016/S0140-6736(05)71082-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766995				2022-12-28	WOS:000227559800026
J	Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD				Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD			A functional dosage compensation complex required for male killing in Drosophila	SCIENCE			English	Article							SEX; MELANOGASTER; GENE; WILLISTONI	Bacteria that selectively kilt males ("male-killers") were first characterized more than 50 years ago in Drosophila and have proved to be common in insects. However, the mechanism by which sex specificity of virulence is achieved has remained unknown. We tested the ability of Spiroplasma poulsonii to kill Drosophila melanogaster mates carrying mutations in genes that encode the dosage compensation complex. The bacterium failed to kill mates lacking any of the five protein components of the complex.	UCL, Dept Biol, London NW1 2HE, England; Cent Res Inst Elect Power Ind, Low Dose Radiat Res Ctr, Tokyo 2018511, Japan; Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales	University of London; University College London; Central Research Institute of Electric Power Industry - Japan; Bangor University	Hurst, GDD (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	g.hurst@ucl.ac.uk	Braig, Henk/I-5477-2013; Hurst, Gregory D D/C-2723-2008	Braig, Henk/0000-0001-9592-1141; Hurst, Gregory D D/0000-0002-7163-7784				CLINE TW, 1984, GENETICS, V107, P231; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; Franke A, 1996, DEVELOPMENT, V122, P2751; Gilfillan GD, 2004, FEBS LETT, V567, P8, DOI 10.1016/j.febslet.2004.03.110; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2003, CONT T ENT, P177; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; MAGNI GE, 1953, NATURE, V172, P81, DOI 10.1038/172081a0; SAKAGUCHI B, 1963, GENETICS, V48, P841; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	13	74	75	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1461	1463		10.1126/science.1107182	http://dx.doi.org/10.1126/science.1107182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746426				2022-12-28	WOS:000227503100045
J	Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C				Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C			Risks and benefits of phase 1 oncology trials, 1991 through 2002	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-CANCER-INSTITUTE; CLINICAL-TRIALS; I TRIALS; THERAPEUTIC RESPONSE; PROGNOSTIC-FACTORS; ANTICANCER AGENTS; ETHICS; DESIGN; SURVIVAL; RATES	BACKGROUND Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in current phase 1 oncology trials. METHODS We reviewed all nonpediatric phase 1 oncology trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute between 1991 and 2002. We report the rates of response to treatment, of stable disease, of grade 4 toxic events, and of treatment-related deaths. RESULTS We analyzed 460 trials involving 11,935 participants, all of whom were assessed for toxicity and 10,402 of whom were assessed for a response to therapy. The overall response rate (i.e., for both complete and partial responses) was 10.6 percent, with considerable variation among trials. ``Classic'' phase 1 trials of single investigational chemotherapeutic agents represented only 20 percent of the trials and had a response rate of 4.4 percent. Studies that included at least one anticancer agent approved by the Food and Drug Administration constituted 46.3 percent of the trials and had a response rate of 17.8. An additional 34.1 percent of participants had stable disease or a less-than-partial response. The overall rate of death due to toxic events was 0.49 percent. Of 3465 participants for whom data on patient-specific grade 4 toxic events were available, 14.3 percent had had at least one episode of grade 4 toxic events. CONCLUSIONS Overall response rates among phase 1 oncology trials are higher than previously reported, although they have not changed for classic phase 1 trials, and toxicity-related death rates have remained stable. Rates of response and toxicity vary, however, among the various types of phase 1 oncology trials.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Canc Therapy Evaluat Program, NIH, Rockville, MD USA; Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	National Institutes of Health (NIH) - USA; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Japan	Grady, C (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov		Rubinstein, Lawrence/0000-0002-9720-9737	CLINICAL CENTER [Z01CL010522] Funding Source: NIH RePORTER	CLINICAL CENTER		Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Annas G J, 1992, Health Matrix Clevel, V2, P119; Ansher SS, 2001, ANN NY ACAD SCI, V949, P333; Bachelot T, 2000, ANN ONCOL, V11, P151, DOI 10.1023/A:1008368319526; *CANC THER EV PROG, 1999, COMM TOX CRIT CTC VE; Chen EX, 2004, JAMA-J AM MED ASSOC, V292, P2150, DOI 10.1001/jama.292.17.2150; Daugherty CK, 1997, ANN INTERN MED, V126, P892, DOI 10.7326/0003-4819-126-11-199706010-00008; DECOSTER G, 1990, ANN ONCOL, V1, P175, DOI 10.1093/oxfordjournals.annonc.a057716; Dent SF, 1996, ANN ONCOL, V7, P561; Eisenhauer EA, 2000, J CLIN ONCOL, V18, P684, DOI 10.1200/JCO.2000.18.3.684; EMANUEL EJ, 1995, J CLIN ONCOL, V13, P1049, DOI 10.1200/JCO.1995.13.5.1049; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Goldman DP, 2003, JAMA-J AM MED ASSOC, V289, P2970, DOI 10.1001/jama.289.22.2970; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; LIPSETT MB, 1982, JAMA-J AM MED ASSOC, V248, P941, DOI 10.1001/jama.248.8.941; MARKMAN M, 1992, J CANCER RES CLIN, V119, P5, DOI 10.1007/BF01209482; Markman M, 2003, CLEV CLIN J MED, V70, P1008, DOI 10.3949/ccjm.70.12.1008; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Miller M, 2001, Int Anesthesiol Clin, V39, P13; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Sekine I, 2002, ANN ONCOL, V13, P1300, DOI 10.1093/annonc/mdf202; Shanafelt TD, 2004, J CLIN ONCOL, V22, P1966, DOI 10.1200/JCO.2004.08.176; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Takimoto CH, 2003, CANCER CHEMOTH PHARM, V52, pS29, DOI 10.1007/s00280-003-0623-y; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562	29	332	340	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					895	904		10.1056/NEJMsa042220	http://dx.doi.org/10.1056/NEJMsa042220			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745980				2022-12-28	WOS:000227310700008
J	Lin, Y; Boker, A; He, JB; Sill, K; Xiang, HQ; Abetz, C; Li, XF; Wang, J; Emrick, T; Long, S; Wang, Q; Balazs, A; Russell, TP				Lin, Y; Boker, A; He, JB; Sill, K; Xiang, HQ; Abetz, C; Li, XF; Wang, J; Emrick, T; Long, S; Wang, Q; Balazs, A; Russell, TP			Self-directed self-assembly of nanoparticle/copolymer mixtures	NATURE			English	Article							BLOCK-COPOLYMERS; NANOSTRUCTURES; ARRAYS	The organization of inorganic nanostructures within self-assembled organic or biological templates(1-11) is receiving the attention of scientists interested in developing functional hybrid materials. Previous efforts have concentrated on using such scaffolds(7,9,12) to spatially arrange nanoscopic elements as a strategy for tailoring the electrical, magnetic or photonic properties(8) (- 11,13 - 16) of the material. Recent theoretical arguments(16 - 18) have suggested that synergistic interactions between self-organizing particles and a self-assembling matrix material can lead to hierarchically ordered structures. Here we show that mixtures of diblock copolymers and either cadmium selenide- or ferritin-based nanoparticles exhibit cooperative, coupled self-assembly on the nanoscale. In thin films, the copolymers assemble into cylindrical domains, which dictate the spatial distribution of the nanoparticles; segregation of the particles to the interfaces mediates interfacial interactions and orients the copolymer domains normal to the surface, even when one of the blocks is strongly attracted to the substrate. Organization of both the polymeric and particulate entities is thus achieved without the use of external fields(10,19), opening a simple and general route for fabrication of nanostructured materials with hierarchical order.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; Univ Bayreuth, Bayreuther Inst Makromol Forsch, D-95440 Bayreuth, Germany; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Univ S Carolina, Dept Chem, Columbia, SC 29208 USA; Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Bayreuth; United States Department of Energy (DOE); Argonne National Laboratory; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Lin, Yao/E-5527-2011; Russell, Thomas Paul/ADL-3689-2022; He, Jinbo/B-1445-2010; Abetz, Clarissa/A-6932-2019; Böker, Alexander/AAA-5106-2022	Lin, Yao/0000-0001-5227-2663; Russell, Thomas Paul/0000-0001-6384-5826; Abetz, Clarissa/0000-0001-6845-0145; Böker, Alexander/0000-0002-5760-6631; Sill, Kevin/0000-0001-9797-7392; Balazs, Anna/0000-0002-5555-2692				Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Balazs AC, 1999, CURR OPIN COLLOID IN, V4, P443, DOI 10.1016/S1359-0294(00)00021-2; Black CT, 2000, SCIENCE, V290, P1131, DOI 10.1126/science.290.5494.1131; Bockstaller M, 2001, ADV MATER, V13, P1783, DOI 10.1002/1521-4095(200112)13:23<1783::AID-ADMA1783>3.0.CO;2-X; Bockstaller MR, 2003, J AM CHEM SOC, V125, P5276, DOI 10.1021/ja034523t; BRANDRUP J, 1998, POLYM HDB, P411; Kim SH, 2004, ADV MATER, V16, P226, DOI 10.1002/adma.200304906; Knoll A, 2004, J CHEM PHYS, V120, P1105, DOI 10.1063/1.1627324; Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080201; Lee JY, 2003, MACROMOLECULES, V36, P7730, DOI 10.1021/ma034765d; Li M, 1999, NATURE, V402, P393, DOI 10.1038/46509; Li Z, 1996, J AM CHEM SOC, V118, P10892, DOI 10.1021/ja961713d; Liang HJ, 2003, J AM CHEM SOC, V125, P11786, DOI 10.1021/ja036529o; LIU Y, 1994, MACROMOLECULES, V27, P4000, DOI 10.1021/ma00092a047; Lopes WA, 2001, NATURE, V414, P735, DOI 10.1038/414735a; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458; Meiners JC, 1997, MACROMOLECULES, V30, P4945, DOI 10.1021/ma970327t; MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0; Morkved TL, 1997, EUROPHYS LETT, V40, P643, DOI 10.1209/epl/i1997-00517-6; Pai RA, 2004, SCIENCE, V303, P507, DOI 10.1126/science.1092627; RAJA KS, 2004, ENCY NANOSCIENCE NAN, P321; Sanchez C, 2001, MRS BULL, V26, P377, DOI 10.1557/mrs2001.91; Shenton W, 1997, NATURE, V389, P585, DOI 10.1038/39287; Soo PP, 1999, J ELECTROCHEM SOC, V146, P32, DOI 10.1149/1.1391560; Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n; Templin M, 1997, SCIENCE, V278, P1795, DOI 10.1126/science.278.5344.1795; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Wong KKW, 1998, CHEM COMMUN, P1621, DOI 10.1039/a802627k	30	856	880	14	904	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					55	59		10.1038/nature03310	http://dx.doi.org/10.1038/nature03310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744296				2022-12-28	WOS:000227334600040
J	McMillan, J; Sheehan, M				McMillan, J; Sheehan, M			Commentary: ethical review and ethical behaviour	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hull, Hull York Med Sch, Dept Philosophy, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Keele, Ctr Profess Eth, Keele ST5 5NA, Staffs, England	University of Hull; University of York - UK; Keele University	McMillan, J (corresponding author), Univ Hull, Hull York Med Sch, Dept Philosophy, Kingston Upon Hull HU6 7RX, N Humberside, England.	john.mcmillan@hyms.ac.uk	; McMillan, John/S-9660-2018	Sheehan, Mark/0000-0002-7191-901X; McMillan, John/0000-0002-7507-1861				Wade DT, 2005, BMJ-BRIT MED J, V330, P468, DOI 10.1136/bmj.330.7489.468	1	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					473	473		10.1136/bmj.330.7489.473	http://dx.doi.org/10.1136/bmj.330.7489.473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731149	Green Published			2022-12-28	WOS:000227315400028
J	Grenier, IA; Casandjian, JM; Terrier, R				Grenier, IA; Casandjian, JM; Terrier, R			Unveiling extensive clouds of dark gas in the solar neighborhood	SCIENCE			English	Article							GAMMA-RAY EMISSION; MOLECULAR CLOUDS; EGRET OBSERVATIONS; INTERSTELLAR-MEDIUM; OUTER GALAXY; CO SURVEY; H-I; CATALOG; BELT	From the comparison of interstellar gas tracers in the solar neighborhood (HI and CO lines from the atomic and molecular gas, dust thermal emission, and gamma rays from cosmic-ray interactions with gas), we unveil vast clouds of cold dust and dark gas, invisible in HI and CO but detected in gamma rays. They surround all the nearby CO clouds and bridge the dense cores to broader atomic clouds, thus providing a key link in the evolution of interstellar clouds. The relation between the masses. in the molecular, dark, and atomic phases in the local clouds implies a dark gas mass in the Milky Way comparable to the molecular one.	Univ Paris 07, CEA, CNRS, DSM,DAPNIA,Serv Astrophys, F-91191 Gif Sur Yvette, France; CEA, CNRS, Grand Accelerateur Natl Ions Lourds, F-14076 Caen, France; Univ Paris 07, CNRS, CEA, F-75005 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Grenier, IA (corresponding author), Univ Paris 07, CEA, CNRS, DSM,DAPNIA,Serv Astrophys, F-91191 Gif Sur Yvette, France.	isabelle.grenier@cea.fr		Casandjian, Jean-Marc/0000-0003-1404-0524; Grenier, Isabelle/0000-0003-3274-674X				BLITZ L, 1990, ASTROPHYS J, V352, pL13, DOI 10.1086/185682; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Combes F, 2002, NEW ASTRON REV, V46, P755, DOI 10.1016/S1387-6473(02)00244-0; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; DAME TM, 2004, ASP C SERIES, P66; Digel SW, 2001, ASTROPHYS J, V555, P12, DOI 10.1086/321446; Eadie W.T., 1971, STAT METHODS EXPT PH; FICHTEL CE, 1991, ASTROPHYS J, V374, P134, DOI 10.1086/170103; Finkbeiner DP, 1999, ASTROPHYS J, V524, P867, DOI 10.1086/307852; Finkbeiner DP, 2004, ASTROPHYS J, V614, P186, DOI 10.1086/423482; FINKBEINER DP, 2004, B AM ASTRON SOC, V36, P2; Grenier IA, 2000, ASTRON ASTROPHYS, V364, pL93; Gry C, 2002, ASTRON ASTROPHYS, V391, P675, DOI 10.1051/0004-6361:20020691; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Hartmann D., 1997, ATLAS GALACTIC NEUTR; Heiles C, 2003, ASTROPHYS J, V586, P1067, DOI 10.1086/367828; Heyer MH, 2001, ASTROPHYS J, V551, P852, DOI 10.1086/320218; Hunter SD, 1997, ASTROPHYS J, V481, P205, DOI 10.1086/304012; Lagache G, 2003, ASTRON ASTROPHYS, V405, P813, DOI [10.1051/0004-6361-20030545, 10.1051/0004-6361:20030545]; Mizuno N, 2001, PUBL ASTRON SOC JPN, V53, P971, DOI 10.1093/pasj/53.6.971; Pohl M, 2003, ASTRON ASTROPHYS, V409, P581, DOI 10.1051/0004-6361:20030823; REACH WT, 1994, ASTROPHYS J, V429, P672, DOI 10.1086/174353; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sreekumar P, 1998, ASTROPHYS J, V494, P523, DOI 10.1086/305222; Strong A. W., 1996, ASTRON ASTROPHYS, V308, P21; Strong AW, 2004, ASTROPHYS J, V613, P962, DOI 10.1086/423193; Strong AW, 2004, ASTROPHYS J, V613, P956, DOI 10.1086/423196; Yamamoto H, 2003, ASTROPHYS J, V592, P217, DOI 10.1086/375128	31	317	318	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1292	1295		10.1126/science.1106924	http://dx.doi.org/10.1126/science.1106924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731450				2022-12-28	WOS:000227313200053
J	Koester, HJ; Johnston, D				Koester, HJ; Johnston, D			Target cell-dependent normalization of transmitter release at neocortical synapses	SCIENCE			English	Article							OPTICAL QUANTAL ANALYSIS; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; RAT NEOCORTEX; ACTION-POTENTIALS; CALCIUM DYNAMICS; NERVE-TERMINALS; NMDA RECEPTORS; DEPRESSION; HETEROGENEITY	The efficacy and short-term modification of neocortical synaptic connections vary with the type of target neuron. We investigated presynaptic Ca(2+) and release probability at single synaptic contacts between pairs of neurons in layer 2/3 of the rat neocortex. The amplitude of Ca(2+) signals in boutons of pyramids contacting bitufted or multipolar interneurons or other pyramids was dependent on the target cell type. Optical quantal analysis at single synaptic contacts suggested that release probabilities are also target cell-specific. Both the Ca(2+) signal and the release probability of different boutons of a pyramid contacting the same target cell varied little. We propose that the mechanisms that regulate the functional properties of boutons of a pyramid normalize the presynaptic Ca(2+) influx and release probability for all those boutons that innervate the same target cell.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Max Planck Society; Baylor College of Medicine	Koester, HJ (corresponding author), Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA.	HKoester@mail.utexas.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48432, MH44754] Funding Source: Medline; NINDS NIH HHS [NNS37444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KULLMANN DM, 1989, J NEUROSCI METH, V30, P231, DOI 10.1016/0165-0270(89)90134-9; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; STRICKER C, 1994, BIOPHYS J, V67, P532, DOI 10.1016/S0006-3495(94)80513-2; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yuste R, 1999, J NEUROSCI, V19, P1976; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	28	160	162	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					863	866		10.1126/science.1100815	http://dx.doi.org/10.1126/science.1100815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774725				2022-12-28	WOS:000228986500051
J	Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P				Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P			Retinoic acid controls the bilateral symmetry of somite formation in the mouse embryo	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; SEGMENTATION CLOCK; BOUNDARY FORMATION; NODAL EXPRESSION; GENE-EXPRESSION; SOMITOGENESIS; FGF	A striking characteristic of vertebrate embryos is their bilaterally symmetric body plan, which is particularly obvious at the level of the somites and their derivatives such as the vertebra[ column. Segmentation of the presomitic mesoderm must therefore be tightly coordinated along the left and right embryonic sides. We show that mutant mice defective for retinoic acid synthesis exhibit delayed somite formation on the right side. Asymmetric somite formation correlates with a left-right desynchronization of the segmentation clock oscillations. These data implicate retinoic acid as an endogenous signal that maintains the bilateral synchrony of mesoderm segmentation, and therefore controls bilateral symmetry, in vertebrate embryos.	Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Mol Biol, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine; Baylor College of Medicine	Vermot, J (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	julien@igbmc.u-strasbg.fr; dolle@igbmc.u-strasbg.fr	Dolle, Pascal/A-8037-2010; Vermot, Julien/I-6568-2016	Dolle, Pascal/0000-0002-9294-9090; , Julien/0000-0002-8924-732X				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; CERFONTAINE P, 2006, ARCH BIOL, P22; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sawada A, 2001, DEVELOPMENT, V128, P4873; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	22	167	175	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					563	566		10.1126/science.1108363	http://dx.doi.org/10.1126/science.1108363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15731404				2022-12-28	WOS:000228810500056
J	Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM				Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM			C-reactive protein levels are not associated with increased risk for colorectal cancer in women	ANNALS OF INTERNAL MEDICINE			English	Article							HORMONE REPLACEMENT THERAPY; INFLAMMATORY-BOWEL-DISEASE; PHASE REACTANT PROTEINS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERUM CARCINOEMBRYONIC ANTIGEN; POSTMENOPAUSAL WOMEN; INTERLEUKIN-6 LEVELS; TUMOR RECURRENCE; SURVIVAL; HEALTH	Background: Observations that risk for colorectal cancer is elevated in patients with inflammatory bowel disease and that longterm use of anti-inflammatory drugs may reduce colorectal cancer risk have raised the possibility that inflammation may play a role in the development of colorectal cancer. While a recent prospective study observed a positive association between C-reactive protein (CRP), a marker of inflammation, and risk for colon cancer, data testing this hypothesis are sparse. Objective: To evaluate whether plasma CRP levels predict colorectal cancer risk in women. Design: Prospective cohort study, with 97% morbidity follow-up and 100% mortality follow-up within the past 2 years. Setting: women's Health Study. Participants: 27 913 apparently healthy women age 45 years or older who had CRP measured at entry into a trial of low-dose aspirin and vitamin E. Maximum length of intervention and follow-up was 10.8 years. Measurements: self-reported incident colorectal adenocarcinoma confirmed by medical record review. Results: 169 women developed colorectal adenocarcinomas during follow-up. Baseline CRP levels were not significantly associated with colorectal cancer risk. The multivariate hazard ratios according to cutoff points for CRP proposed in clinical guidelines were 0.79 (95% CI, 0.53 to 1.17) for the category of 1 to 3 mg/L and 0.66 (CI, 0.43 to 1.03) for the category of greater than 3 mg/L (P for trend = 0.09), as compared with the category of less than 1 mg/L. High CRP levels were also not associated with increased risk in analyses done according to tumor location and stage at diagnosis, according to alternative cutoff points for CRP, or in any of the subgroups evaluated. Limitations: Despite multivariate analysis, residual confounding might still be present. Although this study was prospective, we cannot completely exclude undetected cancer at baseline. Measurements for CRP were available for only 71% of women in the cohort; however, the women who did and those who did not provide blood were mostly similar. Conclusions: Plasma CRP levels do not appear to predict an increased risk for developing colorectal cancer in apparently healthy women. Low-grade inflammation may not play an important role in increasing the risk for colorectal cancer.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, SMM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02115 USA.	shumin.zhang@channing.harvard.edu	Lee, I-Min/ABD-5409-2021		NCI NIH HHS [CA-47988, CA096619] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA096619] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/00042737-200304000-00006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crespo CJ, 2002, DIABETES CARE, V25, P1675, DOI 10.2337/diacare.25.10.1675; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Demissie K, 2004, ANN EPIDEMIOL, V14, P215, DOI 10.1016/j.annepidem.2003.08.002; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; DURDEY P, 1984, BRIT J SURG, V71, P881, DOI 10.1002/bjs.1800711126; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Komoda H, 1998, WORLD J SURG, V22, P895, DOI 10.1007/s002689900489; MCMILLAN DC, 1995, AM J SURG, V170, P319, DOI 10.1016/S0002-9610(99)80296-7; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; MERCER DW, 1985, CLIN CHEM, V31, P1824; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Nielsen HJ, 2000, ANN SURG ONCOL, V7, P617, DOI 10.1007/BF02725342; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Ockene IS, 2001, CLIN CHEM, V47, P444; Panes J, 2001, ACTA PHYSIOL SCAND, V173, P159, DOI 10.1046/j.1365-201X.2001.00905.x; Pasche B, 2004, JAMA-J AM MED ASSOC, V291, P623, DOI 10.1001/jama.291.5.623; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ries L, 1975, SEER CANC STAT REV; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; STAMATIADIS AP, 1992, EUR J SURG ONCOL, V18, P41; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; Vatay A, 2003, IMMUNOGENETICS, V55, P247, DOI 10.1007/s00251-003-0575-8; Wigmore SJ, 2001, BRIT J SURG, V88, P255, DOI 10.1046/j.1365-2168.2001.01669.x; Yuceyar S, 1996, INT SURG, V81, P136; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	43	105	109	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					425	432		10.7326/0003-4819-142-6-200503150-00008	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767620				2022-12-28	WOS:000227621100004
J	Paige, DA				Paige, DA			Ancient mars: Wet in many places	SCIENCE			English	Editorial Material								New results from the Mars Express Orbiter mission reveal multiple deposits of minerals formed in the presence of liquid water. They reinforce the conclusion that ancient Mars was warmer and wetter than it is today, and increase the number of promising localities to search for evidence of past life.	Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Paige, DA (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	dap@mars.ucla.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Kirkland LE, 2001, APPL OPTICS, V40, P4852, DOI 10.1364/AO.40.004852; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171	12	22	22	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1575	1576		10.1126/science.1110530	http://dx.doi.org/10.1126/science.1110530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761146				2022-12-28	WOS:000227622400033
J	Tinker, A; ten Hoope-Bender, P; Azfar, S; Bustreo, H; Bell, R				Tinker, A; ten Hoope-Bender, P; Azfar, S; Bustreo, H; Bell, R			A continuum of care to save newborn lives	LANCET			English	Editorial Material									Save Children USA, Saving Newborn Lives, Washington, DC 20036 USA; Save Children USA, Secretariat Hlth Newborn Partnership, Washington, DC 20036 USA; WHO, Partnership Safe Motherhood & Newborn Hlth Secret, Geneva, Switzerland; UNICEF, Child Survival Partnership, New York, NY USA	Save the Children; Save the Children; World Health Organization; UNICEF	Tinker, A (corresponding author), Save Children USA, Saving Newborn Lives, Washington, DC 20036 USA.	atinker@dc.savechildren.org						ABOUZHAR C, 2003, MATERNAL MORTALITY 2; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; DARMSTADT GL, 2005, LANCET; Freedman L, 2004, MILLENNIUM PROJECT T; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; *HLTH NEWB PARTN, 2004, HNP ANN M ETH ADD AB; Interagency group for safe motherhood, 1997, SAF MOTH ACT AG PRIO; Knippenberg R, 2005, LANCET; LAWN JE, 2005, LANCET; MARTINES J, 2005, LANCET; ROSENFIELD A, 1985, LANCET, V2, P83; *SAV CHILDR, 2000, STAT WORLDS NEWB; Tinker A, 2002, HLTH MOTHERS HLTH NE; UNICEF, 2004, STAT WORLDS CHILDR 2; *WHO, IN PRESS WORLD HLTH; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Zupan J., 2005, PERINATAL MORTALITY	17	77	78	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					822	825		10.1016/S0140-6736(05)71016-3	http://dx.doi.org/10.1016/S0140-6736(05)71016-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752509				2022-12-28	WOS:000227444600004
J	MacKinnon, R				MacKinnon, R			Membrane protein insertion and stability	SCIENCE			English	Editorial Material							DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE		Rockefeller Univ, Howard Hughes Med Inst, New York, NY 11021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 11021 USA.	mackinn@rockefeller.edu						Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153	8	22	23	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2005	307	5714					1425	1426		10.1126/science.1110525	http://dx.doi.org/10.1126/science.1110525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746418				2022-12-28	WOS:000227503100034
J	Beeli, G; Esslen, M; Jancke, L				Beeli, G; Esslen, M; Jancke, L			Synaesthesia - When coloured sounds taste sweet	NATURE			English	Article									Univ Zurich, Inst Neuropsychol, CH-8032 Zurich, Switzerland	University of Zurich	Beeli, G (corresponding author), Univ Zurich, Inst Neuropsychol, CH-8032 Zurich, Switzerland.	l.jaencke@psychologie.unizh.ch	Jäncke, Lutz/D-2910-2013; Jäncke, Lutz/C-3792-2009	Jäncke, Lutz/0000-0003-2110-9067; Jäncke, Lutz/0000-0002-8115-4890				Horn W., 1983, L P S LEISTUNGSPR FS, V2; LURIA AR, 1969, MIND MNEMONIST; Rich AN, 2002, NAT REV NEUROSCI, V3, P43, DOI 10.1038/nrn702; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7	5	77	77	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					38	38		10.1038/434038a	http://dx.doi.org/10.1038/434038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744291	Bronze			2022-12-28	WOS:000227334600035
J	Campisi, J				Campisi, J			Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors	CELL			English	Review							MAMMARY EPITHELIAL-CELLS; REPLICATIVE LIFE-SPAN; HUMAN FIBROBLASTS; STEM-CELL; PREMATURE SENESCENCE; GENE-EXPRESSION; ONCOGENIC RAS; CANCER; P16(INK4A); P53	Cells from organisms with renewable tissues can permanently withdraw from the cell cycle in response to diverse stress, including dysfunctional telomeres, DNA damage, strong mitogenic signals, and disrupted chromatin. This response, termed cellular senescence, is controlled by the p53 and RB tumor suppressor proteins and constitutes a potent anticancer mechanism. Nonetheless, senescent cells acquire phenotypic changes that may contribute to aging and certain age-related diseases, including late-life cancer. Thus, the senescence response may be antagonistically pleiotropic, promoting early-life survival by curtailing the development of cancer but eventually limiting longevity as dysfunctional senescent cells accumulate.	Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Buck Inst Age Res, Novato, CA 94545 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Buck Institute for Research on Aging	Campisi, J (corresponding author), Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	jcampisi@lbl.gov						Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Bandyopadhyay D, 2003, EXP GERONTOL, V38, P1299, DOI 10.1016/j.exger.2003.09.009; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Boulanger CA, 2001, ONCOGENE, V20, P2264, DOI 10.1038/sj.onc.1204312; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen JC, 2004, EXP HEMATOL, V32, P1025, DOI 10.1016/j.exphem.2004.08.001; Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dolle MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545; Ferbeyre G, 2000, GENE DEV, V14, P2015; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara E, 1996, MOL CELL BIOL, V16, P859; HARVEY M, 1993, ONCOGENE, V8, P2457; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holst CR, 2003, CANCER RES, V63, P1596; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Leung JK, 2001, J BIOL CHEM, V276, P39171, DOI 10.1074/jbc.M103435200; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2004, CELL CYCLE, V3, P244; Neumeister P, 2002, INT J BIOCHEM CELL B, V34, P1475, DOI 10.1016/S1357-2725(02)00079-1; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Olumi AF, 1999, CANCER RES, V59, P5002; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Reznikoff CA, 1996, CANCER RES, V56, P2886; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Rincon M, 2004, MECH AGEING DEV, V125, P397, DOI 10.1016/j.mad.2004.03.006; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SAKAMOTO K, 1993, ONCOGENE, V8, P1887; Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	101	1700	1792	13	331	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					513	522		10.1016/j.cell.2005.02.003	http://dx.doi.org/10.1016/j.cell.2005.02.003			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734683	Bronze			2022-12-28	WOS:000227271500008
J	Riley, J; Ross, JR				Riley, J; Ross, JR			Research into care at the end of life	LANCET			English	Editorial Material							PALLIATIVE CARE		Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Riley, J (corresponding author), Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England.	Julia.riley@rmh.nhs.uk						Acquaviva K, 2004, J PAIN SYMPTOM MANAG, V28, P488, DOI 10.1016/j.jpainsymman.2004.08.003; Casarett D, 2001, J Palliat Med, V4, P441, DOI 10.1089/109662101753381566; Casarett DJ, 2000, J PAIN SYMPTOM MANAG, V20, P130, DOI 10.1016/S0885-3924(00)00164-0; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; *NIH, 2004, IN PRESS NIH STAT OF; Patrick D, 2004, J NATL CANC I MONOGR, V32, P9; Rees E, 2003, BRIT MED J, V327, P198, DOI 10.1136/bmj.327.7408.198	7	20	21	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					735	737						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733702				2022-12-28	WOS:000227285300007
J	Tjun, T; Chu, WL; Munday, T; Gaunt, M				Tjun, T; Chu, WL; Munday, T; Gaunt, M			Ruptured abdominal aortic aneurysm	LANCET			English	Editorial Material									Addenbrookes NHS Trust, Vasc Unit, Cambridge CB2 2QQ, England	Addenbrooke's Hospital	Gaunt, M (corresponding author), Addenbrookes NHS Trust, Vasc Unit, Cambridge CB2 2QQ, England.	michael.gaunt@addenbrookes.nhs.uk						ABURAHMA AF, 1991, AM J EMERG MED, V9, P118, DOI 10.1016/0735-6757(91)90170-O	1	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					818	818						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733727				2022-12-28	WOS:000227285300033
J	Alahlafi, A; Burge, S				Alahlafi, A; Burge, S			What should undergraduate medical students know about psoriasis? Involving patients in curriculum development: modified Delphi technique	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; EDUCATION	Objective To identify the content of a psoriasis curriculum for medical students. Design Literature review and modified Delphi technique. Setting Primary and secondary care in Oxfordshire and Buckinghamshire. Subjects 19 dermatologists (7 teaching hospital consultants: 6 consultants in district general hospitals; 6 registrars); 2 general practitioner senior house officers working in dermatology, 5 dermatology nurses, 7 rheumatologists, 25 general practitioner tutors, and 25 patients with chronic psoriasis. Main outcome measures Percentage of agreement by participants to items derived from literature and our existing psoriasis syllabus. Results 71 (84.5%) of 84 questionnaires were returned. A 75% level of consensus was reached on key items that focused on the common presentations of psoriasis, impact, management, and communication skills. Students should be aware of the psychosocial impact of psoriasis, examine the skin while showing sensitivity, and be able to explain psoriasis to patients in a way that enables patients to explain the condition to others. Conclusions The panels identified the important items for a psoriasis curriculum. The views of patients were particularly helpful, mid we encourage educators to involve patients with chronic diseases in developing curriculums in the future. The method and results could be generalised to curriculum development in chronic disease.	Churchill Hosp, Dept Dermatol, Oxford OX3 9LJ, England	University of Oxford	Burge, S (corresponding author), Churchill Hosp, Dept Dermatol, Oxford OX3 9LJ, England.	sue.burge@ndm.ox.ac.uk		Alahlafi, Abdelaziz/0000-0002-7883-3075				Boath E, 1997, BRIT J CLIN PHARMACO, V43, P643, DOI 10.1046/j.1365-2125.1997.00602.x; *BRIT ASS U TEACH, 2000, TEACH REC UND DERM U; Burge SM, 2004, CLIN EXP DERMATOL, V29, P100, DOI 10.1111/j.1365-2230.2004.01426.x; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Department of Health, 2001, EXP PAT NEW APPR CHR; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; *GEN MED COUNC ED, 2002, TOM DOCT REC UND MED; HARDEN RM, 1986, MED EDUC, V20, P458, DOI 10.1111/j.1365-2923.1986.tb01193.x; Holsinger L, 2004, J AM ACAD DERMATOL, V51, pS41, DOI 10.1016/j.jaad.2004.01.026; Howe A, 2003, BRIT MED J, V327, P326, DOI 10.1136/bmj.327.7410.326; McKenna SP, 2003, BRIT J DERMATOL, V149, P323, DOI 10.1046/j.1365-2133.2003.05492.x; Milman U, 2001, ISR MED ASSOC J, V3, P978; NEUFELD VR, 1993, CAN MED ASSOC J, V148, P1471; Neufeld VR, 1998, ACAD MED, V73, P1133, DOI 10.1097/00001888-199811000-00010; SHAW S, 2002, FOCUS HLTH PROFESS E, V4, P33; Spencer J, 2000, MED EDUC, V34, P851, DOI 10.1046/j.1365-2923.2000.00779.x; Stewart J, 1999, BMJ-BRIT MED J, V319, P224, DOI 10.1136/bmj.319.7204.224; Walley T, 1997, BRIT J CLIN PHARMACO, V44, P167, DOI 10.1046/j.1365-2125.1997.00669.x; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x	19	49	49	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					633	636		10.1136/bmj.330.7492.633	http://dx.doi.org/10.1136/bmj.330.7492.633			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774993	Green Published, Bronze			2022-12-28	WOS:000227861700023
J	Stukel, TA; Lucas, FL; Wennberg, DE				Stukel, TA; Lucas, FL; Wennberg, DE			Long-term outcomes of regional variations in intensity of invasive vs medical management of medicare patients with acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIPID-LOWERING THERAPY; ELDERLY-PATIENTS; CORONARY-ANGIOGRAPHY; CARDIAC PROCEDURES; UNSTABLE ANGINA; UNITED-STATES; THROMBOLYTIC THERAPY; GEOGRAPHIC-VARIATION; PRIMARY ANGIOPLASTY; QUALITY	Context The health and policy implications of the marked regional variations in intensity of invasive compared with medical management of patients with acute myocardial infarction (AMI) are unknown. Objectives To evaluate patient clinical characteristics associated with receiving more intensive treatment; and to assess whether AMI patients residing in regions with more intensive invasive treatment and management strategies have better long-term survival than those residing in regions with more intensive medical management strategies. Design, Setting, and Patients National cohort study of 158 831 elderly Medicare patients hospitalized with first episode of confirmed AMI in 1994-1995, followed up for 7 years (mean, 3.6 years), according to the intensity of invasive management (performance of cardiac catheterization within 30 days) and medical management (prescription of beta-blockers to appropriate patients at discharge) in their region of residence. Baseline chart reviews were drawn from the Cooperative Cardiovascular Project and linked to Medicare health administrative data. Main Outcome Measure Long-term survival over 7 years of follow-up. Results Patient baseline AMI severity was similar across regions. In all regions, younger and healthier patients were more likely than older high-risk patients to receive invasive treatment and medical therapy. Regions with more invasive treatment practice styles had more cardiac catheterization laboratory capacity; patients in these regions were more likely to receive interventional treatment, regardless of age, clinical indication, or risk profile. The absolute unadjusted difference in 7-year survival between regions providing the highest rates of both invasive and medical management strategies and those providing the lowest rates of both was 6.2%. For both ST- and non-ST-segment elevation AMI patients, survival improved with regional intensity of both invasive and medical management. In areas with higher rates of medical management, there appeared to be little or no improvement in survival associated with increased invasive treatment. Conclusions In elderly Medicare patients with AMI, more intensive medical treatment provides population survival benefits. However, routine use of more costly and invasive treatment strategies may not be associated with an overall population benefit beyond that seen with excellent medical management. Efforts should focus on directing invasive clinical resources to patients with the greatest expected benefit.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	University of Toronto; Dartmouth College; University of Toronto; Maine Medical Center	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	stukel@ices.on.ca		Stukel, Therese/0000-0002-2951-1360	NIA NIH HHS [P01 AG019783, 1PO1-AG19783-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Aronow HD, 2003, ARCH INTERN MED, V163, P2576, DOI 10.1001/archinte.163.21.2576; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; BLUSTEIN J, 1993, JAMA-J AM MED ASSOC, V270, P344, DOI 10.1001/jama.270.3.344; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Braunwald E, 2003, CIRCULATION, V108, P28; Brophy JM, 2004, ANN INTERN MED, V141, P292, DOI 10.7326/0003-4819-141-4-200408170-00009; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Gattis WA, 2004, J AM COLL CARDIOL, V43, P1534, DOI 10.1016/j.jacc.2003.12.040; Guadagnoli E, 2000, NEW ENGL J MED, V343, P1460, DOI 10.1056/NEJM200011163432006; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Guadagnoli E, 2001, MED CARE, V39, P446, DOI 10.1097/00005650-200105000-00005; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hlatky MA, 2004, NEW ENGL J MED, V350, P2126, DOI 10.1056/NEJMp048071; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Krumholz HM, 1999, ANN INTERN MED, V131, P648, DOI 10.7326/0003-4819-131-9-199911020-00003; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V331, P1130, DOI 10.1056/NEJM199410273311706; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2001, CIRCULATION, V104, P2898, DOI 10.1161/hc4901.100524; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Solomon DH, 2001, J AM COLL CARDIOL, V38, P969, DOI 10.1016/S0735-1097(01)01503-0; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 2004, JAMA-J AM MED ASSOC, V292, P1961, DOI 10.1001/jama.292.16.1961; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	52	109	125	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1329	1337		10.1001/jama.293.11.1329	http://dx.doi.org/10.1001/jama.293.11.1329			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769966	Green Accepted			2022-12-28	WOS:000227698600021
J	Clarke, CE				Clarke, CE			Rasagiline for motor complications in Parkinson's disease	LANCET			English	Editorial Material							QUALITY-OF-LIFE		Univ Birmingham, Birmingham B18 7QH, W Midlands, England; City Hosp, Dept Neurol, Birmingham B18 7QH, W Midlands, England	University of Birmingham; University of Birmingham	Clarke, CE (corresponding author), Univ Birmingham, Birmingham B18 7QH, W Midlands, England.	c.e.clarke@bham.ac.uk		Clarke, Carl/0000-0003-2478-3436				Clarke CE, 2002, NEUROLOGY, V58, pA469; CLARKE CE, 2000, COCHRANE LIB; DEANE KHO, 2004, COCHRANE LIB; *PD MED, LARG RAND ASS REL CO; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Wheatley K, 2002, BMJ-BRIT MED J, V324, P1508, DOI 10.1136/bmj.324.7352.1508	6	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					914	916		10.1016/S0140-6736(05)71056-4	http://dx.doi.org/10.1016/S0140-6736(05)71056-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766976				2022-12-28	WOS:000227559800004
J	Heaney, LG; Robinson, DS				Heaney, LG; Robinson, DS			Severe asthma treatment: need for characterising patients	LANCET			English	Article							ANTIIMMUNOGLOBULIN-E THERAPY; ANTIBODY OMALIZUMAB; EFFICACY; EXACERBATIONS; TOLERABILITY; ALLERGEN; ADULTS	Context Asthma is readily diagnosed in most cases and usually responds to inhaled corticosteroids with or without long-acting beta agonists, theophyllines, or leukotriene-receptor antagonists, adjusted stepwise according to symptoms and lung function. However, up to 40% of adult patients with asthma remain symptomatic, and up to 5% have difficult-to-control asthma despite multiple therapies. It is suggested that higher doses of inhaled steroids with long-acting beta(2) agonists should be used for total control of symptoms; and anti-IgE therapy is newly licensed in the USA. However, difficult-to-control asthma is complex and multifactorial, and is often not due to severe or therapy-resistant asthma. Starting point Last year saw encouraging reports on omalizumab (anti-IgE therapy) in severe allergic asthma, by Stephen Holgate, Jon Ayres, and their respective colleagues (Clin Exp Allergy 2004; 34: 632-38; Allergy 2004; 59: 70148). Omalizumab reduced exacerbation rates, improved asthma symptoms and quality of life, and allowed lower doses of inhaled steroid compared with placebo. In placebo-controlled studies with anti-IgE, many patients were able to substantially reduce and even withdraw inhaled steroids in the placebo arm. Where next Severe asthma is often defined as persisting symptoms despite high-dose inhaled steroids. This definition is likely to include patients with various reasons for their persisting symptoms, for whom additional treatment is not always required. Before starting new therapy, it is important to systematically evaluate asthmatic patients to accurately define their disease and to identify those whose symptoms are caused by other factors, and thus avoid unnecessary medication. There might also be subgroups that have differing underlying inflammatory processes and who will respond differently to individual treatments.	Belfast City Hosp, Reg Resp Ctr, Belfast BT9 7AB, Antrim, North Ireland; Queens Univ Belfast, Dept Med, Belfast, Antrim, North Ireland; Natl Heart & Lung Inst, Allergy & Clin Immunol & Leukocyte Biol Sect, London, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England	Belfast City Hospital; Queens University Belfast; Imperial College London; Imperial College London	Heaney, LG (corresponding author), Belfast City Hosp, Reg Resp Ctr, Belfast BT9 7AB, Antrim, North Ireland.	l.heaney@qub.ac.uk						Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; ABURUZ S, 2002, THORAX S3, V57, P89; Ayres JG, 1998, THORAX, V53, P315, DOI 10.1136/thx.53.4.315; Ayres JG, 2004, ALLERGY, V59, P701, DOI 10.1111/j.1398-9995.2004.00533.x; BABU K, 2003, J ALLERGY CLIN IMMUN, V111, P838; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Coughlan JL, 2001, THORAX, V56, P198, DOI 10.1136/thorax.56.3.198; Custovic A, 1998, THORAX, V53, P63, DOI 10.1136/thx.53.1.63; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; GRIFFITH S, 1990, BRIT J GEN PRACT, V40, P114; Heaney LG, 2003, THORAX, V58, P561, DOI 10.1136/thorax.58.7.561; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Kips JC, 2003, AM J RESP CRIT CARE, V167, P1655, DOI 10.1164/rccm.200206-525OC; Kolbe J, 2002, THORAX, V57, P317, DOI 10.1136/thorax.57.4.317; Lama PJ, 2002, AM J OPHTHALMOL, V134, P749, DOI 10.1016/S0002-9394(02)01699-9; McGeehan Maureen, 2002, Curr Allergy Asthma Rep, V2, P117, DOI 10.1007/s11882-002-0006-1; Mohan G, 1996, BRIT J GEN PRACT, V46, P529; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Thomas M, 2001, BRIT MED J, V322, P1098, DOI 10.1136/bmj.322.7294.1098; Thomas PS, 1999, THORAX, V54, P352, DOI 10.1136/thx.54.4.352; Vignola AM, 2004, ALLERGY, V59, P709, DOI 10.1111/j.1398-9995.2004.00550.x; Walker S, 2003, COCHRANE DB SYST REV, V3; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; Woodcock A, 2003, NEW ENGL J MED, V349, P225, DOI 10.1056/NEJMoa023175	26	109	116	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					974	976		10.1016/S0140-6736(05)71087-4	http://dx.doi.org/10.1016/S0140-6736(05)71087-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767000				2022-12-28	WOS:000227559800031
J	Milne, F; Redman, C; Walker, J; Baker, P; Bradley, J; Cooper, C; de Swiet, M; Fletcher, G; Jokinen, M; Murphy, D; Nelson-Piercy, C; Osgood, V; Robson, S; Shennan, A; Tuffnell, A; Twaddle, S; Waugh, J				Milne, F; Redman, C; Walker, J; Baker, P; Bradley, J; Cooper, C; de Swiet, M; Fletcher, G; Jokinen, M; Murphy, D; Nelson-Piercy, C; Osgood, V; Robson, S; Shennan, A; Tuffnell, A; Twaddle, S; Waugh, J			The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community	BRITISH MEDICAL JOURNAL			English	Article							32 WEEKS GESTATION; CONTROLLED-TRIAL; RISK-FACTORS; HYPERTENSION; PREGNANCY; ECLAMPSIA; WOMEN; PROTEINURIA; MORBIDITY; PREDICT		Act Preeclampsia, Harrow HA1 4HZ, Middx, England; John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; St Marys Hosp, Manchester M13 0JH, Lancs, England; Stony Stratford Hlth Ctr, Stonedean Practice, Milton Keynes MK11 1YA, Bucks, England; Cuckoo Lane Practice, London W7 3EY, England; Queen Charlottes Matern Hosp, Imperial Coll London, London W12 0NN, England; Natl Childbirth Trust, London W3 6NH, England; Royal Coll Midwives, London W1G 9NH, England; Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; Univ London Kings Coll, St Thomas Hosp, London SE1 7EH, England; St Marys Hosp, Portsmouth PO3 6AD, Hants, England; Royal Victoria Infirm, Sch Surg & Reprod Sci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Leicester LE1 5WW, Leics, England	University of Oxford; Saint James's University Hospital; University of Leeds; University of Manchester; Imperial College London; University of Dundee; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Newcastle University - UK; University Hospitals of Leicester NHS Trust; University of Leicester	Milne, F (corresponding author), Act Preeclampsia, Harrow HA1 4HZ, Middx, England.	fionamilne@talk2l.com		Walker, James/0000-0002-8922-083X; Shennan, Andrew/0000-0001-5273-3132; Murphy, Deirdre/0000-0001-6074-6718				ABISAID D, 1995, AM J EPIDEMIOL, V142, P437, DOI 10.1093/oxfordjournals.aje.a117652; BANIAS BB, 1992, AM J PERINAT, V9, P357, DOI 10.1055/s-2007-999264; Barton JR, 2001, AM J OBSTET GYNECOL, V184, P979, DOI 10.1067/mob.2001.112905; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Durnwald C, 2003, AM J OBSTET GYNECOL, V189, P848, DOI 10.1067/S0002-9378(03)00849-4; FERRAZZANI S, 1990, AM J OBSTET GYNECOL, V162, P366, DOI 10.1016/0002-9378(90)90387-M; Henderson J, 2000, J Health Serv Res Policy, V5, P69; Koike T, 2002, GYNECOL OBSTET INVES, V53, P22, DOI 10.1159/000049406; Martin JN, 1999, AM J OBSTET GYNECOL, V180, P1407, DOI 10.1016/S0002-9378(99)70026-8; *MAT CHILD HLTH RE, 1999, CONF ENQ STILLB DEAT; Maternal and Child Health Research Consortium, 2001, CONF ENQ STILLB DEAT; *NAT I CLIN EXC, 2004, 6 REP CONF ENQ MAT D; *NAT I CLIN EXC, 2001, 5 REP CONF ENQ MAT D; *NHS NAT I CLIN EX, GUID DEV PROC INF NA; North RA, 1999, BRIT J OBSTET GYNAEC, V106, P767, DOI 10.1111/j.1471-0528.1999.tb08396.x; Seshadri L, 1997, J REPROD MED, V42, P88; SIBAI BM, 1994, AM J OBSTET GYNECOL, V171, P818, DOI 10.1016/0002-9378(94)90104-X; Stamilio DM, 2000, AM J OBSTET GYNECOL, V182, P589, DOI 10.1067/mob.2000.103890; STETTLER RW, 1992, AM J OBSTET GYNECOL, V167, P1219; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Witlin AG, 1999, AM J OBSTET GYNECOL, V180, P1322, DOI 10.1016/S0002-9378(99)70014-1	24	194	206	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2005	330	7491					576	580		10.1136/bmj.330.7491.576	http://dx.doi.org/10.1136/bmj.330.7491.576			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760998	Green Published, Bronze			2022-12-28	WOS:000227622300019
J	Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD				Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD			Ultrafast memory loss and energy redistribution in the hydrogen bond network of liquid H2O	NATURE			English	Article							INFRARED-SPECTROSCOPY; VIBRATIONAL-RELAXATION; ICE IH; WATER; DYNAMICS; SPECTRA	Many of the unusual properties of liquid water are attributed to its unique structure, comprised of a random and fluctuating three-dimensional network of hydrogen bonds that link the highly polar water molecules(1,2). One of the most direct probes of the dynamics of this network is the infrared spectrum of the OH stretching vibration(3-11), which reflects the distribution of hydrogen-bonded structures and the intermolecular forces controlling the structural dynamics of the liquid. Indeed, water dynamics has been studied in detail(5-14), most recently using multi-dimensional nonlinear infrared spectroscopy(15,16) for acquiring structural and dynamical information on femtosecond timescales. But owing to technical difficulties, only OH stretching vibrations in D2O or OD vibrations in H2O could be monitored. Here we show that using a specially designed, ultrathin sample cell allows us to observe OH stretching vibrations in H2O. Under these fully resonant conditions, we observe hydrogen bond network dynamics more than one order of magnitude faster than seen in earlier studies that include an extremely fast sweep in the OH frequencies on a 50-fs timescale and an equally fast disappearance of the initial inhomogeneous distribution of sites. Our results highlight the efficiency of energy redistribution within the hydrogen-bonded network, and that liquid water essentially loses the memory of persistent correlations in its structure within 50 fs.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	University of Toronto; University of Toronto; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Miller, RJD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	rjdmiller@lphys.chem.utoronto.ca	Elsaesser, Thomas/P-7608-2014; Huse, Nils/A-5712-2017	Elsaesser, Thomas/0000-0003-3056-6665; Huse, Nils/0000-0002-3281-7600; Dwyer, Jason/0000-0002-2938-2888; Bruner, Barry/0000-0003-3915-6304				Asbury JB, 2004, J PHYS CHEM A, V108, P1107, DOI 10.1021/jp036266k; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; CASTNER EW, 1995, J CHEM PHYS, V102, P653, DOI 10.1063/1.469177; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Franks F., 1972, WATER COMPREHENSIVE; Gale GM, 1999, PHYS REV LETT, V82, P1068, DOI 10.1103/PhysRevLett.82.1068; GRAENER H, 1991, PHYS REV LETT, V66, P2092, DOI 10.1103/PhysRevLett.66.2092; Hybl JD, 1998, CHEM PHYS LETT, V297, P307, DOI 10.1016/S0009-2614(98)01140-3; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Lawrence CP, 2002, J CHEM PHYS, V117, P8847, DOI 10.1063/1.1514652; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Lock AJ, 2002, J CHEM PHYS, V117, P1708, DOI 10.1063/1.1485966; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Moller KB, 2004, J PHYS CHEM A, V108, P1275, DOI 10.1021/jp035935r; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Pakoulev A, 2003, CHEM PHYS LETT, V371, P594, DOI 10.1016/S0009-2614(03)00314-2; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; Poulsen JA, 2003, J PHYS CHEM A, V107, P8420, DOI 10.1021/jp0225469; RICE SA, 1983, J PHYS CHEM-US, V87, P4295, DOI 10.1021/j100244a061; Saito S, 1997, J CHEM PHYS, V106, P4889, DOI 10.1063/1.473538; Stenger J, 2002, J PHYS CHEM A, V106, P2341, DOI 10.1021/jp013104k; Stenger J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.027401; Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409; WOJCIK MJ, 1993, J CHEM PHYS, V99, P2332, DOI 10.1063/1.465248; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	28	601	611	4	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					199	202		10.1038/nature03383	http://dx.doi.org/10.1038/nature03383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758995				2022-12-28	WOS:000227494500040
J	Murray, BJ; Knopf, DA; Bertram, AK				Murray, BJ; Knopf, DA; Bertram, AK			The formation of cubic ice under conditions relevant to Earth's atmosphere	NATURE			English	Article							X-RAY-DIFFRACTION; PHASE-TRANSITIONS; WATER; NUCLEATION; CRYSTALLIZATION; MICROPHYSICS; CHEMISTRY; HALO	An important mechanism for ice cloud formation in the Earth's atmosphere is homogeneous nucleation of ice in aqueous droplets, and this process is generally assumed to produce hexagonal ice(1,2). However, there are some reports that the metastable crystalline phase of ice, cubic ice, may form in the Earth's atmosphere(3-5). Here we present laboratory experiments demonstrating that cubic ice forms when micrometre-sized droplets of pure water and aqueous solutions freeze homogeneously at cooling rates approaching those found in the atmosphere. We find that the formation of cubic ice is dominant when droplets freeze at temperatures below 190 K, which is in the temperature range relevant for polar stratospheric clouds and clouds in the tropical tropopause region. These results, together with heat transfer calculations, suggest that cubic ice will form in the Earth's atmosphere. If there were a significant fraction of cubic ice in some cold clouds this could increase their water vapour pressure, and modify their microphysics and ice particle size distributions(5). Under specific conditions this may lead to enhanced dehydration of the tropopause region(5).	Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Bertram, AK (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	bertram@chem.ubc.ca	Murray, Benjamin/C-1219-2010; Knopf, Daniel A/F-2040-2011	Murray, Benjamin/0000-0002-8198-8131; Knopf, Daniel A/0000-0001-7732-3922; Bertram, Allan K./0000-0002-5621-2323				Baker MB, 1997, SCIENCE, V276, P1072, DOI 10.1126/science.276.5315.1072; Bertram AK, 2000, J PHYS CHEM A, V104, P584, DOI 10.1021/jp9931197; Chang HYA, 1999, J PHYS CHEM A, V103, P2673, DOI 10.1021/jp9841034; DeMott P. J., 2002, CIRRUS, P102; DOWELL LG, 1962, BIOCHIM BIOPHYS ACTA, V59, P158, DOI 10.1016/0006-3002(62)90706-0; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; EIDELMAN N, 1986, J CRYST GROWTH, V74, P1, DOI 10.1016/0022-0248(86)90242-3; Gao RS, 2004, SCIENCE, V303, P516, DOI 10.1126/science.1091255; HUANG JF, 1995, J PHYS CHEM-US, V99, P3924, DOI 10.1021/j100012a010; JENNISKENS P, 1994, SCIENCE, V265, P753, DOI 10.1126/science.11539186; KIEFTE H, 1984, J CHEM PHYS, V81, P1419, DOI 10.1063/1.447777; Kohl I, 2000, PHYS CHEM CHEM PHYS, V2, P1579, DOI 10.1039/a908688i; Koop T, 2000, J GEOPHYS RES-ATMOS, V105, P26393, DOI 10.1029/2000JD900413; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; KUHS WF, 1987, J PHYS-PARIS, V48, P631, DOI 10.1051/jphyscol:1987187; Lepault J, 1997, J MICROSC-OXFORD, V187, P158, DOI 10.1046/j.1365-2818.1997.2170787.x; MAYER E, 1987, NATURE, V325, P601, DOI 10.1038/325601a0; MCCLUNE WF, 2002, POWDER DIFFRACTION F, V2; MURPHY DM, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003L018566; Murray BJ, 2003, PHYS CHEM CHEM PHYS, V5, P4129, DOI 10.1039/b305555h; Ostwald W., 1897, Z PHYS CHEM, V22, P289, DOI DOI 10.1515/ZPCH-1897-2233; Peter T, 1997, ANNU REV PHYS CHEM, V48, P785, DOI 10.1146/annurev.physchem.48.1.785; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; Riikonen M, 2000, APPL OPTICS, V39, P6080, DOI 10.1364/AO.39.006080; STEYTLER DC, 1983, J PHYS CHEM-US, V87, P2458, DOI 10.1021/j100237a003; SVISHCHEV IM, 1994, PHYS REV LETT, V73, P975, DOI 10.1103/PhysRevLett.73.975; TAKAHASHI T, 1982, J CRYST GROWTH, V59, P441, DOI 10.1016/0022-0248(82)90365-7; WHALLEY E, 1981, SCIENCE, V211, P389, DOI 10.1126/science.211.4480.389; Yamada M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.195701; Young K., 1993, MICROPHYSICAL PROCES	30	197	201	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					202	205		10.1038/nature03403	http://dx.doi.org/10.1038/nature03403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758996				2022-12-28	WOS:000227494500041
J	Sharp, D				Sharp, D			Chimborazo and the old kilogram	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							ALDERSEYHILL H, 2005, FINDINGS HIDDEN STOR, P65; AUGUST O, 2005, TIMESONLINE     0126; MILLS IM, IN PRESS METROLOGIA; *NAT I STAND TECHN, 2005, REPL KIL ART NOW DEF	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					831	832		10.1016/S0140-6736(05)71021-7	http://dx.doi.org/10.1016/S0140-6736(05)71021-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752514				2022-12-28	WOS:000227444600009
J	Veis, A				Veis, A			A window on biomineralization	SCIENCE			English	Editorial Material							MATRIX; MINERALIZATION; PHOSPHOPHORYN; CRYSTALS; DENTIN		Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Veis, A (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	aveis@northwestern.edu						Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Estroff LA, 2004, ORG BIOMOL CHEM, V2, P137, DOI 10.1039/b309731e; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; LOWENSTA.HA, 1971, SCIENCE, V171, P487, DOI 10.1126/science.171.3970.487; Lowenstam HA, 1989, BIOMINERALIZATION; Rabie AM, 1995, CONNECT TISSUE RES, V31, P197, DOI 10.3109/03008209509010811	9	136	141	6	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2005	307	5714					1419	1420		10.1126/science.1109440	http://dx.doi.org/10.1126/science.1109440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746414				2022-12-28	WOS:000227503100030
J	Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ				Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ			Quantitative determinants of the outcome of asymptomatic mitral regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPPLER ASSESSMENT; NATURAL-HISTORY; ORIFICE AREA; VALVULAR REGURGITATION; AORTIC REGURGITATION; VALVE PROLAPSE; ECHOCARDIOGRAPHY; DISEASE; CARDIOLOGY; SEVERITY	BACKGROUND The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. METHODS We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm(sup 2)). RESULTS The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm(sup 2) increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm(sup 2), those with an orifice of at least 40 mm(sup 2) had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). CONCLUSIONS Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) should promptly be considered for cardiac surgery.	Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiac Surg, Rochester, MN 55905 USA; Mayo Clin, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu		Schaff, Hartzell/0000-0003-0994-027X; Scott, Christopher/0000-0003-1340-0647	NHLBI NIH HHS [HL 64928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; BLUMLEIN S, 1986, CIRCULATION, V74, P306, DOI 10.1161/01.CIR.74.2.306; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Borer JS, 2003, CIRCULATION, V108, P2432, DOI 10.1161/01.CIR.0000096400.00562.A3; BRAUNWALD E, 1963, CIRCULATION, V27, P29, DOI 10.1161/01.CIR.27.1.29; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DELAHAYE JP, 1991, EUR HEART J, V12, P5, DOI 10.1093/eurheartj/12.suppl_B.5; Dujardin KS, 1997, CIRCULATION, V96, P3409; Enriquez-Sarano M, 1999, J AM COLL CARDIOL, V34, P1137, DOI 10.1016/S0735-1097(99)00313-7; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022; EnriquezSarano M, 1997, MAYO CLIN PROC, V72, P1034, DOI 10.4065/72.11.1034; ENRIQUEZSARANO M, 1995, J AM COLL CARDIOL, V25, P703, DOI 10.1016/0735-1097(94)00434-R; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211, DOI 10.1016/0735-1097(93)90248-Y; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V22, P342; ENRIQUEZSARANO M, 1993, CIRCULATION, V87, P841, DOI 10.1161/01.CIR.87.3.841; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443, DOI 10.1016/0735-1097(94)90432-4; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; MACISAAC AI, 1992, AUST NZ J MED, V22, P532, DOI 10.1111/j.1445-5994.1992.tb00473.x; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; OTT DA, 1995, CIRCULATION, V91, P1264, DOI 10.1161/01.CIR.91.4.1264; REN JF, 1983, J AM COLL CARDIOL, V2, P729, DOI 10.1016/S0735-1097(83)80313-1; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SELLERS RD, 1964, AM J CARDIOL, V14, P437, DOI 10.1016/0002-9149(64)90027-X; SELZER A, 1972, MEDICINE, V51, P337, DOI 10.1097/00005792-197209000-00001; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh JP, 1999, AM J CARDIOL, V84, P1143; SPAIN MG, 1989, J AM COLL CARDIOL, V13, P585, DOI 10.1016/0735-1097(89)90597-4; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; VANDERVOORT PM, 1993, CIRCULATION, V88, P1150, DOI 10.1161/01.CIR.88.3.1150; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	39	738	771	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					875	883		10.1056/NEJMoa041451	http://dx.doi.org/10.1056/NEJMoa041451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745978				2022-12-28	WOS:000227310700006
J	Cohen, D				Cohen, D			My six day experience in the Middle East	BRITISH MEDICAL JOURNAL			English	Article																		Summerfield D, 2004, BRIT MED J, V329, P924, DOI 10.1136/bmj.329.7471.924	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					474	477		10.1136/bmj.330.7489.474	http://dx.doi.org/10.1136/bmj.330.7489.474			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731150	Green Published			2022-12-28	WOS:000227315400032
J	Andersen, B				Andersen, B			Space science - Crossroad for European space activity	SCIENCE			English	Editorial Material									Norwegian Space Ctr, Oslo, Norway		Andersen, B (corresponding author), Norwegian Space Ctr, Oslo, Norway.	bo@spacecentre.no						*EUR SPAC AG, 2004, BR222 ESA	1	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1206	1206		10.1126/science.1107684	http://dx.doi.org/10.1126/science.1107684			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731429				2022-12-28	WOS:000227313200028
J	Pincock, S				Pincock, S			Edith Silverglied Lisansky Gomberg - Obituary	LANCET			English	Biographical-Item												stephenpincock@blueyonder.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2005	365	9460					650	650						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15779124				2022-12-28	WOS:000227096800011
J	Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS				Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS			Self-organized patchiness in asthma as a prelude to catastrophic shifts	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; VENTILATION; LUNG; PET; HYPERRESPONSIVENESS; METHACHOLINE; PERFUSION; VOLUME; TREE	Asthma is a common disease affecting an increasing number of children throughout the world. In asthma, pulmonary airways narrow in response to contraction of surrounding smooth muscle. The precise nature of functional changes during an acute asthma attack is unclear. The tree structure of the pulmonary airways has been linked to complex behaviour in sudden airway narrowing(1,2) and avalanche-like reopening(3,4). Here we present experimental evidence that bronchoconstriction leads to patchiness in lung ventilation, as well as a computational model that provides interpretation of the experimental data. Using positron emission tomography, we observe that bronchoconstricted asthmatics develop regions of poorly ventilated lung. Using the computational model we show that, even for uniform smooth muscle activation of a symmetric bronchial tree, the presence of minimal heterogeneity breaks the symmetry and leads to large clusters of poorly ventilated lung units. These clusters are generated by interaction of short- and long-range feedback mechanisms, which lead to catastrophic shifts similar to those linked to self-organized patchiness in nature(5,6). This work might have implications for the treatment of asthma, and might provide a model for studying diseases of other distributed organs.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Venegas, JG (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 55 Fruit St, Boston, MA 02114 USA.	jvenegas@vqpet.mgh.harvard.edu	Melo, Marcos Vidal/AAN-7219-2020; Melo, Marcos F Vidal/C-3452-2013; Winkler, Tilo/B-5337-2009; Bellani, Giacomo/D-2379-2010	Winkler, Tilo/0000-0002-7276-5550; Bellani, Giacomo/0000-0002-3089-205X				Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Altemeier WA, 2000, J APPL PHYSIOL, V88, P1551, DOI 10.1152/jappl.2000.88.5.1551; Anafi RC, 2003, J APPL PHYSIOL, V94, P1003, DOI 10.1152/japplphysiol.00569.2002; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; BATES JH, 1995, COMMENTS THEOR BIOL, V3, P397; Beigelman-Aubry C, 2002, RADIOLOGY, V223, P181, DOI 10.1148/radiol.2231010779; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Danek CJ, 2004, J APPL PHYSIOL, V97, P1946, DOI 10.1152/japplphysiol.01282.2003; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; GUNST SJ, 1988, J APPL PHYSIOL, V64, P2522, DOI 10.1152/jappl.1988.64.6.2522; Judd SL, 2000, PHYSICA D, V136, P45, DOI 10.1016/S0167-2789(99)00154-2; Klarreich E, 2003, NATURE, V424, P873, DOI 10.1038/424873a; Latourelle J, 2002, J APPL PHYSIOL, V92, P771, DOI 10.1152/japplphysiol.01090.2000; Laurent F, 2000, EUR RADIOL, V10, P1404, DOI 10.1007/s003300000504; LAUWERIER H, 1991, FRACTALS ENDLESSLY R, P71; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Smith D, 2003, ANN EMERG MED, V41, P706, DOI 10.1067/mem.2003.144; SMITH JC, 1984, J APPL PHYSIOL, V57, P1422, DOI 10.1152/jappl.1984.57.5.1422; Suki B, 2003, J APPL PHYSIOL, V95, P2122, DOI 10.1152/japplphysiol.00636.2003; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Venegas JG, 2000, J APPL PHYSIOL, V88, P1365, DOI 10.1152/jappl.2000.88.4.1365; Wagers S, 2003, J ALLERGY CLIN IMMUN, V111, P1201, DOI 10.1067/mai.2003.1545; Weibel ER, 1963, MORPHOMETRY HUMAN LU, P115	30	391	403	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					777	782		10.1038/nature03490	http://dx.doi.org/10.1038/nature03490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15772676				2022-12-28	WOS:000228160700044
J	Kawamoto, K; Houlihan, CA; Balas, EA; Lobach, DF				Kawamoto, K; Houlihan, CA; Balas, EA; Lobach, DF			Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH MAINTENANCE ORGANIZATION; PROMOTING SCREENING MAMMOGRAPHY; PRIMARY-CARE PHYSICIANS; INNER-CITY SETTINGS; COMPUTERIZED REMINDERS; PREVENTIVE CARE; GENERAL-PRACTICE; ORDER ENTRY; PATIENT	Objective To identify features of clinical decision support systems critical for improving clinical practice. Design Systematic review of randomised controlled trials. Data sources Literature searches via Medline, CINAHL, and the Cochrane Controlled Trials Register up to 2003; and searches of reference lists of included studies and relevant reviews. Study selection Studies had to evaluate the ability of decision support systems to improve clinical practice. Data extraction Studies were assessed for statistically and clinically significant improvement in clinical practice and for the presence of 15 decision support system features whose importance had been repeatedly suggested in the literature. Results Seventy studies were included. Decision support systems significantly improved clinical practice in 68% of trials. Univariate analyses revealed that, for five of the system features, interventions possessing the feature were significantly more likely to improve clinical practice than interventions lacking the feature. Multiple logistic regression analysis identified four features as independent predictors of improved clinical practice: automatic provision of decision support as part of clinician workflow (P < 0.00001), provision of recommendations rather than just assessments (P = 0.0187), provision of decision support at the time and location of decision making (P = 0.0263), and computer based decision support (P = 0.0294). Of 32 systems possessing all four features, 30 (94%) significantly improved clinical practice. Furthermore, direct experimental justification was found for providing periodic performance feedback, sharing recommendations with patients, and requesting documentation of reasons for not following recommendations. Conclusions Several features were closely correlated with decision support systems' ability to improve patient care significantly. Clinicians and other stakeholders should implement clinical decision support systems that incorporate these features whenever feasible and appropriate.	Duke Univ, Med Ctr, Dept Community & Family Med, Div Clin Informat, Durham, NC 27710 USA; Old Dominion Univ, Coll Hlth Sci, Norfolk, VA 23529 USA	Duke University; Old Dominion University	Lobach, DF (corresponding author), Duke Univ, Med Ctr, Dept Community & Family Med, Div Clin Informat, Box 2914, Durham, NC 27710 USA.	david.lobach@duke.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Balas, Andrew/0000-0003-3535-8822	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010472, R03HS010814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [F37LM008161] Funding Source: NIH RePORTER; AHRQ HHS [R03-HS10814, R01-HS10472] Funding Source: Medline; NIGMS NIH HHS [T32-GM07171] Funding Source: Medline; NLM NIH HHS [F37-LM008161-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Bankhead C, 2001, J MED SCREEN, V8, P99, DOI 10.1136/jms.8.2.99; BARNETT GO, 1983, MED CARE, V21, P400, DOI 10.1097/00005650-198304000-00003; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bates DW, 1995, P ANN S COMP APPL ME, P935; BECKER DM, 1989, AM J PREV MED, V5, P353, DOI 10.1016/S0749-3797(18)31056-0; Bennett JW, 2003, MED J AUSTRALIA, V178, P217, DOI 10.5694/j.1326-5377.2003.tb05166.x; Boekeloo B O, 1990, Am J Prev Med, V6, P51; BUCHSBAUM DG, 1993, ARCH INTERN MED, V153, P1573, DOI 10.1001/archinte.153.13.1573; BURACK RC, 1994, MED CARE, V32, P609, DOI 10.1097/00005650-199406000-00006; Burack RC, 1996, CANCER, V78, P1708, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1708::AID-CNCR11>3.3.CO;2-9; Burack RC, 1998, CANCER, V82, P2391, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2391::AID-CNCR13>3.0.CO;2-K; Burack RC, 1997, MED CARE, V35, P921, DOI 10.1097/00005650-199709000-00005; Chambers C V, 1991, J Am Board Fam Pract, V4, P19; CHENEY C, 1987, AM J MED, V83, P129, DOI 10.1016/0002-9343(87)90507-9; Christakis DA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.2.e15; COHEN SJ, 1987, AM J PUBLIC HEALTH, V77, P313, DOI 10.2105/AJPH.77.3.313; COHEN SJ, 1989, ANN INTERN MED, V110, P648, DOI 10.7326/0003-4819-110-8-648; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Desbiens NA, 1998, PAIN, V75, P237, DOI 10.1016/S0304-3959(97)00225-X; Desbiens NA, 2000, J AM GERIATR SOC, V48, pS183, DOI 10.1111/j.1532-5415.2000.tb03130.x; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; Dowrick C, 1995, FAM PRACT, V12, P461, DOI 10.1093/fampra/12.4.461; DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; Flanagan JR, 1999, J AM MED INFORM ASSN, P755; FORDHAM D, 1990, M D COMPUT, V7, P289; Frame P S, 1994, Arch Fam Med, V3, P581, DOI 10.1001/archfami.3.7.581; Frolich A, 1997, SCAND J CLIN LAB INV, V57, P725, DOI 10.3109/00365519709105235; GANS KM, 1994, AM J PREV MED, V10, P275, DOI 10.1016/S0749-3797(18)30579-8; GERMAN PS, 1987, JAMA-J AM MED ASSOC, V257, P489, DOI 10.1001/jama.257.4.489; Gimotty PA, 2002, HEALTH SERV RES, V37, P65; Harpole LH, 1997, J AM MED INFORM ASSN, V4, P511, DOI 10.1136/jamia.1997.0040511; Hay WI, 1998, CAN FAM PHYSICIAN, V44, P2677; Hetlevik I, 2000, INT J TECHNOL ASSESS, V16, P210, DOI 10.1017/S0266462300161185; Hetlevik I, 1999, SCAND J PRIM HEALTH, V17, P35; HOEPER EW, 1984, LANCET, V1, P33; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Kanouse DE, 1995, HEALTH POLICY, V34, P167, DOI 10.1016/0168-8510(95)00760-1; Kaplan B, 2001, INT J MED INFORM, V64, P39, DOI 10.1016/S1386-5056(01)00184-8; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; LABACH DF, 1996, P AMIA S, P493; Leviton LC, 1999, JAMA-J AM MED ASSOC, V281, P46, DOI 10.1001/jama.281.1.46; LINN LS, 1980, J MED EDUC, V55, P942; LINN LS, 1982, MED CARE, V20, P1233, DOI 10.1097/00005650-198212000-00009; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; LOBACH DF, 1994, J AM MED INFORM ASSN, P787; Lobach DF, 1997, AM J MED, V102, P89, DOI 10.1016/S0002-9343(96)00382-8; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; MATHIAS SD, 1994, J GEN INTERN MED, V9, P606, DOI 10.1007/BF02600303; Mazonson P D, 1996, J Am Board Fam Pract, V9, P336; MCALISTER NH, 1986, BRIT MED J, V293, P670, DOI 10.1136/bmj.293.6548.670; MCDONALD CJ, 1992, M D COMPUT, V9, P304; MCDONALD CJ, 1976, ANN INTERN MED, V84, P162, DOI 10.7326/0003-4819-84-2-162; MCDONALD CJ, 1980, JAMA-J AM MED ASSOC, V244, P1579, DOI 10.1001/jama.244.14.1579; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MCDOWELL I, 1989, J FAM PRACTICE, V28, P420; MCDOWELL I, 1989, MED CARE, V27, P297, DOI 10.1097/00005650-198903000-00008; MCDOWELL I, 1986, CAN MED ASSOC J, V135, P991; MCPHEE SJ, 1989, ARCH INTERN MED, V149, P1866, DOI 10.1001/archinte.149.8.1866; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; MEYER TJ, 1991, J GEN INTERN MED, V6, P133, DOI 10.1007/BF02598309; Nilasena D S, 1995, Proc Annu Symp Comput Appl Med Care, P640; OKANO GJ, 1995, CLIN THER, V17, P525, DOI 10.1016/0149-2918(95)80118-9; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Overhage JM, 1996, ARCH INTERN MED, V156, P1551, DOI 10.1001/archinte.156.14.1551; PIERCE M, 1989, BMJ-BRIT MED J, V299, P160, DOI 10.1136/bmj.299.6692.160; POLLACK MM, 1991, CRIT CARE MED, V19, P12, DOI 10.1097/00003246-199101000-00008; PRITCHARD DA, 1995, AUST J PUBLIC HEALTH, V19, P167; Rascati KL, 1996, MED CARE, V34, P760, DOI 10.1097/00005650-199608000-00004; Ray WA, 2001, MED CARE, V39, P425, DOI 10.1097/00005650-200105000-00003; ROSSER W, 1992, CAN FAM PHYSICIAN, V38, P1623; ROSSER WW, 1992, CAN MED ASSOC J, V146, P911; ROSSER WW, 1991, CAN MED ASSOC J, V145, P807; Rossi RA, 1997, J GEN INTERN MED, V12, P672, DOI 10.1046/j.1525-1497.1997.07140.x; Rotman BL, 1996, J AM MED INFORM ASSN, V3, P340, DOI 10.1136/jamia.1996.97035025; RUBENSTEIN LV, 1989, ANN INTERN MED, V111, P836, DOI 10.7326/0003-4819-111-10-836; SANAZARO PJ, 1978, NEW ENGL J MED, V298, P1171, DOI 10.1056/NEJM197805252982104; Selker HP, 2002, ANN INTERN MED, V137, P87, DOI 10.7326/0003-4819-137-2-200207160-00006; SHAPIRO S, 1987, MED CARE, V25, P327, DOI 10.1097/00005650-198704000-00006; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Somkin CP, 1997, ARCH INTERN MED, V157, P1658, DOI 10.1001/archinte.157.15.1658; SOMMERS LS, 1984, MED CARE, V22, P1115, DOI 10.1097/00005650-198412000-00006; Stamos TD, 2001, AM J CARDIOL, V88, P1420, DOI 10.1016/S0002-9149(01)02125-7; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; van Wijk MAM, 2001, ANN INTERN MED, V134, P274, DOI 10.7326/0003-4819-134-4-200102200-00010; Walton R, 1999, BRIT MED J, V318, P984, DOI 10.1136/bmj.318.7189.984; WALTON RT, 2001, COCHRANE DB SYST REV, V1; WHITE KS, 1984, J AM COLL CARDIOL, V4, P571, DOI 10.1016/S0735-1097(84)80104-7; WHITE P, 1995, BRIT MED J, V311, P1065, DOI 10.1136/bmj.311.7012.1065; Williams RB, 1998, ARCH FAM MED, V7, P338, DOI 10.1001/archfami.7.4.338; Zanetti G, 2003, INFECT CONT HOSP EP, V24, P13, DOI 10.1086/502109	99	1502	1522	5	124	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2005	330	7494					765	768E		10.1136/bmj.38398.500764.8F	http://dx.doi.org/10.1136/bmj.38398.500764.8F			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	914JE	15767266	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000228222900023
J	Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW				Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW			Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex	SCIENCE			English	Article							EUKARYOTIC INITIATION FACTOR-2-ALPHA; FOOD-INTAKE; PREPYRIFORM CORTEX; PROTEIN-SYNTHESIS; DIETS DEFICIENT; KINASE GCN2; RATS; THREONINE; PHOSPHORYLATION; DEPRIVATION	Recognizing a deficiency of indispensable amino acids (IAAs) for protein synthesis is vital for dietary selection in metazoans, including humans. Celts in the brain's anterior piriform cortex (APC) are sensitive to IAA deficiency, Signaling diet rejection and foraging for complementary IAA sources, but the mechanism is unknown. Here we report that the mechanism for recognizing IAA-deficient foods follows the conserved general control (GC) system, wherein uncharged transfer RNA induces phosphorylation of eukaryotic initiation factor 2 (elF2) via the GC nonderepressing 2 (GCN2) kinase. Thus, a basic mechanism of nutritional stress management functions in mammalian brain to guide food selection for survival.	Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	University of California System; University of California Davis; Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gietzen, DW (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	dwgietzen@ucdavis.edu	Anthony, Tracy/K-7951-2017; Cavener, Douglas R/E-3524-2010	Anthony, Tracy/0000-0002-8586-5884; 	NIGMS NIH HHS [GM49164] Funding Source: Medline; NINDS NIH HHS [NS33347, NS043231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033347, R21NS043231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; BEVERLY JL, 1990, AM J PHYSIOL, V259, pR709, DOI 10.1152/ajpregu.1990.259.4.R709; Blevins JE, 2000, BRAIN RES, V879, P65, DOI 10.1016/S0006-8993(00)02734-7; Carpenter KJ, 2003, J NUTR, V133, P638, DOI 10.1093/jn/133.3.638; DELANEY K, 1986, J COMP PHYSIOL A, V159, P281, DOI 10.1007/BF00603975; FIRMAN JD, 1988, BRAIN RES BULL, V21, P637, DOI 10.1016/0361-9230(88)90203-1; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; GIETZEN DW, 1986, PHYSIOL BEHAV, V36, P1071, DOI 10.1016/0031-9384(86)90482-8; GIETZEN DW, 2000, NEURAL METABOLIC CON, pCH23; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Kimball SR, 2001, BIOCHEM BIOPH RES CO, V280, P293, DOI 10.1006/bbrc.2000.4103; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; Koehnle TJ, 2004, J NUTR, V134, P2365, DOI 10.1093/jn/134.9.2365; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; LEUNG PMB, 1971, AM J PHYSIOL, V221, P929, DOI 10.1152/ajplegacy.1971.221.3.929; LEUNG PMB, 1972, PHYSIOL BEHAV, V9, P553, DOI 10.1016/0031-9384(72)90011-X; Markison S, 1999, J NUTR, V129, P1604, DOI 10.1093/jn/129.8.1604; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Monda M, 1997, AM J PHYSIOL-REG I, V273, pR554, DOI 10.1152/ajpregu.1997.273.2.R554; MURPHY ME, 1993, PHYSIOL BEHAV, V53, P689, DOI 10.1016/0031-9384(93)90175-F; PANKSEPP J, 1971, NATURE, V233, P341, DOI 10.1038/233341a0; Russell MC, 2003, NUTR NEUROSCI, V6, P247, DOI 10.1080/1028415031000151567; Sharp JW, 2004, NEUROSCIENCE, V126, P1053, DOI 10.1016/j.neuroscience.2004.03.066; Sharp JW, 2002, MOL BRAIN RES, V105, P11, DOI 10.1016/S0169-328X(02)00380-7; Sood R, 2000, GENETICS, V154, P787; WASHBURN BS, 1994, AM J PHYSIOL, V266, pR1922, DOI 10.1152/ajpregu.1994.266.6.R1922; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	29	252	268	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1776	1778		10.1126/science.1104882	http://dx.doi.org/10.1126/science.1104882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774759				2022-12-28	WOS:000227883900045
J	Walmsley, IA; Raymer, MG				Walmsley, IA; Raymer, MG			Toward quantum-information processing with photons	SCIENCE			English	Editorial Material							TIME		Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Univ Oregon, Oregon Ctr Opt, Eugene, OR 97403 USA	University of Oxford; University of Oregon; University of Oregon	Walmsley, IA (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	walmstey@physics.ox.ac.uk; raymer@uoregon.edu	Raymer, Michael/AAB-2423-2020	Walmsley, Ian/0000-0002-4714-0575				Gasparoni S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020504; Grice WP, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.063815; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; O'Brien JL, 2003, NATURE, V426, P264, DOI 10.1038/nature02054; Ou ZY, 1999, PHYS REV LETT, V83, P2556, DOI 10.1103/PhysRevLett.83.2556; Pittman TB, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.032316; RAYMER MG, 2003, FRONT OPT LAS SCI 19; U'Ren AB, 2003, QUANTUM INF COMPUT, V3, P480	13	49	50	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1733	1734		10.1126/science.1107451	http://dx.doi.org/10.1126/science.1107451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774749				2022-12-28	WOS:000227883900033
J	Anderson, KE; Bloomer, JR; Bonkovsky, HL; Kushner, JP; Pierach, CA; Pimstone, NR; Desnick, RJ				Anderson, KE; Bloomer, JR; Bonkovsky, HL; Kushner, JP; Pierach, CA; Pimstone, NR; Desnick, RJ			Recommendations for the diagnosis and treatment of the acute porphyrias	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE INTERMITTENT PORPHYRIA; ACUTE HEPATIC PORPHYRIAS; FECAL COPROPORPHYRIN ISOMERS; DELTA-AMINOLEVULINIC-ACID; PRIMARY LIVER-CANCER; VARIEGATE PORPHYRIA; HEME-ARGINATE; HEPATOCELLULAR-CARCINOMA; URINARY PORPHOBILINOGEN; HEREDITARY COPROPORPHYRIA	The acute porphyrias, 4 inherited disorders of heme biosynthesis, cause life-threatening attacks of neurovisceral symptoms that mimic many other acute medical and psychiatric conditions. Lack of clinical recognition often delays effective treatment, and inappropriate diagnostic tests may lead to misdiagnosis and inappropriate treatment. We review the clinical manifestations, pathophysiology, and genetics of the acute porphyrias and provide recommendations for diagnosis and treatment on the basis of reviews of the literature and clinical experience. An acute porphyria should be considered in many patients with unexplained abdominal pain or other characteristic symptoms. The diagnosis can be rapidly confirmed by demonstration of a markedly increased urinary porphobilinogen level by using a single-void urine specimen. This specimen should also be saved for quantitative measurement of porphobilinogen, 5-aminolevulinic acid, and total porphyrin levels. Intravenous hemin therapy, started as soon as possible, is the most effective treatment. Intravenous glucose alone is appropriate only for mild attacks (mild pain, no paresis or hyponatremia) or until hemin is available. Precipitating factors should be eliminated, and appropriate supportive and symptomatic therapy should be initiated. Prompt diagnosis and treatment greatly improve prognosis and may prevent development of severe or chronic neuropathic symptoms. We recommend identification of at-risk relatives through enzymatic or gene studies.	NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Texas, Med Branch, Galveston, TX 77550 USA	Icahn School of Medicine at Mount Sinai; New York University; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; University of Connecticut; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston	Desnick, RJ (corresponding author), NYU, Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.	rjdesnick@mssm.edu	Bonkovsky, Herbert L./AAH-1892-2021; Hug, Balthasar L./G-1568-2010	Bonkovsky, Herbert L./0000-0001-7387-3230; Anderson, Karl/0000-0002-6499-8573	NCRR NIH HHS [2 M01 RR00071, M01-RR06192, M01-RR0073] Funding Source: Medline; NIDDK NIH HHS [U01-DK065193, R01 DK38825, N01DK92326, 5 R01 DK26824] Funding Source: Medline; FDA HHS [FD-R-00-1459] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006192, M01RR000073, M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825, N01DK092326, R01DK026824, U01DK065193] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FDA HHS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andant C, 1998, NEW ENGL J MED, V338, P1853, DOI 10.1056/NEJM199806183382518; ANDERSON KE, 1990, ARCH INTERN MED, V150, P1469, DOI 10.1001/archinte.150.7.1469; ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; ANDERSON KE, 2003, PORPHYRIN HDB MED AS, V14, P247; Andersson C, 1996, J INTERN MED, V240, P195, DOI 10.1046/j.1365-2796.1996.21847000.x; ARMAS R, 1992, REV MED CHILE, V120, P259; BLAKE D, 1992, CLIN CHEM, V38, P96; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Bonkovsky HL, 1998, SEMIN LIVER DIS, V18, P57, DOI 10.1055/s-2007-1007141; BONKOWSKY HL, 1971, P NATL ACAD SCI USA, V68, P2725, DOI 10.1073/pnas.68.11.2725; CHURCH SE, 1992, NEPHROL DIAL TRANSPL, V7, P986; Deacon AC, 1998, ANN CLIN BIOCHEM, V35, P726, DOI 10.1177/000456329803500604; DHAR GJ, 1978, ACTA MED SCAND, V203, P437; DOSS M, 1981, KLIN WOCHENSCHR, V59, P727, DOI 10.1007/BF01721260; DOSS M, 1985, J CLIN CHEM CLIN BIO, V23, P505; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; FELSHER BF, 1967, MEDICINE, V46, P217, DOI 10.1097/00005792-196703000-00014; GOETSCH CA, 1986, NEW ENGL J MED, V315, P235, DOI 10.1056/NEJM198607243150406; GOLDBERG A, 1959, Q J MED, V28, P183; GREEN D, 1990, J LAB CLIN MED, V115, P144; GREEN D, 1986, THROMB HAEMOSTASIS, V56, P277; GREEN D, 1983, J LAB CLIN MED, V102, P361; HERRICK AL, 1989, LANCET, V1, P1295; Hift RJ, 2004, CLIN CHEM, V50, P915, DOI 10.1373/clinchem.2003.025213; HIFT RJ, 1993, POSTGRAD MED J, V69, P781, DOI 10.1136/pgmj.69.816.781; Jacob K, 1995, EUR J CLIN CHEM CLIN, V33, P893; Jeans JB, 1996, AM J MED GENET, V65, P269, DOI 10.1002/(SICI)1096-8628(19961111)65:4<269::AID-AJMG4>3.0.CO;2-K; JONES RL, 1986, J EXP MED, V163, P724, DOI 10.1084/jem.163.3.724; KAUPPINEN R, 1988, BRIT J CANCER, V57, P117, DOI 10.1038/bjc.1988.23; KAUPPINEN R, 1992, MEDICINE, V71, P1; KHANDERIA U, 1986, CLIN PHARMACY, V5, P690; Kostrzewska E, 1991, Mater Med Pol, V23, P259; KOSTRZEWSKA E, 1992, GEMATOL TRANSFUZIOL, V37, P3; Kostrzewska E, 1999, Przegl Lek, V56, P576; Kostrzewska Ewa, 1996, Materia Medica Polona, V28, P5; LAMON J, 1974, CLIN CHEM, V20, P1438; LAMON JM, 1978, LANCET, V2, P492; LAMON JM, 1979, MEDICINE, V58, P252, DOI 10.1097/00005792-197905000-00005; LEE JS, 1991, P NATL ACAD SCI USA, V88, P10912, DOI 10.1073/pnas.88.23.10912; Linet MS, 1999, AM J EPIDEMIOL, V149, P1010; LIP GYH, 1991, BRIT MED J, V302, P507, DOI 10.1136/bmj.302.6775.507; LITHNER F, 1984, ACTA MED SCAND, V215, P271; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; MCCOLL KEL, 1981, Q J MED, V50, P161; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; MILO R, 1989, OBSTET GYNECOL, V73, P450; MUSTAJOKI P, 1993, ARCH INTERN MED, V153, P2004; MUSTAJOKI P, 1986, BRIT MED J, V293, P538, DOI 10.1136/bmj.293.6546.538-a; MUSTAJOKI P, 1976, ACTA MED SCAND, V200, P171; NORDMANN Y, 1993, ANN MED INTERNE, V144, P165; Nordmann Y, 2002, CLIN CHIM ACTA, V325, P17, DOI 10.1016/S0009-8981(02)00276-0; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; Ortega XM, 1999, MEDICINA-BUENOS AIRE, V59, P23; OSTROWSKI J, 1983, GASTROENTEROLOGY, V85, P1131; Pierach C A, 1982, Semin Liver Dis, V2, P125, DOI 10.1055/s-2008-1040702; PIERACH CA, 1980, KLIN WOCHENSCHR, V58, P829, DOI 10.1007/BF01491103; PIERACH CA, 1989, LANCET, V2, P213; POHFITZPATRICK MB, 1980, ARCH DERMATOL, V116, P543, DOI 10.1001/archderm.116.5.543; RIDLEY A, 1975, PERIPHERAL NEUROPATH, V2, P942; ROSE JA, 1961, METABOLISM, V10, P514; Shenhav S, 1997, ACTA OBSTET GYN SCAN, V76, P484, DOI 10.3109/00016349709047833; Solis C, 2004, ARCH NEUROL-CHICAGO, V61, P1764, DOI 10.1001/archneur.61.11.1764; Soonawalla ZF, 2004, LANCET, V363, P705, DOI 10.1016/S0140-6736(04)15646-8; STEIN JA, 1972, AM J MED, V53, P784, DOI 10.1016/0002-9343(72)90197-0; STEIN JA, 1970, MEDICINE, V49, P1, DOI 10.1097/00005792-197001000-00001; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stojeba N, 2004, LIVER TRANSPLANT, V10, P935, DOI 10.1002/lt.20136; Tenhunen R, 1998, SEMIN LIVER DIS, V18, P53, DOI 10.1055/s-2007-1007140; Thadani H, 2000, BMJ-BRIT MED J, V320, P1647, DOI 10.1136/bmj.320.7250.1647; THUNELL S, 1992, EUR J CLIN CHEM CLIN, V30, P599; TSCHUDY DP, 1975, ANN INTERN MED, V83, P851, DOI 10.7326/0003-4819-83-6-851; TSCHUDY DP, 1964, METABOLISM, V13, P396, DOI 10.1016/0026-0495(64)90113-1; WALDENSTROM J, 1957, AM J MED, V22, P758, DOI 10.1016/0002-9343(57)90126-2; Watson C J, 1978, Adv Intern Med, V23, P265; WATSON CJ, 1977, P NATL ACAD SCI USA, V74, P2118, DOI 10.1073/pnas.74.5.2118; Watson CJ, 1941, P SOC EXP BIOL MED, V47, P393; WELLAND FH, 1964, METABOLISM, V13, P232, DOI 10.1016/0026-0495(64)90103-9; WILSON J, 2003, PORPHYRIN HDB MED AS, P285	78	366	391	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					439	450		10.7326/0003-4819-142-6-200503150-00010	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767622				2022-12-28	WOS:000227621100005
J	Gaensler, BM; Haverkorn, M; Staveley-Smith, L; Dickey, JM; McClure-Griffiths, NM; Dickel, JR; Wolleben, M				Gaensler, BM; Haverkorn, M; Staveley-Smith, L; Dickey, JM; McClure-Griffiths, NM; Dickel, JR; Wolleben, M			The magnetic field of the Large Magellanic Cloud revealed through Faraday rotation	SCIENCE			English	Article							GALACTIC DYNAMOS; GALAXIES; DEPOLARIZATION; EVOLUTION; DRIVEN; ORIGIN; SCALE	We have measured the Faraday rotation toward a large sample of polarized radio sources behind the Large Magellanic Cloud (LMC) to determine the structure of this galaxy's magnetic field. The magnetic field of the LMC consists of a coherent axisymmetric spiral of field strength similar to1 microgauss. Strong fluctuations in the magnetic field are also seen on small (<0.5 parsec) and large (similar to 100 parsecs) scales. The large bursts of recent star formation and supernova activity in the LMC argue against standard dynamo theory, adding to the growing evidence for rapid field amplification in galaxies.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; Univ Tasmania, Dept Phys, Hobart, Tas 7001, Australia; Univ Illinois, Dept Astron, Urbana, IL 61801 USA; Max Planck Inst Radioastron, D-53121 Bonn, Germany	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society	Gaensler, BM (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,Mail Stop 6, Cambridge, MA 02138 USA.	bgaensler@cfa.harvard.edu	Gaensler, Bryan M/F-8655-2010; Dickey, John M/C-6156-2013; Staveley-Smith, Lister G/A-1683-2011	Dickey, John M/0000-0002-6300-7459; Staveley-Smith, Lister G/0000-0002-8057-0294; McClure-Griffiths, Naomi/0000-0003-2730-957X; Gaensler, Bryan/0000-0002-3382-9558				Beck R, 1996, ANNU REV ASTRON ASTR, V34, P155, DOI 10.1146/annurev.astro.34.1.155; Beck R, 2003, ASTRON ASTROPHYS, V411, P99, DOI 10.1051/0004-6361:20031101; Beck R, 2000, PHILOS T R SOC A, V358, P777, DOI 10.1098/rsta.2000.0558; Bekki K, 2005, MON NOT R ASTRON SOC, V356, P680, DOI 10.1111/j.1365-2966.2004.08510.x; Brown JC, 2003, ASTROPHYS J SUPPL S, V145, P213, DOI 10.1086/346082; BURN BJ, 1966, MON NOT R ASTRON SOC, V133, P67, DOI 10.1093/mnras/133.1.67; Chyzy KT, 2000, ASTRON ASTROPHYS, V355, P128; Chyzy KT, 2004, ASTRON ASTROPHYS, V417, P541, DOI 10.1051/0004-6361:20031778; Fletcher A, 2004, ASTRON ASTROPHYS, V414, P53, DOI 10.1051/0004-6361:20034133; Gaensler BM, 2004, NEW ASTRON REV, V48, P1003, DOI 10.1016/j.newar.2004.09.003; Gaustad JE, 2001, PUBL ASTRON SOC PAC, V113, P1326, DOI 10.1086/323969; Han JL, 2002, CHINESE J ASTRON AST, V2, P293, DOI 10.1088/1009-9271/2/4/293; Han JL, 1998, ASTRON ASTROPHYS, V335, P1117; Hanasz M, 2004, ASTROPHYS J, V605, pL33, DOI 10.1086/420697; Haverkorn M, 2004, ASTROPHYS J, V609, P776, DOI 10.1086/421341; Kim S, 1998, ASTROPHYS J, V503, P674, DOI 10.1086/306030; KRAUSE M, 1989, ASTRON ASTROPHYS, V217, P4; KRONBERG PP, 1994, REP PROG PHYS, V57, P325, DOI 10.1088/0034-4885/57/4/001; KRONBERG PP, 1992, ASTROPHYS J, V387, P528, DOI 10.1086/171104; Kulsrud RM, 1999, ANNU REV ASTRON ASTR, V37, P37, DOI 10.1146/annurev.astro.37.1.37; LEAHY JP, 1987, MON NOT R ASTRON SOC, V226, P433, DOI 10.1093/mnras/226.2.433; MEABURN J, 1980, MON NOT R ASTRON SOC, V192, P365, DOI 10.1093/mnras/192.3.365; Moss D, 1999, ASTRON ASTROPHYS, V343, P120; Olszewski EW, 1996, ANNU REV ASTRON ASTR, V34, P511, DOI 10.1146/annurev.astro.34.1.511; Otmianowska-Mazur K, 2000, ASTRON ASTROPHYS, V359, P29; Ruzmaikin A.A., 1988, MAGNETIC FIELDS GALA, DOI 10.1007/978-94-009-2835-0; Sokoloff DD, 1998, MON NOT R ASTRON SOC, V299, P189, DOI 10.1046/j.1365-8711.1998.01782.x; VANDERMAREL RP, IN PRESS LOCAL GROUP; WINDHORST RA, 1993, ASTROPHYS J, V405, P498, DOI 10.1086/172382	29	147	147	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1610	1612		10.1126/science.1108832	http://dx.doi.org/10.1126/science.1108832			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761149				2022-12-28	WOS:000227622400043
J	Chong, AJ; Klein, MB				Chong, AJ; Klein, MB			Marjolin's ulcer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harborview Med Ctr, Seattle, WA 98104 USA	Harborview Medical Center	Chong, AJ (corresponding author), Harborview Med Ctr, Seattle, WA 98104 USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					E9	E9		10.1056/NEJMicm040020	http://dx.doi.org/10.1056/NEJMicm040020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758002				2022-12-28	WOS:000227491200012
J	Figer, DF				Figer, DF			An upper limit to the masses of stars	NATURE			English	Article							MASSIVE STARS; CLUSTER; ABUNDANCES; EVOLUTION	There is no accepted upper mass limit for stars. Such a basic quantity eludes both theory and observation, because of an imperfect understanding of the star-formation process and because of incompleteness in surveying the Galaxy(1). The Arches cluster(2-7) is ideal for investigating such limits, being large enough to expect stars at least as massive as similar to500 solar masses (similar to500 M-.; based on a typical mass function), and young enough for its most massive members to still be visible. It is also old enough to be free of its natal molecular cloud, it is at a well-established distance, and it is close enough for us to discern its individual stars(2). Here I report an absence of stars with initial masses greater than 130 M-. in the Arches cluster, whereas the typical mass function predicts 18. I conclude that this indicates a firm limit of 150M(.) for stars; the probability that the observations are consistent with there being no upper limit is 10(-8).	STScI, Baltimore, MD 21218 USA	Space Telescope Science Institute	Figer, DF (corresponding author), STScI, 3700 San Martin Dr, Baltimore, MD 21218 USA.	figer@stsci.edu						BEECH M, 1994, ASTROPHYS J SUPPL S, V95, P517, DOI 10.1086/192109; Blum RD, 2001, ASTRON J, V122, P1875, DOI 10.1086/323096; Bohannan B, 1999, ASTROPHYS J, V511, P374, DOI 10.1086/306647; BOND JR, 1984, ASTROPHYS J, V280, P825, DOI 10.1086/162057; Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; DAMINELI A, 2000, APJ, V528, P101; DEBOER KS, 1985, MON NOT R ASTRON SOC, V217, P115, DOI 10.1093/mnras/217.1.115; Elmegreen BG, 2000, ASTROPHYS J, V539, P342, DOI 10.1086/309204; Figer DF, 1999, ASTROPHYS J, V525, P750, DOI 10.1086/307937; Figer DF, 2002, ASTR SOC P, V263, P287; Figer DF, 2002, ASTROPHYS J, V581, P258, DOI 10.1086/344154; Figer DF, 1998, ASTROPHYS J, V506, P384, DOI 10.1086/306237; Figer DF, 1999, ASTROPHYS J, V514, P202, DOI 10.1086/306931; Hillier DJ, 1998, ASTRON ASTROPHYS, V340, P483; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; NAGATA T, 1995, ASTRON J, V109, P1676, DOI 10.1086/117395; Najarro F, 2004, ASTROPHYS J, V611, pL105, DOI 10.1086/423955; Najarro F, 2000, NEW ASTRON REV, V44, P213, DOI 10.1016/S1387-6473(00)00053-1; Ramirez SV, 2000, ASTROPHYS J, V537, P205, DOI 10.1086/309022; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SCHALLER G, 1992, A AS, V269, P331; SCHWARZSCHILD M, 1959, ASTROPHYS J, V129, P637, DOI 10.1086/146662; Serabyn E, 1998, NATURE, V394, P448, DOI 10.1038/28799; Stolte A, 2002, ASTRON ASTROPHYS, V394, P459, DOI 10.1051/0004-6361:20021118; Stolte A, 2004, ASTRON J, V128, P765, DOI 10.1086/422705; Walborn NR, 2002, ASTRON J, V124, P1601, DOI 10.1086/341955; Walborn NR, 2002, ASTRON J, V123, P2754, DOI 10.1086/339831; Weidner C, 2004, MON NOT R ASTRON SOC, V348, P187, DOI 10.1111/j.1365-2966.2004.07340.x; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; [No title captured]	30	217	218	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					192	194		10.1038/nature03293	http://dx.doi.org/10.1038/nature03293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758993	Green Submitted			2022-12-28	WOS:000227494500038
J	Verhagen, E; Sauer, PJJ				Verhagen, E; Sauer, PJJ			The Groningen protocol - Euthanasia in severely ill newborn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIFE		Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	University of Groningen	Verhagen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.		Verhagen, Eduard/F-9784-2013	Verhagen, Eduard/0000-0001-9555-6922				Sauer PJJ, 2001, EUR J PEDIATR, V160, P364, DOI 10.1007/s004310100735; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Verhagen A A E, 2005, Ned Tijdschr Geneeskd, V149, P183	3	218	224	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					959	962		10.1056/NEJMp058026	http://dx.doi.org/10.1056/NEJMp058026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758003				2022-12-28	WOS:000227491200001
J	Bird, TD				Bird, TD			Genetic factors in Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA; Vet Affairs Med Ctr, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bird, TD (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Nussbaum RL, 2003, NEW ENGL J MED, V348, P2588	5	90	93	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					862	864		10.1056/NEJMp058027	http://dx.doi.org/10.1056/NEJMp058027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745976				2022-12-28	WOS:000227310700004
J	Ship, AN				Ship, AN			A 73-year-old man with hearing loss, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Jackler RK, 2003, JAMA-J AM MED ASSOC, V289, P1557, DOI 10.1001/jama.289.12.1557	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1115	1115		10.1001/jama.293.9.1115	http://dx.doi.org/10.1001/jama.293.9.1115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LY	15741534				2022-12-28	WOS:000227285200022
J	Cardol, M; Groenewegen, PP; de Bakker, DH; Spreeuwenberg, P; van Dijk, L; van den Bosch, W				Cardol, M; Groenewegen, PP; de Bakker, DH; Spreeuwenberg, P; van Dijk, L; van den Bosch, W			Shared help seeking behaviour within families: a retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; CHILD; ATTITUDES	Objective To examine the extent to which the family influences individual use of general practitioner care. Design Retrospective cohort study of all consultations in one calendar year. Multilevel modelling was used to analyse contact frequencies of individuals within families within practices. Setting General practice in the Netherlands. Participants 42 262 families with children aged 2-21 years registered in 96 practices. Main outcome measures Family influence on individual frequency of contact with general practice and correlation in frequency of contacts between parents and children. Results After correction for patients' age and sex, analysis of siblings indicates that 22% of the variance in frequencies of contact can be ascribed to influence of the family. This means that contact frequencies of family members within families resemble each other, whereas differences in contact frequencies exist between families. Almost 6% of the variance refers to differences between practices and 73% of the variance refers to individual differences. The strongest correlations were found between mothers and children and between children. Conclusions The extent of shared help seeking behaviour within families has considerable implications in the context of the practice.	Netherlands Inst Hlth Serv Res, NL-3800 BN Utrecht, Netherlands; UMCN St Radboud, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands	Netherlands Institute for Health Services Research; Radboud University Nijmegen	Cardol, M (corresponding author), Netherlands Inst Hlth Serv Res, POB 1568, NL-3800 BN Utrecht, Netherlands.	m.cardol@nivel.nl	Groenewegen, Peter/I-1574-2013; Bosch, W.J.H.M./H-8016-2014	Cardol, Mieke/0000-0002-7771-770X; Groenewegen, Peter/0000-0003-2127-8442				ALDERS M, 2003, BEVOLKINGSTRENDS STA, V51, P31; CAMPBELL TL, 2004, OXFORD TXB PRIMARY M, V1, P299; Cornford CS, 1999, BRIT J GEN PRACT, V49, P617; Cunningham M, 2001, J MARRIAGE FAM, V63, P111, DOI 10.1111/j.1741-3737.2001.00111.x; de Swaan Abram., 1988, CARE STATE HLTH CARE; Elbers E., 1992, LEARN INSTR, V2, P101, DOI DOI 10.1016/0959-4752(92)90026-I; Ester P., 1993, INDIVIDUALIZING SOC, P1; Hippisley-Cox J, 2002, BMJ-BRIT MED J, V325, P636, DOI 10.1136/bmj.325.7365.636; HUIJGEN FJA, 1978, FAMILY MED MED LIFE; Launer J, 1997, BRIT J GEN PRACT, V47, P453; Leyland AH, 2003, SCAND J PUBLIC HEALT, V31, P267, DOI 10.1080/14034940210165028; LITMAN TJ, 1974, SOC SCI MED, V8, P495, DOI 10.1016/0037-7856(74)90072-9; Ma KT, 2000, PATIENT EDUC COUNS, V40, P151, DOI 10.1016/S0738-3991(99)00075-0; MECHANIC D, 1964, PEDIATRICS, V33, P444; MONDEN C, 2003, THESIS U NIJMEGEN NI; Parcel TL, 2001, J MARRIAGE FAM, V63, P32, DOI 10.1111/j.1741-3737.2001.00032.x; SCHOR E, 1987, MED CARE, V25, P616, DOI 10.1097/00005650-198707000-00005; SNIJDERS TAB, 1999, MULTILEVEL ANAL INTR, P234; STARFIELD B, 1984, NEW ENGL J MED, V310, P824, DOI 10.1056/NEJM198403293101305; Stewart P, 2002, BRIT J GEN PRACT, V52, P1000; VANDEBOSCH WJH, 1992, THESIS U NIJMEGEN NI; WESTERT GP, 2005, IN PRESS EUR J PUBLI; Whiteman SD, 2003, J MARRIAGE FAM, V65, P608, DOI 10.1111/j.1741-3737.2003.00608.x; WILCOXGOK VL, 1983, MED CARE, V21, P630, DOI 10.1097/00005650-198306000-00005	24	42	42	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2005	330	7496					882	884B		10.1136/bmj.38411.378229.E0	http://dx.doi.org/10.1136/bmj.38411.378229.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	917UA	15772114	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000228493500019
J	Abrahamsen, B; Andersen, I; Christensen, SS; Madsen, JS; Brixen, K				Abrahamsen, B; Andersen, I; Christensen, SS; Madsen, JS; Brixen, K			Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE-MYELOMA; BONE DENSITOMETRY; CHEMOTHERAPY; ONCOLOGY; FRACTURE; DENSITY; WOMEN; HIP	Objective To determine whether measuring monoclonal bands (M component) in serum should be part of the investigation of patients referred to osteoporosis clinics. Design Retrospective, cross sectional, observational study. Setting Referral centre for osteoporosis in a university hospital, Denmark. Participants 799 people (685 women) aged 19 to 94 years newly referred with suspected osteoporosis. Main outcome measures Proportion of patients fulfilling the Nordic Myeloma Study Group definition for target condition and proportion of patients with other important haematological conditions. Results 4.9% (18 of 366) of patients with osteoporosis and 2.2% (9 of 408) of patients without osteoporosis had M components in serum (chi(2) = 3.66, P = 0.04). Multiple myeloma was diagnosed in three patients with osteoporosis (absolute risk 0.8%, 95% confidence interval 0.11% to 1.7%). The relative risk of multiple myeloma in patients presenting with osteoporosis was 75 (10 to 160). As a diagnostic test for multiple myeloma in patients with osteoporosis, M component in serum had a specificity of 95.0% and a positive predictive value of 17.6%. 122 blood electrophoreses were carried out for each case of multiple myeloma diagnosed. All patients with multiple myeloma had a history of fragility fractures. If lymphoma was included as a target condition, the specificity increased to 95.3% and the positive predictive value increased to 23.5%. Monoclonal gammopathy of undetermined significance was diagnosed in 13 (3.6%) participants with osteoporosis and in eight (2.0%) participants with normal bone mineral density or osteopenia. Conclusions Patients presenting with osteoporosis should be tested for M component in serum, as 1 in 20 patients with newly diagnosed osteoporosis had multiple myeloma or monoclonal gammopathy of undetermined significance.	Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Clin Biochem, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Abrahamsen, B (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	b.abrahamsen@dadlnet.dk	Abrahamsen, Bo/B-8920-2008; Madsen, Jonna Skov/AAF-7054-2019	Abrahamsen, Bo/0000-0002-2730-6080; Madsen, Jonna Skov/0000-0001-6668-4714				Abildgaard N, 1996, EUR J HAEMATOL, V57, P370; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Ben Sedrine W, 2002, OSTEOPOROSIS INT, V13, P434, DOI 10.1007/s001980200051; Blade J, 1996, AGE AGEING, V25, P357, DOI 10.1093/ageing/25.5.357; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Colon-Emeric C, 2000, J AM GERIATR SOC, V48, P1261, DOI 10.1111/j.1532-5415.2000.tb02599.x; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; DAWSONHUGHES B, PHYS GUIDE PREVENTIO; Genvresse I, 2001, ANTI-CANCER DRUG, V12, P345, DOI 10.1097/00001813-200104000-00007; Genvresse I, 2001, ONKOLOGIE, V24, P386, DOI 10.1159/000055113; Gregersen H, 2001, HAEMATOLOGICA, V86, P1172; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; *NAT BOARD HLTH, 2003, CANC INC DENM 1999; Nelson DA, 1998, J CLIN DENSITOM, V1, P5, DOI 10.1385/JCD:1:1:5; *NORD MYEL STUD GO, VARDPR MYEL; *NORD MYEL STUD GR, VARDPR MYEL; Oken MM, 1997, CANCER, V79, P1561, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1561::AID-CNCR18>3.0.CO;2-W; Roux S, 2003, J BONE MINER RES, V18, P231, DOI 10.1359/jbmr.2003.18.2.231; Sim MFV, 2004, INT J CLIN PRACT, V58, P300, DOI 10.1111/j.1368-5031.2004.00151.x; *WHO STUD GROUP OS, 1994, ASS FRACT RISK ITS A	20	33	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 9	2005	330	7495					818	820A		10.1136/bmj.38376.401701.8F	http://dx.doi.org/10.1136/bmj.38376.401701.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15767267	Green Published, Bronze			2022-12-28	WOS:000228273900016
J	Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F				Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F			The brain of LB1, Homo floresiensis	SCIENCE			English	Article							INDONESIA; EVOLUTION; HOMININ; APES	The brain of Homo floresiensis was assessed by comparing a virtual endocast from the type specimen (LB1) with endocasts from great apes, Homo erectus, Homo sapiens, a human pygmy, a human microcephalic, specimen number Sts 5 (Australopithecus africanus), and specimen number WT 17000 (Paranthropus aethiopicus). Morphometric, allometric, and shape data indicate that LB1 is not a microcephalic or pygmy. LB1's brain/body size ratio scales like that of an australopithecine, but its endocast shape resembles that of Homo erectus. LB1 has derived frontal and temporal lobes and a lunate sulcus in a derived position, which are consistent with capabilities for higher cognitive processing.	Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Univ New England, Armidale, NSW 2351, Australia; Indonesian Ctr Archaeol, Jakarta 12001, Indonesia	State University System of Florida; Florida State University; Washington University (WUSTL); University of New England	Falk, D (corresponding author), Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA.	dfalk@fsu.edu	Brown, Peter/C-8763-2018; Falk, Dean/C-6400-2019; Sutikna, Thomas/C-4709-2018	Falk, Dean/0000-0003-1654-0469; Sutikna, Thomas/0000-0002-9742-4226				Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CAVALLISFORZA LL, 1986, AFRICAN PYGMIES, P81; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; Conroy G.C., 1985, P419; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730; Diamond J, 2004, SCIENCE, V306, P2047, DOI 10.1126/science.1107565; FALK D, 1983, SCIENCE, V221, P1072, DOI 10.1126/science.221.4615.1072; Falk D, 2000, J HUM EVOL, V38, P695, DOI 10.1006/jhev.1999.0378; FALK D, 1993, AM J PHYS ANTHROPOL, V92, P81, DOI 10.1002/ajpa.1330920107; FLOWER WH, 1889, J ANTHR I, V18, P3; GROVES C, 2004, BEFORE FARMING, V4; HENNEBERG M, 2004, BEFORE FARMING, V4; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; LEMAY M, 1992, AM J NEURORADIOL, V13, P493; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; PASSINGHAM R, 1975, NEW SCI, V27, P510; Rilling JK, 2002, J HUM EVOL, V42, P505, DOI 10.1006/jhev.2001.0537; Schultz A.H., 1956, PRIMATOLOGIA, P887; Semendeferi K, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P257; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Shea BT, 1996, AM J PHYS ANTHROPOL, V100, P311; Spoor F, 2000, J ANAT, V197, P61, DOI 10.1046/j.1469-7580.2000.19710061.x; VERLOES A, 2004, ORPHANET ENCY; WEIDENREICH FRANZ, 1938, PALEONTOL SINICA SER D, V3, P1	28	172	182	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					242	245		10.1126/science.1109727	http://dx.doi.org/10.1126/science.1109727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15749690	Green Submitted			2022-12-28	WOS:000228273700050
J	Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD				Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD			Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	8th International Conference on Malignancies in AIDS and Other Immunodeficiencies	APR 29-30, 2004	Bethesda, MD				HIGH-RISK HPV; CYTOLOGY; WOMEN; NEOPLASIA; CANCER; ABNORMALITIES; SMEARS	Context Recent cervical cancer screening guidelines state that the interval between screenings can be safely extended to 3 years in healthy women 30 years or older who have normal cytology results and have negative test results for oncogenic human papillomavirus (HPV) DNA. Objective To determine the incidence of squamous intraepithelial lesions (SILs) in HIV-seropositive women with normal cytology results, by baseline HPV DNA results. Design, Setting, and Patients Participants were HIV-seropositive (n=855; mean age, 36 years) and HIV-seronegative (n=343; mean age, 34 years) US women with normal baseline cervical cytology who were enrolled in the Women's Interagency HIV Study (WIHS), a large, multi-institutional prospective cohort study. Since their recruitment during 1994-1995, WIHS participants have been followed up semi-annually with repeated Pap smears for a median of 7 years. Main Outcome Measure The cumulative incidence of any SIL and high-grade SIL or cancer (HSIL+) was estimated according to baseline HPV DNA results, stratified by HIV serostatus and CD4 T-cell count. Results Development of any SIL in women with negative HPV results (both oncogenic and nononcogenic) at 2 years was as follows: in HIV-seropositive women with CD4 counts less than 200/mu L, 9% (95% Cl, 1%-18%); with CD4 counts between 200/mu L and 500/mu L, 9% (95% Cl, 4%-13%); and with CD4 counts greater than 500/ mu L, 4% (95% Cl, 1%-7%). The Cis for these estimates overlapped with those for HIV-seronegative women with normal baseline cytology who were HPV-negative (3%; 95% Cl, 1%-5%), indicating that at 2 years, there were no large absolute differences in the cumulative incidence of any SIL between groups. Furthermore, no HPV-negative participants in any group developed HSIL+ lesions within 3 years. Multivariate Cox models showed that on a relative scale, the incidence of any SIL among HIV-seropositive women with CD4 counts greater than 500/mu L (hazard ratio [HR], 1.2; 95% Cl, 0.5-3.0), but not those with CD4 counts less than or equal to 500/mu L (HR, 2.9; 95% C1, 1.2-7.1), was similar to that in HIV-seronegative women. Conclusion The similar low cumulative incidence of any SIL among HIV-seronegative and HIV-seropositive women with CD4 counts greater than 500/mu L and who had normal cervical cytology and HPV-negative test results suggests that similar cervical cancer screening practices may be applicable to both groups, although this strategy warrants evaluation in an appropriate clinical trial.	Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; So Illinois Univ, Sch Med, Springfield, IL USA; Maimonides Hosp, Brooklyn, NY 11219 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Univ So Calif, Los Angeles, CA USA; NICHHD, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; NCI, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; Southern Illinois University System; Southern Illinois University; Maimonides Medical Center; Georgetown University; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, TG (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave,Belfer 1308A, Bronx, NY 10461 USA.	tharris@aecom.yu.edu	Hall, Charles B./AAX-8216-2020	Hall, Charles/0000-0001-9982-8120; Harris, Tiffany/0000-0003-2212-0874	NCI NIH HHS [R01-CA-085178] Funding Source: Medline; NCRR NIH HHS [M01-RR-0007, M01-RR-00083, M01-RR-00079] Funding Source: Medline; NIAID NIH HHS [U01-AI-34994, U01-AI-34993, U01-AI-34989, U01-AI-31834, U01-AI-42590, U01-AI-35004] Funding Source: Medline; OID CDC HHS [U01-CH-32632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085178] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI034993, U01AI034994, U01AI031834, U01AI042590, U01AI035004] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OID CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*2 NAT CANC I WORK, 1993, ACTA CYTOL, V37, P115; ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; [Anonymous], 1995, Clin Infect Dis, V21 Suppl 1, pS32; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Clavel C, 2004, BRIT J CANCER, V90, P1803, DOI 10.1038/sj.bjc.6601726; COX DR, 1972, J R STAT SOC B, V34, P187; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Goldie SJ, 2001, AM J MED, V111, P140, DOI 10.1016/S0002-9343(01)00780-X; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lawless J.F, 1982, STAT MODELS METHODS; LONKY NM, 1995, OBSTET GYNECOL, V85, P716, DOI 10.1016/0029-7844(95)00041-O; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Rozendaal L, 2000, J CLIN PATHOL, V53, P606, DOI 10.1136/jcp.53.8.606; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; WRIGHT TC, 1995, OBSTET GYNECOL, V85, P202, DOI 10.1016/0029-7844(94)00373-L	24	134	135	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1471	1476		10.1001/jama.293.12.1471	http://dx.doi.org/10.1001/jama.293.12.1471			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	908KA	15784870				2022-12-28	WOS:000227784700026
J	Carroll, DN; Kamath, P; Stewart, L				Carroll, DN; Kamath, P; Stewart, L			Congenital viral infection?	LANCET			English	Editorial Material							NEONATAL HYPERTHYROIDISM		Forth Pk Hosp, Neonatal Unit, Kirkcaldy KY2 6RA, Scotland		Carroll, DN (corresponding author), Forth Pk Hosp, Neonatal Unit, Kirkcaldy KY2 6RA, Scotland.	danielacarroll@doctors.org.uk						Ogilvy-Stuart AL, 2002, ARCH DIS CHILD-FETAL, V87, P165, DOI 10.1136/fn.87.3.F165; PARKER RI, 1994, NEW ENGL J MED, V331, P1005, DOI 10.1056/NEJM199410133311508; Skuza KA, 1996, J PEDIATR-US, V128, P264, DOI 10.1016/S0022-3476(96)70405-5; Smith CM, 2000, BRIT MED J, V320, P1260, DOI 10.1136/bmj.320.7244.1260; Zimmerman D, 1999, THYROID, V9, P727, DOI 10.1089/thy.1999.9.727	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1110	1110						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781108				2022-12-28	WOS:000227731800037
J	Gibson, MC; Perrimon, N				Gibson, MC; Perrimon, N			Extrusion and death of DPP/BMP-compromised epithelial cells in the developing Drosophila wing	SCIENCE			English	Article							DPP MORPHOGEN GRADIENT; JUVENILE POLYPOSIS; THICK VEINS; I RECEPTORS; APOPTOSIS; MUTATIONS; JNK; MECHANISMS; SURVIVAL; KINASE	During animal development, epithelial cell fates are specified according to spatial position by extracellular signaling pathways. Among these, the transforming growth factor beta/bone morphogenetic protein (TGF-beta/BMP) pathways are evolutionarily conserved and play crucial roles in the development and homeostasis of a wide range of multicellular tissues. Here we show that in the developing Drosophila wing imaginal epithelium, cell clones deprived of the BMP-like ligand Decapentaplegic (DPP) do not die as previously thought but rather extrude from the cell layer as viable cysts exhibiting marked abnormalities in cell shape and cytoskeletal organization. We propose that in addition to assigning cell fates, a crucial developmental function of DPP/BMP signaling is the position-specific control of epithelial. architecture.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X; Gibson, Matthew/0000-0001-5588-8842				Adachi-Yamada T, 2004, J BIOCHEM, V136, P13, DOI 10.1093/jb/mvh099; Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Auerbach C., 1936, Transactions of the Royal Society of Edinburgh, V58, P787; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; COHEN SM, 1993, DEV DROSOPHILA MELAN, V2, P74; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ricos MG, 1999, J CELL SCI, V112, P1225; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sayed MG, 2002, ANN SURG ONCOL, V9, P901, DOI 10.1007/BF02557528; Singer MA, 1997, DEVELOPMENT, V124, P79	29	148	150	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1785	1789		10.1126/science.1104751	http://dx.doi.org/10.1126/science.1104751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774762				2022-12-28	WOS:000227883900048
J	Byatt, AS				Byatt, AS			Fiction informed by science	NATURE			English	Article																			0	6	6	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					294	297		10.1038/434294a	http://dx.doi.org/10.1038/434294a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772642				2022-12-28	WOS:000227715100031
J	Najemnik, J; Geisler, WS				Najemnik, J; Geisler, WS			Optimal eye movement strategies in visual search	NATURE			English	Article							SIGNAL-DETECTION; MODEL	To performvisual search, humans, like many mammals, encode a large field of view with retinas having variable spatial resolution, and then use high-speed eye movements to direct the highest-resolution region, the fovea, towards potential target locations(1,2). Good search performance is essential for survival, and hence mammals may have evolved efficient strategies for selecting fixation locations. Here we address two questions: what are the optimal eye movement strategies for a foveated visual system faced with the problem of finding a target in a cluttered environment, and do humans employ optimal eye movement strategies during a search? We derive the ideal bayesian observer(3-6) for search tasks in which a target is embedded at an unknown location within a random background that has the spectral characteristics of natural scenes(7). Our ideal searcher uses precise knowledge about the statistics of the scenes in which the target is embedded, and about its own visual system, to make eye movements that gain the most information about target location. We find that humans achieve nearly optimal search performance, even though humans integrate information poorly across fixations(8-10). Analysis of the ideal searcher reveals that there is little benefit from perfect integration across fixations - much more important is efficient processing of information on each fixation. Apparently, evolution has exploited this fact to achieve efficient eye movement strategies with minimal neural resources devoted to memory.	Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Geisler, WS (corresponding author), Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA.	geisler@psy.utexas.edu		Geisler, Wilson/0000-0003-4630-6614				Blake A., 1992, ACTIVE VISION; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; BURGESS AE, 1984, J OPT SOC AM A, V1, P906, DOI 10.1364/JOSAA.1.000906; Carpenter RHS, 1991, EYE MOVEMENTS; Eckstein MP, 2001, PERCEPTION, V30, P1389, DOI 10.1068/p3128; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; Geman D, 1996, IEEE T PATTERN ANAL, V18, P1, DOI 10.1109/34.476006; Green DM, 1966, SIGNAL DETECTION THE; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Legge GE, 2002, VISION RES, V42, P2219, DOI 10.1016/S0042-6989(02)00131-1; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Rajashekar U., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P119, DOI 10.1145/507072.507096; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Schall J. D., 2004, VISUAL NEUROSCIENCES, P1369; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Zelinsky GJ, 1997, PSYCHOL SCI, V8, P448, DOI 10.1111/j.1467-9280.1997.tb00459.x	26	547	565	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					387	391		10.1038/nature03390	http://dx.doi.org/10.1038/nature03390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772663				2022-12-28	WOS:000227715100053
J	Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D				Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D			The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement	NATURE			English	Article							INDUCED CALCIUM-RELEASE; GUARD-CELL VACUOLES; ION CHANNELS; ARABIDOPSIS; PROTEIN; IDENTIFICATION; TRANSFORMATION; OSCILLATIONS; SODIUM; SYSTEM	Cytosolic free calcium ([Ca2+](cyt)) is a ubiquitous signalling component in plant cells(1). Numerous stimuli trigger sustained or transient elevations of [Ca2+](cyt) that evoke downstream stimulus-specific responses. Generation of [Ca2+](cyt) signals is effected through stimulus-induced opening of Ca2+-permeable ion channels that catalyse a flux of Ca2+ into the cytosol from extracellular or intracellular stores. Many classes of Ca2+ current have been characterized electrophysiologically in plant membranes(2). However, the identity of the ion channels that underlie these currents has until now remained obscure. Here we show that the TPC1 ('two-pore channel 1') gene of Arabidopsis thaliana encodes a class of Ca2+-dependent Ca2+-release channel that is known from numerous electrophysiological studies as the slow vacuolar channel(3-5). Slow vacuolar channels are ubiquitous in plant vacuoles, where they form the dominant conductance at micromolar [Ca2+](cyt). We show that a tpc1 knockout mutant lacks functional slow vacuolar channel activity and is defective in both abscisic acid-induced repression of germination and in the response of stomata to extracellular calcium. These studies unequivocally demonstrate a critical role of intracellular Ca2+-release channels in the physiological processes of plants.	Univ York, Dept Biol, Area 9, York YO10 5YW, N Yorkshire, England; Univ Lancaster, Dept Biol, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of York - UK; Lancaster University; University of Oxford	Sanders, D (corresponding author), Univ York, Dept Biol, Area 9, POB 373, York YO10 5YW, N Yorkshire, England.	ds10@york.ac.uk	Peiter, Edgar/C-2577-2013	Peiter, Edgar/0000-0002-9104-3238; Hetherington, Alistair/0000-0001-6060-9203; Pelloux, Jerome/0000-0002-9371-1711; Knight, Heather/0000-0003-2047-6084	Biotechnology and Biological Sciences Research Council [P18580] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Allen GJ, 1997, ADV BOT RES, V25, P217, DOI 10.1016/S0065-2296(08)60154-8; Allen GJ, 1996, PLANT J, V10, P1055, DOI 10.1046/j.1365-313X.1996.10061055.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bewell MA, 1999, FEBS LETT, V458, P41, DOI 10.1016/S0014-5793(99)01109-6; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hashimoto K, 2004, PLANT CELL PHYSIOL, V45, P496, DOI 10.1093/pcp/pch053; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; HOFTE H, 1991, PLANTA, V184, P431, DOI 10.1007/BF00197889; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kadota Y, 2004, BIOCHEM BIOPH RES CO, V317, P823, DOI 10.1016/j.bbrc.2004.03.114; Kurusu T, 2004, PLANT CELL PHYSIOL, V45, P693, DOI 10.1093/pcp/pch082; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Maathuis FJM, 1995, METHOD CELL BIOL, V49, P293, DOI 10.1016/S0091-679X(08)61461-2; Maathuis FJM, 2001, PLANT PHYSIOL, V127, P1617, DOI 10.1104/pp.010502; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Muir SR, 1997, PLANT PHYSIOL, V114, P1511, DOI 10.1104/pp.114.4.1511; Pottosin II, 2001, J MEMBRANE BIOL, V181, P55, DOI 10.1007/s0023200100073; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schonknecht G, 2002, FEBS LETT, V511, P28, DOI 10.1016/S0014-5793(01)03273-2; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Szponarski W, 2004, PROTEOMICS, V4, P397, DOI 10.1002/pmic.200300607; WARD JM, 1994, PLANT CELL, V6, P669; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1	30	379	402	0	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					404	408		10.1038/nature03381	http://dx.doi.org/10.1038/nature03381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772667				2022-12-28	WOS:000227715100057
J	Beman, JM; Arrigo, KR; Matson, PA				Beman, JM; Arrigo, KR; Matson, PA			Agricultural runoff fuels large phytoplankton blooms in vulnerable areas of the ocean	NATURE			English	Article							GULF-OF-CALIFORNIA; NITROGEN-FIXATION; DENITRIFICATION; VARIABILITY; PHOSPHORUS; PATTERNS; NITRATE; WATERS; SEA; BAY	Biological productivity in most of the world's oceans is controlled by the supply of nutrients to surface waters. The relative balance between supply and removal of nutrients - including nitrogen, iron and phosphorus - determines which nutrient limits phytoplankton growth. Although nitrogen limits productivity in much of the ocean(1,2), large portions of the tropics and subtropics are defined by extreme nitrogen depletion. In these regions, microbial denitrification removes biologically available forms of nitrogen from the water column, producing substantial deficits relative to other nutrients(3-5). Here we demonstrate that nitrogen-deficient areas of the tropical and subtropical oceans are acutely vulnerable to nitrogen pollution. Despite naturally high nutrient concentrations and productivity(6-8), nitrogen-rich agricultural runoff fuels large (54 - 577 km(2)) phytoplankton blooms in the Gulf of California. Runoff exerts a strong and consistent influence on biological processes, in 80% of cases stimulating blooms within days of fertilization and irrigation of agricultural fields. We project that by the year 2050, 27 - 59% of all nitrogen fertilizer will be applied in developing regions located upstream of nitrogen-deficient marine ecosystems. Our findings highlight the present and future vulnerability of these ecosystems to agricultural runoff.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Beman, JM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	beman@stanford.edu		Arrigo, Kevin/0000-0002-7364-876X				Alvarez-Borrego S., 1978, CIENC MAR, V5, P53, DOI [10.7773/cm.v5i2.322, DOI 10.7773/CM.V5I2.322]; Alvarez-Borrego Saul, 2002, P41; Beron-Vera FJ, 2000, J GEOPHYS RES-OCEANS, V105, P11441, DOI 10.1029/2000JC900038; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Corredor JE, 1999, BIOGEOCHEMISTRY, V46, P163; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gaxiola-Castro G, 1999, J PLANKTON RES, V21, P231, DOI 10.1093/plankt/21.2.231; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Harrison J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001991; Harrison J.A., 2003, THESIS STANFORD U; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Kahru M, 2004, DEEP-SEA RES PT II, V51, P139, DOI 10.1016/j.dsr2.2003.04.001; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; NAYLOR RL, 2001, 0101 CIMMYT; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Riley WJ, 2001, NUTR CYCL AGROECOSYS, V61, P223, DOI 10.1023/A:1013758116346; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Switzer AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000444; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Tyrrell T, 1998, NATURE, V393, P318, DOI 10.1038/30632; Tyrrell T, 2002, CONT SHELF RES, V22, P2497, DOI 10.1016/S0278-4343(02)00077-8; VALSARAJ CP, 1994, HYDROBIOLOGIA, V286, P139, DOI 10.1007/BF00006245; ZEITZSCHEL B, 1969, MAR BIOL, V3, P201, DOI 10.1007/BF00360952	28	365	389	17	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					211	214		10.1038/nature03370	http://dx.doi.org/10.1038/nature03370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758999				2022-12-28	WOS:000227494500044
J	Dluhy, RG; Maher, MM; Harris, NL; Grinspoon, SK; Wu, CL				Dluhy, RG; Maher, MM; Harris, NL; Grinspoon, SK; Wu, CL			A 59-year-old woman with an incidentally discovered adrenal nodule - Functional adrenal cortical adenoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEPENDENT CUSHINGS-SYNDROME; HORMONE-RECEPTORS; SUPPRESSION; DIAGNOSIS; FEATURES; THERAPY; TUMORS; ACTH		Brigham & Womens Hosp, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Dluhy, RG (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.							Barzon L, 1999, J CLIN ENDOCR METAB, V84, P520, DOI 10.1210/jc.84.2.520; Barzon L, 1998, J CLIN ENDOCR METAB, V83, P55, DOI 10.1210/jc.83.1.55; Croughs RJM, 2000, CLIN ENDOCRINOL, V52, P235, DOI 10.1046/j.1365-2265.2000.00932.x; DLUHY RG, 2003, WILLIAMS TXB ENDOCRI, P573; Giraldi FP, 2001, CLIN ENDOCRINOL, V54, P601, DOI 10.1046/j.1365-2265.2001.01258.x; GROSS MD, 1994, J NUCL MED, V35, P1145; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Lack EE, 1997, TUMORS ADRENAL GLAND, P91; Lacroix A, 2001, ENDOCR REV, V22, P75, DOI 10.1210/er.22.1.75; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Mircescu H, 2000, J CLIN ENDOCR METAB, V85, P3531, DOI 10.1210/jc.85.10.3531; N'Diaye N, 1999, J CLIN ENDOCR METAB, V84, P2616, DOI 10.1210/jc.84.8.2616; Raff H, 2003, ANN INTERN MED, V138, P980, DOI 10.7326/0003-4819-138-12-200306170-00010; REINCKE M, 1992, J CLIN ENDOCR METAB, V75, P826, DOI 10.1210/jc.75.3.826; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Tsagarakis S, 1998, CLIN ENDOCRINOL, V49, P165, DOI 10.1046/j.1365-2265.1998.00509.x; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001	21	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					1025	1032		10.1056/NEJMcpc059002	http://dx.doi.org/10.1056/NEJMcpc059002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758014				2022-12-28	WOS:000227491200013
J	Labonte, R; Schrecker, T; Sen Gupta, A				Labonte, R; Schrecker, T; Sen Gupta, A			A global health equity agenda for the G8 summit	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Ottawa, Inst Populat Hlth, Globalisat & Hlth Equity Res Program, Ottawa, ON K1N 6N5, Canada; Peoples Hlth Movement India, New Delhi 110017, India	University of Ottawa	Labonte, R (corresponding author), Univ Ottawa, Inst Populat Hlth, Globalisat & Hlth Equity Res Program, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					[Anonymous], 2001, MACR HLTH INV HLTH E; BIRDSALL N, 2002, GLOBALISATION LIVING, P37; Bloom D. E., 2004, Finance & Development, V41, P10; Chang H.-J., 2002, KICKING AWAY LADDER; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; CHERN F, 2001, ECN4200156 UN EC SOC; CHERU F, 1999, ECN4199950 UN EC SOC; CHIRAC J, 2003, NY TIMES        0923; Cornia Giovanni Andrea, 1987, ADJUSTMENT HUMAN FAC, V1; FOSTER M, 2004, HIGH LEV FOR HLTH MD; *G8 INF CTR, 2005, G7 FIN MIN CONCL DEV; *G8 INF CTR, 2001, FIN COMM GEN JUL 22; Global Forum for Health Research, 2005, 10 90 REP HLTH RES 2, P25; HANLON J, 2000, J INT DEV, V12, P877; HUNT P, 2003, EC SOCIAL CULTURAL R; Jawara Fatoumata, 2004, SCENES WTO REAL WORL; LABONTE R, 2004, FATAL INDIFFERENCE G; LABONTE R, 2005, G8 AFRICA GLOBAL HLT; LISTER G, 2004, COUNTRY CASE STUDY U; MACASKILL E, 2004, GUARDIAN        0713; Martin M., 2004, HIPC DEBT RELIEF MYT, P11; MCCURRENCIES, 2003, ECONOMIST       0424; MICHAUD C, 2003, 2 CONS COMM MACR HLT; *NEW PARTN AFR DEV, 2002, HLTH STRAT; *OECD, 2004, AGR POL OECD COUNTR; *ORG EC COOP DEV, 2005, DAC J, V6; PETTIFOR A, 2002, DEBT RELIEF MILLEMIU; RADELET S, 2004, 39 CTR GLOB DEV; Sachs JD, 2004, BROOKINGS PAP ECO AC, P117; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UNAIDS, 2004, UN AIDS PROGR 2004 R; United Nations Development Programme, 2000, HUM DEV REP 2000 HUM; Wagstaff A., 2003, MILLENNIUM DEV GOALS; WATKINS K, 2003, WTO PUBL S CHALL AH; *WORLD BANK, 2003, ECONOMIST       0424	35	13	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					533	536A		10.1136/bmj.330.7490.533	http://dx.doi.org/10.1136/bmj.330.7490.533			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746137	Green Published			2022-12-28	WOS:000227581400025
J	Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP				Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP			A serpentinite-hosted ecosystem: The lost city hydrothermal field	SCIENCE			English	Article							MID-ATLANTIC RIDGE; PERIDOTITE; REDUCTION; FLUIDS; ROCKS; EARTH; CH4; CO2	The serpentinite-hosted Lost City hydrothermal field is a remarkable submarine ecosystem in which geological, chemical, and biological processes are intimately interlinked. Reactions between seawater and upper mantle peridotite produce methane- and hydrogen-rich fluids, with temperatures ranging from <40 degrees to 90 degrees C at pH 9 to 11, and carbonate chimneys 30 to 60 meters tall. A low diversity of microorganisms related to methane-cycling Archaea thrive in the warm porous interiors of the edifices. Macrofaunal communities show a degree of species diversity at least as high as that of black smoker vent sites along the Mid-Atlantic Ridge, but they lack the high biomasses of chemosynthetic organisms that are typical of volcanically driven systems.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; ETH Zentrum, Dept Earth Sci, Zurich, Switzerland; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98115 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Woods Hole Oceanog Inst, MIT WHOI Joint Program, Woods Hole, MA 02543 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Kelley, DS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	kelley@ocean.washington.edu	Larson, Benjamin/K-4859-2016; Butterfield, David/H-3815-2016; Sylva, Sean/D-4400-2014; Summons, Roger Everett/AAL-3789-2020; Proskurowski, Giora/B-3862-2013; Bernasconi, Stefano M/E-5394-2010; Bradley, Alexander/A-9391-2009; Matthew, Schrenk/AAH-5682-2020; Delacour, Adélie/B-8639-2012	Larson, Benjamin/0000-0002-1007-1684; Butterfield, David/0000-0002-1595-9279; Sylva, Sean/0000-0002-4727-440X; Bernasconi, Stefano M/0000-0001-7672-8856; Bradley, Alexander/0000-0002-4044-2802; Schrenk, Matthew/0000-0002-5623-8558; Ludwig, Kristin/0000-0002-0935-9410				ABRAJANO TA, 1988, CHEM GEOL, V71, P211, DOI 10.1016/0009-2541(88)90116-7; Bach W, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000279; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; BONATTI E, 1989, EARTH PLANET SC LETT, V91, P297, DOI 10.1016/0012-821X(89)90005-8; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Fritz P., 1992, P 7 INT S WAT ROCK I, V7, P793; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Fryer P, 1999, GEOLOGY, V27, P103, DOI 10.1130/0091-7613(1999)027<0103:MBMVIF>2.3.CO;2; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gracia E, 2000, EARTH PLANET SC LETT, V177, P89, DOI 10.1016/S0012-821X(00)00034-0; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Karson JA, 1998, GEOPH MONOG SERIES, V106, P177; Kelley DS, 2004, GEOPHYS MONOGR SER, V144, P167, DOI 10.1029/144GM11; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Lagabrielle Y, 1998, GEOPH MONOG SERIES, V106, P153; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; LOWELL RP, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001GL01411; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Michael P, 2002, NATURE, V419, P445, DOI 10.1038/419445a; Mottl MJ, 2003, GEOCHEM GEOPHY GEOSY, V4, P11; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Reston TJ, 2001, GEOLOGY, V29, P587, DOI 10.1130/0091-7613(2001)029<0587:DFMSAS>2.0.CO;2; Reysenbach A.-L., 2002, BIODIVERSITY MICROBI, P345; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Schroeder T, 2002, GEOLOGY, V30, P367, DOI 10.1130/0091-7613(2002)030<0367:GIOSCT>2.0.CO;2; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; Surour AA, 1997, J AFR EARTH SCI, V24, P315, DOI 10.1016/S0899-5362(97)00046-8; Treves B, 1994, OFIOLITI, V19, P435; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; WELHAN J, 1979, EOS, V60, P863; Welhan JA, 1983, HYDROTHERMAL PROCESS, P391, DOI [DOI 10.1007/978-1-4899-0402-7_17, 10.1007/978-1-4899-0402-7_17]; Wetzel LR, 2000, J GEOPHYS RES-SOL EA, V105, P8319, DOI 10.1029/1999JB900382; WILCOCK WW, 2004, GEOPHYSICAL MONOGRAP, V144	44	802	840	9	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1428	1434		10.1126/science.1102556	http://dx.doi.org/10.1126/science.1102556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746419				2022-12-28	WOS:000227503100036
J	Mashelkar, RA				Mashelkar, RA			India's R&D: Reaching for the top	SCIENCE			English	Article									CSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India	Mashelkar, RA (corresponding author), CSIR, New Delhi 110001, India.	dgcsir@hq.csir.res.in						King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; *UN DEV PROGR, 2001, HUM DEP REP 2001 MAK	2	26	27	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1415	1417		10.1126/science.1110729	http://dx.doi.org/10.1126/science.1110729			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15751125				2022-12-28	WOS:000227503100029
J	Alverson, K				Alverson, K			Watching over the world's oceans	NATURE			English	Editorial Material									UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, F-75732 Paris 15, France		Alverson, K (corresponding author), UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, 1 Rue Miollis, F-75732 Paris 15, France.								0	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					19	20		10.1038/434019a	http://dx.doi.org/10.1038/434019a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744274				2022-12-28	WOS:000227334600021
J	Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P				Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P			Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; LIFE-SPAN; METABOLISM; P53	Homeostatic mechanisms in mammals respond to hormones and nutrients to maintain blood glucose levels within a narrow range. Caloric restriction causes many changes in glucose metabolism and extends lifespan; however, how this metabolism is connected to the ageing process is largely unknown. We show here that the Sir2 homologue, SIRT1 - which modulates ageing in several species(1-3) - controls the gluconeogenic/glycolytic pathways in liver in response to fasting signals through the transcriptional coactivator PGC-1alpha. A nutrient signalling response that is mediated by pyruvate induces SIRT1 protein in liver during fasting. We find that once SIRT1 is induced, it interacts with and deacetylates PGC-1alpha at specific lysine residues in an NAD(+)-dependent manner. SIRT1 induces gluconeogenic genes and hepatic glucose output through PGC-1alpha, but does not regulate the effects of PGC-1alpha on mitochondrial genes. In addition, SIRT1 modulates the effects of PGC-1alpha repression of glycolytic genes in response to fasting and pyruvate. Thus, we have identified a molecular mechanism whereby SIRT1 functions in glucose homeostasis as a modulator of PGC-1alpha. These findings have strong implications for the basic pathways of energy homeostasis, diabetes and lifespan.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Puigserver, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	ppuigse1@bs.jhmi.edu	Lerin, Carles/AAP-9916-2020	Lerin, Carles/0000-0003-0950-4363; Rodgers, Joseph/0000-0002-6598-5520				Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MACDONALD M, 1976, AM J PHYSIOL, V231, P619, DOI 10.1152/ajplegacy.1976.231.2.619; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598	22	2425	2533	5	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					113	118		10.1038/nature03354	http://dx.doi.org/10.1038/nature03354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744310				2022-12-28	WOS:000227334600054
J	Rubin, EJ				Rubin, EJ			Clinical implications of basic research: Toward a new therapy for tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rubin, Eric/0000-0001-5120-962X				Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753	1	11	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					933	934		10.1056/NEJMcibr044438	http://dx.doi.org/10.1056/NEJMcibr044438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745987				2022-12-28	WOS:000227310700016
J	Guarente, L; Picard, F				Guarente, L; Picard, F			Calorie restriction - the SIR2 connection	CELL			English	Review							SILENCING PROTEIN SIR2; CEREVISIAE LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; DIETARY-RESTRICTION; METABOLIC-RATE; CELL-SURVIVAL; NEURODEGENERATIVE DISORDERS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; MOLECULAR MECHANISMS	A nutritious diet low in calories improves the health and extends the life span of rodents. Recent studies identified a gene, SIR2, which encodes an NAD-dependent deacetylase and may mediate the effects of calorie restriction. In this review, we discuss SIR2 genes and calorie restriction in the lower organisms yeast and Drosophila. We then describe the physiological changes in mammals during calorie restriction and how they may lead to the observed health benefits. We summarize the roles of mammalian Sirt1 in mediating these changes in tissues and endocrine systems and propose that Sirt1 regulates calorie restriction by sensing low calories and triggering physiological changes linked to health and longevity.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Guarente L, 2000, GENE DEV, V14, P1021; HARMAN D, 1956, J NUTR, V114, P411; HARRISON DE, 1989, GROWTH DEVELOP AGING, V53, P3; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2002, GENETICS, V160, P83; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.suppl_1.41; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee CH, 2002, TRENDS ENDOCRIN MET, V13, P331, DOI 10.1016/S1043-2760(02)00668-9; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; MARGOLSKEE JP, 1988, MOL GEN GENET, V211, P430, DOI 10.1007/BF00425696; MASARO EJ, 1984, PHYSIOLOGIST, V27, P98; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MCCARTER R, 1985, AM J PHYSIOL, V248, pE488; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Pajvani Utpal B, 2003, Curr Diab Rep, V3, P207, DOI 10.1007/s11892-003-0065-2; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; RICHARDSON A, 1985, HDB NUTRITION AGED, P31; RINE J, 1987, GENETICS, V116, P9; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Stern JS, 2001, J NUTR, V131, p913S, DOI 10.1093/jn/131.3.913S; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weindruch R., 1988, RETARDATION AGING DI; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xiao H, 2004, EXP BIOL MED, V229, P479, DOI 10.1177/153537020422900605; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	76	639	670	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					473	482		10.1016/j.cell.2005.01.029	http://dx.doi.org/10.1016/j.cell.2005.01.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734680	Bronze			2022-12-28	WOS:000227271500005
J	Tanzi, RE; Bertram, L				Tanzi, RE; Bertram, L			Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective	CELL			English	Review							INSULIN-DEGRADING ENZYME; GAMMA-SECRETASE ACTIVITY; BLOOD-BRAIN-BARRIER; HEREDITARY CEREBRAL-HEMORRHAGE; APOLIPOPROTEIN-E GENOTYPE; PRECURSOR PROTEIN GENE; BLOCK SPANNING IDE; BETA-PROTEIN; A-BETA; IN-VIVO	From Alois Alzheimer's description of Auguste D.'s brain in 1907 to George Glenner's biochemical dissection of beta-amyloid in 1984, the "amyloid hypothesis" of Alzheimer's disease has continued to gain support over the past two decades, particularly from genetic studies. Here we assess the amyloid hypothesis based on both known and putative Alzheimer's disease genes.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Mass Gen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Mass Gen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Bertram, Lars/K-3889-2015	Tanzi, Rudolph/0000-0002-7032-1454; Bertram, Lars/0000-0002-0108-124X				Abraham R, 2001, HUM GENET, V109, P646, DOI 10.1007/s00439-001-0614-1; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Athan ES, 2002, ARCH NEUROL-CHICAGO, V59, P1793, DOI 10.1001/archneur.59.11.1793; Bamberger ME, 2001, MICROSC RES TECHNIQ, V54, P59, DOI 10.1002/jemt.1121; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bertram L, 2004, NEUROLOGY, V62, P304, DOI 10.1212/01.WNL.0000103283.65914.0B; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2000, EXP GERONTOL, V35, P1353, DOI 10.1016/S0531-5565(00)00193-5; Bian L, 2004, NEUROLOGY, V63, P241, DOI 10.1212/01.WNL.0000129987.70037.DB; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blomqvist MEL, 2004, NEUROGENETICS, V5, P115, DOI 10.1007/s10048-004-0173-4; Boussaha M, 2002, NEUROSCI LETT, V329, P121, DOI 10.1016/S0304-3940(02)00586-4; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Clarimon J, 2003, J NEURAL TRANSM, V110, P651, DOI 10.1007/s00702-002-0807-3; Confaloni A, 2003, NEUROSCI LETT, V353, P61, DOI 10.1016/j.neulet.2003.09.007; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; De Strooper B, 1999, NATURE, V402, P471, DOI 10.1038/44973; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Dermaut B, 2002, AM J HUM GENET, V70, P1568, DOI 10.1086/340732; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Funalot B, 2004, MOL PSYCHIATR, V9, P1122, DOI 10.1038/sj.mp.4001584; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gold G, 2003, AM J MED GENET B, V119B, P44, DOI 10.1002/ajmg.b.10010; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; Guenette SY, 2003, NEUROMOL MED, V4, P147, DOI 10.1385/NMM:4:3:147; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helisalmi S, 2004, NEUROLOGY, V63, P173, DOI 10.1212/01.WNL.0000133153.98139.4E; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Lambert JC, 2001, J MED GENET, V38, P353, DOI 10.1136/jmg.38.6.353; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li L, 1998, HUM GENET, V103, P86, DOI 10.1007/s004390050788; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mukherjee A, 2002, J ALZHEIMERS DIS, V4, P341, DOI 10.3233/JAD-2002-4501; Murray RE, 1997, BONE, V21, P89, DOI 10.1016/S8756-3282(97)00081-1; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Nowotny P, 2001, NEUROREPORT, V12, P1799, DOI 10.1097/00001756-200107030-00008; Olson JM, 2001, AM J HUM GENET, V69, P895, DOI 10.1086/323472; Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Poli M, 2003, NEUROSCI LETT, V350, P77, DOI 10.1016/S0304-3940(03)00857-7; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Rebeck GW, 2000, NEUROSCI LETT, V293, P75, DOI 10.1016/S0304-3940(00)01487-7; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; Rogers JT, 2004, CURR DRUG TARGETS, V5, P535, DOI 10.2174/1389450043345272; Sakai A, 2004, DEMENT GERIATR COGN, V17, P164, DOI 10.1159/000076351; Sakai A, 2004, AM J MED GENET B, V125B, P87, DOI 10.1002/ajmg.b.20106; Saunders A.J, 1999, SCIENCE, V286, P1255, DOI DOI 10.1126/SCIENCE.286.5443.1255A; Saunders AJ, 2003, HUM MOL GENET, V12, P2765, DOI 10.1093/hmg/ddg310; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Scott WK, 2003, AM J HUM GENET, V73, P1041, DOI 10.1086/379083; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Theuns J, 2003, HUM MOL GENET, V12, P869, DOI 10.1093/hmg/ddg098; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Uden E, 2002, J NEUROSCI, V22, P9298; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wragg M, 1996, LANCET, V347, P509, DOI 10.1016/S0140-6736(96)91140-X; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	104	1376	1470	11	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					545	555		10.1016/j.cell.2005.02.008	http://dx.doi.org/10.1016/j.cell.2005.02.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734686	Bronze			2022-12-28	WOS:000227271500011
J	Bartram, J; Lewis, K; Lenton, R; Wright, A				Bartram, J; Lewis, K; Lenton, R; Wright, A			Focusing on improved water and sanitation for health	LANCET			English	Article									World Hlth Org, Geneva, Switzerland; Columbia Univ, Earth Inst, UN, Millennium Project Task Force Water & Sanitat, Palisades, NY USA	World Health Organization; Columbia University	Bartram, J (corresponding author), World Hlth Org, Geneva, Switzerland.			Bartram, Jamie/0000-0002-6542-6315				Evans B. E., 2004, CLOSING SANITATION G; *UN MILL PROJ TASK, 2005, HLTH DIGN DEV WHAT W; [United Nations (UN) World Water Assessment Programme], 2003, UN WORLD WAT DEV REP; WHO, ROLL BACK MAL; *WHO UN INT CHILDR, 2004, M MDG DRINK WAT SAN; World Health Organization, 2004, WAT SAN HYG LINKS HL; World Health Organization (WHO), WAT SAN HLTH	7	127	127	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					810	812						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733725				2022-12-28	WOS:000227285300031
J	Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF				Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF			MicroRNAs regulate brain morphogenesis in zebrafish	SCIENCE			English	Article							RNA-INTERFERENCE; GENE-EXPRESSION; MESSENGER-RNAS; DICER; DROSOPHILA; CELLS; INITIATION; TARGETS; DIFFERENTIATION; MECHANISMS	MicroRNAs (miRNAs) are small RNAs that regulate gene expression posttranscriptionally. To block all miRNA formation in zebrafish, we generated maternal-zygotic dicer (MZdicer) mutants that disrupt the Dicer ribonuclease III and double-stranded RNA-binding domains. Mutant embryos do not process precursor miRNAs into mature miRNAs, but injection of preprocessed miRNAs restores gene silencing, indicating that the disrupted domains are dispensable for later steps in silencing. MZdicer mutants undergo axis formation and differentiate multiple cell types but display abnormal morphogenesis during gastrulation, brain formation, somitogenesis, and heart development. Injection of miR-430 miRNAs rescues the brain defects in MZdicer mutants, revealing essential roles for miRNAs during morphogenesis.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of North Carolina; University of North Carolina Chapel Hill	Giraldez, AJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	giraldez@saturn.med.nyu.edu; schier@saturn.med.nyu.edu	Enright, Anton/F-3094-2011	Enright, Anton/0000-0002-6090-3100; Giraldez, Antonio/0000-0002-6823-137X; Glasner, Margaret/0000-0003-1818-1965; Schier, Alexander Franz/0000-0001-7645-5325				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; GLASNER ME, UNPUB; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	40	996	1144	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					833	838		10.1126/science.1109020	http://dx.doi.org/10.1126/science.1109020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774722				2022-12-28	WOS:000228986500042
J	Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J				Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J			Complement factor H polymorphism in age-related macular degeneration	SCIENCE			English	Article							GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; DISEASE; DRUSEN; ASSOCIATIONS; ACTIVATION; REGIONS; PROJECT; PROTEIN	Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with AMD. Among 116,204 single-nucleotide polymorphisms genotyped, an intronic and common variant in the complement factor H gene (CFH) is strongly associated with AMD (nominal P value <10(-7)). in individuals homozygous for the risk allele, the likelihood of AMD is increased by a factor of 7.4 (95% confidence interval 2.9 to 19). Resequencing revealed a polymorphism in linkage disequilibrium with the Ask allele representing a tyrosine-histidine change at amino acid 402. This polymorphism is in a region of CFH that binds heparin and C-reactive protein. The CFH gene is located on chromosome 1 in a region repeatedly linked to AMD in family-based studies.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; NEI, Bethesda, MD 20892 USA; EMMES Corp, Rockville, MD 20850 USA; Yale Univ, WM Keck Facil, New Haven, CT 06511 USA	Yale University; Rockefeller University; Yale University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Emmes Corporation; Yale University	Hoh, J (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	SanGiovanni, John Paul/AAU-3895-2020; Barnstable, Colin/GLU-9219-2022; SanGiovanni, John Paul/A-7605-2008; Mohammed, Imran/J-8271-2012; Barnstable, Colin/ABB-4822-2021; Klein, Robert/K-1888-2013	Mohammed, Imran/0000-0002-8412-0768; Klein, Robert/0000-0003-3539-5391; SanGiovanni, John Paul/0000-0001-7199-7053; Barnstable, Colin/0000-0002-7011-4068; Ferris, Frederick/0000-0002-4933-0639	NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR016090] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015771, Z01EY000394] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hayashi M, 2004, Ophthalmic Genet, V25, P111; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; McKay GJ, 2004, MOL VIS, V10, P682; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; TEMPLETON AR, 1987, GENETICS, V117, P343; Tuo JS, 2004, PROG RETIN EYE RES, V23, P229, DOI 10.1016/j.preteyeres.2004.02.001; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wistow G, 2002, MOL VIS, V8, P205	30	3158	3470	7	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					385	389		10.1126/science.1109557	http://dx.doi.org/10.1126/science.1109557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761122	Green Accepted			2022-12-28	WOS:000228492000044
J	Jamrozik, K				Jamrozik, K			Estimate of deaths attributable to passive smoking among UK adults: database analysis	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; LUNG-CANCER; OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; ISCHEMIC-STROKE; HEART-DISEASE; RISK	Objective To estimate deaths from passive smoking in employees of the hospitality industry as well as in the general workforce and general population of the United Kingdom. Design Calculation, using the formula for population attributable proportion, of deaths likely to have been caused by passive smoking at home and at work in the UK according to occupation. Sensitivity analyses to examine impact of varying assumptions regarding prevalence and risks of exposure. Setting National UK databases of causes of death, employment, structure of households, and prevalences of active and passive smoking. Main outcome measures Estimates of deaths due to passive smoking according to age group (< 65 or >= 65) and site of exposure (domestic or workplace). Results Across the United Kingdom as a whole, passive smoking at work is likely to be responsible for the deaths of more than two employed people per working day (617 deaths per year), including 54 deaths in the hospitality industry each year. Each year passive smoking at home might account for another 2700 deaths in persons aged 20-64 years and 8000 deaths among people aged >= 65. Conclusion Exposure at work might contribute up to one fifth of all deaths from passive smoking in the general population aged 20-64 years, and up to half of such deaths among employees of the hospitality industry. Adoption of smoke free policies in all workplaces and reductions in the general prevalence of active smoking would lead to substantial reductions in these avoidable deaths.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Jamrozik, K (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	k.jamrozik@sph.uq.edu.au						*BMRB INT, 2002, COMP UK LAB FORC STA; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; DONNAN GA, 1989, LANCET, V2, P643; Glantz SA, 2000, TOB CONTROL, V9, P111; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 2001, QUANTITATIVE SURVEY; Johnsson T, 2003, AM J IND MED, V43, P523, DOI 10.1002/ajim.10207; KAWACHI I, 1989, NEW ZEAL MED J, V102, P337; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Law MR, 1996, BRIT MED BULL, V52, P22, DOI 10.1093/oxfordjournals.bmb.a011528; LEE PN, 1986, BRIT J CANCER, V54, P97, DOI 10.1038/bjc.1986.157; MCDONNELL S, 1991, AUSTRALIAN      0613, P3; MOLGAARD C A, 1986, Neuroepidemiology, V5, P88, DOI 10.1159/000110818; *NAT HLTH MED RES, 1997, HLTH EFF PASS SMOK S; Nurminen MM, 2001, J OCCUP ENVIRON MED, V43, P687, DOI 10.1097/00043764-200108000-00006; *OFF NAT STAT, EMPL WORKF JOBS IND; *OFF NAT STAT, GEN HOUS SURV LIV BR; *OFF NAT STAT, 2004, MID 2002 POP EST UK; *OFF NAT STAT, EMPL WORKF JOS IND; *OFF NAT STAT, MID 2002 POP EST UK; *OFF NAT STAT, DEATHS AG SEX UND CA; *SECT SKILLS DEV A, 2002, MARK ASS HOSP LEIS T; Stead LF, 2006, REP SCI COMM TOB HLT, DOI 10.1002/14651858.CD002850.pub2; The Office of Environmental Health Hazard Assessment, 1997, HLTH EFF EXP ENV TOB; TRICHOPOULOS D, 1981, INT J CANCER, V27, P1, DOI 10.1002/ijc.2910270102; Wakefield M, 2002, AUST NZ J PUBL HEAL, V26, P375, DOI 10.1111/j.1467-842X.2002.tb00190.x; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; White V, 2003, TOB CONTROL, V12, P67, DOI 10.1136/tc.12.suppl_2.ii67; WOODWARD A, 2000, DEATHS NZ ATTRIBUTAB; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572	32	81	83	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 9	2005	330	7495					812	+		10.1136/bmj.38370.496632.8F	http://dx.doi.org/10.1136/bmj.38370.496632.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15741188	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000228273900014
J	Macq, J				Macq, J			Commentary: Trials should inform structures and processes needed for tailoring interventions	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; DESIGN		Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Macq, J (corresponding author), Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, CP 597,808 Route Lennik, B-1070 Brussels, Belgium.	jmacq@ulb.ac.be						Battersby MW, 2005, BRIT MED J, V330, P662, DOI 10.1136/bmj.330.7492.662; Cretin S, 2004, EVALUATION REV, V28, P28, DOI 10.1177/0193841X03256298; Kumpers S, 2002, PUBLIC ADMIN, V80, P339, DOI 10.1111/1467-9299.00307; Segal L, 2004, HEALTH POLICY, V69, P215, DOI 10.1016/j.healthpol.2004.02.001; Singh D, 2005, TRANSFORMING CHRONIC	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					665	666		10.1136/bmj.330.7492.665	http://dx.doi.org/10.1136/bmj.330.7492.665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15775002	Green Published			2022-12-28	WOS:000227861700035
J	Renzetti, CM				Renzetti, CM			Gender-based violence	LANCET			English	Editorial Material									St Josephs Univ, Dept Sociol, Philadelphia, PA 19131 USA	Saint Joseph's University	Renzetti, CM (corresponding author), St Josephs Univ, Dept Sociol, Philadelphia, PA 19131 USA.	crenzeti@sju.edu						Heyzer Noeline, 2004, WOMEN WAR PEACE MOBI; LACEY M, 2004, NY TIMES        1218, pA8; Lacey Marc, 2004, NY TIMES, pA1; *UN DEV FUND WOM, 2003, NOT MIN MOR 2003; *UN DEV FUND WOM, 2005, AB TRUSTF; *UN DEV FUND WOM, 2004, GROUPS REC GRANTS EN; Warren Mary Anne, 1985, GENDERCIDE IMPLICATI	7	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1009	1010						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781082				2022-12-28	WOS:000227731800007
J	MacFadden, BJ				MacFadden, BJ			Fossil horses - Evidence for evolution	SCIENCE			English	Editorial Material									Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	MacFadden, BJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	bmacfadd@flmnh.uft.edu						Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Kelly Thomas S., 1995, Contributions in Science (Los Angeles), V455, P1; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; Nowak R. M., 1997, WALKERS MAMMALS WORL; Oakenfull E. Ann, 2000, Conservation Genetics, V1, P341, DOI 10.1023/A:1011559200897; SCHUCHERT C, 1940, MARSH PIONEER PALEON; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764	10	86	91	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1728	1730		10.1126/science.1105458	http://dx.doi.org/10.1126/science.1105458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774746				2022-12-28	WOS:000227883900030
J	Duckitt, K; Harrington, D				Duckitt, K; Harrington, D			Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies	BRITISH MEDICAL JOURNAL			English	Article							HEALTHY NULLIPAROUS WOMEN; POPULATION-BASED COHORT; SEVERE PRE-ECLAMPSIA; ANTIPHOSPHOLIPID ANTIBODIES; HYPERTENSIVE DISORDERS; MATERNAL MORBIDITY; REMOTE PROGNOSIS; 2ND PREGNANCY; ASSOCIATIONS; METAANALYSIS	Objective To determine the risk of pre-eclampsia associated with factors that may be present at antenatal booking. Design Systematic review of controlled studies published 1966-2002. Data synthesis Unadjusted relative risks were calculated from published data. Results Controlled cohort studies showed that the risk of pre-eclampsia is increased in women with a previous history of pre-eclampsia (relative risk 7.19, 95% confidence interval 5.85 to 8.83) and in those with antiphospholipid antibodies (9.72,4.34 to 21.75), pre-existing diabetes (3.56, 2.54 to 4.99), multiple (twin) pregnancy (2.93, 2.04 to 4.2 1), nulliparity (2.9 1, 1.28 to 6.61), family history (2.90, 1.70 to 4.93), raised blood pressure (diastolic >= 80 min Hg) at booking (1.38, 1.01 to 1.87), raised body mass index before pregnancy (2.47, 1.66 to 3.67) or at booking (1.55, 1.28 to 1.88), or maternal age >= 40 (1.96, 1.34 to 2.87) for multiparous women. Individual studies show that risk is also increased with an interval of 10 years or more since a previous pregnancy, autoimmune disease, renal disease, and chronic hypertension. Conclusions These factors and the underlying evidence base can be used to assess risk at booking so that a suitable surveillance routine to detect pre-eclampsia can be planned for the rest of the pregnancy.	John Radcliffe Hosp, Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Duckitt, K (corresponding author), John Radcliffe Hosp, Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	Kduckitt@doctors.org.uk						[Anonymous], 2001, WHY MOTHERS DIE 1997; [Anonymous], 2001, 8 MAT CHILD HLTH RES; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; BANIAS BB, 1992, AM J PERINAT, V9, P357, DOI 10.1055/s-2007-999264; Basso O, 2001, EPIDEMIOLOGY, V12, P624, DOI 10.1097/00001648-200111000-00008; Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2; Bianco AT, 1998, OBSTET GYNECOL, V91, P97, DOI 10.1016/S0029-7844(97)00578-4; Bowers D, 1999, J Perinatol, V19, P216, DOI 10.1038/sj.jp.7200143; BRADFORD JA, 1989, AUST NZ J OBSTET GYN, V29, P1, DOI 10.1111/j.1479-828X.1989.tb02865.x; BRANCH DW, 1989, OBSTET GYNECOL, V73, P541; BROWN HL, 1991, SOUTHERN MED J, V84, P46, DOI 10.1097/00007611-199101000-00012; CAMPBELL DM, 1985, BRIT J OBSTET GYNAEC, V92, P131, DOI 10.1111/j.1471-0528.1985.tb01064.x; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; Chen C L, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P869; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; COONROD DV, 1995, OBSTET GYNECOL, V85, P645, DOI 10.1016/0029-7844(95)00049-W; DAVIES AM, 1970, ISRAEL J MED SCI, V6, P253; Dreyfus M, 2001, OBSTET GYNECOL, V97, P29, DOI 10.1016/S0029-7844(00)01099-1; Dukler D, 2001, EUR J OBSTET GYN R B, V96, P69, DOI 10.1016/S0301-2115(00)00392-4; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; Fields SJ, 1996, ANN HUM BIOL, V23, P353, DOI 10.1080/03014469600004602; GARNER PR, 1990, AM J OBSTET GYNECOL, V163, P505, DOI 10.1016/0002-9378(90)91184-E; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hartikainen AL, 1998, HYPERTENS PREGNANCY, V17, P31, DOI 10.3109/10641959809072236; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Khan KS, 1996, INT J GYNECOL OBSTET, V53, P111, DOI 10.1016/0020-7292(95)02634-7; KONJE JC, 1992, BRIT J OBSTET GYNAEC, V99, P969, DOI 10.1111/j.1471-0528.1992.tb13699.x; Lawoyin TO, 1996, E AFR MED J, V73, P404; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Makkonen N, 2000, HYPERTENS PREGNANCY, V19, P173, DOI 10.1081/PRG-100100133; MARTINELL J, 1990, BRIT MED J, V300, P840, DOI 10.1136/bmj.300.6728.840; Mattar F, 2000, AM J OBSTET GYNECOL, V182, P307, DOI 10.1016/S0002-9378(00)70216-X; Maxwell CV, 2001, AM J OBSTET GYNECOL, V185, P819, DOI 10.1067/mob.2001.117352; McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x; MILNE F, 2005, IN PRESS BMJ; MILNE F, 2002, BRIT MED J, V330, P576; MOORE MP, 1983, BRIT MED J, V287, P580, DOI 10.1136/bmj.287.6392.580; *NAT I CLIN EXC, 2003, NICE GUID CG6 ANT CA; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; PATTISON NS, 1993, BRIT J OBSTET GYNAEC, V100, P909, DOI 10.1111/j.1471-0528.1993.tb15105.x; REISS RE, 1987, AM J OBSTET GYNECOL, V156, P894, DOI 10.1016/0002-9378(87)90347-4; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; SANTEMA JG, 1995, EUR J OBSTET GYN R B, V58, P9, DOI 10.1016/0028-2243(94)01982-D; Sattar N, 2001, OBSTET GYNECOL, V97, P268, DOI 10.1016/S0029-7844(00)01136-4; Savvidou MD, 2001, ULTRASOUND OBST GYN, V18, P228, DOI 10.1046/j.0960-7692.2001.00470.x; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Skupski DW, 1996, AM J OBSTET GYNECOL, V175, P1029, DOI 10.1016/S0002-9378(96)80047-0; SLETNES KE, 1992, ACTA OBSTET GYN SCAN, V71, P112, DOI 10.3109/00016349209007966; Stamilio DM, 2000, AM J OBSTET GYNECOL, V182, P589, DOI 10.1067/mob.2000.103890; STONE JL, 1994, OBSTET GYNECOL, V83, P357; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Thadhani R, 1999, OBSTET GYNECOL, V94, P543, DOI 10.1016/S0029-7844(99)00400-7; van Hoorn J, 2002, AUST NZ J OBSTET GYN, V42, P29; VASUDA M, 1995, OBSTET GYNECOL, V86, P555	63	1035	1095	4	53	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2005	330	7491					565	567		10.1136/bmj.38380.674340.E0	http://dx.doi.org/10.1136/bmj.38380.674340.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15743856	Green Published, Bronze			2022-12-28	WOS:000227622300015
J	Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ				Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ			RAS is regulated by the let-7 MicroRNA family	CELL			English	Article							C-ELEGANS; PATTERN-FORMATION; CELL FATES; SMALL RNAS; GENE; ENCODES; VULVAR; IDENTIFICATION; ACTIVATION; INHIBITION	MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including humans, where they are implicated in cancer. The let-7 miRNA times seam cell terminal differentiation in C. elegans. Here we show that the let-7 family negatively regulates let-60/RAS. Loss of let-60/RAS suppresses let-7, and the let-60/RAS 3'UTR contains multiple let-7 complementary sites (LCSs), restricting reporter gene expression in a let-7-dependent manner. mir-84, a let-7 family member, is largely absent in vulval precursor cell P6.p at the time that let-60/RAS specifies the 1 degrees vulval fate in that cell, and mir-84 overexpression suppresses the multivulva phenotype of activating let-60/ RAS mutations. The 3'UTRs of the human RAS genes contain multiple LCSs, allowing let-7 to regulate RAS expression. let-7 expression is lower in lung tumors than in normal lung tissue, while RAS protein is significantly higher in lung tumors, providing a possible mechanism for let-7 in cancer.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Ambion Inc, Austin, TX 78744 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Grosshans, Helge/W-8931-2019; Vickers, Michael M/E-4095-2010; Johnson, Steven M/B-3940-2013; Jackson, Benjamin L/C-4297-2012; Ferrua, Camila/F-5439-2015	Grosshans, Helge/0000-0002-8169-6905; Ferrua, Camila/0000-0001-8071-377X; Slack, Frank/0000-0001-8263-0409; Labourier, Emmanuel/0000-0001-8010-0674; Johnson, Steven/0000-0002-7399-8153	NIGMS NIH HHS [R01 GM062594, GM62594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Ambros V, 1999, DEVELOPMENT, V126, P1947; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dent JA, 1998, MECH DEVELOP, V72, P179, DOI 10.1016/S0925-4773(98)00026-4; Eisenmann DM, 1997, GENETICS, V146, P553; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; HAN M, 1990, GENETICS, V126, P899; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MCKAY IA, 1986, EMBO J, V5, P2617, DOI 10.1002/j.1460-2075.1986.tb04542.x; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michael MZ, 2003, MOL CANCER RES, V1, P882; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	56	2818	3146	7	296	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					635	647		10.1016/j.cell.2005.01.014	http://dx.doi.org/10.1016/j.cell.2005.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766527	Bronze			2022-12-28	WOS:000227771400010
J	Garne, D; Watson, M; Chapman, S; Byrne, F				Garne, D; Watson, M; Chapman, S; Byrne, F			Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry	LANCET			English	Article							SECONDHAND SMOKE; 2ND-HAND SMOKE; DOCUMENTS; RISK	In the late 1980s, the international tobacco industry assisted in the establishment of the International Society of the Built Environment, which published the journal Indoor and Built Environment. Using evidence from tobacco industry documents, we examine the industry associations of the Society's executive, the journal's editor and board, and the extent to which the journal publishes papers on environmental tobacco smoke that would be deemed favourable by the tobacco industry. The society's executive has been dominated by paid consultants to the tobacco industry: all six members in 1992 and seven of eight members in 2002 had financial associations through industry lawyers. 67% of the editorial board in 1992 and 66% in 2002 had histories of financial associations with the tobacco industry. 61% (40/66) of papers related to environmental tobacco smoke published in Indoor and Built Environment in the study period reached conclusions that could be judged to be industry-positive. Of these, 90% (36/40) had at least one author with a history of association with the tobacco industry. The executive of the International Society of the Built Environment and the editorial board of Indoor and Built Environment are in large part consisted of people with histories of consultancies to the tobacco industry. On the basis of the evidence presented in this paper, there is a serious concern the tobacco industry may have been unduly influential on the content of the journal.	Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simonchapman@health.usyd.edu.au	Chapman, Simon/D-4114-2009		NATIONAL CANCER INSTITUTE [R01CA087110] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA87110-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguinaga Bialous S., 2002, PROFITS PEOPLE TOBAC; Assunta M, 2004, Tob Control, V13 Suppl 2, pii4, DOI 10.1136/tc.2003.005199; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BRIGGS D, 1987, TI M WASH MARCH 18 1; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P769; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; Glantz S.A., 1996, CIGARETTE PAPERS; GREEN C, 1987, JOINT TAC VDC JTI TI; GREEN C, COMMUNICATION   0406; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Hirschhorn N, 2001, TOB CONTROL, V10, P375, DOI 10.1136/tc.10.4.375; Hong MK, 2002, BRIT MED J, V325, P1413, DOI 10.1136/bmj.325.7377.1413; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; Lee K, 2004, ADDICTION, V99, P394, DOI 10.1111/j.1360-0443.2004.00718.x; Liberman J, 2002, TOB CONTROL, V11, P271, DOI 10.1136/tc.11.3.271; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; *SAG PUBL, IND BUILT ENV	23	28	29	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					804	809		10.1016/S0140-6736(05)17990-2	http://dx.doi.org/10.1016/S0140-6736(05)17990-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733724				2022-12-28	WOS:000227285300030
J	Frankenberg, C; Meirink, JF; van Weele, M; Platt, U; Wagner, T				Frankenberg, C; Meirink, JF; van Weele, M; Platt, U; Wagner, T			Assessing methane emissions from global space-borne observations	SCIENCE			English	Article							TRACE GASES; CO2; SCIAMACHY; RETRIEVAL; BIOMASS; COLUMN; MODEL; CH4	In the past two centuries, atmospheric methane has more than doubled and now constitutes 20% of the anthropogenic climate forcing by greenhouse gases. Yet its sources are not well quantified, introducing uncertainties in its global budget. We retrieved the global methane distribution by using space-borne near-infrared absorption spectroscopy. In addition to the expected latitudinal gradient, we detected large-scale patterns of anthropogenic and natural methane emissions. Furthermore, we observed unexpectedly high methane concentrations over tropical rainforests, revealing that emission inventories considerably underestimated methane sources in these regions during the time period of investigation (August through November 2003).	Heidelberg Univ, Inst Environm Phys, D-69120 Heidelberg, Germany; Royal Netherlands Meteorol Inst, Sect Atmospher Composit, NL-3730 AE De Bilt, Netherlands	Ruprecht Karls University Heidelberg; Royal Netherlands Meteorological Institute	Frankenberg, C (corresponding author), Heidelberg Univ, Inst Environm Phys, INF 229, D-69120 Heidelberg, Germany.		Frankenberg, Christian/A-2944-2013	Frankenberg, Christian/0000-0002-0546-5857				Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Buchwitz M, 2000, J GEOPHYS RES-ATMOS, V105, P15231, DOI 10.1029/2000JD900191; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Clerbaux C, 2003, ATMOS CHEM PHYS, V3, P1495, DOI 10.5194/acp-3-1495-2003; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Dentener F, 2003, ATMOS CHEM PHYS, V3, P73, DOI 10.5194/acp-3-73-2003; DEVOL AH, 1990, J GEOPHYS RES-ATMOS, V95, P16417, DOI 10.1029/JD095iD10p16417; Frankenberg C, 2005, ATMOS CHEM PHYS, V5, P9, DOI 10.5194/acp-5-9-2005; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Hein R., 1997, CYCLES, V11, P43; Houghton J. T., 2001, CLIMATE CHANGE 2001; Houweling S, 1999, J GEOPHYS RES-ATMOS, V104, P26137, DOI 10.1029/1999JD900428; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P8981, DOI 10.1029/1999JD901149; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; MORRISSEY LA, 1992, J GEOPHYS RES-ATMOS, V97, P16661, DOI 10.1029/92JD00063; O'Brien DM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000617; Olivier J. G. J., 2001, CLIMATE SYSTEM, P33; Olsen SC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003968; PLATT U, 1994, DIFFERENTIAL OPTICAL; Sanderson MG, 1996, GLOBAL BIOGEOCHEM CY, V10, P543, DOI 10.1029/96GB01893; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; WAGNER T, 2002, MONITORING TRACE GAS, V10; Walter BP, 2000, GLOBAL BIOGEOCHEM CY, V14, P745, DOI 10.1029/1999GB001204	25	285	315	8	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1010	1014		10.1126/science.1106644	http://dx.doi.org/10.1126/science.1106644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15774724				2022-12-28	WOS:000229190700043
J	Dunavan, CP				Dunavan, CP			Jambo, Jahi	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												cpanosian@mednet.ucla.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1430	1431						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784849				2022-12-28	WOS:000227784700001
J	Villeneuve, DM				Villeneuve, DM			Toward creating a Rutherford atom	SCIENCE			English	Editorial Material									Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Villeneuve, DM (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	david.villeneuve@nrc.ca	Villeneuve, David M/I-4140-2012	Villeneuve, David M/0000-0002-2810-3648				Ahn J, 2001, PHYS REV LETT, V86, P1179, DOI 10.1103/PhysRevLett.86.1179; Fischer M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230802; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Gallagher T. F., 1994, RYDBERG ATOMS; Maeda H, 2005, SCIENCE, V307, P1757, DOI 10.1126/science.1108470; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; Robinson MP, 2000, PHYS REV LETT, V85, P4466, DOI 10.1103/PhysRevLett.85.4466	7	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1730	1731		10.1126/science.1110367	http://dx.doi.org/10.1126/science.1110367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774747				2022-12-28	WOS:000227883900031
J	Darmstadt, GL; Bhutta, ZA; Cousens, S; Adam, T; Walker, N; de Bernis, L				Darmstadt, GL; Bhutta, ZA; Cousens, S; Adam, T; Walker, N; de Bernis, L		Neonatal Survival Steering Team	Evidence-based, cost-effective interventions: how many newborn babies can we save?	LANCET			English	Review							NEONATAL-MORTALITY; HEALTH-SYSTEMS; CHILD HEALTH; MANAGEMENT	In this second article of the neonatal survival series, we identify 16 interventions with proven efficacy (implementation under ideal conditions) for neonatal survival and combine them into packages for scaling up in health systems, according to three service delivery modes (outreach, family-community, and facility-based clinical care). All the packages of care are cost effective compared with single interventions. Universal (99%) coverage of these interventions could avert an estimated 41-72% of neonatal deaths worldwide. At 90% coverage, intrapartum and postnatal packages have similar effects on neonatal mortality-two-fold to three-fold greater than that of antenatal care. However, running costs are two-fold higher for intrapartum than for postnatal care. A combination of universal-ie, for all settings-outreach and family-community care at 90% coverage averts 18-37% of neonatal deaths. Most of this benefit is derived from family-community care, and greater effect is seen in settings with very high neonatal mortality. Reductions in neonatal mortality that exceed 50% can be achieved with an integrated, high-coverage programme of universal outreach and family-community care, consisting of 12% and 26%, respectively, of total running costs, plus universal facility-based clinical services, which make up 62% of the total cost. Early success in averting neonatal deaths is possible in settings with high mortality and weak health systems through outreach and family-community care, including health education to improve home-care practices, to create demand for skilled care, and to improve care seeking. Simultaneous expansion of clinical care for babies and mothers is essential to achieve the reduction in neonatal deaths needed to meet the Millennium Development Goal for child survival.	Aga Khan Univ, Dept Pediat & Child Hlth, Karachi 74800, Pakistan; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Save Children USA, Washington, DC USA; London Sch Hyg & Trop Med, London WC1, England; WHO, Dept Hlth Syst Financing Expenditure & Resource A, CH-1211 Geneva, Switzerland; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; UNICEF, New York, NY USA	Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; World Health Organization; UNICEF	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Darmstadt, Gary/AAU-7488-2020					Adam T, 2003, INT J TECHNOL ASSESS, V19, P407, DOI 10.1017/S0266462303000369; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Baltussen RM., 2003, MAKING CHOICES HLTH; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BHUTTA Z, 2004, GLOBAL FORUM UPDATE, P107; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, ARCH DIS CHILD, V89, P483, DOI 10.1136/adc.2003.045732; Bhutta ZA, 2004, MATERNAL CHILD HLTH, V1st; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; DRUMMOND M, 1997, COST EFFECTIVENESS H; Edejer T, 2003, MAKING CHOICES HLTH; FULLERTON J, 2003, COMMUNITY PARTNERSHI; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; HOWARDGRABMAN L, 2002, WARMI PROJECT PARTIC; JOHNS B, 2004, COST EFF RESOUR ALLO, V1, P1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KNIPPENBERG R, 2005, SYSTEMATIC SCALING N; Lawn J., 2005, 4 MILLION NEONATAL D; LAWN J, 2005, DIS CONTROL PRIORITI; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lawn JE, 2005, ESTIMATING CAUSES 4; Macfarlane A, 1999, TUBERCULOSIS NONTUBE, P3; Management Sciences for Health, 2004, INT DRUG PRIC IND GU; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MARTINES J, 2005, NEONATAL SURVIVAL CA; MCKEOWN T, 1975, POP STUD-J DEMOG, V29, P391, DOI 10.2307/2173935; Mulligan J, 2003, 9 DCPP; *SAV CHILDR US, 2002, SAV NEWB LIV BIRTH A; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SEIMS L, 2004, AM PUBL HLTH ASS 132; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNICEF, 2004, CHILD INF PROJ; *UNICEF, 2005, UNICEF SUPPL DIV CAT; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; *WHO, 2004, CHOOS INT ARE COST E; WHO, 2002, REP COMM MACR HLTH; World Bank, 2004, WORLD DEV REP 2004 M; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	42	1014	1031	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					977	988		10.1016/S0140-6736(05)71088-6	http://dx.doi.org/10.1016/S0140-6736(05)71088-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767001				2022-12-28	WOS:000227559800032
J	Ham, C				Ham, C			US and UK health care: a special relationship? Money can't buy you satisfaction	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; KAISER-PERMANENTE; NHS	Organisational differences between the US and UK healthcare systems mean that ideas have to be adapted through learning partnerships rather than simply copied.	Univ Birmingham, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Ham, C (corresponding author), Univ Birmingham, Birmingham B15 2RT, W Midlands, England.	cj.ham@bham.ac.uk						Blendon RJ, 2002, HEALTH AFFAIR, V21, P182, DOI 10.1377/hlthaff.21.3.182; Enthoven A.C., 1985, REFLECTIONS MANAGEME; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Ham C, 2003, BRIT MED J, V327, P1257, DOI 10.1136/bmj.327.7426.1257; Hussey PS, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.3.89; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Klein R, 1997, J HEALTH POLIT POLIC, V22, P1267, DOI 10.1215/03616878-22-5-1267; KLEIN R, 1991, MILBANK Q, V69, P275, DOI 10.2307/3350205; LEATHERMAN S, 2003, QUEST QUALITY NHS; Levit K, 2004, HEALTH AFFAIR, V23, P147, DOI 10.1377/hlthaff.23.1.147; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; OECD, 2004, HIGH PERF HLTH SYST; *OECD, 2003, HLTH GLANC; Robinson JC, 2001, JAMA-J AM MED ASSOC, V285, P2622, DOI 10.1001/jama.285.20.2622; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; SCHOEN C, 2004, HLTH AFF MILLWO 1028; Starfield B, 2002, HEALTH POLICY, V60, P201, DOI 10.1016/S0168-8510(01)00208-1; World Health Organization, 2000, WORLD HLTH REP 2000	20	14	14	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2005	330	7491					597	599		10.1136/bmj.330.7491.597	http://dx.doi.org/10.1136/bmj.330.7491.597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15761003	Green Published			2022-12-28	WOS:000227622300027
J	Kucher, N; Koo, S; Quiroz, R; Cooper, JM; Paterno, MD; Soukonnikov, B; Goldhaber, SZ				Kucher, N; Koo, S; Quiroz, R; Cooper, JM; Paterno, MD; Soukonnikov, B; Goldhaber, SZ			Electronic alerts to prevent venous thromboembolism among hospitalized patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY ANGIOGRAPHY; PROSPECTIVE REGISTRY; CLINICAL-PRACTICE; CONTROLLED-TRIAL; PROPHYLAXIS; THROMBOSIS; CARE; GUIDELINES; DIAGNOSIS; EMBOLISM	BACKGROUND: Prophylaxis against deep-vein thrombosis in hospitalized patients remains underused. We hypothesized that the use of a computer-alert program to encourage prophylaxis might reduce the frequency of deep-vein thrombosis among high-risk hospitalized patients. METHODS: We developed a computer program linked to the patient database to identify consecutive hospitalized patients at risk for deep-vein thrombosis in the absence of prophylaxis. The program used medical-record numbers to randomly assign 1255 eligible patients to an intervention group, in which the responsible physician was alerted to a patient's risk of deep-vein thrombosis, and 1251 patients to a control group, in which no alert was issued. The physician was required to acknowledge the alert and could then withhold or order prophylaxis, including graduated compression stockings, pneumatic compression boots, unfractionated heparin, low-molecular-weight heparin, or warfarin. The primary end point was clinically diagnosed, objectively confirmed deep-vein thrombosis or pulmonary embolism at 90 days. RESULTS: More patients in the intervention group than in the control group received mechanical prophylaxis (10.0 percent vs. 1.5 percent, P<0.001) or pharmacologic prophylaxis (23.6 percent vs. 13.0 percent, P<0.001). The primary end point occurred in 61 patients (4.9 percent) in the intervention group, as compared with 103 (8.2 percent) in the control group; the Kaplan-Meier estimates of the likelihood of freedom from deep-vein thrombosis or pulmonary embolism at 90 days were 94.1 percent (95 percent confidence interval, 92.5 to 95.4 percent) and 90.6 percent (95 percent confidence interval, 88.7 to 92.2 percent), respectively (P<0.001). The computer alert reduced the risk of deep-vein thrombosis or pulmonary embolism at 90 days by 41 percent (hazard ratio, 0.59; 95 percent confidence interval, 0.43 to 0.81; P=0.001). CONCLUSIONS: The institution of a computer-alert program increased physicians' use of prophylaxis and markedly reduced the rates of deep-vein thrombosis and pulmonary embolism among hospitalized patients at risk.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Cardiovasc, Boston, MA USA; Univ Penn, Med Ctr, Dept Med, Philadelphia, PA 19104 USA; Partners Healthcare Syst, Wellesley, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Partners Healthcare System	Goldhaber, SZ (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	sgoldhaber@partners.org		Koo, Sophia/0000-0002-4973-7439				Ageno W, 2002, HAEMATOLOGICA, V87, P746; Alikhan R, 2001, BLOOD, V98, p271A; ANDERSON FA, 1994, ARCH INTERN MED, V154, P669, DOI 10.1001/archinte.154.6.669; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; BECKER DM, 1989, ARCH INTERN MED, V149, P1731, DOI 10.1001/archinte.149.8.1731; Bergmann JF, 1996, LANCET, V348, P205, DOI 10.1016/S0140-6736(05)66160-0; Berwick DM, 2003, NEW ENGL J MED, V348, P2570, DOI 10.1056/NEJMe030044; Bobb A, 2004, ARCH INTERN MED, V164, P785, DOI 10.1001/archinte.164.7.785; COHEN AT, 2003, J THROMB HAEMOST S1, V1, P2040; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; Gardlund B, 1996, LANCET, V347, P1357; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; HIRSCH DR, 1995, JAMA-J AM MED ASSOC, V274, P335, DOI 10.1001/jama.274.4.335; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Joffe HV, 2004, CIRCULATION, V110, P1605, DOI 10.1161/01.CIR.0000142289.94369.D7; KEANE MG, 1994, CHEST, V106, P13, DOI 10.1378/chest.106.1.13; Kucher N, 2004, AM J CARDIOL, V94, P403, DOI 10.1016/j.amjcard.2004.04.050; Kuperman GJ, 2003, ANN INTERN MED, V139, P31, DOI 10.7326/0003-4819-139-1-200307010-00010; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Nicolaides AN, 2001, INT ANGIOL, V20, P1; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	29	676	714	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					969	977		10.1056/NEJMoa041533	http://dx.doi.org/10.1056/NEJMoa041533			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758007				2022-12-28	WOS:000227491200005
J	Ashcroft, DM; Dimmock, P; Garside, R; Stein, K; Williams, HC				Ashcroft, DM; Dimmock, P; Garside, R; Stein, K; Williams, HC			Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM MANAGEMENT; QUALITY-OF-LIFE; ADULT PATIENTS; SDZ ASM-981; HYDROCORTISONE ACETATE; CREAM 1-PERCENT; CLINICAL-TRIALS; OINTMENT; SAFETY; CHILDREN	Objective To determine the efficacy and tolerability of topical pimecrolimus and tacrolimus compared with other treatments for atopic dermatitis. Design Systematic review and meta-analysis. Data sources Electronic searches of Cochrane Library, Medline, and Embase. Study selection Randomised controlled trials of topical pimecrolimus or tacrolimus reporting efficacy outcomes or tolerability. Data extraction Efficacy: investigators' global assessment of response; patients' global assessment of response; proportions of patients with flares of atopic dermatitis; and improvements in quality of life. Tolerability: overall rates of withdrawal, withdrawal due to adverse events, and the proportions of patients with burning of the skin and skin infections. Data synthesis 4186 of 6897 participants in 25 randomised controlled trials received pimecrolimus or tacrolimus. Both drugs were significantly more effective than a vehicle control. Tacrolimus 0.1% was as effective as potent topical corticosteroids at three weeks and more effective than combined treatment with hydrocortisone butyrate 0.1% (potent used on trunk) plus hydrocortisone acetate 1% (weak used on face) at 12 weeks (number needed to treat (NNT) = 6). Tacrolimus 0.1% was also more effective than hydrocortis one acetate 1% (NNT = 4). In comparison, tacrolimus 0.03% was more effective than hydrocortisone acetate 1% (NNT = 5) but less effective than hydrocortisone butyrate 0.1% (NNT = - 8). Direct comparisons of tacrolimus 0.03% and tacrolimus 0.1% consistently favoured the higher strength formulation, but efficacy differed significantly between the two strengths only after 12 weeks' treatment (rate ratio 0.80, 95% confidence interval 0.65 to 0.99). Pimecrolinius was far less effective than betamethasone valerate 0.1% (NNT = - 3 at three weeks). Pimecrolimus and tacrolimus caused significantly more skin burning than topical corticosteroids. Rates of skin infections in an), of the comparisons did not differ. Conclusions Both topical pimecrolimus and topical tacrolimus are more effective than placebo treatments for atopic dermatitis, but in the absence of studies that show long term safety gains, any advantage over topical corticosteroids is unclear. Topical tacrolimus is similar to potent topical corticosteroids and may have a place for long term use in patients with resistant atopic dermatitis on sites where side effects from topical corticosteroids might develop quickly. In the absence of key comparisons with mild corticosteroids. the clinical need for topical pimecrolimus is unclear. The usefulness of either treatment in patients who have failed to respond adequately to topical corticosteroids is also unclear.	Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England; Univ Exeter, Peninsula Technol Assessment Grp, Exeter EX4 4QJ, Devon, England; Univ Plymouth, Peninsula Technol Assessment Grp, Plymouth, Devon, England; Univ Nottingham, Dept Dermatol, Nottingham NG7 2RD, England	University of Manchester; University of Exeter; University of Plymouth; University of Nottingham	Ashcroft, DM (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England.	darren.ashcroft@manchester.ac.uk	Ashcroft, Darren M/G-3244-2015	Ashcroft, Darren M/0000-0002-2958-915X; williams, hywel/0000-0002-5646-3093; Garside, Ruth/0000-0003-1649-4773				BARBA JF, 2003, J EUR ACAD DERMATOL, V17; Beattie PE, 2003, CLIN EXP DERMATOL, V28, P549, DOI 10.1046/j.1365-2230.2003.01357.x; Boguniewicz M, 1998, J ALLERGY CLIN IMMUN, V102, P637, DOI 10.1016/S0091-6749(98)70281-7; Charman C, 2000, ARCH DERMATOL, V136, P763, DOI 10.1001/archderm.136.6.763; Charman C, 2003, J INVEST DERMATOL, V120, P932, DOI 10.1046/j.1523-1747.2003.12251.x; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drake L, 2001, J AM ACAD DERMATOL, V44, pS65, DOI 10.1067/mjd.2001.109814; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Emerson RM, 2001, BRIT J DERMATOL, V144, P514, DOI 10.1046/j.1365-2133.2001.04077.x; *FK506 OINTM STUD, 1997, NISHINIHON J DERMATO, V59, P870; Hanifin J, 1998, J INVEST DERMATOL, V110, P680; Hanifin JM, 2001, J AM ACAD DERMATOL, V44, pS28, DOI 10.1067/mjd.2001.109810; HERD RM, 2000, ATOPIC DERMATITIS; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho VC, 2003, J PEDIATR-US, V142, P155, DOI 10.1067/mpd.2003.65; Iskedjian M, 2004, AM J CLIN DERMATOL, V5, P267, DOI 10.2165/00128071-200405040-00006; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kang S, 1998, J INVEST DERMATOL, V110, P681; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; KEMPERS S, 2003, J EUR ACAD DERMATOL, V17, pP2; Kiebert G, 2002, INT J DERMATOL, V41, P151, DOI 10.1046/j.1365-4362.2002.01436.x; Kyllonen H, 2004, BRIT J DERMATOL, V150, P1174, DOI 10.1111/j.1365-2133.2004.06017.x; Lewis-Jones MS, 2001, BRIT J DERMATOL, V144, P104, DOI 10.1046/j.1365-2133.2001.03960.x; LING M, 2002, J EUR ACAD DERMATOL, V16, pP2; Luger T, 2001, BRIT J DERMATOL, V144, P788, DOI 10.1046/j.1365-2133.2001.04134.x; Luger T A, 2004, J Dermatolog Treat, V15, P169; Meurer M, 2002, DERMATOLOGY, V205, P271, DOI 10.1159/000065863; Nakagawa H, 1998, J INVEST DERMATOL, V110, P683; *NAT I CLIN EXC, 2004, TECHN APPR GUID 82 T; Pacor ML, 2004, CLIN EXP ALLERGY, V34, P639, DOI 10.1111/j.1365-2222.2004.1907.x; Paller A, 2001, J AM ACAD DERMATOL, V44, pS47, DOI 10.1067/mjd.2001.109813; Queille-Roussel C, 2001, BRIT J DERMATOL, V144, P507, DOI 10.1046/j.1365-2133.2001.04076.x; Reitamo S, 2004, BRIT J DERMATOL, V150, P554, DOI 10.1046/j.1365-2133.2004.05782.x; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P547, DOI 10.1067/mai.2002.121832; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P539, DOI 10.1067/mai.2002.121831; REITAMO S, 2003, J EUR ACAD DERMATOL, V17, P20; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; Wahn U, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e2; Whalley D, 2002, PEDIATRICS, V110, P1133, DOI 10.1542/peds.110.6.1133; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Williams H, 2002, BRIT MED J, V324, P1533, DOI 10.1136/bmj.324.7353.1533	43	169	185	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					516	522		10.1136/bmj.38376.439653.D3	http://dx.doi.org/10.1136/bmj.38376.439653.D3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15731121	Green Published, Bronze			2022-12-28	WOS:000227581400019
J	Bridgewater, B				Bridgewater, B		Adult Cardiac Surgeons NW England	Mortality data in adult cardiac surgery for named surgeons: retrospective examination of prospectively collected data on coronary artery surgery and aortic valve replacement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEW-YORK; PERFORMANCE; EUROSCORE	Objectives To present named surgeon mortality for isolated first time coronary artery surgery and aortic valve surgery. Design Retrospective analysis of prospectively collected data. Setting All NHS hospitals undertaking adult cardiac surgery in north west England. Participants 25 consultant surgeons carrying out coronary artery surgery and aortic valve replacement between April 2001 and March 2004. Main outcome measures Mortality for both operations according to surgeon. EuroSCORE to stratify patients into low and high risk. Results 10 163 patients underwent surgery under 25 surgeons. The average number of patients per surgeon was 363 for coronary artery surgery and 44 for aortic valve replacement. Seventeen per cent of the patients undergoing coronary artery surgery and half of those undergoing aortic valve surgery were considered high risk. The average mortality was 1.8% (range 0-3.8%) for coronary surgery and 1.9% (0-12.5%) for aortic valve surgery. Mortality for all surgeons fell below 99% control limits of the national mean for both operations. Conclusions The presented mortality figures for the two cardiac operations fell within accepted limits for all surgeons. The division of outcomes according to low and high risk patients is imperfect but may help to inform the public about the complexities of this type of analysis and prevent surgeons avoiding high risk patents who may benefit from an operation.	Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Bridgewater, B (corresponding author), Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	ben.bridgewater@smuht.nwest.nhs.uk		Grayson, Antony/0000-0003-2940-0828				[Anonymous], LEARNING BRISTOL REP; Blackstone EH, 2004, J THORAC CARDIOV SUR, V128, P807, DOI 10.1016/j.jtcvs.2004.03.022; Bridgewater B, 2003, BMJ-BRIT MED J, V327, P13, DOI 10.1136/bmj.327.7405.13; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Chassin MR, 1996, NEW ENGL J MED, V335, P1060, DOI 10.1056/NEJM199610033351413; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Hannan EL, 1997, MED CARE, V35, P49, DOI 10.1097/00005650-199701000-00004; Keogh B, 2004, BMJ-BRIT MED J, V329, P450, DOI 10.1136/bmj.329.7463.450; Keogh B, 2004, 5 NATL ADULT CARDIAC; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; *SHIP INQ, 5 SHIPM INQ; Stark J, 2000, LANCET, V355, P1004, DOI 10.1016/S0140-6736(00)90001-1; NW QUALITY IMPROVEME	14	53	53	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					506	510		10.1136/bmj.330.7490.506	http://dx.doi.org/10.1136/bmj.330.7490.506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746131	Bronze, Green Published			2022-12-28	WOS:000227581400016
J	Costello, A; Osrin, D				Costello, A; Osrin, D			Epidemiological transition, medicalisation of childbirth, and neonatal mortality: three Brazilian birth-cohorts	LANCET			English	Editorial Material							TRIAL; NEPAL; WOMEN		UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England	University of London; University College London	Costello, A (corresponding author), UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk		Osrin, David/0000-0001-9691-9684				Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; Carrette L, 2001, FUEL CELLS, V1, P5, DOI 10.1002/1615-6854(200105)1:1<5::AID-FUCE5>3.0.CO;2-G; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Silverman WA, 2002, PAEDIATR PERINAT EP, V16, P98, DOI 10.1046/j.1365-3016.2002.00400.x; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	10	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					825	826		10.1016/S0140-6736(05)71017-5	http://dx.doi.org/10.1016/S0140-6736(05)71017-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752510				2022-12-28	WOS:000227444600005
J	Hyman, SD; Lazio, JW; Kassim, NE; Ray, PS; Markwardt, CB; Yusef-Zadeh, F				Hyman, SD; Lazio, JW; Kassim, NE; Ray, PS; Markwardt, CB; Yusef-Zadeh, F			A powerful bursting radio source towards the Galactic Centre	NATURE			English	Article							EMISSION; TRANSIENTS; SPECTRA; SEARCH; DWARFS	Transient astronomical sources are typically powered by compact objects and usually signify highly explosive or dynamic events(1). Although high-time-resolution observations are often possible in radio astronomy(2), they are usually limited to quite narrow fields of view. The dynamic radio sky is therefore poorly sampled, in contrast to the situation in the X-ray and gamma-ray bands in which wide-field instruments routinely detect transient sources(3). Here we report a transient radio source, GCRT J1745 - 3009, which was detected during a moderately wide-field monitoring programme of the Galactic Centre region(4,5) at 0.33 GHz. The characteristics of its bursts are unlike those known for any other class of radio transient. If located in or near the Galactic Centre, its brightness temperature (, 10 16 K) and the implied energy density within GCRT J1745 - 3009 vastly exceed those observed in most other classes of radio astronomical sources(6), and are consistent with coherent emission processes(7) that are rarely observed. We conclude that it represents a hitherto unknown class of transient radio sources, the first of possibly many new classes that may be discovered by emerging wide-field radio telescopes(8).	Sweet Briar Coll, Dept Phys & Engn, Sweet Briar, VA 24595 USA; USN, EO Hulburt Ctr Space Res, Res Lab, Washington, DC 20375 USA; NASA, High Energy Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Northwestern University	Hyman, SD (corresponding author), Sweet Briar Coll, Dept Phys & Engn, Sweet Briar, VA 24595 USA.	shyman@sbc.edu		Ray, Paul/0000-0002-5297-5278				BASTIAN TS, 1990, ASTROPHYS J, V353, P265, DOI 10.1086/168613; Bastian TS, 2000, ASTROPHYS J, V545, P1058, DOI 10.1086/317864; Berger E, 2002, ASTROPHYS J, V572, P503, DOI 10.1086/340301; Berger E, 2001, NATURE, V410, P338, DOI 10.1038/35066514; Bradt H, 2001, AIP CONF PROC, V599, P35, DOI 10.1063/1.1434617; BRUGGMANN G, 1990, ASTRON ASTROPHYS, V239, P347; Burgasser AJ, 2002, ASTROPHYS J, V564, P421, DOI 10.1086/324033; CORDES JM, 2004, DYNAMIC RADIO SKY; Cutri R. M., 2003, 2MASS ALL SKY CATALO; DULK GA, 1982, ASTROPHYS J, V259, P350, DOI 10.1086/160171; Farrell WM, 1999, J GEOPHYS RES-PLANET, V104, P14025, DOI 10.1029/1998JE900050; Fender RP, 1999, MON NOT R ASTRON SOC, V304, P865, DOI 10.1046/j.1365-8711.1999.02364.x; GRAY AD, 1991, NATURE, V353, P237, DOI 10.1038/353237a0; Gudel M, 2002, ANNU REV ASTRON ASTR, V40, P217, DOI 10.1146/annurev.astro.40.060401.093806; Hankins TH, 2003, NATURE, V422, P141, DOI 10.1038/nature01477; Hyman SD, 2003, ASTRON NACHR, V324, P79, DOI 10.1002/asna.200385028; Hyman SD, 2002, ASTRON J, V123, P1497, DOI 10.1086/338905; Joseph T, 2004, ASTROPHYS J, V612, P511, DOI 10.1086/422449; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Marscher AP, 2002, NATURE, V417, P625, DOI 10.1038/nature00772; Melrose DB, 2002, PUBL ASTRON SOC AUST, V19, P34, DOI 10.1071/AS01111; *NAV RES LAB, 2004, LONG WAV ARR; Nord ME, 2004, ASTRON J, V128, P1646, DOI 10.1086/424001; PUTMAN ME, 2003, B AM ASTRON SOC, V35; READHEAD ACS, 1994, ASTROPHYS J, V426, P51, DOI 10.1086/174038; Reich W., 1984, Astronomy & Astrophysics Supplement Series, V57, P165; WOODS PM, IN PRESS COMPACT STE; YUSEFZADEH F, 1987, NATURE, V330, P455, DOI 10.1038/330455a0; ZHAO JH, 1992, SCIENCE, V255, P1538, DOI 10.1126/science.255.5051.1538	30	109	111	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					50	52		10.1038/nature03400	http://dx.doi.org/10.1038/nature03400			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744294				2022-12-28	WOS:000227334600038
J	Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP				Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP			CD4(+) T-cell help controls CD8(+) T-cell memory via TRAIL-mediated activation-induced cell death	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; CD8-T-CELL MEMORY; CD4-T-CELL HELP; ACUTE INFECTION; LIGAND TRAIL; FAS-LIGAND; APOPTOSIS; EXPRESSION; RECEPTOR; FAMILY	The 'help' provided by CD4(+) T lymphocytes during the priming of CD8(+) T lymphocytes confers a key feature of immune memory: the capacity for autonomous secondary expansion following re-encounter with antigen(1-4). Once primed in the presence of CD4(+) T cells, 'helped' CD8(+) T cells acquire the ability to undergo a second round of clonal expansion upon restimulation in the absence of T-cell help. 'Helpless' CD8(+) T cells that are primed in the absence of CD4(+) T cells, in contrast, can mediate effector functions such as cytotoxicity and cytokine secretion upon restimulation, but do not undergo a second round of clonal expansion. These disparate responses have features of being 'programmed', that is, guided by signals that are transmitted to naive CD8(+) T cells during priming, which encode specific fates for their clonal progeny. Here we explore the instructional programme that governs the secondary response of CD8(+) T cells and find that helpless cells undergo death by activation-induced cell death upon secondary stimulation. This death is mediated by tumour-necrosis factor (TNF)- related apoptosis-inducing ligand ( TRAIL). Regulation of Trail expression can therefore account for the role of CD4(+) T cells in the generation of CD8(+) T cell memory and represents a novel mechanism for controlling adaptive immune responses.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Iowa, Dept Urol, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	La Jolla Institute for Immunology; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org; sps@liai.org	Griffith, Thomas/ABF-8225-2020; Droin, Nathalie M/Y-5506-2018; Green, Douglas R/N-8083-2018	Droin, Nathalie M/0000-0002-6099-5324; Green, Douglas R/0000-0002-7332-1417				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pinkoski MJ, 2002, J BIOL CHEM, V277, P42380, DOI 10.1074/jbc.M208167200; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	26	478	500	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					88	93		10.1038/nature03337	http://dx.doi.org/10.1038/nature03337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744305				2022-12-28	WOS:000227334600049
J	Nurock, S				Nurock, S			Commentary: patients may be less risk averse than committees	BRITISH MEDICAL JOURNAL			English	Editorial Material												s_nurock@hotmail.com						BALDWIN C, 2004, PROG NEUROL PSYCHIAT, V8; Wade DT, 2005, BMJ-BRIT MED J, V330, P468, DOI 10.1136/bmj.330.7489.468	2	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					471	472		10.1136/bmj.330.7489.471	http://dx.doi.org/10.1136/bmj.330.7489.471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731147	Green Published			2022-12-28	WOS:000227315400026
J	Balaban, RS; Nemoto, S; Finkel, T				Balaban, RS; Nemoto, S; Finkel, T			Mitochondria, oxidants, and aging	CELL			English	Review							NEMATODE CAENORHABDITIS-ELEGANS; ELECTRON-TRANSPORT CHAIN; EXTENDS LIFE-SPAN; OXIDATIVE STRESS; REACTIVE OXYGEN; DROSOPHILA-MELANOGASTER; SUPEROXIDE-DISMUTASE; CYTOCHROME-C; UNCOUPLING PROTEINS; HEART-MITOCHONDRIA	The free radical theory of aging postulates that the production of intracellular reactive oxygen species Is the major determinant of life span. Numerous cell culture, invertebrate, and mammalian models exist that lend support to this half-century-old hypothesis. Here we review the evidence that both supports and conflicts with the free radical theory and examine the growing link between mitochondrial metabolism, oxidant formation, and the biology of aging.	NIH, Cardiovasc Branch, Bethesda, MD 20892 USA; NIH, Cardiac Energet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Finkel, T (corresponding author), NIH, Cardiovasc Branch, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov	Balaban, Robert S/A-7459-2009	Balaban, Robert S/0000-0003-4086-0948	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012, ZIAHL004601, Z01HL004601] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; BUTLER J, 1975, BIOCHIM BIOPHYS ACTA, V408, P215, DOI 10.1016/0005-2728(75)90124-3; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FRIDOVICH I, 1961, J BIOL CHEM, V236, P1836; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartman P, 2004, MECH AGEING DEV, V125, P417, DOI 10.1016/j.mad.2004.02.007; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Joubert F, 2004, BIOPHYS J, V86, P629, DOI 10.1016/S0006-3495(04)74141-7; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Maklashina E, 2004, AGING CELL, V3, P21, DOI 10.1111/j.1474-9728.2003.00078.x; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; ORII Y, 1982, J BIOL CHEM, V257, P9246; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pearl R., 1928, RATE LIVING; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; QUARRIE JK, 2004, SCI AGING KNOWLEDGE, V31, pRE5; RADI R, 1991, J BIOL CHEM, V266, P22028; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; Sun JT, 1999, MOL CELL BIOL, V19, P216; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	107	3083	3209	20	645	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					483	495		10.1016/j.cell.2005.02.001	http://dx.doi.org/10.1016/j.cell.2005.02.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734681	Bronze			2022-12-28	WOS:000227271500006
J	Annas, GJ				Annas, GJ			"Culture of life'' politics at the bedside - The case of Terri Schiavo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; ANNAS GJ, 1975, RIGHTS HOSP PATIENTS, P81; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; EISENBERG D, 2005, TIME            0404, P23; GOODNOUGH A, 2005, NY TIMES        0427, pA1; Kirkpatrick David D, 2005, N Y Times Web, pA18; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130; Shannon TA, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3528689	8	95	97	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1710	1715		10.1056/NEJMlim050643	http://dx.doi.org/10.1056/NEJMlim050643			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784657	Green Published			2022-12-28	WOS:000228515200015
J	Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG				Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG			U-Pb ages from the neoproterozoic Doushantuo Formation, China	SCIENCE			English	Article							SNOWBALL EARTH HYPOTHESIS; SOUTH CHINA; MARINOAN GLACIATION; METAZOAN EVOLUTION; CONSTRAINTS; FOSSILS; NAMIBIA; OMAN; CARBONATES; AUSTRALIA	U-Pb zircon dates from volcanic ash beds within the Doushantuo Formation (China) indicate that its deposition occurred between 635 and 551 million years ago. The base records termination of the global-scale Marinoan glaciation and is coeval with similar dated rocks from Namibia, indicating synchronous deglaciation. Carbon isotopic and sequence-stratigraphic data imply that the spectacular animal fossils of the Doushantuo Formation are for the most part younger than 580 million years old. The uppermost Doushantuo Formation contains a pronounced negative carbonate carbon isotopic excursion, which we interpret as a global event at circa 551 million years ago.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Condon, D (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dcondon@mit.edu	Condon, Daniel/A-4249-2008; Zhu, Maoyan/K-1124-2014	Condon, Daniel/0000-0002-9082-3283; Zhu, Maoyan/0000-0001-7327-9856				Allen P.A., 2002, 16 INT SED C VOL JOA, P7; Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bowring SA, 2003, GEOPH RES ABSTR, V5, P13219; BURNS SJ, 1993, ECLOGAE GEOL HELV, V86, P595; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Chen DF, 2004, PRECAMBRIAN RES, V132, P123, DOI 10.1016/j.precamres.2004.02.005; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Cozzi A, 2004, GEOL SOC AM BULL, V116, P1367, DOI 10.1130/B25387.1; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; HALVERSON GP, IN PRESS GEOL SOC AM; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hoffmann KH, 2004, GEOLOGY, V32, P817, DOI 10.1130/G20519.1; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Jiang GQ, 2003, GEOLOGY, V31, P917, DOI 10.1130/G19790.1; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Macouin M, 2004, EARTH PLANET SC LETT, V224, P387, DOI 10.1016/j.epsl.2004.05.015; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Myrow PM, 1999, J SEDIMENT RES, V69, P784, DOI 10.2110/jsr.69.784; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; [王伟 Wang Wei], 2002, [微体古生物学报, Acta Micropalaeontologica Sinica], V19, P382; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2004, PRECAMBRIAN RES, V130, P1, DOI 10.1016/j.precamres.2003.10.013; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; Yang JD, 1999, PRECAMBRIAN RES, V93, P215; Zhou CM, 2004, GEOLOGY, V32, P437, DOI 10.1130/G20286.1; Zhu MY, 2003, PROG NAT SCI-MATER, V13, P951, DOI 10.1080/10020070312331344710	35	974	1157	11	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					95	98		10.1126/science.1107765	http://dx.doi.org/10.1126/science.1107765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15731406				2022-12-28	WOS:000228221500040
J	Battersby, MW				Battersby, MW		SA HlthPlus Team	Health reform through coordinated care: SA HealthPlus	BRITISH MEDICAL JOURNAL			English	Article								How can care for chronic illness best be coordinated? An Australian study sought to move towards collaborative and patient centred planned care.	Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, Adelaide, SA 5001, Australia	Flinders University South Australia	Battersby, MW (corresponding author), Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, GPO Box 2100, Adelaide, SA 5001, Australia.	malcolm.battersby@flinders.edu.au		Battersby, Malcolm/0000-0001-7306-5591				Australian Government Department of Health and Ageing, AUSTR PRIM CAR COLL; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Battersby M, 2002, AUSTR COORDINATED CA, P201; Battersby MW., 2003, AUSTR J PRIM HLTH, V9, P41, DOI [10.1071/PY03022, DOI 10.1071/PY03022]; Chen A., 2000, BEST PRACTICES COORD; *COMM DEP HLTH AG, 2004, LOOK OUR PEOPL INF H; *COMM DEP HLTH AG, 2001, 2911 COMM DEP HLTH A; *COMM DEP HLTH AG, 1999, EXPR INT PRIM CAR I; Commonwealth Department of Health and Aged Care, 1999, AUSTR COORD CAR TRIA; GAMBLE C, 2000, WORKING SERIOUS MENT; Harvey P, 2000, AUST NZ J PUBL HEAL, V24, P217, DOI 10.1111/j.1467-842X.2000.tb00149.x; HARVEY PW, 2001, AUST J RURAL HEALTH, V9, P70, DOI DOI 10.1046/J.1440-1584.2001.00319.X; HARVEY PW, 2001, THESIS U W AUSTR PER; HEARD A, 2002, AUST J PRIM HEALTH, V8, P52; Henning JH, 2002, BRIT MED J, V325, P1; Marks I, 1986, BEHAV PSYCHOTHERAPY; Marks IM, 1977, NURSING BEHAV PSYCHO; Murray C. J. L., 1996, GLOBAL BURDEN DIS; *S AUSTR DEP HUM S, 2003, FIN REP GEN HLTH REV; Smith BJ, 2002, MED J AUSTRALIA, V177, P481, DOI 10.5694/j.1326-5377.2002.tb04915.x; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	23	69	71	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					662	665		10.1136/bmj.330.7492.662	http://dx.doi.org/10.1136/bmj.330.7492.662			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	909LP	15775001	Green Published, Green Submitted			2022-12-28	WOS:000227861700034
J	Juma, C; Yee-Cheong, L				Juma, C; Yee-Cheong, L			Reinventing global health: the role of science, technology, and innovation	LANCET			English	Article									Harvard Univ, John F Kennedy Sch Govt, Belfer Ctr Sci & Int Affairs, Cambridge, MA 02138 USA; World Federat Engn Org, Paris, France; Acad Sci Malaysia, Kuala Lumpur, Malaysia	Harvard University	Juma, C (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Belfer Ctr Sci & Int Affairs, 79 John F Kennedy St, Cambridge, MA 02138 USA.	calestous_juma@harvard.edu						Acharya T, 2003, NAT BIOTECHNOL, V21, P1434, DOI 10.1038/nbt1203-1434; Daar A.S., 2002, TOP 10 BIOTECHNOLOGI; JUMA C, 2003, GEORGET J INT AF WIN, P105; JUMA C, IN PRESS BIOSCIENCE; *UN MILL, 2005, INN APPL KNOW DEV	5	21	21	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1105	1107						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781106				2022-12-28	WOS:000227731800035
J	O'Connell, PA; McKenna, GB				O'Connell, PA; McKenna, GB			Rheological measurements of the thermoviscoelastic response of ultrathin polymer films	SCIENCE			English	Article							GLASS-TRANSITION TEMPERATURE; CHAIN CONFORMATION; THIN-FILMS; CONFINEMENT; INFLATION; DYNAMICS; BEHAVIOR; LIQUIDS; PERSPECTIVES; RELAXATION	Measurement of the thermoviscoelastic behavior of glass-forming liquids in the nanometer size range offers the possibility of increased understanding of the fundamental nature of the glass-transition phenomenon itself. We present results from use of a previously unknown method for characterizing the rheological response of nanometer-thick polymer films. The method relies on the imaging capabilities of the atomic force microscope and the reduction in size of the classical bubble inflation method of measuring the biaxial creep response of ultrathin polymer films. Creep compliance as a function of time and temperature was measured in the linear viscoelastic regime for films of poly(vinyl acetate) at a thickness of 27.5 nanometers. Although little evidence for a change in the glass temperature is found, the material exhibits previously unobserved stiffening in the rubbery response regime.	Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	McKenna, GB (corresponding author), Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA.	greg.mckenna@ttu.edu	McKenna, Gregory B/O-1134-2013	McKenna, Gregory B/0000-0002-5676-9930				ANDERSON PW, 1995, SCIENCE, V268, P1154, DOI 10.1126/science.268.5214.1154; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; Boltzmann L., SITZUNGSBERICHTE AKA, V70, p275+300, DOI 10.1002/andp.18782411107; Buenviaje CK, 1998, MATER RES SOC SYMP P, V522, P187, DOI 10.1557/PROC-522-187; Chow TS, 2002, J PHYS-CONDENS MAT, V14, pl333, DOI 10.1088/0953-8984/14/19/101; Dalnoki-Veress K, 1999, PHYS REV E, V59, P2153, DOI 10.1103/PhysRevE.59.2153; Forrest JA, 2002, EUR PHYS J E, V8, P261, DOI 10.1140/epje/i2002-10005-5; GREEN AE, 1970, LARGE ELASTIC DEFORM; Hassager O, 1999, J NON-NEWTON FLUID, V88, P185, DOI 10.1016/S0377-0257(99)00018-X; JACKSON CL, 1991, J NON-CRYST SOLIDS, V131, P221, DOI 10.1016/0022-3093(91)90305-P; Johannsmann D, 2002, EUR PHYS J E, V8, P257, DOI 10.1140/epje/i2002-10013-5; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; Jones RL, 2001, MACROMOLECULES, V34, P559, DOI 10.1021/ma001141o; JOYE DD, 1972, T SOC RHEOL, V16, P421, DOI 10.1122/1.549259; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Kim SD, 2002, MACROMOLECULES, V35, P5943, DOI 10.1021/ma0200322; Kugler R, 2002, MACROMOL CHEM PHYSIC, V203, P923, DOI 10.1002/1521-3935(20020401)203:7<923::AID-MACP923>3.0.CO;2-W; Lu H, 2003, MECH TIME-DEPEND MAT, V7, P189, DOI 10.1023/B:MTDM.0000007217.07156.9b; LUN S, IN PRESS PHYS REV LE; Mattsson J, 2000, PHYS REV E, V62, P5187, DOI 10.1103/PhysRevE.62.5187; McKenna GB, 2003, EUR PHYS J E, V12, P191, DOI 10.1140/epje/i2003-10040-8; McKenna GB, 2000, J PHYS IV, V10, P53, DOI 10.1051/jp4:2000710; ORTS WJ, 1993, PHYS REV LETT, V71, P867, DOI 10.1103/PhysRevLett.71.867; Park JY, 2000, PHYS REV B, V61, P6667, DOI 10.1103/PhysRevB.61.6667; PLAZEK DJ, 1980, POLYM J, V12, P43, DOI 10.1295/polymj.12.43; Raptis I, 2002, MICROELECTRON ENG, V61-2, P829, DOI 10.1016/S0167-9317(02)00503-8; Roth CB, 2003, EUR PHYS J E, V12, pS103, DOI 10.1140/epjed/e2003-01-024-2; Simon SL, 2002, EUR PHYS J E, V8, P209, DOI 10.1140/epje/i2001-10072-0; Treloar L. R. G., 1975, PHYS TODAY, DOI DOI 10.1063/1.3060678; VanLandingham MR, 2001, MACROMOL SYMP, V167, P15, DOI 10.1002/1521-3900(200103)167:1<15::AID-MASY15>3.0.CO;2-T; WALLACE WE, 1995, PHYS REV E, V52, pR3329, DOI 10.1103/PhysRevE.52.R3329; WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008; WINEMAN AS, 1976, T SOC RHEOL, V20, P203, DOI 10.1122/1.549410; Yuan CG, 1999, MACROMOLECULES, V32, P2329, DOI 10.1021/ma980774o	34	248	250	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1760	1763		10.1126/science.1105658	http://dx.doi.org/10.1126/science.1105658			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774754				2022-12-28	WOS:000227883900040
J	Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R				Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R		AdHOC Project Res Grp	Potentially inappropriate among elderly home medication use care patients in Europe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; OLDER-ADULTS; EXPLICIT CRITERIA; CONSENSUS PANEL; COMMUNITY; POPULATION; RESIDENTS; POLYPHARMACY; INPATIENTS; PEOPLE	Context Criteria for potentially inappropriate medication use among elderly patients have been used in the past decade in large US epidemiological surveys to identify populations at risk and specifically target risk-management strategies. In contrast, in Europe little information is available about potentially inappropriate medication use and is based on small studies with uncertain generalizability. Objective To estimate the prevalence and associated factors of potentially inappropriate medication use among elderly home care patients in European countries. Design, Setting, and Participants Retrospective cross-sectional study of 2707 elderly patients receiving home care (mean [SDI age, 82.2 [7.2] years) representatively enrolled in metropolitan areas of the Czech Republic, Denmark, Finland, Iceland, Italy, the Netherlands, Norway, and the United Kingdom. Patients were prospectively assessed between September 2001 and January 2002 using the Minimum Data Set in Home Care instrument. Main Outcome Measures Prevalence of potentially inappropriate medication use was documented using all expert panels criteria for community-living elderly persons (Beers and McLeod). Patient-related characteristics independently associated with inappropriate medication use were identified with a multiple logistic regression model. Results Combining all 3 sets of criteria, we found that 19.8% of patients in the total sample used at least 1 inappropriate medication; using older 1997 criteria it was 9.8% to 10.9%. Substantial differences were documented between Eastern Europe (41.1% in the Czech Republic) and Western Europe (mean 15.8%, ranging from 5.8% in Denmark to 26.5% in Italy). Potentially inappropriate medication use was associated with patient's poor economic situation (adjusted relative risk [RR], 1.96; 95% confidence interval [CI], 1.58-2.36), polypharmacy (RR, 1.91; 95% Cl, 1.62-2.22), anxiolytic drug use (RR, 1.82; 95% Cl, 1.51-2.15), and depression (RR, 1.29; 95% Cl, 1.06-1.55). Negatively associated factors were age 85 years and older (RR, 0.78; 95% Cl, 0.65-0.92) and living alone (RR, 0.76; 95% Cl, 0.64-0.89). The odds of potentially inappropriate medication use significantly increased with the number of associated factors (P<.001). Conclusions Substantial differences in potentially inappropriate medication use exist between European countries and might be a consequence of different regulatory measures, clinical practices, or inequalities in socioeconomic background. Since financial resources and selected patient-related characteristics are associated with such prescribing, specific educational strategies and regulations should reflect these factors to improve prescribing quality in elderly individuals in Europe.	Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Prague 12000 2, Czech Republic; Charles Univ Prague, Fac Pharm, Dept Social & Clin Pharm, CS-50165 Hradec Kralove, Czech Republic; Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; Natl Res & Dev Ctr Social Welf & Hlth, STATES CHESS, Helsinki, Finland; Univ Iceland, Landspitali Univ Hosp, Dept Geriatr, Reykjavik, Iceland; Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England; E Kent Hosp NHS Trust, Canterbury, Kent, England; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Decon Coll, Oslo, Norway; Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; AS CR, Inst Comp Sci, EuroMISE Ctr, Prague, Czech Republic	Charles University Prague; Charles University Prague; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Landspitali National University Hospital; University of Iceland; University of Kent; University of Copenhagen; Bispebjerg Hospital; Netherlands Institute for Health Services Research; Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences	Fialova, D (corresponding author), Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Londynska 15, Prague 12000 2, Czech Republic.	fickova@faf.cuni.cz	Bernabei, Roberto/AAB-2704-2019; Reissigova, Jindra/B-3201-2014; Topinkova, Eva/A-5076-2019	Bernabei, Roberto/0000-0002-9197-004X; Topinkova, Eva/0000-0002-6786-4116				ADAMS SR, 2002, 48325 HCFAOBRA MEDPA; Balogun SA, 2003, J AM GERIATR SOC, V51, pS103; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; *BRIT MED ASS ROYA, 2004, BRIT NAT FORM; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chutka DS, 2004, MAYO CLIN PROC, V79, P122, DOI 10.4065/79.1.122; Cohen JS, 2000, GERIATRICS-US, V55, P54; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; *CZECH NAT FORM, 2003, PHARM BREV; Fick D, 2001, J MANAGE CARE PHARM, V7, P407, DOI [10.18553/jmcp.2001.7.5.407, DOI 10.18553/JMCP.2001.7.5.407]; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Giron MST, 2001, J AM GERIATR SOC, V49, P277, DOI 10.1046/j.1532-5415.2001.4930277.x; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Gray SL, 2003, ANN PHARMACOTHER, V37, P988, DOI 10.1345/aph.1C365; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hanlon JT, 2004, ANN PHARMACOTHER, V38, P9, DOI 10.1345/aph.1D313; *IC NAT FORM, 2003, SERL 2002 2003; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Lane CJ, 2004, J AM GERIATR SOC, V52, P861, DOI 10.1111/j.1532-5415.2004.52250.x; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Linjakumpu T, 2002, INT J GERIATR PSYCH, V17, P874, DOI 10.1002/gps.712; Malik AB, 2003, J AM GERIATR SOC, V51, pS123; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; MCNUTT LA, 1994, J CLIN EPIDEMIOL, V47, P613, DOI 10.1016/0895-4356(94)90209-7; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; *NORW MED AG, NORW PHARM PROD COMP; Onder G, 2003, EUR J CLIN PHARMACOL, V59, P157, DOI 10.1007/s00228-003-0600-8; ONDER G, IN PRESS EUR J CLIN; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Schmader KE, 2004, AM J MED, V116, P394, DOI 10.1016/j.amjmed.2003.10.031; STEWART RB, 1994, DRUG AGING, V4, P449, DOI 10.2165/00002512-199404060-00002; STUCK AE, 1994, ARCH INTERN MED, V154, P2195; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Thirstrup S, 2001, LANCET, V358, P1734, DOI 10.1016/S0140-6736(01)06760-5; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	41	482	503	5	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1348	1358		10.1001/jama.293.11.1348	http://dx.doi.org/10.1001/jama.293.11.1348			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769968	Green Published, Bronze			2022-12-28	WOS:000227698600023
J	Froemke, RC; Poo, MM; Dan, Y				Froemke, RC; Poo, MM; Dan, Y			Spike-timing-dependent synaptic plasticity depends on dendritic location	NATURE			English	Article							ACTION-POTENTIALS; NMDA RECEPTORS; CALCIUM; MECHANISM; INPUTS; COINCIDENCE; SUMMATION; CHANNELS; NEURONS; CELLS	In the neocortex, each neuron receives thousands of synaptic inputs distributed across an extensive dendritic tree. Although postsynaptic processing of each input is known to depend on its dendritic location(1-8), it is unclear whether activity-dependent synaptic modification is also location-dependent. Here we report that both the magnitude and the temporal specificity of spike-timing-dependent synaptic modification(9-17) vary along the apical dendrite of rat cortical layer 2/3 pyramidal neurons. At the distal dendrite, the magnitude of long-termpotentiation is smaller, and the window of pre-/postsynaptic spike interval for long-term depression (LTD) is broader. The spike-timing window for LTD correlates with the window of action potential-induced suppression of NMDA (N-methyl-D-aspartate) receptors; this correlation applies to both their dendritic location-dependence and pharmacological properties. Presynaptic stimulation with partial blockade of NMDA receptors induced LTD and occluded further induction of spike-timing-dependent LTD, suggesting that NMDA receptor suppression underlies LTD induction. Computer simulation studies showed that the dendritic inhomogeneity of spike-timing-dependent synaptic modification leads to differential input selection at distal and proximal dendrites according to the temporal characteristics of presynaptic spike trains. Such location-dependent tuning of inputs, together with the dendritic heterogeneity of postsynaptic processing, could enhance the computational capacity of cortical pyramidal neurons.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X; Froemke, Robert/0000-0002-1230-6811				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waters J, 2003, J NEUROSCI, V23, P8558; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	30	266	270	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					221	225		10.1038/nature03366	http://dx.doi.org/10.1038/nature03366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759002				2022-12-28	WOS:000227494500047
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Fussner, S; Giese, B; Grazier, K; Helfenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, P; Tiscareno, M; Turtle, EP; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Fussner, S; Giese, B; Grazier, K; Helfenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, P; Tiscareno, M; Turtle, EP; Vasavada, AR; Veverka, J; Wagner, R; West, R			Imaging of Titan from the Cassini spacecraft	NATURE			English	Article							TROPOSPHERIC CLOUDS; GRAVITY-WAVES; SURFACE; ATMOSPHERE; SUPERROTATION; TEMPERATURE; CHEMISTRY; ROTATION; METHANE; LIQUID	Titan, the largest moon of Saturn, is the only satellite in the Solar System with a substantial atmosphere. The atmosphere is poorly understood and obscures the surface, leading to intense speculation about Titan's nature. Here we present observations of Titan from the imaging science experiment onboard the Cassini spacecraft that address some of these issues. The images reveal intricate surface albedo features that suggest aeolian, tectonic and fluvial processes; they also show a few circular features that could be impact structures. These observations imply that substantial surface modification has occurred over Titan's history. We have not directly detected liquids on the surface to date. Convective clouds are found to be common near the south pole, and the motion of mid-latitude clouds consistently indicates eastward winds, from which we infer that the troposphere is rotating faster than the surface. A detached haze at an altitude of 500 km is 150 - 200 km higher than that observed by Voyager, and more tenuous haze layers are also resolved.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, CE Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012; Evans, Michael W/AAG-4117-2020; Tiscareno, Matthew/D-6963-2011	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				ALLISON M, 1994, J ATMOS SCI, V51, P694, DOI 10.1175/1520-0469(1994)051<0694:ZPVEFT>2.0.CO;2; BOUCHEZ A, 2005, KECK OBSERVATORY TIT; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; Coustenis A, 2001, ICARUS, V154, P501, DOI 10.1006/icar.2001.6643; CROFT SK, 1988, ICARUS, V73, P279, DOI 10.1016/0019-1035(88)90098-X; DelGenio AD, 1996, ICARUS, V120, P332, DOI 10.1006/icar.1996.0054; DELGENIO AD, 1993, ICARUS, V101, P1, DOI 10.1006/icar.1993.1001; Dimitrov V, 2003, ICARUS, V166, P440, DOI 10.1016/j.icarus.2003.07.007; Dobrovolskis AR, 2004, ICARUS, V169, P462, DOI 10.1016/j.icarus.2004.01.006; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; FRIEDSON AJ, 1994, ICARUS, V109, P40, DOI 10.1006/icar.1994.1076; Gibbard SG, 2004, ICARUS, V169, P429, DOI 10.1016/j.icarus.2003.12.026; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; HINSON DP, 1983, ICARUS, V54, P337, DOI 10.1016/0019-1035(83)90202-6; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; Hutzell WT, 1996, ICARUS, V119, P112, DOI 10.1006/icar.1996.0005; KHARE BN, 1978, SCIENCE, V199, P1199, DOI 10.1126/science.199.4334.1199; KORYCANSKY DG, IN PRESS PLANET SPAC; LEMMON M, 2004, 35 COSPAR SCI ASS PA; LEMMON MT, UNPUB ICARUS; LORENZ RD, 1994, PLANET SPACE SCI, V42, P1, DOI 10.1016/0032-0633(94)90134-1; LORENZ RD, 2005, IN PRESS PLANET SPAC; Lunine JI, 2002, SPACE SCI REV, V104, P191, DOI 10.1023/A:1023601009802; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; McKay CP, 1997, ICARUS, V129, P498, DOI 10.1006/icar.1997.5751; Perron JT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019802; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; Rannou P, 2004, ICARUS, V170, P443, DOI 10.1016/j.icarus.2004.03.007; Raulin F, 2002, SPACE SCI REV, V104, P377, DOI 10.1023/A:1023636623006; Richardson J, 2004, ICARUS, V170, P113, DOI 10.1016/j.icarus.2004.03.010; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; ROSSOW WB, 1990, J ATMOS SCI, V47, P2053, DOI 10.1175/1520-0469(1990)047<2053:CTWFVO>2.0.CO;2; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; Sicardy B, 1999, ICARUS, V142, P357, DOI 10.1006/icar.1999.6219; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; SOTIN C, UNPUB NATURE; STROBEL DF, 1982, PLANET SPACE SCI, V30, P839, DOI 10.1016/0032-0633(82)90116-7; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; WEST RA, 1991, ICARUS, V90, P330, DOI 10.1016/0019-1035(91)90113-8; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4	45	311	313	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					159	168		10.1038/nature03436	http://dx.doi.org/10.1038/nature03436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758990				2022-12-28	WOS:000227494500034
J	Buddha, S				Buddha, S			Complication of urethral catheterisation	LANCET			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales		Buddha, S (corresponding author), Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales.								0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					909	909		10.1016/S0140-6736(05)71051-5	http://dx.doi.org/10.1016/S0140-6736(05)71051-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752537				2022-12-28	WOS:000227444600035
J	Smith, JM; Burnham, G				Smith, JM; Burnham, G			Conceiving and dying in Afghanistan	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, JHPIEGO Afghanistan, KArte Se, Kabul, Afghanistan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jhpiego	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	gburnham@jhsph.edu						Ahmad K, 2003, LANCET, V362, P622, DOI 10.1016/S0140-6736(03)14195-5; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Mateos D, 2002, J HIGH ENERGY PHYS; *MIN HLTH PUBL NUT, 2004, PUBL NUTR POL STRAT, P1383; *WHO, 2002, HLTH MILL DEV GOALS; WHO, 2004, MAT MORT 2000 EST DE	7	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					827	828		10.1016/S0140-6736(05)71018-7	http://dx.doi.org/10.1016/S0140-6736(05)71018-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752511				2022-12-28	WOS:000227444600006
J	Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR				Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR			What kind of farming works best?	SCIENCE			English	Letter									Ctr Global Food Issues, Hudson Inst, Churchville, VA 24421 USA; Tuskegee Univ, Ctr Plant Biotechnol Res, Tuskegee, AL 36088 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Houston, Dept Econ, Houston, TX 77204 USA	Tuskegee University; University of California System; University of California Riverside; University of Edinburgh; University of Houston System; University of Houston	Avery, AA (corresponding author), Ctr Global Food Issues, Hudson Inst, POB 202, Churchville, VA 24421 USA.	aavery@cgfi.org	McHughen, Alan/AAM-9215-2021; McHughen, Alan/HII-3301-2022					Dobbs TL, 1996, J SUSTAIN AGR, V9, P63, DOI 10.1300/J064v09n01_06; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; SHEPARD M, 2003, ASSESSMENT ENV IMPAC; SMIL V, COMMUNICATION; *SOIL WAT CONS SOC, 1995, FARM BETT ENV	5	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1410	1410						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15751124				2022-12-28	WOS:000227503100022
J	Burns, RB; Curhan, GC				Burns, RB; Curhan, GC			A 44-year-old woman with kidney stones	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Department of Medicine Grand Rounds Conference	MAR 04, 2004	Boston, MA	Beth Israel Deaconess Med Ctr			SHOCK-WAVE LITHOTRIPSY; HELICAL COMPUTERIZED-TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; URETERAL STONES; DOUBLE-BLIND; PERCUTANEOUS NEPHROSTOLITHOTOMY; CALCIUM NEPHROLITHIASIS; NATURAL-HISTORY; DIETARY CALCIUM; RENAL CALCULI		Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Curhan, GC (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood,3rd Floor, Boston, MA 02115 USA.	gcurhan@partners.org			NIDDK NIH HHS [DK59583] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059583] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5; ASO Y, 1996, KIDNEY STONES MED SU, P651; Asplin J, 1998, J UROLOGY, V159, P1821, DOI 10.1016/S0022-5347(01)63164-1; ASPLIN J, 1996, KIDNEY STONES MED SU, P773; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Bihl G, 2001, LANCET, V358, P651, DOI 10.1016/S0140-6736(01)05782-8; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Cervenakov I., 2002, International Urology and Nephrology, V34, P25; Chandhoke PS, 2002, J UROLOGY, V168, P937, DOI 10.1016/S0022-5347(05)64546-6; Chandhoke PS, 2002, J UROLOGY, V167, P1981, DOI 10.1016/S0022-5347(05)65067-7; COE FL, 1977, JAMA-J AM MED ASSOC, V238, P1519, DOI 10.1001/jama.238.14.1519; COE FL, 2003, THERAPY NEPHROLOGY H, P399; COE FL, 1988, NEPHROLITHIASIS PATH; Cohen TD, 1996, SEMIN NEPHROL, V16, P425; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645; CURHAN GC, 2003, THERAPY NEPHROLOGY H, P405; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Fowler KAB, 2002, RADIOLOGY, V222, P109, DOI 10.1148/radiol.2221010453; GLOWACKI LS, 1992, J UROLOGY, V147, P319, DOI 10.1016/S0022-5347(17)37225-7; GUPTA M, 1996, KIDNEY STONES MED SU, P463; HIATT RA, 1982, AM J EPIDEMIOL, V115, P255, DOI 10.1093/oxfordjournals.aje.a113297; Hiatt RA, 1996, AM J EPIDEMIOL, V144, P25, DOI 10.1093/oxfordjournals.aje.a008851; Iguchi M, 2002, INT J UROL, V9, P475, DOI 10.1046/j.1442-2042.2002.00504.x; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Kekec Z, 2000, BJU INT, V85, P783, DOI 10.1046/j.1464-410x.2000.00613.x; Kober A, 2003, J UROLOGY, V170, P741, DOI 10.1097/01.ju.0000080570.83834.ad; Kramer HJ, 2003, KIDNEY INT, V64, P1022, DOI 10.1046/j.1523-1755.2003.t01-2-00171.x; LABRECQUE M, 1994, ARCH INTERN MED, V154, P1381, DOI 10.1001/archinte.154.12.1381; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; Lang EK, 2003, UROLOGY, V61, P528, DOI 10.1016/S0090-4295(02)02408-1; Li J, 2001, J UROLOGY, V165, P782, DOI 10.1016/S0022-5347(05)66525-1; LJUNGHALL S, 1984, BRIT J UROL, V56, P122, DOI 10.1111/j.1464-410X.1984.tb05346.x; Lopes T, 2001, BJU INT, V87, P322, DOI 10.1046/j.1464-410x.2001.00068.x; May DJ, 1998, J UROLOGY, V159, P24, DOI 10.1016/S0022-5347(01)63999-5; Moe OW, 2002, ENDOCRIN METAB CLIN, V31, P895, DOI 10.1016/S0889-8529(02)00032-4; MUELLER SC, 1986, J UROLOGY, V135, P831, DOI 10.1016/S0022-5347(17)45870-8; Nadler RB, 2003, J UROLOGY, V169, P475, DOI 10.1016/S0022-5347(05)63936-5; Pak CYC, 2003, AM J MED, V115, P26, DOI 10.1016/S0002-9343(03)00201-8; Parks JH, 1996, KIDNEY INT, V50, P1706, DOI 10.1038/ki.1996.489; Parks JH, 2002, J UROLOGY, V167, P1607, DOI 10.1016/S0022-5347(05)65163-4; Parks JH, 2001, J UROLOGY, V166, P2057, DOI 10.1016/S0022-5347(05)65505-X; PEARLE M, 2004, UROLOGIC DIS AM; Pearle MS, 1999, J UROLOGY, V162, P23, DOI 10.1097/00005392-199907000-00006; Reid IR, 2000, AM J MED, V109, P362, DOI 10.1016/S0002-9343(00)00510-6; RODMAN JS, 1991, J UROLOGY, V145, P97, DOI 10.1016/S0022-5347(17)38258-7; Rodman JS, 1999, NEPHRON, V81, P50, DOI 10.1159/000046299; RODMAN JS, 1996, KIDNEY STONES MED SU, P973; Romics I, 2003, BJU INT, V92, P92, DOI 10.1046/j.1464-410X.2003.04262.x; Rudnick DM, 1999, J ENDOUROL, V13, P483, DOI 10.1089/end.1999.13.483; Scheinman SJ, 1999, SEMIN NEPHROL, V19, P381; SCHWILLE PO, 1984, J UROLOGY, V132, P650, DOI 10.1016/S0022-5347(17)49808-9; Sheafor DH, 2000, RADIOLOGY, V217, P792, DOI 10.1148/radiology.217.3.r00dc41792; Shekarriz B, 2002, ENDOCRIN METAB CLIN, V31, P951, DOI 10.1016/S0889-8529(02)00054-3; SMITH CL, 1984, MED CLIN N AM, V68, P455, DOI 10.1016/S0025-7125(16)31140-3; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Teichman JMH, 2004, NEW ENGL J MED, V350, P684, DOI 10.1056/NEJMcp030813; Tligui M, 2003, EUR UROL, V43, P552, DOI 10.1016/S0302-2838(03)00086-1; Travaglini F, 2004, UROL INT, V72, P20, DOI 10.1159/000076586; URIBARRI J, 1989, ANN INTERN MED, V111, P1006, DOI 10.7326/0003-4819-111-12-1006; Vieweg J, 1998, J UROLOGY, V160, P679, DOI 10.1016/S0022-5347(01)62754-X; WILLIAMS JJ, 1984, NEW ENGL J MED, V311, P760, DOI 10.1056/NEJM198409203111203; WILLIAMS R E, 1963, Br J Urol, V35, P416, DOI 10.1111/j.1464-410X.1963.tb11762.x; Wong SK, 2001, ANN ACAD MED SINGAP, V30, P568	70	1	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1107	1114		10.1001/jama.293.9.1107	http://dx.doi.org/10.1001/jama.293.9.1107			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	901LY	15741533				2022-12-28	WOS:000227285200021
J	Dixon, AN				Dixon, AN			Nausea and vomiting due to insulin glargine in patient with type 1 diabetes mellitus	BRITISH MEDICAL JOURNAL			English	Article									Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England; Univ Birmingham, Birmingham Heartlands Hosp, Undergrad Ctr, Div Med Sci, Birmingham B15 2TT, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham	Dixon, AN (corresponding author), Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England.	Anthony.Dixon@heartsol.wmids.nhs.uk						Campbell RK, 2001, CLIN THER, V23, P1938, DOI 10.1016/S0149-2918(01)80148-X; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644	2	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					455	455		10.1136/bmj.330.7489.455	http://dx.doi.org/10.1136/bmj.330.7489.455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731143	Green Published, Bronze			2022-12-28	WOS:000227315400020
J	Kirkwood, TBL				Kirkwood, TBL			Understanding the odd science of aging	CELL			English	Review							POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY; MITOCHONDRIAL-DNA MUTATIONS; EXTENDED LIFE-SPAN; PROGEROID SYNDROME; NATURAL-SELECTION; OXIDATIVE STRESS; STEM-CELLS; EVOLUTION; SENESCENCE; LONGEVITY	Evolutionary considerations suggest aging is caused not by active gene programming but by evolved limitations in somatic maintenance, resulting in a build-up of damage. Ecological factors such as hazard rates and food availability influence the trade-offs between investing in growth, reproduction, and somatic survival, explaining why species evolved different life spans and why aging rate can sometimes be altered, for example, by dietary restriction. To understand the cell and molecular basis of aging is to unravel the multiplicity of mechanisms causing damage to accumulate and the complex array of systems working to keep damage at bay.	Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol Res, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle University - UK	Kirkwood, TBL (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol Res, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	tom.kirkwood@ncl.ac.uk			Biotechnology and Biological Sciences Research Council [BEP17042] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abrams PA, 2004, NATURE, V431, P1048, DOI 10.1038/4311048a; Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Barbujani G., 1999, EVOLUTION HLTH DIS; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; BELL G, 1984, AM NAT, V124, P600, DOI 10.1086/284300; BERRY RJ, 1992, BIOL REV, V67, P519, DOI 10.1111/j.1469-185X.1992.tb01192.x; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chapuisat M, 2002, P ROY SOC B-BIOL SCI, V269, P909, DOI 10.1098/rspb.2002.1962; Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621; Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; CUTLER RG, 1975, P NATL ACAD SCI USA, V72, P4664, DOI 10.1073/pnas.72.11.4664; Finch C, 2000, CHANCE DEV AGING; Finch CE, 1990, LONGEVITY SENESCENCE; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARRISON DE, 1988, GROWTH DEVELOP AGING, V52, P65; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kirkwood T., 1985, HDB BIOL AGING, P2743; Kirkwood T.B.L., 1981, P165; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kowald A, 1996, MUTAT RES-DNAGING G, V316, P209, DOI 10.1016/S0921-8734(96)90005-3; Lack D., 1954, P343; Lai CY, 2002, GENETICS, V162, P73; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MARTIN GM, 1979, FED PROC, V38, P1962; Martin K, 1998, EXP CELL RES, V241, P316, DOI 10.1006/excr.1998.4001; Martin K, 1998, J CELL SCI, V111, P2297; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Medawar P., 1952, UNSOLVED PROBLEM BIO; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muiras ML, 1998, J MOL MED-JMM, V76, P346, DOI 10.1007/s001090050226; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; OMHOLT SW, 2004, SCI AGING KNOWLEDGE, pE28; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PHELAN JP, 1989, GROWTH DEVELOP AGING, V53, P4; PROMISLOW DEL, 1994, J THEOR BIOL, V170, P291, DOI 10.1006/jtbi.1994.1190; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Shaw FH, 1999, GENETICS, V152, P553; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Terman A, 2004, INT J BIOCHEM CELL B, V36, P2365, DOI 10.1016/j.biocel.2004.03.009; Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X; Travis JMJ, 2004, J GERONTOL A-BIOL, V59, P301; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Von Zglinicki T, 2003, EXP GERONTOL, V38, P1259, DOI 10.1016/j.exger.2003.09.015; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Weindruch R, 2002, MECH AGEING DEV, V123, P177, DOI 10.1016/S0047-6374(01)00344-X; Weismann A, 1889, ESSAYS HEREDITY KIND, V1; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	79	1138	1182	7	227	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					437	447		10.1016/j.cell.2005.01.027	http://dx.doi.org/10.1016/j.cell.2005.01.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734677	Bronze, Green Submitted			2022-12-28	WOS:000227271500002
J	Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR				Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR			Bacterial injectisomes: Needle length does matter	SCIENCE			English	Article									Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	guy.cornelis@unibas.ch	Mota, Luis/B-9497-2008	Mota, Luis/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962				Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610	6	111	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1278	1278		10.1126/science.1107679	http://dx.doi.org/10.1126/science.1107679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731447				2022-12-28	WOS:000227313200049
J	West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM				West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM			Optimization of virulence functions through glucosylation of Shigella LPS	SCIENCE			English	Article							O-ANTIGEN MODIFICATION; IPAB PROTEIN; PLASMID; INVASION; GENES	Shigella, the leading cause of bacillary dysentery, uses a type III secretion system (TTSS) to inject proteins into human cells, leading to bacterial invasion and a vigorous inflammatory response. The bacterium is protected against the response by the O antigen of lipopolysaccha ride (LPS) on its surface. We show that bacteriophage-encoded glucosylation of Shigella O antigen, the basis of different serotypes, shortens the LPS molecule by around half. This enhances TTSS function without compromising the protective properties of the LPS. Thus, LPS glucosylation promotes bacterial invasion and evasion of innate immunity, which may have contributed to the emergence of serotype diversity in Shigella.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne, F-75724 Paris 15, France; Inst Pasteur, Plate Forme Microscopie Elect, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris 15, France	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	c.tang@imperial.ac.uk	West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890				Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOCK K, 1982, J CHEM SOC PERK T 2, P59, DOI 10.1039/p29820000059; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Clement MJ, 2003, J BIOL CHEM, V278, P47928, DOI 10.1074/jbc.M308259200; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Huan PT, 1997, GENE, V195, P217, DOI 10.1016/S0378-1119(97)00143-1; ITO K, 1991, MICROBIOL IMMUNOL, V35, P335, DOI 10.1111/j.1348-0421.1991.tb01563.x; KENNE L, 1978, EUR J BIOCHEM, V91, P279, DOI 10.1111/j.1432-1033.1978.tb20963.x; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; SIMMONS DAR, 1990, BIOCHEM SOC T, V18, P1271, DOI 10.1042/bst0181271; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; VENKATESAN MM, 1992, J BACTERIOL, V174, P1990, DOI 10.1128/jb.174.6.1990-2001.1992; WEST NP, UNPUB	20	231	249	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1313	1317		10.1126/science.1108472	http://dx.doi.org/10.1126/science.1108472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731456				2022-12-28	WOS:000227313200060
J	Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP				Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP			Risk of oral infection with bovine spongiform encephalopathy agent in primates	LANCET			English	Article							BSE; TRANSMISSION; HEALTH; TISSUE; CATTLE	The uncertain extent of human exposure to bovine spongiform encephalopathy (BSE)-which can lead to variant Creutzfeldt-jakob disease (vCJD)-is compounded by incomplete knowledge about the efficiency of oral infection and the magnitude of any bovine-to-human biological barrier to transmission. We therefore investigated oral transmission of BSE to non-human primates. We gave two macaques a 5 g oral dose of brain homogenate from a BSE-infected cow. One macaque developed vCjD-Iike neurological disease 60 months after exposure, whereas the other remained free of disease at 76 months. On the basis of these findings and data from other studies, we made a preliminary estimate of the food exposure risk for man, which provides additional assurance that existing public health measures can prevent transmission of BSE to man.	Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, F-92265 Fontenay Aux Roses, France; Vet Labs Agcy, Addlestone, Surrey, England	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Veterinary Laboratories Agency	Deslys, JP (corresponding author), Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	jpdeslys@cea.fr	Konold, Timm/C-6498-2011; Hawkins, Stephen/F-1136-2011					Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; *EUR COMM, OP SCI STEER COMM HU; Grassi J, 2001, VET REC, V149, P577, DOI 10.1136/vr.149.19.577; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981	9	73	74	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					781	783		10.1016/S0140-6736(05)17985-9	http://dx.doi.org/10.1016/S0140-6736(05)17985-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733719				2022-12-28	WOS:000227285300025
J	Patel, RR; Murphy, DJ; Peters, TJ				Patel, RR; Murphy, DJ; Peters, TJ		ALSPAC	Operative delivery and postnatal depression: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; CHILDREN; IMPACT	Objectives To assess the association between elective caesarean section and postnatal depression compared with planned vaginal delivery and whether emergency caesarean section or assisted vaginal delivery is associated with postnatal depression compared with spontaneous vaginal delivery. Design Prospective population based cohort study. Setting ALSPAC (the Avon longitudinal study of parents and children). Participants 14 663 women recruited antenatally with a due date between I April 1991 and 31 December 1992. Main outcome measure Edinburgh postnatal depression scale score >= 13 at eight weeks postnatal on self completed questionnaire. Results Albeit with wide confidence intervals, there was no evidence that elective caesarean section altered the odds of postnatal depression compared with planned vaginal delivery (adjusted odds ratio 1.06, 95% confidence interval 0.66 to 1.70, P = 0.80). Among planned vaginal deliveries there was similarly little evidence of a difference between women who have emergency caesarean section or assisted vaginal delivery and those who have spontaneous vaginal delivery (1.17, 0.77 to 1.79, P = 0.46, and 0.89, 0.68 to 1.18, P = 0.42, respectively). Conclusions There is no reason for women at risk of postnatal depression to be managed differently with regard to mode of delivery. Elective caesarean section does not protect against postnatal depression. Women who plan vaginal delivery and require emergency caesarean section or assisted vaginal delivery can be reassured that there is no reason to believe that they are at increased risk of postnatal depression.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol; University of Dundee; University of Bristol	Patel, RR (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Level D, Bristol BS2 8EG, Avon, England.	roshni.patel@bristol.ac.uk		Murphy, Deirdre/0000-0001-6074-6718; Patel, Roshni/0000-0002-1399-3131; Peters, Tim/0000-0003-2881-4180				BOYCE PM, 1992, MED J AUSTRALIA, V157, P172, DOI 10.5694/j.1326-5377.1992.tb137080.x; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hay DF, 2001, J CHILD PSYCHOL PSYC, V42, P871, DOI 10.1111/1469-7610.00784; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Koo V, 2003, J OBSTET GYNAECOL RE, V29, P246, DOI 10.1046/j.1341-8076.2003.00104.x; Lydon-Rochelle MT, 2001, PAEDIATR PERINAT EP, V15, P232, DOI 10.1046/j.1365-3016.2001.00345.x; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; *NAT COLL CTR WOM, 2004, CAESAREAN SECTION CL; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; ONEILL T, 1990, IRISH MED J, V83, P17; PATEL RR, 2004, IN PRESS INT J EPIDE; Saisto T, 2001, ACTA OBSTET GYN SCAN, V80, P39, DOI 10.1080/791201832; Sharp D, 1995, J CHILD PSYCHOL PSYC, V36, P1315, DOI 10.1111/j.1469-7610.1995.tb01666.x; Singleton N., 2001, PSYCHIAT MORBIDITY A; Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x; Verdoux H, 2002, ACTA PSYCHIAT SCAND, V106, P212, DOI 10.1034/j.1600-0447.2002.02398.x; WRATE RM, 1985, BRIT J PSYCHIAT, V146, P622, DOI 10.1192/bjp.146.6.622; 2003, AVON LONGITUDINAL ST	24	53	56	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2005	330	7496					879	881		10.1136/bmj.38376.603426.D3	http://dx.doi.org/10.1136/bmj.38376.603426.D3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	917UA	15734748	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000228493500018
J	Falck, J; Coates, J; Jackson, SP				Falck, J; Coates, J; Jackson, SP			Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; S-PHASE; IONIZING-RADIATION; MRE11 COMPLEX; IN-VITRO; CHECKPOINT; ACTIVATION; REPAIR	Ataxia-telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) are members of the phosphoinositide-3-kinase-related protein kinase (PIKK) family, and are rapidly activated in response to DNA damage. ATM and DNA-PKcs respond mainly to DNA double-strand breaks, whereas ATR is activated by single-stranded DNA and stalled DNA replication forks. In all cases, activation involves their recruitment to the sites of damage. Here we identify related, conserved carboxy-terminal motifs in human Nbs1, ATRIP and Ku80 proteins that are required for their interaction with ATM, ATR and DNA-PKcs, respectively. These motifs are essential not only for efficient recruitment of ATM, ATR and DNA-PKcs to sites of damage, but are also critical for ATM-, ATR- and DNA-PKcs-mediated signalling events that trigger cell cycle checkpoints and DNA repair. Our findings reveal that recruitment of these PIKKs to DNA lesions occurs by common mechanisms through an evolutionarily conserved motif, and provide direct evidence that PIKK recruitment is required for PIKK-dependent DNA-damage signalling.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 				Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brewerton SC, 2004, J STRUCT BIOL, V145, P295, DOI 10.1016/j.jsb.2003.11.024; Brodsky MH, 2000, GENE DEV, V14, P666; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	42	948	1004	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					605	611		10.1038/nature03442	http://dx.doi.org/10.1038/nature03442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15758953				2022-12-28	WOS:000228011000036
J	Yuspa, SH; Epstein, EH				Yuspa, SH; Epstein, EH			An anchor for tumor cell invasion	SCIENCE			English	Editorial Material							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; TRANSFORMING-GROWTH-FACTOR; COLLAGEN VII; CARCINOMA		NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94108 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	Yuspa, SH (corresponding author), NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA.	sy12j@nih.gov; epsteine@derm.ucsf.edu						Arbiser JL, 2004, J INVEST DERMATOL, V123, P788, DOI 10.1111/j.0022-202X.2004.23418.x; Arbiser JL, 1998, MOL MED, V4, P191, DOI 10.1007/BF03401916; Calonge MJ, 2004, J BIOL CHEM, V279, P23759, DOI 10.1074/jbc.M402178200; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Glick AB, 2004, CANCER BIOL THER, V3, P276, DOI 10.4161/cbt.3.3.849; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Ortiz-Urda S, 2005, SCIENCE, V307, P1773, DOI 10.1126/science.1106209; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Woodley DT, 2004, NAT MED, V10, P693, DOI 10.1038/nm1063	10	7	7	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1727	1728		10.1126/science.1110346	http://dx.doi.org/10.1126/science.1110346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774745				2022-12-28	WOS:000227883900029
J	Bylander, J; Duty, T; Delsing, P				Bylander, J; Duty, T; Delsing, P			Current measurement by real-time counting of single electrons	NATURE			English	Article							ONE-DIMENSIONAL ARRAYS; SMALL TUNNEL-JUNCTIONS; ULTRASMALL JUNCTIONS; COULOMB BLOCKADE; TRANSISTOR; OSCILLATIONS; FLUCTUATIONS; PUMP	The fact that electrical current is carried by individual charges has been known for over 100 years, yet this discreteness has not been directly observed so far. Almost all current measurements involve measuring the voltage drop across a resistor, using Ohm's law, in which the discrete nature of charge does not come into play. However, by sending a direct current through a microelectronic circuit with a chain of islands connected by small tunnel junctions, the individual electrons can be observed one by one. The quantum mechanical tunnelling of single charges in this one-dimensional array is time correlated(1-3), and consequently the detected signal has the average frequency f = I/e, where I is the current and e is the electron charge. Here we report a direct observation of these time-correlated single-electron tunnelling oscillations, and show electron counting in the range 5 fA - 1 pA. This represents a fundamentally new way to measure extremely small currents, without offset or drift. Moreover, our current measurement, which is based on electron counting, is self-calibrated, as the measured which is based on electron counting, is self-calibrated, as the measured frequency is related to the current only by a natural constant.	Chalmers, Dept Microtechnol & Nanosci MC2, SE-41296 Gothenburg, Sweden	Chalmers University of Technology	Bylander, J (corresponding author), Chalmers, Dept Microtechnol & Nanosci MC2, SE-41296 Gothenburg, Sweden.	jonas.bylander@mc2.chalmers.se	Duty, Timothy L/B-4747-2010; Bylander, Jonas/A-4636-2011; Delsing, Per/F-7288-2010	Duty, Timothy L/0000-0003-1903-3745; Bylander, Jonas/0000-0003-4521-710X; Delsing, Per/0000-0002-1222-3506				Averin D. V., 1985, Soviet Physics - JETP, V61, P407; AVERIN DV, 1986, J LOW TEMP PHYS, V62, P345, DOI 10.1007/BF00683469; Bakhvalov N. S., 1989, Soviet Physics - JETP, V68, P581; BENJACOB E, 1985, PHYS LETT A, V108, P289, DOI 10.1016/0375-9601(85)90750-9; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; CLELAND AN, 1990, PHYS REV LETT, V64, P1565, DOI 10.1103/PhysRevLett.64.1565; DELSING P, 1989, PHYS REV LETT, V63, P1861, DOI 10.1103/PhysRevLett.63.1861; DELSING P, 1989, PHYS REV LETT, V63, P1180, DOI 10.1103/PhysRevLett.63.1180; DELSING P, 1991, IEEE T MAGN, V27, P2581, DOI 10.1109/20.133743; DOLAN GJ, 1977, APPL PHYS LETT, V31, P337, DOI 10.1063/1.89690; Flensberg K, 1999, INT J MOD PHYS B, V13, P2651, DOI 10.1142/S0217979299002587; Fujisawa T, 2004, APPL PHYS LETT, V84, P2343, DOI 10.1063/1.1691491; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; GEERLIGS LJ, 1990, PHYS REV LETT, V64, P2691, DOI 10.1103/PhysRevLett.64.2691; Kaplan DM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045321; Keller MW, 1996, APPL PHYS LETT, V69, P1804, DOI 10.1063/1.117492; Korotkov AN, 1998, APPL PHYS LETT, V72, P3226, DOI 10.1063/1.121557; KOROTKOV AN, 1994, PHYS REV B, V50, P17674, DOI 10.1103/PhysRevB.50.17674; KUZMIN LS, 1991, PHYS REV LETT, V67, P1161, DOI 10.1103/PhysRevLett.67.1161; Levitov LS, 1996, J MATH PHYS, V37, P4845, DOI 10.1063/1.531672; LIKHAREV KK, 1991, NATO ADV SCI I B-PHY, V251, P371; LIKHAREV KK, 1985, J LOW TEMP PHYS, V59, P347, DOI 10.1007/BF00683782; LIKHAREV KK, 1987, IEEE T MAGN, V23, P1142, DOI 10.1109/TMAG.1987.1065001; LIKHAREV KK, 1989, IEEE T MAGN, V25, P1436, DOI 10.1109/20.92566; MIDDLETON AA, 1993, PHYS REV LETT, V71, P3198, DOI 10.1103/PhysRevLett.71.3198; Pashkin YA, 1999, APPL PHYS LETT, V74, P132, DOI 10.1063/1.122973; POTHIER H, 1992, EUROPHYS LETT, V17, P249, DOI 10.1209/0295-5075/17/3/011; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; VISSCHER E, 1996, THESIS DELFT U TECHN; Visscher EH, 1996, APPL PHYS LETT, V68, P2014, DOI 10.1063/1.115622	31	181	185	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					361	364		10.1038/nature03375	http://dx.doi.org/10.1038/nature03375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772655	Green Submitted			2022-12-28	WOS:000227715100045
J	Lee, TH				Lee, TH			Quiet in the library	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1068	1068		10.1056/NEJMp048360	http://dx.doi.org/10.1056/NEJMp048360			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784662				2022-12-28	WOS:000227655000003
J	Currie, GP; Devereux, GS; Lee, DKC; Ayres, JG				Currie, GP; Devereux, GS; Lee, DKC; Ayres, JG			Recent developments in asthma management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; ANTIIMMUNOGLOBULIN-E THERAPY; PLACEBO-CONTROLLED TRIAL; SMOOTH-MUSCLE-CELLS; DOUBLE-BLIND; AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; FLUTICASONE; MONTELUKAST; SALMETEROL		Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland; Dept Environm & Occupat Med, Aberdeen AB25 2ZP, Scotland; Ipswich Hosp, Dept Resp Med, Ipswich IP4 5PD, Suffolk, England	University of Aberdeen; University of Aberdeen; Ipswich Hospital NHS Trust; Ipswich Hospital	Currie, GP (corresponding author), Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland.	graeme.currie@nhs.net		Currie, Graeme P/0000-0002-5711-9147				Anderson HR, 2005, BRIT MED J, V330, P117, DOI 10.1136/bmj.38316.729907.8F; Ayres JG, 2004, ALLERGY, V59, P701, DOI 10.1111/j.1398-9995.2004.00533.x; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Camargo CA, 2003, AM J RESP CRIT CARE, V167, P528, DOI 10.1164/rccm.200208-802OC; Cooper S, 2003, THORAX, V58, P674, DOI 10.1136/thorax.58.8.674; Currie GP, 2003, AM J RESP CRIT CARE, V167, P1232, DOI 10.1164/rccm.200209-1116OC; Currie GP, 2003, CLIN EXP ALLERGY, V33, P783, DOI 10.1046/j.1365-2222.2003.01688.x; Currie GP, 2003, EUR J CLIN PHARMACOL, V59, P11, DOI 10.1007/s00228-003-0571-9; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; Fogarty A, 2003, CLIN EXP ALLERGY, V33, P1355, DOI 10.1046/j.1365-2222.2003.01777.x; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; *GINA, NIH PUBL; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; HOLLOWAY E, 2001, COCHRANE DATABASE SY; Holt S, 2001, BRIT MED J, V323, P253, DOI 10.1136/bmj.323.7307.253; Ilowite J, 2004, ANN ALLERG ASTHMA IM, V92, P641, DOI 10.1016/S1081-1206(10)61430-5; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Leuppi JD, 2001, AM J RESP CRIT CARE, V163, P406, DOI 10.1164/ajrccm.163.2.9912091; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pearson PJK, 2004, THORAX, V59, P652, DOI 10.1136/thx.2004.022616; Plant PK, 2003, THORAX, V58, P537, DOI 10.1136/thorax.58.6.537; Porter R S, 2001, Eur J Emerg Med, V8, P9, DOI 10.1097/00063110-200103000-00003; Powell RM, 2003, EXPERT OPIN THER TAR, V7, P485; RAM FS, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000993.PUB2; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Silverman RA, 2002, CHEST, V122, P489, DOI 10.1378/chest.122.2.489; Silverman RA, 2004, CHEST, V126, P1480, DOI 10.1378/chest.126.5.1480; Vignola AM, 2004, ALLERGY, V59, P709, DOI 10.1111/j.1398-9995.2004.00550.x; Woodcock A, 2003, NEW ENGL J MED, V349, P225, DOI 10.1056/NEJMoa023175; WOODS RK, 2000, COCHRANE DB SYST REV; 2003, THORAX S1, V58, P1	39	13	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					585	589		10.1136/bmj.330.7491.585	http://dx.doi.org/10.1136/bmj.330.7491.585			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15761000	Green Published			2022-12-28	WOS:000227622300021
J	Dieppe, PA; Lohmander, LS				Dieppe, PA; Lohmander, LS			Pathogenesis and management of pain in osteoarthritis	LANCET			English	Review							RADIOGRAPHIC KNEE OSTEOARTHRITIS; BONE-MINERAL DENSITY; HAND OSTEOARTHRITIS; HIP OSTEOARTHRITIS; OSTEO-ARTHRITIS; MUSCULOSKELETAL DISORDERS; GENETIC CONTRIBUTION; JOINT REPLACEMENT; UNITED-STATES; BRISTOL OA500	The term osteoarthritis describes a common, age-related, heterogeneous group of disorders characterised pathologically by focal areas of loss of articular cartilage in synovial joints, associated with varying degrees of orsteophyte formation, subchondral bone change, and synovitis. joint damage is caused by a mixture of systemic factors that predispose to the disease, and local mechanical factors that dictate its distribution and severity. Various genetic abnormalities have been described, but most sporadic osteoarthritis probably depends on minor contributions from several genetic loci. Osteoarthritic joint damage may be associated with clinical problems, but the severity of joint disease is only weakly related to that of the clinical problem. For this reason the associations and pathogenesis of pain are in as much need of investigation as joint damage. Subchondral bone and synovium may be responsible for nociceptive stimuli, and peripheral neuronal sensitisation. is an important feature, and can result in normal activities (such as walking) causing pain. Central pain sensitisation can also occur, and psychosocial factors are important determinants of pain severity. We present a stepwise approach to the management of osteoarthritis.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Lund Univ, Dept Orthopaed, Inst Musculoskeletal Dis, Lund, Sweden	University of Bristol; Lund University	Dieppe, PA (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	p.Dieppe@bristol.ac.uk	Lohmander, Stefan/AAL-8314-2021; Lohmander, Stefan/I-8326-2012	Lohmander, Stefan/0000-0002-5424-9448; 				Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; ALTMAN RD, 1991, SEMIN ARTHRITIS RHEU, V20, P40, DOI 10.1016/0049-0172(91)90026-V; Amin S, 2004, ARTHRITIS RHEUM, V50, pS142; Bajaj P, 2001, PAIN, V93, P107, DOI 10.1016/S0304-3959(01)00300-1; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bettica P, 2002, ARTHRITIS RHEUM, V46, P3178, DOI 10.1002/art.10630; Bischoff HA, 2003, OSTEOARTHRITIS, P381; BRADLEY LA, 2004, NOVART FDN SYMP, V260, P270; Bradley Laurence A, 2004, Novartis Found Symp, V260, P258; BRANDT KD, 1991, ARTHRITIS RHEUM, V34, P1381; Brooks P, 2003, B WORLD HEALTH ORGAN, V81, P689; Burr D, 2003, OSTEOARTHRITIS, P125; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Creamer P, 1999, ARTHRIT CARE RES, V12, P3, DOI 10.1002/1529-0131(199902)12:1<3::AID-ART2>3.0.CO;2-K; Creamer P, 1996, J RHEUMATOL, V23, P1031; CROFT P, 1993, J RHEUMATOL, V20, P710; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; DEKKER J, 1993, BEHAV RES THER, V31, P203, DOI 10.1016/0005-7967(93)90073-4; Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364; Dieppe P, 2003, RHEUM DIS CLIN N AM, V29, P687, DOI 10.1016/S0889-857X(03)00054-1; DIEPPE P, 1993, ANN RHEUM DIS, V52, P557, DOI 10.1136/ard.52.8.557; Dieppe P, 2000, OSTEOARTHR CARTILAGE, V8, P63, DOI 10.1053/joca.1999.0272; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; DOHERTY M, 1983, LANCET, V2, P8; Ehrlich G E, 2001, Curr Rheumatol Rep, V3, P484, DOI 10.1007/s11926-001-0062-x; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Englund M, 2004, ARTHRITIS RHEUM, V50, P469, DOI 10.1002/art.20035; Farrell M, 2000, J RHEUMATOL, V27, P441; Felson DT, 2003, ANN INTERN MED, V139, P330, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00008; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Forster T, 2004, HUM GENET, V114, P391, DOI 10.1007/s00439-004-1083-0; Greenspan Adam, 2003, Semin Musculoskelet Radiol, V7, P155; HADLER N, 2003, OSTEOARTHRITIS, P189; Hannan MT, 2000, J RHEUMATOL, V27, P1513; HEINEGARD D, 2003, OSTEOARTHRITIS, P73; HOCHBERG MC, 1989, SEMIN ARTHRITIS RHEU, V18, P4, DOI 10.1016/0049-0172(89)90008-5; Hochberg MC, 2004, J RHEUMATOL, V31, P6; Hunter D, 2004, ARTHRITIS RHEUM, V50, pS141; HUNTER DJ, 2004, T ORTHOP RES SOC, V29, P284; Ingvarsson T, 2001, ARTHRITIS RHEUM-US, V44, P2548, DOI 10.1002/1529-0131(200111)44:11<2548::AID-ART435>3.0.CO;2-S; Ingvarsson T, 2000, ARTHRITIS RHEUM, V43, P2785, DOI 10.1002/1529-0131(200012)43:12<2785::AID-ANR19>3.0.CO;2-I; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kaila-Kangas L, 2004, SPINE, V29, P1823, DOI 10.1097/01.BRS.0000134572.46151.0A; Keefe FJ, 2004, PAIN, V110, P571, DOI 10.1016/j.pain.2004.03.028; KELLGREN JH, 1952, BRIT MED J, V1, P181, DOI 10.1136/bmj.1.4751.181; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kidd BL, 2003, NEUROREPORT, V14, P2189, DOI 10.1097/00001756-200312020-00011; Kidd BL, 2004, NOVART FDN SYMP, V260, P33; Kidd BL, 2004, NOVART FDN SYMP, V260, P277; Kidd Bruce L, 2004, Novartis Found Symp, V260, P122; Lanyon P, 2000, BRIT MED J, V321, P1179, DOI 10.1136/bmj.321.7270.1179; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LICHTENBERG PA, 1986, J PSYCHOSOM RES, V30, P327, DOI 10.1016/0022-3999(86)90010-3; Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155; Linaker CH, 1999, BEST PRACT RES CL RH, V13, P197, DOI 10.1053/berh.1999.0016; LINDBERG H, 1986, CLIN ORTHOP RELAT R, V203, P273; Lohmander S, 2004, ARTHRITIS RHEUM, V50, pS140; Loughlin J, 1999, AM J HUM GENET, V65, P1795, DOI 10.1086/302685; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Loughlin J, 2003, CURR OPIN PHARMACOL, V3, P295, DOI 10.1016/S1471-4892(03)00018-3; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Mazzuca SA, 2004, J RHEUMATOL, V31, P329; MCALINDON T, 1989, ANN RHEUM DIS, V48, P531, DOI 10.1136/ard.48.7.531; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; MCCRAE F, 1992, ANN RHEUM DIS, V51, P938, DOI 10.1136/ard.51.8.938; Melzack R, 2001, ANN NY ACAD SCI, V933, P157; Murray C. J. L., 1996, GLOBAL BURDEN DIS; O'Reilly SC, 1998, BRIT J RHEUMATOL, V37, P870; Paradowski Przemyslaw T, 2004, Health Qual Life Outcomes, V2, P38, DOI 10.1186/1477-7525-2-38; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; PETERFY CG, 2003, OSTEOARTHRITIS, P433; Petersson IF, 1996, ANN RHEUM DIS, V55, P659, DOI 10.1136/ard.55.9.659; Picavet HSJ, 2004, ANN RHEUM DIS, V63, P723, DOI 10.1136/ard.2003.010769; Pritzker K. P. H, 2003, OSTEOARTHRITIS, P49; Quilty B, 2003, J RHEUMATOL, V30, P1311; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; SAHLSTROM A, 1997, CLIN ORTHOP RELAT R, V340, P152; Sanders C, 2004, RHEUMATOLOGY, V43, P353, DOI 10.1093/rheumatology/keh044; SANDY JD, 2003, OSTEOARTHRITIS, P82; Schneider DL, 2002, J RHEUMATOL, V29, P1467; Scott D, 2004, CLIN EVID, V11, P1560; Sharma L, 2003, OSTEOARTHRITIS, V2, P177; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Smith AJP, 2004, GENES IMMUN, V5, P451, DOI 10.1038/sj.gene.6364107; Spector T D, 1993, Osteoarthritis Cartilage, V1, P203, DOI 10.1016/S1063-4584(05)80325-5; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Van den Berg W, 2003, OSTEOARTHRITIS, P147; Watson P J, 1993, Agents Actions Suppl, V39, P261; Watt IDM., 2003, OSTEOARTHRITIS 2, P211; WESTACOTT CI, 2003, OSTEOARTHRITIS, P133; *WORK BACKS SCOTL, YELL FLAGS; World Health Organization, 2003, BURD MUSC COND START; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang YQ, 2000, J RHEUMATOL, V27, P1032	103	736	765	3	137	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					965	973		10.1016/S0140-6736(05)71086-2	http://dx.doi.org/10.1016/S0140-6736(05)71086-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766999				2022-12-28	WOS:000227559800030
J	Rascol, O; Brooks, DJ; Melamed, E; Oertel, W; Poewe, W; Stocchi, F; Tolosa, E				Rascol, O; Brooks, DJ; Melamed, E; Oertel, W; Poewe, W; Stocchi, F; Tolosa, E		LARGO Study Grp	Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial	LANCET			English	Article							ENTACAPONE; PRAMIPEXOLE; INHIBITOR; PLACEBO	Background Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as monotherapy in early disease. Ibis study investigated rasagiline efficacy and safety in levodopa-treated patients with Parkinson's disease and motor fluctuations. Methods In an 18-week, double-blind, multicentre (74 hospitals and academic centres in Israel, Argentina, and Europe) trial, 687 outpatients were randomly assigned to oral rasagiline (231 individuals; 1 mg once daily), entacapone (227; 200 mg with every levodopa dose), or placebo (229). Primary outcome was change in total daily off-time (intention-to-treat population). Other measures included the clinical global improvement (CGI) score and unified Parkinson's disease rating scale (UPDRS) scores. Analysis was by intention to treat. Findings 88 (13%) patients who were assigned treatment did not complete the study (23 rasagiline, 30 entacapone, 35 placebo), mainly because of withdrawal of consent (n=34) and adverse events (n=34). Both rasagiline and entacapone reduced mean daily off-time (-1.18 h rasagiline and -1.2 h entacapone vs placebo -0.4 h; p=0.0001, p<0.0001, respectively) and increased daily on-time without troublesome dyskinesia. (0.85 h vs placebo 0.03 h; p=0.0005 for both). We recorded significant mean improvements in CGI scores (-0.86 rasagiline and -0.72 entacapone vs -0.37 placebo; p<0.0001, p=0.0002, respectively). Changes in UPDRS scores also significantly improved for activities of daily living during off-time (-1.71 and -1.38 vs placebo; p<0.0001, p=0.0006, respectively) and motor function during on-time (-2.94 and -2.73 vs placebo; both p<0.0001). Frequency of adverse events was similar for all treatments. Interpretation Once-daily rasagiline reduces mean daily off-time and improves symptoms of Parkinson's disease in levodopa-treated patients with motor fluctuations, an effect similar to that of entacapone.	Univ Hosp, Fac Med, Dept Clin Pharmacol, Clin Invest Ctr, F-31073 Toulouse, France; Hammersmith Hosp, Imperial Coll, Fac Med, Div Neurosci, London, England; Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; Univ Marburg, Ctr Nervous Dis, Marburg, Germany; Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; IRCCS Neuromed, Inst Neurol, Pozzilli, Italy; Univ Barcelona, IDIBAPS, Hosp Clin, Inst Malalties Sistema Nervios,Neurol Serv, Barcelona, Spain	CHU de Toulouse; Imperial College London; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Philipps University Marburg; University of Innsbruck; IRCCS Neuromed; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Rascol, O (corresponding author), Univ Hosp, Fac Med, Dept Clin Pharmacol, Clin Invest Ctr, 37 Allees Jules Guesde, F-31073 Toulouse, France.	rascol@cict.fr	stocchi, fabrizio/K-5089-2016	stocchi, fabrizio/0000-0002-5763-0033; Brooks, David/0000-0003-2602-2518				CLARKE CE, 2004, COCHRANE DATABASE SY, V2; CLARKE CE, 2004, COCHRANE DATABASE SY, V2; CLARKE CE, 2004, COCHRANE DATABASE SY, V2; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOULD AL, 1992, COMMUN STAT THEORY, V21, P2833, DOI 10.1080/03610929208830947; Guttman M, 1997, NEUROLOGY, V49, P1060, DOI 10.1212/WNL.49.4.1060; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Hauser RA, 2000, CLIN NEUROPHARMACOL, V23, P75, DOI 10.1097/00002826-200003000-00003; Heikkinen H, 2001, EUR J CLIN PHARMACOL, V56, P821, DOI 10.1007/s002280000244; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kieburtz K, 1997, ANN NEUROL, V42, P747; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; *MOV DIS SOC TASK, 2002, MOV DISORD S4, V17, P166; Rabey JM, 2000, CLIN NEUROPHARMACOL, V23, P324, DOI 10.1097/00002826-200011000-00005; RASCAL O, 2003, ANN NEUROL, V53, P15; Rascol O, 2002, LANCET, V359, P1589, DOI 10.1016/S0140-6736(02)08520-3; Rinne UK, 1998, NEUROLOGY, V51, P1309, DOI 10.1212/WNL.51.5.1309; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; *US DHEW, 1995, COD SYMB THES ADV DR; Wermuth L, 1998, EUR J NEUROL, V5, P235, DOI 10.1046/j.1468-1331.1998.530235.x	22	441	461	2	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					947	954		10.1016/S0140-6736(05)71083-7	http://dx.doi.org/10.1016/S0140-6736(05)71083-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766996	Green Published			2022-12-28	WOS:000227559800027
J	Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS				Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS			Environmental enrichment reduces A beta levels and amyloid deposition in transgenic mice	CELL			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; DENTATE GYRUS; IN-VIVO; MEMORY CONSOLIDATION; SYNAPTIC PLASTICITY; PHYSICAL-ACTIVITY; GENE-EXPRESSION; AGING BRAIN	Cerebral deposition of beta-amyloid (A beta) peptides is an invariant pathological hallmark in brains of patients with Alzheimer's disease (AD) and transgenic mice coexpressing familial AD-linked APP and PS1 variants. We now report that exposure of transgenic mice to an "enriched environment" results in pronounced reductions in cerebral A beta levels and amyloid deposits, compared to animals raised under "standard housing" conditions. The enzymatic activity of an A beta-degrading endopeptidase, neprilysin, is elevated in the brains of "enriched" mice and inversely correlated with amyloid burden. Moreover, DNA microarray analysis revealed selective upregulation in levels of transcripts encoded by genes associated with learning and memory, vasculogenesis, neurogenesis, cell survival pathways, A beta sequestration, and prostaglandin synthesis. These studies provide evidence that environmental enrichment leads to reductions in steady-state levels of cerebral A beta peptides and amyloid deposition and selective upregulation in levels of specific transcripts in brains of transgenic mice.	Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of Chicago; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Kentucky	Mirnics, K (corresponding author), Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA.	karoly+@pitt.edu; ssisodia@drugs.bsd.uchicago.edu	Hairston, Ilana/AAT-7442-2021; Mirnics, Karoly/E-6730-2010; Tang, Ya-Ping/A-1035-2011; Lazarov, Orly/F-9406-2015	Mirnics, Karoly/0000-0002-5521-0254; Lazarov, Orly/0000-0002-5887-948X; Tang, Ya-Ping/0000-0002-0445-4072; Korade, Zeljka/0000-0002-8690-4507	NATIONAL INSTITUTE ON AGING [R01AG019323, P01AG011542, R01AG021494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER; NIA NIH HHS [AG19323, AG021494, AG11542] Funding Source: Medline; NIDA NIH HHS [DA02243] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abe Mayumi, 2001, Angiogenesis, V4, P289, DOI 10.1023/A:1016018617152; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BENZING WC, 1993, BRAIN RES, V625, P125, DOI 10.1016/0006-8993(93)90145-D; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kramer AF, 2002, J MOL NEUROSCI, V19, P227, DOI 10.1007/s12031-002-0038-y; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; LI CW, 1995, METHOD ENZYMOL, V248, P253; Marr RA, 2003, J NEUROSCI, V23, P1992; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Sapolsky RM., 1993, PRIMATE SOCIAL CONFL, P171; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Seo J, 2004, BIOINFORMATICS, V20, P2534, DOI 10.1093/bioinformatics/bth280; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Stein TD, 2002, J NEUROSCI, V22, P7380; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6	63	681	706	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					701	713		10.1016/j.cell.2005.01.015	http://dx.doi.org/10.1016/j.cell.2005.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766532	Bronze			2022-12-28	WOS:000227771400015
J	Lowe, JB				Lowe, JB			Does Notch take the sweet road to success?	SCIENCE			English	Editorial Material							PROTEIN O-FUCOSYL-TRANSFERASE-1; MODULATION; DELTA		Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Lowe, JB (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	johnlowe@umich.edu			NCI NIH HHS [1P01CA71932] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Moohr OL, 1919, GENETICS, V4, P252; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434	12	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1570	1572		10.1126/science.1110533	http://dx.doi.org/10.1126/science.1110533			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761143				2022-12-28	WOS:000227622400030
J	Chaiyasate, K; Hramiec, J				Chaiyasate, K; Hramiec, J			Images in clinical medicine: Tuberculosis empyema necessitatis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Providence Hosp & Med Ctr, Southfield, MI 48075 USA		Chaiyasate, K (corresponding author), Providence Hosp & Med Ctr, Southfield, MI 48075 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					E8	E8		10.1056/NEJMicm040373	http://dx.doi.org/10.1056/NEJMicm040373			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745972				2022-12-28	WOS:000227310700011
J	van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH				van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH			Phospholipase C gamma 1 controls surface expression of TRPC3 through an intermolecular PH domain	NATURE			English	Article							CHANNELS; RECEPTOR; DATABASE; FOLD	Many ion channels are regulated by lipids(1-3), but prominent motifs for lipid binding have not been identified in most ion channels. Recently, we reported that phospholipase Cgamma1 (PLC-gamma1) binds to and regulates TRPC3 channels(4), components of agonist-induced Ca2+ entry into cells. This interaction requires a domain in PLC-gamma1 that includes a partial pleckstrin homology (PH)domain - a consensus lipid-binding and protein-binding sequence(5,6). We have developed a gestalt algorithm to detect hitherto 'invisible' PH and PH-like domains, and now report that the partial PH domain of PLC-gamma1 interacts with a complementary partial PH-like domain in TRPC3 to elicit lipid binding and cell-surface expression of TRPC3. Our findings imply a far greater abundance of PH domains than previously appreciated, and suggest that intermolecular PH-like domains represent a widespread signalling mode.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kornberg, Michael Davin/K-3329-2019	Kornberg, Michael Davin/0000-0003-2588-7325; van Rossum, Damian/0000-0003-1011-2586				Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; DINITTO JP, 2003, SCI STKE; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	15	151	159	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					99	104		10.1038/nature03340	http://dx.doi.org/10.1038/nature03340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744307				2022-12-28	WOS:000227334600051
J	Chien, KR; Karsenty, G				Chien, KR; Karsenty, G			Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone	CELL			English	Review							GROWTH-FACTOR-I; MITOCHONDRIAL-DNA DELETIONS; SKELETAL-MUSCLE; LIFE-SPAN; OXIDATIVE STRESS; MICE; OSTEOCLAST; DIFFERENTIATION; HYPERTROPHY; REGULATOR	Human aging is characterized by debilitating diseases, including heart failure, cardiac pacemaker defects, muscle wasting, and osteoporosis, in heart, skeletal muscle, and bone. Recent studies are identifying pathways for these aging-related diseases by examining how the process of aging influences tissue-specific progenitors and differentiated cell lineages in these organ systems. These advances form a foundation for new therapeutic strategies to delay the onset of aging-related disorders.	Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Genet, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine	Chien, KR (corresponding author), Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA.	kchien@partners.org; karsenty@bcm.tmc.edu						Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bernecker Oliver Y, 2003, Semin Thorac Cardiovasc Surg, V15, P268, DOI 10.1016/S1043-0679(03)70006-9; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Cheng G, 1999, DEVELOPMENT, V126, P5041; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cooper Cyrus, 1996, P419; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; DUERR RL, 1995, J CLIN INVEST, V95, P619, DOI 10.1172/JCI117706; Elefteriou F, 2003, ENDOCRINOLOGY, V144, P3842, DOI 10.1210/en.2003-0369; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Harada T, 2003, PATHOL INT, V53, P382, DOI 10.1046/j.1440-1827.2003.01485.x; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Perls T, 2003, ANN INTERN MED, V139, P445, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00013; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Ruiz-Lozano P, 2003, NAT GENET, V33, P8, DOI 10.1038/ng0103-8; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SCHWARTZ JB, 2005, BRAUNWALDS HEART DIS, P1925; SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace D C, 2001, Novartis Found Symp, V235, P247; Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687; Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; YOSHIDA H, 1990, NATURE, V16, P391; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	83	105	110	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					533	544		10.1016/j.cell.2005.02.006	http://dx.doi.org/10.1016/j.cell.2005.02.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734685	Bronze			2022-12-28	WOS:000227271500010
J	Laurberg, P				Laurberg, P			Global or Gaelic epidemic of hypothyroidism?	LANCET			English	Editorial Material							IODINE INTAKE; THYROID-DISEASE; POPULATION; HYPERTHYROIDISM; HEALTH		Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Laurberg, P (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark.	laurberg@aas.nja.dk						Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; HALL R, 1987, BRIT MED J, V294, P721, DOI 10.1136/bmj.294.6574.721; Hetzel B.S., 2004, GLOBAL ELIMINATION B; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Laurberg P, 1999, THYROID, V9, P33, DOI 10.1089/thy.1999.9.33; Laurberg P, 2001, THYROID, V11, P457, DOI 10.1089/105072501300176417; LAURBERG P, 2003, IDD NEWSLETTER   NOV, P55; Pedersen IB, 2002, J CLIN ENDOCR METAB, V87, P4462, DOI 10.1210/jc.2002-020750; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; *UN CHILDREN FUND, 2001, ASS IOD DEF DIS MON; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wittig Holger, 2003, Leg Med (Tokyo), V5 Suppl 1, pS173, DOI 10.1016/S1344-6223(02)00103-7	12	18	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					738	740						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733704				2022-12-28	WOS:000227285300009
J	Hewitt, C; Hahn, S; Torgerson, DJ; Watson, J; Bland, MJ				Hewitt, C; Hahn, S; Torgerson, DJ; Watson, J; Bland, MJ			Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONTROLLED CLINICAL-TRIALS; QUALITY; BIAS		Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; Seoul Natl Univ Hosp, Coll Med, Med Res Collaborating Ctr, Seoul 110744, South Korea	University of York - UK; Seoul National University (SNU); Seoul National University Hospital	Hewitt, C (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	ceh121@york.ac.uk	Watson, Judith/H-5821-2019; Torgerson, David/L-4566-2019; Hahn, Seokyung/J-5705-2012	Watson, Judith/0000-0003-0694-3854; Torgerson, David/0000-0002-1667-4275; Hahn, Seokyung/0000-0002-4684-4917; Hewitt, Catherine Elizabeth/0000-0002-0415-3536				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; EMERSON JD, 1990, CONTROL CLIN TRIALS, V11, P339, DOI 10.1016/0197-2456(90)90175-2; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408	5	140	144	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1057	1058		10.1136/bmj.38413.576713.AE	http://dx.doi.org/10.1136/bmj.38413.576713.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15760970	Green Published, Bronze			2022-12-28	WOS:000229090900019
J	Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM				Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM			Amplification of acetylcholine-binding catenanes from dynamic combinatorial libraries	SCIENCE			English	Article							SELECTION; CHEMISTRY; RECEPTORS; HOSTS	Directed chemical synthesis can produce a vast range of molecular structures, but the intended product must be known at the outset. In contrast, evolution in nature can lead to efficient receptors and catalysts whose structures defy prediction. To access such unpredictable structures, we prepared dynamic combinatorial libraries in which reversibly binding building blocks assemble around a receptor target. We selected for an acetylcholine receptor by adding the neurotransmitter to solutions of dipeptide hydrazones [proline-phenylalanine or proline-(cyclohexyl)alanine], which reversibly combine through hydrazone linkages. At thermodynamic equilibrium, the dominant receptor structure was an elaborate [2]-catenane consisting of two interlocked macrocyclic trimers. This complex receptor with a 100 nM affinity for acetylcholine could be isolated on a preparative scale in 67% yield.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Sanders, JKM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jkms@cam.ac.uk	Naumann, Christoph/A-4552-2010; Jarrosson, Thibaut/K-8730-2018; Otto, Sijbren/E-9568-2014	Jarrosson, Thibaut/0000-0002-2673-4198; Otto, Sijbren/0000-0003-0259-5637; Sanders, Jeremy Keith Morris/0000-0002-5143-5210	Engineering and Physical Sciences Research Council [GR/S76892/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BRADY PA, 1996, CHEM COMMUN, V35, P2143; Brisig B, 2003, ANGEW CHEM INT EDIT, V42, P1270, DOI 10.1002/anie.200390326; Corbett PT, 2004, CHEM-EUR J, V10, P3139, DOI 10.1002/chem.200400300; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; Dietrich-Buchecker C, 1999, CHEM COMMUN, P615, DOI 10.1039/a809885i; Godt A, 2004, EUR J ORG CHEM, V2004, P1639, DOI 10.1002/ejoc.200300503; HUNTER CA, 1992, J AM CHEM SOC, V114, P5303, DOI 10.1021/ja00039a047; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Otto S, 2002, SCIENCE, V297, P590, DOI 10.1126/science.1072361; Otto S, 2003, J AM CHEM SOC, V125, P7804, DOI 10.1021/ja0351589; Otto S, 2003, CURR OPIN DRUG DISC, V6, P509; Raehm L, 2002, SYNLETT, P1743; Ramstrom O, 2002, NAT REV DRUG DISCOV, V1, P26, DOI 10.1038/nrd704; Roberts SL, 2003, ORG BIOMOL CHEM, V1, P1625, DOI 10.1039/b300956d; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Sarri P, 2004, J ORG CHEM, V69, P3654, DOI 10.1021/jo049899j; Vignon SA, 2004, ORG LETT, V6, P1095, DOI 10.1021/ol0364881	17	242	242	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					667	669		10.1126/science.1109999	http://dx.doi.org/10.1126/science.1109999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15761119				2022-12-28	WOS:000228810900041
J	Lindholt, JS; Juul, S; Fasting, H; Henneberg, EW				Lindholt, JS; Juul, S; Fasting, H; Henneberg, EW			Screening for abdominal aortic aneurysms: single centre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION; MORTALITY; MASS; SURVEILLANCE; PROGRAM; REPAIR	Objective To determine whether mass screening of Danish men aged 65 or more for abdominal aortic aneurysms reduces mortality. Design Single centre randomised controlled trial. Setting All five hospitals in Viborg County, Denmark. Participants All 12 639 men born during 1921-33 and living in Viborg County. In 1994 we included men born 1921-9 (64-73 years). We also included men who became 65 during 1995-8. Interventions Men were randomised to the intervention group (screening by abdominal ultrasonography) or control group. Participants with an abdominal aortic aneurysm > 5 cm were referred for surgical evaluation, and those with smaller aneurysms were offered annual scans. Outcome measures Specific mortality due to abdominal aortic aneurysm, overall mortality, and number of planned and emergency operations for abdominal aortic aneurysms. Results 4860 of 6333 men were screened (attendance rate 76.6%).191 (4.0% of those screened) had abdominal aortic aneurysms. The mean follow-up time was 52 months. The screened group underwent 75% (95% confidence interval 34% to 91%) fewer emergency operations than the control group. Deaths due to abdominal aortic aneurysms occurred in nine patients in the screened group and 27 in the control group. The number needed to screen to save one life was 352. Specific mortality was significantly reduced by 67% (29% to 84%). Mortality due to non-abdominal aortic aneurysms was non-significantly reduced by 8%. The benefits of screening may increase with time. Conclusion Mass screening of men aged 65 or more for abdominal aortic aneurysms reduces mortality.	Sygehus Viborg, Dept Vasc Surg, Vasc Res Unit, DK-8800 Viborg, Denmark; Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, DK-8000 Aarhus, Denmark	Aarhus University	Lindholt, JS (corresponding author), Sygehus Viborg, Dept Vasc Surg, Vasc Res Unit, DK-8800 Viborg, Denmark.	jes.s.lindholt@sygehusvriborg.dk	Lindholt, Jes/J-2907-2014	Lindholt, Jes/0000-0001-9536-4488				Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; BENGTSSON H, 1993, J VASC SURG, V18, P74, DOI 10.1067/mva.1993.42107; BERRIDGE DC, 1995, BRIT J SURG, V82, P906, DOI 10.1002/bjs.1800820716; Forbes JF, 1998, LANCET, V352, P1656; Harris PL, 2000, J VASC SURG, V32, P739, DOI 10.1067/mva.2000.109990; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lindholt J S, 1996, J Med Screen, V3, P43; Lindholt JS, 1998, J PUBLIC HEALTH MED, V20, P211, DOI 10.1093/oxfordjournals.pubmed.a024745; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P79, DOI 10.1053/ejvs.1999.1087; Lindholt JS, 1997, BRIT J SURG, V84, P40; LINDHOLT JS, 1995, EUR J VASC ENDOVASC, V10, P466, DOI 10.1016/S1078-5884(05)80170-4; Lindholt JS, 2002, EUR J VASC ENDOVASC, V23, P55, DOI 10.1053/ejvs.2001.1534; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; LINDHOLT JS, 1998, THESIS COPENHAGEN; LUCAROTTI M, 1993, EUR J VASCULAR SURG, V7, P397, DOI 10.1016/S0950-821X(05)80256-7; MORRIS GE, 1994, EUR J VASCULAR SURG, V8, P156, DOI 10.1016/S0950-821X(05)80451-7; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Powell JT, 1998, LANCET, V352, P1649; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; SMITH FCT, 1993, BRIT J SURG, V80, P1406, DOI 10.1002/bjs.1800801117	23	268	270	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2005	330	7494					750	752B		10.1136/bmj.38369.620162.82	http://dx.doi.org/10.1136/bmj.38369.620162.82			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914JE	15757960	Bronze, Green Published			2022-12-28	WOS:000228222900014
J	Gask, L				Gask, L			Role of specialists in common chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; CHRONIC ILLNESS; MANAGEMENT; MODEL	Consultant care is currently available to only a small proportion of people with chronic illness. How can we enable many more people to benefit front specialist expertise?	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9DL, Lancs, England	University of Manchester	Gask, L (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9DL, Lancs, England.	linda.gask@manchester.ac.uk						Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; BAILEY JJ, 1994, BRIT MED J, V308, P1083, DOI 10.1136/bmj.308.6936.1083; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Department of Health, IMPR CHRON DIS MAN; Dixon J, 2004, BRIT MED J, V328, P223, DOI 10.1136/bmj.328.7433.223; Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3; Esterman AJ, 2002, MED J AUSTRALIA, V177, P469, DOI 10.5694/j.1326-5377.2002.tb04911.x; Gask L, 2004, ANN FAM MED, V2, P150, DOI 10.1370/afm.58; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; GLASGOW RE, 1995, DIABETES CARE, V18, P117, DOI 10.2337/diacare.18.1.117; Katon W, 2001, GEN HOSP PSYCHIAT, V23, P138, DOI 10.1016/S0163-8343(01)00136-0; McCulloch D K, 1998, Eff Clin Pract, V1, P12; SEAL L, 2004, HLTH POLICY, V69, P215; WAGNER EH, 1995, PATIENT EDUC COUNS, V26, P225, DOI 10.1016/0738-3991(95)00761-N; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wanger EH, 1998, ANN INTERN MED, V129, P654, DOI 10.7326/0003-4819-129-8-199810150-00015	16	30	30	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					651	653		10.1136/bmj.330.7492.651	http://dx.doi.org/10.1136/bmj.330.7492.651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774998	Green Published			2022-12-28	WOS:000227861700028
J	Mangili, A; Gendreau, MA				Mangili, A; Gendreau, MA			Transmission of infectious diseases during commercial air travel	LANCET			English	Review							ACUTE RESPIRATORY SYNDROME; MYCOBACTERIUM-TUBERCULOSIS; IN-FLIGHT; OUTBREAK; AIRCRAFT; MANAGEMENT; EXPOSURE; QUALITY; ILLNESS; CHOLERA	Because of the increasing ease and affordability of air travel and mobility of people, airborne, food-borne, vector-borne, and zoonotic infectious diseases transmitted during commercial air travel are an important public health issue. Heightened fear of bioterrorism agents has caused health officials to re-examine the potential of these agents to be spread by air travel. The severe acute respiratory syndrome outbreak of 2002 showed how air travel can have an important role in the rapid spread of newly emerging infections and could potentially even start pandemics. In addition to the flight crew, public health officials and health care professionals have an important role in the management of infectious diseases transmitted on airlines and should be familiar with guidelines provided by local and international authorities.	Lahey Clin Med Ctr, Dept Emergency Med, Burlington, MA 01805 USA; Tufts Univ New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	Lahey Hospital & Medical Center; Tufts Medical Center	Gendreau, MA (corresponding author), Lahey Clin Med Ctr, Dept Emergency Med, Burlington, MA 01805 USA.	mark.a.gendreau@lahey.org						*AER MED ASS, 1997, MED GUID AIRL TRAV; AMLER RW, 1982, JAMA-J AM MED ASSOC, V248, P2129, DOI 10.1001/jama.248.17.2129; Amornkul PN, 2004, J INFECT DIS, V189, pS81, DOI 10.1086/377698; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P109; *ASS FLIGHT ATT, 2003, AIRCR AIR QUAL WHATS; *ASS PORT HLTH AUT, COD PRACT DEAL INF D; *AV HLTH WORK GROU, 2001, AIR TRAV HLTH GOV RE; *AV HLTH WORK GROU, 2001, HLTH AIRCR CAB STAG; *AV HLTH WORK GROU, 2004, EXT CAB AIR MEAS INC; BRILEY J, 2003, WASHINGTON POST 0603; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, pRR16; *CDCP, 1963, MMWR-MORBID MORTAL W, V12, P56; *CDCP, FACT SHEET LEG AUTH; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P309; *CDCP, 2004, EP PREV VACC PREV DI; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241; Centers for Disease Control and Prevention, 2003, GUID ENV INF CONTR H; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P137; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P485; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P215; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; CHIN J, 2000, CONTROL COMMUNICABLE; DRIVER CR, 1994, JAMA-J AM MED ASSOC, V272, P1031, DOI 10.1001/jama.272.13.1031; EberhartPhillips J, 1996, EPIDEMIOL INFECT, V116, P9, DOI 10.1017/S0950268800058891; EISENBERG MS, 1975, LANCET, V2, P595; *FLIGHT SAF FDN, 1998, GUID EN HLTH CAR AUT; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; HARDIMAN M, 2003, 41 ANN M INF DIS SOC; Hatakka M., 2000, HYGIENIC QUALITY FOO; Hocking MB, 1998, AM IND HYG ASSOC J, V59, P446, DOI 10.1080/15428119891010181; Hocking MB, 2000, CHEMOSPHERE, V41, P603, DOI 10.1016/S0045-6535(99)00537-8; *INF CONTR COMM, 2004, INF CONTR MAN; Jelinek T., 1998, Journal of Travel Medicine, V5, P44; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; KLONTZ KC, 1989, AM J EPIDEMIOL, V129, P341, DOI 10.1093/oxfordjournals.aje.a115137; Ko G, 2004, RISK ANAL, V24, P379, DOI 10.1111/j.0272-4332.2004.00439.x; LAKSHMANAN I, 2003, BOSTON GLOBE    0518, pA1; LAUREL J, 1999, CLIN INFECT DIS, V32, P1639; Lester R, 1991, COMMUN DIS INTELL, V15, P292; Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x; MCFARLAND JW, 1993, LANCET, V342, P112, DOI 10.1016/0140-6736(93)91311-9; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P707; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; NAGDA NL, 1989, DOTP15895; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; National Research Council, 1986, AIRL CAB ENV AIR QUA; National Research Council, 2002, AIRL CAB ENV HLTH PA, DOI [DOI 10.17226/10238, 10.17226/10238]; O'Brien KK, 2003, AM FAM PHYSICIAN, V67, P1927; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; *PALL CORP, 1998, PALL CAB AIR FILT BR; PERZ J, 2001, J INFECT DIS, V5, P189; Rayman RB, 1997, AVIAT SPACE ENVIR MD, V68, P432; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; RITZINGER FR, 1965, AEROMED REV, V4, P1; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; *SAF HLTH TEAM, 2004, AIRCR DIS REQ; Sampathkumar P, 2003, MAYO CLIN PROC, V78, P882, DOI 10.4065/78.7.882; Sato K, 2000, EPIDEMIOL INFECT, V124, P507, DOI 10.1017/S0950268899003738; *SEL COMM SCI TECH, 2000, 5 SEL COMM SCI TECHN; SIMPSON REH, 1952, LANCET, V263, P549; SLATER P, TRAVEL MED INT, V13, P92; SUTTON RGA, 1974, J HYG-CAMBRIDGE, V72, P441, DOI 10.1017/S0022172400023688; TAUXE RV, 1987, AM J EPIDEMIOL, V125, P150, DOI 10.1093/oxfordjournals.aje.a114498; Thibeault C, 1997, AVIAT SPACE ENVIR MD, V68, P80; *US GEN ACC OFF, 2004, AV SAF MOR RES NEED; *US HR, 2003, AIRCR CAB ENV; Van den Ende J, 1998, ACTA CLIN BELG, V53, P259; VERGANO D, 2003, US TODAY        0930; Wang PD, 2000, AM J INFECT CONTROL, V28, P233, DOI 10.1067/mic.2000.103555; *WHO, 1998, WHOTB98256; *WHO, 2003, UPD 62 MOR 8000 CAS; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P157; WICK RL, 1995, AVIAT SPACE ENVIR MD, V66, P220; Wilder-Smith A, 2003, J TRAVEL MED, V10, P299, DOI 10.2310/7060.2003.2737; Withers MR, 2000, MIL MED, V165, P1; World Health Organization, 2003, CONS DOC EP SEV AC R; World Health Organization, PRACT GUID INF CONTR; World Health Organization (WHO), 2003, SUMM SARS AIR TRAV; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zitter JN, 2002, JAMA-J AM MED ASSOC, V288, P483, DOI 10.1001/jama.288.4.483	87	355	374	3	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					989	996		10.1016/S0140-6736(05)71089-8	http://dx.doi.org/10.1016/S0140-6736(05)71089-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767002	Green Published, Bronze			2022-12-28	WOS:000227559800033
J	Pincock, S				Pincock, S			Elizabeth Nabel: new director of US National Heart, Lung, and Blood Institute	LANCET			English	Biographical-Item												stephenpincock@blueyonder.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					931	931		10.1016/S0140-6736(05)71067-9	http://dx.doi.org/10.1016/S0140-6736(05)71067-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766982				2022-12-28	WOS:000227559800012
J	Markel, H				Markel, H			The accidental addict	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA.							FREUD S, 1974, COCAINE PAPERS, P48; Halsted WS, 1885, NY MED J, V42, P294; HEUER G W, 1952, Bull Johns Hopkins Hosp, V90, P1; OLCH PD, 1975, ANESTHESIOLOGY, V42, P479, DOI 10.1097/00000542-197504000-00019; OSLER W, 1969, JOHNS HOPKINS MED J, V125, P184	5	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					966	968		10.1056/NEJMp048240	http://dx.doi.org/10.1056/NEJMp048240			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904JC	15758006				2022-12-28	WOS:000227491200004
J	Lawn, JE; Cousens, S; Zupan, J				Lawn, JE; Cousens, S; Zupan, J		Lancet Neonatal Survival Steering	Neonatal survival 1 - 4 million neonatal deaths: When? where? why?	LANCET			English	Review							LOW-BIRTH-WEIGHT; PERINATAL-MORTALITY; MATERNAL MORTALITY; RISK-FACTORS; PREGNANCY; HEALTH; CHINA; CARE; EPIDEMIOLOGY; SYPHILIS	The proportion of child deaths that occurs in the neonatal period (38% in 2000) is increasing, and the Millennium Development Goal for child survival cannot be met without substantial reductions in neonatal mortality. Every year an estimated 4 million babies die in the first 4 weeks of life (the neonatal period). A similar number are stillborn, and 0.5 million mothers die from pregnancy-related causes. Three-quarters of neonatal deaths happen in the first week-the highest risk of death is on the first day of life. Almost all (99%) neonatal deaths arise in low-income and middle-income countries, yet most epidemiological and other research focuses on the 1% of deaths in rich countries. The highest numbers of neonatal deaths are in south-central Asian countries and the highest rates are generally in sub-Saharan Africa. The countries in these regions (with some exceptions) have made little progress in reducing such deaths in the past 10-15 years. Globally, the main direct causes of neonatal death are estimated to be preterm birth (28%), severe infections (26%), and asphyxia (23%). Neonatal tetanus accounts for a smaller proportion of deaths (7%), but is easily preventable. Low birthweight is an important indirect cause of death. Maternal complications in labour carry a high risk of neonatal death, and poverty is strongly associated with an increased risk. Preventing deaths in newborn babies has not been a focus of child survival or safe motherhood programmes. While we neglect these challenges, 450 newborn children die every hour, mainly from preventable causes, which is unconscionable in the 21st century.	Saving Newborn Lives Save Children, ZA-7405 Cape Town, South Africa; Inst Child Hlth, Int Perinatal Care Unit, ZA-7405 Cape Town, South Africa; London Sch Hyg & Trop Med, London WC1, England; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	Save the Children; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Lawn, JE (corresponding author), Saving Newborn Lives Save Children, 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				Abhay Bang, 2002, Economic and Political Weekly, V37, P4947; ABOUZHAR C, 2003, MATERNAL MORTALITY 2; Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Aleman J, 1998, TROP DOCT, V28, P88, DOI 10.1177/004947559802800211; BACCI A, 1993, INT J GYNECOL OBSTET, V40, P19, DOI 10.1016/0020-7292(93)90767-Q; BAM RH, 1994, INT J GYNECOL OBSTET, V44, P113, DOI 10.1016/0020-7292(94)90063-9; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARROS FC, 1987, B WORLD HEALTH ORGAN, V65, P95; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BLANC AK, IN PRESS B WHO; Bloland P, 1996, AM J TROP MED HYG, V55, P82, DOI 10.4269/ajtmh.1996.55.82; BUGALHO A, 1993, GYNECOL OBSTET INVES, V36, P239, DOI 10.1159/000292637; Chalumeau M, 2000, ACTA PAEDIATR, V89, P1115, DOI 10.1080/713794568; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; CONDEAGUDELO A, 2003, COCHRANE LIB; DARMSTADT GL, 2005, EVIDENCE BASED COST; DATTA N, 1988, Indian Journal of Pediatrics, V55, P599, DOI 10.1007/BF02868443; Duke Trevor, 2000, Papua New Guinea Medical Journal, V43, P127; ELSHAFEI AM, 1988, AUST NZ J OBSTET GYN, V28, P293, DOI 10.1111/j.1479-828X.1988.tb01685.x; ELZIBDEH MY, 1988, INT J GYNECOL OBSTET, V26, P399, DOI 10.1016/0020-7292(88)90336-0; Godlee F, 2004, LANCET, V364, P295, DOI 10.1016/S0140-6736(04)16681-6; GREENWOOD AM, 1987, B WORLD HEALTH ORGAN, V65, P635; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; KNIPPENBERG R, 2005, SYSTEMATIC SCALING N; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; Kulmala T, 2000, ACTA OBSTET GYN SCAN, V79, P984, DOI 10.1034/j.1600-0412.2000.079011984.x; Kusiako T, 2000, B WORLD HEALTH ORGAN, V78, P621; Lawn J, 2001, HLTH NEWBORN REFER 2; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lawn JE, 2005, ESTIMATING CAUSES 4; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Lumbiganon P, 2002, INT J STD AIDS, V13, P486, DOI 10.1258/09564620260079653; LUMBIGANON P, 1990, INT J EPIDEMIOL, V19, P997, DOI 10.1093/ije/19.4.997; Luo ZC, 2004, EPIDEMIOLOGY, V15, P679, DOI 10.1097/01.ede.0000142149.34095.88; Macfarlane A, 1999, TUBERCULOSIS NONTUBE, P3; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MCCARTHY BJ, 1980, AM J PUBLIC HEALTH, V70, P977, DOI 10.2105/AJPH.70.9.977; McDermott J, 1996, B WORLD HEALTH ORGAN, V74, P165; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nielsen BB, 1997, BMJ-BRIT MED J, V314, P1521, DOI 10.1136/bmj.314.7093.1521; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Plafker T, 2002, BRIT MED J, V324, P1233; Sarkar Mohan Lal, 2002, J Indian Med Assoc, V100, P52; Schumacher R, 2002, MORTALITY STUDY GUIN; Sibai AM, 2004, B WORLD HEALTH ORGAN, V82, P83; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Ulizzi L, 2002, HUM BIOL, V74, P879, DOI 10.1353/hub.2003.0012; *UN ADM COMM COORD, 2000, LOW BIRTH WEIGHT REP; UNICEF, 2000, STATE WORLDS CHILDRE; UNICEF, 2004, STAT WORLDS CHILDR 2; UNICEF WHO UNFPA., 2000, MAT NEON TET EL 2005; Vanneste AM, 2000, HEALTH POLICY PLANN, V15, P1, DOI 10.1093/heapol/15.1.1; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Walker N, 2004, LANCET, V363, P2180, DOI 10.1016/S0140-6736(04)16511-2; *WORLD BANK GROUP, DAT STAT COUNTR GROU; World Health Organization (WHO), 1996, PERINATAL MORTALITY; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Xu BZ, 1997, SOC BIOL, V44, P170; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Zupan J., 2005, PERINATAL MORTALITY	67	2346	2422	4	174	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					891	900		10.1016/S0140-6736(05)71048-5	http://dx.doi.org/10.1016/S0140-6736(05)71048-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	903RZ	15752534				2022-12-28	WOS:000227444600032
J	Cheng, SP; Liu, CL				Cheng, SP; Liu, CL			Images in clinical medicine: Dermopathy of Graves' disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mackay Mem Hosp, Taipei 10449, Taiwan	Mackay Memorial Hospital	Cheng, SP (corresponding author), Mackay Mem Hosp, Taipei 10449, Taiwan.		Cheng, Shih-Ping/Q-3014-2018	Cheng, Shih-Ping/0000-0002-6301-5096					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					918	918		10.1056/NEJMicm040001	http://dx.doi.org/10.1056/NEJMicm040001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745982				2022-12-28	WOS:000227310700010
J	Cimino, JJ; Bakken, S				Cimino, JJ; Bakken, S			Personal digital educators	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Sch Nursing, New York, NY 10027 USA	Columbia University; Columbia University	Cimino, JJ (corresponding author), Columbia Coll Phys & Surg, New York, NY 10032 USA.			Cimino, James/0000-0003-4101-1622				Greenberg R, 2004, MED EDUC, V38, P570, DOI 10.1111/j.1365-2929.2004.01882.x; Leung GM, 2003, BMJ-BRIT MED J, V327, P1090, DOI 10.1136/bmj.327.7423.1090; Sellman JS, 2004, J AM MED INFORM ASSN, V11, P281, DOI 10.1197/jamia.M1493; YING A, 2004, IMPACT HOSP COMPUTER	4	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					860	862		10.1056/NEJMp048149	http://dx.doi.org/10.1056/NEJMp048149			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745975				2022-12-28	WOS:000227310700003
J	Partridge, L; Gems, D; Withers, DJ				Partridge, L; Gems, D; Withers, DJ			Sex and death: What is the connection?	CELL			English	Review							LIFE-SPAN EXTENSION; NEMATODE CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR HOMOLOG; DROSOPHILA-MELANOGASTER; CALORIE RESTRICTION; DIETARY RESTRICTION; MICE LACKING; STRESS RESISTANCE; SIGNALING PATHWAY; NATURAL-SELECTION	A cost of reproduction, where lifespan and fecundity are negatively correlated, is of widespread occurrence. Mutations in insulin/IGF signaling (IIS) pathways and dietary restriction (DR) can extend lifespan in model organisms but do not always reduce fecundity, suggesting that the link between lifespan and fecundity is not inevitable. Understanding the molecular basis of the cost of reproduction will be informed by elucidation of the mechanisms by which DR and IIS affect these two traits.	UCL, Ctr Res Ageing, Dept Biol, London WC1E 6BT, England; UCL, Rayne Inst, Ctr Diabet & Endocrinol, London, England	University of London; University College London; University of London; King's College London; University College London	Partridge, L (corresponding author), UCL, Ctr Res Ageing, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Withers, Dominic J/D-7671-2014	Withers, Dominic J/0000-0002-8009-7521; Gems, David/0000-0002-6653-4676; Partridge, Linda/0000-0001-9615-0094				ABBAS SMA, 1986, ARCH ANDROLOGY, V16, P161, DOI 10.3109/01485018608986937; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Antebi A, 2000, GENE DEV, V14, P1512; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Austad SN, 2003, AGING CELL, V2, P201, DOI 10.1046/j.1474-9728.2003.00053.x; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Chandrashekar Varadaraj, 2003, Reprod Biol, V3, P7; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHAPMAN T, 1994, J EVOLUTION BIOL, V7, P51, DOI 10.1046/j.1420-9101.1994.7010051.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DEJONG G, 1993, FUNCT ECOL, V7, P75, DOI 10.2307/2389869; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Duvillie B, 2002, ENDOCRINOLOGY, V143, P1530, DOI 10.1210/en.143.4.1530; EICHER EM, 1980, J HERED, V71, P187, DOI 10.1093/oxfordjournals.jhered.a109344; ELLISON PT, 1993, HUM REPROD, V8, P2248, DOI 10.1093/oxfordjournals.humrep.a138015; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Graf R, 1997, INSECT MOL BIOL, V6, P151, DOI 10.1111/j.1365-2583.1997.tb00083.x; HAMILTON JB, 1969, J GERONTOL, V24, P395, DOI 10.1093/geronj/24.4.395; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; HOLEHAN AM, 1985, MECH AGEING DEV, V32, P179, DOI 10.1016/0047-6374(85)90078-8; HOLEHAN AM, 1985, MECH AGEING DEV, V33, P19, DOI 10.1016/0047-6374(85)90106-X; Holmes DJ, 2001, EXP GERONTOL, V36, P869, DOI 10.1016/S0531-5565(00)00247-3; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Jiang JC, 2000, FASEB J, V14, P2135; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; JOHNSON TE, 1993, GENETICA, V91, P65, DOI 10.1007/BF01435988; Johnson TE, 1990, GENETIC EFFECTS AGIN, V2, P101; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lane MA, 2004, J GERONTOL A-BIOL, V59, P405; LAW R, 1979, AM NAT, V113, P3, DOI 10.1086/283361; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Linnen C, 2001, EVOL ECOL RES, V3, P877; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; LUNN PG, 1984, AM J CLIN NUTR, V39, P227, DOI 10.1093/ajcn/39.2.227; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; McCulloch D, 2003, AGING CELL, V2, P165, DOI 10.1046/j.1474-9728.2003.00047.x; MERRY BJ, 1979, J REPROD FERTIL, V57, P253, DOI 10.1530/jrf.0.0570253; MERRY BJ, 1981, EXP GERONTOL, V16, P431, DOI 10.1016/0531-5565(81)90025-5; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; NIESCHLAG E, 1993, NATURE, V366, P215, DOI 10.1038/366215a0; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; PARTRIDGE L, 2005, IN PRESS MECH AGEING; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; RICHARD DS, 2005, IN PRESS J INSECT PH; Roberts SB, 2001, J GERONTOL A-BIOL, V56, P66, DOI 10.1093/gerona/56.suppl_1.66; ROBERTS SB, 1982, T ROY SOC TROP MED H, V76, P668, DOI 10.1016/0035-9203(82)90239-5; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Takeshita M, 1996, EXP ANIM TOKYO, V45, P205, DOI 10.1538/expanim.45.205; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 1998, GENETICS, V148, P703; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; WALKER G, 2005, IN PRESS MECH AGEING; WEINDRUCH R, 1988, RETARDATION AGING  D; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; WORTHMAN CM, 1993, J BIOSOC SCI, V25, P425, DOI 10.1017/S0021932000021817; Ylonen H, 2003, OECOLOGIA, V135, P372, DOI 10.1007/s00442-003-1207-6; Zaczek D, 2002, BIOL REPROD, V67, P1115, DOI 10.1095/biolreprod67.4.1115; ZAMIRI MJ, 1978, AUST J BIOL SCI, V31, P629	119	325	347	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					461	472		10.1016/j.cell.2005.01.026	http://dx.doi.org/10.1016/j.cell.2005.01.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734679	Bronze			2022-12-28	WOS:000227271500004
J	Sibai, B; Dekker, G; Kupferminc, M				Sibai, B; Dekker, G; Kupferminc, M			Pre-eclampsia	LANCET			English	Review							UTERINE ARTERY DOPPLER; INTRAUTERINE GROWTH-RETARDATION; ENDOVASCULAR TROPHOBLAST INVASION; SYSTEMIC INFLAMMATORY RESPONSE; FETAL INHERITED THROMBOPHILIAS; SOCIETY CONSENSUS CONFERENCE; NATURAL-KILLER-CELLS; LOW-DOSE ASPIRIN; HYPERTENSIVE DISORDERS; GESTATIONAL HYPERTENSION	Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of angiogenic growth factors and increased placental debris in the maternal circulation resulting in a (mainly hypertensive) maternal inflammatory response. The final phenotype, maternal pre-eclamptic syndrome, is further modulated by pre-existing maternal cardiovascular or metabolic fitness. Currently, women at risk are identified on the basis of epidemiological and clinical risk factors, but the diagnostic criteria of pre-eclampsia remain unclear, with no known biomarkers. Treatment is still prenatal care, timely diagnosis, proper management, and timely delivery. Many interventions to lengthen pregnancy (eg, treatment for mild hypertension, plasma-volume expansion, and corticosteroid use) have a poor evidence base. We review findings on the diagnosis, risk factors, and pathogenesis of pre-eclampsia and the present status of its prediction, prevention, and management.	Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Univ Adelaide, Med Sch N, Lyell McEwin Hlth Serv, Womens & Childrens Div, Adelaide, SA 5005, Australia; Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp,Dept Obstet & Gynecol, IL-69978 Tel Aviv, Israel	University System of Ohio; University of Cincinnati; Lyell McEwin Hospital; University of Adelaide; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Sibai, B (corresponding author), Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, 231 Albert Sabin Way,ML 0526, Cincinnati, OH 45267 USA.	baha.sibai@uc.edu						Abalos E, 2001, COCHRANE DB SYST REV, V1; Al RA, 2004, OBSTET GYNECOL, V104, P367, DOI 10.1097/01.AOG.0000134788.01016.2a; Alfirevic Z, 2002, EUR J OBSTET GYN R B, V101, P6, DOI 10.1016/S0301-2115(01)00496-1; Aly AS, 2004, AM J OBSTET GYNECOL, V190, P252, DOI 10.1016/j.ajog.2003.07.003; Amorim MMR, 1999, AM J OBSTET GYNECOL, V180, P1283, DOI 10.1016/S0002-9378(99)70630-7; Anteby EY, 2004, EUR J OBSTET GYN R B, V113, P31, DOI 10.1016/j.ejogrb.2003.05.002; Ashton SV, 2005, ARTERIOSCL THROM VAS, V25, P102, DOI 10.1161/01.ATV.0000148547.70187.89; ATALLAH AN, 2002, COCHRANE DB SYST REV, V1; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Benyo DF, 2001, J CLIN ENDOCR METAB, V86, P2505, DOI 10.1210/jc.86.6.2505; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chames MC, 2002, AM J OBSTET GYNECOL, V186, P1174, DOI 10.1067/mob.2002.123824; Chaouat G, 2003, J REPROD IMMUNOL, V59, P205, DOI 10.1016/S0165-0378(03)00048-2; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Chien PFW, 2000, BRIT J OBSTET GYNAEC, V107, P196, DOI 10.1111/j.1471-0528.2000.tb11690.x; CHURCHILL D, 2002, COCHRANE DB SYST REV, V3; Conde-Agudelo A, 2004, OBSTET GYNECOL, V104, P1367, DOI 10.1097/01.AOG.0000147599.47713.5d; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P882; Coomarasamy A, 2003, OBSTET GYNECOL, V101, P1319, DOI 10.1016/S0029-7844(03)00169-8; Coomarasamy A, 2001, OBSTET GYNECOL, V98, P861, DOI 10.1016/S0029-7844(01)01569-1; Cross JC, 2003, CLIN GENET, V64, P96, DOI 10.1034/j.1399-0004.2003.00127.x; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; Dekker G, 2003, J REPROD IMMUNOL, V59, P245, DOI 10.1016/S0165-0378(03)00051-2; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Djurovic S, 2002, BJOG-INT J OBSTET GY, V109, P759, DOI 10.1111/j.1471-0528.2002.01330.x; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duley L, 2003, BRIT MED BULL, V67, P161, DOI 10.1093/bmb/ldg005; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 1999, COCHRANE DB SYST REV, V4; DULEY L, 2003, COCHRANE DB SYST REV, V2; Durnwald C, 2003, AM J OBSTET GYNECOL, V189, P848, DOI 10.1067/S0002-9378(03)00849-4; Einarsson JI, 2003, AM J OBSTET GYNECOL, V188, P1241, DOI 10.1067/mob.2003.401; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Friedman SA, 1999, CLIN OBSTET GYNECOL, V42, P470, DOI 10.1097/00003081-199909000-00005; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Giudice LC, 2002, J CLIN ENDOCR METAB, V87, P2359, DOI 10.1210/jc.87.5.2359; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Haddad B, 2004, AM J OBSTET GYNECOL, V190, P1590, DOI 10.1016/j.ajog.2004.03.050; Hahn S, 2002, HUM REPROD UPDATE, V8, P501, DOI 10.1093/humupd/8.6.501; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Harlow FH, 2001, HYPERTENS PREGNANCY, V20, P57, DOI 10.1081/PRG-100104172; Haukkamaa L, 2004, AM J CARDIOL, V93, P805, DOI 10.1016/j.amjcard.2003.11.065; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Heilmann L, 2001, CLIN HEMORHEOL MICRO, V25, P83; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hnat MD, 2002, AM J OBSTET GYNECOL, V186, P422, DOI 10.1067/mob.2002.120280; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; HUNT JS, 1997, BIOL REPROD, V34, P419; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; JAFFE R, 1995, AM J ROENTGENOL, V164, P1255, DOI 10.2214/ajr.164.5.7717242; Jivraj S, 2001, HUM REPROD, V16, P102, DOI 10.1093/humrep/16.1.102; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; KNIGHT M, 2000, COCHRANE DB SYST REV, V2; Kupferminc Michael J, 2003, Reprod Biol Endocrinol, V1, P111, DOI 10.1186/1477-7827-1-111; Kupferminc MJ, 2001, HYPERTENS PREGNANCY, V20, P35, DOI 10.1081/PRG-100104170; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Livingston JC, 2001, AM J OBSTET GYNECOL, V185, P153, DOI 10.1067/mob.2001.114691; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; MAGEE LA, 2003, BMJ-BRIT MED J, V327, P1; MAKRIDES M, 2001, COCHRANE DB SYST REV, V4; Martin RD, 1996, NEWS PHYSIOL SCI, V11, P149, DOI 10.1152/physiologyonline.1996.11.4.149; MATCHABA P, 2002, COCHRANE DB SYST REV, V4; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Matzinger P, 2004, VOX SANG, V87, P18, DOI 10.1111/j.1741-6892.2004.00508.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Mor G, 2002, BIOCHEM PHARMACOL, V64, P1305, DOI 10.1016/S0006-2952(02)01267-4; Moretti M, 2004, AM J OBSTET GYNECOL, V190, P1184, DOI 10.1016/j.ajog.2003.11.008; Morrison ER, 2002, THROMB HAEMOSTASIS, V87, P779, DOI 10.1055/s-0037-1613083; Neale D, 2003, J Matern Fetal Neonatal Med, V13, P39, DOI 10.1080/713605755; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x; NORTH RA, 1995, AUST NZ J OBSTET GYN, V35, P357, DOI 10.1111/j.1479-828X.1995.tb02141.x; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Ramsay JE, 2003, BJOG-INT J OBSTET GY, V110, P1029, DOI 10.1111/j.1471-0528.2003.02069.x; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P237, DOI 10.1007/s10024-003-8083-2; REDMAN CWG, 1990, NEW ENGL J MED, V323, P478, DOI 10.1056/NEJM199008163230710; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reister F, 2001, LAB INVEST, V81, P1143, DOI 10.1038/labinvest.3780326; Rey E, 1997, CAN MED ASSOC J, V157, P1245; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Robertson SA, 2002, J REPROD IMMUNOL, V57, P109, DOI 10.1016/S0165-0378(02)00015-3; Sacks GP, 2003, CLIN EXP IMMUNOL, V131, P490, DOI 10.1046/j.1365-2249.2003.02082.x; Saftlas AF, 2003, AM J EPIDEMIOL, V157, P1108, DOI 10.1093/aje/kwg101; Saito S, 2003, J REPROD IMMUNOL, V59, P161, DOI 10.1016/S0165-0378(03)00045-7; Salomon LJ, 2003, AM J OBSTET GYNECOL, V189, P1517, DOI 10.1016/S0002-9378(03)00902-5; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Schlembach D, 2003, CLIN SCI, V105, P279, DOI 10.1042/CS20030073; Shu F, 2000, GYNECOL OBSTET INVES, V49, P17, DOI 10.1159/000010206; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Sibai BM, 1998, AM J OBSTET GYNECOL, V179, P1275, DOI 10.1016/S0002-9378(98)70146-2; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Subtil D, 2003, BJOG-INT J OBSTET GY, V110, P485, DOI 10.1016/S1470-0328(03)02997-5; Thadhani R, 2004, HYPERTENSION, V43, P988, DOI 10.1161/01.HYP.0000124460.67539.1d; Tjoa ML, 2004, HYPERTENS PREGNANCY, V23, P171, DOI 10.1081/PRG-120028292; van der Meer A, 2004, MOL HUM REPROD, V10, P189, DOI 10.1093/molehr/gah032; van Pampus MG, 1999, AM J OBSTET GYNECOL, V180, P1146, DOI 10.1016/S0002-9378(99)70608-3; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Vigil-De Gracia P, 2003, EUR J OBSTET GYN R B, V107, P24, DOI 10.1016/S0301-2115(02)00269-5; VISSER W, 1995, BRIT J OBSTET GYNAEC, V102, P111, DOI 10.1111/j.1471-0528.1995.tb09062.x; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; WALLENBURG HCS, 1986, LANCET, V1, P1; Wang JX, 2002, LANCET, V359, P673, DOI 10.1016/S0140-6736(02)07804-2; Wang YP, 2004, AM J OBSTET GYNECOL, V190, P817, DOI 10.1016/j.ajog.2003.09.049; Waugh JJS, 2004, OBSTET GYNECOL, V103, P769, DOI 10.1097/01.AOG.0000118311.18958.63; Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P254, DOI 10.1016/j.ajog.2003.12.003; Wilson BJ, 2003, BMJ-BRIT MED J, V326, P1; Witlin AG, 2001, HYPERTENSIVE DISORDE, P221; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Wolf M, 2001, OBSTET GYNECOL, V98, P757, DOI 10.1016/S0029-7844(01)01551-4; Wolfberg AJ, 2004, OBSTET GYNECOL, V103, P1190, DOI 10.1097/01.AOG.0000126279.87151.e1; Yu CKH, 2003, ULTRASOUND OBST GYN, V22, P233, DOI 10.1002/uog.218; Yu CKH, 2002, ULTRASOUND OBST GYN, V20, P535, DOI 10.1046/j.1469-0705.2002.00865.x; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	143	2407	2554	5	254	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					785	799		10.1016/S0140-6736(05)17987-2	http://dx.doi.org/10.1016/S0140-6736(05)17987-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733721				2022-12-28	WOS:000227285300027
J	Douglass, A; Bramble, MG; Barrison, I				Douglass, A; Bramble, MG; Barrison, I			National survey of UK emergency endoscopy units	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UPPER-GASTROINTESTINAL HEMORRHAGE		James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; Friarage Hosp, Northallerton DL6 1JG, England; Hemel Hempstead Gen Hosp, Hemel Hempstead HP2 4AD, Herts, England	James Cook University Hospital	Bramble, MG (corresponding author), James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England.	lmike.bramble@stees.nhs.uk						*BRIT SOC GASTR WO, 2001, PROV END REL SERV DI; COOK DJ, 1992, GASTROENTEROLOGY, V102, P139, DOI 10.1016/0016-5085(92)91793-4; *NAT CONF ENQ PAT, 2004, SCOP PRACT 2004 REP; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Sanders DS, 2004, EUR J GASTROEN HEPAT, V16, P487, DOI 10.1097/00042737-200405000-00009	5	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1000	1001		10.1136/bmj.38379.662616.F7	http://dx.doi.org/10.1136/bmj.38379.662616.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15764625	Bronze, Green Published			2022-12-28	WOS:000228935100021
J	Edwards, M				Edwards, M			Historical keywords - Placebo	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Edwards, M (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.	martin.edwards@ucl.ac.uk							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1023	1023						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781087				2022-12-28	WOS:000227731800012
J	McCoy, CB; Rodriguez, F				McCoy, CB; Rodriguez, F			Global overview of injecting drug use and HIV infection	LANCET			English	Editorial Material									Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA; Univ Costa Rica, Inst Hlth Res, San Jose, Costa Rica	University of Miami; Universidad Costa Rica	McCoy, CB (corresponding author), Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA.	cmccoy@med.miami.edu						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; [Anonymous], 1992, AIDS WORLD; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; DESJARLAIS DC, 1992, AIDS, V6, P1053, DOI 10.1097/00002030-199210000-00001; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Pisani E., 2003, ESTIMATING SIZE POPU; Stimson G. V., 1993, Bulletin on Narcotics, V45, P3; *UNAIDS, 2003, FOLL UP 2001 UN GEN	8	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1008	1009						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781081				2022-12-28	WOS:000227731800006
J	Meehl, GA; Washington, WM; Collins, WD; Arblaster, JM; Hu, AX; Buja, LE; Strand, WG; Teng, HY				Meehl, GA; Washington, WM; Collins, WD; Arblaster, JM; Hu, AX; Buja, LE; Strand, WG; Teng, HY			How much more global warming and sea level rise?	SCIENCE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; NORTH-ATLANTIC OCEAN; CLIMATE SYSTEM MODEL; THERMOHALINE CIRCULATION; HEAT UPTAKE; EL-NINO; SENSITIVITY; CO2; SIMULATIONS	Two global coupled climate models show that even if the concentrations of greenhouse gases in the atmosphere had been stabilized in the year 2000, we are already committed to further global warming of about another half degree and an additional 320% sea level rise caused by thermal expansion by the end of the 21st century. Projected weakening of the meridional. overturning circulation in the North Atlantic Ocean does not lead to a net cooling in Europe. At any given point in time, even if concentrations are stabilized, there is a commitment to future climate changes that will be greater than those we have already observed.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Meehl, GA (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	meehl@ncar.ucar.edu	Arblaster, Julie/C-1342-2010; Hu, Aixue/E-1063-2013; Collins, William D/J-3147-2014	Arblaster, Julie/0000-0002-4287-2363; Hu, Aixue/0000-0002-1337-287X; Collins, William D/0000-0002-4463-9848; Strand, Warren/0000-0001-9740-0104				Bretherton FP, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P173; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Church JA, 2004, J CLIMATE, V17, P2609, DOI 10.1175/1520-0442(2004)017<2609:EOTRDO>2.0.CO;2; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; Gent PR, 2004, J CLIMATE, V17, P4058, DOI 10.1175/1520-0442(2004)017<4058:HUATTC>2.0.CO;2; HALL MM, 1982, DEEP-SEA RES, V29, P150; HOYT DV, 1993, J GEOPHYS RES-SPACE, V98, P18895, DOI 10.1029/93JA01944; Hu AX, 2004, J CLIMATE, V17, P4267, DOI 10.1175/JCLI3208.1; Kattenberg A, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P285; LEAN J, 1995, GEOPHYS RES LETT, V107; MCCARTNEY MS, 1984, J PHYS OCEANOGR, V14, P922, DOI 10.1175/1520-0485(1984)014<0922:WTCWCI>2.0.CO;2; Meehl GA, 2004, CLIM DYNAM, V23, P495, DOI 10.1007/s00382-004-0442-9; Meehl GA, 2004, J CLIMATE, V17, P1584, DOI 10.1175/1520-0442(2004)017<1584:FACSIG>2.0.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meehl GA, 2001, CLIM DYNAM, V17, P515, DOI 10.1007/PL00007929; Meehl GA, 2000, J CLIMATE, V13, P1879, DOI 10.1175/1520-0442(2000)013<1879:ROTNCS>2.0.CO;2; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Miller L, 2004, NATURE, V428, P406, DOI 10.1038/nature02309; Mitchell JFB, 2000, GEOPHYS RES LETT, V27, P2977, DOI 10.1029/1999GL011213; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P349; Raper SCB, 2002, J CLIMATE, V15, P124, DOI 10.1175/1520-0442(2002)015<0124:TROCSA>2.0.CO;2; ROEMMICH D, 1985, DEEP-SEA RES, V32, P619, DOI 10.1016/0198-0149(85)90070-6; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Stouffer RJ, 1999, J CLIMATE, V12, P2224, DOI 10.1175/1520-0442(1999)012<2224:ROACOA>2.0.CO;2; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Wetherald RT, 2001, GEOPHYS RES LETT, V28, P1535, DOI 10.1029/2000GL011786; Wigley T.M.L., 2003, CLIMATE SEA LEVEL CH, P111; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934	31	454	471	7	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1769	1772		10.1126/science.1106663	http://dx.doi.org/10.1126/science.1106663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774757				2022-12-28	WOS:000227883900043
J	Carrel, L; Willard, HF				Carrel, L; Willard, HF			X-inactivation profile reveals extensive variability in X-linked gene expression in females	NATURE			English	Article							CHROMOSOME INACTIVATION; MAMMALIAN X; FACULTATIVE HETEROCHROMATIN; REPEAT HYPOTHESIS; METHYLATION; REGION	In female mammals, most genes on one X chromosome are silenced as a result of X-chromosome inactivation(1,2). However, some genes escape X-inactivation and are expressed from both the active and inactive X chromosome. Such genes are potential contributors to sexually dimorphic traits, to phenotypic variability among females heterozygous for X-linked conditions, and to clinical abnormalities in patients with abnormal X chromosomes(3). Here, we present a comprehensive X-inactivation profile of the human X chromosome, representing an estimated 95% of assayable genes in fibroblast-based test systems(4,5). In total, about 15% of X-linked genes escape inactivation to some degree, and the proportion of genes escaping inactivation differs dramatically between different regions of the X chromosome, reflecting the evolutionary history of the sex chromosomes. An additional 10% of X-linked genes show variable patterns of inactivation and are expressed to different extents from some inactive X chromosomes. This suggests a remarkable and previously unsuspected degree of expression heterogeneity among females.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University	Carrel, L (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	lcarrel@psu.edu						Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, SEMIN CELL DEV BIOL, V14, P359, DOI 10.1016/j.semcdb.2003.09.016; Esposito T, 1997, GENOMICS, V43, P183, DOI 10.1006/geno.1997.4797; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LYON MF, 1962, AM J HUM GENET, V14, P135; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Miller AP, 1998, P NATL ACAD SCI USA, V95, P8709, DOI 10.1073/pnas.95.15.8709; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Ohno S., 1967, SEX CHROMOSOMES SEX; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Willard HF, 2000, METABOLIC MOL BASES, P1191; Wizemann T. M., 2001, EXPLORING BIOL CONTR	28	1428	1472	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					400	404		10.1038/nature03479	http://dx.doi.org/10.1038/nature03479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772666				2022-12-28	WOS:000227715100056
J	High, K				High, K			Anemia and gene therapy - A matter of control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	High, K (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Kirn D, 2002, TRENDS MOL MED, V8, pS68, DOI 10.1016/S1471-4914(02)02318-3; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Takacs K, 2004, P NATL ACAD SCI USA, V101, P16298, DOI 10.1073/pnas.0405271101	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1146	1147		10.1056/NEJMcibr044437	http://dx.doi.org/10.1056/NEJMcibr044437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784669				2022-12-28	WOS:000227655000016
J	Zatorre, R; McGill, J				Zatorre, R; McGill, J			Music, the food of neuroscience?	NATURE			English	Article							ABSOLUTE PITCH; LANGUAGE; BRAIN		Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Zatorre, R (corresponding author), Montreal Neurol Inst, Montreal, PQ, Canada.							Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Meyer L., 1956, EMOTION MEANING MUSI; PANTEV C, 2003, COGNITIVE NEUROSCIEN, P382; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Saffran J.R., 2003, COGNITIVE NEUROSCIEN, P32; SCHLAUG G, 2003, COGNITIVE NEUROSCIEN, P366; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	16	183	189	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					312	315		10.1038/434312a	http://dx.doi.org/10.1038/434312a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	907KG	15772648				2022-12-28	WOS:000227715100037
J	Busby, A; Abramsky, L; Dolk, H; Armstrong, B				Busby, A; Abramsky, L; Dolk, H; Armstrong, B		Eurocat Folic Acid Working Grp	Preventing neural tube defects in Europe: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Northwick Pk Hosp & Clin Res Ctr, N Thames W Congenital Malformat Register, Harrow HA1 3UJ, Middx, England; Univ Ulster, EUROCAT Cent Registry, Newtownabbey BT37 0QB, Antrim, North Ireland	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Ulster University	Busby, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	araceli.busby@lshtm.ac.uk		Relton, Caroline/0000-0003-2052-4840; armstrong, benedict/0000-0003-4407-0409				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BUSBY A, 2005, EUROCAT SPECIAL REPO; CLARK NAC, 1994, BRIT J OBSTET GYNAEC, V101, P709, DOI 10.1111/j.1471-0528.1994.tb13190.x; DOLK H, 1991, J EPIDEMIOL COMMUN H, V45, P52, DOI 10.1136/jech.45.1.52; *EUR FOL AC WORK G, 2003, EUR SPEC REP PREV NE; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Persad VL, 2002, CAN MED ASSOC J, V167, P241	7	86	98	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					574	575		10.1136/bmj.330.7491.574	http://dx.doi.org/10.1136/bmj.330.7491.574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760997	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000227622300018
J	Gitai, Z				Gitai, Z			The new bacterial cell biology: Moving parts and subcellular architecture	CELL			English	Review							DIVISION SITE SELECTION; ACTIN-LIKE FILAMENTS; TO-POLE OSCILLATION; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CHROMOSOME SEGREGATION; MEMBRANE-PROTEIN; MIN PROTEINS; RAPID POLE; BIOFILM FORMATION	Recent advances have demonstrated that bacterial cells have an exquisitely organized and dynamic subcellular architecture. Like their eukaryotic counterparts, bacteria employ a full complement of cytoskeletal proteins, localize proteins and DNA to specific subcellular addresses at specific times, and use intercellular signaling to coordinate multicellular events. The striking conceptual and molecular similarities between prokaryotic and eukaryotic cell biology thus make bacteria powerful model systems for studying fundamental cellular questions.Recent advances have demonstrated that bacterial cells have an exquisitely organized and dynamic subcellular architecture. Like their eukaryotic counterparts, bacteria employ a full complement of cytoskeletal proteins, localize proteins and DNA to specific subcellular addresses at specific times, and use intercellular signaling to coordinate multicellular events. The striking conceptual and molecular similarities between prokaryotic and eukaryotic cell biology thus make bacteria powerful model systems for studying fundamental cellular questions.	Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Stanford University; Princeton University	Gitai, Z (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	zgitai@princeton.edu	Gitai, Zemer/AAI-6989-2021					AGARD DA, 1989, METHOD CELL BIOL, V30, P353; Aldridge P, 2001, TRENDS MICROBIOL, V9, P209, DOI 10.1016/S0966-842X(01)02014-5; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; CARRINGTON WA, 1995, SCIENCE, V268, P1483, DOI 10.1126/science.7770772; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Espeli O, 2003, MOL MICROBIOL, V50, P495, DOI 10.1046/j.1365-2958.2003.03736.x; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Fung DC, 1998, CURR OPIN MICROBIOL, V1, P346, DOI 10.1016/S1369-5274(98)80040-4; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; KOCKS C, 1993, J CELL SCI, V105, P699; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; McGrath PT, 2004, CURR OPIN MICROBIOL, V7, P192, DOI 10.1016/j.mib.2004.02.012; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Niki H, 2000, GENE DEV, V14, P212; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Pogliano K, 2003, CURR OPIN MICROBIOL, V6, P586, DOI 10.1016/j.mib.2003.10.015; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shimkets, 2000, PROKARYOTIC DEV, V114; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Takeda T, 2004, NAT CELL BIOL, V6, P1142, DOI 10.1038/ncb1189; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; TSIEN RY, 2003, NAT REV MOL CELL B S, V8, pS516; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; WEBB CD, 1995, J BACTERIOL, V177, P5906, DOI 10.1128/jb.177.20.5906-5911.1995; Webb JS, 2003, CURR OPIN MICROBIOL, V6, P578, DOI 10.1016/j.mib.2003.10.014; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	86	129	136	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					577	586		10.1016/j.cell.2005.02.026	http://dx.doi.org/10.1016/j.cell.2005.02.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766522	Bronze			2022-12-28	WOS:000227771400005
J	Lee, TT; Agarwalla, S; Stroud, RM				Lee, TT; Agarwalla, S; Stroud, RM			A unique RNA fold in the RumA-RNA-Cofactor ternary complex contributes to substrate selectivity and enzymatic function	CELL			English	Article							IRON-SULFUR CLUSTER; CRYSTAL-STRUCTURE; PSEUDOURIDINE SYNTHASE; ESCHERICHIA-COLI; METHYLTRANSFERASE; MECHANISM; RECOGNITION; BASE; NUCLEOSIDES; M(5)U1939	A single base (U1939) within E. coli 23S ribosomal RNA is methylated by its dedicated enzyme, RumA. The structure of RumA/RNA/S-adenosylhomocysteine uncovers the mechanism for achieving unique selectivity. The single-stranded substrate is "refolded" on the enzyme into a compact conformation with six key intra-RNA interactions. The RNA substrate contributes directly to catalysis. In addition to the target base, a second base is "flipped out" from the core loop to stack against the adenine of the cofactor S-adenosylhomocysteine. Nucleotides in permuted sequence order are stacked into the site vacated by the everted target U1939 and compensate for the energetic penalty of base eversion. The 3' hairpin segment of the RNA binds distal to the active site and provides binding energy that contributes to enhanced catalytic efficiency. Active collaboration of RNA in catalysis leads us to conclude that RumA and its substrate RNA may reflect features from the earliest RNA-protein era.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda/0000-0001-5242-8015	NIGMS NIH HHS [GM51232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; Agarwalla S, 2002, J BIOL CHEM, V277, P8835, DOI 10.1074/jbc.M111825200; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2002, STRUCTURE, V10, P127, DOI 10.1016/S0969-2126(02)00710-4; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gimenez JAM, 1998, J THEOR BIOL, V194, P485, DOI 10.1006/jtbi.1998.0770; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; LIU L, 1992, BIOCHEMISTRY-US, V31, P5100, DOI 10.1021/bi00137a002; Madsen CT, 2003, NUCLEIC ACIDS RES, V31, P4738, DOI 10.1093/nar/gkg657; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PERRY KM, 1990, PROTEINS, V8, P315, DOI 10.1002/prot.340080406; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOLIE TN, 1968, J MOL BIOL, V33, P61, DOI 10.1016/0022-2836(68)90281-7; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu J C, 1985, Prog Clin Biol Res, V198, P119; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	49	91	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					599	611		10.1016/j.cell.2004.12.037	http://dx.doi.org/10.1016/j.cell.2004.12.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766524	Bronze			2022-12-28	WOS:000227771400007
J	Larson, EB; Yao, X				Larson, EB; Yao, X			Clinical empathy as emotional labor in the patient-physician relationship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	64th Annual Meeting of the Academy-of-Management	AUG 06-11, 2004	New Orleans, LA	Acad Management			PRIVATE SELF-CONSCIOUSNESS; BREAKING BAD-NEWS; EXPRESSION; CARE; COMMUNICATION; CONSEQUENCES; LONELINESS; DISCLOSURE; BEHAVIORS; CANCER	Empathy should characterize all health care professions. Despite advancement in medical technology, the healing relationship between physicians and patients remains essential to quality care. We propose that physicians consider empathy as emotional labor (ie, management of experienced and displayed emotions to present a certain image). Since the publication of Hochschild's The Managed Heart in 1983, researchers in management and organization behavior have been studying emotional labor by service workers, such as flight attendants and bill collectors. In this article, we focus on physicians as professionals who are expected to be empathic caregivers. They engage in such emotional labor through deep acting (ie, generating empathy-consistent emotional and cognitive reactions before and during empathic interactions with the patient, similar to the method-acting tradition used by some stage and screen actors), surface acting (ie, forging empathic behaviors toward the patient, absent of consistent emotional and cognitive reactions), or both. Although deep acting is preferred, physicians may rely on surface acting when immediate emotional and cognitive understanding of patients is impossible. Overall, we contend that physicians are more effective healers-and enjoy more professional satisfaction-when they engage in the process of empathy. We urge physicians first to recognize that their work has an element of emotional labor and, second, to consciously practice deep and surface acting to empathize with their patients. Medical students and residents can benefit from long-term regular training that includes conscious efforts to develop their empathic abilities. This will be valuable for both physicians and patients facing the increasingly fragmented and technological world of modern medicine.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Sch Business, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle	Larson, EB (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.							ASHFORTH BE, 1993, ACAD MANAGE REV, V18, P88, DOI 10.2307/258824; Authier J., 1986, HDB COMMUNICATION SK, P441; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; BENNETT JA, 1995, ADV NURS SCI, V18, P36, DOI 10.1097/00012272-199509000-00005; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brotheridge Celeste M, 2002, J Occup Health Psychol, V7, P57; BROWN AD, 1994, LANCET, V344, P1436, DOI 10.1016/S0140-6736(94)90603-3; Cassel EJ, 1997, DOCTORING NATURE PRI; Clark PA, 2001, ACAD MED, V76, P419, DOI 10.1097/00001888-200105000-00008; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M.H., 1991, ADV PERSONAL RELATIO, V3, P75; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1987, J PERS SOC PSYCHOL, V53, P397, DOI 10.1037/0022-3514.53.2.397; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1992, PERS SOC PSYCHOL B, V18, P76, DOI 10.1177/0146167292181011; DAVIS MH, 1986, J PERS SOC PSYCHOL, V51, P595, DOI 10.1037/0022-3514.51.3.595; DAVIS MH, 1985, 93 ANN CONV AM PSYCH; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Di Blasi Z, 2003, EVAL HEALTH PROF, V26, P166, DOI 10.1177/0163278703026002003; Eisenberg N., 1991, HDB MORAL BEHAV DEV, P63; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; FEFFER M, 1966, J PERS SOC PSYCHOL, V4, P415, DOI 10.1037/h0023807; FINCHAM FD, 1989, J MARRIAGE FAM, V51, P27, DOI 10.2307/352365; FINESTONE HM, 1994, LANCET, V344, P801, DOI 10.1016/S0140-6736(94)92349-3; FRANZOI SL, 1985, J PERS SOC PSYCHOL, V48, P768, DOI 10.1037/0022-3514.48.3.768; Froggatt K, 1998, J ADV NURS, V28, P332, DOI 10.1046/j.1365-2648.1998.00688.x; Grandey A A, 2000, J Occup Health Psychol, V5, P95, DOI 10.1037/1076-8998.5.1.95; Greenberg LW, 1999, PEDIATRICS, V103, P1210, DOI 10.1542/peds.103.6.1210; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Halpern Jodi., 2001, DETACHED CONCERN EMP; HAVENS L, 2000, REAL WORLD GUIDE PSY; Henderson A, 2001, Nurs Inq, V8, P130, DOI 10.1046/j.1440-1800.2001.00097.x; Hochschild A. R., 1983, J POLICY ANAL MANAG, DOI DOI 10.1002/PAM.4050030365; Hoffman M. L., 1984, EMOTIONS COGNITIONS; Irving Pauline, 2004, Int J Health Care Qual Assur Inc Leadersh Health Serv, V17, P212; JAMES N, 1992, SOCIOL HEALTH ILL, V14, P488, DOI 10.1111/1467-9566.ep10493127; KARR MD, 1994, LANCET, V344, P1436; KASH KM, 1989, HDB PSYCHOONCOLOGY P, P647; KERR LW, 1988, TASK MED DIALOGUE WI; Larson EB, 2003, AM J MED, V114, P168, DOI 10.1016/S0002-9343(02)01564-4; Lee Stephanie J, 2002, Hematology Am Soc Hematol Educ Program, P464, DOI 10.1182/asheducation-2002.1.464; MATTHEWS DA, 1993, ANN INTERN MED, V118, P973, DOI 10.7326/0003-4819-118-12-199306150-00010; Morris JA, 1996, ACAD MANAGE REV, V21, P986, DOI 10.2307/259161; ODEGAARD CE, 1986, DEAR DOCTOR PERSONAL; Parker PA, 2001, J CLIN ONCOL, V19, P2049, DOI 10.1200/JCO.2001.19.7.2049; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Ptacek JT, 1996, JAMA-J AM MED ASSOC, V276, P496; RAFAELI A, 1989, RES ORGAN BEHAV, V11, P1; RAFAELI A, 1987, ACAD MANAGE REV, V12, P23, DOI 10.2307/257991; ROGERS CR, 1957, J CONSULT PSYCHOL, V21, P95, DOI 10.1037/0022-006X.60.6.827; SMITH P, 1991, J ADV NURS, V16, P74, DOI 10.1111/j.1365-2648.1991.tb01500.x; Smith P., 1992, EMOTIONAL LABOUR NUR; Sotile Wayne M, 2003, J Med Pract Manage, V18, P314; SPIRO H, 1992, ANN INTERN MED, V116, P843, DOI 10.7326/0003-4819-116-10-843; SUCHMAN AL, 1988, ANN INTERN MED, V108, P125, DOI 10.7326/0003-4819-108-1-125; SUTTON RI, 1991, ADMIN SCI QUART, V36, P245, DOI 10.2307/2393355; Testerman JK, 1996, ACAD MED, V71, pS43, DOI 10.1097/00001888-199610000-00040; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x; YOUNG A, 2004, WHAT PATIENTS TAUGHT; Zoppi K, 2002, FAM MED, V34, P319	63	431	450	6	105	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1100	1106		10.1001/jama.293.9.1100	http://dx.doi.org/10.1001/jama.293.9.1100			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	901LY	15741532	Bronze			2022-12-28	WOS:000227285200020
J	Coyne, JA				Coyne, JA			Retrospective: Evolution - Ernst Mayr (1904-2005)	SCIENCE			English	Biographical-Item									Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Coyne, JA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	j-coyne@uchicago.edu							0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1212	1213		10.1126/science.1110718	http://dx.doi.org/10.1126/science.1110718			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731434				2022-12-28	WOS:000227313200033
J	Normark, S; Nilsson, C; Normark, BH				Normark, S; Nilsson, C; Normark, BH			Microbiology - A pathogen attacks while keeping up defense	SCIENCE			English	Editorial Material							III SECRETION; BACTERIAL VIRULENCE; SHIGELLA-FLEXNERI; IDENTIFICATION; YERSINIA		Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Normark, S (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.	staffan.normark@stratresearch.se						Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Korres H, 2004, J BIOL CHEM, V279, P22469, DOI 10.1074/jbc.M401316200; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472	12	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1211	1212		10.1126/science.1109836	http://dx.doi.org/10.1126/science.1109836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731433				2022-12-28	WOS:000227313200032
J	Jefferson, T; Smith, S; Demicheli, V; Harnden, A; Rivetti, A; Di Pietrantonj, C				Jefferson, T; Smith, S; Demicheli, V; Harnden, A; Rivetti, A; Di Pietrantonj, C			Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review	LANCET			English	Article							LIVE RECOMBINANT; VIRUS-VACCINE; TRIVALENT; SCHOOLCHILDREN; GRIPPOVAC	Background We aimed to assess evidence of efficacy and effectiveness of live attenuated and inactivated influenza vaccines in children up to 16 years of age. Methods We searched the Cochrane Library, MEDLINE, EMBASE Biological Abstracts, and Science Citation Index to June, 2004, in any language, and contacted vaccine manufacturers and authors of relevant studies to identify additional data. We included randomised, cohort, and case-control studies comparing efficacy of vaccines against influenza (reduction in laboratory-confirmed cases), effectiveness of vaccines against influenza-like illness (reduction in symptomatic cases), or both, with placebo or no intervention. We analysed the following outcomes: influenza, influenza-like illness, admissions, school absences, complications, and secondary transmission. Findings We included 14 randomised controlled trials, eight cohort studies, one case-control study, and one randomised controlled trial of intraepidemic use of the vaccines. Live attenuated influenza vaccines had 79% efficacy and 38% effectiveness in children older than 2 years compared with placebo or no immunisation. Inactivated vaccines had lower efficacy (65%) than live attenuated vaccines, and in children aged 2 years or younger they had similar effects to placebo. Effectiveness of inactivated vaccines was about 28% in children older than 2 years. Vaccines were effective in reducing long school absences (relative risk 0 . 14 [95% Cl 0.07-0.271]). Studies assessing the effects of vaccines against secondary cases, lower-respiratory tract disease, acute otifis media, and hospital stay suggested no difference with placebo or standard care, but lacked statistical power. Interpretation Influenza vaccines (especially two-dose live attenuated vaccines) are efficacious in children older than 2 years. Efficacy and effectiveness of the vaccines differed strikingly. Only two small studies assessed the effects of influenza vaccines on hospital admissions and no studies assessed reductions in mortality, serious complications, and community transmission of influenza. If influenza immunisation in children is to be recommended as public-health policy, large-scale studies assessing such important outcomes and undertaking direct comparisons of vaccines are urgently needed.	Cochrane Vaccines Field, I-15100 Alessandria, Italy; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Jefferson, T (corresponding author), Cochrane Vaccines Field, ASL 20, I-15100 Alessandria, Italy.	Toj1@aol.com	Di Pietrantonj, Carlo/AAK-1340-2020	Di Pietrantonj, Carlo/0000-0002-7302-5714				ALDERSON P, 2004, COCHRANE REV HDB MAR; ALEXANDROVA GI, 1986, VACCINE, V4, P114, DOI 10.1016/0264-410X(86)90049-6; BASHLYAEVA ZA, 1986, ZH MIKROB EPID IMMUN, P49; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BEUTNER KR, 1979, J INFECT DIS, V140, P844, DOI 10.1093/infdis/140.6.844; BURTSEVA EI, 1991, VOP VIRUSOL+, V36, P375; CHUMAKOV MP, 1987, VOP VIRUSOL+, P175; CLOVER RD, 1991, J INFECT DIS, V163, P300, DOI 10.1093/infdis/163.2.300; Colombo C, 2001, REV EPIDEMIOL SANTE, V49, P157; DEEKS JJ, 2004, COCHRANE REV HDB MAR; DEMICHELI V, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001269.PUB2.ART; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Elshina G. A., 2000, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P50; Grigoryeva E. P., 2002, Voprosy Virusologii, V47, P24; GRUBER WC, 1990, AM J DIS CHILD, V144, P595, DOI 10.1001/archpedi.1990.02150290089035; Han JP, 1999, VACCINE, V17, pS57, DOI 10.1016/S0264-410X(99)00107-3; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIROTA Y, 1992, INT J EPIDEMIOL, V21, P574, DOI 10.1093/ije/21.3.574; Hoberman A, 2003, JAMA-J AM MED ASSOC, V290, P1608, DOI 10.1001/jama.290.12.1608; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kawai N, 2003, VACCINE, V21, P4507, DOI 10.1016/S0264-410X(03)00508-5; Khan AS, 1996, J INFECT DIS, V173, P453, DOI 10.1093/infdis/173.2.453; Maeda T, 2004, PEDIATR INT, V46, P122, DOI 10.1046/j.1442-200x.2004.01852.x; Maeda T, 2002, PEDIATR INT, V44, P43, DOI 10.1046/j.1442-200X.2002.01503.x; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Orr P, 2004, Can Commun Dis Rep, V30, P1; Principi N, 2004, LANCET INFECT DIS, V4, P75, DOI 10.1016/S1473-3099(04)00926-0; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Rennels MB, 2004, PEDIATRICS, V113, P1441, DOI 10.1542/peds.113.5.1441; Rudenko LG, 1996, VOP VIRUSOL+, V41, P37; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Rudenko LG, 1996, B WORLD HEALTH ORGAN, V74, P77; SLEPUSHKIN AN, 1974, ZH MIKROB EPID IMMUN, P24; Slobodenyuk A. V., 2002, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P36; SMITH S, 2004, COCHRANE DB SYST REV, V3; Wells G., NEWCASTLE OTTAWA SCA	40	145	158	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					773	780						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733718				2022-12-28	WOS:000227285300024
J	Lee, JW				Lee, JW			Public health is a social issue	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Lee, JW (corresponding author), WHO, CH-1211 Geneva, Switzerland.	averyd@who.int						CHISHOLM B, 1959, LECT B CHISH CHAP HI, P30	1	36	38	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1005	1006						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907QB	15781079				2022-12-28	WOS:000227731800004
J	Bowles, S; Posel, D				Bowles, S; Posel, D			Genetic relatedness predicts South African migrant workers' remittances to their families	NATURE			English	Article							RECIPROCITY; TRANSFERS; FORAGERS; TESTS	Inclusive fitness models(1,2) predict many commonly observed behaviours: among humans, studies of within-household violence(3), the allocation of food(4,5) and child care(6) find that people favour those to whom they are more closely related. In some cases however, kin-altruism effects appear to be modest(7-9). Do individuals favour kin to the extent that kin-altruism models predict? Data on remittances sent by South African migrant workers to their rural households of origin allow an explicit test, to our knowledge the first of its kind for humans. Using estimates of the fitness benefits and costs associated with the remittance, the genetic relatedness of the migrant to the beneficiaries of the transfer, and their age- and sex-specific reproductive values, we estimate the level of remittance that maximizes the migrant worker's inclusive fitness. This is a much better predictor of observed remittances than is average relatedness, even when we take account ( by means of a multiple regression) of covarying influences on the level of remittance. But the effect is modest: less than a third of the observed level of remittances can be explained by our kin-altruism model.	Univ KwaZulu Natal, ZA-4001 Durban, South Africa; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Siena, I-53100 Siena, Italy	University of Kwazulu Natal; The Santa Fe Institute; University of Siena	Posel, D (corresponding author), Univ KwaZulu Natal, King George V Ave, ZA-4001 Durban, South Africa.	posel@ukzn.ac.za	Posel, Dorrit/AAF-7750-2021	Posel, Dorrit/0000-0002-3343-875X				Anderson KG, 1999, EVOL HUM BEHAV, V20, P433, DOI 10.1016/S1090-5138(99)00022-7; [Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], 1998, S AFR DEM HLTH SURV; Bird RB, 2002, EVOL HUM BEHAV, V23, P297; Case A, 2000, ECON J, V110, P781, DOI 10.1111/1468-0297.00565; DALY M, 1982, AM ANTHROPOL, V84, P372, DOI 10.1525/aa.1982.84.2.02a00090; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fisher, 1930, GENETICAL THEORY NAT, P27; Grafen A, 1999, P ROY SOC B-BIOL SCI, V266, P799, DOI 10.1098/rspb.1999.0708; GRAFEN A, 2004, THEORY FISHERS REPRO; Gurven M, 2002, J ANTHROPOL RES, V58, P93, DOI 10.1086/jar.58.1.3631070; Gurven M, 2000, HUM ECOL, V28, P171, DOI 10.1023/A:1007067919982; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Kostelanetz R, 1993, DICT AVANT GARDES; MENCARINI L, 1999, P 3 AFR POP C AFR PO, P6; Posel DR, 2001, S AFR J ECON, V69, P501; STEVENSON AC, 1966, B WHO              S, V34, P1; Taylor PD, 1996, J MATH BIOL, V34, P654; *U CAP TOWN S AFR, 1993, S AFR INT HOUS SURV	21	31	34	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					380	383		10.1038/nature03420	http://dx.doi.org/10.1038/nature03420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907KG	15772661				2022-12-28	WOS:000227715100051
J	Nimishikavi, S; Stead, L				Nimishikavi, S; Stead, L			Streptococcal pharyngitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Nimishikavi, S (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Ganti, Latha/AAF-6268-2020	Ganti, Latha/0000-0001-7717-3864					0	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					E10	E10		10.1056/NEJMicm040442	http://dx.doi.org/10.1056/NEJMicm040442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784659				2022-12-28	WOS:000227655000010
J	Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR				Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR			The DNA sequence of the human X chromosome	NATURE			English	Article							LINKED MENTAL-RETARDATION; MAMMALIAN Y-CHROMOSOME; HUMAN GENOME SEQUENCE; INACTIVATION CENTER; REPEAT HYPOTHESIS; GENE FAMILY; EVOLUTION; MUTATIONS; REGION; RNA	The human X chromosome has a unique biology that was shaped by its evolution as the sex chromosome shared by males and females. We have determined 99.3% of the euchromatic sequence of the X chromosome. Our analysis illustrates the autosomal origin of the mammalian sex chromosomes, the stepwise process that led to the progressive loss of recombination between X and Y, and the extent of subsequent degradation of the Y chromosome. LINE1 repeat elements cover one-third of the X chromosome, with a distribution that is consistent with their proposed role as way stations in the process of X-chromosome inactivation. We found 1,098 genes in the sequence, of which 99 encode proteins expressed in testis and in various tumour types. A disproportionately high number of mendelian diseases are documented for the X chromosome. Of this number, 168 have been explained by mutations in 113 X-linked genes, which in many cases were characterized with the aid of the DNA sequence.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; Inst Mol Biotechnol, D-07745 Jena, Germany; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Munich, D-80336 Munich, Germany; UCL, Galton Lab, HUGO Gen Nomenclature Comm, Dept Biol, London NW1 2HE, England; Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; PE Appl Biosyst, Adv Ctr Genet Technol, Foster City, CA 94404 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Inst Genet & Biophys, I-80100 Naples, Italy; Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Paris 05, INSERM, U567,Inst Cochin, Lab Genet & Physiopathol Retards Mentaux, F-75014 Paris, France; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; GSF, Natl Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; RZPD Resource Ctr Genome Res, D-14059 Berlin, Germany; NHGRI, NIH, Bethesda, MD 20892 USA; NIA, Genet Lab, Baltimore, MD 21224 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Wellcome Trust Sanger Institute; Baylor College of Medicine; Washington University (WUSTL); Max Planck Society; University of Kiel; University of Munich; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Thermo Fisher Scientific; Applied Biosystems; European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University	Ross, MT (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mtr@sanger.ac.uk	Hubbard, Tim J.P./AAT-4571-2020; Weinstock, George M/C-6314-2013; Lyne, Rachel/AAE-2189-2020; Glöckner, Gernot/A-7800-2010; Hubbard, Tim J/C-2567-2008; Norouzi, Neil/H-2530-2012; Francis, Fiona/B-5854-2016; Johnson, David/A-3907-2011; Durbin, Richard/AAE-7178-2019; Bruford, Elspeth/AAU-4961-2020; Wheeler, David A/M-9740-2018; Meitinger, Thomas/O-1318-2015; Evans, Kathryn KL/I-5910-2012; BALLABIO, Andrea/AAL-2672-2020; Driemeier, David/H-3461-2012; Frankish, Adam/G-6545-2011; Wilson, Richard K./AAF-4139-2019; Andrews, Dan/ABG-4815-2020; Sudbrak, Ralf/HHZ-8821-2022	Hubbard, Tim J.P./0000-0002-1767-9318; Weinstock, George M/0000-0002-2997-4592; Lyne, Rachel/0000-0001-8050-402X; Glöckner, Gernot/0000-0002-9061-1061; Hubbard, Tim J/0000-0002-1767-9318; Johnson, David/0000-0003-0887-3343; Durbin, Richard/0000-0002-9130-1006; Bruford, Elspeth/0000-0002-8380-5247; Wheeler, David A/0000-0002-9056-6299; BALLABIO, Andrea/0000-0003-1381-4604; Driemeier, David/0000-0003-3766-0654; Wilson, Richard K./0000-0002-1992-1358; Keenan, Stephen/0000-0002-9141-7690; Worley, Kim/0000-0002-0282-1000; Gilbert, James/0000-0001-8079-3159; Zoghbi, Huda/0000-0002-0700-3349; Evans, Kathryn/0000-0002-7884-5877; Wilming, Laurens/0000-0002-4154-7358; Ciccodicola, Alfredo/0000-0002-9924-1482; Fosker, Christine/0000-0002-3799-9474; /0000-0002-9833-2817; Frankish, Adam/0000-0002-4333-628X; Meitinger, Thomas/0000-0002-8838-8403; Andrews, Dan/0000-0003-3922-6376; Howe, Kevin/0000-0002-1751-9226; Delgado, Oliver/0000-0003-2547-5857; Steward, Charles/0000-0001-8829-5349; Hunt, Sarah/0000-0002-8350-1235; Swarbreck, David/0000-0002-5453-1013; Wass, Elizabeth/0000-0002-8605-9921; Davidson, Claire/0000-0002-4910-8202; Hunt, Adrienne/0000-0002-1227-0310; Loveland, Jane/0000-0002-7669-2934; Trevanion, Stephen/0000-0002-4862-3333; Reinhardt, Richard/0000-0001-9376-2132; Bridgeman, Anne/0000-0002-9478-6125; Gregory, Simon/0000-0002-7805-1743; Storey, Roy/0000-0003-1375-7136; Francis, Fiona/0000-0001-8542-7537; ARADHYA, SWAROOP/0000-0001-6219-2931	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, Z01HG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000647] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bourque G, 2002, GENOME RES, V12, P26; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Chomez P, 2001, CANCER RES, V61, P5544; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Hurst LD, 2001, NATURE, V411, P149, DOI 10.1038/35075697; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; *J HOPK U NAT CTR, 2000, OMIM ONL MEND INH MA; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ohno S., 1967, SEX CHROMOSOMES SEX; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sargent CA, 1996, GENOMICS, V32, P200, DOI 10.1006/geno.1996.0106; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Toder R, 2000, CYTOGENET CELL GENET, V91, P285, DOI 10.1159/000056858	67	762	1543	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					325	337		10.1038/nature03440	http://dx.doi.org/10.1038/nature03440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772651	Bronze, Green Accepted			2022-12-28	WOS:000227715100040
J	Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM				Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM			Regionalization of care for acute coronary syndromes - More evidence is needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; IMMEDIATE THROMBOLYSIS; FIBRINOLYTIC THERAPY; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; VOLUME; MORTALITY; INTERVENTION; SPECIALTY		Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & EValuat, New Haven, CT 06504 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Vet Affairs Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; University of Pennsylvania	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Epstein, Andrew/0000-0001-5078-6564; Volpp, Kevin/0000-0003-1423-4599	NIGMS NIH HHS [T32 GM007205, T32 GM007205-35, GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Armstrong PW, 2003, NEW ENGL J MED, V349, P2168; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bogaty P, 2003, LANCET, V361, P1813, DOI 10.1016/S0140-6736(03)13407-1; Califf RM, 2003, CIRCULATION, V107, P1467, DOI 10.1161/01.CIR.0000065160.19016.26; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; DEVERS KJ, 2003, SPECIALTY HOSP FOCUS; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Epstein AJ, 2004, J AM COLL CARDIOL, V43, P1755, DOI 10.1016/j.jacc.2003.09.070; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; *GEN ACC OFF, 2003, PUBL GEN ACC OFF; Gibson CM, 2004, EUR HEART J, V25, P1001, DOI 10.1016/j.ehj.2004.04.029; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Ho V, 2000, CIRCULATION, V101, P1806, DOI 10.1161/01.CIR.101.15.1806; Ho V, 2002, J HEALTH ECON, V21, P873, DOI 10.1016/S0167-6296(02)00057-7; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kansagra SM, 2004, JAMA-J AM MED ASSOC, V292, P1717, DOI 10.1001/jama.292.14.1717; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Kent DM, 2002, J GEN INTERN MED, V17, P887, DOI 10.1046/j.1525-1497.2002.11232.x; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; NALLAMOTHU BK, IN PRESS CIRCULATION; *NAT HEART ATT AL, 1998, J THROMB THROMBOLYS, V6, P19; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Shahian DM, 2003, ANN THORAC SURG, V75, P1048, DOI 10.1016/S0003-4975(02)04308-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Topol EJ, 2003, CIRCULATION, V107, P1463, DOI 10.1161/01.CIR.0000063680.45780.A0; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	40	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1383	1387		10.1001/jama.293.11.1383	http://dx.doi.org/10.1001/jama.293.11.1383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769973	Green Accepted			2022-12-28	WOS:000227698600028
J	Baker, R				Baker, R			Placing principle before expediency: the Shipman inquiry	LANCET			English	Editorial Material							PROFESSIONALISM		Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Baker, R (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England.	rb14@le.ac.uk						Barondess JA, 2003, ARCH INTERN MED, V163, P145, DOI 10.1001/archinte.163.2.145; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Freidson E., 2001, PROFESSIONALISM 3 LO; *GEN ACC OFF, 1995, GEN ACCOUNTING OFF P, P1; Ham C, 2002, BRIT MED J, V324, P838, DOI 10.1136/bmj.324.7341.838; IRVINE D, 2003, DOCTORS STORY PROFES; *LEIC NORTH RUTL S, 2004, EXT REV CLIN GOV ACT; ONEILL O, 2002, BBC REITH LECT LECT, V3; ROSEN R, 2004, BEING DOCTOR REDEFIN; *SHIPM INQ, 2004, 5 SHIPM INQ; Tallis R, 2004, HIPPOCRATIC OATHS ME; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL	12	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					919	921		10.1016/S0140-6736(05)71059-X	http://dx.doi.org/10.1016/S0140-6736(05)71059-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766979				2022-12-28	WOS:000227559800007
J	Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES				Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES			Differential lysosomal proteolysis in antigen-presenting CeRs determines antigen fate	SCIENCE			English	Article							CLASS-II COMPLEXES; DENDRITIC CELLS; PROTEIN ANTIGENS; TRANSPORT; IMMUNITY; HIV	Antigen-presenting cells (APCs) internalize antigens and present antigen-derived peptides to T cells. Although APCs have been thought to exhibit a well-developed capacity for lysosomal proteolysis, here we found that they can exhibit two distinct strategies upon antigen encounter. Whereas macrophages contained high levels of lysosomal proteases and rapidly degraded internalized proteins, dendritic cells (DCs) and B lymphocytes were protease-poor, resulting in a limited capacity for lysosomal degradation. Consistent with these findings, DCs in vivo degraded internalized antigens slowly and thus retained antigen in lymphoid organs for extended periods. Limited lysosomal proteolysis also favored antigen presentation. These results help explain why DCs are able to efficiently accumulate, process, and disseminate antigens and microbes systemically for purposes of tolerance and immunity.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.	ira.mellman@yale.edu; sergio.trombetta@yale.edu	Mellman, Ira/ABG-5896-2020		NIAID NIH HHS [R37-AI34098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara A, 2003, J CELL BIOL, V162, P371, DOI 10.1083/jcb.200307062; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Niedergang F, 2004, TRENDS MICROBIOL, V12, P79, DOI 10.1016/j.tim.2003.12.011; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RICHARDS FM, 1971, BOVINE PANCREATIC RI, V4; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; TROMBETTA ES, UNPUB; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522	21	542	564	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1630	1634		10.1126/science.1108003	http://dx.doi.org/10.1126/science.1108003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761154				2022-12-28	WOS:000227622400049
J	Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y				Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y			Isolation of an algal morphogenesis inducer from a marine bacterium	SCIENCE			English	Article							AXENIC CULTURE; MONOSTROMA-OXYSPERMUM; ULVA; CHLOROPHYCEAE		Marine Biotechnol Inst Co Ltd, Kamaishi, Iwate 0260001, Japan; Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan	Japanese Society of Marine Biotechnology; Tokushima Bunri University	Matsuo, Y (corresponding author), Marine Biotechnol Inst Co Ltd, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	yoshihide.matsuo@mbio.jp						BONNEAU ER, 1977, J PHYCOL, V13, P133, DOI 10.1111/j.1529-8817.1977.tb00569.x; FRIES L, 1975, BOT MAR, V18, P251, DOI 10.1515/botm.1975.18.4.251; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; MATSUO Y, UNPUB; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; PROVASOLI L, 1963, P INT SEAWEED S, V4, P1; TATEWAKI M, 1983, J PHYCOL, V19, P409, DOI 10.1111/j.0022-3646.1983.00409.x	9	161	167	7	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1598	1598		10.1126/science.1105486	http://dx.doi.org/10.1126/science.1105486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	906ED	15761147				2022-12-28	WOS:000227622400040
J	Inoue, N; Ikawa, M; Isotani, A; Okabe, M				Inoue, N; Ikawa, M; Isotani, A; Okabe, M			The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs	NATURE			English	Article							PLASMA-MEMBRANE; CD9-DEFICIENT MICE; ACROSOME REACTION; HUMAN-SPERMATOZOA; GAMETE FUSION; FERTILIN-BETA; MOUSE; BINDING; RECEPTORS; CALMEGIN	Representing the 60 trillion cells that build a human body, a sperm and an egg meet, recognize each other, and fuse to form a new generation of life. The factors involved in this important membrane fusion event, fertilization, have been sought for a long time(1). Recently, CD9 on the egg membrane was found to be essential for fusion(2-4), but sperm-related fusion factors remain unknown. Here, by using a fusion-inhibiting monoclonal antibody(5) and gene cloning, we identify a mouse sperm fusion-related antigen and show that the antigen is a novel immunoglobulin superfamily protein. We have termed the gene Izumo and produced a gene-disrupted mouse line. Izumo(-/-) mice were healthy but males were sterile. They produced normal-looking sperm that bound to and penetrated the zona pellucida but were incapable of fusing with eggs. Human sperm also contain Izumo and addition of the antibody against human Izumo left the sperm unable to fuse with zona-free hamster eggs.	Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Okabe, M (corresponding author), Osaka Univ, Genome Informat Res Ctr, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@gen-info.osaka-u.ac.jp	Inoue, Naokazu/A-9911-2009; Isotani, Ayako/D-4564-2017; ikawa, masahito/A-5315-2009; Isotani, Ayako/A-9929-2009; Okabe, Masaru/B-6917-2015	Isotani, Ayako/0000-0002-4720-2318; ikawa, masahito/0000-0001-9859-6217; Isotani, Ayako/0000-0002-4720-2318; Inoue, Naokazu/0000-0002-6187-8293; Okabe, Masaru/0000-0002-0803-9044				ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Ellerman DA, 2003, MOL BIOL CELL, V14, P5098, DOI 10.1091/mbc.E03-04-0244; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; He ZY, 2003, DEV BIOL, V254, P226, DOI 10.1016/S0012-1606(02)00043-X; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ilayperuma I, 2002, J EXP ZOOL, V293, P617, DOI 10.1002/jez.10182; Inoue N, 2003, MOL CELL BIOL, V23, P2614, DOI 10.1128/MCB.23.7.2614-2622.2003; Inoue N, 2001, J IMMUNOL, V166, P424, DOI 10.4049/jimmunol.166.1.424; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Manandhar G, 2001, BIOL REPROD, V65, P1425, DOI 10.1095/biolreprod65.5.1425; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; OKABE M, 1990, FERTIL STERIL, V54, P1121; OKABE M, 1987, J REPROD IMMUNOL, V11, P91, DOI 10.1016/0165-0378(87)90014-3; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; OVERSTREET JW, 1980, FERTIL STERIL, V33, P534; ROCHWERGER L, 1992, DEV BIOL, V153, P83, DOI 10.1016/0012-1606(92)90093-V; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	31	528	572	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					234	238		10.1038/nature03362	http://dx.doi.org/10.1038/nature03362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759005				2022-12-28	WOS:000227494500050
J	Bartlett, LA; Mawji, S; Whitehead, S; Crouse, C; Dalil, S; Ionete, D; Salama, P				Bartlett, LA; Mawji, S; Whitehead, S; Crouse, C; Dalil, S; Ionete, D; Salama, P		Afghan Maternal Mortality Study Te	Where giving birth is a forecast of death: maternal mortality in four districts of Afghanistan, 1999-2002	LANCET			English	Article								Background Maternal mortality in Afghanistan is uniformly identified as an issue of primary public-health importance. To guide the implementation of reproductive-health services, we examined the numbers, causes, and preventable factors for maternal deaths among women in four districts. Methods We did a retrospective cohort study of women of reproductive age (15-49 years) who died between March 21, 1999, and March 21, 2002, in four selected districts in four provinces: Kabul city, Kabul province (urban); Alisheng district, Laghman province (semirural); Maywand, Kandahar province (rural); and Ragh, Badakshan province (rural, most remote). Deaths among women of reproductive age were identified through a survey of all households in randomly selected villages and investigated through verbal-autopsy interviews of family members. Findings In a population of 90 816, 357 women of reproductive age died; 154 deaths were related to complications during pregnancy, childbirth, or the puerperal period. Most maternal deaths were caused by ante-partum haemorrhage, except in Ragh, where a greater proportion of women died of obstructed labour. All measures of maternal risk were high, especially in the more remote areas; the maternal mortality ratio (per 100 000 livebirths) was 418 (235-602) in Kabul, 774 (433-1115) in Alisheng, 2182 (1451-2913) in Maywand, and 6507 (5026-7988) in Ragh. In the two rural sites, no woman who died was assisted by a skilled birth attendant. Interpretation Maternal mortality in Afghanistan is high and becomes significantly greater with increasing remoteness. Deaths could be averted if complications were prevented through optimisation of general health status and if complications that occurred were treated to reduce their severity-efforts that require a multisectoral approach to increase availability and accessibility of health care.	Ctr Dis Control & Prevent, Maternal & Infant Hlth Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA USA; UNICEF Afghanistan Off, Kabul, Afghanistan	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bartlett, LA (corresponding author), Ctr Dis Control & Prevent, Maternal & Infant Hlth Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	LBartiett@cdc.gov						*AFGH NAT HLTH RES, MAN SCI HLTH; AGUGIN CA, 2000, BRIT MED J, V321, P1255; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V288, P1284, DOI 10.1001/jama.288.10.1284; [Anonymous], V5th; Bartlett LA, 2002, LANCET, V359, P643, DOI 10.1016/S0140-6736(02)07808-X; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Christian P, 2002, NUTR REV, V60, pS59, DOI 10.1301/00296640260130759; Cook RJ, 2004, LANCET, V363, P73, DOI 10.1016/S0140-6736(03)15178-1; GRAHAM W, 1996, WHORHTMSM951; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; HERTZ E, 1994, SOC SCI MED, V39, P105, DOI 10.1016/0277-9536(94)90170-8; KHAN AR, 1986, STUD FAMILY PLANN, V17, P7, DOI 10.2307/1966950; Miller LH, 1998, NAT MED, V4, P1244, DOI 10.1038/3223; Rashid Ahmed, 2000, ISLAM OIL NEW GREAT; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; *TRANS ISL GOV AFG, 2003, NAT REPR HLTH STRAT; Transitional Islamic Government of Afghanistan Ministry of Health, 2003, BAS PACK HLTH SERV A; VANLERBERGHE W, 2001, SAFE MOTHERHOOD STRA; Waldman R, 2002, PUBLIC HLTH SYSTEM A; *WHO, 1987, WHOFHE877; *WHO, ESS OBST CAR FACTSH; *WHO, 1995, WHOFHEMSM9515; WHO/ UN/ UNICEF, MAT MORT 2000 EST DE; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; INITIATIVE MATERNAL; AFGHANISTAN INFORMAT	26	160	160	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					864	870		10.1016/S0140-6736(05)71044-8	http://dx.doi.org/10.1016/S0140-6736(05)71044-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752530				2022-12-28	WOS:000227444600028
J	Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW				Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW			Postprandial cardiac hypertrophy in pythons	NATURE			English	Editorial Material							HEART; MODEL		Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Orthopaed, Irvine, CA 92697 USA; Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Long Beach	Andersen, JB (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	jhicks@uci.edu						COOPER G, 1987, ANNU REV PHYSIOL, V49, P501, DOI 10.1146/annurev.ph.49.030187.002441; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Quinn KE, 1998, BIOPHYS J, V74, pA355; Richey PA, 1998, J SPORT SCI, V16, P129; Secor SM, 1997, AM J PHYSIOL-REG I, V272, pR902, DOI 10.1152/ajpregu.1997.272.3.R902; Secor SM, 2000, J EXP BIOL, V203, P2447; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Starck JM, 2001, J EXP BIOL, V204, P325; VLIEGEN HW, 1990, COMP BIOCHEM PHYS A, V95, P109, DOI 10.1016/0300-9629(90)90017-M	9	84	88	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					37	38		10.1038/434037a	http://dx.doi.org/10.1038/434037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744290				2022-12-28	WOS:000227334600034
J	Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP				Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP			An anaerobic mitochondrion that produces hydrogen	NATURE			English	Article							CHYTRID NEOCALLIMASTIX SP; PYRUVATE-FORMATE-LYASE; COMPLEX-I; ORGANELLES; GENOME; EVOLUTION; EUKARYOTE; MEMBRANE; SEQUENCE; ORIGINS	Hydrogenosomes are organelles that produce ATP and hydrogen(1), and are found in various unrelated eukaryotes, such as anaerobic flagellates, chytridiomycete fungi and ciliates(2). Although all of these organelles generate hydrogen, the hydrogenosomes from these organisms are structurally and metabolically quite different, just like mitochondria where large differences also exist(3). These differences have led to a continuing debate about the evolutionary origin of hydrogenosomes(4,5). Here we show that the hydrogenosomes of the anaerobic ciliate Nyctotherus ovalis, which thrives in the hindgut of cockroaches, have retained a rudimentary genome encoding components of a mitochondrial electron transport chain. Phylogenetic analyses reveal that those proteins cluster with their homologues from aerobic ciliates. In addition, several nucleus-encoded components of the mitochondrial proteome, such as pyruvate dehydrogenase and complex II, were identified. The N. ovalis hydrogenosome is sensitive to inhibitors of mitochondrial complex I and produces succinate as a major metabolic end product - biochemical traits typical of anaerobic mitochondria(3). The production of hydrogen, together with the presence of a genome encoding respiratory chain components, and biochemical features characteristic of anaerobic mitochondria, identify the N. ovalis organelle as a missing link between mitochondria and hydrogenosomes.	Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Microscop Imaging Ctr, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Groningen, Dept Eukaryot Microbiol, NL-9750 AA Haren, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; University of Freiburg; University of Groningen	Hackstein, JHP (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.hackstein@science.ru.nl	Huynen, Martijn A/A-1530-2014; van Hellemond, Jaap/T-7555-2019; Koopman, Werner J.H./D-3592-2009; de Graaf, Rob/E-7665-2012; Gabaldón, Toni/A-7336-2008; Koopman, Werner J.H./AAC-9668-2020; Huijnen, M.A./H-8051-2014	Huynen, Martijn A/0000-0001-6189-5491; van Hellemond, Jaap/0000-0003-4862-7796; Koopman, Werner J.H./0000-0002-5340-6747; Gabaldón, Toni/0000-0003-0019-1735; Koopman, Werner J.H./0000-0002-5340-6747; de Graaf, Rob/0000-0001-9143-8961				Akhmanova A, 1999, MOL MICROBIOL, V32, P1103, DOI 10.1046/j.1365-2958.1999.01434.x; Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Boxma B, 2004, MOL MICROBIOL, V51, P1389, DOI 10.1046/j.1365-2958.2003.03912.x; Brunk CF, 2003, NUCLEIC ACIDS RES, V31, P1673, DOI 10.1093/nar/gkg270; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Curtis EA, 1999, ANN NY ACAD SCI, V870, P349, DOI 10.1111/j.1749-6632.1999.tb08900.x; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Koopman WJH, 2001, BIOPHYS J, V81, P57, DOI 10.1016/S0006-3495(01)75679-2; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Van Hoek AHAM, 1999, J EUKARYOT MICROBIOL, V46, P427, DOI 10.1111/j.1550-7408.1999.tb04623.x; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; vanderGiezen M, 1997, FEBS LETT, V408, P147, DOI 10.1016/S0014-5793(97)00409-2; VanHellemond JJ, 1995, J BIOL CHEM, V270, P31065, DOI 10.1074/jbc.270.52.31065; Voncken F, 2002, MOL MICROBIOL, V44, P1441, DOI 10.1046/j.1365-2958.2002.02959.x; Voncken FGJ, 2002, GENE, V284, P103, DOI 10.1016/S0378-1119(02)00388-8	30	156	166	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					74	79		10.1038/nature03343	http://dx.doi.org/10.1038/nature03343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744302	Green Published, Green Submitted			2022-12-28	WOS:000227334600046
J	Cruz, FW; Burns, SJ; Karmann, I; Sharp, WD; Vuille, M; Cardoso, AO; Ferrari, JA; Dias, PLS; Viana, O				Cruz, FW; Burns, SJ; Karmann, I; Sharp, WD; Vuille, M; Cardoso, AO; Ferrari, JA; Dias, PLS; Viana, O			Insolation-driven changes in atmospheric circulation over the past 116,000 years in subtropical Brazil	NATURE			English	Article							ISOTOPIC COMPOSITION; SOUTH-AMERICA; CLIMATE; ATLANTIC; PRECIPITATION; RAINFALL; OXYGEN; BASIN	During the last glacial period, large millennial- scale temperature oscillations - the 'Dansgaard/Oeschger' cycles - were the primary climate signal in Northern Hemisphere climate archives from the high latitudes to the tropics(1-6). But whether the influence of these abrupt climate changes extended to the tropical and subtropical Southern Hemisphere, where changes in insolation are thought to be the main direct forcing of climate, has remained unclear. Here we present a high-resolution oxygen isotope record of a U/Th-dated stalagmite from subtropical southern Brazil, covering the past 116,200 years. The oxygen isotope signature varies with shifts in the source region and amount of rainfall in the area, and hence records changes in atmospheric circulation and convective intensity over South America. We find that these variations in rainfall source and amount are primarily driven by summer solar radiation, which is controlled by the Earth's precessional cycle. The Dansgaard/ Oeschger cycles can be detected in our record and therefore we confirm that they also affect the tropical hydrological cycle, but that in southern subtropical Brazil, millennial-scale climate changes are not as dominant as they are in the Northern Hemisphere.	Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA; Univ Sao Paulo, Inst Geociencias, BR-05508080 Sao Paulo, Brazil; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Sao Paulo, Inst Astron Geofis & Ciencias Atmosfer, Dept Ciencias Atmosfer, BR-05508090 Sao Paulo, Brazil; Inst Geol, BR-04301903 Sao Paulo, Brazil	University of Massachusetts System; University of Massachusetts Amherst; Universidade de Sao Paulo; Berkeley Geochronolgy Center; Universidade de Sao Paulo	Cruz, FW (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA.	fdacruz@geo.umass.edu	FERRARI, JOSE/G-2452-2012; Vuille, Mathias/O-8128-2019; da Silva Dias, Pedro Leite/H-1183-2016; Cruz, Francisco W/G-6059-2012; Vuille, Mathias/S-3906-2019; Burns, Stephen/H-9419-2013; karmann, ivo/H-8106-2013; Cardoso, Andrea O/E-6651-2019	FERRARI, JOSE/0000-0003-1299-7808; Vuille, Mathias/0000-0002-9736-4518; da Silva Dias, Pedro Leite/0000-0002-4051-2962; Cardoso, Andrea O/0000-0001-9914-7501; karmann, ivo/0000-0001-6905-8962; Cruz, Francisco/0000-0002-4030-4581				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; Burns SJ, 2003, SCIENCE, V301, P1365, DOI 10.1126/science.1086227; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Friedman I., 1977, US GEOL SURV PROF PA, P1; Gan MA, 2004, J CLIMATE, V17, P47, DOI 10.1175/1520-0442(2004)017&lt;0047:TSAMCA&gt;2.0.CO;2; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; IAEA/WMO, 1994, IGBP PAGES WORLD DAT, V94-005; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Maslin MA, 2000, SCIENCE, V290, P2285; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; NoguesPaegle J, 1997, MON WEATHER REV, V125, P279, DOI 10.1175/1520-0493(1997)125<0279:AWADCO>2.0.CO;2; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rao VB, 1996, J GEOPHYS RES-ATMOS, V101, P26539, DOI 10.1029/96JD01936; Rozanski K., 1993, GEOPHYS MONOGR SER, V78, P1, DOI DOI 10.1029/GM078P0001; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Seltzer G, 2000, GEOLOGY, V28, P35; Sharp WD, 2003, QUATERNARY RES, V59, P139, DOI 10.1016/S0033-5894(03)00003-6; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Vera CS, 2002, MON WEATHER REV, V130, P684, DOI 10.1175/1520-0493(2002)130<0684:CSSSWO>2.0.CO;2; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Zhou JY, 1998, J CLIMATE, V11, P1020, DOI 10.1175/1520-0442(1998)011<1020:DAMCEO>2.0.CO;2	30	490	519	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					63	66		10.1038/nature03365	http://dx.doi.org/10.1038/nature03365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744298				2022-12-28	WOS:000227334600042
J	Coaker, G; Falick, A; Staskawicz, B				Coaker, G; Falick, A; Staskawicz, B			Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin	SCIENCE			English	Article							III EFFECTOR; SACCHAROMYCES-CEREVISIAE; DISEASE RESISTANCE; INNATE IMMUNITY; AVRRPT2; ARABIDOPSIS; RIN4; SECRETION; CLEAVAGE; PROTEASES	Innate immunity in higher plants invokes a sophisticated surveillance system capable of recognizing bacterial effector proteins. In Arabidopsis, resistance to infection by strains of Pseudomonas syringae expressing the effector AvrRpt2 requires the plant resistance protein RPS2. AvrRpt2 was identified as a putative cysteine protease that results in the elimination of the Arabidopsis protein RIN4. RIN4 cleavage serves as a signal to activate RP52-mediated resistance. AvrRpt2 is delivered into the plant cell, where it is activated by a eukaryotic factor that we identify as cyclophilin. This activation of AvrRpt2 is necessary for protease activity. Active AvrRpt2 can then directly cleave RIN4.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Staskawicz, B (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	stask@nature.berkeley.edu			PHS HHS [R01-FM069680-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; COAKER, UNPUB; CORCORAN ML, 1995, ADV EXP MED BIOL, V385, P151; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x	22	185	198	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					548	550		10.1126/science.1108633	http://dx.doi.org/10.1126/science.1108633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15746386				2022-12-28	WOS:000228810500051
J	Quill, TE				Quill, TE			Terri Schiavo - A tragedy compounded	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA	University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA.							ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gostin L, 1991, Law Med Health Care, V19, P9; JENNETT B, 2002, VEGETATIVE STATE MED; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130	5	77	80	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1630	+		10.1056/NEJMp058062	http://dx.doi.org/10.1056/NEJMp058062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784658				2022-12-28	WOS:000228515200002
J	Elden, H; Ladfors, L; Olsen, MF; Ostgaard, HC; Hagberg, H				Elden, H; Ladfors, L; Olsen, MF; Ostgaard, HC; Hagberg, H			Effects of acupuncture and stabilising exercises as adjunct to standard treatment in pregnant women with pelvic girdle pain: randomised single blind controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN	Objectives To compare the efficacy of standard treatment, standard treatment plus acupuncture, and standard treatment plus stabihsing exercises for pelvic girdle pain during pregnancy. Design Randomised single blind controlled trial. Settings East Hospital and 27 maternity care centres in Gothenburg, Sweden. Participants 386 pregnant women with pelvic girdle pain. Interventions Treatment for six weeks with standard treatment (n = 130), standard treatment plus acupuncture (n = 125), or standard treatment plus stabilising exercises (n = 11). Main outcome measures Primary outcome measure was pain (visual analogue scale); secondary outcome measure was assessment of severity of pelvic girdle pain by an independent examiner before and after treatment. Results After treatment the stabilising exercise group had less pain than the standard group in the morning (median difference = 9, 95% confidence interval 1.7 to 12.8; P = 0.0312) and in the evening (13, 2.7 to 17.5; P = 0.0245). The acupuncture group bad less pain in the evening than the stabilising exercise group (- 14, - 18.1 to - 3.3; P = 0.0130). The acupuncture group had less pain than the standard treatment group in the morning (12, 5.9 to 17.3; P < 0.001) and in the evening (27,13.3 to 29.5; P < 0.001). Attenuation of pelvic girdle pain as assessed by the independent examiner was greatest in the acupuncture group. Conclusion Acupuncture and stabilising exercises are efficient complements to standard treatment for the management of pelvic girdle pain during pregnancy. Acupuncture was superior to stabilising exercises in this study.	East Hosp, Sahlgrenska Acad, Inst Hlth Women & Children, Dept Obstet & Gynecol,Perinatal Ctr, S-41685 Gothenburg, Sweden; Sahlgrenska Hosp, Sahlgrenska Acad, Dept Occupat Therapy & Phys Therapy, Antenatal Unit, Gothenburg, Sweden; Molndal Cty Hosp, Sahlgrenska Acad, Dept Orthoped, Molndal, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Elden, H (corresponding author), East Hosp, Sahlgrenska Acad, Inst Hlth Women & Children, Dept Obstet & Gynecol,Perinatal Ctr, S-41685 Gothenburg, Sweden.	helen.elden@vgregion.se	Corteling, Shavonne/A-8424-2012	Elden, Helen/0000-0003-0000-0476; Ladfors, Lars/0000-0002-7512-2059; Hagberg, Henrik/0000-0003-3962-1448				Albert H, 2000, EUR SPINE J, V9, P161, DOI 10.1007/s005860050228; Albert HB, 2002, SPINE, V27, P2831, DOI 10.1097/00007632-200212150-00020; ANDERSSON S, 1995, MED HYPOTHESES, V45, P271, DOI 10.1016/0306-9877(95)90117-5; Bjorklund K, 2000, ACTA OBSTET GYN SCAN, V79, P24, DOI 10.1034/j.1600-0412.2000.079001024.x; Carlsson CPO, 2001, CLIN J PAIN, V17, P296, DOI 10.1097/00002508-200112000-00003; COAN RM, 1980, AM J CHINESE MED, V8, P181, DOI 10.1142/S0192415X80000141; Kristiansson P, 1996, SPINE, V21, P2337, DOI 10.1097/00007632-199610150-00006; Kvorning N, 2004, ACTA OBSTET GYN SCAN, V83, P246; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Ostgaard H C, 1994, Eur Spine J, V3, P258, DOI 10.1007/BF02226575; Ostgaard HC, 1996, SPINE, V21, P2777, DOI 10.1097/00007632-199612010-00013; OSTGAARD HC, 1994, SPINE, V19, P894; Ostgaard HC, 1997, SPINE, V22, P2945, DOI 10.1097/00007632-199712150-00018; Pool-Goudzwaard A. L., 1998, Man Ther, V3, P12, DOI 10.1054/math.1998.0311; Richardson CA, 2002, SPINE, V27, P399, DOI 10.1097/00007632-200202150-00015; RICHARDSON CA, 2000, MAN THER, V1, P2; Sihvonen T, 1998, ARCH PHYS MED REHAB, V79, P1210, DOI 10.1016/S0003-9993(98)90264-7; Stuge B, 2004, SPINE, V29, pE197, DOI 10.1097/00007632-200405150-00021; Stuge B, 2003, ACTA OBSTET GYN SCAN, V82, P983, DOI 10.1034/j.1600-0412.2003.00125.x; Wedenberg K, 2000, ACTA OBSTET GYN SCAN, V79, P331, DOI 10.1034/j.1600-0412.2000.079005331.x; Wu WH, 2004, EUR SPINE J, V13, P575, DOI 10.1007/s00586-003-0615-y; Young G L, 2002, Cochrane Database Syst Rev, pCD000121	22	110	118	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2005	330	7494					761	764A		10.1136/bmj.38397.507014.E0	http://dx.doi.org/10.1136/bmj.38397.507014.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914JE	15778231	Green Published, Bronze			2022-12-28	WOS:000228222900022
J	Rumpel, S; LeDoux, J; Zador, A; Malinow, R				Rumpel, S; LeDoux, J; Zador, A; Malinow, R			Postsynaptic receptor trafficking underlying a form of associative learning	SCIENCE			English	Article							LONG-TERM POTENTIATION; DRIVING AMPA RECEPTORS; SYNAPTIC PLASTICITY; SPATIAL MEMORY; FEAR; LTP; HIPPOCAMPUS; EXPRESSION; SYNAPSES; AMYGDALA	To elucidate molecular, cellular, and circuit changes that occur in the brain during learning, we investigated the rote of a glutamate receptor subtype in fear conditioning. In this form of learning, animals associate two stimuli, such as a tone and a shock. Here we report that fear conditioning drives AMPA-type glutamate receptors into the synapse of a large fraction of postsynaptic neurons in the lateral amygdala, a brain structure essential for this learning process. Furthermore, memory was reduced if AMPA receptor synaptic incorporation was blocked in as few as 10 to 20% of lateral amygdala neurons. Thus, the encoding of memories in the lateral amygdala is mediated by AMPA receptor trafficking, is widely distributed, and displays little redundancy.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, New York, NY 10003 USA	Cold Spring Harbor Laboratory; New York University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.edu		Zador, Anthony/0000-0002-8431-9136				Andersen P, 2003, PHILOS T R SOC B, V358, P613, DOI 10.1098/rstb.2002.1232; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANDERSEN P, 1995, J NEUROBIOL, V26, P396, DOI 10.1002/neu.480260311; Bahi A, 2004, EUR J NEUROSCI, V19, P1621, DOI 10.1111/j.1460-9568.2004.03260.x; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; FREUD S, 1895, ORIGINS PSYCHOANALYS, P356; GOOD MA, 2004, ANN M SOC NEUR SAN D; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Goss James R, 2004, Methods Mol Biol, V246, P309; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb Donald O., 1949, ORG BEHAV; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lynch G, 2003, PHILOS T ROY SOC B, V358, P625, DOI 10.1098/rstb.2002.1253; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McNaughton BL, 2003, PHILOS T ROY SOC B, V358, P629, DOI 10.1098/rstb.2002.1231; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Neve R L, 1999, Adv Neurol, V79, P1027; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Sandler VM, 2002, J NEUROSCI METH, V121, P211, DOI 10.1016/S0165-0270(02)00262-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	52	546	560	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					83	88		10.1126/science.1103944	http://dx.doi.org/10.1126/science.1103944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15746389	Bronze			2022-12-28	WOS:000228221500037
J	Glasziou, P; Irwig, L; Mant, D				Glasziou, P; Irwig, L; Mant, D			Monitoring in chronic disease: a rational approach	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; TO-MODERATE HYPERTENSION; GENERAL-PRACTICE; ASTHMA; INTERVENTION; MANAGEMENT; THERAPY; LEVEL		Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Glasziou, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Begg CB, 2000, J ROY STAT SOC A STA, V163, P15, DOI 10.1111/1467-985X.00153; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Boggs P B, 1999, Jt Comm J Qual Improv, V25, P163; Bonnet C, 1998, PATIENT EDUC COUNS, V35, P139, DOI 10.1016/S0738-3991(98)00051-2; BRAITHWAITE RA, 1982, THER DRUG MONIT, V4, P27, DOI 10.1097/00007691-198204000-00004; Brueren MM, 1997, FAM PRACT, V14, P130, DOI 10.1093/fampra/14.2.130; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Chen P, 2003, AM J CLIN PATHOL, V119, P432, DOI 10.1309/A96XU9YKU298HB2R; CLAGUE HW, 1983, THER DRUG MONIT, V5, P249, DOI 10.1097/00007691-198309000-00003; DAUBER TR, 1980, FRAMINGHAM STUDY EPI; GIBSON PG, 1995, ANN INTERN MED, V123, P488, DOI 10.7326/0003-4819-123-7-199510010-00002; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; IRWIG L, 1991, JAMA-J AM MED ASSOC, V266, P1678, DOI 10.1001/jama.266.12.1678; Irwig L, 2003, BRIT MED J, V326, P1336, DOI 10.1136/bmj.326.7402.1336; Jannuzzi G, 2000, EPILEPSIA, V41, P222, DOI 10.1111/j.1528-1157.2000.tb00144.x; LOWY A, 1998, BRIT MED J, V316, P1467; Peyvandi F, 2004, CLIN PHARMACOL THER, V75, P198, DOI 10.1016/j.clpt.2003.09.015; Pirmohamed M, 2003, BRIT MED J, V327, P1179, DOI 10.1136/bmj.327.7425.1179; Rachmani R, 2002, DIABETIC MED, V19, P385, DOI 10.1046/j.1464-5491.2002.00701.x; ROBERTSON I, 1992, BRIT J GEN PRACT, V42, P469; RYAN PJ, 1989, BRIT MED J, V299, P1207, DOI 10.1136/bmj.299.6709.1207; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; *SCOTT INT GUID NE, 1999, LIP PRIM PREV COR HE; SIDWELL A, 2003, NZ MED J, V116, pU704; Smith DHG, 2000, J CLIN PHARMACOL, V40, P1380; Thoonen BPA, 2003, THORAX, V58, P30, DOI 10.1136/thorax.58.1.30; Yoos HL, 2002, ANN ALLERG ASTHMA IM, V88, P283, DOI 10.1016/S1081-1206(10)62010-8	28	135	138	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					644	648		10.1136/bmj.330.7492.644	http://dx.doi.org/10.1136/bmj.330.7492.644			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774996	Green Published			2022-12-28	WOS:000227861700026
J	Ong, BN; Evans, D; Bartlam, A				Ong, BN; Evans, D; Bartlam, A			A patient's journey with myalgic encephalomyelitis	BRITISH MEDICAL JOURNAL			English	Review							CHRONIC ILLNESS; CHRONIC PAIN		Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England; Light Oaks, Stoke On Trent ST2 7DE, Staffs, England; Keele Med Sch, Keele ST5 5BG, Staffs, England	Keele University; Keele University	Ong, BN (corresponding author), Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England.	b.n.ong@kcele.ac.uk						Barry CA, 2001, SOC SCI MED, V53, P487, DOI 10.1016/S0277-9536(00)00351-8; BENDELOW GA, 1995, SOCIOL HEALTH ILL, V17, P139, DOI 10.1111/1467-9566.ep10933376; COMAROFF J, 1981, SOC SCI MED-MED ANTH, V15, P115, DOI 10.1016/0160-7987(81)90034-X; HUTCHINSON A, 2002, REPORT CHIEF MED OFF; Hyden LC, 2002, HEALTH, V6, P325, DOI 10.1177/136345930200600305; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; POLANYI M, 1997, MEANING; Risdon A, 2003, SOC SCI MED, V56, P375, DOI 10.1016/S0277-9536(02)00043-6; Smith M., 1998, PERSPECTIVES PAIN MA, P26; Werner A, 2004, SOC SCI MED, V59, P1035, DOI 10.1016/j.socscimed.2003.12.001; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	11	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					648	650		10.1136/bmj.330.7492.648	http://dx.doi.org/10.1136/bmj.330.7492.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774997	Green Published			2022-12-28	WOS:000227861700027
J	Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P				Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P		HRSC Co-Investigator Team	Discovery of a flank caldera and very young glacial activity at Hecates Tholus, Mars	NATURE			English	Article							GROUND ICE; SUBLIMATION; VOLCANISM; EVOLUTION; WATER; DEPOSITS	The majority of volcanic products on Mars are thought to be mafic and effusive(1,2). Explosive eruptions of basic to ultrabasic chemistry are expected to be common(3,4), but evidence for them is rare and mostly confined to very old surface features(5). Here we present new image and topographic data from the High Resolution Stereo Camera that reveal previously unknown traces of an explosive eruption at 30 degrees N and 149 degrees E on the northwestern flank of the shield volcano Hecates Tholus. The eruption created a large, 10-km-diameter caldera similar to 350 million years ago. We interpret these observations to mean that large-scale explosive volcanism on Mars was not confined to the planet's early evolution. We also show that glacial deposits partly fill the caldera and an adjacent depression. Their age, derived from crater counts, is about 5 to 24 million years. Climate models predict that near-surface ice is not stable at mid-latitudes today(6), assuming a thermo-dynamic steady state. Therefore, the discovery of very young glacial features at Hecates Tholus suggests recent climate changes. We show that the absolute ages of these very recent glacial deposits correspond very well to a period of increased obliquity of the planet's rotational axis(7).	DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; FU Berlin, Inst Geosci, D-12249 Berlin, Germany; Russian Acad Sci, Inst Dynam Geospheres, Moscow 117334, Russia; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England; UCL, Dept Geomat Engn, London WC1E 6BT, England	Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Brown University; Arizona State University; Arizona State University-Tempe; Lancaster University; University of London; University College London	Hauber, E (corresponding author), DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany.	Ernst.Hauber@dlr.de	Hauber, Ernst/U-2521-2018; Werner, Stephanie C/A-6438-2012; Mitchell, Karl Leon/AGL-9516-2022; Muller, Jan-Peter/Q-8886-2019; Jaumann, Ralf/N-1001-2018; van Gasselt, Stephan/L-9762-2013; Mitchell, Karl Leon/AAG-3821-2020	Hauber, Ernst/0000-0002-1375-304X; Werner, Stephanie C/0000-0001-5704-0909; Muller, Jan-Peter/0000-0002-5077-3736; Jaumann, Ralf/0000-0002-9759-6597; van Gasselt, Stephan/0000-0003-2130-6343; Mitchell, Karl Leon/0000-0003-1093-8441				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FRANCIS PW, 1982, J GEOPHYS RES, V87, P9881, DOI 10.1029/JB087iB12p09881; GREELEY R, 1990, J GEOPHYS RES-SOLID, V95, P7133, DOI 10.1029/JB095iB05p07133; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HELBERT J, 2003, 6 INT C MARS LUN PLA; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mouginis-Mark P.J., 1992, MARS PP, P424; MOUGINISMARK PJ, 1982, J GEOPHYS RES, V87, P9890, DOI 10.1029/JB087iB12p09890; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WALL SD, 1981, ICARUS, V47, P173, DOI 10.1016/0019-1035(81)90165-2; WERNER SC, 2004, LUNAR PLANET SCI, V35; Wewel F., 2000, Canadian Journal of Remote Sensing, V26, P466; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113	30	66	66	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					356	361		10.1038/nature03423	http://dx.doi.org/10.1038/nature03423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772654				2022-12-28	WOS:000227715100044
J	Markowitz, AJ; McPhee, S				Markowitz, AJ; McPhee, S			Caring for the child with cancer at the close of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article														Markowitz, Amy/0000-0001-9314-2814				Hurwitz CA, 2004, JAMA-J AM MED ASSOC, V292, P2141, DOI 10.1001/jama.292.17.2141	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1382	1382		10.1001/jama.293.11.1382	http://dx.doi.org/10.1001/jama.293.11.1382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769972				2022-12-28	WOS:000227698600027
J	Partridge, AH; Wong, JS; Knudsen, K; Gelman, R; Sampson, E; Gadd, M; Bishop, KL; Harris, JR; Winer, EP				Partridge, AH; Wong, JS; Knudsen, K; Gelman, R; Sampson, E; Gadd, M; Bishop, KL; Harris, JR; Winer, EP			Offering participants results of a clinical trial: sharing results of a negative study	LANCET			English	Article								In general, patients are not given information about the results of trials in which they have participated. We aimed to assess the process and effect of providing clinical trial participants with results of a negative study. We offered results to 135 participants in a phase II trial of breast excision alone for women with ductal carcinoma in situ, which was stopped early because of an early high rate of local recurrence. 85 (90%) of 94 respondents chose to receive results; these women were more educated (57 [67%] of 85 college graduates) than those who chose not to (two [22%] of nine, p=0.006). Most participants reported positive feelings about being offered results and about clinical trials in general. These preliminary findings from sharing clinical trial results are encouraging.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med & Radiat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Partridge, AH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med & Radiat Oncol, 44 Binney St,D1210, Boston, MA 02115 USA.	ahpartridge@partners.org						Fernandez Conrad V, 2003, IRB, V25, P12, DOI 10.2307/3564300; Partridge AH, 2004, J NATL CANCER I, V96, P629, DOI 10.1093/jnci/djh096; Partridge AH, 2003, J NATL CANCER I, V95, P491, DOI 10.1093/jnci/95.6.491; Partridge AH, 2002, JAMA-J AM MED ASSOC, V288, P363, DOI 10.1001/jama.288.3.363; Wong JS, 2003, BREAST CANCER RES TR, V82, pS10	5	71	71	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					963	964		10.1016/S0140-6736(05)71085-0	http://dx.doi.org/10.1016/S0140-6736(05)71085-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766998				2022-12-28	WOS:000227559800029
J	Settleman, J				Settleman, J			Intercalating Arabidopsis leaf cells: A jigsaw puzzle of lobes, necks, ROPs, and RICs	CELL			English	Editorial Material							CONVERGENT EXTENSION; RHO	Intercalation of cells is an evolutionarily conserved strategy used for a variety of developmental processes in animals. In this issue of Cell, Fu et al. have uncovered an elaborate Rho GTPase-mediated mechanism by which cytoskeletal-dependent intercalation of Arabidopsis leaf cells is achieved, suggesting that conserved Rho GTPase signaling pathways may similarly regulate tissue morphogenesis in animals and plants.	MGH Canc Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University	Settleman, J (corresponding author), MGH Canc Ctr, Charlestown, MA 02129 USA.							Baum B, 2004, CURR BIOL, V14, pR716, DOI 10.1016/j.cub.2004.08.047; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Nikolaidou KK, 2005, TRENDS GENET, V21, P70, DOI 10.1016/j.tig.2004.12.002; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1	9	6	6	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					570	572		10.1016/j.cell.2005.02.025	http://dx.doi.org/10.1016/j.cell.2005.02.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766519	Bronze			2022-12-28	WOS:000227771400002
J	Venning, G				Venning, G			Recent developments in vitamin D deficiency and muscle weakness among elderly people	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; D SUPPLEMENTATION; CALCIUM SUPPLEMENTATION; OLDER-ADULTS; WOMEN; FALLS; FRACTURES; 25-HYDROXYVITAMIN-D; INTERVENTIONS; DETERMINANTS	Elderly people's liability to falls and fractures is increased by many factors, including visual impairment, neurological disorders, orthopaedic disabilities, and drug effects. In one study showing that more than a third of people aged over 65 fell each year, the main risk factor was muscle weakness.' Poor muscle strength and weakness may be associated with vitamin D deficiency, which is common among elderly people 2 because the capacity of the skin to synthesise the provitamin calcidiol (25-hydroxycholecalciferol) decreases with age. Serious dcficiency of vitamin D is common among elderly housebound people in old people's homes, nursing homes, and long stay wards and has been identified as an important public health problem.(2-5) In this review I discuss recent developments in screening and treating vitamin D deficiency among elderly housebound people aimed at reducing the incidence of falls and fractures.			Venning, G (corresponding author), 14 Lucas Rd, High Wycombe HP13 6QG, Bucks, England.	venning@hdd.co.uk						Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CHAPUY MC, 1992, NEW ENGL J MED, P327; Compston JE, 1998, BRIT MED J, V317, P1466, DOI 10.1136/bmj.317.7171.1466; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Dhesi JK, 2002, J BONE MINER RES, V17, P891, DOI 10.1359/jbmr.2002.17.5.891; EGSMOSE C, 1987, AGE AGEING, V16, P35, DOI 10.1093/ageing/16.1.35; EVANS JG, 1988, AGE AGEING, V17, P361, DOI 10.1093/ageing/17.6.361; Gallagher JC, 1998, J BONE MINER RES, V13, P475, DOI 10.1359/jbmr.1998.13.3.475; GLOTH FM, 1995, JAMA-J AM MED ASSOC, V274, P1683, DOI 10.1001/jama.274.21.1683; GRANT WB, 2004, VITAMIN D LARGELY OV; HEIKINHEIMO RJ, 1992, CALCIFIED TISSUE INT, V51, P105, DOI 10.1007/BF00298497; *HLTH AG, ROL VIT D PRES MUSCL; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; *I MED, 1997, DIET REF INT; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Janssen HCJP, 2002, AM J CLIN NUTR, V75, P611, DOI 10.1093/ajcn/75.4.611; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; *LOOKSM, VIT DS MUSCL STRENGT; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016/0002-9343(92)90682-2; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Mingrone G, 1999, LANCET, V353, P806, DOI 10.1016/S0140-6736(98)10206-4; Mowe M, 1999, J AM GERIATR SOC, V47, P220, DOI 10.1111/j.1532-5415.1999.tb04581.x; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Semba RD, 2000, AM J CLIN NUTR, V72, P1529; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Vieth R, 1999, AM J CLIN NUTR, V69, P842	30	80	87	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 5	2005	330	7490					524	526		10.1136/bmj.330.7490.524	http://dx.doi.org/10.1136/bmj.330.7490.524			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746134	Green Published			2022-12-28	WOS:000227581400022
J	Anderson, BL; Winawer, J				Anderson, BL; Winawer, J			Image segmentation and lightness perception	NATURE			English	Article							ILLUMINATION; ORGANIZATION; DEPENDS	The perception of surface albedo ( lightness) is one of the most basic aspects of visual awareness. It is well known that the apparent lightness of a target depends on the context in which it is embedded(1-6), but there is extensive debate about the computations and representations underlying perceived lightness. One view asserts that the visual system explicitly separates surface reflectance from the prevailing illumination and atmospheric conditions in which it is embedded(7-10), generating layered image representations. Some recent theory has challenged this view and asserted that the human visual system derives surface lightness without explicitly segmenting images into multiple layers(11,12). Here we present new lightness illusions - the largest reported to date - that unequivocally demonstrate the effect that layered image representations can have in lightness perception. We show that the computations that underlie the decomposition of luminance into multiple layers under conditions of transparency can induce dramatic lightness illusions, causing identical texture patches to appear either black or white. These results indicate that mechanisms involved in decomposing images into layered representations can play a decisive role in the perception of surface lightness.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; MIT, Cambridge, MA 02139 USA	University of New South Wales Sydney; Massachusetts Institute of Technology (MIT)	Anderson, BL (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	bart.a@unsw.edu.au	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586; Anderson, Barton/0000-0003-0313-4285				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ADELSON EH, 1999, NEW COGNITIVE NEUROS, P339; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Anderson BL, 2003, PERCEPTION, V32, P269, DOI 10.1068/p3216; Anderson BL, 1999, NEURON, V24, P919, DOI 10.1016/S0896-6273(00)81039-9; Barrow H., 1978, COMPUT VIS SYST, V2, P2; BERGSTROM SS, 1977, SCAND J PSYCHOL, V18, P180, DOI 10.1111/j.1467-9450.1977.tb00275.x; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Eagleman DM, 2004, NATURE, V428, P854, DOI 10.1038/nature02467; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1979, SCI AM, V240, P112, DOI 10.1038/scientificamerican0379-112; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Koffka K, 1935, PRINCIPLES GESTALT P; Rutherford MD, 2002, PSYCHOL SCI, V13, P142, DOI 10.1111/1467-9280.00426; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492	18	116	118	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					79	83		10.1038/nature03271	http://dx.doi.org/10.1038/nature03271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744303				2022-12-28	WOS:000227334600047
J	Krakauer, AH				Krakauer, AH			Kin selection and cooperative courtship in wild turkeys	NATURE			English	Article							MELEAGRIS-GALLOPAVO; NATURAL-POPULATIONS; LEK; EVOLUTION; ORNAMENTATION; RELATEDNESS; VERTEBRATES; PATERNITY; MARKERS; MALES	In the few species of birds in which males form display partnerships to attract females, one male secures most or all of the copulations(1,2). This leads to the question of why subordinate males help in the absence of observable reproductive benefits. Hamilton's concept of kin selection(3), whereby individuals can benefit indirectly by helping a relative, was a crucial breakthrough for understanding apparently altruistic systems. However in the only direct test of kin selection in coordinated display partnerships, partners were unrelated(1), discounting kin selection as an explanation for the evolution of cooperation. Here I show, using genetic measures of relatedness and reproductive success, that kin selection can explain the evolution of cooperative courtship in wild turkeys. Subordinate ( helper) males do not themselves reproduce, but their indirect fitness as calculated by Hamilton's rule(3,4) more than offsets the cost of helping. This result confirms a textbook example of kin selection(2) that until now has been controversial(5) and also extends recent findings(6-8) of male relatedness on avian leks by quantifying the kin-selected benefits gained by non-reproducing males.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krakauer, AH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	krakauer@berkeley.edu		Krakauer, Alan/0000-0001-9177-7963				BALPH DF, 1980, AUK, V97, P854; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brown J.L., 1987, HELPING COMMUNAL BRE; Buchholz R, 1997, J AVIAN BIOL, V28, P223, DOI 10.2307/3676973; BUCHHOLZ R, 1995, ANIM BEHAV, V50, P929, DOI 10.1016/0003-3472(95)80095-6; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Donoghue AM, 1999, BIOL REPROD, V61, P422, DOI 10.1095/biolreprod61.2.422; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; GOODENOUGH J, 2001, PERSPECTIVES ANIMAL; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Healy W., 1992, WILD TURKEY BIOL MAN, P46; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 2003, ANN ZOOL FENN, V40, P249; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Lank DB, 2002, BEHAV ECOL, V13, P209, DOI 10.1093/beheco/13.2.209; Lucas JR, 1996, ANIM BEHAV, V51, P225, DOI 10.1006/anbe.1996.0019; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Mock KE, 2002, MOL ECOL, V11, P643, DOI 10.1046/j.1365-294X.2002.01467.x; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed KM, 2000, ANIM GENET, V31, P140, DOI 10.1046/j.1365-2052.2000.00571.x; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; WATTS CR, 1971, SCI AM, V224, P112; Wilson E.O., 1975, P1	27	139	141	4	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					69	72		10.1038/nature03325	http://dx.doi.org/10.1038/nature03325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744300				2022-12-28	WOS:000227334600044
J	Hargreaves, S; Holmes, A; Friedland, JS				Hargreaves, S; Holmes, A; Friedland, JS			Charging failed asylum seekers for health care in the UK	LANCET			English	Editorial Material							NHS		Hammersmith Hosp, Imperial Coll, Fac Med, Dept Infect Dis,Int Hlth Unit, London W12 0NN, England	Imperial College London	Hargreaves, S (corresponding author), Hammersmith Hosp, Imperial Coll, Fac Med, Dept Infect Dis,Int Hlth Unit, London W12 0NN, England.	s.hargreaves@imperial.ac.uk		Friedland, Jonathan S/0000-0001-7789-9649; Hargreaves, Sally/0000-0003-2974-4348				British Medical Association, 2002, AS SEEK M THEIR HEAL; Burnett A, 2001, BRIT MED J, V322, P485, DOI 10.1136/bmj.322.7284.485; COWEN T, 2001, UNEQUAL TREATMENTS F; Department of Health, 2004, PROP EXCL OV VIS EL; HEATH T, 2004, HOME OFFICE STAT B; *HM GOV, 2005, CONTR OUR BORD MAK M; *MED SANS FRONT, 2004, PROP EXCL OV VIS EL; *PARL HLTH COMM, 2005, NEW DEV HIV AIDS SEX; Pollard AJ, 2004, BRIT MED J, V329, P346, DOI 10.1136/bmj.329.7461.346; Williams PD, 2004, BMJ-BRIT MED J, V329, P298, DOI 10.1136/bmj.329.7460.298	10	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					732	733						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733700				2022-12-28	WOS:000227285300005
J	Wang, GX; Poo, MM				Wang, GX; Poo, MM			Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones	NATURE			English	Article							CATION CHANNEL; CA2+ CHANNELS; CALCIUM; XENOPUS; BRAIN; CELLS; MODULATION; ACTIVATION; GUIDANCE; CURRENTS	Ion channels formed by the TRP ( transient receptor potential) superfamily of proteins act as sensors for temperature, osmolarity, mechanical stress and taste(1,2). The growth cones of developing axons are responsible for sensing extracellular guidance factors, many of which trigger Ca2+ influx at the growth cone(3,4); however, the identity of the ion channels involved remains to be clarified. Here, we report that TRP-like channel activity exists in the growth cones of cultured Xenopus neurons and can be modulated by exposure to netrin-1 and brain-derived neurotrophic factor, two chemoattractants for axon guidance. Whole-cell recording from growth cones showed that netrin-1 induced a membrane depolarization, part of which remained after all major voltage-dependent channels were blocked. Furthermore, the membrane depolarization was sensitive to blockers of TRP channels. Pharmacological blockade of putative TRP currents or downregulation of Xenopus TRP-1 (xTRPC1) expression with a specific morpholino oligonucleotide abolished the growth-cone turning and Ca2+ elevation induced by a netrin-1 gradient. Thus, TRPC currents reflect early events in the growth cone's detection of some extracellular guidance signals, resulting in membrane depolarization and cytoplasmic Ca2+ elevation that mediates the turning of growth cones.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu		Wang, Gordon/0000-0002-2707-7118				Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GU X, 1993, J NEUROSCI, V13, P4936; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	29	251	261	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					898	904		10.1038/nature03478	http://dx.doi.org/10.1038/nature03478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758951				2022-12-28	WOS:000228327600041
J	Darmstadt, GL; Saha, SK; Ahmed, ASMNU; Chowdhury, MAKA; Law, PA; Ahmed, S; Alam, MA; Black, RE; Santosham, M				Darmstadt, GL; Saha, SK; Ahmed, ASMNU; Chowdhury, MAKA; Law, PA; Ahmed, S; Alam, MA; Black, RE; Santosham, M			Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial	LANCET			English	Article							BIRTH-WEIGHT INFANTS; EPIDERMAL WATER-LOSS; NEONATAL-MORTALITY; OINTMENT THERAPY; NEWBORN-INFANTS; BLOOD; SEPSIS; CARE; RATES; ACID	Background Infections and complications of prematurity are main causes of neonatal mortality. Very low birthweight premature infants have compromised skin barrier function, and are at especially high risk for serious infections and mortality. Our aim was to ascertain whether topical application of emollients to enhance skin barrier function would prevent nosocomial infections in this population. Methods We randomly assigned infants born before week 33 of gestation after admission to Dhaka Shishu Hospital, Bangladesh, to daily massage with sunflower seed oil (n=159) or Aquaphor (petrolatum, mineral oil, mineral wax, lanolin alcohol; n=157). We then compared incidence of nosocomial infections among infants in these two groups with an untreated control group (n=181) by an intention-to-treat analysis. Findings 20 patients in the control group, and 22 in each of the treatment groups left the hospital early, but were included in the final analysis. Overall, infants treated with sunflower seed oil were 41% less likely to develop nosocomial infections than controls (adjusted incidence rate ratio [IRR] 0.59, 95% CI 0.37-0.96, p=0.032). Aquaphor did not significantly reduce the risk of infection (0.60, 0.35-1.03, p=0.065). No adverse events were seen. Interpretation Our findings confirm that skin application of sunflower seed oil provides protection against nosocomial infections in preterm. very low birthweight infants. The low cost, availability, simplicity, and effect of treatment make it an important intervention for very low birthweight infants admitted to hospital in developing countries.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD USA; Save Children USA, Washington, DC USA; Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Neonatol, Dhaka, Bangladesh; Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Haematol & Pathol, Dhaka, Bangladesh; Kumudini Womens Med Coll, Dept Pediat, Mirzapur, Tangail, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children	Darmstadt, GL (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth E8153, 615 N Wolfe St, Baltimore, MD 21205 USA.	gdarmsta@jhsph.edu	Darmstadt, Gary/AAU-7488-2020	Black, Robert/0000-0001-9926-7984; Darmstadt, Gary/0000-0002-7522-5824				Agarwal KN, 2000, INDIAN J MED RES, V112, P212; Ahmed A S M Nawshad Uddin, 2002, Indian Pediatr, V39, P1034; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BHATIA B D, 1988, Indian Pediatrics, V25, P1058; Bhutta Z., 1999, SEMIN NEONATOL, V4, P159, DOI [10.1016/S1084-2756(99)90040-4, DOI 10.1016/S1084-2756(99)90040-4]; DANGIO CT, 1989, J PEDIATR-US, V114, P1029, DOI 10.1016/S0022-3476(89)80457-3; DARMSTADT G, IN PRESS J PERINATOL; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; Darmstadt GL, 1998, J CLIN INVEST, V101, P128, DOI 10.1172/JCI680; Darmstadt GL, 2002, ACTA PAEDIATR, V91, P546, DOI 10.1080/080352502753711678; Darmstadt GL, 2000, PEDIATR CLIN N AM, V47, P757, DOI 10.1016/S0031-3955(05)70239-X; DARMSTADT GL, 2002, J HEALTH POPUL NUTR, V20, P175; Darmstadt GL., 1998, EUR J PEDIAT DERMATO, V8, P221; Darmstadt GL., 2003, PERINATOLOGY, V5, P205; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Edwards WH, 2004, PEDIATRICS, V113, P1195, DOI 10.1542/peds.113.5.1195; FERNANDEZ A, 1987, Indian Pediatrics, V24, P1111; FRIEDMAN Z, 1976, PEDIATRICS, V58, P650; GRUBAUER G, 1989, J LIPID RES, V30, P323; HAMMARLUND K, 1979, ACTA PAEDIATR SCAND, V68, P795; JOHANSON RB, 1992, ACTA PAEDIATR, V81, P859, DOI 10.1111/j.1651-2227.1992.tb12123.x; Kalia YN, 1998, J INVEST DERMATOL, V111, P320, DOI 10.1046/j.1523-1747.1998.00289.x; KEYWORTH N, 1992, ARCH DIS CHILD-FETAL, V67, P797, DOI 10.1136/adc.67.7_Spec_No.797; Kumhar GD, 2002, J HEALTH POPUL NUTR, V20, P343; LANE AT, 1993, PEDIATRICS, V92, P415; MaoQiang M, 1996, J INVEST DERMATOL, V106, P1096, DOI 10.1111/1523-1747.ep12340135; Merialdi M, 2003, J NUTR, V133, p1626S, DOI 10.1093/jn/133.5.1626S; MULLANY L, IN PRESS J TROP PEDI; *NAT COMM CLIN LAB, 1998, 1 NCCLS, V18; Nopper AJ, 1996, J PEDIATR-US, V128, P660, DOI 10.1016/S0022-3476(96)80132-6; Pabst R C, 1999, J Perinatol, V19, P278, DOI 10.1038/sj.jp.7200157; SAHA SK, 1992, T ROY SOC TROP MED H, V86, P554, DOI 10.1016/0035-9203(92)90109-P; Saha SK, 2001, J CLIN MICROBIOL, V39, P3583, DOI 10.1128/JCM.39.10.3583-3585.2001; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; SCHURER N, 1995, SKIN PHARMACOL, V8, P30; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Wallace M, 1998, INFECT CONT HOSP EP, V19, P689; Williams M., 2001, TXB NEONATAL DERMATO, P46; Williams M L, 1998, J Investig Dermatol Symp Proc, V3, P75; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	43	124	129	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1039	1045						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781099				2022-12-28	WOS:000227731800028
J	Upshur, REG				Upshur, REG			Commentary: Using patients' narratives in complex research	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Toronto, Dept Family & Community Med, Toronto, ON M5T 1W7, Canada	University of Toronto	Upshur, REG (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON M5T 1W7, Canada.	Ross.Upshur@sw.ca		Upshur, Ross/0000-0003-1128-0557				Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					631	631		10.1136/bmj.330.7492.631	http://dx.doi.org/10.1136/bmj.330.7492.631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774991	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000227861700021
J	Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE				Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE			Human symbionts use a host-like pathway for surface fucosylation	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDES; EPITHELIAL-CELLS; SIALIC-ACID; BLOOD-GROUP; FUCOSE; COMMENSAL; BIOSYNTHESIS; ARABIDOPSIS; INTESTINE; ECOSYSTEM	The mammalian intestine harbors a beneficial microbiota numbering approximately 10(12) organisms per gram of colonic content. The host tolerates this tremendous bacterial. load while maintaining the ability to efficiently respond to pathogenic organisms. In this study, we show that the Bacteroides use a mammalian-like pathway to decorate numerous surface capsular polysaccharides and glycoproteins with L-fucose, an abundant surface molecule of intestinal epithelial cells, resulting in the coordinated expression of this surface molecule by host and symbiont. A Bacteroides mutant deficient in the ability to cover its surface with L-fucose is defective in colonizing the mammalian intestine under competitive conditions.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA.	lcomstock@channing.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044193, R01AI053694, R56AI044193] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053694-03, AI53694, R01 AI053694, AI44193, R01 AI044193, R01 AI044193-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BERG RD, 1975, INFECT IMMUN, V11, P320, DOI 10.1128/IAI.11.2.320-329.1975; BJORK S, 1987, J BIOL CHEM, V262, P6758; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; FINNE J, 1989, J BIOL CHEM, V264, P5720; FOO MC, 1974, INFECT IMMUN, V9, P1066, DOI 10.1128/IAI.9.6.1066-1069.1974; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Gaskins H. R., 1997, GASTROINTESTINAL MIC, V2, P537, DOI [10.1007/978-1-4757-0322-1_14, DOI 10.1007/978-1-4757-0322-1_14]; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9	17	203	227	5	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1778	1781		10.1126/science.1106469	http://dx.doi.org/10.1126/science.1106469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774760				2022-12-28	WOS:000227883900046
J	Gebhardt, MC; Rosenthal, DI; Harris, NL; Arnell, PM				Gebhardt, MC; Rosenthal, DI; Harris, NL; Arnell, PM			Case 8-2005: A 10-year-old boy with pain in the right thigh - Osteoid osteoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCUTANEOUS RADIOFREQUENCY ABLATION; TOMOGRAPHY-GUIDED THERMOCOAGULATION; OSTEOBLASTOMA; BIOPSY; LESIONS; SPINE; BONE; SYNOVITIS; TUMORS; HIP		Beth Israel Deaconess Med Ctr, Dept Orthoped, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gebhardt, MC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Orthoped, Boston, MA 02215 USA.							Aboulafia A J, 1999, J Am Acad Orthop Surg, V7, P377; Abril JC, 2000, ORTHOPEDICS, V23, P285; ALANI WO, 1987, CLIN ORTHOP RELAT R, V223, P308; AYALA AG, 1986, J BONE JOINT SURG AM, V68A, P747, DOI 10.2106/00004623-198668050-00018; Aydinli Ufuk, 2003, Acta Orthop Belg, V69, P350; Barei DP, 2000, CLIN ORTHOP RELAT R, P115; Baruffi MR, 2001, CANCER GENET CYTOGEN, V124, P127, DOI 10.1016/S0165-4608(00)00327-7; Bickels J, 1999, CLIN ORTHOP RELAT R, P212; CAPANNA R, 1991, REV CHIR ORTHOP, V77, P545; Cove JA, 2000, SPINE, V25, P1283, DOI 10.1097/00007632-200005150-00014; D'Errico G, 2002, TUMORI, V88, pS30, DOI 10.1177/030089160208800333; DEBERG JC, 1995, LANCET, V346, P350, DOI 10.1016/S0140-6736(95)92228-8; DONAHUE F, 1999, CLIN ORTHOP RELAT R, V366, P191; Dupuy DE, 2000, AM J ROENTGENOL, V175, P1263, DOI 10.2214/ajr.175.5.1751263; Dupuy DE, 1998, AM J ROENTGENOL, V171, P759, DOI 10.2214/ajr.171.3.ajronline_171_3_001; Foeldvari I, 1998, CLIN RHEUMATOL, V17, P534, DOI 10.1007/BF01451295; GITELIS S, 1989, ORTHOP CLIN N AM, V20, P313; GREENSPAN A, 1993, SKELETAL RADIOL, V22, P485; HASEGAWA T, 1993, HISTOPATHOLOGY, V22, P487, DOI 10.1111/j.1365-2559.1993.tb00163.x; HAYES CW, 1992, RADIOGRAPHICS, V12, P1119, DOI 10.1148/radiographics.12.6.1439015; HEALEY JH, 1986, CLIN ORTHOP RELAT R, P76; Hsich GE, 2002, PEDIATR NEUROL, V26, P148, DOI 10.1016/S0887-8994(01)00359-9; Ilyas I, 2002, CAN J SURG, V45, P435; JACKSON RP, 1977, CLIN ORTHOP RELAT R, P303; KIERS L, 1990, ARCH DIS CHILD, V65, P851, DOI 10.1136/adc.65.8.851; KNEISL JS, 1992, J BONE JOINT SURG AM, V74A, P179, DOI 10.2106/00004623-199274020-00004; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Lindner NJ, 2001, J BONE JOINT SURG BR, V83B, P391, DOI 10.1302/0301-620X.83B3.11679; Liu PT, 2003, RADIOLOGY, V227, P691, DOI 10.1148/radiol.2273020111; Mirra JM, 1989, BONE TUMORS CLIN RAD; O'Connell JX, 1998, MODERN PATHOL, V11, P175; Okuda R, 2003, CLIN ORTHOP RELAT R, P149, DOI 10.1097/01.blo.0000068769.86536.37; Osti O L, 1998, Eur Spine J, V7, P422, DOI 10.1007/s005860050101; PETTINE KA, 1986, J BONE JOINT SURG AM, V68A, P354, DOI 10.2106/00004623-198668030-00007; Rosenthal DI, 2003, RADIOLOGY, V229, P171, DOI 10.1148/radiol.2291021053; Rosenthal DI, 2003, RADIOLOGY, V226, P125, DOI 10.1148/radiol.2261011993; SIMM RJ, 1975, AUST NZ J SURG, V45, P412, DOI 10.1111/j.1445-2197.1975.tb05785.x; Sluga M, 2002, J BONE JOINT SURG BR, V84B, P249, DOI 10.1302/0301-620X.84B2.12347; TAYLOR GA, 1986, PEDIATR RADIOL, V16, P313, DOI 10.1007/BF02386870; TILLOTSON CL, 1989, INVEST RADIOL, V24, P888, DOI 10.1097/00004424-198911000-00009; Weber KL, 1999, J BONE JOINT SURG AM, V81A, P1111, DOI 10.2106/00004623-199908000-00006; Witt JD, 2000, J BONE JOINT SURG BR, V82B, P1125, DOI 10.1302/0301-620X.82B8.11307; Woertler K, 2001, J VASC INTERV RADIOL, V12, P717, DOI 10.1016/S1051-0443(07)61443-2; WOLD LE, 1988, MODERN PATHOL, V1, P129	44	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1122	1129		10.1056/NEJMcpc049038	http://dx.doi.org/10.1056/NEJMcpc049038			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784666				2022-12-28	WOS:000227655000011
J	Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS				Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS			A potential decline in life expectancy in the United States in the 21st century	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; BODY-MASS INDEX; YOUNG ADULTHOOD; HUMAN LONGEVITY; US ADULTS; FOLLOW-UP; OBESITY; MORTALITY; OVERWEIGHT; DISEASE	Forecasts of life expectancy are an important component of public policy that influence age-based entitlement programs such as Social Security and Medicare. Although the Social Security Administration recently raised its estimates of how long Americans are going to live in the 21st century, current trends in obesity in the United States suggest that these estimates may not be accurate. From our analysis of the effect of obesity on longevity, we conclude that the steady rise in life expectancy during the past two centuries may soon come to an end.	Univ Illinois, Chicago, IL 60612 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Int Longev Ctr, New York, NY USA; Univ Alabama Birmingham, Birmingham, AL USA; Childrens Hosp, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Harvard University; Boston Children's Hospital	Olshansky, SJ (corresponding author), Univ Illinois, 1603 W Taylor St,Rm 885, Chicago, IL 60612 USA.	sjayo@uic.edu	Hayflick, Leonard/AAW-2460-2020	Allison, David/0000-0003-3566-9399; Ludwig, David/0000-0003-3307-8544	NIA NIH HHS [AG00979-05, K02 AG00785-05] Funding Source: Medline; NIDDK NIH HHS [1R01DK59240] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG000785] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; ANDERSON RN, 1999, DHHS PUBLICATION; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; ARIAS E, 2000, DHHS PUBLICATION; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; BAYO F, 1974, 72 SOC SEC ADM; BAYO F, 1966, 62 SOC SEC ADM; BELL FC, 2002, 116 SOC SEC ADM; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P724, DOI DOI 10.1001/JAMA.282.8.724; CHENG AW, 2004, SSA PUBLICATION; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; Dean H, 2002, DIABETES, V51, pA24; *DEP EC SOC AFF, 2004, STESASERA236 DEP EC; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; *EC SOC AFF POP DI, 2004, STESASERA229 POP DIV; FABER JF, 1982, SSA PUBLICATION; FABER JF, 1981, SSA PUBLICATION; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Koplan J., 2005, PREVENTING CHILDHOOD; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MacDonell WR, 1913, BIOMETRIKA, V9, P366, DOI 10.1093/biomet/9.3-4.366; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McDonald LC, 1997, EMERG INFECT DIS, V3, P311, DOI 10.3201/eid0303.970307; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; MYERS RJ, 1952, 33 SOC SEC ADM; NHLBI Obesity Education Initiative, 2000, NIH PUBL; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Olshansky S.J., 1996, HLTH MORTALITY ELDER, P39; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 1997, POPUL BULL, V52, P2; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Osmon S, 2003, CHEST, V124, P1021, DOI 10.1378/chest.124.3.1021; Peeters A, 2003, JAMA-J AM MED ASSOC, V289, P2941, DOI 10.1001/jama.289.22.2941-a; Pietrobelli A, 2002, J ENDOCRINOL INVEST, V25, P884, DOI 10.1007/BF03344052; *PRES COUNC BIOETH, 2004, THER BIOT PURS HAPP; *SOC SEC ADM, 2003 OASDI TRUST REP; *SOC SEC ADM, 1995, ANN REP BOARD TRUST; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; *TECHN PAN ASS MET, 2003, 2003 REP SOC SEC ADV; Todoriki H., 2004, OKINAWAN J AM STUDIE, V1, P55; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *U AL SCH PUBL HLT, RES TABL; UTTLEY AHC, 1988, LANCET, V1, P57; WADE A, 1986, SSA PUBLICATION; WADE JF, 1984, SSA PUBLICATION; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; World Health Organization (WHO), 1999, INFL PAND PLAN ROL W	65	1728	1769	2	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1138	1145		10.1056/NEJMsr043743	http://dx.doi.org/10.1056/NEJMsr043743			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784668				2022-12-28	WOS:000227655000015
J	Montori, VM; Permanyer-Miralda, G; Ferreira-Gonzalez, I; Busse, JW; Pacheco-Huergo, V; Bryant, D; Alonso, J; Akl, EA; Domingo-Salvany, A; Mills, E; Wu, P; Schunemann, HJ; Jaeschke, R; Guyatt, GH				Montori, VM; Permanyer-Miralda, G; Ferreira-Gonzalez, I; Busse, JW; Pacheco-Huergo, V; Bryant, D; Alonso, J; Akl, EA; Domingo-Salvany, A; Mills, E; Wu, P; Schunemann, HJ; Jaeschke, R; Guyatt, GH			Validity of composite end points in clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED TRIAL; DISEASE; EVENTS; RISK	Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?	Hosp Gen Valle Hebron, Epidemiol Unit, Serv Cardiol, Barcelona 08035, Spain; Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; Inst Catala Salut, EAP Vilapicina, Primary Care Ctr Turo, Barcelona, Spain; Inst Municipal Invest Med, Hlth Serv Res Unit, E-08003 Barcelona, Spain; SUNY Buffalo, Dept Med & Social Prevent Med, Buffalo, NY 14214 USA; Canadian Coll Naturopath Med, Dept Res, Toronto, ON M2K 1E2, Canada	Hospital Universitari Vall d'Hebron; Mayo Clinic; McMaster University; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Permanyer-Miralda, G (corresponding author), Hosp Gen Valle Hebron, Epidemiol Unit, Serv Cardiol, Barcelona 08035, Spain.	gpermany@vhebron.net	Akl, Elie A/R-2079-2016; Busse, Jason/CAH-3696-2022; Bryant, Dianne M/K-6766-2013; Akl, Elie/K-5269-2019; Alonso, Jordi/A-5514-2010	Akl, Elie A/0000-0002-3444-8618; Busse, Jason/0000-0002-0178-8712; Bryant, Dianne M/0000-0002-7535-8707; Alonso, Jordi/0000-0001-8627-9636; Montori, Victor/0000-0003-0595-2898; Schunemann, Holger/0000-0003-3211-8479; Domingo-Salvany, Antonia/0000-0003-3302-4538				Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Pfisterer M, 2001, LANCET, V358, P951; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Yusuf S, 2000, NEW ENGL J MED, V342, P145	7	280	290	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					594	596		10.1136/bmj.330.7491.594	http://dx.doi.org/10.1136/bmj.330.7491.594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15761002	Green Published			2022-12-28	WOS:000227622300023
J	Rogers, R; Williams, S; Jarman, B; Aylin, P				Rogers, R; Williams, S; Jarman, B; Aylin, P			Dr Foster's case notes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PAYMENT		Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Rogers, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743				Department of Health, 2002, REF NHS FIN FLOWS IN; Dixon J, 2004, BMJ-BRIT MED J, V328, P969, DOI 10.1136/bmj.328.7446.969; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; Silverman E, 2004, J HEALTH ECON, V23, P369, DOI 10.1016/j.jhealeco.2003.09.007	4	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					563	+		10.1136/bmj.330.7491.563	http://dx.doi.org/10.1136/bmj.330.7491.563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760996	Green Published			2022-12-28	WOS:000227622300014
J	Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB				Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB			Arabidopsis interdigitating cell growth requires two antagonistic pathways with opposing action on cell morphogenesis	CELL			English	Article							F-ACTIN; MICROTUBULE; SHAPE; POLLEN; PROTEINS; DYNAMICS; GTPASES; ARP2/3; PLANTS; GENE	Coordinating growth and communication between adjacent cells is a critical yet poorly understood aspect of tissue development and organ morphogenesis. We report a Rho GTPase signaling network underlying the jigsaw puzzle appearance of Arabidopsis leaf pavement cells, in which localized outgrowth in one cell is coordinated with localized inhibition of outgrowth of the adjacent cell to form interdigitating lobes and indentations. Locally activated ROP2, a Rho-related GTPase from plants, activates RIC4 to promote the assembly of cortical actin microfilaments required for localized outgrowth. Meanwhile, ROP2 inactivates another target RIC1, whose activity promotes well-ordered cortical microtubules. RIC1-dependent microtubule organization not only locally inhibits outgrowth but in turn suppresses ROP2 activation in the indentation zones. Thus, outgrowth-promoting ROP2 and outgrowth-inhibiting RIC1 pathways antagonize each other. We propose that the counteractivity of these two pathways demarcates outgrowing and indenting cortical domains, coordinating a process that gives rise to interdigitations between adjacent pavement cells.	Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California Riverside; University of California System; University of California Riverside; University of British Columbia	Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	zhenbiao.yang@ucr.edu	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994; Gu, Ying/0000-0001-8415-4768				Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Le J, 2003, CURR BIOL, V13, P1341, DOI 10.1016/S0960-9822(03)00493-7; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1998, PLANT PHYSIOL, V118, P407, DOI 10.1104/pp.118.2.407; Li SD, 2003, PLANT PHYSIOL, V132, P2034, DOI 10.1104/pp.103.028563; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Mathur J, 2003, PLANT CELL, V15, P1632, DOI 10.1105/tpc.011676; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065	29	402	431	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					687	700		10.1016/j.cell.2004.12.026	http://dx.doi.org/10.1016/j.cell.2004.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766531	Bronze			2022-12-28	WOS:000227771400014
J	Soler-Gonzalez, J; Ruiz, MC				Soler-Gonzalez, J; Ruiz, MC			Mondor's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Equipo Atenc Primaria Balafia Pardinyes Seca, Lleida 25007, Spain		Soler-Gonzalez, J (corresponding author), Equipo Atenc Primaria Balafia Pardinyes Seca, Lleida 25007, Spain.		soler-gonzalez, jorge/D-1686-2011	soler-gonzalez, jorge/0000-0001-8359-3355					0	7	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					1024	1024		10.1056/NEJMicm040419	http://dx.doi.org/10.1056/NEJMicm040419			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758013				2022-12-28	WOS:000227491200011
J	Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E				Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E			Composition of saturnian stream particles	SCIENCE			English	Article							DUST; JUPITER	During Cassini's approach to Saturn, the Cosmic Dust Analyser (CDA) discovered streams of tiny (less than 20 nanometers) high-velocity (similar to100 kilometers per second) dust particles escaping from the saturnian system. A fraction of these impactors originated from the outskirts of Saturn's dense A ring. The CDA time-of-flight mass spectrometer recorded 584 mass spectra from the stream particles. The particles consist predominantly of oxygen, silicon, and iron, with some evidence of water ice, ammonium, and perhaps carbon. The stream particles primarily consist, of silicate materials, and this implies that the particles are impurities from the icy ring material rather than the ice particles themselves.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Open University - UK; University of Hawaii System	Kempf, S (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	Sascha.Kempf@mpi-hd.mpg.de	Green, Simon F/C-7408-2009; Postberg, Frank/AAE-6295-2019	Green, Simon F/0000-0002-9153-9786; Postberg, Frank/0000-0002-5862-4276; KEMPF, SASCHA/0000-0001-5236-3004				Ahrens TJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001912; [Anonymous], 1984, SATURN; Auer S, 2001, ASTR AST LI, P385; GUERNSEY C, COMMUNICATION; HAMILTON DP, 1993, NATURE, V364, P695, DOI 10.1038/364695a0; Horanyi M, 2000, PHYS PLASMAS, V7, P3847, DOI 10.1063/1.1288909; HORANYI M, 1993, J GEOPHYS RES-SPACE, V98, P21245, DOI 10.1029/93JA02588; JESSBERGER EK, 1991, ASTROPHYS SPACE SC L, V167, P1075, DOI 10.1017/S0252921100012823; Kempf S, 2005, NATURE, V433, P289, DOI 10.1038/nature03218; KNABE W, 1983, THESIS U HEIDELBERG; MOCKER A, UNPUB; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; STUBIG M, 2002, THESIS U HEIDELBERG; TIMMERMANN T, 1991, ORIGIN EVOLUTION INT, P387	14	67	67	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1274	1276		10.1126/science.1106218	http://dx.doi.org/10.1126/science.1106218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731446				2022-12-28	WOS:000227313200048
J	Lave, J; Yule, D; Sapkota, S; Basant, K; Madden, C; Attal, M; Pandey, R				Lave, J; Yule, D; Sapkota, S; Basant, K; Madden, C; Attal, M; Pandey, R			Evidence for a great medieval earthquake (approximate to 1100 AD) in the Central Himalayas, Nepal	SCIENCE			English	Article							GPS MEASUREMENTS; SOUTHERN TIBET; FRONTAL THRUST; SEISMIC CYCLE; INDIA; DEFORMATION; CONVERGENCE; CALIBRATION; UPLIFT	The Himalayan orogen has produced three thrust earthquakes with moment magnitude (M-w) 7.8 to 8.5 during the past century, yet no surface ruptures associated with these great earthquakes have been documented. Here, we present paleoseismic evidence from east central Nepal that, since similar to700 A.D., a single earthquake ruptured the Frontal Thrust fault at similar to1100 A.D., with a surface displacement of similar to17 (+5/-3) meters and a lateral extent and size that could have exceeded 240 kilometers and similar toM(w) 8.8, respectively. Ruptures associated with M-w <8.2 events would contribute to the frontal Himalayas folding but would stop before reaching the surface. These findings could require substantial modifications to current regional seismic hazard models.	Lab Geodynam Chaines Alpines, F-38041 Grenoble, France; Calif State Univ Northridge, Northridge, CA 91330 USA; Dept Mines & Geol, Seismolab, Kathmandu, Nepal; Earth Consultants Int, Tustin, CA 92780 USA	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); California State University System; California State University Northridge	Lave, J (corresponding author), Lab Geodynam Chaines Alpines, BP53, F-38041 Grenoble, France.	jlave@ujf-grenoble.fr	Attal, Mikael/H-8127-2013	Attal, Mikael/0000-0001-8639-6090				Ambraseys N, 2003, CURR SCI INDIA, V84, P570; Ambraseys NN, 2004, GEOPHYS J INT, V159, P165, DOI 10.1111/j.1365-246X.2004.02323.x; [Anonymous], 1990, J HIM GEOL; Avouac JP, 2001, CR ACAD SCI II A, V333, P513, DOI 10.1016/S1251-8050(01)01573-7; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; Bilham R, 2001, SCIENCE, V293, P1442, DOI 10.1126/science.1062584; CHEN WP, 1977, J GEOPHYS RES, V82, P2945, DOI 10.1029/JB082i020p02945; Dominguez S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000951; JACKSON M, 1994, J GEOPHYS RES-SOL EA, V99, P13897, DOI 10.1029/94JB00714; KANAMORI H, 1983, TECTONOPHYSICS, V93, P185, DOI 10.1016/0040-1951(83)90273-1; Kumar S, 2001, SCIENCE, V294, P2328, DOI 10.1126/science.1066195; Larson KM, 1999, J GEOPHYS RES-SOL EA, V104, P1077, DOI 10.1029/1998JB900043; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; MA HF, 1999, EOS T AGU, V80, P605; Nakata T., 1998, EOS T AM GEOPHYS UN, V79, pF615; Nakata T., 1989, TECTONICS W HIMALAYA, V232, P232, DOI DOI 10.1130/SPE232-P243; Pandey M., 1988, J NEPAL GEOL SOC, V5, P22, DOI [10.3126/jngs.v5i1.32559, DOI 10.3126/JNGS.V5I1.32559]; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; SCHOLZ CH, 2002, MECH EARTHQUAKES FAU, P179; Seeber L, 1981, M EWING SERIES AM GE, P259; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Upreti B., 2000, P HOK INT S SCH ACT, P533; Wesnousky SG, 1999, TECTONICS, V18, P967, DOI 10.1029/1999TC900026; ZHAO WJ, 1993, NATURE, V366, P557, DOI 10.1038/366557a0	25	201	208	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1302	1305		10.1126/science.1104804	http://dx.doi.org/10.1126/science.1104804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731452				2022-12-28	WOS:000227313200056
J	Sanchez-Lavega, A				Sanchez-Lavega, A			Viewpoint - How long is the day on Saturn?	SCIENCE			English	Editorial Material							CLOUD LEVEL; ZONAL FLOW; RADIO; ATMOSPHERE; PLANETS; WINDS	Determining a planet's rotation period can be difficult if the planet tacks a solid surface. However, for planets with an internal magnetic field, emissions at radio wavelengths are modulated by the planet's rotation rate. The latest results from the Cassini spacecraft seem to indicate that Saturn's rotation rate has slowed down by 6 minutes since the Voyager 1 and 2 spacecraft flew by the planet in 1980 and 1981, but it is unclear whether a slowdown has in fact occurred. Future data collected by Cassini may be able to resolve the question.	Univ Basque Country, Escuela Super Ingn, Bilbao 48013, Spain	University of Basque Country	Sanchez-Lavega, A (corresponding author), Univ Basque Country, Escuela Super Ingn, Bilbao 48013, Spain.	wupsalaa@bi.ehu.es	Sanchez-Lavega, Agustin/Z-3639-2019	Sanchez-Lavega, Agustin/0000-0001-7234-7634; Sanchez-Lavega, Agustin/0000-0001-7355-1522				ALLISON M, 1983, ICARUS, V54, P296, DOI 10.1016/0019-1035(83)90199-9; CARR TD, 1981, NATURE, V292, P745, DOI 10.1038/292745a0; DESH MD, 1981, GEOPHYS RES LETT, V8, P253; DRESSLER AJ, 1985, GEOPHYS RES LETT, V12, P299; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Giampieri G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020194; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; KIRK RL, 1987, ASTROPHYS J, V316, P836, DOI 10.1086/165248; Porco CC, 2005, SCIENCE, V307, P1243, DOI 10.1126/science.1107691; SANCHEZ-LAVEGA A, 1982, ICARUS, V49, P1, DOI 10.1016/0019-1035(82)90052-5; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465	16	32	32	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1223	1224		10.1126/science.1104956	http://dx.doi.org/10.1126/science.1104956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731437				2022-12-28	WOS:000227313200036
J	Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF				Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF			Genotypic diversity within a natural coastal bacterioplankton population	SCIENCE			English	Article							LATERAL GENE-TRANSFER; SULFATE-REDUCING BACTERIA; ESCHERICHIA-COLI; EVOLUTION; SEQUENCE; GENOME; PATHOGENICITY; COMMUNITY; DYNAMICS	The genomic diversity and relative importance of distinct genotypes within natural bacterial populations have remained largely unknown. Here, we analyze the diversity and annual dynamics of a group of coastal bacterioplankton (greater than 99% 16S ribosomal RNA identity to Vibrio splendidus). We show that this group consists of at least a thousand distinct genotypes, each occurring at extremely low environmental concentrations (on average less than one cell per milliliter). Overall, the genomes show extensive allelic diversity and size variation. Individual genotypes rarely recurred in samples, and allelic distribution did not show spatial or temporal substructure. Ecological considerations suggest that much genotypic and possibly phenotypic variation within natural populations should be considered neutral.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; New England Biolabs Inc, Ocean Genome Legacy, Beverly, MA 01915 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Preheim, Sarah P/B-3432-2010; Hunt, Dana/A-2051-2012; Thompson, Janelle/AAJ-8225-2020; Polz, Martin/ABE-7199-2020; Distel, Daniel/A-8047-2017	Preheim, Sarah P/0000-0001-7365-2382; Hunt, Dana/0000-0002-8801-9624; Thompson, Janelle/0000-0003-0445-3720; Distel, Daniel/0000-0002-3860-194X; /0000-0001-9296-3733; Klepac-Ceraj, Vanja/0000-0001-5387-5706; Polz, Martin/0000-0002-4975-2946				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sass H, 1998, ARCH MICROBIOL, V170, P243, DOI 10.1007/s002030050639; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thompson J. O. F., UNPUB; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	30	289	297	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1311	1313		10.1126/science.1106028	http://dx.doi.org/10.1126/science.1106028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731455	Green Submitted			2022-12-28	WOS:000227313200059
J	Wadman, M				Wadman, M			Disappointment in slow-down for biomedical funding	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2005	433	7026					559	559						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15729751				2022-12-28	WOS:000226862000004
J	Clarke, J; Cranswick, G; Dennis, MS; Flaig, R; Fraser, A; Grant, S; Gunkel, A; Hunter, J; Lewis, S; Perry, D; Soosay, V; Williams, C; Williamson, A; Young, A; Bulpitt, CJ; Grant, A; Murray, G; Sandercock, P; Anderson, N; Bahar, S; Hankey, G; Ricci, S; Bathgate, G; Chalmers, C; Cranswick, G; Dennis, MS; Farrell, B; Forbes, J; Ghosh, S; Langhorne, P; Levis, S; MacIntyre, J; McAteer, CA; O'Neill, P; Potter, J; Roberts, M; Warlow, C; Dennis, MS; Lewis, SC; Warlow, C				Clarke, J; Cranswick, G; Dennis, MS; Flaig, R; Fraser, A; Grant, S; Gunkel, A; Hunter, J; Lewis, S; Perry, D; Soosay, V; Williams, C; Williamson, A; Young, A; Bulpitt, CJ; Grant, A; Murray, G; Sandercock, P; Anderson, N; Bahar, S; Hankey, G; Ricci, S; Bathgate, G; Chalmers, C; Cranswick, G; Dennis, MS; Farrell, B; Forbes, J; Ghosh, S; Langhorne, P; Levis, S; MacIntyre, J; McAteer, CA; O'Neill, P; Potter, J; Roberts, M; Warlow, C; Dennis, MS; Lewis, SC; Warlow, C		FOOD Trial Collaboration	Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial	LANCET			English	Article							NUTRITIONAL-STATUS; MALNUTRITION	Background Undernutrition is common inpatients admitted with stroke. We aimed to establish whether the timing and route of enteral tube feeding after stroke affected patients' outcomes at 6 months. Methods The FOOD trials consist of three pragmatic multicentre randomised controlled trials, two of which included dysphagic stroke patients. In one trial, patients enrolled within 7 days of admission were randomly allocated to early enteral tube feeding or no tube feeding for more than 7 days (early versus avoid). In the other, patients were allocated percutaneous endoscopic gastrostomy (PEG) or nasogastric feeding. The primary outcome was death or poor outcome at 6 months. Analysis was by intention to treat. Findings Between Nov 1, 1996, and July 31, 2003, 859 patients were enrolled by 83 hospitals in 15 countries into the early versus avoid trial. Early tube feeding was associated with an absolute reduction in risk of death of 5 . 8% (95% CI -0 . 8 to 12 . 5, p=0.09) and a reduction in death or poor outcome of 1 . 2% (-4.2 to 6.6, p=0.7). In the PEG versus nasogastric tube trial, 321 patients were enrolled by 47 hospitals in 11 countries. PEG feeding was associated with an absolute increase in risk of death of 1 . 0% (-10 . 0 to 11 . 9, p=0 . 9) and an increased risk of death or poor outcome of 7.8% (0 . 0 to 15 . 5, p=0 . 05). Interpretation Early tube feeding might reduce case fatality, but at the expense of increasing the proportion surviving with poor outcome. Our data do not support a policy of early initiation of PEG feeding in dysphagic stroke patients.	Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, MS (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk	Lindley, Richard/B-8148-2013; Forbes, John F/L-2558-2013; Hankey, Graeme J/H-4968-2014	Lindley, Richard/0000-0002-0104-5679; Forbes, John F/0000-0002-8255-3762; Hankey, Graeme J/0000-0002-6044-7328; Cohen, David/0000-0001-7318-8567; dennis, martin/0000-0003-1148-8972	National Institute for Health Research [96/29/01] Funding Source: researchfish; Department of Health [96/29/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		AXELSSON K, 1988, ACTA MED SCAND, V224, P217; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; BARER DH, J NEUROL NEUROSURG P, V52, P236; BATH PMW, 2002, COCHRANE LIB; Choi-Kwon S, 1998, ACTA NEUROL SCAND, V98, P187, DOI 10.1111/j.1600-0404.1998.tb07292.x; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; COUNSELL CE, 1998, THESIS U CAMBRIDGE C; Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; Dennis M, 2003, STROKE, V34, P127, DOI 10.1161/01.STR.0000044165.41303.50; Dolan P, 1995, SOCIAL TARIFF EUROQO; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; EBRAHIM S, 1999, STROKE CARE MATTER C; FINESTONE HM, 1995, ARCH PHYS MED REHAB, V76, P310, DOI 10.1016/S0003-9993(95)80655-5; *FOOD TRIAL COLL, 2003, STROKE, V34, P140; Gariballa SE, 1998, AM J CLIN NUTR, V68, P275, DOI 10.1093/ajcn/68.2.275; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Mead GE, 1998, INT J CLIN PRACT, V52, P316; Norton B, 1996, BRIT MED J, V312, P13, DOI 10.1136/bmj.312.7022.13; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; UNOSSON M, 1994, STROKE, V25, P366, DOI 10.1161/01.STR.25.2.366; Weir NU, 2003, J NEUROL NEUROSUR PS, V74, P447, DOI 10.1136/jnnp.74.4.447	22	179	215	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					764	772						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733717	Green Published			2022-12-28	WOS:000227285300023
J	McKinney, PA; Jones, S; Parslow, R; Davey, N; Darowski, M; Chaudhry, B; Stack, C; Parry, G; Draper, ES				McKinney, PA; Jones, S; Parslow, R; Davey, N; Darowski, M; Chaudhry, B; Stack, C; Parry, G; Draper, ES		PICANet Consent Study Grp	A feasibility study of signed consent for the collection of patient identifiable information for a national paediatric clinical audit database	BRITISH MEDICAL JOURNAL			English	Article							CONFIDENTIALITY	Objectives To investigate the feasibility of obtaining signed consent for submission of patient identifiable data to a national clinical audit database and to identify factors influencing the consent process and its success. Design Feasibility study. Setting Seven paediatric intensive care units in England. Participants Parents/guardians of patients, or patients aged 12-16 years old, approached consecutively over three months for signed consent for submission of patient identifiable data to the national clinical audit database the Paediatric Intensive Care Audit Network (PICANet). Main outcome measures The numbers and proportions of admissions for which signed consent was given, refused, or not obtained (form not returned or form partially completed but not signed), by age, sex, level of deprivation, ethnicity (South Asian or not), paediatric index of mortality score, length of hospital stay (days in paediatric intensive care). Results One unit did not start and one did not fully implement the protocol, so analysis excluded these two units. Consent was obtained for 182 of 422 admissions (43%) (range by unit 9% to 84%). Most (101/182; 55%) consents were taken by staff nurses. One refusal (0.2%) was received. Consent rates were significantly better for children who were more severely ill on admission and for hospital stays of six days or more, and significantly poorer for children aged 10-14 years. Long hospital stays and children aged 10-14 years remained significant in a stepwise regression model of the factors that were significant in the univariate model. Conclusion Systematically obtaining individual signed consent for sharing patient identifiable information with an externally located clinical audit database is difficult. Obtaining such consent is unlikely to be successful unless additional resources are specifically allocated to training, staff time, and administrative support.	Univ Leeds, Paediat Epidemiol Grp, Leeds LS2 9LN, W Yorkshire, England; Univ Sheffield, Sch Hlth & Related Res, Crit Care Grp, Sheffield S1 4DA, S Yorkshire, England; Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; Gen Infirm, Leeds Teaching Hosp Trust, Leeds LS1 3EX, W Yorkshire, England; Sheffield Childrens NHS Trust, Sheffield S10 2TH, S Yorkshire, England; Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	University of Leeds; University of Sheffield; University of Leicester; Leeds General Infirmary; University of Leeds; Sheffield Children's NHS Foundation Trust; Newcastle General Hospital	McKinney, PA (corresponding author), Univ Leeds, Paediat Epidemiol Grp, Leeds LS2 9LN, W Yorkshire, England.	p.a.mckinney@leeds.ac.uk	Draper, Elizabeth/S-6874-2019; Parslow, Roger/AAV-1477-2020; Parry, Gareth/CAF-6975-2022; Draper, Elizabeth S/I-6304-2018	Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Parslow, Roger/0000-0002-3945-5294				Coleman MP, 2003, CLIN MED, V3, P219, DOI 10.7861/clinmedicine.3-3-219; Verity C, 2002, BRIT MED J, V324, P1210, DOI 10.1136/bmj.324.7347.1210; Willison DJ, 2003, BRIT MED J, V326, P373, DOI 10.1136/bmj.326.7385.373	3	21	21	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 16	2005	330	7496					877	879		10.1136/bmj.38404.650208.ae	http://dx.doi.org/10.1136/bmj.38404.650208.ae			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	917UA	15778230	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000228493500017
J	Milne, E				Milne, E			NHS smoking cessation services and smoking prevalence: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Northumberland Tyne & Wear Strateg Hlth Author, Newcastle Upon Tyne NE15 8NY, Tyne & Wear, England		Milne, E (corresponding author), Northumberland Tyne & Wear Strateg Hlth Author, Newcastle Upon Tyne NE15 8NY, Tyne & Wear, England.	eugene.milne@nhs.net						California Department of Health Services Tobacco Control Section, 1998, MOD CHANG CAL EXP TO; Department of Health, 2004, NAT STAND LOC ACT HL; Soulier-Parmeggiani L, 1999, SCHWEIZ MED WSCHR, V129, P395; 2001, BANDOLIER, V86, P3; 2000, BANDOLIER, V79, P3	5	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2005	330	7494					760	760		10.1136/bmj.38407.755521.F7	http://dx.doi.org/10.1136/bmj.38407.755521.F7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914JE	15778229	Green Published, Bronze			2022-12-28	WOS:000228222900021
J	Meder, D; Simons, K				Meder, D; Simons, K			Ras on the roundabout	SCIENCE			English	Editorial Material							MEMBRANE; RECEPTOR; BINDING		Max Planck Inst Mol Cell Biol, D-01307 Dresden, Germany	Max Planck Society	Meder, D (corresponding author), Max Planck Inst Mol Cell Biol, D-01307 Dresden, Germany.	meder@mpi-cbg.de; simons@mpi-cbg.de		Simons, Kai/0000-0002-9231-9996				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; HANCOCK JF, IN PRESS BIOCH J; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; ROCKS O, 2005, SCIENCE         0210, DOI DOI 10.1126/SCIENCE.1105654; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	14	24	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1731	1733		10.1126/science.1110551	http://dx.doi.org/10.1126/science.1110551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774748				2022-12-28	WOS:000227883900032
J	Riskin, DK; Hermanson, JW				Riskin, DK; Hermanson, JW			Biomechanics - Independent evolution of running in vampire bats	NATURE			English	Editorial Material							BODY SIZE; LOCOMOTION; MECHANICS; SPEED		Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Riskin, DK (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	dkr8@cornell.edu		Riskin, Daniel K./0000-0001-8742-8509				ALTENBACH JS, 1979, SPEC PUBL ANN SOC MA, V6, P137; Gambaryan PP, 2002, ZH OBSHCH BIOL, V63, P426; Greenhall A. M., 1988, NATURAL HIST VAMPIRE; HEGLUND NC, 1988, J EXP BIOL, V138, P301; Hildebrand M., 1985, P38; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; RISKIN DK, IN PRESS J EXP BIOL; Schutt WA, 1997, J EXP BIOL, V200, P3003; TAYLOR CR, 1982, J EXP BIOL, V97, P1; VAUGHAN TERRY A., 1959, UNIV KANSAS PUBL MUS NAT HIST, V12, P1	11	32	32	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					292	292		10.1038/434292a	http://dx.doi.org/10.1038/434292a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772640	Bronze			2022-12-28	WOS:000227715100029
J	Back, AL; Arnold, RM				Back, AL; Arnold, RM			Dealing with conflict in caring for the seriously ill - "It was just out of the question"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; DOCTOR-NURSE GAME; INTERPERSONAL CONFLICTS; PROLONGED STAY; CRITICALLY-ILL; FOLLOW-UP; COMMUNICATION; LIFE; PHYSICIANS; END	Physicians often assume that conflict is undesirable and destructive, yet conflict handled Well can be productive, and the clarity that results can lead to clearer decision making and greater family, patient, and clinician satisfaction. We review the course of Mrs B, an 84-year-old woman with advanced dementia and an advance directive stating no artificial hydration or nutrition. Over the course of her illness, her family and physicians had conflicting opinions about the use of short-term tube feeding and intravenous hydration in her care. We describe the conflicts that arose between her physicians and family and a typology of conflicts common in care of patients who are seriously ill (family vs team, team member vs team member). Drawing from the business, psychology, and mediation literature, we describe useful communication tools and common pitfalls. We outline a step-wise approach that physicians can use to deal with conflicts and the use of treatment trials as a strategy to address conflicts about the use of life-sustaining medical interventions.	Univ Washington, Dept Med, Seattle, WA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Back, AL (corresponding author), Seattle Canc Care Alliance, 825 Eastlake Ave E,POB 19023, Seattle, WA 98109 USA.	tonyback@u.washington.edu			PHS HHS [R25 92055] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM MED ASS, 2004, END PAT PHYS REL; Andrew L B, 1999, Physician Exec, V25, P38; Aschenbrener C A, 1999, Physician Exec, V25, P44; Aulisio MP, 2004, CRIT CARE CLIN, V20, P505, DOI 10.1016/j.ccc.2004.03.006; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Bowman KW, 2000, J PALLIATIVE CARE, V16, pS17, DOI 10.1177/082585970001601S05; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Brett AS, 2003, ARCH INTERN MED, V163, P1645, DOI 10.1001/archinte.163.14.1645; Burns JP, 2003, CRIT CARE MED, V31, P2107, DOI 10.1097/01.CCM.0000069732.65524.72; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Dowdy MD, 1998, CRIT CARE MED, V26, P252, DOI 10.1097/00003246-199802000-00020; DUBLER N, 2003, BIOETHICS MED GUIDE; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; FARBER NJ, 1990, ACAD MED, V65, P713, DOI 10.1097/00001888-199011000-00019; Fetters MD, 2001, CRIT CARE MED, V29, P921, DOI 10.1097/00003246-200105000-00001; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fisher R., 1991, GETTING YES NEGOTIAT; Frederich Michael E, 2002, J Palliat Med, V5, P155; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Goleman D., 2002, PRIMAL LEADERSHIP RE; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; Green P, 2004, AM J DRUG ALCOHOL AB, V30, P489, DOI 10.1081/ADA-120037390; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Jain A, 1999, BRIT MED J, V318, P1596, DOI 10.1136/bmj.318.7198.1596; Jameson JK, 2003, J HEALTH COMMUN, V8, P563, DOI 10.1080/716100415; Kalisch B J, 1977, J Nurs Adm, V7, P50, DOI 10.1097/00005110-197701000-00014; Kressel Kenneth, 2002, J Health Care Law Policy, V5, P364; Kristjanson LJ, 1997, J PALLIATIVE CARE, V13, P5; LEVENSON RW, 1994, J PERS SOC PSYCHOL, V67, P56, DOI 10.1037/0022-3514.67.1.56; Levine C, 1999, Trustee, V52, P24; Levine C, 2004, CLIN MED, V4, P244, DOI 10.7861/clinmedicine.4-3-244; Levinson W, 1999, JAMA-J AM MED ASSOC, V282, P1477, DOI 10.1001/jama.282.15.1477; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Orr Robert D., 2001, American Journal of Bioethics, V1, P45, DOI 10.1162/152651601317139397; PORTER S, 1991, J ADV NURS, V16, P728, DOI 10.1111/j.1365-2648.1991.tb01731.x; Prendergast TJ, 2000, JAMA-J AM MED ASSOC, V283, P3200; PRESCOTT PA, 1985, ANN INTERN MED, V103, P127, DOI 10.7326/0003-4819-103-1-127; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; Rosenbaum JR, 2004, AM J MED, V116, P402, DOI 10.1016/j.amjmed.2003.09.044; Rosenstein AH, 2002, AM J NURS, V102, P26, DOI 10.1097/00000446-200206000-00040; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; STEIN LI, 1967, ARCH GEN PSYCHIAT, V16, P699; STEIN LI, 1990, NEW ENGL J MED, V322, P546, DOI 10.1056/NEJM199002223220810; Stone D., 1999, DIFFICULT CONVERSATI; Studdert DM, 2003, INTENS CARE MED, V29, P1489, DOI 10.1007/s00134-003-1853-5; Studdert DM, 2003, PEDIATRICS, V112, P553, DOI 10.1542/peds.112.3.553; TANNEN D, 2000, YOU JUST DONT UNDERS; Taylor SR, 2004, BMJ-BRIT MED J, V329, P233, DOI 10.1136/bmj.329.7459.233; The AM, 2002, BRIT MED J, V325, P1326, DOI 10.1136/bmj.325.7376.1326; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; Ury W., 1991, GETTING PAST NO NEGO; VAILLANT GE, 1972, NEW ENGL J MED, V287, P372, DOI 10.1056/NEJM197208242870802; Valdimarsdottir U, 2004, PALLIATIVE MED, V18, P432, DOI 10.1191/0269216304pm891oa; Weitzman PF, 2003, CLIN PSYCHOL REV, V23, P523, DOI 10.1016/S0272-7358(02)00209-X; Weitzman PF, 2001, INT J AGING HUM DEV, V52, P281, DOI 10.2190/H3LH-59KQ-8WJP-ULM5	62	84	86	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1374	1381		10.1001/jama.293.11.1374	http://dx.doi.org/10.1001/jama.293.11.1374			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769971				2022-12-28	WOS:000227698600026
J	Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD				Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD			Chromosomal translocations in yeast induced by low levels of DNA polymerase: A model for chromosome fragile sites	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; GENOMIC INSTABILITY; GENETIC INSTABILITY; REARRANGEMENTS; RECOMBINATION; COMMON; REPLICATION; REPAIR; PALINDROMES	In the yeast Saccharomyces cerevisiae, reduced levels of the replicative a DNA polymerase result in greatly elevated frequencies of chromosome translocations and chromosome loss. We selected translocations in a small region of chromosome III and found that they involve homologous recombination events between yeast retrotransposons (Ty elements) on chromosome III and retrotransposons located on other chromosomes. One of the two preferred sites of these translocations on chromosome III involve two Ty elements arrayed head-to-head; disruption of this site substantially reduces the rate of translocations. We demonstrate that this pair of T elements constitutes a preferred site for double-strand DNA breaks when DNA replication is compromised, analogous to the fragile sites observed in mammalian chromosomes.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Georgia Inst Technol, Sch Biol, Inst Bioengn & Biosci, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology	Petes, TD (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	tompetes@duke.edu	Degtyareva, Natalya/AAI-5500-2021	Degtyareva, Natalya/0000-0002-7141-6308	NCI NIH HHS [CA09156] Funding Source: Medline; NIGMS NIH HHS [GM52319] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GORDENIN DA, 1991, YEAST, V7, P37, DOI 10.1002/yea.320070105; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Guthrie C, 1991, GUIDE YEAST GENETICS; HAWTHORNE DC, 1963, GENETICS, V48, P1721; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kokoska RJ, 2000, MOL CELL BIOL, V20, P7490, DOI 10.1128/MCB.20.20.7490-7504.2000; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; MCCUSKER JH, 1981, GENETICS, V99, P383; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROEDER GS, 1980, CELL, V21, P239, DOI 10.1016/0092-8674(80)90131-2; RUSKIN B, 1993, GENETICS, V134, P43; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Umezu K, 2002, GENETICS, V160, P97; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	33	247	251	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					587	598		10.1016/j.cell.2004.12.039	http://dx.doi.org/10.1016/j.cell.2004.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766523	Bronze			2022-12-28	WOS:000227771400006
J	Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS				Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS			Plant nuclear RNA polymerase IV mediates siRNA and DNA methylation-dependent heterochromatin formation	CELL			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION; METHYLTRANSFERASES; PURIFICATION; CHROMOSOMES; ARGONAUTE4; HOLOENZYME; RESOLUTION; GENES; DRM	All eukaryotes have three nuclear DNA-dependent RNA polymerases, namely, Pol I, II, and III. Interestingly, plants have catalytic subunits for a fourth nuclear polymerase, Pol IV. Genetic and biochemical evidence indicates that Pol IV does not functionally overlap with Pol I, II, or III and is nonessential for viability. However, disruption of the Pol IV catalytic subunit genes NRPD1 or NRPD2 inhibits heterochromatin association into chromocenters, coincident with losses in cytosine methylation at pericentromeric 5S gene clusters and AtSN1 retroelements. Loss of CG, CNG, and CNN methylation in Pol IV mutants implicates a partnership between Pol IV and the methyltransferase responsible for RNA-directed de novo methylation. Consistent with this hypothesis, 5S gene and AtSN1 siRNAs are essentially eliminated in Pol IV mutants. The data suggest that Pol IV helps produce siRNAs that target de novo cytosine methylation events required for facultative heterochromatin formation and higher-order heterochromatin associations.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Hokkaido Univ, Fac Agr, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; Inst Super Agron, Ctr Bot & Engn Biol, Seccao Genet, P-1349017 Lisbon, Portugal	Washington University (WUSTL); Hokkaido University; Universidade de Lisboa	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM60380] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; HERR A, 2005, IN PRESS SCIENC 0203, DOI DOI 10.1126/SCIENCE.1106910; Houben A, 1996, CHROMOSOME RES, V4, P191, DOI 10.1007/BF02254958; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Larkin RM, 1999, GENE, V231, P41, DOI 10.1016/S0378-1119(99)00090-6; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Saez-Vasquez J, 2000, J BIOL CHEM, V275, P37173, DOI 10.1074/jbc.M006057200; SaezVasquez J, 1997, P NATL ACAD SCI USA, V94, P11869, DOI 10.1073/pnas.94.22.11869; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5898; Schwarzacher HG, 2000, CYTOGENET CELL GENET, V91, P243, DOI 10.1159/000056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	36	485	510	6	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					613	622		10.1016/j.cell.2005.02.007	http://dx.doi.org/10.1016/j.cell.2005.02.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766525	Bronze			2022-12-28	WOS:000227771400008
J	Rutkowski, S; Bode, U; Deinlein, F; Ottensmeier, H; Warmuth-Metz, M; Soerensen, N; Graf, N; Emser, A; Pietsch, T; Wolff, JEA; Kortmann, RD; Kuehl, J				Rutkowski, S; Bode, U; Deinlein, F; Ottensmeier, H; Warmuth-Metz, M; Soerensen, N; Graf, N; Emser, A; Pietsch, T; Wolff, JEA; Kortmann, RD; Kuehl, J			Treatment of early childhood medulloblastoma by postoperative chemotherapy alone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANT BRAIN-TUMORS; STUDY-GROUP ANZCCSG; YOUNG-CHILDREN; PREIRRADIATION CHEMOTHERAPY; MOPP CHEMOTHERAPY; INFANTS; IRRADIATION; RADIATION; AGE; PATTERNS	BACKGROUND: The prognosis for young children with medulloblastoma is poor, and survivors are at high risk for cognitive deficits. We conducted a trial of the treatment of this brain tumor by intensive postoperative chemotherapy alone. METHODS: After surgery, children received three cycles of intravenous chemotherapy (cyclophosphamide, vincristine, methotrexate, carboplatin, and etoposide) and intraventricular methotrexate. Treatment was terminated if a complete remission was achieved. Leukoencephalopathy and cognitive deficits were evaluated. RESULTS: Forty-three children were treated according to protocol. In children who had complete resection (17 patients), residual tumor (14), and macroscopic metastases (12), the five-year progression-free and overall survival rates (+/-SE) were 82+/-9 percent and 93+/-6 percent, 50+/-13 percent and 56+/-14 percent, and 33+/-14 percent and 38+/-15 percent, respectively. The rates in 31 patients without macroscopic metastases were 68+/-8 percent and 77+/-8 percent. Desmoplastic histology, metastatic disease, and an age younger than two years were independent prognostic factors for tumor relapse and survival. Treatment strategies at relapse were successful in 8 of 16 patients. There were no major instances of unexpected toxicity. In 19 of 23 children, asymptomatic leukoencephalopathy was detected by magnetic resonance imaging. After treatment, the mean IQ was significantly lower than that of healthy controls within the same age group but higher than that of patients in a previous trial who had received radiotherapy. CONCLUSIONS: Postoperative chemotherapy alone is a promising treatment for medulloblastoma in young children without metastases.	Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; Univ Wurzburg, Dept Pediat Neurosurg, Wurzburg, Germany; Univ Bonn, Dept Neuropathol, Natl Reference Ctr Brain Tumors, D-5300 Bonn, Germany; Univ Bonn, Childrens Hosp, Dept Pediat Oncol, D-5300 Bonn, Germany; Univ Homburg, Childrens Hosp, Dept Pediat Oncol, D-6650 Homburg, Germany; Univ Mainz, Inst Med Stat Epidemiol & Informat, D-6500 Mainz, Germany; Univ Regensburg, Childrens Hosp, Dept Pediat Oncol, D-8400 Regensburg, Germany; Univ Leipzig, Dept Radiotherapy, D-7010 Leipzig, Germany	University of Wurzburg; University of Wurzburg; University of Bonn; University of Bonn; Johannes Gutenberg University of Mainz; University of Regensburg; Leipzig University	Rutkowski, S (corresponding author), Univ Wurzburg, Childrens Hosp, Dept Pediat Oncol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	rutkowski@mail.uni-wuerzburg.de	Graf, Norbert/H-1328-2011	Graf, Norbert/0000-0002-2248-323X; Wolff, Johannes/0000-0003-0278-1309				Ater JL, 1997, J NEURO-ONCOL, V32, P243, DOI 10.1023/A:1005744527443; ATTARDMONTALTO S, 1993, BRIT J RADIOL, V66, P807, DOI 10.1259/0007-1285-66-789-807; BARAM TZ, 1987, CANCER, V60, P173, DOI 10.1002/1097-0142(19870715)60:2<173::AID-CNCR2820600209>3.0.CO;2-F; CHANG CH, 1969, RADIOLOGY, V93, P1351, DOI 10.1148/93.6.1351; DUFFNER PK, 1993, NEW ENGL J MED, V328, P1725, DOI 10.1056/NEJM199306173282401; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; EVANS AE, 1990, J NEUROSURG, V72, P572, DOI 10.3171/jns.1990.72.4.0572; FAZEKAS F, 1989, EUR NEUROL, V29, P164, DOI 10.1159/000116401; Gottschling S, 2003, MED PEDIATR ONCOL, V41, P491, DOI 10.1002/mpo.10117; Hartsell WF, 1997, INT J RADIAT ONCOL, V39, P15, DOI 10.1016/S0360-3016(97)00136-3; HOPPEHIRSCH E, 1995, CHILD NERV SYST, V11, P340, DOI 10.1007/BF00301666; Jenkin D, 1998, MED PEDIATR ONCOL, V31, P506, DOI 10.1002/(SICI)1096-911X(199812)31:6<506::AID-MPO7>3.0.CO;2-X; Kaatsch P, 2001, CANCER-AM CANCER SOC, V92, P3155, DOI 10.1002/1097-0142(20011215)92:12<3155::AID-CNCR10158>3.0.CO;2-C; Kellie SJ, 1999, CHILD NERV SYST, V15, P592, DOI 10.1007/s003810050548; Kiltie AE, 1997, MED PEDIATR ONCOL, V28, P348, DOI 10.1002/(SICI)1096-911X(199705)28:5<348::AID-MPO4>3.0.CO;2-H; Kuehl J, 1995, MED PEDIAT ONCOL S, V25, P250; MULHERN RK, 1989, J CLIN ONCOL, V7, P1660, DOI 10.1200/JCO.1989.7.11.1660; Packer RJ, 2003, PEDIATR NEUROSURG, V39, P60, DOI 10.1159/000071316; Palmer SL, 2001, J CLIN ONCOL, V19, P2302, DOI 10.1200/JCO.2001.19.8.2302; Riva D, 2002, NEUROLOGY, V59, P48, DOI 10.1212/WNL.59.1.48; Ruggiero A, 2001, PEDIATR DRUGS, V3, P237, DOI 10.2165/00128072-200103040-00001; Vezmar S, 2003, CHEMOTHERAPY, V49, P92, DOI 10.1159/000069773; WHITE L, 1993, CANCER CHEMOTH PHARM, V32, P403, DOI 10.1007/BF00735928; White L, 1998, J PEDIAT HEMATOL ONC, V20, P125, DOI 10.1097/00043426-199803000-00007; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832	25	499	517	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					978	986		10.1056/NEJMoa042176	http://dx.doi.org/10.1056/NEJMoa042176			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758008	Bronze			2022-12-28	WOS:000227491200006
J	Andresen, D; Donaldson, A; Choo, L; Knox, A; Klaassen, M; Ursic, C; Vonthethoff, L; Krilis, S; Konecny, P				Andresen, D; Donaldson, A; Choo, L; Knox, A; Klaassen, M; Ursic, C; Vonthethoff, L; Krilis, S; Konecny, P			Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka	LANCET			English	Article								A man injured in the tsunami of Dec 26, 2004, returned to Sydney for management of his soft-tissue injuries. Despite broad-spectrum antibiotics, surgical wound debridement, and vigilant wound care, his condition worsened. Muscle and fat necrosis developed in a previously debrided thigh wound, and necrotising lesions arose from previous abrasions. Histological analysis showed mucormycosis in three non-contiguous sites, and Apophysomyces elegans was isolated from excised wound tissue. Wound infections, both bacterial and fungal, will undoubtedly add to the morbidity and mortality already recorded in tsunami-affected areas. Other causes of cutaneous mucormycosis might develop in survivors, but this disease can be difficult to diagnose and even harder to treat, particularly in those remaining in affected regions.	St George Hosp, Dept Immunol Allergy & Infect Dis, Sydney, NSW, Australia; St George Hosp, Dept Microbiol, SE Area Lab Serv, Sydney, NSW, Australia; St George Hosp, Dept Plast & Reconstruct Surg, Sydney, NSW, Australia; St George Hosp, Dept Trauma Surg, Sydney, NSW, Australia; St George Hosp, Dept Pathol Anat, SE Area Lab Serv, Sydney, NSW, Australia	St George Hospital; St George Hospital; St George Hospital; St George Hospital; St George Hospital	Konecny, P (corresponding author), St George Hosp, Dept Immunol Allergy & Infect Dis, Sydney, NSW, Australia.	konecnyp@sesahs.nsw.gov.au						ADAM RD, 1994, CLIN INFECT DIS, V19, P67, DOI 10.1093/clinids/19.1.67; Bentur Y, 1998, PLAST RECONSTR SURG, V102, P822, DOI 10.1097/00006534-199809030-00030; Ender PT, 1997, CLIN INFECT DIS, V25, P896, DOI 10.1086/515532; Panda A, 1997, CORNEA, V16, P295, DOI 10.1097/00003226-199705000-00007; PATINO JF, 1991, WORLD J SURG, V15, P240, DOI 10.1007/BF01659059; SUGAR A, 2004, MANDELL DOUGLAS BENN, P2973; *WHO, HLTH ACT CRIS	7	118	121	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					876	878		10.1016/S0140-6736(05)71046-1	http://dx.doi.org/10.1016/S0140-6736(05)71046-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752532				2022-12-28	WOS:000227444600030
J	Lapsley, P				Lapsley, P			Commentary: Itching for a solution	BRITISH MEDICAL JOURNAL			English	Editorial Material									Skin Care Campaign, London N19 5NA, England		Lapsley, P (corresponding author), Skin Care Campaign, Highgate Hill, London N19 5NA, England.	plapsley@eczema.org						Ashcroft DM, 2005, BMJ-BRIT MED J, V330, P516, DOI 10.1136/bmj.38376.439653.D3; Beattie PE, 2003, CLIN EXP DERMATOL, V28, P549, DOI 10.1046/j.1365-2230.2003.01357.x; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x	3	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 5	2005	330	7490					522	522		10.1136/bmj.38391.604826.7C	http://dx.doi.org/10.1136/bmj.38391.604826.7C			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15731120	Green Published			2022-12-28	WOS:000227581400020
J	Oransky, I				Oransky, I			Edward D Freis - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					840	840		10.1016/S0140-6736(05)71030-8	http://dx.doi.org/10.1016/S0140-6736(05)71030-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15779117				2022-12-28	WOS:000227444600014
J	Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J				Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J			Extensive DNA inversions in the B. fragilis genome control variable gene expression	SCIENCE			English	Article							BACTEROIDES-FRAGILIS; ANTIGENIC VARIATION; POLYSACCHARIDES; SALMONELLA	The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic pathogen and inhabitant,of the normal human colonic microbiota, exhibits considerable within-strain phase and antigenic variation of surface components. The complete genome sequence has revealed an unusual breadth (in number and in effect) of DNA inversion events that potentially control expression of man different components, including surface and secreted components, regulatory molecules, and restriction-modification proteins. Invertible promoters of two different types (12 group 1 and 11 group 2) were identified. One group has inversion crossover (fix) sites similar to the hix sites of Salmonella typhimurium. There are also four independent intergenic shufflons that potentially alter the expression and function of varied genes. The composition of the 10 different polysaccharide biosynthesis gene clusters identified (7 with associated invertible promoters) suggests a mechanism of synthesis similar to the O-antigen capsules of Escherichia coli.	Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland; Sanger Inst, Cambridge CB10 1SA, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa; Univ Edinburgh, Sch Med, Div Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Wales Coll Med, Dept Med Microbiol, Cardiff CF14 4XN, S Glam, Wales	Queens University Belfast; Wellcome Trust Sanger Institute; University of Edinburgh; University of Cape Town; University of Edinburgh; Cardiff University	Patrick, S (corresponding author), Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Grosvenor Rd, Belfast BT12 6BN, Antrim, North Ireland.	s.patrick@qub.ac.uk; parkhill@sanger.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Parkhill, Julian/G-4703-2011	Holden, Matthew TG/0000-0002-4958-2166; Parkhill, Julian/0000-0002-7069-5958; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Crossman, Lisa/0000-0003-2390-4750				Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; Horino A, 2003, J BACTERIOL, V185, P231, DOI 10.1128/JB.185.1.231-242.2003; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LINDBERG AA, 1990, REV INFECT DIS, V12, P133; LUTTON DA, 1991, J MED MICROBIOL, V35, P229, DOI 10.1099/00222615-35-4-229; Patrick S., 2002, Molecular medical microbiology: Volumes 1-3, P1921; Patrick S, 1999, INFECT IMMUN, V67, P4346, DOI 10.1128/IAI.67.9.4346-4351.1999; PATRICK S, 1986, J GEN MICROBIOL, V132, P1099; Patrick S, 2003, MICROBIOL-SGM, V149, P915, DOI 10.1099/mic.0.26166-0; POXTON IR, 1986, J GEN MICROBIOL, V132, P2475; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	18	205	530	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1463	1465		10.1126/science.1107008	http://dx.doi.org/10.1126/science.1107008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746427	Green Submitted			2022-12-28	WOS:000227503100046
J	Gombosi, TI; Hansen, KC				Gombosi, TI; Hansen, KC			Viewpoint - Saturn's variabie magnetosphere	SCIENCE			English	Editorial Material								Since the Cassini spacecraft reached Saturn's orbit in 2004, its instruments have been sending back a wealth of data on the planet's magnetosphere (the region dominated by the magnetic field of the planet). In this Viewpoint, we discuss some of these results, which are reported in a collection of reports in this issue. The magnetosphere is shown to be highly variable and influenced by the planet's rotation, sources of plasma within the planetary system, and the solar wind. New insights are also gained into the chemical composition of the magnetosphere, with surprising results. These early results from Cassini's first orbit around Saturn bode well for the future as the spacecraft continues to orbit the planet.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Gombosi, TI (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA.	tamas@umich.edu; kenhan@umich.edu	Hansen, Kenneth C/F-3693-2011; Gombosi, Tamas I/G-4238-2011	Hansen, Kenneth C/0000-0002-8502-1980; Gombosi, Tamas I/0000-0001-9360-4951				Blanc M, 2002, SPACE SCI REV, V104, P253, DOI 10.1023/A:1023605110711; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; JURAC S, IN PRESS J GEOPHYS R; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Sanchez-Lavega A, 2005, SCIENCE, V307, P1223, DOI 10.1126/science.1104956; Waite JH, 2005, SCIENCE, V307, P1260, DOI 10.1126/science.1105734; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	10	10	10	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1224	1226		10.1126/science.1108226	http://dx.doi.org/10.1126/science.1108226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731438				2022-12-28	WOS:000227313200037
J	Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D				Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D			Opportunity cost of antidepressant prescribing in England: analysis of routine data	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol; University of Bristol	Hollinghurst, S (corresponding author), Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England.	s.p.hollinghurst@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Kessler, david/ABB-6489-2021	Gunnell, David/0000-0002-0829-6470; Peters, Tim/0000-0003-2881-4180				[Anonymous], 2004, MAN DEPR PRIM SEC CA; Curtis, 2003, UNIT COSTS HLTH SOCI; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Lawrenson RA, 2000, J AFFECT DISORDERS, V59, P149, DOI 10.1016/S0165-0327(99)00147-0; *OFF NAT STAT, 2001, PSYCH MORT AD LIV PR	5	27	27	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 30	2005	330	7498					999	1000		10.1136/bmj.38377.715799.F7	http://dx.doi.org/10.1136/bmj.38377.715799.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923UP	15778232	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000228935100020
J	Cooper, CB; Tashkin, DP				Cooper, CB; Tashkin, DP			Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							AIR-FLOW LIMITATION; LONG-TERM TREATMENT; COPD PATIENTS; FLUTICASONE PROPIONATE; TIOTROPIUM BROMIDE; EXERCISE CAPACITY; LUNG-FUNCTION; SALMETEROL; FORMOTEROL; CORTICOSTEROIDS		Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cooper, CB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.	ccooper@mednet.ucla.edu						Aalbers R, 2002, EUR RESPIR J, V19, P936, DOI 10.1183/09031936.02.00240902; Alsaeedi A, 2002, AM J MED, V113, P59, DOI 10.1016/S0002-9343(02)01143-9; Bourbeau J, 2003, EUR RESPIR J, V22, P286, DOI 10.1183/09031936.03.00113802; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Calverley PMA, 2003, THORAX, V58, P855, DOI 10.1136/thorax.58.10.855; Calvet D, 2003, MACROMOLECULES, V36, P449, DOI 10.1021/ma011729a; Cazzola M, 2004, PULM PHARMACOL THER, V17, P35, DOI 10.1016/j.pupt.2003.09.001; Celli B, 2003, CHEST, V124, P1743, DOI 10.1378/chest.124.5.1743; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chapman Kenneth R, 2002, Can Respir J, V9, P178; Donohue JF, 2002, CHEST, V122, P47, DOI 10.1378/chest.122.1.47; Donohue JF, 2003, RESP MED, V97, P1014, DOI 10.1016/S0954-6111(03)00131-8; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; *GLOB IN CHRON OBS, 2003, GLOB STRAT DIAGN MAN; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Highland KB, 2003, ANN INTERN MED, V138, P969, DOI 10.7326/0003-4819-138-12-200306170-00008; Jones PW, 2003, EUR RESPIR J, V21, p13S, DOI 10.1183/09031936.03.00077803; Liesker JJW, 2002, RESP MED, V96, P559, DOI 10.1053/rmed.2001.1335; Liesker JJW, 2002, CHEST, V121, P597, DOI 10.1378/chest.121.2.597; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Moody A, 2004, THORAX, V59, P1; NANNINI L, 2003, COCHRANE DB SYST REV, V4; O'Donnell Denis E, 2003, Can Respir J, V10 Suppl A, p11A; Ramsey SD, 2000, CHEST, V117, P33; Rennard SI, 1996, CHEST, V110, P62, DOI 10.1378/chest.110.1.62; Richy F, 2003, OSTEOPOROSIS INT, V14, P179, DOI 10.1007/s00198-003-1398-z; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Suissa S, 2004, EUR RESPIR J, V23, P391, DOI 10.1183/09031936.04.00062504; Sutherland ER, 2003, THORAX, V58, P937, DOI 10.1136/thorax.58.11.937; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin D, 2003, CHEST, V123, P1441, DOI 10.1378/chest.123.5.1441; Tashkin DP, 2004, CHEST, V125, P249, DOI 10.1378/chest.125.1.249; Tennant RC, 2003, CURR OPIN PHARMACOL, V3, P270, DOI 10.1016/S1471-4892(03)00047-X; van Noord JA, 2000, EUR RESPIR J, V15, P878, DOI 10.1034/j.1399-3003.2000.15e11.x; Wadbo M, 2002, EUR RESPIR J, V20, P1138, DOI 10.1183/09031936.02.00301702; Wilson JD, 1996, EUR RESPIR REV, V6, P286	39	28	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					640	644		10.1136/bmj.330.7492.640	http://dx.doi.org/10.1136/bmj.330.7492.640			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774995	Green Published			2022-12-28	WOS:000227861700025
J	DiPiero, A; Sanders, D				DiPiero, A; Sanders, D			Condition based payment: improving care of chronic illness	BRITISH MEDICAL JOURNAL			English	Article							US HEALTH-CARE; PHYSICIAN ORGANIZATIONS; PUBLIC RELEASE; QUALITY; MANAGEMENT	Fee-for-service is more than a payment method; it defines the method of care. Fee-for-condition-a payment method that rewards superior results and encourages innovation-could greatly improve care for chronic conditions.	HealthOregon, Portland, OR 97232 USA		DiPiero, A (corresponding author), Oregon Hlth Sci Univ, Div Gen Internal Med & Geriatr, L475,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	dipieroa@ohsu.edu						Anderson GF, 1999, HEALTH AFFAIR, V18, P178, DOI 10.1377/hlthaff.18.3.178; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hughes JS, 2004, MED CARE, V42, P81, DOI 10.1097/01.mlr.0000102367.93252.70; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Li R, 2004, DIABETES CARE, V27, P2312, DOI 10.2337/diacare.27.10.2312; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Marshall MN, 2002, BRIT MED J, V325, P1278, DOI 10.1136/bmj.325.7375.1278; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Porter ME, 2004, HARVARD BUS REV, V82, P64; Porter R., 1999, MED HIST, DOI DOI 10.1017/S0025727300065443; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; Robinson AR, 2002, ARCH INTERN MED, V162, P2186, DOI 10.1001/archinte.162.19.2186; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958	20	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					654	657		10.1136/bmj.330.7492.654	http://dx.doi.org/10.1136/bmj.330.7492.654			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774999	Green Published			2022-12-28	WOS:000227861700032
J	Pruitt, SD; Epping-Jordan, JE				Pruitt, SD; Epping-Jordan, JE			Preparing the 21st century global healthcare workforce	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC DISEASE; BRAIN-DRAIN; MANAGEMENT; COUNTRIES; MIGRATION	To meet the growing global demands of caring for the increasing numbers of patients with chronic conditions, we need to develop a new approach to training.	WHO, Hlth Care, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; Kaiser Permanente, Behav Sci Integrat, Sacramento, CA USA	World Health Organization; Kaiser Permanente	Epping-Jordan, JE (corresponding author), WHO, Hlth Care, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland.	eppingj@who.int						[Anonymous], 2004, HLTH WORKF CURR CHAL; Beaglehole R., 2003, WORLD HLTH REPORT 20; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Buchan J, 2004, B WORLD HEALTH ORGAN, V82, P587; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Griner PF, 1996, 2020 VISION, P102; Holman H, 2004, JAMA-J AM MED ASSOC, V292, P1057, DOI 10.1001/jama.292.9.1057; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; *JOINT LEARN IN HU, COMB HIV AIDS GLOB H; Leeder S, 2004, RACE TIME CHALLENGE; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Pestana JAX, 1996, S AFR MED J, V86, P679; Saravia NG, 2004, B WORLD HEALTH ORGAN, V82, P608; Setel PW, 2004, AM J PUBLIC HEALTH, V94, P384, DOI 10.2105/AJPH.94.3.384; Stilwell B, 2004, B WORLD HEALTH ORGAN, V82, P595; *WHO, 2004, CHANG HIST; *WHO, IN PRESS PREP WORKF; *WHO, 2004, INT MAN AD AD ILLN M; *WHO, 2002, HUM RES NAT HLTH SYS; *WHO, 1994, MAK MED PRACT ED MOR	20	121	124	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					637	639		10.1136/bmj.330.7492.637	http://dx.doi.org/10.1136/bmj.330.7492.637			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774994	Bronze, Green Published			2022-12-28	WOS:000227861700024
J	Tarr, PI; Gordon, CA; Chandler, WL				Tarr, PI; Gordon, CA; Chandler, WL			Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome	LANCET			English	Review							THROMBOTIC THROMBOCYTOPENIC PURPURA; VON-WILLEBRAND-FACTOR; RANDOMIZED CONTROLLED-TRIAL; FACTOR-CLEAVING PROTEASE; NF-KAPPA-B; C-X-C; O157-H7 INFECTIONS; O157H7 INFECTIONS; HEMORRHAGIC COLITIS; BLOODY DIARRHEA	Most cases of diarrhoea-associated haemolytic uraemic syndrome (HUS) are caused by Shiga-toxin-producing bacteria; the pathophysiology differs from that of thrombotic thrombocytopenic purpura. Among Shiga-toxin-producing Escherichia coli (STEC), O157:H7 has the strongest association worldwide with HUS. Many different vehicles, in addition to the commonly suspected ground (minced) beef can transmit this pathogen to people. Antibiotics, antimotility agents, narcotics, and non-steroidal anti-inflammatory drugs should not be given to acutely infected patients, and we advise hospital admission and administration of intravenous fluids. Management of HUS remains supportive; there are no specific therapies to ameliorate the course. The vascular injury leading to HUS is likely to be well under way by the time infected patients seek medical attention for diarrhoea. The best way to prevent HUS is to prevent primary infection with Shiga-toxin-producing bacteria.	Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, Div Gastroenterol, St Louis, MO 63110 USA; Univ Vermont, Coll Med, Barbara Bush Childrens Hosp, Maine Med Ctr,Dept Pediat, Portland, ME USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA	Washington University (WUSTL); Maine Medical Center; University of Vermont; University of Washington; University of Washington Seattle	Tarr, PI (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, Div Gastroenterol, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	tarr@wustl.edu			NIDDK NIH HHS [R01 DK52081] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052081] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; AKE JA, IN PRESS PEDIATRICS; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; BALE JF, 1980, AM J DIS CHILD, V134, P869, DOI 10.1001/archpedi.1980.02130210053014; Bamforth J, 1923, J PATHOL BACTERIOL, V26, P40, DOI 10.1002/path.1700260105; BARNARD P. J., 1965, CENT AFRICAN J MED, V11, P4; BARRETT TJ, 1989, J INFECT DIS, V159, P774, DOI 10.1093/infdis/159.4.774; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; BELONGIA EA, 1993, JAMA-J AM MED ASSOC, V269, P883, DOI 10.1001/jama.269.7.883; Bender JB, 1997, NEW ENGL J MED, V337, P388, DOI 10.1056/NEJM199708073370604; BERGSTEIN JM, 1992, NEW ENGL J MED, V327, P755, DOI 10.1056/NEJM199209103271102; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; Bhimma R, 1997, PEDIATR NEPHROL, V11, P560, DOI 10.1007/s004670050338; Bhimma R, 2001, CLIN NEPHROL, V55, P133; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; Brandt J, 2002, PEDIATRICS, V110, P371, DOI 10.1542/peds.110.2.371; BRANDT JR, 1994, J PEDIATR-US, V125, P519, DOI 10.1016/S0022-3476(94)70002-8; Brandt JR, 1998, PEDIATR NEPHROL, V12, P222, DOI 10.1007/s004670050442; BRICHARD B, 1993, ACTA CLIN BELG, V48, P156, DOI 10.1080/17843286.1993.11718303; BRIZEE L, 1994, RENAL NUTR FORUM, V13, P1; Brooks JT, 2004, CLIN INFECT DIS, V38, P190, DOI 10.1086/380634; CALDERWOOD SB, 1987, P NATL ACAD SCI USA, V84, P4364, DOI 10.1073/pnas.84.13.4364; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; CIMOLAI N, 1992, PEDIATRICS, V90, P616; Cohen MB, 2002, J PEDIATR-US, V141, P155, DOI 10.1067/mpd.2002.126920; *COMM INF DIS, 2000, ESCH COL, P246; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Corrigan J J Jr, 2001, Pediatr Rev, V22, P365; Crump JA, 2002, NEW ENGL J MED, V347, P555, DOI 10.1056/NEJMoa020524; Cummings KC, 2002, AM J EPIDEMIOL, V155, P941, DOI 10.1093/aje/155.10.941; Cunin P, 1999, EMERG INFECT DIS, V5, P285, DOI 10.3201/eid0502.990217; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Decludt B, 2000, EPIDEMIOL INFECT, V124, P215, DOI 10.1017/S0950268899003623; DIEKMANN L, 1980, KLIN PADIATR, V192, P430, DOI 10.1055/s-2008-1035620; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Effler P, 2001, EMERG INFECT DIS, V7, P812; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Foster GH, 2002, J LEUKOCYTE BIOL, V71, P107; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; Friedrich AW, 2004, J CLIN MICROBIOL, V42, P4697, DOI 10.1128/JCM.42.10.4697-4701.2004; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; GAUTIER E, 1992, HEMOLYTIC UREMIC SYN, P1; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; GIANVITI A, 1993, AM J KIDNEY DIS, V22, P264, DOI 10.1016/S0272-6386(12)70316-5; GIANVITI A, 1994, PEDIATR NEPHROL, V8, P705, DOI 10.1007/BF00869095; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Haack JP, 2003, EMERG INFECT DIS, V9, P1226; HABIB R, 1992, HEMOLYTIC UREMIC SYN, P315; Hassan H, 2000, AM J KIDNEY DIS, V35, P146, DOI 10.1016/S0272-6386(00)70314-3; HAVENS PL, 1989, CLIN PEDIATR, V28, P482; Heuvelink AE, 1999, PEDIATR INFECT DIS J, V18, P709, DOI 10.1097/00006454-199908000-00011; Hughes AK, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027873.85792.52; HUGHES DA, 1991, SCOT MED J, V36, P9, DOI 10.1177/003693309103600105; Igarashi T, 1999, J PEDIATR-US, V135, P768, DOI 10.1016/S0022-3476(99)70100-9; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Janka A, 2003, INFECT IMMUN, V71, P3634, DOI 10.1128/IAI.71.6.3634-3638.2003; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Jelacic S, 2002, J INFECT DIS, V185, P214, DOI 10.1086/338480; JERNIGAN SM, 1994, PEDIATR NEPHROL, V8, P545, DOI 10.1007/BF00858122; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kaplan BS, 1998, J AM SOC NEPHROL, V9, P1126; KAPLAN BS, 1975, NEW ENGL J MED, V292, P1090, DOI 10.1056/NEJM197505222922102; Karch H, 2001, J CLIN MICROBIOL, V39, P2043, DOI 10.1128/JCM.39.6.2043-2049.2001; Karmali MA, 2004, J INFECT DIS, V189, P355, DOI 10.1086/381130; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Karpman D, 2001, BLOOD, V97, P3100, DOI 10.1182/blood.V97.10.3100; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; KATZ J, 1971, J PEDIATR-US, V78, P426, DOI 10.1016/S0022-3476(71)80222-6; Keene WE, 1997, J INFECT DIS, V176, P815, DOI 10.1086/517310; Keene WE, 1997, JAMA-J AM MED ASSOC, V277, P1229, DOI 10.1001/jama.277.15.1229; KEENE WE, 1994, NEW ENGL J MED, V331, P579, DOI 10.1056/NEJM199409013310904; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Kokai-Kun JF, 2000, J BIOL CHEM, V275, P3713, DOI 10.1074/jbc.275.5.3713; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; KOSTER F, 1978, NEW ENGL J MED, V298, P927, DOI 10.1056/NEJM197804272981702; Lahti E, 2002, EUR J CLIN MICROBIOL, V21, P189, DOI 10.1007/s10096-001-0682-0; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LINGWOOD CA, 1994, NEPHRON, V66, P21, DOI 10.1159/000187761; Lingwood Clifford A, 2003, Methods Mol Med, V73, P165; LOIRAT C, 1988, PEDIATR NEPHROL, V2, P279, DOI 10.1007/BF00858677; LOIRAT C, 2004, PEDIAT NEPHROLOGY, P887; LOPEZ EL, 1995, J PEDIATR-US, V127, P364, DOI 10.1016/S0022-3476(95)70064-1; LOPEZ EL, 1989, J INFECT DIS, V160, P469, DOI 10.1093/infdis/160.3.469; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; MARTIN DL, 1990, NEW ENGL J MED, V323, P1161, DOI 10.1056/NEJM199010253231703; McCarthy TA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e59; Miceli S, 1999, JPN J INFECT DIS, V52, P33; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Misselwitz J, 2003, PEDIATR INFECT DIS J, V22, P349; MURRAY MD, 1993, ANNU REV PHARMACOL, V33, P434; Nevard CHF, 1997, THROMB HAEMOSTASIS, V78, P1450; NEWLAND JW, 1987, INFECT IMMUN, V55, P2675, DOI 10.1128/IAI.55.11.2675-2680.1987; Nielsen EM, 2002, VET MICROBIOL, V88, P259, DOI 10.1016/S0378-1135(02)00107-4; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; OBRIEN AD, 1983, LANCET, V1, P702; OGBORN MR, 1990, CAN MED ASSOC J, V143, P1323; OREGAN S, 1980, J PEDIATR-US, V97, P473, DOI 10.1016/S0022-3476(80)80210-1; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; Park CH, 1996, DIAGN MICR INFEC DIS, V26, P69, DOI 10.1016/S0732-8893(96)00180-0; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; PATON AW, 1995, GENE, V153, P71, DOI 10.1016/0378-1119(94)00777-P; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; Perez N, 1998, PEDIATR NEPHROL, V12, P101, DOI 10.1007/s004670050413; Perkins SJ, 2002, J MOL BIOL, V316, P217, DOI 10.1006/jmbi.2001.5337; Proulx F, 2002, PEDIATR RES, V52, P928, DOI 10.1203/01.PDR.0000034233.75228.0B; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Ramegowda B, 1996, INFECT IMMUN, V64, P1173, DOI 10.1128/IAI.64.4.1173-1180.1996; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; RICHARDSON SE, 1992, INFECT IMMUN, V60, P4154, DOI 10.1128/IAI.60.10.4154-4167.1992; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; RIZZONI G, 1988, J PEDIATR-US, V112, P284, DOI 10.1016/S0022-3476(88)80071-4; Robinson LA, 1995, PEDIATR NEPHROL, V9, P700, DOI 10.1007/BF00868715; RODRIGUE DC, 1995, J INFECT DIS, V172, P1122, DOI 10.1093/infdis/172.4.1122; ROGERS MF, 1986, AM J EPIDEMIOL, V123, P137, DOI 10.1093/oxfordjournals.aje.a114207; Rogers TJ, 2003, INFECT IMMUN, V71, P5623, DOI 10.1128/IAI.71.10.5623-5632.2003; Rowe PC, 1998, J PEDIATR-US, V132, P777, DOI 10.1016/S0022-3476(98)70303-8; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Schoolwerth AC, 2001, CIRCULATION, V104, P1985, DOI 10.1161/hc4101.096153; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; SIEGLER RL, 1993, PEDIATRICS, V91, P666; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Smith JM, 2002, PEDIATR NEPHROL, V17, P1047, DOI 10.1007/s00467-002-0970-7; Sprouse JT, 2001, BLOOD COAGUL FIBRIN, V12, P283, DOI 10.1097/00001721-200106000-00009; Stapp JR, 2000, J CLIN MICROBIOL, V38, P3404, DOI 10.1128/JCM.38.9.3404-3406.2000; Starr M, 1998, CLIN INFECT DIS, V27, P310, DOI 10.1086/514656; Strauch E, 2001, INFECT IMMUN, V69, P7588, DOI 10.1128/IAI.69.12.7588-7595.2001; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; SWERDLOW DL, 1992, ANN INTERN MED, V117, P812, DOI 10.7326/0003-4819-117-10-812; Taguchi T, 1998, KIDNEY INT, V53, P1681, DOI 10.1046/j.1523-1755.1998.00939.x; TAKEDA T, 1993, J INFECTION, V27, P339, DOI 10.1016/0163-4453(93)92474-B; TAPPER D, 1995, J PEDIATR SURG, V30, P158, DOI 10.1016/0022-3468(95)90554-5; TARR PI, 1989, AM J EPIDEMIOL, V129, P582, DOI 10.1093/oxfordjournals.aje.a115170; TARR PI, 1987, PEDIATRICS, V80, P41; Tarr PI, 2001, GASTROENTEROL CLIN N, V30, P735, DOI 10.1016/S0889-8553(05)70208-9; TAYLOR CM, 1986, BRIT MED J, V292, P1513, DOI 10.1136/bmj.292.6534.1513; Taylor FB, 1999, AM J PATHOL, V154, P1285, DOI 10.1016/S0002-9440(10)65380-1; Tazzari PL, 2004, CYTOM PART B-CLIN CY, V61B, P40, DOI 10.1002/cyto.b.20022; te Loo DMWM, 2000, BLOOD, V95, P3396, DOI 10.1182/blood.V95.11.3396.011k19_3396_3402; te Loo DMWM, 2001, J AM SOC NEPHROL, V12, P800, DOI 10.1681/ASN.V124800; Terajima Jun, 2002, Nihon Rinsho, V60, P1070; TESH VL, 1994, INT CONGR SER, V1072, P189; Thayu M, 2003, PEDIATR NEPHROL, V18, P286, DOI 10.1007/s00467-002-1039-3; THOMAS A, 1993, EPIDEMIOL INFECT, V110, P591, DOI 10.1017/S0950268800051013; Thorpe CM, 2001, INFECT IMMUN, V69, P6140, DOI 10.1128/IAI.69.10.6140-6147.2001; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Trachtman H, 2003, JAMA-J AM MED ASSOC, V290, P1337, DOI 10.1001/jama.290.10.1337; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 2001, PEDIATR RES, V49, P653, DOI 10.1203/00006450-200105000-00008; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Uchida H, 1999, PEDIATR RES, V45, P133, DOI 10.1203/00006450-199901000-00022; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Van Geet C, 1998, KIDNEY INT, V54, P1324, DOI 10.1046/j.1523-1755.1998.00103.x; VANDEKAR NCAJ, 1994, PEDIATR RES, V36, P257, DOI 10.1203/00006450-199408000-00019; VANDEKAR NCAJ, 1995, NEPHRON, V71, P309, DOI 10.1159/000188737; Varma JK, 2003, JAMA-J AM MED ASSOC, V290, P2709, DOI 10.1001/jama.290.20.2709; Williams DM, 2002, ARCH PEDIAT ADOL MED, V156, P893, DOI 10.1001/archpedi.156.9.893; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Wong CS, 2002, JAMA-J AM MED ASSOC, V288, P3111, DOI 10.1001/jama.288.24.3111-JLT1225-2-2; YUTSUDO T, 1987, MICROB PATHOGENESIS, V3, P21, DOI 10.1016/0882-4010(87)90034-9; Zhang WL, 2002, J CLIN MICROBIOL, V40, P1441, DOI 10.1128/JCM.40.4.1441-1446.2002; Zoja C, 2002, KIDNEY INT, V62, P846, DOI 10.1046/j.1523-1755.2002.00503.x	180	1255	1303	4	105	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1073	1086		10.1016/S0140-6736(05)71144-2	http://dx.doi.org/10.1016/S0140-6736(05)71144-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781103				2022-12-28	WOS:000227731800032
J	Cavanagh, P				Cavanagh, P			The artist as neuroscientist	NATURE			English	Article							PERCEPTION; FACES; RECOGNITION		Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Cavanagh, P (corresponding author), Harvard Univ, Dept Psychol, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Bruno VJ, 1977, FORM COLOUR GREEK PA; BUSEY TA, 1990, PERCEPT PSYCHOPHYS, V48, P1, DOI 10.3758/BF03205006; CASATI R, 2004, SHADOW CLUB; Cavanagh P, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P35, DOI 10.1109/TDPVT.2004.1335139; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Croucher CJ, 2002, J EXP PSYCHOL HUMAN, V28, P546, DOI 10.1037//0096-1523.28.3.546; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; GOMBRICH EH, 1995, SHADOWS; Hills Paul, 1987, LIGHT EARLY ITALIAN; KENNEDY JM, 1974, PERCEPTION, V3, P313, DOI 10.1068/p030313; KENNEDY JM, 1975, PERCEPTION, V4, P391, DOI 10.1068/p040391; Koenderink JJ, 2003, LOOKING INTO PICTURES, P239; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MILLER J, 1998, REFLECTION; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; OSTROVSKY Y, IN PRESS PERCEPTION; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; SAVARESE S., 2004, P 1 S APPL PERC GRAP, P115, DOI DOI 10.1145/1012551.1012571; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WASSERSTEIN J, 1987, BRAIN COGNITION, V6, P1, DOI 10.1016/0278-2626(87)90042-X; YONAS A, 1978, SCIENCE, V200, P77, DOI 10.1126/science.635576; YONAS A, 1994, PERCEPTION, V23, P1427, DOI 10.1068/p231427	24	146	148	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					301	307		10.1038/434301a	http://dx.doi.org/10.1038/434301a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772645				2022-12-28	WOS:000227715100034
J	Boden, G; Sargrad, K; Homko, C; Mozzoli, M; Stein, TP				Boden, G; Sargrad, K; Homko, C; Mozzoli, M; Stein, TP			Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-FAT DIET; CALORIC REQUIREMENTS; SERUM LEPTIN; WEIGHT; HYPERINSULINEMIA; REAPPRAISAL; NUTRITION; ADULTS	Background: it is not known how a low-carbohydrate, high-protein, high-fat diet causes weight loss or how it affects blood glucose levels in patients with type 2 diabetes. Objective: To determine effects of a strict low-carbohydrate diet on body weight, body water, energy intake and expenditure, glycemic control, insulin sensitivity, and lipid levels in obese patients with type 2 diabetes. Design: Inpatient comparison of 2 diets. Setting: General clinical research center of a university hospital. Patients: 10 obese patients with type 2 diabetes. Intervention: Usual diets for 7 days followed by a low-carbohydrate diet for 14 days. Measurements: Body weight, water, and composition; energy intake and expenditure; diet satisfaction; hemoglobin A(1c); insulin sensitivity; 24-hour urinary ketone excretion; and plasma profiles of glucose, insulin, leptin, and ghrelin. Results: on the low-carbohydrate rate diet, mean energy intake decreased from 3111 kcal/d to 2164 kcal/d. The mean energy deficit of 1027 kcal/d (median, 737 kcal/d) completely accounted for the weight loss of 1.65 kg in 14 days (median, 1.34 kg in 14 days). Mean 24-hour plasma profiles of glucose levels normalized, mean hemoglobin A(1c) decreased from 7.3% to 6.8%, and insulin sensitivity improved by approximately 75%. Mean plasma triglyceride and cholesterol levels decreased (change, -35% and -10%, respectively). Limitations: The study was limited by the short duration, small number of participants, and lack of a strict control group. Conclusion: in a small group of obese patients with type 2 diabetes, a low-carbohydrate diet followed for 2 weeks resulted in spontaneous reduction in energy intake to a level appropriate to their height; weight loss that was completely accounted for by reduced caloric intake; much improved 24-hour blood glucose profiles, insulin sensitivity, and hemoglobin A(1c); and decreased plasma triglycericle and cholesterol levels. The long-term effects of this diet, however, remain uncertain.	Temple Univ, Sch Med, Philadelphia, PA USA; Univ Med & Dent New Jersey, Sch Osteopath Med, Stratford, NJ 08084 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Boden, G (corresponding author), Temple Univ Hosp & Med Sch, 3401 N Broad St, Philadelphia, PA 19140 USA.		Stein, T. Peter/R-4244-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066003, R01DK058895] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-00349] Funding Source: Medline; NHLBI NIH HHS [R01-HL0733267] Funding Source: Medline; NIA NIH HHS [R01-AG15353] Funding Source: Medline; NIDDK NIH HHS [R01-DK066003, R01-DK58895] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKINS R, 1992, DR ATKINS NEW DIET R; Atkins R.C., 1972, DR ATKINS DIET REVOL; Boden G, 2003, DIABETES, V52, P133, DOI 10.2337/diabetes.52.1.133; Boden G, 1997, J CLIN INVEST, V100, P1107, DOI 10.1172/JCI119621; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; CAMPFIELD LA, 2003, HDB OBESITY, P461; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; GARG A, 1994, JAMA-J AM MED ASSOC, V271, P1421, DOI 10.1001/jama.271.18.1421; Greene P, 2003, OBES RES, V11, pA23; HAWK PB, 1947, PRACTICAL PHYSL CHEM, P814; HILL AJ, 1983, J PSYCHIATR RES, V17, P203, DOI 10.1016/0022-3956(82)90023-1; HOLT SHA, 1995, APPETITE, V24, P43, DOI 10.1016/S0195-6663(95)80005-0; Homko CJ, 2003, DIABETES, V52, P487, DOI 10.2337/diabetes.52.2.487; JENKINS DJA, 1984, LANCET, V2, P388; LEWIS SB, 1977, AM J CLIN NUTR, V30, P160, DOI 10.1093/ajcn/30.2.160; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; MOLINA JM, 1990, AM J PHYSIOL, V258, pE16, DOI 10.1152/ajpendo.1990.258.1.E16; OWEN OE, 1986, AM J CLIN NUTR, V44, P1; OWEN OE, 1980, DIABETES, V29, P365, DOI 10.2337/diab.29.5.365; OWEN OE, 1987, AM J CLIN NUTR, V46, P875, DOI 10.1093/ajcn/46.6.875; RICH AJ, 1988, J PARENTER ENTERAL N, V13, pS7; RODIN J, 1985, METABOLISM, V34, P826, DOI 10.1016/0026-0495(85)90106-4; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; TAPPY L, 1988, DIABETES, V37, P1212, DOI 10.2337/diabetes.37.9.1212; VANITALLIE TB, 1977, NEW ENGL J MED, V297, P1158, DOI 10.1056/NEJM197711242972106; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	33	339	347	1	79	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					403	411		10.7326/0003-4819-142-6-200503150-00006	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767618				2022-12-28	WOS:000227621100002
J	Kumarevel, T; Mizuno, H; Kumar, PKR				Kumarevel, T; Mizuno, H; Kumar, PKR			Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand	NATURE			English	Article							RNA-BINDING PROTEIN; X-RAY-DIFFRACTION; BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATION; GENOME SEQUENCE; MESSENGER-RNA; ATTENUATION PROTEIN; CRYSTAL-STRUCTURE; IN-VITRO; OPERON	HutP regulates the expression of the hut structural genes of Bacillus subtilis by an anti-termination mechanism and requires two components, Mg2+ ions and L-histidine. HutP recognizes three UAG triplet units, separated by four non-conserved nucleotides on the terminator region. Here we report the 1.60-Angstrom resolution crystal structure of the quaternary complex ( HutP - L- histidine - Mg2+ 21-base single-stranded RNA). In the complex, the RNA adopts a novel triangular fold on the hexameric surface of HutP, without any base-pairing, and binds to the protein mostly by specific protein - base interactions. The structure explains how the HutP and RNA interactions are regulated critically by the L- histidine and Mg2+ ion through the structural rearrangement. To gain insights into these structural rearrangements, we solved two additional crystal structures ( uncomplexed HutP and HutP - L- histidine - Mg2+) that revealed the intermediate structures of HutP ( before forming an active structure) and the importance of the Mg2+ ion interactions in the complexes.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Tsukuba, Ibaraki 3058566, Japan; Natl Inst Agrobiol Sci, Dept Biochem, Tsukuba, Ibaraki 3058602, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan	Kumar, PKR (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	pkr-kumar@aist.go.jp	Penmetcha, Kumar/K-8834-2017; Kumarevel, Thirumananseri/C-6275-2012	Penmetcha, Kumar/0000-0002-3512-704X; Kumarevel, Thirumananseri/0000-0001-9326-6585				Alpert CA, 1997, J BACTERIOL, V179, P1555, DOI 10.1128/jb.179.5.1555-1562.1997; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Arnaud M, 1996, J BIOL CHEM, V271, P18966, DOI 10.1074/jbc.271.31.18966; AYMERICH S, 1992, P NATL ACAD SCI USA, V89, P10410, DOI 10.1073/pnas.89.21.10410; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Gollnick P, 2002, BBA-GENE STRUCT EXPR, V1577, P240, DOI 10.1016/S0167-4781(02)00455-4; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HOUMAN F, 1990, CELL, V62, P1153, DOI 10.1016/0092-8674(90)90392-R; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kimmhi Y., 1970, J BIOL CHEM, V245, P3545; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumarevel T, 2004, STRUCTURE, V12, P1269, DOI 10.1016/j.str.2004.05.005; Kumarevel TS, 2004, NUCLEIC ACIDS RES, V32, P3904, DOI 10.1093/nar/gkh725; Kumarevel TS, 2002, J STRUCT BIOL, V138, P237, DOI 10.1016/S1047-8477(02)00024-2; KUMAREVEL TS, 2003, NUCL ACIDS RES S, V3, P199; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODA M, 1988, J BACTERIOL, V170, P3199, DOI 10.1128/jb.170.7.3199-3205.1988; Oda M, 2000, MOL MICROBIOL, V35, P1244, DOI 10.1046/j.1365-2958.2000.01795.x; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WRAY LV, 1994, J BACTERIOL, V176, P5466, DOI 10.1128/JB.176.17.5466-5473.1994; Yang YS, 2002, EMBO J, V21, P1987, DOI 10.1093/emboj/21.8.1987; Yanofsky C, 2001, ANNU REV BIOCHEM, V70, P1, DOI 10.1146/annurev.biochem.70.1.1	39	38	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					183	191		10.1038/nature03355	http://dx.doi.org/10.1038/nature03355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758992				2022-12-28	WOS:000227494500037
J	Luman, ET; Barker, LE; Shaw, KM; McCauley, MM; Buehler, JW; Pickering, LK				Luman, ET; Barker, LE; Shaw, KM; McCauley, MM; Buehler, JW; Pickering, LK			Timeliness of childhood vaccinations in the United States - Days undervaccinated and number of vaccines delayed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOOL-AGE-CHILDREN; IMMUNIZATION RATES; YOUNG INFANTS; RISK-FACTORS; COVERAGE; PERTUSSIS; INTERVENTIONS; CHICAGO	Context Only 18% of children in the United States receive all vaccinations at the recommended times or acceptably early. Objective To determine the extent of delay of vaccination during the first 24 months of life. Design, Setting, and Participants The 2003 National Immunization Survey was conducted by random-digit dialing of households and mailings to vaccination providers to estimate vaccination coverage rates for US children aged 19 to 35 months. Data for this study were limited to 14810 children aged 24 to 35 months. Main Outcome Measures Cumulative days undervaccinated during the first 24 months of life for each of 6 vaccines (diphtheria and tetanus toxoids and acellular pertussis; poliovirus; measles, mumps, and rubella; Haemophilus influenzae type b; hepatitis 13; and varicella) and all vaccines combined, number of late vaccines, and risk factors for severe delay of vaccination. Results Children were undervaccinated a mean of 172 days (median, 126 days) for all vaccines combined during their first 24 months of life. Approximately 34% were undervaccinated for less than 1 month and 29% for 1 to 6 months, while 37% were undervaccinated for more than 6 months. Vaccine-specific undervaccination of more than 6 months ranged from 9% for poliovirus vaccine to 21 % for Haemophilus influenzae type b vaccine. An estimated 25% of children had delays in receipt of 4 or more of the 6 vaccines. Approximately 21 % of children were severely delayed (undervaccinated for more than 6 months and for greater than or equal to4 vaccines). Factors associated with severe delay included having a mother who was unmarried or who did not have a college degree, living in a household with 2 or more children, being non-Hispanic black, having 2 or more vaccination providers, and using public vaccination provider(s). Conclusions More than 1 in 3 children were undervaccinated for more than 6 months during their first 24 months of life and 1 in 4 children were delayed for at least 4 vaccines. Standard measures of vaccination coverage mask substantial shortfalls in ensuring that recommendations are followed regarding age at vaccination throughout the first 24 months of life.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Luman, ET (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,MS E62, Atlanta, GA 30333 USA.	ECL7@cdc.gov	Buehler, James/B-8419-2014	Shaw, Kate/0000-0002-1087-2457				[Anonymous], 1991, MMWR Recomm Rep, V40, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Atkinson William L., 1992, Morbidity and Mortality Weekly Report, V41, P1; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Bolton P, 1998, PUBLIC HEALTH REP, V113, P527; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; Butte AJ, 2001, PEDIATR INFECT DIS J, V20, P561, DOI 10.1097/00006454-200106000-00003; *CDCP, 2004, MMWR-MORBID MORTAL W, V51, P1; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P190; *CDCP, 2002, MMWR-MORBID MORTAL W, V50, P1159; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P687; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P36; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, pQ1; Cohen NJ, 2003, PEDIATRICS, V111, P925, DOI 10.1542/peds.111.5.925; Cotter JJ, 2002, J NATL MED ASSOC, V94, P833; DALAKER J, 1999, CURRENT POPULATION R; Dombkowski KJ, 2004, PUBLIC HEALTH REP, V119, P144, DOI 10.1177/003335490411900207; Dombkowski KJ, 2002, AM J PREV MED, V23, P36, DOI 10.1016/S0749-3797(02)00442-7; Dominguez SR, 2004, PEDIATRICS, V114, pE741, DOI 10.1542/peds.2004-1053; Ehresmann KR, 1998, PEDIATR INFECT DIS J, V17, P711, DOI 10.1097/00006454-199808000-00010; Frankel MR, 2003, STAT MED, V22, P1611, DOI 10.1002/sim.1515; Glauber JH, 2003, PEDIATRICS, V112, pE39, DOI 10.1542/peds.112.1.e39; GUYER B, 1994, PEDIATRICS, V94, P53; Hamlin JS, 1996, AM J PUBLIC HEALTH, V86, P1812, DOI 10.2105/AJPH.86.12.1812; Hughart N, 1999, MED CARE, V37, P44, DOI 10.1097/00005650-199901000-00008; Izurieta HS, 1996, CLIN INFECT DIS, V22, P503, DOI 10.1093/clinids/22.3.503; LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327; Luman ET, 2002, PEDIATRICS, V110, P935, DOI 10.1542/peds.110.5.935; LUMAN ET, IN PRESS AM J PUBLIC; NORDIN J, 1999, ALL KIDS COUNT ANN I; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; RODEWALD LE, 1995, ARCH PEDIAT ADOL MED, V149, P393, DOI 10.1001/archpedi.1995.02170160047007; Ross A, 1998, PEDIATRICS, V101, P970, DOI 10.1542/peds.101.6.970; SANTIBANEZ TA, 2004, 38 NAT IMM C MAY 14; Smith PJ, 2001, AM J PREV MED, V20, P17, DOI 10.1016/S0749-3797(01)00285-9; SMITH PJ, 2001, VITAL HLTH STAT, V2133, P1; Steiner RP, 1999, AM J PREV MED, V16, P189, DOI 10.1016/S0749-3797(98)00095-6; Strine TW, 2003, AM J PREV MED, V25, P45, DOI 10.1016/S0749-3797(03)00093-X; Szilagyi P., 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003941, DOI 10.1002/14651858.CD003941]; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Yusuf HR, 2000, JAMA-J AM MED ASSOC, V284, P978, DOI 10.1001/jama.284.8.978; ZELL ER, 1994, JAMA-J AM MED ASSOC, V271, P833, DOI 10.1001/jama.271.11.833; 2004, MMWR MORB MORTAL WKL, V53, P658	47	220	221	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1204	1211		10.1001/jama.293.10.1204	http://dx.doi.org/10.1001/jama.293.10.1204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755943	Bronze			2022-12-28	WOS:000227498400021
J	Nolan, D; James, I; Mallal, S				Nolan, D; James, I; Mallal, S			HIV: experiencing the pressures of modern life	SCIENCE			English	Editorial Material							GENE; ESCAPE		Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Perth, WA 6000, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University	Mallal, S (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia.	S.Mallal@murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309				de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; KewalRamani VN, 2003, SCIENCE, V301, P923, DOI 10.1126/science.1088965; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927	10	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1422	1424		10.1126/science.1110009	http://dx.doi.org/10.1126/science.1110009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746416				2022-12-28	WOS:000227503100032
J	Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J				Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J			Cross-presentation by intercellular peptide transfer through gap junctions	NATURE			English	Article							MHC CLASS-I; CD8(+) T-CELLS; ANTIGEN PRESENTATION; COMMUNICATION; PROTEIN; DEGRADATION; GROWTH; VITRO	Major histocompatibility complex (MHC) class I molecules present peptides that are derived from endogenous proteins1. These antigens can also be transferred to professional antigen-presenting cells in a process called cross-presentation, which precedes initiation of a proper T-cell response(2,3); but exactly how they do this is unclear. We tested whether peptides can be transferred directly from the cytoplasm of one cell into the cytoplasm of its neighbour through gap junctions. Here we show that peptides with a relative molecular mass of up to,1,800 diffuse intercellularly through gap junctions unless a three-dimensional structure is imposed. This intercellular peptide transfer causes cytotoxic T-cell recognition of adjacent, innocent bystander cells as well as activated monocytes. Gap-junction-mediated peptide transfer is restricted to a few coupling cells owing to the high cytosolic peptidase activity. We present a mechanism of antigen acquisition for cross-presentation that couples the antigen presentation system of two adjacent cells and is lost in most tumours: gap-junction-mediated intercellular peptide coupling for presentation by bystander MHC class I molecules and transfer to professional antigen presenting cells for cross-priming.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr, Dept Immunohematol & Blood Transfus Leiden, NL-2333 RC Leiden, Netherlands	Netherlands Cancer Institute	Neijssen, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	J.Neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017; Drijfhout, Jan Wouter/ABA-6318-2021	Neefjes, Jacques J.C./0000-0001-6763-2211; Drijfhout, Jan Wouter/0000-0003-4808-5296; Janssen, Lennert/0000-0001-9705-0204; Neijssen, Joost/0000-0001-6697-4324				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; ESINDUY CB, 1995, CARCINOGENESIS, V16, P915, DOI 10.1093/carcin/16.4.915; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Fischer NO, 2001, J VIROL METHODS, V91, P157, DOI 10.1016/S0166-0934(00)00260-3; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; GOLDBERG GS, 1993, BIOCHEM J, V295, P735, DOI 10.1042/bj2950735; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kurts C, 1998, CIBA F SYMP, V215, P172; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Mesnil M, 2000, CANCER RES, V60, P3989; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; OELZE L, 1995, J VIROL, V69, P4489; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Savinov AY, 2003, J EXP MED, V197, P643, DOI 10.1084/jem.20021378; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Verra NCV, 2004, CANCER RES, V64, P2153, DOI 10.1158/0008-5472.CAN-03-1339; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	30	327	340	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					83	88		10.1038/nature03290	http://dx.doi.org/10.1038/nature03290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744304				2022-12-28	WOS:000227334600048
J	Cisne, JL				Cisne, JL			How science survived: Medieval manuscripts' "demography" and classic texts' extinction	SCIENCE			English	Article								Determining what fraction of texts and manuscripts have survived from Antiquity and the Middle Ages has been highly problematic. Analyzing the transmission of texts as the "pateodemography" of their manuscripts yields definite and surprisingly high estimates. Parchment copies of the foremost medieval textbooks on arithmetical and calendrical calculation closely fit age distributions expected for populations with logistic growth and manuscripts with exponential survivorship. The estimated half-lives of copies agree with Bischoff's paleographically based suggestion that roughly one in seven manuscripts survive in some form from ninth-century Carolingian workshops. On this basis, many if not most of the leading technical titles circulating in Latin probably survived, even from late Antiquity.	Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA	Cornell University	Cisne, JL (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	cisne@geology.cornell.edu						BEDE, 1977, CORPUS CHRISTIANOR B, V123, P237; BEDE, 1969, BEDES ECCLESIASTICAL, P566; BISCHOFF B, 1990, LATIN PALAEOGRAPHY, P7; BORST A, 1993, ORDERING TIME ANCIEN, pCH5; Brown GK, 1994, COST 94 POST-HARVEST TREATMENT OF FRUIT AND VEGETABLES - SYSTEMS AND OPERATIONS FOR POST-HARVEST QUALITY, PROCEEDINGS OF WORKSHOP, P1; CISNE JL, 1979, ENCY PALEONTOLOGY, P628; CONTRENI JJ, 1995, NEW CAMBRIDGE MEDIEV, V2, P709; de Solla Price D. J., 1963, LITTLE SCI BIG SCI F; FELLER W, 1957, INTRO PROBABILITY TH, V1, P407; Jones Charles W., 1943, BEDAE OPERA TEMPORIB; LAISTNER MLW, 1943, HAND LIST BEDE MANUS, P154; McKitterick Rosamond, 1989, CAROLINGIANS WRITTEN, P135; MENNINGER K, 1969, NUMBER WORDS NUMBER, P201; PLINY, 1991, NATURAL HIST, P2; Reynolds L.D., 1983, TEXTS TRANSMISSION, P307; SARTON G, 1927, INTRO HIST SCI, V1, P503; THOMPSON JW, 1939, MEDIEVAL LIB, P613; Wang H.F., 1999, DICT TIME RECKONING	18	18	18	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1305	1307		10.1126/science.1104718	http://dx.doi.org/10.1126/science.1104718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	901WP	15731453				2022-12-28	WOS:000227313200057
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Saturn's atmosphere	SCIENCE			English	Article							ZONAL WINDS; ELECTROSTATIC DISCHARGES; JUPITERS ATMOSPHERE; CLOUD LEVEL; MORPHOLOGY; MOTIONS	The Cassini Imaging Science Subsystem (ISS) began observing Saturn in early February 2004. From analysis of cloud motions through early October 2004, we report vertical wind shear in Saturn's equatorial jet and a maximum wind speed of similar to375 meters per second, a value that differs from both Hubble Space Telescope and Voyager values. We also report a particularly active narrow southern mid-latitude region in which dark ovals are observed both to merge with each other and to arise from the eruptions of large, bright storms. Bright storm eruptions are correlated with Saturn's electrostatic discharges, which are thought to originate from lightning.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Evans, Michael W/AAG-4117-2020; Tiscareno, Matthew/D-6963-2011; Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BEZARD B, 1984, ICARUS, V60, P274, DOI 10.1016/0019-1035(84)90189-1; BURNS JA, 1983, ICARUS, V54, P280, DOI 10.1016/0019-1035(83)90198-7; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; INGERSOLL AP, 1984, SATURN, P195; Kaiser M. L., 1984, SATURN, P378; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2004, ICARUS, V170, P519, DOI 10.1016/j.icarus.2004.05.002; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SanchezLavega A, 1996, SCIENCE, V271, P631, DOI 10.1126/science.271.5249.631; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; SROMOVSKY LA, 1983, J GEOPHYS RES-SPACE, V88, P8650, DOI 10.1029/JA088iA11p08650; TEMMA T, IN PRESS ICARUS; WEST RA, 1982, ICARUS, V51, P51, DOI 10.1016/0019-1035(82)90029-X	20	94	94	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1243	1247		10.1126/science.1107691	http://dx.doi.org/10.1126/science.1107691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731441				2022-12-28	WOS:000227313200040
J	Glotzer, M				Glotzer, M			The molecular requirements for cytokinesis	SCIENCE			English	Review							FISSION YEAST CYTOKINESIS; CENTRAL-SPINDLE FORMATION; FORMIN HOMOLOGY PROTEIN; REGULATORY LIGHT-CHAIN; KINASE RHO-KINASE; CAENORHABDITIS-ELEGANS; CONTRACTILE RING; CITRON KINASE; MITOTIC SPINDLE; CLEAVAGE FURROW	After anaphase onset, animal cells build an actomyosin contractile ring that constricts the plasma membrane to generate two daughter cells connected by a cytoplasmic bridge. The bridge is ultimately severed to complete cytokinesis. Myriad techniques have been used to identify proteins that participate in cytokinesis in vertebrates, insects, and nematodes. A conserved core of about 20 proteins are individually involved with cytokinesis in most animal cells. These components are found in the contractile ring, on the central spindle, within the RhoA pathway, and on vesicles that expand the membrane and sever the bridge. Cytokinesis involves additional proteins, but they, or their requirement in cytokinesis, are not conserved among animal cells.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Glotzer, M (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	mglotzer@impunivie.ac.at		Glotzer, Michael/0000-0002-8723-7232				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DANIELS MJ, 2004, SCIENCE         0916, DOI DOI 10.1126/SCIENCE.1102574; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 2002, J CELL SCI, V115, P4819, DOI 10.1242/jcs.00163; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lakshmikanth GS, 2004, P NATL ACAD SCI USA, V101, P16519, DOI 10.1073/pnas.0407304101; Larochelle DA, 1996, J CELL BIOL, V133, P1321, DOI 10.1083/jcb.133.6.1321; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; McCollum D, 1999, J BIOL CHEM, V274, P17691, DOI 10.1074/jbc.274.25.17691; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Nagasaki A, 2002, J CELL SCI, V115, P2241; Naim V, 2004, MOL BIOL CELL, V15, P5053, DOI 10.1091/mbc.E04-06-0536; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neujahr R, 1997, J CELL SCI, V110, P123; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; OSTROW BD, 1994, J CELL BIOL, V127, P1945, DOI 10.1083/jcb.127.6.1945; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Piekny AJ, 2002, J CELL SCI, V115, P2271; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; PRUYNE D, 2002, SCIENCE         0606, DOI DOI 10.1126/SCIENCE.1072309; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shandala T, 2004, DEVELOPMENT, V131, P5053, DOI 10.1242/dev.01382; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; SONNICHSEN B, IN PRESS NATURE; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Stevens RC, 1998, J CELL BIOL, V142, P711, DOI 10.1083/jcb.142.3.711; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Swan KA, 1998, J CELL SCI, V111, P2017; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427	92	533	562	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1735	1739		10.1126/science.1096896	http://dx.doi.org/10.1126/science.1096896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774750				2022-12-28	WOS:000227883900034
J	Mahadevan, L; Rica, S				Mahadevan, L; Rica, S			Self-organized origami	SCIENCE			English	Article							CONVECTION		Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Chile, Dept Fis, Santiago, Chile	Harvard University; Harvard University; Universidad de Chile	Mahadevan, L (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Rica, Sergio/G-9865-2011					Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Haas F, 1996, P ROY SOC B-BIOL SCI, V263, P1651, DOI 10.1098/rspb.1996.0241; Kobayashi H, 1998, P ROY SOC B-BIOL SCI, V265, P147, DOI 10.1098/rspb.1998.0276; Kresling Biruta, 1995, Biomimetics, V3, P105; Miura K., 1980, P 31 C INT ASTRONAUT, P1; NEWELL AC, 1969, J FLUID MECH, V38, P279, DOI 10.1017/S0022112069000176; RIZZIERI R, COMMUNICATION; SEGEL LA, 1969, J FLUID MECH, V38, P203, DOI 10.1017/S0022112069000127	8	173	177	9	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1740	1740		10.1126/science.1105169	http://dx.doi.org/10.1126/science.1105169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774751				2022-12-28	WOS:000227883900035
J	Shen, J; Dahmann, C				Shen, J; Dahmann, C			Extrusion of cells with inappropriate Dpp signaling from Drosophila wing disc epithelia	SCIENCE			English	Article							TGF-BETA; APOPTOSIS; MORPHOGENESIS; SURVIVAL; ROLES; JNK	Decapentaplegic (Dpp) is a signaling molecule that controls growth and patterning of the developing Drosophila wing. Mutant cells lacking Dpp signal transduction have been shown to activate c-Jun amino-terminal kinase (JNK)-dependent apoptosis and to be lost from the wing disc epithelium. These observations have led to the hypothesis that Dpp promotes cell survival by preventing apoptosis. Here, we show that in the absence of JNK-dependent apoptosis, mutant cells tacking Dpp signal transduction can survive; however, they are still lost from the wing disc epithelium. This loss correlates with extensive cytoskeletal changes followed by basal epithelial extrusion. We propose that Dpp promotes cell survival within disc epithelia by affecting cytoskeletal organization.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Dahmann, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	dahmann@mpi-cbg.de	Dahmann, Christian/B-5841-2017; shen, jie/H-9087-2016; shen, jie/W-9807-2019	shen, jie/0000-0002-6021-7151				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208	13	127	130	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1789	1790		10.1126/science.1104784	http://dx.doi.org/10.1126/science.1104784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774763				2022-12-28	WOS:000227883900049
J	Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM				Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM			The MET oncogene drives a genetic programme linking cancer to haemostasis	NATURE			English	Article							LENTIVIRAL VECTORS; EXPRESSION; GROWTH; RECEPTORS; CYCLOOXYGENASE-2; MOUSE; CELLS	The close relationship between activation of blood coagulation and cancer is an old enigma. In 1865, migrans trombophlebitis ('a condition of the blood that predisposes it to spontaneous coagulation') was described as a forewarning of occult malignancy ( Trousseau's sign(1)). This pioneering observation emphasized the existence of haemostasis disorders associated with cancer onset; this phenomenon has since been extensively reported in clinical and epidemiological studies(2-4), but has so far resisted a mechanistic explanation. Here we report a mouse model of sporadic tumorigenesis based on genetic manipulation of somatic cells. Targeting the activated, human MET oncogene to adult liver caused slowly progressing hepatocarcinogenesis. This was preceded and accompanied by a syndrome manifesting first with blood hypercoagulation ( venous thromboses), and then evolving towards fatal internal haemorrhages. The pathogenesis of this syndrome is driven by the transcriptional response to the oncogene, including prominent upregulation of plasminogen activator inhibitor type 1 (PAI-1) and cyclooxygenase-2 (COX-2) genes. In vivo analysis showed that both proteins support the thrombohaemorrhagic phenotype, thus providing direct genetic evidence for the long-sought-after link between oncogene activation and haemostasis.	Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy	University of Turin	Boccaccio, C (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, Str Prov 142, I-10060 Turin, Italy.	carla.boccaccio@ircc.it	Boccaccio, Carla/AHE-7875-2022; Girolami, Flavia/K-6304-2013; Medico, Enzo/AAC-3185-2021; Naldini, Luigi/E-9083-2012	Boccaccio, Carla/0000-0003-2620-9083; Girolami, Flavia/0000-0001-9005-5301; Medico, Enzo/0000-0002-3917-2438; REATO, GIGLIOLA/0000-0003-3463-2930; sottile, antonino/0000-0003-4252-3240; NALDINI, Luigi/0000-0002-7835-527X; Follenzi, Antonia/0000-0001-9780-300X; Comoglio, Paolo/0000-0002-7056-5328	Telethon [TGT06S01, TGT03D03] Funding Source: Medline	Telethon(Fondazione Telethon)		Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Friederich PW, 1997, CIRCULATION, V96, P916; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Muller-Berghaus G, 1999, THROMB HAEMOSTASIS, V82, P706; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Oshima M, 2001, CANCER RES, V61, P1733; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Rickles FR, 2001, ACTA HAEMATOL-BASEL, V106, P6, DOI 10.1159/000046583; Rickles FR, 2000, HEMOSTASIS THROMBOSI, P1132; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Trousseau A, 1865, CLIN MED HOTEL DIEU, P654; Trusolino L, 1998, FASEB J, V12, P1267, DOI 10.1096/fasebj.12.13.1267; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2000, J GENE MED, V2, P308; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200	30	200	219	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					396	400		10.1038/nature03357	http://dx.doi.org/10.1038/nature03357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772665				2022-12-28	WOS:000227715100055
J	Dobson, DP; Brodholt, JP				Dobson, DP; Brodholt, JP			Subducted banded iron formations as a source of ultralow-velocity zones at the core-mantle boundary	NATURE			English	Article							HIGH-PRESSURE; PHASE; EARTH; FEO; ENERGY; BELT	Ultralow-velocity zones (ULVZs) are regions of the Earth's core mantle boundary about 1 - 10 kilometres thick exhibiting seismic velocities that are lower than radial-Earth reference models by about 10 - 20 per cent for compressional waves and 10 - 30 per cent for shear waves. It is also thought that such regions have an increased density of about 0 - 20 per cent (ref. 1). A number of origins for ULVZs have been proposed, such as ponding of dense silicate melt(2), core - mantle reaction zones(3) or underside sedimentation from the core(4). Here we suggest that ULVZs might instead be relics of banded iron formations subducted to the core - mantle boundary between 2.8 and 1.8 billion years ago. Consisting mainly of interbedded iron oxides and silica, such banded iron formations were deposited in the world's oceans during the late Archaean and early Proterozoic eras. We argue that these layers, as part of the ocean floor, would be recycled into the Earth's interior by subduction(5), sink to the bottom of the mantle and may explain all of the observed features of ULVZs.	UCL, Dept Earth Sci, London WC1E 6BT, England	University of London; University College London	Dobson, DP (corresponding author), UCL, Dept Earth Sci, Gower St, London WC1E 6BT, England.	d.dobson@ucl.ac.uk	Brodholt, John/B-7136-2011	Brodholt, John/0000-0001-7395-5834; Dobson, David/0000-0002-0890-0121				[Anonymous], 2000, HIST DYNAMICS GLOBAL, DOI DOI 10.1029/GM121P0277; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; BUFFETT BA, 1992, J GEOPHYS RES-SOL EA, V97, P19581, DOI 10.1029/92JB00977; CASTRO LO, 1994, ECON GEOL BULL SOC, V89, P1384, DOI 10.2113/gsecongeo.89.6.1384; CLOUD P, 1973, ECON GEOL, V68, P1135, DOI 10.2113/gsecongeo.68.7.1135; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FEI YW, 1994, SCIENCE, V266, P1678, DOI 10.1126/science.266.5191.1678; Garnero EJ, 1998, GEODYNAMICS-US, V28, P319; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; Holme R, 1998, GEOPHYS J INT, V132, P167, DOI 10.1046/j.1365-246x.1998.00424.x; Jacobsen SD, 2004, P NATL ACAD SCI USA, V101, P5867, DOI 10.1073/pnas.0401564101; James H. L., 1983, IRON FORMATION FACTS, P472; KNITTLE E, 1991, J GEOPHYS RES-SOL EA, V96, P16169, DOI 10.1029/90JB00653; KNITTLE E, 1986, GEOPHYS RES LETT, V13, P1541, DOI 10.1029/GL013i013p01541; KNITTLE E, 1989, GEOPHYS RES LETT, V16, P609, DOI 10.1029/GL016i007p00609; Kondo T, 2004, PHYS EARTH PLANET IN, V143, P201, DOI 10.1016/j.pepi.2003.10.008; Kusky TM, 2001, SCIENCE, V292, P1142, DOI 10.1126/science.1059426; MAO HK, 1974, J GEOPHYS RES, V79, P1165, DOI 10.1029/JB079i008p01165; Persh SE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002768; Poirier JP, 1998, GEODYNAMICS, V28, P131; Polat A, 2002, CHEM GEOL, V184, P231, DOI 10.1016/S0009-2541(01)00363-1; RAO TG, 1995, CHEM GEOL, V121, P217, DOI 10.1016/0009-2541(94)00116-P; ROSS NL, 1990, AM MINERAL, V75, P739; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; STIX M, 1984, PHYS EARTH PLANET IN, V36, P49, DOI 10.1016/0031-9201(84)90098-0; TAIRA A, 1992, TECTONICS, V11, P1224, DOI 10.1029/92TC00597; WILL G, 1980, PHYS CHEM MINER, V6, P157, DOI 10.1007/BF00311052; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528	28	123	128	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					371	374		10.1038/nature03430	http://dx.doi.org/10.1038/nature03430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772658				2022-12-28	WOS:000227715100048
J	McMullen, K				McMullen, K			Experimental physics, experimental art	NATURE			English	Article																			0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					310	311		10.1038/434310a	http://dx.doi.org/10.1038/434310a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772647	Bronze			2022-12-28	WOS:000227715100036
J	Reynolds, R				Reynolds, R			The evolution of sensibility	NATURE			English	Article									Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Reynolds, R (corresponding author), Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA.							Levitin DJ, 2004, MUSIC PERCEPT, V22, P167, DOI 10.1525/mp.2004.22.2.167; MCADAMS S, IN PRESS PERCEPTION	2	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					316	319		10.1038/434316a	http://dx.doi.org/10.1038/434316a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772649				2022-12-28	WOS:000227715100038
J	Shankar, P; Manjunath, N; Lieberman, J				Shankar, P; Manjunath, N; Lieberman, J			The prospect of silencing disease using RNA interference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOUBLE-STRANDED-RNA; HEPATITIS-B-VIRUS; FAS PROTECTS MICE; GENE-EXPRESSION; MESSENGER-RNA; IN-VIVO; INHIBITION; REPLICATION; THERAPY; SUPPRESSION	The discovery of RNA interference (RNAi), an endogenous cellular gene-silencing mechanism, has already provided a powerful tool for basic science researchers to study gene function. The subsequent finding that RNAi also operates in mammalian cells has generated excitement regarding potential therapeutic applications. In this article we discuss the basic mechanism of RNA! and the therapeutic opportunities and obstacles for harnessing RNAi for therapy of human disease.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015		NIAID NIH HHS [AI058695, AI056900] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058695, U19AI056900] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banerjea A, 2003, MOL THER, V8, P62, DOI 10.1016/S1525-0016(03)00140-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Buckingham SD, 2004, HUM MOL GENET, V13, pR275, DOI 10.1093/hmg/ddh224; Chang JH, 2003, J VIROL, V77, P11910, DOI 10.1128/JVI.77.22.11910-11917.2003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser A, 2004, NATURE, V428, P375, DOI 10.1038/428375a; Friedrich I, 2004, SEMIN CANCER BIOL, V14, P223, DOI 10.1016/j.semcancer.2004.04.001; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; He ML, 2003, JAMA-J AM MED ASSOC, V290, P2665, DOI 10.1001/jama.290.20.2665; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Klein C, 2003, GASTROENTEROLOGY, V125, P9, DOI 10.1016/S0016-5085(03)00720-0; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lee NS, 2004, VIRUS RES, V102, P53, DOI 10.1016/j.virusres.2004.01.015; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lieberman J, 2003, TRENDS MOL MED, V9, P397, DOI 10.1016/S1471-4914(03)00143-6; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; MINKS MA, 1979, J BIOL CHEM, V254, P180; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Orba Y, 2004, J VIROL, V78, P7270, DOI 10.1128/JVI.78.13.7270-7273.2004; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Radhakrishnan S, 2004, J VIROL, V78, P7264, DOI 10.1128/JVI.78.13.7264-7269.2004; Radhakrishnan SK, 2004, VIROLOGY, V323, P173, DOI 10.1016/j.virol.2004.02.021; Reich S, 2003, MOL VIS, V9, P210; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356; SHANKAR P, IN PRESS HIV CHEMOTH; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stevenson M, 2003, NAT REV IMMUNOL, V3, P851, DOI 10.1038/nri1227; Sumimoto H, 2005, GENE THER, V12, P95, DOI 10.1038/sj.gt.3302391; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	70	110	146	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1367	1373		10.1001/jama.293.11.1367	http://dx.doi.org/10.1001/jama.293.11.1367			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769970				2022-12-28	WOS:000227698600025
J	Sellal, F; Stoll-Keller, F				Sellal, F; Stoll-Keller, F			Rabies: ancient yet contemporary cause of encephalitis	LANCET			English	Editorial Material									Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France; Hop Univ Strasbourg, Inst Virol, F-67091 Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sellal, F (corresponding author), Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France.	Francois.Sellal@chru-strasbourg.fr						Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Coleman PG, 2004, EMERG INFECT DIS, V10, P140, DOI 10.3201/eid1001.020744; Dietzschold B, 2004, LANCET, V364, P648, DOI 10.1016/S0140-6736(04)16912-2; Galperine T, 2004, PRESSE MED, V33, P791, DOI 10.1016/S0755-4982(04)98745-3; Hemachudha T, 2004, CLIN INFECT DIS, V39, P1085, DOI 10.1086/423813; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Laothamatas J, 2003, AM J NEURORADIOL, V24, P1102; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; RAY NB, 1995, J VIROL, V69, P764, DOI 10.1128/JVI.69.2.764-772.1995; Schankin CJ, 2005, LANCET, V365, P358; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					921	923		10.1016/S0140-6736(05)71060-6	http://dx.doi.org/10.1016/S0140-6736(05)71060-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766980	Green Published, Bronze			2022-12-28	WOS:000227559800008
J	Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M				Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M			Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NECROTIC CELL-DEATH; INDUCED APOPTOSIS; REDOX REGULATION; CYTOCHROME-C; LIVER-REGENERATION; FACTOR RECEPTOR; IKK-BETA; PROTEIN	TNF alpha is a pleiotropic cytokine that induces either cell proliferation or cell death. Inhibition of NF-kappa B activation increases susceptibility to TNF alpha-induced death, concurrent with sustained JNK activation, an important contributor to the death response. Sustained JNK activation in NF-kappa B-deficient cells was suggested to depend on reactive oxygen species (ROS), but how RIDS affect JNK activation was unclear. We now show that TNF alpha-induced ROS, whose accumulation is suppressed by mitochondrial superoxide dismutase, cause oxidation and inhibition of JNK-inactivating phosphatases by converting their catalytic cysteine to sulfenic acid. This results in sustained JNK activation, which is required for cytochrome c release and caspase 3 cleavage, as well as necrotic cell death. Treatment of cells or experimental animals with an antioxidant prevents H(2)O(2) accumulation, JNK phosphatase oxidation, sustained JNK activity, and both forms of cell death. Antioxidant treatment also prevents TNF alpha-mediated fulminant liver failure without affecting liver regeneration.	Univ Calif San Diego, Sch Med, Lab Gene Regulat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hyogo	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Kamata, Hideaki/N-3907-2017		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151, P42ES010337, R01ES006376] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376, 5P42 ES10337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amanullah A, 2003, NATURE, V424, P741, DOI 10.1038/424741b; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Smith ML, 1996, ONCOGENE, V13, P2255; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441	52	1422	1475	3	145	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					649	661		10.1016/j.cell.2004.12.041	http://dx.doi.org/10.1016/j.cell.2004.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766528	Bronze			2022-12-28	WOS:000227771400011
J	Tobler, PN; Fiorillo, CD; Schultz, W				Tobler, PN; Fiorillo, CD; Schultz, W			Adaptive coding of reward value by dopamine neurons	SCIENCE			English	Article							NEURAL BASIS; PREDICTION; MOTIVATION; MECHANISMS; CONTRAST	It is important for animals to estimate the value of rewards as accurately as, possible. Because the number of potential reward values is very large, it is necessary that the brain's limited resources be allocated so as to discriminate! better among more likely reward outcomes at the expense of less likely outcomes. We found that midbrain dopamine neurons rapidly adapted to the information provided by reward-predicting stimuli. Responses shifted relative to the expected reward value, and the gain adjusted to the variance of reward value. In this way, dopamine neurons maintained their reward sensitivity over a large range of reward values.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of Cambridge; University of Fribourg	Schultz, W (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ws234@cam.ac.uk	Fiorillo, Christopher Dante/C-1718-2011; schultz, wolfram/H-8958-2016	Tobler, Philippe/0000-0002-4915-9448; schultz, wolfram/0000-0002-8530-4518; Fiorillo, Christopher/0000-0002-7232-9505	Wellcome Trust [095495] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnauld A., 1662, LOGIQUE LHRT PENSER; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Glimcher PW, 2003, BRADFORD BOOKS, P1; Kawakami D, 2004, COMP EXPTL METHODS, V10, P13; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Leon MI, 1998, J EXP PSYCHOL ANIM B, V24, P265, DOI 10.1037/0097-7403.24.3.265; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pavlov IP, 1927, CONDITIONAL REFLEXES; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	25	839	850	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1642	1645		10.1126/science.1105370	http://dx.doi.org/10.1126/science.1105370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761155	Green Submitted			2022-12-28	WOS:000227622400052
J	Chua, LL; Zaumseil, J; Chang, JF; Ou, ECW; Ho, PKH; Sirringhaus, H; Friend, RH				Chua, LL; Zaumseil, J; Chang, JF; Ou, ECW; Ho, PKH; Sirringhaus, H; Friend, RH			General observation of n-type field-effect behaviour in organic semiconductors	NATURE			English	Article							LIGHT-EMITTING-DIODES; HIGH-ELECTRON-MOBILITY; THIN-FILM TRANSISTORS; SILICON; SPECTROSCOPY; INTERFACES; MONOLAYERS; AIR	Organic semiconductors have been the subject of active research for over a decade now, with applications emerging in light-emitting displays and printable electronic circuits. One characteristic feature of these materials is the strong trapping of electrons but not holes(1): organic field-effect transistors (FETs) typically show p-type, but not n-type, conduction even with the appropriate low-work- function electrodes, except for a few special high-electron-affinity(2-4) or low-bandgap(5) organic semiconductors. Here we demonstrate that the use of an appropriate hydroxyl-free gate dielectric - such as a divinyltetramethylsiloxanebis( benzocyclobutene) derivative ( BCB; ref. 6) - can yield n-channel FET conduction in most conjugated polymers. The FET electron mobilities thus obtained reveal that electrons are considerably more mobile in these materials than previously thought. Electron mobilities of the order of 10(-3) to 10(-2) cm(2) V-1 s(-1) have been measured in a number of polyfluorene copolymers and in a dialkyl-substituted poly(p-phenylenevinylene), all in the unaligned state. We further show that the reason why n-type behaviour has previously been so elusive is the trapping of electrons at the semiconductor - dielectric interface by hydroxyl groups, present in the form of silanols in the case of the commonly used SiO2 dielectric. These findings should therefore open up new opportunities for organic complementary metal-oxide semiconductor (CMOS) circuits, in which both p-type and n-type behaviours are harnessed.	Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Natl Univ Singapore, Dept Phys, Singapore S117542, Singapore; Inst Mat Res & Engn, Singapore S117602, Singapore	University of Cambridge; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Ho, PKH (corresponding author), Univ Cambridge, Cavendish Lab, Madingley Rd, Cambridge CB3 0HE, England.	phyhop@nus.edu.sg; rhf10@cam.ac.uk	Zaumseil, Jana/C-1731-2018; Sirringhaus, Henning/ABD-1555-2021	Zaumseil, Jana/0000-0002-2048-217X; Sirringhaus, Henning/0000-0001-9827-6061; Friend, Richard Henry/0000-0001-6565-6308	Engineering and Physical Sciences Research Council [GR/R97122/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANGST DL, 1991, LANGMUIR, V7, P2236, DOI 10.1021/la00058a043; Babel A, 2003, J AM CHEM SOC, V125, P13656, DOI 10.1021/ja0371810; Bozano L, 1999, APPL PHYS LETT, V74, P1132, DOI 10.1063/1.123959; BROWN AR, 1994, SYNTHETIC MET, V66, P257, DOI 10.1016/0379-6779(94)90075-2; Chua LL, 2004, APPL PHYS LETT, V84, P3400, DOI 10.1063/1.1710716; Chua LL, 2004, ADV MATER, V16, P1609, DOI 10.1002/adma.200400392; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; DODABALAPUR A, 1995, SCIENCE, V269, P1560, DOI 10.1126/science.269.5230.1560; Dugas V, 2003, J COLLOID INTERF SCI, V264, P354, DOI 10.1016/S0021-9797(03)00552-6; HARTSTEIN A, 1981, APPL PHYS LETT, V38, P631, DOI 10.1063/1.92459; Ho PKH, 2000, NATURE, V404, P481, DOI 10.1038/35006610; Katz HE, 2000, NATURE, V404, P478, DOI 10.1038/35006603; Kim JS, 2000, J APPL PHYS, V88, P1073, DOI 10.1063/1.373779; Malenfant PRL, 2002, APPL PHYS LETT, V80, P2517, DOI 10.1063/1.1467706; Meijer EJ, 2003, NAT MATER, V2, P678, DOI 10.1038/nmat978; NAGASAWA Y, 1990, J APPL PHYS, V68, P1429, DOI 10.1063/1.346669; NICOLLIA.EH, 1971, J APPL PHYS, V42, P5654, DOI 10.1063/1.1659996; PERRY CC, 1991, J CHEM SOC FARADAY T, V87, P3857, DOI 10.1039/ft9918703857; Salleo A, 2002, APPL PHYS LETT, V81, P4383, DOI 10.1063/1.1527691; Sirringhaus H, 2000, APPL PHYS LETT, V77, P406, DOI 10.1063/1.126991; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Tardif F, 2003, J ELECTROCHEM SOC, V150, pG333, DOI 10.1149/1.1567269; Veres J, 2003, ADV FUNCT MATER, V13, P199, DOI 10.1002/adfm.200390030; WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035; WILSON RJ, 2002, THESIS U CAMBRIDGE	25	2035	2071	27	1090	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					194	199		10.1038/nature03376	http://dx.doi.org/10.1038/nature03376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758994				2022-12-28	WOS:000227494500039
J	Cranmer, HH				Cranmer, HH			The public health emergency in Indonesia - One patient at a time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Cranmer, HH (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, 75 Francis St, Boston, MA 02115 USA.							TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381	1	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					965	965		10.1056/NEJMp058045	http://dx.doi.org/10.1056/NEJMp058045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904JC	15758005				2022-12-28	WOS:000227491200003
J	Werner, RM; Asch, DA				Werner, RM; Asch, DA			The unintended consequences of publicly reporting quality information	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; BYPASS GRAFT-SURGERY; OF-CARE; PERFORMANCE REPORTS; HEALTH-CARE; HOSPITAL PERFORMANCE; IMPROVEMENT EFFORTS; CONSUMER REPORTS; PATIENT SAFETY; MARKET SHARE	Health care report cards publicly report information about physician, hospital, and health plan quality in an attempt to improve that quality. Reporting quality information publicly is presumed to motivate quality improvement through 2 main mechanisms. First, public quality information allows patients, referring physicians, and health care purchasers to preferentially select high-quality physicians. Second, public report cards may motivate physicians to compete on quality and, by providing feedback and by identifying areas for quality improvement initiatives, help physicians to do so. Despite these plausible mechanisms of quality improvement, the value of publicly reporting quality information is largely undemonstrated and public reporting may have unintended and negative consequences on health care. These unintended consequences include causing physicians to avoid sick patients in an attempt to improve their quality ranking, encouraging physicians to achieve "target rates" for health care interventions even when it may be inappropriate among some patients, and discounting patient preferences and clinical judgment. Public reporting of quality information promotes a spirit of openness that may be valuable for enhancing trust of the health professions, but its ability to improve health remains undemonstrated, and public reporting may inadvertently reduce, rather than improve, quality. Given these limitations, it may be necessary to reassess the role of public quality reporting in quality improvement.	Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equit Res & Promot, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Werner, RM (corresponding author), Univ Penn, Div Gen Internal Med, 1208 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rwerner@wharton.upenn.edu		Werner, Rachel/0000-0003-3435-4221; Asch, David/0000-0002-7970-286X	AHRQ HHS [2-T32-HS-00009, F32-HS-14644-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS014644, T32HS000009] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR RES Q, 2003, NAT HLTH CAR QUAL RE; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Altman DE, 2004, NEW ENGL J MED, V351, P2041, DOI 10.1056/NEJMp048243; [Anonymous], 2004, STAT HLTH CAR QUAL; [Anonymous], 2004, NAT SURV CONS EXP PA; ARROW KJ, 1963, AM ECON REV, V53, P941; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Baker DW, 2003, MED CARE, V41, P729, DOI 10.1097/00005650-200306000-00006; Berner ES, 2003, MED CARE, V41, P420, DOI 10.1097/00005650-200303000-00010; Berwick DM, 2003, MED CARE, V41, pI30; Berwick DM, 2002, JAMA-J AM MED ASSOC, V288, P1523, DOI 10.1001/jama.288.12.1523; BILLI JE, 1992, J GEN INTERN MED, V7, P411, DOI 10.1007/BF02599158; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; *CA CABG MORT REP, 2001, CAL REP COR ART BYP; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40; *CTR MED MED SERV, 2003, NURS HOM COMP; DEMBNER A, 2004, BOSTON GLOBE    1213, V31, pA1; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; Erickson LC, 2000, JAMA-J AM MED ASSOC, V283, P1976, DOI 10.1001/jama.283.15.1976; FARLEY D, 1998, ASSESSING QUALITY MA; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Fiscella K, 1999, ANN INTERN MED, V131, P745, DOI 10.7326/0003-4819-131-10-199911160-00005; Gibbs DA, 1996, HEALTH CARE FINANC R, V18, P55; Hannan EL, 2003, MED CARE, V41, P1164, DOI 10.1097/01.MLR.0000088452.82637.40; Hannan EL, 1997, AM HEART J, V134, P55, DOI 10.1016/S0002-8703(97)70106-6; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Harpole LH, 1996, J GEN INTERN MED, V11, P431, DOI 10.1007/BF02600192; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2003, MED CARE, V41, pI61; Hibbard JH, 2002, HEALTH SERV RES, V37, P291, DOI 10.1111/1475-6773.024; Hibbard JH, 2001, HEALTH AFFAIR, V20, P199, DOI 10.1377/hlthaff.20.3.199; Institute of Medicine, 2003, PAT SAF ACH NEW STAN; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jewett JJ, 1996, HEALTH CARE FINANC R, V18, P75; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *KAIS FAM FDN AG H, 2000, AM HLTH CAR CONS UPD; Leatherman ST, 2003, MED CARE, V41, pI80; Longo DR, 1997, JAMA-J AM MED ASSOC, V278, P1579, DOI 10.1001/jama.278.19.1579; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; McGee J, 1999, MED CARE, V37, pMS32, DOI 10.1097/00005650-199903001-00004; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Mukamel DB, 2002, HEALTH SERV RES, V37, P1129, DOI 10.1111/1475-6773.10212; *NJ DEP HLTH SEN S, 2003, CARD SURG NEW JERS C; *NY STAT DEP HLTH, 1993, COR ART BYP SURG NEW; *NY STAT DEP HLTH, 1996, COR ART BYP SURG NEW; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; *PA HLTH CAR COST, 1992, CONS GUID COR ART BY; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Romano PS, 1999, MED CARE, V37, P295, DOI 10.1097/00005650-199903000-00009; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Spranca M, 2000, HEALTH SERV RES, V35, P933; Steinberg EP, 2003, NEW ENGL J MED, V348, P2681, DOI 10.1056/NEJMe030085; Stiglitz J., 1989, HDB IND ORG, V1, P769, DOI DOI 10.1016/S1573-448X(89)01016-2; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; WERNER RM, IN PRESS CIRCULATION	61	420	425	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1239	1244		10.1001/jama.293.10.1239	http://dx.doi.org/10.1001/jama.293.10.1239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755946				2022-12-28	WOS:000227498400024
J	Stone, GW; Webb, J; Cox, DA; Brodie, BR; Qureshi, M; Kalynych, A; Turco, M; Schultheiss, HP; Dulas, D; Rutherford, BD; Antoniucci, D; Krucoff, MW; Gibbons, RJ; Jones, D; Lansky, AJ; Mehran, R				Stone, GW; Webb, J; Cox, DA; Brodie, BR; Qureshi, M; Kalynych, A; Turco, M; Schultheiss, HP; Dulas, D; Rutherford, BD; Antoniucci, D; Krucoff, MW; Gibbons, RJ; Jones, D; Lansky, AJ; Mehran, R		EMERALD	Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR FUNCTION; AORTOCORONARY BYPASS GRAFTS; PERCUSURGE GUARDWIRE DEVICE; PRIMARY ANGIOPLASTY; ASPIRATION SYSTEM; BLUSH GRADE; MICROVASCULAR REPERFUSION; ANGIOGRAPHIC ASSESSMENT; TEMPORARY OCCLUSION; STRONG PREDICTOR	Context Atheromatous and thrombotic embolization during percutaneous coronary intervention (PCI in acute myocardial infarction is common and may result in microcirculatory dysfunction, the prevention of which may improve reperfusion success, reduce infarct size, and enhance event-free survival. Objective To determine whether protection of the distal microcirculation from thromboembolic debris liberated during primary PCI results in improved reperfusion and decreased infarct size. Design, Setting, and Patients Prospective randomized controlled trial at 38 academic and community-based institutions in 7 countries enrolling 501 patients aged 18 years or older with ST-segment elevation myocardial infarction (STEMI) presenting within 6 hours of symptom onset and undergoing primary PCI or rescue intervention after failed thrombolysis. Interventions Patients were randomized between May 20, 2002, and November 21, 2003, to receive PCI with a balloon occlusion and aspiration distal microcirculatory protection system vs angioplasty without distal protection. Main Outcome Measures Coprimary end points were ST-segment resolution (STR) measured 30 minutes after PCI by continuous Holter monitoring and infarct size measured by technetium Tc 99m sestamibi imaging between days 5 and 14. Secondary end points included major adverse cardiac events. Results Among 252 patients assigned to distal protection, aspiration was performed in 97% (242/251), all angioplasty balloon inflations were fully protected in 79% (193/245), and visible debris was retrieved from 73 % (182/250). Complete STR was achieved in a similar proportion reperfused with vs without distal protection (63.3% [152/240] vs 61.9% [148/2391, respectively; absolute difference, 1.4% [95% confidence interval, -7.7% to 10.5%; P=.781), and left ventricular infarct size was similar in both groups (median, 12.0% [n=2291 vs9.5% [n=2081, respectively; P=.15). Major adverse cardiac events at 6 months occurred with similar frequency in the distal protection and control groups (10.0% vs 11.0%, respectively; P=.66). Conclusions A distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute STEMI undergoing emergent PCI. Nonetheless, distal embolic protection did not result in improved microvascular flow, greater reperfusion success, reduced infarct size, or enhanced event-free survival.	Columbia Univ, Med Ctr, New York, NY 10022 USA; Cardiovasc Res Fdn, New York, NY 10022 USA; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Mid Carolina Cardiol, Charlotte, NC USA; Moses Cone Hosp, Greensboro, NC USA; St Joseph Mercy Hosp, Ypsilanti, MI USA; Emory Univ, Crawford Long Hosp, Atlanta, GA 30365 USA; Washington Adventist Hosp, Takoma Pk, MD USA; Univ Hosp Benjamin Franklin, Berlin, Germany; Mercy Hosp, Coon Rapids, MN USA; St Lukes Hosp, Kansas City, MO USA; Policlin Careggi, Florence, Italy; Duke Univ, Med Ctr, Durham, NC USA; Mayo Clin Fdn, Rochester, MN USA; Medtron Corp, Santa Rosa, CA USA	Columbia University; Cardiovascular Research Foundation (CRF); St. Paul's Hospital; University of Saskatchewan; Moses Cone Memorial Hospital; Saint Joseph Mercy Health System (SJMHS); Emory University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint Luke's Hospital - Missouri; University of Florence; Azienda Ospedaliero Universitaria Careggi; Duke University; Mayo Clinic	Stone, GW (corresponding author), Columbia Univ, Med Ctr, 55 E 59th St,6th Floor, New York, NY 10022 USA.	gs2184@columbia.edu	Mehran, Roxana/ABF-4160-2021	Gibbons, Raymond/0000-0003-0704-1350				ARMIGER LC, 1975, LAB INVEST, V33, P51; Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; CHRISTIAN TF, 1992, CIRCULATION, V86, P81, DOI 10.1161/01.CIR.86.1.81; Claeys MJ, 1999, CIRCULATION, V99, P1972, DOI 10.1161/01.CIR.99.15.1972; Costantini CO, 2004, J AM COLL CARDIOL, V44, P305, DOI 10.1016/j.jacc.2004.03.058; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Gibbons RJ, 2000, CIRCULATION, V101, P101, DOI 10.1161/01.CIR.101.1.101; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Henriques JPS, 2003, CIRCULATION, V107, P2115, DOI 10.1161/01.CIR.0000065221.06430.ED; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; Hoffmann R, 2003, AM J CARDIOL, V92, P1015, DOI 10.1016/j.amjcard.2003.07.001; Huang Z, 2003, CATHETER CARDIO INTE, V60, P443, DOI 10.1002/ccd.10691; Kastrati A, 2002, LANCET, V359, P920, DOI 10.1016/S0140-6736(02)08022-4; Kopecky SL, 2003, AM HEART J, V146, P146, DOI 10.1016/S0002-8703(03)00172-8; Kotani JI, 2003, AM J CARDIOL, V92, P728, DOI 10.1016/S0002-9149(03)00840-3; KRUCOFF MW, 1993, AM J CARDIOL, V71, P145, DOI 10.1016/0002-9149(93)90729-V; Kusuyama T, 2004, AM J CARDIOL, V94, P1041, DOI 10.1016/j.amjcard.2004.06.063; Li SSL, 2003, INT J CARDIOL, V92, P281, DOI 10.1016/S0167-5273(03)00097-4; Limbruno U, 2003, CIRCULATION, V108, P171, DOI 10.1161/01.CIR.0000079223.47421.78; Matetzky S, 1999, J AM COLL CARDIOL, V34, P1932, DOI 10.1016/S0735-1097(99)00466-0; McLaughlin MG, 2004, J AM COLL CARDIOL, V44, P1215, DOI 10.1016/j.jacc.2004.06.053; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; Nakamura T, 2004, CIRC J, V68, P763, DOI 10.1253/circj.68.763; OCONNOR MK, 1995, J NUCL MED, V36, P1130; Orrego PS, 2003, CATHETER CARDIO INTE, V60, P152, DOI 10.1002/ccd.10638; Poli A, 2002, CIRCULATION, V106, P313, DOI 10.1161/01.CIR.0000022691.71708.94; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Roe MT, 2004, J AM COLL CARDIOL, V43, P549, DOI 10.1016/j.jacc.2003.09.039; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Schomig A, 2003, CIRCULATION, V108, P1084, DOI 10.1161/01.CIR.0000086346.32856.9C; SCHRODER R, 1995, J AM COLL CARDIOL, V26, P1657, DOI 10.1016/0735-1097(95)00372-X; SCHRODER R, 1994, J AM COLL CARDIOL, V24, P384, DOI 10.1016/0735-1097(94)90292-5; Sievert H, 2004, AM J CARDIOL, V94, P1134, DOI 10.1016/j.amjcard.2004.07.079; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Stone GW, 2003, CIRCULATION, V108, P414; Stone GW, 2003, CIRCULATION, V108, P548, DOI 10.1161/01.CIR.0000080894.51311.0A; Stone GW, 2002, J AM COLL CARDIOL, V39, P591, DOI 10.1016/S0735-1097(01)01779-X; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; vantHof AWJ, 1997, LANCET, V350, P615, DOI 10.1016/S0140-6736(96)07120-6; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Watanabe J, 2001, AM J CARDIOL, V88, P956, DOI 10.1016/S0002-9149(01)01969-5; Yip HK, 2004, CATHETER CARDIO INTE, V61, P503, DOI 10.1002/ccd.10685; Yip HK, 2003, AM J CARDIOL, V92, P1331, DOI 10.1016/j.amjcard.2003.08.019	50	423	467	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1063	1072		10.1001/jama.293.9.1063	http://dx.doi.org/10.1001/jama.293.9.1063			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LY	15741528	Bronze			2022-12-28	WOS:000227285200016
J	Kenyon, C				Kenyon, C			The plasticity of aging: Insights from long-lived mutants	CELL			English	Review							INSULIN-RECEPTOR SUBSTRATE; LIFE-SPAN EXTENSION; TRANSCRIPTION FACTOR FOXO3A; HEAT-SHOCK FACTOR; AGE-1 PI3 KINASE; C-ELEGANS DAF-16; FACTOR-I LEVELS; CAENORHABDITIS-ELEGANS; STRESS RESISTANCE; OXIDATIVE STRESS	Mutations in genes affecting endocrine signaling, stress responses, metabolism, and telomeres can all increase the life spans of model organisms. These mutations have revealed evolutionarily conserved pathways for aging, some of which appear to extend life span in response to sensory cues, caloric restriction, or stress. Many mutations affecting longevity pathways delay age-related disease, and the molecular analysis of these pathways is leading to a mechanistic understanding of how these two processesaging and disease susceptibility-are linked.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	Raskin, David/AAZ-5973-2021; Gimenez, Luis E Diaz/D-9291-2011	Raskin, David/0000-0001-7421-7809; Kenyon, Cynthia/0000-0003-3446-2636				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; BIELSCHOWSKY F, 1961, BRIT J CANCER, V15, P257, DOI 10.1038/bjc.1961.32; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROUGHTON S, 2005, IN PRESS P NATL ACAD; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Fabrizio P, 2003, GENETICS, V163, P35; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; FRIEDMAN DB, 1988, GENETICS, V118, P75; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Gems D, 1998, GENETICS, V150, P129; Gems D, 2000, GENETICS, V154, P1597; Gerisch B, 2004, DEVELOPMENT, V131, P1765, DOI 10.1242/dev.01068; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Joeng KS, 2004, NAT GENET, V36, P607, DOI 10.1038/ng1356; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirchman PA, 1999, GENETICS, V152, P179; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Ookuma S, 2003, CURR BIOL, V13, P427, DOI 10.1016/S0960-9822(03)00108-8; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ramsey MM, 2002, ENDOCRINOLOGY, V143, P4139, DOI 10.1210/en.2002-220717; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Riddle DL, 1997, C ELEGANS; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Sun JT, 2002, GENETICS, V161, P661; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200	135	979	1039	0	183	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					449	460		10.1016/j.cell.2005.02.002	http://dx.doi.org/10.1016/j.cell.2005.02.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734678	Bronze			2022-12-28	WOS:000227271500003
J	Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S				Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S			Oxygen ions observed near Saturn's A ring	SCIENCE			English	Article								Ions were detected in the vicinity of Saturn's A ring by the Ion and Neutral Mass Spectrometer (INMS) instrument onboard the Cassini Orbiter during the spacecraft's passage over the rings. The INMS saw signatures of molecular and atomic oxygen ions and of protons, thus demonstrating the existence of an ionosphere associated with the A ring. A likely explanation for these ions is photoionization by solar ultraviolet radiation of neutral O-2 molecules associated with a tenuous ring atmosphere. INMS neutral measurements made during the ring encounter are dominated by a background signal.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England	University of Kansas; University of Michigan System; University of Michigan; National Central University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Imperial College London	Cravens, TE (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	cravens@ku.edu	McNutt, Ralph L/E-8006-2010; Mueller-Wodarg, Ingo C. F./M-9945-2014	McNutt, Ralph L/0000-0002-4722-9166; Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826				[Anonymous], 1984, SATURN; COATES AJ, 1991, GEOPHYS MONOGR SER, V61, P301; CONNERNEY JEP, 1984, SATURN, P354; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HUEBNER WF, 1980, ASTROPHYS J, V238, P753, DOI 10.1086/158033; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; IP WH, 1983, NATURE, V302, P599, DOI 10.1038/302599a0; Johnson R.E., 1990, ENERGETIC CHARGED PA, DOI [10.1007/978-3-642-48375-2, DOI 10.1007/978-3-642-48375-2]; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; Kliore AJ, 1997, SCIENCE, V277, P355, DOI 10.1126/science.277.5324.355; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; LUHMANN JG, 1991, GEOPHYS MONOGR, V61, P5; WAITE JH, IN PRESS SPACE SCI R; WILSON GR, 1989, J GEOPHYS RES, P17287; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	16	54	54	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1260	1262		10.1126/science.1105734	http://dx.doi.org/10.1126/science.1105734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731442				2022-12-28	WOS:000227313200044
J	Oransky, I				Oransky, I			William Trager - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					748	748						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15779108				2022-12-28	WOS:000227285300012
J	Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA				Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA			Complement factor H variant increases the risk of age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; SUSCEPTIBILITY LOCI; GENOMEWIDE-SCAN; MACULOPATHY; DISEASE; ASSOCIATION; ACTIVATION; MEMBRANE; PATHWAY; COMMON	Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD. We used single-nucleotide polymorphisms to interrogate this region and identified a strongly associated haplotype in two independent data sets. DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant, Y402H, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This common variant likely explains similar to 43% of AMD in older adults.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Duke Univ Eye Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University; Vanderbilt University; Vanderbilt University; Duke University; Duke University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, DUMC Box 3445,595 LaSalle St, Durham, NC 27710 USA.	mpv@chg.duhs.duke.edu	Haines, Jonathan/C-3374-2012; Mohammed, Imran/J-8271-2012; Scott, William/A-7593-2009	Haines, Jonathan/0000-0002-4351-4728; Mohammed, Imran/0000-0002-8412-0768; Scott, William/0000-0001-9336-6404	NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NEI NIH HHS [EY015216, EY12118] Funding Source: Medline; NIA NIH HHS [AG11268] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012118, R03EY015216, U10EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; CDC (Cent. Dis. Control Prev.), 2004, MMWR-MORBID MORTAL W, V53, P1069; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; GURNE DH, 1991, OPHTHALMOLOGY, V98, P602; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; MOLD C, 1984, J IMMUNOL, V133, P882; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Oksjoki R, 2003, ARTERIOSCL THROM VAS, V23, P630, DOI 10.1161/01.ATV.0000057808.91263.A4; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476	22	1863	2017	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					419	421		10.1126/science.1110359	http://dx.doi.org/10.1126/science.1110359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761120				2022-12-28	WOS:000228492000055
J	Sharrock, NE; Finerty, E				Sharrock, NE; Finerty, E			Hip replacement, hip seeding, and epidural anaesthesia	LANCET			English	Editorial Material							BLADDER MANAGEMENT; ARTHROPLASTY; MORTALITY		Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; Hosp Special Surg, Dept Nursing, Infect Control & Occupat Hlth Serv, New York, NY 10021 USA		Sharrock, NE (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.	sharrockn@hss.edu						Gedney JA, 1998, ANAESTHESIA, V53, P1148, DOI 10.1046/j.1365-2044.1998.00636.x; Knight RM, 1996, J ARTHROPLASTY, V11, P882, DOI 10.1016/S0883-5403(96)80127-6; Macdowell AD, 2004, J BONE JOINT SURG BR, V86B, P1115, DOI 10.1302/0301-620X.86B8.14240; MICHELSON JD, 1988, NEW ENGL J MED, V319, P321; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Salvati EA, 2000, J BONE JOINT SURG AM, V82A, P252; SHARROCK NE, 1995, ANESTH ANALG, V80, P242, DOI 10.1097/00000539-199502000-00008; Sharrock NE, 2005, REGION ANESTH PAIN M, V30, P123, DOI 10.1016/j.rapm.2004.12.005; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Williams A, 1995, J ROY SOC MED, V88, pP699; Wong ES., 1981, GUIDELINE PREVENTION; WROBLEWSKI BM, 1980, CLIN ORTHOP RELAT R, P209	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1011	1012						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781083				2022-12-28	WOS:000227731800008
J	Hemberger, J; Lunkenheimer, P; Fichtl, R; von Nidda, HAK; Tsurkan, V; Loidl, A				Hemberger, J; Lunkenheimer, P; Fichtl, R; von Nidda, HAK; Tsurkan, V; Loidl, A			Relaxor ferroelectricity and colossal magnetocapacitive coupling in ferromagnetic CdCr2S4	NATURE			English	Article							SPINELS; POLARIZATION	Materials in which magnetic and electric order coexist - termed 'multiferroics' or 'magnetoelectrics' - have recently become the focus of much research(1-4). In particular, the simultaneous occurrence of ferromagnetism and ferroelectricity, combined with an intimate coupling of magnetization and polarization via magnetocapacitive effects, holds promise for new generations of electronic devices. Here we present measurements on a simple cubic spinel compound with unusual, and potentially useful, magnetic and electric properties: it shows ferromagnetic order coexisting with relaxor ferroelectricity ( a ferroelectric cluster state with a smeared-out phase transition), both having sizable ordering temperatures and moments. Close to the ferromagnetic ordering temperature, the magnetocapacitive coupling ( characterized by a variation of the dielectric constant in an external magnetic field) reaches colossal values, approaching 500 per cent. We attribute the relaxor properties to geometric frustration, which is well known for magnetic moments but here is found to impede long-range order of the structural degrees of freedom that drive the formation of the ferroelectric state.	Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86159 Augsburg, Germany; Moldavian Acad Sci, Inst Phys Appl, MD-2028 Kishinev, Moldova	University of Augsburg; Academy of Sciences of Moldova; Institute of Applied Physics - Moldova	Lunkenheimer, P (corresponding author), Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86159 Augsburg, Germany.	peter.lunkenheimer@physik.uni-augsburg.de	Hemberger, Joachim/D-3677-2018; Loidl, Alois/L-8199-2015; Lunkenheimer, Peter/C-6196-2008	Loidl, Alois/0000-0002-5579-0746; Lunkenheimer, Peter/0000-0002-4525-1394				AUSTIN IG, 1969, ADV PHYS, V18, P41, DOI 10.1080/00018736900101267; BALTZER PK, 1965, PHYS REV LETT, V15, P493, DOI 10.1103/PhysRevLett.15.493; CALLEN E, 1968, PHYS REV LETT, V20, P1045, DOI 10.1103/PhysRevLett.20.1045; Cao D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215902; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Fichtl R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.027601; Fritsch V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.116401; Gobel H., 1976, Journal of Magnetism and Magnetic Materials, V3, P143, DOI 10.1016/0304-8853(76)90025-1; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; GRIMES NW, 1972, PHILOS MAG, V26, P1217, DOI 10.1080/14786437208227375; HARBEKE G, 1966, PHYS REV LETT, V17, P1090, DOI 10.1103/PhysRevLett.17.1090; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI [10.1021/jp000114x, 10.1021/jpc00114x]; HOCHLI UT, 1990, ADV PHYS, V39, P405, DOI 10.1080/00018739000101521; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Kamba S, 2000, J PHYS-CONDENS MAT, V12, P497, DOI 10.1088/0953-8984/12/4/309; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; KNORR K, 1986, PHYS REV LETT, V57, P460, DOI 10.1103/PhysRevLett.57.460; LEHMANN HW, 1966, J APPL PHYS, V37, P1389, DOI 10.1063/1.1708485; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Lunkenheimer P, 2000, CONTEMP PHYS, V41, P15, DOI 10.1080/001075100181259; Lunkenheimer P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052105; MARTIN GW, 1969, J APPL PHYS, V40, P1015, DOI 10.1063/1.1657509; Ramirez AP, 2003, NATURE, V421, P483, DOI 10.1038/421483a; Ramirez AP., 2001, HDB MAGNETIC MAT, Vvol 13, P423, DOI DOI 10.1016/S1567-2719(01)13008-8; Samara GA, 2003, J PHYS-CONDENS MAT, V15, pR367, DOI 10.1088/0953-8984/15/9/202; Smolenskii G. A., 1982, Soviet Physics - Uspekhi, V25, P475, DOI 10.1070/PU1982v025n07ABEH004570; Verwey EJW, 1939, NATURE, V144, P327, DOI 10.1038/144327b0; WAKAMURA K, 1988, J APPL PHYS, V63, P5824, DOI 10.1063/1.340321	29	445	454	2	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					364	367		10.1038/nature03348	http://dx.doi.org/10.1038/nature03348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772656	Green Submitted			2022-12-28	WOS:000227715100046
J	Okie, S				Okie, S			What ails the FDA?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*FOOD DRUG ADM, CDER REP NAT 2003; *OFF INSP GEN, 2003, FDAS REV PROC NEW DR; VEDANTAM S, 2004, WASHINGTON POST 0810, pA6; 2004, FED REG, V69, P12162	4	55	55	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1063	1066		10.1056/NEJMp058003	http://dx.doi.org/10.1056/NEJMp058003			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784660				2022-12-28	WOS:000227655000001
J	Lemmon, MA				Lemmon, MA			Pleckstrin homology domains: Two halves make a hole?	CELL			English	Editorial Material								In a recent issue of Nature, van Rossum et al. report binding of a "split" pleckstrin homology (PH) domain from phospholipase C-gamma(1) to the TRPC3 ion channel. Through sequence analyses and in vitro studies, they suggest a novel mode of protein-protein interaction in which two PH domain fragments in distinct proteins associate to form an "intermolecular" PH domain that binds inositol phospholipids and is required for ion channel location and function.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.			Lemmon, Mark/0000-0002-3379-5319				Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	8	32	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					574	576		10.1016/j.cell.2005.02.023	http://dx.doi.org/10.1016/j.cell.2005.02.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766521	Bronze			2022-12-28	WOS:000227771400004
J	Stupp, R; Mason, WP; van den Bent, MJ; Weller, M; Fisher, B; Taphoorn, MJB; Belanger, K; Brandes, AA; Marosi, C; Bogdahn, U; Curschmann, J; Janzer, RC; Ludwin, SK; Gorlia, T; Allgeier, A; Lacombe, D; Cairncross, JG; Eisenhauer, E; Mirimanoff, RO; Van Den Weyngaert, D; Kaendler, S; Krauseneck, P; Vinolas, N; Villa, S; Wurm, RE; Maillot, MHB; Spagnolli, F; Kantor, G; Malhaire, JP; Renard, L; De Witte, O; Scandolaro, L; Vecht, CJ; Maingon, P; Lutterbach, J; Kobierska, A; Bolla, M; Souchon, R; Mitine, C; Tzuk-Shina, T; Kuten, A; Haferkamp, G; de Greve, J; Priou, F; Menten, J; Rutten, I; Clavere, P; Malmstrom, A; Jancar, B; Newlands, E; Pigott, K; Twijnstra, A; Chinot, O; Reni, M; Boiardi, A; Fabbro, M; Campone, M; Bozzino, J; Frenay, M; Gijtenbeek, J; Brandes, AA; Delattre, JY; Bogdahn, U; De Paula, U; van den Bent, MJ; Hanzen, C; Pavanato, G; Schraub, S; Pfeffer, R; Soffietti, R; Weller, M; Kortmann, RD; Taphoorn, M; Torrecilla, JL; Marosi, C; Grisold, W; Huget, P; Forsyth, P; Fulton, D; Kirby, S; Wong, R; Fenton, D; Fisher, B; Cairncross, G; Whitlock, P; Belanger, K; Burdette-Radoux, S; Gertler, S; Saunders, S; Laing, K; Siddiqui, J; Martin, LA; Gulavita, S; Perry, J; Mason, W; Thiessen, B; Pai, H; Alam, ZY; Eisenstat, D; Mingrone, W; Hofer, S; Pesce, G; Curschmann, J; Dietrich, PY; Stupp, R; Mirimanoff, RO; Thum, P; Baumert, B; Ryan, G				Stupp, R; Mason, WP; van den Bent, MJ; Weller, M; Fisher, B; Taphoorn, MJB; Belanger, K; Brandes, AA; Marosi, C; Bogdahn, U; Curschmann, J; Janzer, RC; Ludwin, SK; Gorlia, T; Allgeier, A; Lacombe, D; Cairncross, JG; Eisenhauer, E; Mirimanoff, RO; Van Den Weyngaert, D; Kaendler, S; Krauseneck, P; Vinolas, N; Villa, S; Wurm, RE; Maillot, MHB; Spagnolli, F; Kantor, G; Malhaire, JP; Renard, L; De Witte, O; Scandolaro, L; Vecht, CJ; Maingon, P; Lutterbach, J; Kobierska, A; Bolla, M; Souchon, R; Mitine, C; Tzuk-Shina, T; Kuten, A; Haferkamp, G; de Greve, J; Priou, F; Menten, J; Rutten, I; Clavere, P; Malmstrom, A; Jancar, B; Newlands, E; Pigott, K; Twijnstra, A; Chinot, O; Reni, M; Boiardi, A; Fabbro, M; Campone, M; Bozzino, J; Frenay, M; Gijtenbeek, J; Brandes, AA; Delattre, JY; Bogdahn, U; De Paula, U; van den Bent, MJ; Hanzen, C; Pavanato, G; Schraub, S; Pfeffer, R; Soffietti, R; Weller, M; Kortmann, RD; Taphoorn, M; Torrecilla, JL; Marosi, C; Grisold, W; Huget, P; Forsyth, P; Fulton, D; Kirby, S; Wong, R; Fenton, D; Fisher, B; Cairncross, G; Whitlock, P; Belanger, K; Burdette-Radoux, S; Gertler, S; Saunders, S; Laing, K; Siddiqui, J; Martin, LA; Gulavita, S; Perry, J; Mason, W; Thiessen, B; Pai, H; Alam, ZY; Eisenstat, D; Mingrone, W; Hofer, S; Pesce, G; Curschmann, J; Dietrich, PY; Stupp, R; Mirimanoff, RO; Thum, P; Baumert, B; Ryan, G		European Org Res Treatment Canc Br	Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY-ONCOLOGY-GROUP; MALIGNANT GLIOMA; RADIATION-THERAPY; POSTOPERATIVE TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PHASE-II; CHEMOTHERAPY; MULTIFORME; CARMUSTINE	BACKGROUND: Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety. METHODS: Patients with newly diagnosed, histologically confirmed glioblastoma were randomly assigned to receive radiotherapy alone (fractionated focal irradiation in daily fractions of 2 Gy given 5 days per week for 6 weeks, for a total of 60 Gy) or radiotherapy plus continuous daily temozolomide (75 mg per square meter of body-surface area per day, 7 days per week from the first to the last day of radiotherapy), followed by six cycles of adjuvant temozolomide (150 to 200 mg per square meter for 5 days during each 28-day cycle). The primary end point was overall survival. RESULTS: A total of 573 patients from 85 centers underwent randomization. The median age was 56 years, and 84 percent of patients had undergone debulking surgery. At a median follow-up of 28 months, the median survival was 14.6 months with radiotherapy plus temozolomide and 12.1 months with radiotherapy alone. The unadjusted hazard ratio for death in the radiotherapy-plus-temozolomide group was 0.63 (95 percent confidence interval, 0.52 to 0.75; P<0.001 by the log-rank test). The two-year survival rate was 26.5 percent with radiotherapy plus temozolomide and 10.4 percent with radiotherapy alone. Concomitant treatment with radiotherapy plus temozolomide resulted in grade 3 or 4 hematologic toxic effects in 7 percent of patients. CONCLUSIONS: The addition of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clinically meaningful and statistically significant survival benefit with minimal additional toxicity.	CHU Vaudois, Multidisciplinary Oncol Ctr, CH-1011 Lausanne, Switzerland; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Erasmus MC, Daniel den Hoed Oncol Ctr, Rotterdam, Netherlands; Univ Tubingen, Sch Med, Tubingen, Germany; Univ Western Ontario, London, ON, Canada; Univ Med Ctr, Utrecht, Netherlands; Ctr Hosp Univ, Hop Notre Dame, Montreal, PQ, Canada; Azienda Osped Univ, Padua, Italy; Med Univ Vienna, Vienna, Austria; Univ Kliniken Regensburg, Regensburg, Germany; Univ Bern, Inselspital, CH-3010 Bern, Switzerland; Queens Univ, Kingston, ON, Canada; European Org Res & Treatment Canc Data, Brussels, Belgium; Univ Calgary, Calgary, AB, Canada; Natl Canc Inst Canada Clin Trials Grp, Kingston, ON, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Eberhard Karls University of Tubingen; Western University (University of Western Ontario); Utrecht University; Utrecht University Medical Center; Universite de Montreal; University of Padua; Azienda Ospedaliera - Universita di Padova; Medical University of Vienna; University of Regensburg; University of Bern; Queens University - Canada; European Organisation for Research & Treatment of Cancer; University of Calgary; Queens University - Canada; Canadian Cancer Trials Group	Stupp, R (corresponding author), CHU Vaudois, Multidisciplinary Oncol Ctr, 46 Rue Bugnon, CH-1011 Lausanne, Switzerland.	roger.stupp@chuv.hospvd.ch	Baumert, Brigitta G./AAM-6549-2020; Soffietti, Riccardo/AAA-7965-2022; CHINOT, Olivier/M-9196-2018; Stupp, Roger/L-3303-2019; De Greve, Jacques/J-4939-2012; Reni, Michele/J-8296-2016; Eisenstat, David/AAA-4653-2020	Baumert, Brigitta G./0000-0001-8871-4654; Soffietti, Riccardo/0000-0002-9204-7038; CHINOT, Olivier/0000-0001-6317-9691; De Greve, Jacques/0000-0002-2389-0742; Reni, Michele/0000-0002-6463-0293; Weller, Michael/0000-0002-1748-174X; van den Bent, Martin/0000-0001-5710-5127; Brandes, Alba/0000-0002-2503-9089	NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER; NCI NIH HHS [5U10CA11488-30, 5U10CA11488-31, 5U10CA11488-32, 5U10CA11488-33, 5U10CA11488-34] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afra D, 2002, LANCET, V359, P1011; Armitage JO, 2003, J CLIN ONCOL, V21, P897, DOI 10.1200/JCO.2003.07.113; Ataman F, 2004, EUR J CANCER, V40, P1724, DOI 10.1016/j.ejca.2004.03.026; Brock CS, 1998, CANCER RES, V58, P4363; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; CHANG CH, 1983, CANCER, V52, P997, DOI 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; DEUTSCH M, 1989, INT J RADIAT ONCOL, V16, P1389, DOI 10.1016/0360-3016(89)90939-5; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; GREEN SB, 1983, CANCER TREAT REP, V67, P121; Grossman SA, 2003, J CLIN ONCOL, V21, P1485, DOI 10.1200/JCO.2003.10.035; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; KLEIHUES P, 2000, WHO CLASSIFICATION T, V1; Kovacs JA, 2000, NEW ENGL J MED, V342, P1416, DOI 10.1056/NEJM200005113421907; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; SHAPIRO WR, 1992, REV NEUROL-FRANCE, V148, P428; SHAPIRO WR, 1989, J NEUROSURG, V71, P1, DOI 10.3171/jns.1989.71.1.0001; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2001, LANCET ONCOL, V2, P552, DOI 10.1016/S1470-2045(01)00489-2; STUPP R, 2003, ASCO 2003 ED BOOK, P779; Thomas D, 2001, J CLIN ONCOL, V19, P509, DOI 10.1200/JCO.2001.19.2.509; Tolcher AW, 2003, BRIT J CANCER, V88, P1004, DOI 10.1038/sj.bjc.6600827; van Rijn J, 2000, INT J RADIAT ONCOL, V47, P779, DOI 10.1016/S0360-3016(99)00539-8; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wedge SR, 1997, ANTI-CANCER DRUG, V8, P92, DOI 10.1097/00001813-199701000-00013; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wick W, 2002, CANCER RES, V62, P1915; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316	35	13678	14142	46	1145	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					987	996		10.1056/NEJMoa043330	http://dx.doi.org/10.1056/NEJMoa043330			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758009	Green Published			2022-12-28	WOS:000227491200007
J	Kanagalingam, J; Hajioff, D; Bennett, S				Kanagalingam, J; Hajioff, D; Bennett, S			10-minute consultation - Vertigo	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Charing Cross Hosp, London W6 8RF, England; Prospect Med Practice, Norwich, Norfolk, England	Imperial College London	Kanagalingam, J (corresponding author), Charing Cross Hosp, London W6 8RF, England.	jeevekana@hotmail.com							0	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					523	523		10.1136/bmj.330.7490.523	http://dx.doi.org/10.1136/bmj.330.7490.523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746133	Green Published, Bronze			2022-12-28	WOS:000227581400021
J	Quam, L; Smith, R				Quam, L; Smith, R			US and UK health care: a special relationship? What can the UK and US health systems learn from each other?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KAISER-PERMANENTE; PROGRAM; NHS	The NHS and US insurance based health systems seem worlds apart. Despite the differences, each has much to learn from examples of good practice in the other.	UnitedHlth Europe, London SW1P 1SB, England; Ovations, Minneapolis, MN 55440 USA		Smith, R (corresponding author), UnitedHlth Europe, London SW1P 1SB, England.	Richard_S_Smith@uhc.com						*COMM QUAL HEALTHC, 1999, ERR IS HUM BUILD SAF; Committee on Quality of Healthcare in America, 2001, CROSS QUAL CHASM NEW; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; *GEN MED COUNC, 1998, GOOD MED PRACT; Ham C, 2003, BRIT MED J, V327, P1257, DOI 10.1136/bmj.327.7426.1257; Humber M, 2004, BRIT MED J, V328, P1145, DOI 10.1136/bmj.328.7449.1145; Murphy E, 2004, BMJ-BRIT MED J, V329, P1251, DOI 10.1136/bmj.329.7477.1251; Rawlins MD, 2004, NEW ENGL J MED, V351, P1383, DOI 10.1056/NEJMp048221; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Royal College of General Practitioners, 2002, GOOD MED PRACT GEN P; Senge P.M., 1993, 5 DISCIPLINE ART PRA; Talbot-Smith A, 2004, BRIT J GEN PRACT, V54, P415; Wanless, 2002, SECURING OUR FUTURE; 2002, BMJ, V324, P1332	15	17	17	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					530	533		10.1136/bmj.330.7490.530	http://dx.doi.org/10.1136/bmj.330.7490.530			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746136	Green Published			2022-12-28	WOS:000227581400024
J	Wang, PY; Weng, F; Anderson, RGW				Wang, PY; Weng, F; Anderson, RGW			OSBP is a cholesterol-regrulated scaffolding protein in control of ERK1/2 activation	SCIENCE			English	Article							OXYSTEROL-BINDING-PROTEIN; GOLGI LOCALIZATION; CELLS; PHOSPHORYLATION; EXPRESSION; MOTIF; VAP	Oxysterol-binding protein (OSBP) is the founding member of a family of sterol-binding proteins implicated in vesicle transport, lipid metabolism, and signal transduction. Here, OSBP was found to function as a cholesterol-binding scaffolding protein coordinating the activity of two phosphatases to control the extracellular signal-regulated kinase (ERK) signaling pathway. Cytosolic OSBP formed a similar to440-kilodalton oligomer with a member of the PTPPBS family of tyrosine phosphatases, the serine/threonine phosphatase PP2A, and cholesterol. This oligomer had dual specific phosphatase activity for phosphorylated ERK (pERK). When cell cholesterol was lowered, the oligomer disassembled and the level of pERK rose. The oligomer also disassembled when exposed to oxysterols. Increasing the amount of OSBP oligomer rendered cells resistant to the effects of cholesterol depletion and decreased the basal level of pERK. Thus, cholesterol functions through its interaction with OSBP outside of membranes to regulate the assembly of an oligomeric phosphatase that controls a key signaling pathway in the cell.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Anderson, RGW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	richard.anderson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 52016] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ares MPS, 2000, ATHEROSCLEROSIS, V153, P23, DOI 10.1016/S0021-9150(00)00380-4; Augustine KA, 2000, ANAT REC, V258, P221, DOI 10.1002/(SICI)1097-0185(20000301)258:3<221::AID-AR1>3.0.CO;2-W; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mohammadi A, 2001, J LIPID RES, V42, P1062; Munro S, 2003, NATURE, V426, P775, DOI 10.1038/426775a; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yoon JH, 2004, HEPATOLOGY, V39, P732, DOI 10.1002/hep.20125	13	222	236	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1472	1476		10.1126/science.1107710	http://dx.doi.org/10.1126/science.1107710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746430				2022-12-28	WOS:000227503100049
J	King, M; Nazareth, I; Lampe, F; Bower, P; Chandler, M; Morou, M; Sibbald, B; Lai, R				King, M; Nazareth, I; Lampe, F; Bower, P; Chandler, M; Morou, M; Sibbald, B; Lai, R			Impact of participant and physician intervention preferences on randomized trials - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SURGICAL VACUUM ASPIRATION; COGNITIVE-BEHAVIOR THERAPY; GENERAL-PRACTITIONER CARE; PATIENT PREFERENCE; MEDICAL ABORTION; CLINICAL-TRIALS; NONRANDOMIZED PATIENTS; FOLLOW-UP; DEPRESSION; EFFICACY	Context Allocation on the basis of randomization rather than patient choice is the gold standard of unbiased estimates of efficacy in clinical medicine. However, randomly allocating patients to treatments that do not accord with their preferences may influence internal and external validity. Objective To determine whether preferences affect recruitment to trials (external validity) and outcomes in trials (internal validity) Data Sources We searched MEDLINE, EMBASE, PsycINFO, CINAHL, AMED, and the Cochrane Library for articles published between 1966 and September 2004. We also hand-searched several major medical journals, searched reference lists of relevant articles, and contacted authors of published preference designs. The 2 themes in the first filter of the search strategy were preferences and possible determinants of preferences. Study Selection Comprehensive cohorts and 2-stage trials that measured or recorded patient or physician preference, included allocation of participants to random and preference cohorts, and followed up all participants. We excluded trials with no recording of preference; of decision aids; with measurements of preferences for economic analyses; in which patients who refused randomization were followed up without reference to preferences; and of nonclinical populations. Data Extraction Up to 4 reviewers independently evaluated the articles, and disagreements were resolved at project steering group meetings. We extracted data on study design, measurement of preference, recruitment, attrition, and summary data on the primary outcome(s) at baseline and each follow-up point. Data Synthesis Of 10023 citations identified, 170 articles met screening criteria and 32 (27 comprehensive cohorts and 5 two-stage trials) were determined to be eligible and were used in the final review. Although treatment preferences led to a substantial proportion of people refusing randomization, there was less evidence of bias in the characteristics of individuals agreeing to be randomized. Differences in outcome across the trials between randomized and preference groups were generally small, particularly in large trials and after accounting for baseline measures of outcome. Therefore, there was little evidence that preferences substantially interfere with the internal validity of randomized trials. Conclusions Preferences influence whether people participate in randomized trials, but there is little evidence that they significantly affect validity.	UCL Royal Free & Univ Coll Med Sch, Dept Mental Hlth Sci, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Med Lib, London NW3 2PF, England; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of Manchester	King, M (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Mental Hlth Sci, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	m.king@medsch.ucl.ac.uk	King, Michael B/D-7477-2011; Lampe, Fiona/I-5826-2019; Bower, Peter/A-1508-2011	King, Michael B/0000-0003-4715-7171; Lampe, Fiona/0000-0001-6851-5471; Bower, Peter/0000-0001-9558-3349; Nazareth, Irwin/0000-0003-2146-9628				[Anonymous], 1984, J AM COLL CARDIOL, V3, P114; Ashok PW, 2002, HUM REPROD, V17, P92, DOI 10.1093/humrep/17.1.92; Bain C, 2001, GYNAECOL ENDOSC, V10, P223, DOI 10.1046/j.1365-2508.2001.00457.x; Bakker A, 1999, J CLIN PSYCHIAT, V60, P831, DOI 10.4088/JCP.v60n1205; Bedi N, 2000, BRIT J PSYCHIAT, V177, P312, DOI 10.1192/bjp.177.4.312; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Chilvers C, 2001, BMJ-BRIT MED J, V322, P772, DOI 10.1136/bmj.322.7289.772; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook T.D., 1979, QUASIEXPERIMENTATION; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1360, DOI 10.1111/j.1471-0528.1997.tb11004.x; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1367, DOI 10.1111/j.1471-0528.1997.tb11005.x; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; GOSSOP M, 1986, BRIT MED J, V293, P103, DOI 10.1136/bmj.293.6539.103; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; HENSHAW RC, 1993, BRIT MED J, V307, P714, DOI 10.1136/bmj.307.6906.714; HENSHAW RC, 1994, HUM REPROD, V9, P2167, DOI 10.1093/oxfordjournals.humrep.a138412; Hitchcock P, 1998, DIABETES CARE, V21, P896, DOI 10.2337/diacare.21.6.896; Howie FL, 1997, BRIT J OBSTET GYNAEC, V104, P829, DOI 10.1111/j.1471-0528.1997.tb12028.x; Janevic MR, 2003, SOC SCI MED, V56, P1581, DOI 10.1016/S0277-9536(02)00158-2; Jensen L, 2003, J BONE MINER RES, V18, P333, DOI 10.1359/jbmr.2003.18.2.333; Kendrick D, 2001, Health Technol Assess, V5, P1; KERRY S, 2000, HLTH TECHNOL ASSESS, V4; KING M, 2000, HEALTH TECHNOL ASSES, V4, P19; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KINGSMORE SF, 1995, IMMUNOGENETICS, V42, P59, DOI 10.1007/BF00164988; Kitchener HC, 2004, BJOG-INT J OBSTET GY, V111, P63, DOI 10.1046/j.1471-0528.2003.00007.x; Maor Y, 2001, J CLIN EPIDEMIOL, V54, P565, DOI 10.1016/S0895-4356(00)00338-3; McKay JR, 1998, J CONSULT CLIN PSYCH, V66, P697, DOI 10.1037/0022-006X.66.4.697; MCKAY JR, 1995, J CONSULT CLIN PSYCH, V63, P70, DOI 10.1037/0022-006X.63.1.70; Melchart D, 2002, J ALTERN COMPLEM MED, V8, P265, DOI 10.1089/10755530260127952; *NHS CTR REV DISS, 2001, CTR REV DISS GUID TH; NICOLAIDES K, 1994, LANCET, V344, P435, DOI 10.1016/S0140-6736(94)91769-8; OLSCHEWSKI M, 1992, CONTROL CLIN TRIALS, V13, P226, DOI 10.1016/0197-2456(92)90005-K; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; PARADISE JL, 1990, JAMA-J AM MED ASSOC, V263, P2066, DOI 10.1001/jama.263.15.2066; Pawson R., 1997, REALISTIC EVALUATION; Reddihough DS, 1998, DEV MED CHILD NEUROL, V40, P763; Riedl S, 2001, CHIRURG, V72, P1160, DOI 10.1007/s001040170055; Rokke PD, 1999, PSYCHOL AGING, V14, P155, DOI 10.1037/0882-7974.14.1.155; Rovers MM, 2001, J CLIN EPIDEMIOL, V54, P789, DOI 10.1016/S0895-4356(01)00340-7; ROVERS MM, 2000, THESIS, V1, P2; RUCKER G, 1989, STAT MED, V8, P477, DOI 10.1002/sim.4780080411; Schmoor C, 1996, STAT MED, V15, P263, DOI 10.1002/(SICI)1097-0258(19960215)15:3<263::AID-SIM165>3.0.CO;2-K; SCHUMACHER M, 1994, J CLIN ONCOL, V12, P2086, DOI 10.1200/JCO.1994.12.10.2086; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383; WENNBERG JE, 1993, ANN NY ACAD SCI, V703, P52, DOI 10.1111/j.1749-6632.1993.tb26335.x; Williams ACC, 1999, PAIN, V83, P57, DOI 10.1016/S0304-3959(99)00074-3; Woodward J, 2004, BJOG-INT J OBSTET GY, V111, P537, DOI 10.1111/j.1471-0528.2004.00132.x	53	198	199	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2005	293	9					1089	1099		10.1001/jama.293.9.1089	http://dx.doi.org/10.1001/jama.293.9.1089			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LY	15741531				2022-12-28	WOS:000227285200019
J	Eerenstein, W; Morrison, FD; Dho, J; Blamire, MG; Scott, JF; Mathur, ND				Eerenstein, W; Morrison, FD; Dho, J; Blamire, MG; Scott, JF; Mathur, ND			Comment on "Epitaxial BiFeO3 multiferroic thin film heterostructures"	SCIENCE			English	Editorial Material							FERROELECTRICITY		Univ Cambridge, Dept Mat Sci, Cambridge CB2 3QZ, England; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge; University of Cambridge	Eerenstein, W (corresponding author), Univ Cambridge, Dept Mat Sci, Pembroke St, Cambridge CB2 3QZ, England.	we212@cam.ac.uk	Morrison, Finlay D/C-4214-2008	Morrison, Finlay D/0000-0002-2813-3142				Ederer C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060401; Garg A, 2000, INTEGR FERROELECTR, V31, P13, DOI 10.1080/10584580008215636; Gruverman A, 1998, ANNU REV MATER SCI, V28, P101, DOI 10.1146/annurev.matsci.28.1.101; Kiselev SV, 1963, SOV PHYS DOKL, V7, P742; Kumar MM, 2000, APPL PHYS LETT, V76, P2764, DOI 10.1063/1.126468; Neaton JB, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014113; SASNOVSKA I, 1982, J PHYS C SOLID STATE, V15, P4835; SchedelNiedrig T, 1995, PHYS REV B, V52, P17449, DOI 10.1103/PhysRevB.52.17449; Scott J.F., 2000, FERROELECTRIC MEMORI; SMOLENSKII GA, 1963, SOV PHYS JETP-USSR, V16, P622; TEAGUE JR, 1970, SOLID STATE COMMUN, V8, P1073, DOI 10.1016/0038-1098(70)90262-0; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Yun KY, 2003, APPL PHYS LETT, V83, P3981, DOI 10.1063/1.1626267; Zafar S, 1998, APPL PHYS LETT, V73, P175, DOI 10.1063/1.121746	14	515	523	8	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1203	1203		10.1126/science.1105422	http://dx.doi.org/10.1126/science.1105422			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731427				2022-12-28	WOS:000227313200024
J	Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J				Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J			Dynamics of Saturn's magnetosphere from MIMI during Cassini's orbital insertion	SCIENCE			English	Article							NITROGEN TORI; HOT PLASMA; PARTICLES; INNER; GAS	The Magnetospheric Imaging Instrument (MIMI) onboard the Cassini spacecraft observed the saturnian magnetosphere from January 2004 until Saturn orbit insertion (Sol) on 1 July 2004. The MIMI sensors observed frequent energetic particle activity in interplanetary space for several months before Sol. When the imaging sensor was switched to its energetic neutral atom (ENA) operating mode on 20 February 2004, at similar to10(3) times Saturn's radius R-s (0.43 astronomical units), a weak but persistent signal was observed from the magnetosphere. About 10 days before Sol, the magnetosphere exhibited a day-night asymmetry that varied with an similar to 11-hour periodicity. Once Cassini entered the magnetosphere, in situ measurements showed high concentrations of H+, H-2(+), O+, OH+, and H2O+ and low concentrations of N+. The radial dependence of ion intensity profiles implies neutral gas densities sufficient to produce high loss rates of trapped ions from the middle and inner magnetosphere. ENA imaging has revealed a radiation belt that resides inward of the D ring and is probably the result of double charge exchange between the main radiation belt and the upper layers of Saturn's exosphere.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Lindau, Germany; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; Fundamental Technol Inc, Lawrence, KS 66049 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; Natl Cent Univ, Grad Inst Astron, Jhongli City, Peoples R China; Bell Labs, Murray Hill, NJ 07974 USA; New Jersey Inst Technol, Newark, NJ 07102 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; AT&T; New Jersey Institute of Technology	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Dandouras, Iannis/V-2709-2017; Mitchell, Donald G/H-4601-2016; Brandt, Pontus C/N-1218-2016; Saur, Joachim/V-6780-2019; Mauk, Barry H/E-8420-2017; Korpi-Lagg, Andreas/W-8166-2019; Paranicas, Christopher/B-1470-2016; Krimigis, Stamatios/G-4591-2019; Roelof, Edmond/G-6654-2019; Kusterer, Martha/AAE-5505-2021; Bolton, Scott/M-4392-2019	Dandouras, Iannis/0000-0002-7121-1118; Mitchell, Donald G/0000-0003-1960-2119; Brandt, Pontus C/0000-0002-4644-0306; Saur, Joachim/0000-0003-1413-1231; Mauk, Barry H/0000-0001-9789-3797; Korpi-Lagg, Andreas/0000-0003-1459-7074; Paranicas, Christopher/0000-0002-4391-8255; Krimigis, Stamatios/0000-0003-2781-2386; Roelof, Edmond/0000-0002-2270-0652; bolton, scott/0000-0002-9115-0789; Turner, Franklin/0000-0002-7935-7621; Kusterer, Martha/0000-0002-7943-1852; Manweiler, Jerry/0000-0002-8800-2128; Hamilton, Douglas/0000-0001-6103-8019				CHENG AF, 1989, OUTSTANDING PROBLEMS, P253; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; EVIATAR A, 1983, J GEOPHYS RES-SPACE, V88, P833, DOI 10.1029/JA088iA02p00833; FILLIUS W, 1980, SCIENCE, V207, P425, DOI 10.1126/science.207.4429.425; GLOECKLER G, 2001, S-P B ASTROPHYS, P287; IP WH, 1992, ADV SPACE RES-SERIES, V12, P73, DOI 10.1016/0273-1177(92)90379-C; KIRSCH E, 1981, NATURE, V292, P718, DOI 10.1038/292718a0; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; KRIMIGIS SM, 1982, SCIENCE, V215, P571, DOI 10.1126/science.215.4532.571; KRIMIGIS SM, 1981, SCIENCE, V212, P225, DOI 10.1126/science.212.4491.225; KRIMIGIS SM, 1983, J GEOPHYS RES-SPACE, V88, P8871, DOI 10.1029/JA088iA11p08871; KRIMIGIS SM, 2004, 36 DIV PLAN SCI M LO; Mauk BH, 1999, J GEOPHYS RES-SPACE, V104, P22759, DOI 10.1029/1999JA900097; Mitchell DG, 2001, GEOPHYS RES LETT, V28, P1151, DOI 10.1029/2000GL012395; Moritz J., 1972, Zeitschrift fur Geophysik, V38, P701; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; ROELOF EC, 1985, J GEOPHYS RES-SPACE, V90, P991, DOI 10.1029/JA090iA11p10991; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; VANALLEN JA, 1980, SCIENCE, V207, P415, DOI 10.1126/science.207.4429.415	20	154	154	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1270	1273		10.1126/science.1105978	http://dx.doi.org/10.1126/science.1105978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731445				2022-12-28	WOS:000227313200047
J	Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ				Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ			The restoration potential of the Mesopotamian marshes of Iraq	SCIENCE			English	Article							SELENIUM; ENVIRONMENT; RIVER	Uncontrolled releases of Tigris and Euphrates River waters after the 2003 war have partially restored some former marsh areas in southern Iraq, but restoration is failing in others because of high soil and water salinities. Nearly 20% of the original 15,000-square-kilometer marsh area was reflooded by March 2004, but the extent of marsh restoration is unknown. High-quality water, nonsaline soils, and the densest native vegetation were found in the only remaining natural marsh, the Al-Hawizeh, located on the Iranian border. Although substantially reduced in area and under current threat of an Iranian dike, it has the potential to be a native repopulation center for the region. Rapid reestablishment, high productivity, and reproduction of native flora and fauna in reflooded former marsh areas indicate a high probability for successful restoration, provided the restored wetlands are hydraulically designed to allow sufficient flow of noncontaminated water and flushing of salts through the ecosystem.	Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Res Triangle Pk, NC 27709 USA; Dev Alternat, Bethesda, MD 20895 USA; Univ Basra, Coll Sci, Basra, Iraq; Iraq Fdn, Washington, DC 20005 USA; Int Resources Grp, Washington, DC 20036 USA	Duke University; University of Basrah	Richardson, CJ (corresponding author), Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Box 80333, Res Triangle Pk, NC 27709 USA.	curtr@duke.edu	Richardson, Curt/P-5905-2019; Richardson, Curtis J/A-8202-2009					Al-Mousawi AHA, 1983, ARAB GULF J SCI RES, V1, P237; ALHILLI MR, 1977, THESIS U CAIRO; BANAT KM, IN PRESS J ARID ENV; BRASINGTON J, 2002, IRAQI MARSHLANDS HUM, P151; Buringh P., 1960, SOILS SOIL CONDITION; DOUABUL AA, 1988, ARCH ENVIRON CON TOX, V17, P405, DOI 10.1007/BF01055178; ELDEMERDASH MA, 1994, VEGETATIO, V112, P141, DOI 10.1007/BF00044688; EVANS MI, 2002, IRAQI MARSHLANDS HUM, P201; Farber E, 2004, GEOCHIM COSMOCHIM AC, V68, P1989, DOI 10.1016/j.gca.2003.09.021; HUSSAIN NA, 1992, AHWAR IRAQ ENV APPRO; *IR FDN, 2003, ED AG INT TECHN ADV; Lemly AD, 1999, HUM ECOL RISK ASSESS, V5, P1139, DOI 10.1080/10807039.1999.10518883; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; LEMLY AD, 1985, ECOTOX ENVIRON SAFE, V10, P314; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Maas E. V., 1999, Agricultural drainage., P55; Maltby E, 1994, DRAFT CONSULTIVE B; MAULOOD BK, 1981, HYDROBIOLOGIA, V80, P269, DOI 10.1007/BF00018367; Meyerson L. A., 2000, Wetlands Ecology and Management, V8, P89, DOI 10.1023/A:1008432200133; Nicholson E., 2003, IRAQI MARSHLANDS HUM; PARTOW H, 2001, UNEP PUBLICATION; RICHARDS LA, 1954, AGR HDB USDA, V60; Saeed T, 1999, WATER SCI TECHNOL, V40, P89, DOI 10.2166/wst.1999.0335; Salim S.M., 1962, MARSH DWELLERS EUPHR; Serag MS, 2001, ENVIRONMETRICS, V12, P219, DOI 10.1002/env.458; Thesinger W, 1964, MARSH ARABS; UNEP, 2003, ENV IR UNEP PROGR RE; YOUNG G, 1977, RETURN MARSHES LIFE	28	92	106	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1307	1311		10.1126/science.1105750	http://dx.doi.org/10.1126/science.1105750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731454				2022-12-28	WOS:000227313200058
J	Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP				Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP			Nicotinic acid limitation regulates silecing of Candida adhesins during UTI	SCIENCE			English	Article							ESCHERICHIA-COLI; GENE FAMILY; GLABRATA; DEACETYLASE; METABOLISM; EVOLUTION; CHROMATIN	The adherence of Candida glabrata to host cells is mediated, at least in part, by the EPA genes, a family of adhesins encoded at subtelomeric loci, where they are subject to transcriptional silencing. We show that normally silent EPA genes are expressed during murine urinary tract infection (UTI) and that the inducing signal is the limitation of nicotinic acid (NA), a precursor of nicotinamide adenine dinucleotide (NAD(+)). C. glabrata is an NA auxotroph, and NA-induced EPA expression is likely the result of a reduction in NAD(+) availability for the NAD(+)-dependent histone deacetylase Sir2p. The adaptation of C. glabrata to the host, therefore, involves a loss of metabolic capacity and exploitation of the resulting auxotrophy to signal a particular host environment.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Dept Vet Affairs, Res Serv, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Cormack, BP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	bcormack@jhmi.edu	De Las Penas, Alejandro/M-7719-2013	De Las Penas, Alejandro/0000-0002-2933-2856; Castano, Irene/0000-0002-5968-2101	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049720] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI46223] Funding Source: Medline; NIDDK NIH HHS [2PO1DK49720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; DAI J, UNPUB; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fukuwatari T, 2004, BIOSCI BIOTECH BIOCH, V68, P44, DOI 10.1271/bbb.68.44; Guarente L, 2000, GENE DEV, V14, P1021; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; KUNIN CM, 1993, J CLIN MICROBIOL, V31, P47, DOI 10.1128/JCM.31.1.47-49.1993; LIDIA Do CARMO-SOUSA, 1969, The yeasts. Vol. I. Biology of yeasts., P79; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; ROBESON JP, 1980, NATURE, V283, P104, DOI 10.1038/283104a0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; VANPILSUN J, 1974, BIOL DATA BOOK, P1496; Vazquez JA, 1999, CLIN INFECT DIS, V28, P1025, DOI 10.1086/514746	27	204	219	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					866	870		10.1126/science.1108640	http://dx.doi.org/10.1126/science.1108640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774723				2022-12-28	WOS:000228986500052
J	Bruno, S; Maisonneuve, P; Castellana, P; Rotmensz, N; Rossi, S; Maggioni, M; Persico, M; Colombo, A; Monasterolo, F; Casadei-Giunchi, D; Desiderio, F; Stroffolini, T; Sacchini, V; Decensi, A; Veronesi, U				Bruno, S; Maisonneuve, P; Castellana, P; Rotmensz, N; Rossi, S; Maggioni, M; Persico, M; Colombo, A; Monasterolo, F; Casadei-Giunchi, D; Desiderio, F; Stroffolini, T; Sacchini, V; Decensi, A; Veronesi, U		Italian Tamoxifen Study Grp	Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FATTY LIVER-DISEASE; BREAST-CANCER; HEPATIC STEATOSIS; NATURAL-HISTORY; PREVENTION; FIBROSIS; FREQUENCY; CIRRHOSIS; SPECTRUM	Objective To assess the incidence, cofactors, and excess risk of development of non-alcoholic fatty liver disease, including non-alcoholic steatohepatitis, attributable to tamoxifen in women. Design Prospective, randomised, double blind, placebo controlled trial. Setting and participants 5408 healthy women who had had hysterectomies recruited into the Italian tamoxifen chemoprevention trial from 58 centres in Italy. Intervention Women were randomly assigned to receive tamoxifen (20 mg daily) or placebo for five years. Main outcome measure Development of non-alcoholic fatty liver disease in all women with normal baseline liver function who showed at least two elevations of alanine amino transferase ( >= 1.5 times upper limit of normal) over a six month period. Results During follow up, 64 women met the predefined criteria: 12 tested positive for hepatitis C virus, and the remaining 52 were suspected of having developed non-alcoholic fatty liver disease (34 tamoxifen, 18 placebo)-hazard ratio = 2.0 (95% confidence interval 1.1 to 3.5; P = 0.04). In all 52 women ultrasonography confirmed the presence of fatty liver. Other factors associated with the development of non-alcoholic fatty liver disease included overweight (2.4, 1.2 to 4.8), obesity (3.6, 1.7 to 7.6), hypercholesterolaemia (3.4, 1.4 to 7.8), and arterial hypertension (2.0, 1.0 to 3.8). Twenty women had liver biopsies: 15 were diagnosed as having mild to moderate steatohepatitis (12 tamoxifen, 3 placebo), and five had fatty liver alone (I tamoxifen, 4 placebo). No clinical, biochemical, ultrasonic, or histological signs suggestive of progression to cirrhosis were observed after a median follow up of 8.7 years. Conclusions Tamoxifen was associated with higher risk of development of non-alcoholic steatohepatitis only in overweight and obese women with features of metabolic syndrome, but the disease, in both the tamoxifen and the placebo group, after 10 years of follow-up seems to be indolent.	Azienda Osped Fatebenefratelli & Oftalmico, Liver Unit, I-20121 Milan, Italy; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; European Inst Oncol, Epidemiol Unit, Milan, Italy; European Inst Oncol, Data Qual Control Unit, Milan, Italy; European Inst Oncol, Chemoprevent Unit, Milan, Italy; European Inst Oncol, Breast Dept, Milan, Italy; Univ Milan, Azienda Osped San Paolo, Dept Internal Med, Milan, Italy; Univ Milan, Azienda Osped San Paolo, Dept Pathol, Milan, Italy; Univ Naples Federico II, Dept Internal Med 2A, Naples, Italy; Azienda Osped Sant Anna, Liver Unit, Como, Italy; Casa Cura Citta Bra, Bra, Italy; Osped GB Morgagni, Forli, Italy; Osped Infermi, Rimini, Italy; Osped San Giacomo Augusta, Gastroenterol Unit, Rome, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; University of Naples Federico II; Ospedale Sant'Anna di Como; Hospital of Rimini	Bruno, S (corresponding author), Azienda Osped Fatebenefratelli & Oftalmico, Liver Unit, Corso Porta Nuova 23, I-20121 Milan, Italy.	Italysavino.bruno@fbf.milano.it	Maisonneuve, Patrick/U-9789-2018; persico, marcello/AAB-3562-2019; DeCensi, Andrea/AEF-2941-2022	Maisonneuve, Patrick/0000-0002-5309-4704; DeCensi, Andrea/0000-0003-2635-4491; Persico, Marcello/0000-0002-1399-6498; Maggioni, Marco/0000-0001-8603-8998; Bruno, Savino/0000-0002-3887-864X				Adams LA, 2003, HEPATOLOGY, V38, p206A; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Charlton M, 2001, LIVER TRANSPLANT, V7, P608, DOI 10.1053/jlts.2001.25453; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Laine F, 2004, HEPATOLOGY, V39, P1639, DOI 10.1002/hep.20219; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Nishino M, 2003, AM J ROENTGENOL, V180, P129, DOI 10.2214/ajr.180.1.1800129; Oien KA, 1999, LANCET, V353, P36, DOI 10.1016/S0140-6736(05)74872-8; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; PRATT DS, 1995, ANN INTERN MED, V123, P236, DOI 10.7326/0003-4819-123-3-199508010-00018; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; VanHoof M, 1996, ANN INTERN MED, V124, P855, DOI 10.7326/0003-4819-124-9-199605010-00015; VANNESS MM, 1989, ANN INTERN MED, V111, P473, DOI 10.7326/0003-4819-111-6-473; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 1995, BREAST, V4, P267, DOI 10.1016/S0960-9776(95)80002-6; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Yano E, 2001, J CLIN EPIDEMIOL, V54, P945, DOI 10.1016/S0895-4356(01)00355-9	24	153	157	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					932	935		10.1136/bmj.38391.663287.E0	http://dx.doi.org/10.1136/bmj.38391.663287.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15746106	Green Published, Bronze			2022-12-28	WOS:000228715900018
J	Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR				Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR			Evolution of oxygen secretion in fishes and the emergence of a complex physiological system	SCIENCE			English	Article							STRUCTURAL BASIS; MEMBRANE-TRANSPORT; HEMOGLOBIN; ERYTHROCYTES; AFFINITY; MECHANISM; TELEOST; BLOOD; EYE	We have reconstructed the events that led to the evolution of a key physiological innovation underpinning the large adaptive radiation of fishes, namely their unique ability to secrete molecular oxygen (O-2). We show that O-2 secretion into the swimbladder evolved some 100 million years after another O-2-secreting system in the eye. We unravel the likely sequence in which the functional components of both systems evolved. These components include ocular and swimbladder countercurrent exchangers, the Bohr and Root effects, the buffering power and surface histidine content of hemoglobins, and red blood cell Na+/H+ exchange activity. Our synthesis reveals the dynamics of gains and losses of these multiple traits over time, accounting for part of the huge diversity of form and function in living fishes.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Humboldt Univ, Dept Anim Physiol, D-10115 Berlin, Germany	University of Liverpool; Humboldt University of Berlin	Berenbrink, M (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	michaelb@liv.ac.uk	Berenbrink, Michael/W-7519-2019; Kepp, Oliver/N-2763-2017; Kepp, Oliver/GPX-8627-2022	Kepp, Oliver/0000-0002-6081-9558; Cossins, Andrew/0000-0002-0813-5212				ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; Berenbrink M, 2000, J PHYSIOL-LONDON, V526, P69, DOI 10.1111/j.1469-7793.2000.t01-1-00069.x; Bohr C, 1894, J Physiol, V15, P494; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; FAIRBANKS MB, 1974, J GEN PHYSIOL, V64, P263, DOI 10.1085/jgp.64.3.263; Fang TY, 1999, BIOCHEMISTRY-US, V38, P13423, DOI 10.1021/bi9911379; FARMER M, 1979, COMP BIOCHEM PHYS A, V62, P109, DOI 10.1016/S0300-9629(79)80004-3; FONNER DB, 1973, COMP BIOCHEM PHYSIOL, V46, P559, DOI 10.1016/0300-9629(73)90107-2; GILLEN RG, 1977, ARCH BIOCHEM BIOPHYS, V183, P678, DOI 10.1016/0003-9861(77)90401-5; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; Heisler N., 1986, P397; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; JENSEN FB, 1989, J EXP BIOL, V143, P225; KILLMARTIN JV, 1976, BR MED B, V32, P209; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; MOTAIS R, 1987, J GEN PHYSIOL, V90, P197, DOI 10.1085/jgp.90.2.197; Nikinmaa M, 1997, J EXP BIOL, V200, P369; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; Pelster B, 1998, FISH RESP, P113; Perutz MF, 1996, NAT STRUCT BIOL, V3, P211, DOI 10.1038/nsb0396-211; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402; WITTENBERG JB, 1962, NATURE, V194, P106, DOI 10.1038/194106a0; Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200	28	170	176	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1752	1757		10.1126/science.1107793	http://dx.doi.org/10.1126/science.1107793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774753				2022-12-28	WOS:000227883900038
J	Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR				Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR		Rabies Transplant Recipients Inves	Transmission of rabies virus from an organ donor to four transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORTHOTOPIC LIVER-TRANSPLANTATION; ARTERIAL REVASCULARIZATION; UNITED-STATES; EPIDEMIOLOGY; PREVENTION; CONDUITS; DEATHS; GRAFTS	BACKGROUND: In 2004, four recipients of kidneys, a liver, and an arterial segment from a common organ donor died of encephalitis of an unknown cause. METHODS: We reviewed the medical records of the organ donor and the recipients. Blood, cerebrospinal fluid, and tissues from the recipients were tested with a variety of assays and pathological stains for numerous causes of encephalitis. Samples from the recipients were also inoculated into mice. RESULTS: The organ donor had been healthy before having a subarachnoid hemorrhage that led to his death. Encephalitis developed in all four recipients within 30 days after transplantation and was accompanied by rapid neurologic deterioration characterized by agitated delirium, seizures, respiratory failure, and coma. They died an average of 13 days after the onset of neurologic symptoms. Mice inoculated with samples from the affected patients became ill seven to eight days later, and electron microscopy of central nervous system (CNS) tissue demonstrated rhabdovirus particles. Rabies-specific immunohistochemical and direct fluorescence antibody staining demonstrated rabies virus in multiple tissues from all recipients. Cytoplasmic inclusions consistent with Negri bodies were seen in CNS tissue from all recipients. Antibodies against rabies virus were present in three of the four recipients and the donor. The donor had told others of being bitten by a bat. CONCLUSIONS: This report documenting the transmission of rabies virus from an organ donor to multiple recipients underscores the challenges of preventing and detecting transmission of unusual pathogens through transplantation.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv Branch, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Baylor Univ, Med Ctr, Dallas, TX USA; Texas Dept State Hlth Serv, Austin, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Baylor University; Baylor University Medical Center; Texas Department of State Health Services	Srinivasan, A (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Rupprecht, Charles/AAI-1544-2020; Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541				ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; Awasthi M, 2001, AM J NEURORADIOL, V22, P677; BLECK TP, 2000, PRINCIPLES PRACTICE, P1811; DOE J, 2000, MMWR RECOMM REP, V49, P737; DOE J, 1999, MMWR RECOMM REP, V48, P16; DOE J, 1999, MMWR RECOMM REP, V48, P1; ESIRI MM, 1992, GREENFIELDS NEUROPAT, P335; GODE GR, 1988, LANCET, V2, P791; GOLDSTEIN RM, 1990, SURGERY, V107, P540; HOUFF SA, 1979, NEW ENGL J MED, V300, P603, DOI 10.1056/NEJM197903153001105; Human death associated with bat rabies-California, 2003, MMWR MORB MORTAL WKL, V53, P33; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; *JOINT COMM ACCR H, PROP TISS STOR ISS S; Mani J, 2003, POSTGRAD MED J, V79, P352, DOI 10.1136/pmj.79.932.352; Muiesan P, 1998, LIVER TRANSPLANT SUR, V4, P232, DOI 10.1002/lt.500040314; Muralidharan V, 2004, TRANSPL INT, V17, P163, DOI 10.1007/s00147-004-0701-z; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; *ORG PROC TRANSPL, MIN PROC STAND ORG P; Organ Procurement and Transplantation Network, ORG PROC TRANSPL NET; Pinna AD, 1996, TRANSPLANTATION, V62, P1584, DOI 10.1097/00007890-199612150-00010; Sellers MT, 2002, AM J TRANSPLANT, V2, P471, DOI 10.1034/j.1600-6143.2002.20513.x; Shames BD, 2003, ANN SURG, V237, P116, DOI 10.1097/00000658-200301000-00016; SUREAU P, 1981, CR ACAD SCI III-VIE, V293, P689; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zamboni F, 2002, DIGEST LIVER DIS, V34, P122, DOI 10.1016/S1590-8658(02)80241-9; 2004, MMWR MORB MORTAL WKL, V53, P1171; 1981, MMWR MORB MORTAL WKL, V30, P473; PROTOCOL POSTMORTEM; 2003, MMWR MORB MORTAL WKL, V52, P1102; 1980, MMWR MORB MORTAL WKL, V29, P25; CASES RABIES HUMAN B	32	278	303	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1103	1111		10.1056/NEJMoa043018	http://dx.doi.org/10.1056/NEJMoa043018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784663				2022-12-28	WOS:000227655000007
J	Freedman, LP; Waldman, RJ; de Pinho, H; Wirth, ME; Mushtaque, A; Chowdhury, R; Rosenfield, A				Freedman, LP; Waldman, RJ; de Pinho, H; Wirth, ME; Mushtaque, A; Chowdhury, R; Rosenfield, A			Transforming health systems to improve the lives of women and children	LANCET			English	Article							POOR		Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; UN Millennium Project, New York, NY USA; BRAC Univ, James P Grant Sch Publ Hlth, BRAC, Dhaka, Bangladesh	Columbia University; Bangladesh Rural Advancement Committee BRAC; BRAC University	Freedman, LP (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	lpf1@columbia.edu	Chowdhury, Rajiv/AHB-1253-2022					Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BLOOM G, 2001, 103 IDS U SUSS; Daulaire N, 2002, PROMISES KEEP; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; MACKINTOSH M, 2001, POVERTY INEQUALITY H; Maine D, 1991, SAFE MOTHERHOOD PROG; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; Narayan D., 2000, VOICES POOR CAN ANYO, DOI DOI 10.1002/JID.793; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Pritchett L, 2004, WORLD DEV, V32, P191, DOI 10.1016/j.worlddev.2003.08.009; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SINGH S, 2004, ADDING IT BENEFITS I; UN Millennium Project, 2005, INV DEV PRACT PLAN A; UN Millennium Project, 2005, WHOS GOT POW TRANSF; Wagstaff A, 2004, MILLENNIUM DEV GOALS; WHO UNICEF and UNFPA, 2003, MAT MORT 2000 EST DE; WIRTH M, 2004, SETTING STAGE EQUITY; World Health Organization (WHO) and World Bank, 2002, DYING CHANG POOR PEO	19	65	66	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					997	1000		10.1016/S0140-6736(05)71090-4	http://dx.doi.org/10.1016/S0140-6736(05)71090-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767003				2022-12-28	WOS:000227559800034
J	Osrin, D; Vaidya, A; Shrestha, Y; Baniya, RB; Manandhar, DS; Adhikari, RK; Filteau, S; Tomkins, A; Costello, AMD				Osrin, D; Vaidya, A; Shrestha, Y; Baniya, RB; Manandhar, DS; Adhikari, RK; Filteau, S; Tomkins, A; Costello, AMD			Effects of antenatal multiple micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind, randomised controlled trial	LANCET			English	Article							INTRAUTERINE GROWTH-RETARDATION; INFANT-MORTALITY; NIGHT BLINDNESS; RURAL NEPAL; PREGNANCY; SIZE; OUTCOMES; COMMUNITY; LENGTH; WOMEN	Background Neonatal mortality is the biggest contributor to global mortality of children younger than 5 years, and low birthweight is a crucial underlying factor. We tested the hypotheses that antenatal multiple micronutrient supplementation would increase infant birthweight and gestational duration. Methods We did a double-blind, randomised controlled trial in Dhanusha district, Nepal. Women attending for antenatal care with singleton pregnancies at up to 20 weeks' gestation were invited to participate. Participants were randomly allocated either routine iron and folic acid supplements (control; n=600) or a multiple micronutrient supplement providing a recommended daily allowance of 15 vitamins and minerals (intervention; n=600). Supplementation began at a minimum of 12 weeks' gestation and continued until delivery. Primary outcome measures were birthweight and gestational duration. Analysis was by intention to treat. The study is registered as an International Standard Randomised Controlled Trial, number ISRCTN88625934. Findings Birthweight was available for 523/600 infants in the control group and 529/600 in the intervention group. Mean birthweight was 2733 g (SD 422) in the control group and 2810 g (453) in the intervention group, representing a mean difference of 77 g (95% CI 24-130; p=0.004) and a relative fall in the proportion of low birthweight by 25%. No difference was recorded in the duration of gestation (0.2 weeks [-0.1 to 0.4]; p=0.12), infant length (0.3 cm [-0.1 to 0.6]; p=0.16), or head circumference (0.2 cm [-0.1 to 0.4]; p=0.18). Interpretation In a poor community in Nepal, consumption of a daily supplement containing a recommended daily allowance of 15 micronutrients in the second and third trimesters of pregnancy was associated with increased birthweight when compared with a standard iron and folic acid preparation. The effects on perinatal morbidity and mortality need further comparisons between studies.	UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England; UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; Mother & Infant Res Act, Kathmandu, Nepal; Tribhuvan Univ, Inst Med, Kathmandu, Nepal	University of London; University College London; University of London; University College London; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Osrin, D (corresponding author), UCL, Inst Child Hlth, Int Perinatal Care Unit, 30 Guilford St, London WC1N 1EH, England.	d.osrin@ich.ucl.ac.uk		Osrin, David/0000-0001-9691-9684				AlbertssonWikland K, 1997, ACTA PAEDIATR, V86, P193; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; ARONSON JK, 1992, BRIT MED J, V305, P1009, DOI 10.1136/bmj.305.6860.1009; Ashworth A, 1998, EUR J CLIN NUTR, V52, P223, DOI 10.1038/sj.ejcn.1600553; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Central Bureau of Statistics, 2001, POP CENS 2001 NEP; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, J NUTR, V133, p1969S, DOI 10.1093/jn/133.6.1969S; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Christian P, 1998, INT J EPIDEMIOL, V27, P231, DOI 10.1093/ije/27.2.231; Costello AMD, 2003, J NUTR, V133, p1757S, DOI 10.1093/jn/133.5.1757S; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; de Onis M, 1998, EUR J CLIN NUTR, V52, pS83; Dreyfuss M. L., 1997, JNMA, Journal of the Nepal Medical Association, V35, P234; Erhardt JG, 2002, BRIT J NUTR, V87, P471, DOI 10.1079/BJN2002566; *FAM HLTH DIV, 1996, NAT MAT CAR GUID; *FAM HLTH DIV, 1999, REPR HLTH CLIN PROT; Fawzi WW, 1998, LANCET, V351, P1477, DOI 10.1016/S0140-6736(98)04197-X; Friis H, 2004, AM J CLIN NUTR, V80, P178; Gluckman PD, 1997, ACTA PAEDIATR, V86, P69; Goldenberg RL, 1998, EUR J CLIN NUTR, V52, pS54; Hack M, 1998, EUR J CLIN NUTR, V52, pS65; HUFFMAN S, 1998, CASE PROMOTION MULTI; KATZ J, 1995, J NUTR, V125, P2122, DOI 10.1093/jn/125.8.2122; KRAMER M, 2003, COCHRANE DB SYST REV, V3; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; MANANDHAR D, 2000, MULTIHOSPITAL BASED; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; *MIN HLTH, 2001, NEP MICR STAT SURV 1; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; MOSER PB, 1988, AM J CLIN NUTR, V47, P729, DOI 10.1093/ajcn/47.4.729; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *NAT PLANN COMM, 1997, EARL CHILDH FEED NUT; Osrin D, 2000, Semin Neonatol, V5, P209, DOI 10.1053/siny.2000.0024; OSRIN D, 1999, SEMIN NEONATOL, V4, P173; Pradhan A., 1997, NEPAL FAMILY HLTH SU; Ramakrishnan U, 1999, NUTR RES, V19, P103, DOI 10.1016/S0271-5317(98)00178-X; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Ramakrishnan U, 2003, AM J CLIN NUTR, V77, P720, DOI 10.1093/ajcn/77.3.720; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; *SAV CHILDR, 2001, SAV NEWB LIV STAT WO; SHARMA H, 2002, DISTRICT DEMOGRAPHIC; Stevens-Simon C, 1999, BIRTH-ISS PERINAT C, V26, P184, DOI 10.1046/j.1523-536x.1999.00184.x; *UNICEF WHO UNU, 1999, COMP MULT S US PIL P; VICTORA CG, 1987, INT J EPIDEMIOL, V16, P239, DOI 10.1093/ije/16.2.239; VILLAR J, 1986, EARLY HUM DEV, V14, P307, DOI 10.1016/0378-3782(86)90193-3; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	52	164	168	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					955	962		10.1016/S0140-6736(05)71084-9	http://dx.doi.org/10.1016/S0140-6736(05)71084-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766997				2022-12-28	WOS:000227559800028
J	Talhari, C; Angerstein, W; Becker, J; Ruzicka, T; Megahed, M				Talhari, C; Angerstein, W; Becker, J; Ruzicka, T; Megahed, M			Long-standing oral ulcers	LANCET			English	Editorial Material							IGA BULLOUS DERMATOSIS		Univ Dusseldorf, Fac Med, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Phoniatry & Peraudiol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Oral Surg, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Megahed, M (corresponding author), Univ Dusseldorf, Fac Med, Dept Dermatol, D-40225 Dusseldorf, Germany.	megahed@uni-duesseldorf.de						Bouldin MB, 2000, MAYO CLIN PROC, V75, P967, DOI 10.4065/75.9.967; Egan CA, 1999, INT J DERMATOL, V38, P818, DOI 10.1046/j.1365-4362.1999.00813.x; Megahed M, 2001, J AM ACAD DERMATOL, V45, P256, DOI 10.1067/mjd.2001.114746; MEGAHED M, 2004, HISTOPATHOLOGY BLIST, P17; Scully C, 2000, BRIT MED J, V321, P162, DOI 10.1136/bmj.321.7254.162	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					1002	1002		10.1016/S0140-6736(05)71092-8	http://dx.doi.org/10.1016/S0140-6736(05)71092-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767005				2022-12-28	WOS:000227559800036
J	Wang, YC; Ferguson, EL				Wang, YC; Ferguson, EL			Spatial bistability of Dpp-receptor interactions during Drosophila dorsal-ventral patterning	NATURE			English	Article							TWISTED GASTRULATION; SIGNAL-TRANSDUCTION; ACTIVITY GRADIENT; BMP ACTIVITY; I RECEPTORS; EMBRYO; GENE; SOG; IDENTIFICATION; ACTIVATION	In many developmental contexts, a locally produced morphogen specifies positional information by forming a concentration gradient over a field of cells(1). However, during embryonic dorsal - ventral patterning in Drosophila, two members of the bone morphogenetic protein (BMP) family, Decapentaplegic (Dpp) and Screw (Scw), are broadly transcribed but promote receptor-mediated signalling in a restricted subset of expressing cells(2-4). Here we use a novel immunostaining protocol to visualize receptor-bound BMPs and show that both proteins become localized to a sharp stripe of dorsal cells. We demonstrate that proper BMP localization involves two distinct processes. First, Dpp undergoes directed, long-range extracellular transport. Scw also undergoes long-range movement, but can do so independently of Dpp transport. Second, an intracellular positive feedback circuit promotes future ligand binding as a function of previous signalling strength. These data elicit a model in which extracellular Dpp transport initially creates a shallow gradient of BMP binding that is acted on by positive intracellular feedback to produce two stable states of BMP - receptor interactions, a spatial bistability in which BMP binding and signalling capabilities are high in dorsal-most cells and low in lateral cells.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ferguson, EL (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	elfergus@midway.uchicago.edu	; Wang, Yu-Chiun/N-6541-2015	Ferguson, Edwin/0000-0003-4125-4253; Wang, Yu-Chiun/0000-0002-3797-4138				ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dorfman R, 2001, DEVELOPMENT, V128, P965; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Kosman D, 1997, DEVELOPMENT, V124, P1343; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; RUSHLOW C, 1987, GENE DEV, V1, P1268, DOI 10.1101/gad.1.10.1268; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; SHIMMI O, IN PRESS CELL; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577	31	165	169	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					229	234		10.1038/nature03318	http://dx.doi.org/10.1038/nature03318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759004				2022-12-28	WOS:000227494500049
J	Wattanawaitunechai, C; Peacock, SJ; Jitpratoom, P				Wattanawaitunechai, C; Peacock, SJ; Jitpratoom, P			Tsunami in Thailand - Disaster management in a district hospital	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Takuapa Gen Hosp, Phangnga, Thailand; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol University	Wattanawaitunechai, C (corresponding author), Takuapa Gen Hosp, Phangnga, Thailand.		Peacock, Sharon J/ABE-6331-2020	Peacock, Sharon/0000-0002-1718-2782				*NAT STAT OFF THAI, POP HOUS CENS 2000; *WHO, 2005, 31 WHO; *WHO THAIL, 2005, TID WAV DIS	3	32	33	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					962	964		10.1056/NEJMp058040	http://dx.doi.org/10.1056/NEJMp058040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758004	Bronze			2022-12-28	WOS:000227491200002
J	Elmore, JG; Armstrong, K; Lehman, CD; Fletcher, SW				Elmore, JG; Armstrong, K; Lehman, CD; Fletcher, SW			Screening for breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FIELD DIGITAL MAMMOGRAPHY; POSITIVE PREDICTIVE VALUE; COMPUTER-AIDED DETECTION; RANDOMIZED-TRIAL; HIGH-RISK; FILM MAMMOGRAPHY; SELF-EXAMINATION; PHYSICAL-EXAMINATION; FOLLOW-UP; AGE 40	Context Breast cancer screening in community practices maybe different from that in randomized controlled trials. New screening modalities are becoming available. Objectives To review breast cancer screening, especially in the community and to examine evidence about new screening modalities. Data Sources and Study Selection English-language articles of randomized controlled trials assessing effectiveness of breast cancer screening were reviewed, as well as meta-analyses, systematic reviews, studies of breast cancer screening in the community, and guidelines. Also, studies of newer screening modalities were assessed. Data Synthesis All major US medical organizations recommend screening mammography for women aged 40 years and older. Screening mammography reduces breast cancer mortality by about 20% to 35% in women aged 50 to 69 years and slightly less in women aged 40 to 49 years at 14 years of follow-up. Approximately 95% of women with abnormalities on screening mammograms do not have breast cancer with variability based on such factors as age of the woman and assessment category assigned by the radiologist. Studies comparing full-field digital mammography to screen film have not shown statistically significant differences in cancer detection while the impact on recall rates (percentage of screening mammograms considered to have positive results) was unclear. One study suggested that computer-aided detection increases cancer detection rates and recall rates while a second larger study did not find any significant differences. Screening clinical breast examination detects some cancers missed by mammography, but the sensitivity reported in the community is lower (28% to 36%) than in randomized trials (about 54%). Breast self-examination has not been shown to be effective in reducing breast cancer mortality, but it does increase the number of breast biopsies performed because of false-positives. Magnetic resonance imaging and ultrasound are being studied for screening women at high risk for breast cancer but are not recommended for screening the general population. Sensitivity of magnetic resonance imaging in high-risk women has been found to be much higher than that of mammography but specificity is generally lower. Effect of the magnetic resonance imaging on breast cancer mortality is not known. A balanced discussion of possible benefits and harms of screening should be undertaken with each woman. Conclusions In the community, mammography remains the main screening tool while the effectiveness of clinical breast examination and self-examination are less. New screening modalities are unlikely to replace mammography in the near future for screening the general population.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98104 USA; Univ Washington, Sch Med, Seattle Canc Care Alliance, Seattle, WA 98104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; University of Pennsylvania; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Elmore, JG (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, 325 9th Ave,Box 359780, Seattle, WA 98104 USA.	jelmore@u.washington.edu			NCI NIH HHS [R01 CA107623-04, R01 CA107623, K05-CA10469, K05 CA104699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K05CA104699, R01CA107623] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 1998, LANCET, V352, P930; *ACRIN, 2003, 6652 ACRIN; Adair FE, 1933, NEW ENGL J MED, V208, P1250, DOI 10.1056/NEJM193306152082404; Alaszewski A, 2003, BMJ-BRIT MED J, V327, P728, DOI 10.1136/bmj.327.7417.728; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; American College of Radiology, 1998, ILL BREAST IM REP DA; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Baines CJ, 2003, J NATL CANCER I, V95, P1508, DOI 10.1093/jnci/djg026; Baines CJ, 2003, J NATL CANCER I, V95, P1512, DOI 10.1093/jnci/djg066; BAINES CJ, 1990, CANCER, V65, P1663, DOI 10.1002/1097-0142(19900401)65:7<1663::AID-CNCR2820650735>3.0.CO;2-A; Barlow WE, 2002, J NATL CANCER I, V94, P1151; BARTOLUCCI G, 1989, STRESS MEDICINE, V5, P195, DOI 10.1002/smi.2460050310; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Barton MB, 1999, ANN INTERN MED, V130, P651, DOI 10.7326/0003-4819-130-8-199904200-00005; Beam CA, 2003, J NATL CANCER I, V95, P282, DOI 10.1093/jnci/95.4.282; Beam CA, 1996, ARCH INTERN MED, V156, P209, DOI 10.1001/archinte.156.2.209; Berg A, 2003, J NATL CANCER I, V95, P1511, DOI 10.1093/jnci/djg067; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Bjurstam N, 1997, J Natl Cancer Inst Monogr, P53; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Bobo JK, 2000, J NATL CANCER I, V92, P971, DOI 10.1093/jnci/92.12.971; BOYD NF, 1982, J NATL CANCER I, V68, P357; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; BROWN ML, 1995, AM J ROENTGENOL, V165, P1373, DOI 10.2214/ajr.165.6.7484568; Buchberger W, 1999, AM J ROENTGENOL, V173, P921, DOI 10.2214/ajr.173.4.10511149; CAMPBELL HS, 1991, AM J PREV MED, V7, P1; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Clarke M, 1998, LANCET, V351, P1451; *COMM EUR COMM, 2001, EUR GUID QUAL ASS MA; Crosier M, 1999, CLIN CANCER RES, V5, P2682; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; DOrsi C.J, 1998, BREAST IMAGING REPOR; Dullum JR, 2000, RADIOLOGY, V214, P547, DOI 10.1148/radiology.214.2.r00fe23547; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P250, DOI 10.1093/jnci/95.4.250; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Esserman L, 2002, JNCI-J NATL CANCER I, V94, P369; Feig S A, 1997, J Natl Cancer Inst Monogr, P119; FLETCHER SW, 1985, JAMA-J AM MED ASSOC, V253, P2224, DOI 10.1001/jama.253.15.2224; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Frank E, 2000, J WOMEN HEALTH GEN-B, V9, P791, DOI 10.1089/15246090050147763; Freedman GM, 2003, CANCER-AM CANCER SOC, V98, P918, DOI 10.1002/cncr.11605; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Frisell J, 1997, J Natl Cancer Inst Monogr, P49; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Gordon PB, 2002, RADIOL CLIN N AM, V40, P431, DOI 10.1016/S0033-8389(01)00014-8; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; GRAM IT, 1992, AM J PUBLIC HEALTH, V82, P249, DOI 10.2105/AJPH.82.2.249; Groenendijk RPR, 2000, BRIT J CANCER, V82, P381; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hackshaw AK, 2003, BRIT J CANCER, V88, P1047, DOI 10.1038/sj.bjc.6600847; HALL DC, 1980, CANCER, V46, P408, DOI 10.1002/1097-0142(19800715)46:2<408::AID-CNCR2820460233>3.0.CO;2-P; Hansen NM, 2004, ARCH SURG-CHICAGO, V139, P634, DOI 10.1001/archsurg.139.6.634; HARVEY JA, 1993, AM J ROENTGENOL, V161, P1167, DOI 10.2214/ajr.161.6.8249720; Hendrick RE, 2005, AM J ROENTGENOL, V184, P433, DOI 10.2214/ajr.184.2.01840433; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Hou MF, 2002, ULTRASOUND MED BIOL, V28, P415, DOI 10.1016/S0301-5629(02)00483-0; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Huo ZM, 2002, RADIOLOGY, V224, P560, DOI 10.1148/radiol.2242010703; IKEDA DM, 1992, AM J ROENTGENOL, V159, P287, DOI 10.2214/ajr.159.2.1632342; Irwig L, 2004, BRIT J CANCER, V90, P2118, DOI 10.1038/sj.bjc.6601836; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Kaplan SS, 2000, RADIOLOGY, V217, P318; Kerlikowske K, 2003, ANN INTERN MED, V139, P274, DOI 10.7326/0003-4819-139-4-200308190-00010; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; KLEMI PJ, 1992, BRIT MED J, V304, P467, DOI 10.1136/bmj.304.6825.467; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Kolb TM, 1998, RADIOLOGY, V207, P191, DOI 10.1148/radiology.207.1.9530316; Kornguth PJ, 1996, PAIN, V66, P187, DOI 10.1016/0304-3959(96)03057-6; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; LAST JM, 1995, DICT EPIDEMIOLOGY, P52; Leach MO, 2002, J EXP CLIN CANC RES, V21, P107; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lewin JM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790671; Lewin JM, 2001, RADIOLOGY, V218, P873, DOI 10.1148/radiology.218.3.r01mr29873; LINVER MN, 1992, RADIOLOGY, V184, P39, DOI 10.1148/radiology.184.1.1609100; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Morris EA, 2003, AM J ROENTGENOL, V181, P619, DOI 10.2214/ajr.181.3.1810619; Moss S, 1999, J MED SCREEN, V6, P144, DOI 10.1136/jms.6.3.144; Nass S. J., 2001, MAMMOGRAPHY DEV TECH; *NAT GUID CLEAR WE, BREAST CANC SCREEN; *NAT HLTH SERV BRE, 1998, NHSBSP PUBL, V40; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; O'Driscoll D, 2001, J MED SCREEN, V8, P106, DOI 10.1136/jms.8.2.106; Oestreicher N, 2002, BREAST CANCER RES TR, V76, P73, DOI 10.1023/A:1020280623807; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; OLSEN O, 2003, COCHRANE LIB; OMALLEY MS, 1987, JAMA-J AM MED ASSOC, V257, P2197; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Podo F, 2002, J EXP CLIN CANC RES, V21, P115; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Quality mammography standards-FDA, 1997, FED REGISTER, V62, P55852; Ries L, 2004, SEER CANC STAT REV 1; RUTTER DR, 1992, BRIT MED J, V305, P443, DOI 10.1136/bmj.305.6851.443; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SAUNDERS KJ, 1986, CANCER, V58, P2531, DOI 10.1002/1097-0142(19861201)58:11<2531::AID-CNCR2820581128>3.0.CO;2-J; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Seidell JC, 2002, SIGNIFICANT TRENDS F; Shapiro S., 1988, SCREEN BREAST CANC, P3; Shapiro S, 1988, PERIODIC SCREENING B; Skaane P, 2004, RADIOLOGY, V232, P197, DOI 10.1148/radiol.2321031624; Skaane P, 2003, RADIOLOGY, V229, P877, DOI 10.1148/radiol.2293021171; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Stoutjesdijk MJ, 2001, JNCI-J NATL CANCER I, V93, P1095, DOI 10.1093/jnci/93.14.1095; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Thomas DB, 1997, JNCI-J NATL CANCER I, V89, P355, DOI 10.1093/jnci/89.5.355; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Thornton H, 2003, BMJ-BRIT MED J, V327, P693, DOI 10.1136/bmj.327.7417.693; Tilanus-Linthorst MMA, 2000, BREAST CANCER RES TR, V63, P53, DOI 10.1023/A:1006480106487; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vainio H, 2002, INT AGENCY RES CANC, V7; VanDijck JAAM, 1996, INT J CANCER, V66, P727, DOI 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1; Walter LC, 2001, J GEN INTERN MED, V16, P779, DOI 10.1046/j.1525-1497.2001.10113.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Welch HG, 2004, SHOULD I BE TESTED C; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	134	522	542	0	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1245	1256		10.1001/jama.293.10.1245	http://dx.doi.org/10.1001/jama.293.10.1245			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755947	Green Accepted			2022-12-28	WOS:000227498400025
J	Hayward, R				Hayward, R			Historical keywords - Development	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Hayward, R (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.	Rhodri.Hayward@ucl.ac.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					839	839		10.1016/S0140-6736(05)71028-X	http://dx.doi.org/10.1016/S0140-6736(05)71028-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752517	Bronze			2022-12-28	WOS:000227444600012
J	Rawlins, MD				Rawlins, MD			5 NICE years	LANCET			English	Editorial Material							DECISION		Natl Inst Clin Excellence, London WC1V 6NA, England	National Institute for Health & Care Excellence	Rawlins, MD (corresponding author), Natl Inst Clin Excellence, 71 High Holborn, London WC1V 6NA, England.	michael.rawlins@nice.nhs.uk						Antes G, 2003, LANCET, V361, P978, DOI 10.1016/S0140-6736(03)12838-3; Cookson R, 2001, BRIT MED J, V323, P743, DOI 10.1136/bmj.323.7315.743; *DEP HLTH, 2004, REC DEP HLTHS ARMS L; *DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Devlin N, 2003, BRIT MED J, V327, P1061, DOI 10.1136/bmj.327.7423.1061; Devlin Nancy, 2003, J Health Serv Res Policy, V8, P183, DOI 10.1258/135581903322029557; Dyer O, 2002, BRIT MED J, V324, P1413, DOI 10.1136/bmj.324.7351.1413; Gafni A, 2003, PHARMACOECONOMICS, V21, P149, DOI 10.2165/00019053-200321030-00001; Hill S, 2003, TECHNOLOGY APPRAISAL; JONES A, 2003, FOCUS, V14, P5; Kmietowicz Z, 2000, BRIT MED J, V321, P980; Kmietowicz Z, 2001, BRIT MED J, V323, P1324, DOI 10.1136/bmj.323.7325.1324a; Motson RW, 2002, BRIT MED J, V324, P1092, DOI 10.1136/bmj.324.7345.1092; *NAT AUD OFF, 2003, HIP REPL UPD; *NAT I CLIN EXC, 2003, GUID NICE; *NAT I CLIN EXC, 2003, 59 NAT I CLIN EXC; *NAT I CLIN EXC SE, 2002, 5151 HC NAT I CLIN E; Oliver Adam, 2002, J Health Serv Res Policy, V7, P129, DOI 10.1258/135581902760082274; Parr JR, 2003, CHILD CARE HLTH DEV, V29, P215, DOI 10.1046/j.1365-2214.2003.00333.x; Poole-Wilson PA, 2002, HEART, V87, P510, DOI 10.1136/heart.87.6.510; Quennell P, 2001, J Manag Med, V15, P202, DOI 10.1108/EUM0000000005509; Rawlins M, 1999, LANCET, V353, P1079, DOI 10.1016/S0140-6736(99)02381-8; RAWLINS M, 2001, SCRIP, V2701, P6; RAWLINS MD, BMJ, V329, P224; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Westcott K, 2002, BRIT J ORAL MAX SURG, V40, P304, DOI 10.1016/S0266-4356(02)00120-1; Wroblewski BM, 2003, J BONE JOINT SURG BR, V85B, P376, DOI 10.1302/0301-620X.85B3.13817; 2003, BMJ, V327, P1368; 2001, COMMAND52078	29	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					904	908		10.1016/S0140-6736(05)71050-3	http://dx.doi.org/10.1016/S0140-6736(05)71050-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752536				2022-12-28	WOS:000227444600034
J	Brunthaler, A; Reid, MJ; Falcke, H; Greenhill, LJ; Henkel, C				Brunthaler, A; Reid, MJ; Falcke, H; Greenhill, LJ; Henkel, C			The geometric distance and proper motion of the Triangulum Galaxy (M33)	SCIENCE			English	Article							LARGE-MAGELLANIC-CLOUD; WATER-VAPOR MASERS; SPIRAL NEBULA; LOCAL GROUP; MESSIER 33; MASS	We measured the angular rotation and proper motion of the Triangulum Galaxy (M33) with the Very Long Baseline Array by observing two H2O masers on opposite sides of the galaxy. By comparing the angular rotation rate with the inclination and rotation speed, we obtained a distance of 730 +/- 168 kiloparsecs. This distance is consistent With the most recent Cepheid distance measurement M33 is moving with a velocity of 190 +/- 59 kilometers per second relative to the Milky Way. These measurements promise a method to determine dynamical models for the Local Group and the mass and dark-matter halos of M31, M33, and the Milky Way.	Max Planck Inst Radioastron, D-53121 Bonn, Germany; Joint Inst Very Long Baseline Interferometry Euro, NL-7990 AA Dwingeloo, Netherlands; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; ASTRON, NL-7990 AA Dwingeloo, Netherlands; Radboud Univ Nijmegen, Dept Astron, NL-6500 GL Nijmegen, Netherlands	Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Radboud University Nijmegen	Brunthaler, A (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	brunthaler@jive.nl	Falcke, Heino D. E./H-5262-2012	Falcke, Heino D. E./0000-0002-2526-6724; Brunthaler, Andreas/0000-0003-4468-761X				Argon AL, 2004, ASTROPHYS J, V615, P702, DOI 10.1086/424731; ARGON AL, 1994, ASTROPHYS J, V422, P586, DOI 10.1086/173751; Corbelli E, 1997, ASTROPHYS J, V479, P244, DOI 10.1086/303849; Dehnen W, 1998, MON NOT R ASTRON SOC, V298, P387, DOI 10.1046/j.1365-8711.1998.01600.x; Evans NW, 2000, MON NOT R ASTRON SOC, V316, P929, DOI 10.1046/j.1365-8711.2000.03645.x; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Gottesman ST, 2002, MON NOT R ASTRON SOC, V337, P34, DOI 10.1046/j.1365-8711.2002.05793.x; GREENHILL LJ, 1993, ASTROPHYS J, V406, P482, DOI 10.1086/172460; GREENHILL LJ, 1990, ASTROPHYS J, V364, P513, DOI 10.1086/169433; HARTWICK FDA, 1978, ASTROPHYS J, V221, P512, DOI 10.1086/156053; Hubble E, 1926, ASTROPHYS J, V63, P236, DOI 10.1086/142976; ISRAEL FP, 1974, ASTRON ASTROPHYS, V32, P363; JONES BF, 1994, ASTRON J, V107, P1333, DOI 10.1086/116947; KAHN FD, 1959, ASTROPHYS J, V130, P705, DOI 10.1086/146762; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; KULESSA AS, 1992, MON NOT R ASTRON SOC, V255, P105, DOI 10.1093/mnras/255.1.105; Lee MG, 2002, ASTROPHYS J, V565, P959, DOI 10.1086/324719; McConnachie AW, 2005, MON NOT R ASTRON SOC, V356, P979, DOI 10.1111/j.1365-2966.2004.08514.x; McConnachie AW, 2004, MON NOT R ASTRON SOC, V350, P243, DOI 10.1111/j.1365-2966.2004.07637.x; Reid MJ, 2004, ASTROPHYS J, V616, P872, DOI 10.1086/424960; Schweitzer AE, 1995, ASTRON J, V110, P2747, DOI 10.1086/117727; Udalski A, 1998, ASTROPHYS J, V509, pL25, DOI 10.1086/311763; van den Bergh S, 1999, ASTRON ASTROPHYS REV, V9, P273, DOI 10.1007/s001590050019; Van Maanen A, 1923, ASTROPHYS J, V57, P264, DOI 10.1086/142755	24	116	120	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2005	307	5714					1440	1443		10.1126/science.1108342	http://dx.doi.org/10.1126/science.1108342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746420	Green Submitted			2022-12-28	WOS:000227503100038
J	Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J				Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J			Supramolecular assembly of amelogenin nanospheres into birefringent microribbons	SCIENCE			English	Article							EMBRYONIC BOVINE ENAMEL; NEUTRAL-SOLUBLE PROTEINS; DYNAMIC LIGHT-SCATTERING; TOOTH ENAMEL; ORGANIC MATRIX; RAT; MATURATION; CRYSTALS; APATITE; GROWTH	Although both tooth enamel and bone are composed of organized assemblies of carbonated apatite crystals, enamel is unusual in that it does not contain collagen nor does it remodel. Self-assembly of amelogenin protein into nanospheres has been recognized. as a key factor in controlling the oriented and elongated growth of carbonated apatite crystals during dental enamel biomineralization. We report the in vitro formation of birefringent microribbon structures that were generated through the supramolecular assembly of amelogenin nanospheres. These microribbons have diffraction patterns that indicate a periodic structure of crystalline units along the long axis. The growth of apatite crystals orientated along the c axis and parallel to the long axes of the microribbons was observed in vitro. The linear arrays (chains) of nanospheres observed as intermediate states before the microribbon formation give an important indication as to the function of amelogenin in controlling the oriented growth of apatite crystals during enamel mineralization.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Southern California; University of Bologna	Moradian-Oldak, J (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Du, Chang/H-4200-2012	Du, Chang/0000-0002-6460-0764	NIDCR NIH HHS [R01-DE-13414, R01 DE013414, R21-DE-15332] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015332] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BETKE U, 1995, DISCRETE COMPUT GEOM, V13, P297, DOI 10.1007/BF02574046; BONAR LC, 1965, J ULTRA MOL STRUCT R, V13, P308, DOI 10.1016/S0022-5320(65)80079-X; Bouropoulos N, 2004, J DENT RES, V83, P278, DOI 10.1177/154405910408300402; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; EASTOE JE, 1960, NATURE, V187, P411, DOI 10.1038/187411b0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; MECHANIC GL, 1967, BIOCHIM BIOPHYS ACTA, V133, P97, DOI 10.1016/0005-2795(67)90042-6; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NIKIFORUK G, 1965, J DENT RES, V44, P1119, DOI 10.1177/00220345650440061101; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; REITH EJ, 1961, J BIOPHYS BIOCHEM CY, V9, P825, DOI 10.1083/jcb.9.4.825; RENUGOPALAKRISHNAN V, 1989, BIOPOLYMERS, V28, P297, DOI 10.1002/bip.360280130; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483; ROBINSON C, 1978, CARIES RES, V12, P1, DOI 10.1159/000260309; Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200; SMALES FC, 1975, NATURE, V258, P772, DOI 10.1038/258772a0; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; TRAVIS DF, 1964, J CELL BIOL, V23, P447, DOI 10.1083/jcb.23.3.447; WATSON ML, 1960, J BIOPHYS BIOCHEM CY, V7, P489, DOI 10.1083/jcb.7.3.489; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173; ZHENG SD, 1987, BIOPOLYMERS, V26, P1809, DOI 10.1002/bip.360261012	29	279	292	14	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1450	1454		10.1126/science.1105675	http://dx.doi.org/10.1126/science.1105675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746422				2022-12-28	WOS:000227503100041
J	Jokipii, JR				Jokipii, JR			Our interstellar neighborhood	SCIENCE			English	Editorial Material							WIND TERMINATION SHOCK; SOLAR-WIND; STREAMING ANISOTROPIES; PARTICLES		Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA	University of Arizona	Jokipii, JR (corresponding author), Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA.	jokipii@lpl.arizona.edu						Burlaga LF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018291; Fisk LA, 2004, AIP CONF PROC, V719, P365, DOI 10.1063/1.1809542; FRISCH PC, 1995, SPACE SCI REV, V72, P499, DOI 10.1007/BF00749006; Gurnett DA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018514; Jokipii JR, 2004, ASTROPHYS J, V611, pL141, DOI 10.1086/423993; Jokipii JR, 2004, ASTROPHYS J, V605, pL145, DOI 10.1086/420783; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; Kurth WS, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009860; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McDonald FB, 2004, AIP CONF PROC, V719, P139, DOI 10.1063/1.1809511; McDonald FB, 2003, NATURE, V426, P48, DOI 10.1038/nature02066; Ratkiewicz R, 2004, AIP CONF PROC, V719, P93, DOI 10.1063/1.1809504	12	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1424	1425		10.1126/science.1109701	http://dx.doi.org/10.1126/science.1109701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746417				2022-12-28	WOS:000227503100033
J	Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS				Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS			Disruptive coloration and background pattern matching	NATURE			English	Article								Effective camouflage renders a target indistinguishable from irrelevant background objects. Two interrelated but logically distinct mechanisms for this are background pattern matching (crypsis(1,2)) and disruptive coloration: in the former, the animal's colours are a random sample of the background(1,2); in the latter, bold contrasting colours on the animal's periphery break up its outline. The latter has long been proposed as an explanation for some apparently conspicuous coloration in animals(3,4), and is standard textbook material. Surprisingly, only one quantitative test(5) of the theory exists, and one experimental test of its effectiveness against non-human predators(6). Here we test two key predictions: that patterns on the body's outline should be particularly effective in promoting concealment and that highly contrasting colours should enhance this disruptive effect. Artificial moth-like targets were exposed to bird predation in the field, with the experimental colour patterns on the 'wings' and a dead mealworm as the edible 'body'. Survival analysis supported the predictions, indicating that disruptive coloration is an effective means of camouflage, above and beyond background pattern matching.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol; University of Bristol	Cuthill, IC (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	i.cuthill@bristol.ac.uk	Parraga, C. Alejandro/D-2329-2011	Parraga, C. Alejandro/0000-0002-3809-241X; Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council [S18903] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Behrens RR., 2002, FALSE COLORS ART DES; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Cott H.B., 1940, ADAPTIVE COLORATION; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill Innes C., 2000, Acta Ethologica, V3, P29, DOI 10.1007/s102110000027; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; KILTIE RA, 1988, TRENDS ECOL EVOL, V3, P21, DOI 10.1016/0169-5347(88)90079-1; Maddocks SA, 2001, J EXP BIOL, V204, P2509; Majerus MEN, 2000, J EVOLUTION BIOL, V13, P155, DOI 10.1046/j.1420-9101.2000.00170.x; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Rasband W., 2003, IMAGEJ; Ruxton GD, 2004, ANIM BEHAV, V68, P445, DOI 10.1016/j.anbehav.2003.12.009; SILBERGLIED RE, 1980, SCIENCE, V209, P617, DOI 10.1126/science.209.4456.617; *SPSS INC, 2003, SPSS WIND REL 9 0; THAYER AH, 1896, AUK, V13, P124; Thayer GH, 1909, CONCEALING COLORATIO; WALDBAUER GP, 1983, EVOLUTION, V37, P1085, DOI 10.1111/j.1558-5646.1983.tb05635.x	24	381	388	25	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					72	74		10.1038/nature03312	http://dx.doi.org/10.1038/nature03312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744301				2022-12-28	WOS:000227334600045
J	Huckman, RS; Pisano, GP				Huckman, RS; Pisano, GP			Adopting new technologies: Turf battles in coronary revascularization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Huckman, RS (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Edmondson A, 1999, ADMIN SCI QUART, V44, P350, DOI 10.2307/2666999; Huckman RS, 2003, MANAGE SCI, V49, P599, DOI 10.1287/mnsc.49.5.599.15145; Pisano GP, 2001, MANAGE SCI, V47, P752, DOI 10.1287/mnsc.47.6.752.9811	3	19	20	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					857	859		10.1056/NEJMp048242	http://dx.doi.org/10.1056/NEJMp048242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745974				2022-12-28	WOS:000227310700002
J	Hadley, EC; Lakatta, EG; Morrison-Bogorad, M; Warner, HR; Hodes, RJ				Hadley, EC; Lakatta, EG; Morrison-Bogorad, M; Warner, HR; Hodes, RJ			The future of aging therapies	CELL			English	Review							CARDIOVASCULAR-DISEASE ENTERPRISES; MILD COGNITIVE IMPAIRMENT; CONTROLS OXIDATIVE STRESS; AMES DWARF MICE; LIFE-SPAN; CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; CALORIE RESTRICTION; TRANSGENIC MICE; C-ELEGANS	Advances in understanding aging processes and their consequences are leading to the development of therapies to slow or reverse adverse changes formerly considered to be "normal" aging and processes that underlie multiple age-related conditions. Estimating the effectiveness of candidate aging therapies, whose effects on human aging may require many years to determine, is a particular challenge. Strategies for identifying candidate interventions can be developed through multiple approaches, including the screening of molecular targets and pathways in vitro and in animal models, informed as well by evidence from human genetic and epidemiologic data. A number of recently established programs and networks can serve as resources for such research. For all these research approaches, from in vitro molecular studies to clinical trials, contributions of cell and molecular biology are crucial and offer the prospect of therapeutic advances that address fundamental biological processes as well as the clinically important challenges of aging.	NIA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hadley, EC (corresponding author), NIA, NIH, Bethesda, MD 20892 USA.	ehadley@nih.gov	Lakatta, Edward G/AAL-1447-2020	Lakatta, Edward/0000-0002-4772-0035	NATIONAL CANCER INSTITUTE [Z01BC009405, ZIABC009405] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Butler RN, 2004, J GERONTOL A-BIOL, V59, P560; Carter CS, 2002, J GERONTOL A-BIOL, V57, pB177, DOI 10.1093/gerona/57.5.B177; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; ESQUIFINO AI, 1991, ACTA ENDOCRINOL-COP, V125, P67, DOI 10.1530/acta.0.1250067; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Floyd RA, 2002, MECH AGEING DEV, V123, P1021, DOI 10.1016/S0047-6374(01)00385-2; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gates PE, 2004, HYPERTENSION, V44, P35, DOI 10.1161/01.HYP.0000132767.74476.64; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Hadley EC, 2005, MECH AGEING DEV, V126, P231, DOI 10.1016/j.mad.2004.08.014; Hadley EC, 2001, J GERONTOL A-BIOL, V56, P5, DOI 10.1093/gerona/56.suppl_1.5; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JM, 2004, MECH AGEING DEV, V125, P381, DOI 10.1016/j.mad.2004.03.003; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lichtenthaler SF, 2004, J CLIN INVEST, V113, P1384, DOI 10.1172/JCI200421746; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; LITHGOW GJ, 2003, AGING KNOWLEDGE ENV, V25, DOI DOI 10.1126/SAGEKE.2003.25.PE16; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Milgram NW, 2004, EXP GERONTOL, V39, P753, DOI 10.1016/j.exger.2004.01.007; Miller R A, 2001, Sci Aging Knowledge Environ, V2001, ppe2; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Mufson EJ, 2002, J COMP NEUROL, V443, P136, DOI 10.1002/cne.10122; Munoz MJ, 2003, MECH AGEING DEV, V124, P43, DOI 10.1016/S0047-6374(02)00168-9; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Roberts SB, 2001, J GERONTOL A-BIOL, V56, P66, DOI 10.1093/gerona/56.suppl_1.66; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thinakaran G, 2004, PHARMACOL RES, V50, P411, DOI 10.1016/j.phrs.2003.12.026; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Vaitkevicius PV, 2001, P NATL ACAD SCI USA, V98, P1171, DOI 10.1073/pnas.98.3.1171; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45; Warner HR, 2004, J GERONTOL A-BIOL, V59, P692; WARNER HR, 2003, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.2003.6.REL; Warner Huber R., 2000, Mechanisms of Ageing and Development, V115, P199, DOI 10.1016/S0047-6374(00)00118-4; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	93	67	69	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					557	567		10.1016/j.cell.2005.01.030	http://dx.doi.org/10.1016/j.cell.2005.01.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734687	Bronze			2022-12-28	WOS:000227271500012
J	Martin, GM				Martin, GM			Genetic modulation of senescent phenotypes in Homo sapiens	CELL			English	Review							GILFORD-PROGERIA-SYNDROME; CONGENITAL GENERALIZED LIPODYSTROPHY; FAMILIAL ADENOMATOUS POLYPOSIS; COMMON LRRK2 MUTATION; WRN HELICASE ACTIVITY; WERNER-SYNDROME; ATAXIA-TELANGIECTASIA; PARKINSONS-DISEASE; LAMIN-A; SKIN FIBROBLASTS	Single-gene mutations can produce human progeroid syndromes-phenotypes that mimic usual or "normative" aging. These can be divided into two classes-those that have their impacts upon multiple organs and tissues (segmental progeroid syndromes) and those that have their major impacts upon a single organ or tissue (unimodal progeroid syndromes). The prototypic example of the former is the Werner syndrome, a condition caused by mutations of the RecQ family of DNA helicases. Research on the Werner syndrome and a surprising number of other progeroid syndromes support the importance of the maintenance of genomic stability as a partial antidote to aging. The prototypic examples of the latter are Alzheimer type dementias. The three gene products that cause rare autosomal-dominant early-onset varieties of these disorders all participate in the modulation of the P amyloid precursor protein. They thus support the importance of the maintenance of proper protein processing and folding as a partial antidote to aging.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Martin, GM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	gmmartin@u.washington.edu			NATIONAL CANCER INSTITUTE [R24CA078088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019711] Funding Source: NIH RePORTER; NCI NIH HHS [CA078088] Funding Source: Medline; NIA NIH HHS [AG019711] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agarwal AK, 2004, TRENDS MOL MED, V10, P440, DOI 10.1016/j.molmed.2004.07.009; Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Bonifati V, 2004, CELL MOL LIFE SCI, V61, P1729, DOI 10.1007/s00018-004-4104-1; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Brown V. K., 1983, DIAPAUSE LIFE CYCLE; BROWN WT, 2003, CHROMOSOMAL INSTABIL, P245; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; COVLIN L, 2003, CHROMOSOMAL INSTABIL, P441; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Di Fonzo A, 2005, LANCET, V365, P412; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Dork T, 2004, AM J MED GENET A, V126A, P272, DOI 10.1002/ajmg.a.20601; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; EGGEN DA, 1968, LAB INVEST, V18, P571; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Fischel-Ghodsian N, 2000, MOL GENET METAB, V71, P93, DOI 10.1006/mgme.2000.3014; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; George-Hyslop PH, 2000, DRUG NEWS PERSPECT, V13, P281; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; GOTO M, 2001, PREMATURE GRAY HAIR; GOTO M, 1996, BIOMARKERS PREV, V5, P239; HOEHN H, 2003, CHROMOSOMAL INSTABIL, P375; HOFER AC, 2004, J GERONTOL BIOL SCI, V59; HU P, 2004, CHROMOSOMAL INSTABIL, P187; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jaramillo C, 1985, Birth Defects Orig Artic Ser, V21, P119; Javor ED, 2004, J CLIN ENDOCR METAB, V89, P3199, DOI 10.1210/jc.2003-032140; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kim KM, 2004, AM J PATHOL, V164, P1369, DOI 10.1016/S0002-9440(10)63223-3; KITAO S, 2003, CHROMOSOMAL INSTABIL, P223; Le W, 2004, CURR OPIN PHARMACOL, V4, P79, DOI 10.1016/j.coph.2003.09.005; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Leone A, 2005, SKELETAL RADIOL, V34, P47, DOI 10.1007/s00256-004-0792-8; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; Martin G M, 1982, Natl Cancer Inst Monogr, V60, P241; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Martin GM, 2002, ARCH NEUROL-CHICAGO, V59, P1702, DOI 10.1001/archneur.59.11.1702; MARTIN GM, 1972, LANCET, V2, P1370; MARTIN GM, 2002, SCI AGING KNOWLEDGE, V9; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; MEYS MS, 2003, CHROMOSOMAL INSTABIL, P263; MONNAT RJ, 2004, SCI AGING KNOWLEDGE, V13, pRE3; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Oshima J, 2002, CANCER RES, V62, P547; Oxombre B, 2004, BIOCHEM J, V383, P573, DOI 10.1042/BJ20040473; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; SALK D, 1981, CYTOGENET CELL GENET, V30, P108, DOI 10.1159/000131597; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; SEIP M, 1963, ARCH DIS CHILD, V38, P447, DOI 10.1136/adc.38.201.447; Shahrabani-Gargir L, 2004, ENDOCRINOLOGY, V145, P5679, DOI 10.1210/en.2004-0613; Sharma S, 2004, HUM MOL GENET, V13, P2247, DOI 10.1093/hmg/ddh234; Shen H, 2004, J MED GENET, V41, P743, DOI 10.1136/jmg.2004.020396; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Sutton IJ, 2004, ANN NEUROL, V55, P891, DOI 10.1002/ana.20139; Szatkiewicz JP, 2004, AM J HUM GENET, V75, P906, DOI 10.1086/425523; TSUCHIYA H, 1991, JPN J CLIN ONCOL, V21, P135, DOI 10.1093/oxfordjournals.jjco.a039443; UND HOV, 2004, PROG NEUROBIOL, V73, P151; Venesio T, 2003, LAB INVEST, V83, P1859, DOI 10.1097/01.LAB.0000106722.37873.8D; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	88	125	132	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					523	532		10.1016/j.cell.2005.01.031	http://dx.doi.org/10.1016/j.cell.2005.01.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734684	Bronze			2022-12-28	WOS:000227271500009
J	Mooij, H				Mooij, H			Physics - The road to quantum computing	SCIENCE			English	Editorial Material									Delft Univ Technol, Kavli Inst Neurosci, Appl Phys Lab, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Mooij, H (corresponding author), Delft Univ Technol, Kavli Inst Neurosci, Appl Phys Lab, NL-2628 CJ Delft, Netherlands.	j.e.mooij@tnw.tudelft.nl						McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	4	22	22	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1210	1211		10.1126/science.1109554	http://dx.doi.org/10.1126/science.1109554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731432				2022-12-28	WOS:000227313200031
J	Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S				Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S			NMR structure of Mistic, a membrane-integrating protein for membrane protein expression	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RESONANCE; CHANNEL; SPECTROSCOPY; SENSITIVITY	Although structure determination of soluble proteins has become routine, our understanding of membrane proteins has been limited by experimental bottlenecks in obtaining both sufficient yields of protein and ordered crystals. Mistic is an unusual Bacillus subtilis integral membrane protein that folds autonomously into the membrane, bypassing the cellular translocon machinery. Using paramagnetic probes, we determined by nuclear magnetic resonance (NMR) spectroscopy that the protein forms a helical bundle with a surprisingly polar lipid-facing surface. Additional experiments suggest that Mistic can be used for high-level production of other membrane proteins in their native conformations, including many eukaryotic proteins that have previously been intractable to bacterial. expression.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Riek, R (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	riek@salk.edu; choe@salk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM056653] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kiefer H, 2000, RECEPTOR CHANNEL, V7, P109; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ritter C, 2004, J BIOMOL NMR, V28, P289, DOI 10.1023/B:JNMR.0000013698.89582.dc; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Wuthrich K, 1998, NAT STRUCT BIOL, V5, P492, DOI 10.1038/728; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	25	214	229	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1317	1321		10.1126/science.1106392	http://dx.doi.org/10.1126/science.1106392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731457				2022-12-28	WOS:000227313200061
J	Solomon, SC; Aharonson, O; Aurnou, JM; Banerdt, WB; Carr, MH; Dombard, AJ; Frey, HV; Golombek, MP; Hauck, SA; Head, JW; Jakosky, BM; Johnson, CL; McGovern, PJ; Neumann, GA; Phillips, RJ; Smith, DE; Zuber, MT				Solomon, SC; Aharonson, O; Aurnou, JM; Banerdt, WB; Carr, MH; Dombard, AJ; Frey, HV; Golombek, MP; Hauck, SA; Head, JW; Jakosky, BM; Johnson, CL; McGovern, PJ; Neumann, GA; Phillips, RJ; Smith, DE; Zuber, MT			New perspectives on ancient Mars	SCIENCE			English	Review							MARTIAN HYDROTHERMAL SYSTEMS; HF-W CHRONOMETRY; MAGNETIC-FIELD; THERMAL EVOLUTION; TERRESTRIAL PLANETS; GLOBAL DISTRIBUTION; NORTHERN PLAINS; CRUSTAL MAGNETIZATION; EARLY DIFFERENTIATION; MANTLE CONVECTION	Mars was most active during its first billion years. The core, mantle, and crust formed within similar to50 million years of solar system formation. A magnetic dynamo in a convecting fluid core magnetized the crust, and the global field shielded a more massive early atmosphere against solar wind stripping. The Tharsis province became a focus for volcanism, deformation, and outgassing of water and carbon dioxide in quantities possibly sufficient to induce episodes of climate warming. Surficial and near-surface water contributed to regionally extensive erosion, sediment transport, and chemical alteration. Deep hydrothermal circulation accelerated crustal cooling, preserved variations in crustal thickness, and modified patterns of crustal magnetization.	Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; NASA, Terr Phys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Carnegie Institution for Science; California Institute of Technology; University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Case Western Reserve University; Brown University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Solomon, SC (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	scs@dtm.ciw.edu	Banerdt, William/Q-7324-2019; Neumann, Gregory A/I-5591-2013; Hauck, Steven A/A-7865-2008	Banerdt, William/0000-0003-3125-1542; Neumann, Gregory A/0000-0003-0644-9944; Hauck, Steven A/0000-0001-8245-146X; McGovern, Patrick/0000-0001-9647-3096; Aharonson, Oded/0000-0001-9930-2495				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Anderson RC, 2001, J GEOPHYS RES-PLANET, V106, P20563, DOI 10.1029/2000JE001278; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Banerdt W.A., 2001, LUNAR PLANET SCI, VXXXII; Banerdt W.B., 2000, LUNAR PLANET SCI, V31, P2038; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; BULLOCK MA, 2001, EOS S, V82, pF708; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; CARR MH, 1995, J GEOPHYS RES-PLANET, V100, P7479, DOI 10.1029/95JE00260; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Connerney JEP, 2001, GEOPHYS RES LETT, V28, P4015, DOI 10.1029/2001GL013619; CONNERNEY JEP, 2004, LUNAR PLANET SCI, V35, P1114; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; Dohm JM, 1999, PLANET SPACE SCI, V47, P411, DOI 10.1016/S0032-0633(98)00141-X; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Elkins-Tanton LT, 2003, METEORIT PLANET SCI, V38, P1753, DOI 10.1111/j.1945-5100.2003.tb00013.x; Fairen AG, 2003, ICARUS, V165, P53, DOI 10.1016/S0019-1035(03)00144-1; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FOLEY CN, UNPUB GEOCHIM COSMOC; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013832; FREY HV, 2003, LUNAR PLANET SCI, V34, P1838; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Harder H, 1996, NATURE, V380, P507, DOI 10.1038/380507a0; HARPER CL, 1995, SCIENCE, V267, P213, DOI 10.1126/science.7809625; Harrison KP, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001616; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; HESS PC, 2001, LUNAR PLANET SCI, V32, P1319; Hood LL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016657; Hynek BM, 2003, GEOLOGY, V31, P757, DOI 10.1130/G19607.1; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Johnson CL, 2005, EARTH PLANET SC LETT, V230, P241, DOI 10.1016/j.epsl.2004.10.038; JOHNSON HP, 1993, J GEOPHYS RES-SOL EA, V98, P435, DOI 10.1029/92JB01322; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; KORTENKAMP SJ, 2000, ORIGIN EARTH MOON, P85; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; Lenardic A, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002172; Lunine JI, 2003, ICARUS, V165, P1, DOI 10.1016/S0019-1035(03)00172-6; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Mathew KJ, 2001, J GEOPHYS RES-PLANET, V106, P1401, DOI 10.1029/2000JE001255; McEwen AS, 1999, NATURE, V397, P584, DOI 10.1038/17539; McGovern PJ, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001854; McLennan SM, 2001, GEOPHYS RES LETT, V28, P4019, DOI 10.1029/2001GL013743; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; Montesi LGJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001974; Neumann GA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002262; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Nimmo F, 2000, GEOLOGY, V28, P391, DOI 10.1130/0091-7613(2000)028<0391:DIAAPC>2.3.CO;2; Nimmo F, 2001, J GEOPHYS RES-PLANET, V106, P12315, DOI 10.1029/2000JE001325; Norman MD, 1999, METEORIT PLANET SCI, V34, P439, DOI 10.1111/j.1945-5100.1999.tb01352.x; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Parker RL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2001JE001760; PARMENTIER EM, 2002, LUNAR PLANET SCI, V33, P1737; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Scott ERD, 2004, EARTH PLANET SC LETT, V220, P83, DOI 10.1016/S0012-821X(04)00032-9; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; Shock EL, 1997, J GEOPHYS RES-PLANET, V102, P23687, DOI 10.1029/97JE01087; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SOLOMON SC, 1992, ANNU REV EARTH PL SC, V20, P329; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; TANAKA KL, 1988, P 18 LUN PLAN SCI C, P665; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; Travis BJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001877; Varnes ES, 2003, ASTROBIOLOGY, V3, P407, DOI 10.1089/153110703769016479; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P449, DOI 10.1016/S0012-821X(02)00728-8; Wenzel MJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019306; Wieczorek MA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002153; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; Williams JP, 2004, GEOLOGY, V32, P97, DOI 10.1130/G19975.1; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Yoder CF, 2003, SCIENCE, V300, P299, DOI 10.1126/science.1079645; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	102	219	223	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1214	1220		10.1126/science.1101812	http://dx.doi.org/10.1126/science.1101812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731435	Green Submitted			2022-12-28	WOS:000227313200034
J	Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N				Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N			Model of outcomes of screening mammography: information to support informed choices	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA IN-SITU; BREAST-CANCER; WOMEN; METAANALYSIS	Objective To provide easy to use estimates of the benefits and harms of biennial screening mammography for women aged 40, 50, 60, and 70 years. Design Markov process model, with data from BreastScreen Australia, the Australian Institute of Health and Welfare, and the Australian Bureau of Statistics. Main outcome measure Age specific outcomes expressed per 1000 women over 10 years. Results For every 1000 women screened over 10 years, 167-251 (depending on age) receive an abnormal result; 56-64 of these women undergo at least one biopsy, 9-26 have an invasive cancer detected by screening, and 3-6 have ductal carcinoma in situ (DCIS) detected by screening. More breast cancers (both invasive and DCIS) are diagnosed among screened than unscreened women. For example, among 1000 women aged 50 who have five biennial screens, 33 breast cancers are diagnosed: 28 invasive cancers (18 detected at screening and 10 interval cancers) and five DCTS (all detected at screening). By comparison, among 1000 women aged 50 who decline screening, 20 cancers are diagnosed over 10 years. There are about 0.5, 2, 3, and 2 fewer deaths from breast cancer over 10 years per 1000 women aged 40, 50, 60, and 70, respectively, who choose to be screened compared with women who decline screening at times determined by relevant policy. Conclusion Benefits and harms of screening mammography are relatively finely balanced. Quantitative estimates such as these can be used to support individual informed choices about screening.	Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Barratt, A (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	alexb@usyd.edu.au	Barratt, Alexandra/A-7349-2011; Houssami, Nehmat/ABC-1103-2020	Barratt, Alexandra/0000-0002-2561-3319; Houssami, Nehmat/0000-0002-3641-952X; Howard, Kirsten/0000-0002-0918-7540				Anttila A, 2002, J MED SCREEN, V9, P153, DOI 10.1136/jms.9.4.153; *AUSTR I HLH WELF, 2000, CANC SER AUSTR I HLT, V13; *AUSTR I HLTH WELF, 2003, BREASTSCREEN AUSTR M; *AUSTR I HLTH WELF, 2000, CANC SER AUSTR I HLT, V13; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; *BREASTSCREEN AUST, WHO SHOULD HAV MAMM; *BREASTSCREEN SA, 2003, BREASTSCREEN SA STAT; *BREASTSCREEN VICT, 2002, BREASTSCREEN VICT 20; Chen H H, 1995, J Med Screen, V2, P10; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Ernster VL, 2002, J NATL CANCER I, V94, P1546; *GEN MED COUNC, SEEK PAT CONS ETH CO; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; IRWIG I, 1997, REV EVIDENCE VALUE M; Irwig L., 1997, REV EVIDENCE VALUE M; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Paci E, 2004, J MED SCREEN, V11, P23, DOI 10.1258/096914104772950718; *QUEENSL HLTH, 2001, BREASTSCREEN QUEENSL; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Taylor R, 2001, J MED SCREEN, V8, P73, DOI 10.1136/jms.8.2.73; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; *UK NAT SCREEN COM, 2 UK NAT SCREEN COMM; Van Zee KJ, 1999, CANCER-AM CANCER SOC, V86, P1757, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1757::AID-CNCR18>3.0.CO;2-V; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	26	94	95	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					936	938		10.1136/bmj.38398.469479.8F	http://dx.doi.org/10.1136/bmj.38398.469479.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15755755	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000228715900019
J	Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR				Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR		Canc Genome Project	Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders	LANCET			English	Article							POLYCYTHEMIA-VERA; DIAGNOSTIC-CRITERIA; ESSENTIAL THROMBOCYTHEMIA; PROGENITOR CELLS; STEM-CELL; BCL-X; EXPRESSION; RECEPTOR; HYPERSENSITIVITY; MYELOFIBROSIS	Background Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis. The molecular pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders. We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder. Methods We obtained DNA samples from patients with polycythaemia vera, essential thrombocythaemia, or idiopathic myelofibrosis. The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both. Allele-specific PCR, molecular cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients. Findings A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis. The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the negative regulatory JH2 domain, and is predicted to dysregulate kinase activity. It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells. The mutation was present in all erythropoietin-independent erythroid colonies. Interpretation A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder. Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biological feature of these disorders. Relevance to practice Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.	Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	Erber, Wendy/A-1955-2012; Scott, Linda/D-9777-2012	Scott, Linda/0000-0003-0334-1479; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Vassiliou, George/0000-0003-4337-8022; Green, Anthony/0000-0002-9795-0218; Erber, Wendy/0000-0002-1028-9376; Raine, Keiran/0000-0002-5634-1539	Wellcome Trust [088340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; FIALKOW PJ, 1981, BLOOD, V58, P916; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Green AR, 2004, HEMATOL J, V5, pS126, DOI 10.1038/sj.thj.6200438; Griesshammer M, 2004, ANN HEMATOL, V83, P364, DOI 10.1007/s00277-004-0864-9; Harrison CN, 2003, HEMATOL ONCOL CLIN N, V17, P1175, DOI 10.1016/S0889-8588(03)00082-0; Hinshelwood S, 1997, BLOOD REV, V11, P224, DOI 10.1016/S0268-960X(97)90021-7; Klippel S, 2003, BLOOD, V102, P3569, DOI 10.1182/blood-2003-03-0919; KOBAYASHI S, 1993, BRIT J HAEMATOL, V83, P539, DOI 10.1111/j.1365-2141.1993.tb04688.x; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Kralovics R, 2005, BLOOD REV, V19, P1, DOI 10.1016/j.blre.2004.02.002; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; LI Y, 1994, BRIT J HAEMATOL, V87, P471, DOI 10.1111/j.1365-2141.1994.tb08300.x; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skoda RC, 2004, HEMATOL J, V5, pS122, DOI 10.1038/sj.thj.6200437; Spivak Jerry L, 2003, Hematology Am Soc Hematol Educ Program, P200; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Wadleigh M, 2005, BLOOD, V105, P22, DOI 10.1182/blood-2003-11-3896	36	2642	2898	1	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1054	1061		10.1016/S0140-6736(05)71142-9	http://dx.doi.org/10.1016/S0140-6736(05)71142-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781101				2022-12-28	WOS:000227731800030
J	Doust, JA; Pietrzak, E; Dobson, A; Glasziou, PP				Doust, JA; Pietrzak, E; Dobson, A; Glasziou, PP			How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review	BRITISH MEDICAL JOURNAL			English	Article							LEFT-VENTRICULAR DYSFUNCTION; PROGNOSTIC VALUE; RISK STRATIFICATION; PLASMA-LEVELS; TROPONIN-T; MORTALITY; SURVIVAL; CARDIOMYOPATHY; COMBINATION; POPULATION	Objective To assess how well B-type natriuretic peptide (BNP) predicts prognosis in patients with heart failure. Design Systematic review of studies assessing BNP for prognosis m patients with heart failure or asymptomatic patients. Data sources Electronic searches of Medline and Embase from January 1994 to March 2004 and reference lists of included studies. Study selection and data extraction We included all studies that estimated the relation between BNP measurement and the risk of death, cardiac death, sudden death, or cardiovascular event in patients with heart failure or asymptomatic patients, including initial values and changes in values in response to treatment. Multivariable models that included both BNP and left ventricular ejection fraction as predictors were used to compare the prognostic value of each variable. Two reviewers independently selected studies and extracted data. Data synthesis 19 studies used BNP to estimate the relative risk of death or cardiovascular events in heart failure patients and five studies in asymptomatic patients. In heart failure patients, each 100 pg/ml increase was associated with a 35% increase in the relative risk of death. BNP was used in 35 multivariable models of prognosis. In nine of the models, it was the only variable to reach significance-that is, other variables contained no prognostic information beyond that of BNP. Even allowing for the scale of the variables, it seems to be a strong indicator of risk. Conclusion Although systematic reviews of prognostic studies have inherent difficulties, including die possibility of publication bias, the results of the studies in this review show that BNP is a strong prognostic indicator for both asymptomatic patients mid for patients with heart failure at all stages of disease.	Univ Queensland, Sch Med, Ctr Gen Practice, Herston, Qld 4006, Australia; Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia; Ctr Evidence Based Practice, Oxford, England	University of Queensland; University of Queensland; University of Oxford	Doust, JA (corresponding author), Univ Queensland, Sch Med, Ctr Gen Practice, Herston Rd, Herston, Qld 4006, Australia.	j.doust@sph.uq.edu.au	Dobson, Annette J/B-5273-2008; Doust, Jenny/AGI-8773-2022; Glasziou, Paul/A-7832-2008	Doust, Jenny/0000-0002-4024-9308; Glasziou, Paul/0000-0001-7564-073X				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bettencourt P, 2002, AM J MED, V113, P215, DOI 10.1016/S0002-9343(02)01184-1; Bettencourt P, 2000, J CARD FAIL, V6, P306, DOI 10.1054/jcaf.2000.20558; Bouvy ML, 2003, HEART, V89, P605, DOI 10.1136/heart.89.6.605; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; Cowie MR, 2000, HEART, V83, P505, DOI 10.1136/heart.83.5.505; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; Hulsmann M, 2002, EUR HEART J, V23, P886, DOI 10.1053/euhj.2001.3115; Imamura Y, 2001, JPN CIRC J, V65, P155, DOI 10.1253/jcj.65.155; Ishii J, 2002, AM J CARDIOL, V89, P691, DOI 10.1016/S0002-9149(01)02341-4; Ishii J, 2003, CLIN CHEM, V49, P2020, DOI 10.1373/clinchem.2003.021311; Isnard R, 2003, AM HEART J, V146, P729, DOI 10.1016/S0002-8703(03)00365-x; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Matsui T, 2002, CIRC J, V66, P537, DOI 10.1253/circj.66.537; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Murdoch DR, 1999, AM HEART J, V138, P1126, DOI 10.1016/S0002-8703(99)70079-7; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; SCRUTINIO D, 1994, EUR HEART J, V15, P1089, DOI 10.1093/oxfordjournals.eurheartj.a060633; Selvais PL, 2000, J CARD FAIL, V6, P201, DOI 10.1054/jcaf.2000.8833; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Tamura K, 2001, GERONTOLOGY, V47, P46, DOI 10.1159/000052769; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 1997, CIRCULATION, V96, P509; Tsutamoto T, 1999, EUR HEART J, V20, P1799, DOI 10.1053/euhj.1999.1746; Tsutamoto T, 2001, J CARD FAIL, V7, P322, DOI 10.1054/jcaf.2001.30134; Tsutsui T, 2002, J AM COLL CARDIOL, V39, P957, DOI 10.1016/S0735-1097(02)01721-7; Ueda R, 2003, AM J MED, V114, P266, DOI 10.1016/S0002-9343(02)01525-5; Vrtovec B, 2003, CIRCULATION, V107, P1764, DOI 10.1161/01.CIR.0000057980.84624.95; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wijeysundera HC, 2003, AM HEART J, V146, P291, DOI 10.1016/S0002-8703(03)00171-6; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5; Zugck C, 2002, J AM COLL CARDIOL, V39, P1615, DOI 10.1016/S0735-1097(02)01840-5	41	540	568	2	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					625	627		10.1136/bmj.330.7492.625	http://dx.doi.org/10.1136/bmj.330.7492.625			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774989	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000227861700019
J	Knippenberg, R; Lawn, JE; Darmstadt, GL; Begkoyian, G; Fogstad, H; Walelign, N; Paul, VK				Knippenberg, R; Lawn, JE; Darmstadt, GL; Begkoyian, G; Fogstad, H; Walelign, N; Paul, VK		Lancet Neonatal Survival Steering	Neonatal survival 3 - Systematic scaling up of neonatal care in countries	LANCET			English	Article							PERINATAL AUDIT; HEALTH-SYSTEMS; OBSTETRIC CARE; MORTALITY; MANAGEMENT; METAANALYSIS; INFANTS; RATES; POOR	Every year about 70% of neonatal deaths (almost 3 million) happen because effective yet simple interventions do not reach those most in need. Coverage of interventions is low, progress in scaling up is slow, and inequity is high, especially for skilled clinical interventions. Situations vary between and within countries, and there is no single solution to saving lives of newborn babies. To scale up neonatal care, two interlinked processes are required: a systematic, data-driven decision-making process, and a participatory, rights-based policy process. The first step is to assess the situation and create a policy environment conducive to neonatal health. The next step is to achieve optimum care of newborn infants within health system constraints; in the absence of strong clinical services, programmes can start with family and community care and outreach services. Addressing missed opportunities within the limitations of health systems, and integrating care of newborn children into existing programmes eg, safe motherhood and integrated management of child survival initiatives-reduces deaths at a low marginal cost. Scaling up of clinical care is a challenge but necessary if maximum effect and equity are to be achieved in neonatal health, and maternal deaths are to be reduced. This step involves systematically strengthening supply of, and demand for, services. Such a phased programmatic implementation builds momentum by reaching achievable targets early on, while building stronger health systems over the longer term. Purposeful orientation towards the poor is vital. Monitoring progress and effect is essential to refining strategies. National aims to reduce neonatal deaths should be set, and interventions incorporated into national plans and existing programmes.	UNICEF, Hlth Sect, New York, NY 10017 USA; Save Children USA, Saving Newborn Lives, Washington, DC USA; Inst Child Hlth, Int Perinatal Care Unit, Cape Town, South Africa; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; WHO, Making Pregnancy Safer Initiat, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; Essential Serv Hlth Project Ethiopia, Addis Ababa, Ethiopia; All India Inst Med Sci, WHO Collaborating Ctr Training & Res Newborn Care, Dept Pediat,Save Children USA, Saving Newborn Lives, New Delhi, India	UNICEF; Save the Children; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; All India Institute of Medical Sciences (AIIMS) New Delhi; Save the Children	Knippenberg, R (corresponding author), UNICEF, Hlth Sect, 3 UN Plaza, New York, NY 10017 USA.	rknippenberg@unicef.org	Darmstadt, Gary/AAU-7488-2020; Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Buekens P, 2003, BRIT MED J, V326, P136, DOI 10.1136/bmj.326.7381.136; BUGALHO A, 1993, GYNECOL OBSTET INVES, V36, P239, DOI 10.1159/000292637; Coco Gina, 2002, J Perinatol, V22 Suppl 2, ps1; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Costello A, 2000, BRIT MED J, V321, P827, DOI 10.1136/bmj.321.7264.827; DADHICH J, ADV AGENDA NEWBORN P; DARMSTADT GL, 2005, LANCET NEONATAL SURV; DATTA N, 1985, STUDY HLTH PROBLEMS; Deorari AK, 2000, J TROP PEDIATRICS, V46, P315, DOI 10.1093/tropej/46.5.315; FREEDMAN L, TASK FORCE 4 CHILD H; GERTLER PJ, 2000, EXPT INCENTIVES BASE; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Haines A, 2004, LANCET, V364, P1204, DOI 10.1016/S0140-6736(04)17160-2; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; *HLTH NEWB PARTN, NEWB HLTH POL PLANN; Janowitz B., 1988, Health Policy and Planning, V3, P48, DOI 10.1093/heapol/3.1.48; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KHADKA N, HEPALS NEONATAL HLTH; Knippenberg R, 1997, INT J HEALTH PLAN M, V12, pS9, DOI 10.1002/(SICI)1099-1751(199706)12:1+<S9::AID-HPM471>3.3.CO;2-U; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Lawn J, 2001, HLTH NEWBORN REFER 2; LAWN J, 2005, DIS CONTROL PRIORITI; LAWN JE, 2005, LANCET NEONATAL SURV; LAWN JE, 2002, 4 SETTINGS NEWBORN H; Lawn JE, 2005, ESTIMATING CAUSES 4; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; ManceyJones M, 1997, HEALTH POLICY PLANN, V12, P183, DOI 10.1093/heapol/12.3.183; Martey J O, 1998, West Afr J Med, V17, P58; MARTINES J, 2005, NEONATAL SERVIVAL CA; *MEASURE, 1999, IMPR MON EV MAT PER; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Okuonzi SA, 2004, BMJ-BRIT MED J, V329, P1173, DOI 10.1136/bmj.329.7475.1173; Osrin D, 2004, CURR OPIN INFECT DIS, V17, P217, DOI 10.1097/00001432-200406000-00008; Osrin D, 2003, T ROY SOC TROP MED H, V97, P18, DOI 10.1016/S0035-9203(03)90008-3; Parlato R, 2004, QUALITATIVE RES IMPR; PATTINSON RC, SAVING BABIES 2001 2; Paul Vinod K, 2004, Semin Neonatol, V9, P117, DOI 10.1016/j.siny.2003.08.010; Penny S, 2000, HEALTH POLICY PLANN, V15, P386, DOI 10.1093/heapol/15.4.386; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; Preker AS, 2002, B WORLD HEALTH ORGAN, V80, P143; Ronsmans C, 2001, TROP MED INT HEALTH, V6, P799, DOI 10.1046/j.1365-3156.2001.00780.x; Russell S, 1997, INT J HEALTH SERV, V27, P359, DOI 10.2190/YHL2-F0EA-JW1M-DHEJ; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Soucat A, 2002, MARGINAL BUDGETING B; SOUCAT A, 2005, INT J HEALTH PLAN MA, V12, P137; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UNICEF, 2004, STAT WORLDS CHILDR 2; World Bank, 2004, MAK SERV WORK POOR P; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2003, MAN NEWB PROBL GUID; World Health Organization, 2000, MAN COMPL PREGN CHIL	58	200	204	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1087	1098		10.1016/S0140-6736(05)71145-4	http://dx.doi.org/10.1016/S0140-6736(05)71145-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781104				2022-12-28	WOS:000227731800033
J	Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M				Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M			Lophenteropneust' hypothesis refuted by collection and photos of new deep-sea hemichordates	NATURE			English	Article							PACIFIC	The deep ocean is home to a group of broad-collared hemichordates - the so-called 'lophenteropneusts' - that have been photographed gliding on the sea floor(1-8) but have not previously been collected. It has been claimed that these worms have collar tentacles and blend morphological features of the two main hemichordate body plans, namely the tentacle-less enteropneusts and the tentacle-bearing pterobranchs. Consequently, lophenteropneusts have been invoked as missing links to suggest that the former evolved into the latter(5). The most significant aspect of the lophenteropneust hypothesis is its prediction that the fundamental body plan within a basal phylum of deuterostomes was enteropneust-like. The assumption of such an ancestral state influences ideas about the evolution of the vertebrates from the invertebrates(9-14). Here we report on the first collected specimen of a broad-collared, deep-sea enteropneust and describe it as a new family, genus and species. The collar, although disproportionately broad, lacks tentacles. In addition, we find no evidence of tentacles in the available deep-sea photographs ( published and unpublished) of broad-collared enteropneusts, including those formerly designated as lophenteropneusts. Thus, the lophenteropneust hypothesis was based on misinterpretation of deep-sea photographs of low quality and should no longer be used to support the idea that the enteropneust body plan is basal within the phylum Hemichordata.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117851, Russia; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; Natl Museum Nat Hist, NOAA, Natl Systemat Lab, Washington, DC 20013 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Russian Academy of Sciences; Shirshov Institute of Oceanology; Smithsonian Institution; Smithsonian National Museum of Natural History; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Holland, ND (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	nholland@ucsd.edu	Gebruk, Andrey/A-9041-2016					Bateson W., 1886, Q J MICROSC SCI, V26, P535; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; BOURNE DW, 1965, SCIENCE, V150, P60, DOI 10.1126/science.150.3692.60; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Dilly P.N., 1975, Symposia Zool Soc Lond, VNo. 36, P1; Ewing M., 1967, DEEP SEA PHOTOGRAPHY, P259; FOELL EJ, 1986, OHIO J SCI, V86, P61; Gage J. D., 1991, DEEP SEA BIOL NATURA; GAILLARD C, 1991, Palaios, V6, P302, DOI 10.2307/3514910; Heezen B.C., 1971, FACE DEEP; JACOBS SS, 1970, HYDROGRAPHIC STATION, P32; Jefferies RPS, 2001, SYST ASSOC SPEC VOL, V61, P40; JOLLIE M, 1973, ACTA ZOOLOGICA, V54, P81; LEMCHE H, 1976, VINDENSK MEDDR DANSK, V139, P262; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; PAWSON D, 2003, DEEP SEA NEWSL, V32, P6; SPENGEL JW, 1893, MONOGRAPH, V18; Tendal Ole Secher, 1998, Deep-Sea Newsletter, V27, P21; TENDAL OS, 1999, DEEP SEA NEWSL, V28, P8; Thiel H., 1979, Ambio Special Report, P25; THORNDIKE EM, 1982, OCEAN FLOOR, P255; WOODWICK KH, 1985, P BIOL SOC WASH, V98, P351; WOODWICK KH, 1993, TAXONOMIC ATLAS BENT, V14, P251; Young CM, 2003, ECOSY WORLD, V28, P381	25	39	42	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					374	376		10.1038/nature03382	http://dx.doi.org/10.1038/nature03382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772659				2022-12-28	WOS:000227715100049
J	Lonn, E; Bosch, J; Yusuf, S; Sheridan, P; Pogue, J; Arnold, JMO; Ross, C; Arnold, A; Sleight, P; Probstfield, J; Dagenais, GR				Lonn, E; Bosch, J; Yusuf, S; Sheridan, P; Pogue, J; Arnold, JMO; Ross, C; Arnold, A; Sleight, P; Probstfield, J; Dagenais, GR		HOPE Investigators; HOPE-TOO Investigators	Effects of long-term supplementation on and cancer vitamin E cardiovascular events - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; SERUM ALPHA-TOCOPHEROL; ANTIOXIDANT VITAMINS; BETA-CAROTENE; LUNG-CANCER; PROSTATE-CANCER; PREVENTION; RISK; DISEASE; ATHEROSCLEROSIS	Context Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration. Objective To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events. Design, Setting, and Patients A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003. Of the initial 267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial. Of 7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up. Median duration of follow-up was 7.0 years. Intervention Daily dose of natural source vitamin E (400 IU) or matching placebo. Main Outcome Measures Primary outcomes included cancer incidence, cancer deaths, and major cardiovascular events (myocardial infarction, stroke, and cardiovascular death). Secondary outcomes included heart failure, unstable angina, and revascularizations. Results Among all HOPE patients, there were no significant differences in the primary analysis: for cancer incidence, there were 552 patients (11.6%) in the vitamin E group vs 586 (12.3%) in the placebo group (relative risk [RR], 0.94; 95% confidence interval [CI], 0.84-1.06; P=30); for cancer deaths, 156 (3.3%) vs 178 (3.7%), respectively (RR, 0.88; 95% Cl, 0.71-1.09; P=.24); and for major cardiovascular events, 1022 (21.5%) vs 985 (20.6%), respectively (RR, 1.04; 95% Cl, 0.96-1.14; P=34). Patients in the vitamin E group had a higher risk of heart failure (RR, 1.13; 95% Cl, 1.01 -1.26; P=.03) and hospitalization for heart failure (RR, 1.21; 95% Cl, 1.00-1.47; P=.045). Similarly, among patients enrolled at the centers participating in the HOPE-TOO trial, there were no differences in cancer incidence, cancer deaths, and major cardiovascular events, but higher rates of heart failure and hospitalizations for heart failure. Conclusion In patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent cancer or major cardiovascular events and may increase the risk for heart failure.	Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci Corp, Hamilton, ON L8L 2X2, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; McMaster Univ, Dept Med & Med Oncol, Hamilton, ON, Canada; Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; Univ Washington, Sch Med, Seattle, WA USA; Univ Laval, Inst Cardiol, Ste Foy, PQ G1K 7P4, Canada	Population Health Research Institute; McMaster University; Western University (University of Western Ontario); McMaster University; University of Oxford; University of Washington; University of Washington Seattle; Laval University	Lonn, E (corresponding author), Populat Hlth Res Inst, Gen Site,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	lonnem@mcmaster.ca	Arnold, Malcolm/G-2869-2011; Zinman, Bernard/E-7266-2013; Hegele, Robert/G-3301-2011; Bosch, Jacqueline/AAP-6910-2021; Hramiak, Irene/G-3305-2011	Bosch, Jacqueline/0000-0001-6292-4207; Yusuf, Salim/0000-0003-4776-5601				Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bursell SE, 1999, DIABETES RES CLIN PR, V45, P169, DOI 10.1016/S0168-8227(99)00047-9; *COLL GROUP PRIM P, 2001, LANCET, V342, P154; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; GRIDLEY G, 1992, AM J EPIDEMIOL, V135, P1083, DOI 10.1093/oxfordjournals.aje.a116208; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Klein EA, 2000, PROSTATE CANCER P D, V3, P145, DOI 10.1038/sj.pcan.4500412; KNEKT P, 1988, AM J EPIDEMIOL, V127, P28, DOI 10.1093/oxfordjournals.aje.a114788; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; LONGNECKER MP, 1992, JNCI-J NATL CANCER I, V84, P430, DOI 10.1093/jnci/84.6.430; Lonn E, 2004, J AM COLL CARDIOL, V43, P2200, DOI 10.1016/j.jacc.2003.10.073; MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8; Meydani SN, 1998, NUTR REV, V56, pS49; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Ocke MC, 1997, AM J EPIDEMIOL, V145, P358, DOI 10.1093/oxfordjournals.aje.a009113; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PRASAD KN, 1992, J AM COLL NUTR, V11, P487; Shklar G, 1996, ORAL ONCOL, V32B, P114, DOI 10.1016/0964-1955(95)00077-1; Sigounas G, 1997, NUTR CANCER, V28, P30, DOI 10.1080/01635589709514549; Skyrme-Jones RAP, 2000, J AM COLL CARDIOL, V36, P94, DOI 10.1016/S0735-1097(00)00720-8; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINER M, 1991, J AM COLL NUTR, V10, P466; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VERLANGIERI AJ, 1992, J AM COLL NUTR, V11, P131; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Woodson K, 1999, JNCI-J NATL CANCER I, V91, P1738, DOI 10.1093/jnci/91.20.1738; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Ziegler RG, 1996, CANCER CAUSE CONTROL, V7, P157, DOI 10.1007/BF00115646	39	858	890	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1338	1347						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769967	Bronze			2022-12-28	WOS:000227698600022
J	Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL				Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL			Regulation of the polarity protein Par6 by TGF beta receptors controls epithelial cell plasticity	SCIENCE			English	Article							MESENCHYMAL TRANSITION; TIGHT JUNCTIONS; KINASE-C; TRANSDIFFERENTIATION; MECHANISMS; PATHWAYS; COMPLEX; GROWTH; SIGNAL; RHO	The transition of cells from an epithelia[ to a mesenchymal phenotype is a critical event during morphogenesis in multicellular organisms and underlies the pathology of many diseases, including the invasive phenotype associated with metastatic carcinomas. Transforming growth factor beta (TGFbeta) is a key regulator of epithetial-to-mesenchymal transition (EMT). However, the molecular mechanisms that control the dissolution of tight junctions, an early event in EMT, remain elusive. We demonstrate that Par6, a regulator of epithelia[ cell polarity and tight-junction assembly, interacts with TGFbeta receptors and is a substrate of the type II receptor, TbetaRII Phosphorylation of Par6 is required for TGFbeta-dependent EMT in mammary gland epithelia[ cells and controls the interaction of Par6 with the E3 ubiquitin ligase Smurf1. Smurf1, in turn, targets the guanosine triphosphatase RhoA for degradation, thereby leading to a loss of tight junctions. These studies define how an extracellular cue signals to the polarity machinery to control epithelia[ cell morphology.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Wrana, JL (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada.	wrana@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Bose, Rohit/O-9825-2018	Bose, Rohit/0000-0002-6785-0697; Wang, Hong-Rui/0000-0002-2916-8849				Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ehrlich M, 2001, J CELL SCI, V114, P1777; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Fujita H, 2000, BIOCHEM J, V346, P617, DOI 10.1042/0264-6021:3460617; Gao C, 2002, MOL CANCER RES, V1, P12; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kaartinen V, 2002, INT J MOL MED, V9, P563; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; OZDAMAR B, UNPUB; Pagan R, 1996, EXP CELL RES, V222, P333, DOI 10.1006/excr.1996.0043; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watts JL, 1996, DEVELOPMENT, V122, P3133; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	48	684	726	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1603	1609		10.1126/science.1105718	http://dx.doi.org/10.1126/science.1105718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761148				2022-12-28	WOS:000227622400042
J	Paradise, J; Andrews, L; Holbrook, T				Paradise, J; Andrews, L; Holbrook, T			Patents on human genes: An analysis of scope and claims	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY-RIGHTS; POLICY		Chicago Kent Coll Law, IIT, Chicago, IL 60661 USA	Illinois Institute of Technology	Paradise, J (corresponding author), Chicago Kent Coll Law, IIT, 565 W Adams, Chicago, IL 60661 USA.	jparadise@kent-law.edu						Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; BLANTON K, 2002, BOSTON GLOBE    0224, P10; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Gad S, 2001, J MED GENET, V38, P388, DOI 10.1136/jmg.38.6.388; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; MERGES RP, 1999, BERKELEY TECH L J, V14, P577; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a	9	41	43	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1566	1567		10.1126/science.1105162	http://dx.doi.org/10.1126/science.1105162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761140	Green Submitted			2022-12-28	WOS:000227622400027
J	Sablowski, R; Harberd, NP				Sablowski, R; Harberd, NP			Plant sciences on steroids	SCIENCE			English	Editorial Material							ARABIDOPSIS; GROWTH		John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Sablowski, R (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	robert.sablowski@bbsrc.ac.uk		Sablowski, Robert/0000-0002-1732-2909	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000594, P19972, BBS/E/J/00000583] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Wang ZY, 2004, TRENDS PLANT SCI, V9, P91, DOI 10.1016/j.tplants.2003.12.009; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044	9	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1569	1570		10.1126/science.1110534	http://dx.doi.org/10.1126/science.1110534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761142				2022-12-28	WOS:000227622400029
J	Weaver, RL				Weaver, RL			Information from seismic noise	SCIENCE			English	Editorial Material							CODA		Univ Illinois, Dept Theoret & Appl Mech, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Weaver, RL (corresponding author), Univ Illinois, Dept Theoret & Appl Mech, Urbana, IL 61801 USA.	r-weaver@uiuc.edu		Weaver, Richard/0000-0002-4526-5219				Fehler M, 2003, PURE APPL GEOPHYS, V160, P541, DOI 10.1007/PL00012549; Fink M, 1997, PHYS TODAY, V50, P34, DOI 10.1063/1.881692; Gough DO, 1996, SCIENCE, V272, P1281, DOI 10.1126/science.272.5266.1281; Hennino R, 2001, PHYS REV LETT, V86, P3447, DOI 10.1103/PhysRevLett.86.3447; Kedar S, 2005, SCIENCE, V307, P682, DOI 10.1126/science.1108380; Larose E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048501; Lobkis OI, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.254302; Sabra KG, 2005, J ACOUST SOC AM, V117, P164, DOI 10.1121/1.1835507; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Skipetrov S., 2003, WAVE SCATTERING COMP; Snieder R, 2002, SCIENCE, V295, P2253, DOI 10.1126/science.1070015; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301	12	91	106	5	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1568	1569		10.1126/science.1109834	http://dx.doi.org/10.1126/science.1109834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761141				2022-12-28	WOS:000227622400028
J	Barros, FC; Victora, CG; Barros, AJD; Santos, IS; Albernaz, E; Matijasevich, A; Domingues, MR; Sclowitz, IKT; Hallal, PC; Silveira, MF; Vaughan, JP				Barros, FC; Victora, CG; Barros, AJD; Santos, IS; Albernaz, E; Matijasevich, A; Domingues, MR; Sclowitz, IKT; Hallal, PC; Silveira, MF; Vaughan, JP			The challenge of reducing neonatal mortality in middle-income countries: findings from three Brazilian birth cohorts in 1982, 1993, and 2004	LANCET			English	Article							CESAREAN-SECTIONS; GESTATIONAL-AGE; PRETERM BIRTH; WEIGHT; DETERMINANTS; CHILDREN; HEALTH; TRENDS; RATES	Background Middle-income countries will need to drastically reduce neonatal deaths to achieve the Millennium Development Goal for child survival. The evolution of antenatal and perinatal care indicators in the Brazilian city of Pelotas from 1982 to 2004 provides a useful case study of potential challenges. Methods We prospectively studied three birth cohorts representing all urban births in 1982, 1993, and from January to July, 2004. The same methods were used in all three studies. Findings Despite improvements in maternal characteristics, prevalence of preterm births increased from 6.3% (294 of 4665) in 1982 to 16.2% (342 of 2112) in 2004, corresponding to a 47 g reduction in mean birthweight. Average number of antenatal visits in 2004 was 8.3 per woman, but quality of care was still inadequate - 97% of women had an ultrasound scan, but only 1830 (77%) had a vaginal examination and 559 of 1748 non-immunised women did not receive tetanus toxoid. Rate of Caesarean sections increased greatly, from 28% (1632 of 5914) in 1982 to 43% (1039 of 2403) in 2004, reaching 374 of 456 (82%) of all private deliveries in 2004. The increased rate of preterm births seemed to result largely from Caesarean sections or inductions. Newborn care improved, and gestational-age-specific mortality rates had fallen by about 50% since 1982. As a result, neonatal mortality rates had been stable since 1990, despite the increase in preterm deliveries. Interpretation Excessive medicalisation-including labour induction, Caesarean sections, and inaccurate ultrasound scans-led by an unregulated private sector with spill-over effects to the public sector, might offset the gains resulting from improved maternal health and newborn survival. These challenges will have to be faced by middle-income countries striving to achieve the child survival Millennium Development Goal.	Hosp Clin Montevideo, PAHO WHO Latin Amer Ctr Perinatol & Human Dev, Montevideo 11300, Uruguay; Univ Fed Pelotas, Pelotas, Brazil; Univ Catolica Pelotas, Pelotas, Brazil; London Sch Hyg & Trop Med, London WC1, England	Universidad de la Republica, Uruguay; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; University of London; London School of Hygiene & Tropical Medicine	Barros, FC (corresponding author), Hosp Clin Montevideo, PAHO WHO Latin Amer Ctr Perinatol & Human Dev, Piso 16, Montevideo 11300, Uruguay.	barrosfe@clap.ops-oms.org	Matijasevich, Alícia/D-5324-2013; Victora, Cesar Gomes/Y-2455-2019; Barros, Aluisio JD/A-7417-2008; Barros, Fernando C/D-4857-2013; Sandall, Jane/D-4146-2009; Silveira, Mariangela F/L-6868-2013; Domingues, Marlos R/A-4758-2009; Hallal, Pedro C/A-3249-2011; Matijasevich, Alicia/C-5576-2009; Victora, Cesar G/D-4476-2013; Santos, Ina S/C-2001-2009	Victora, Cesar Gomes/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Sandall, Jane/0000-0003-2000-743X; Silveira, Mariangela F/0000-0002-3551-9713; Domingues, Marlos R/0000-0002-2503-2944; Hallal, Pedro C/0000-0003-1470-6461; Matijasevich, Alicia/0000-0003-0060-1589; Victora, Cesar G/0000-0002-2465-2180; 	Wellcome Trust [WT072403] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1996, CADERNOS SAUDE PUBLI, DOI DOI 10.1590/S0102-311X1996000500005; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J; Barros FC, 2001, PAEDIATR PERINAT EP, V15, P4, DOI 10.1046/j.1365-3016.2001.00320.x; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Bettiol H, 2000, PAEDIATR PERINAT EP, V14, P30, DOI 10.1046/j.1365-3016.2000.00222.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bricker L, 2000, COCHRANE DB SYST REV, V2; BRUGHA R, 2003, B WORLD HEALTH ORGAN, V81, P8616; Demissie K, 2001, AM J EPIDEMIOL, V154, P307, DOI 10.1093/aje/154.4.307; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; GUYER B, 1995, PEDIATRICS, V96, P1029; Joseph KS, 2002, SEMIN PERINATOL, V26, P250, DOI 10.1053/sper.2002.34769; Joseph KS, 1998, NEW ENGL J MED, V339, P1434, DOI 10.1056/NEJM199811123392004; Joseph KS, 2001, AM J EPIDEMIOL, V153, P110, DOI 10.1093/aje/153.2.110; Kramer M. S., 2001, Nutrition and health in developing countries, P57; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Menezes A M, 1997, J Pediatr (Rio J), V73, P383; *MIN SAUD, 2004, MAN COM PREV OB INF; *MIN SAUD, 2004, SAUD BRAS 2004 AN SI, P78; *MIN SAUD, 2000, ASS PREN NORM MAN TE; Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155; *SAV CHILDR, 2001, STAT WORLDS NEWB REP; Silva AAM, 2004, INT J EPIDEMIOL, V33, P821, DOI 10.1093/ije/dyh101; Silveira D S, 2001, Cad Saude Publica, V17, P131, DOI 10.1590/S0102-311X2001000100013; UNICEF, 2004, STAT WORLDS CHILDR 2; Victora C G, 2001, Sao Paulo Med J, V119, P33; VICTORA CG, 1994, REV SAUDE PUBL, V28, P423, DOI 10.1590/S0034-89101994000600006; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Victora CG, 1996, CAD SAUDE PUBLICA S1, V12, P7; *WORLD BANK GROUP, DAT STAT COUNTR CLAS; *WORLD BANK GROUP, HLTH NUTR POP CHILD; Yang H, 2002, AM J OBSTET GYNECOL, V186, P433, DOI 10.1067/mob.2002.120487	34	202	228	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					847	854		10.1016/S0140-6736(05)71042-4	http://dx.doi.org/10.1016/S0140-6736(05)71042-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752528				2022-12-28	WOS:000227444600026
J	Briss, PA				Briss, PA			Evidence-based: US road and public-health side of the street	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Community Guide Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Briss, PA (corresponding author), Ctr Dis Control & Prevent, Community Guide Branch, Atlanta, GA 30333 USA.	Pbriss@cdc.gov						Briss PA, 2004, ANNU REV PUBL HEALTH, V25, P281, DOI 10.1146/annurev.publhealth.25.050503.153933; Brownson R. C., 2003, EVIDENCE BASED PUBLI; BUNKER JP, 1994, MILBANK Q, V72, P225, DOI 10.2307/3350295; *CANC CONTR PLANET, LINKS RES COMPR CANC; *COCHR COLL, COCHR HLTH PROM PUBL; *HLTH DEV AG, IMPR PEOPL HLTH; Lipkus IM, 2000, AM J PREV MED, V18, P1, DOI 10.1016/S0749-3797(99)00106-3; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; *TASK FORC COMM PR, 2004, GUID COMM PREV SERV; US Task Force on Community Preventive Services, 2005, GUIDE COMMUNITY PREV	11	9	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					828	830		10.1016/S0140-6736(05)71019-9	http://dx.doi.org/10.1016/S0140-6736(05)71019-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	903RZ	15752512				2022-12-28	WOS:000227444600007
J	El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW				El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW			Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1	NATURE			English	Article							I COVALENT COMPLEXES; TOPOISOMERASE-I; BASE DAMAGES; PHOSPHODIESTERASE; XRCC1; MUTATION; TDP1; ELONGATION; PATHWAYS; ABSENCE	Spinocerebellar ataxia with axonal neuropathy- 1 (SCAN1) is a neurodegenerative disease that results from mutation of tyrosyl phosphodiesterase 1 (TDP1)(1). In lower eukaryotes, Tdp1 removes topoisomerase 1 (top1) peptide from DNA termini during the repair of double-strand breaks created by collision of replication forks with top1 cleavage complexes in proliferating cells(2-4). Although TDP1 most probably fulfils a similar function in human cells, this role is unlikely to account for the clinical phenotype of SCAN1, which is associated with progressive degeneration of post-mitotic neurons. In addition, this role is redundant in lower eukaryotes, and Tdp1 mutations alone confer little phenotype(4-7). Moreover, defects in processing or preventing double-strand breaks during DNA replication are most probably associated with increased genetic instability and cancer, phenotypes not observed in SCAN1 ( ref. 8). Here we show that in human cells TDP1 is required for repair of chromosomal singlestrand breaks arising independently of DNA replication from abortive top1 activity or oxidative stress. We report that TDP1 is sequestered into multi-protein single-strand break repair (SSBR) complexes by direct interaction with DNA ligase IIIalpha and that these complexes are catalytically inactive in SCAN1 cells. These data identify a defect in SSBR in a neurodegenerative disease, and implicate this process in the maintenance of genetic integrity in post-mitotic neurons.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Stockholm, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England	University of Sussex; Baylor College of Medicine; University of Alberta; Stockholm University; University of Sheffield	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	k.w.caldecott@sussex.ac.uk	Caldecott, Keith/S-4245-2019; Helleday, Thomas/D-5224-2013	, Sherif/0000-0003-2721-7763; Caldecott, Keith/0000-0003-4255-9016; Helleday, Thomas/0000-0002-7384-092X	Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Lambert S, 2001, ONCOGENE, V20, P6627, DOI 10.1038/sj.onc.1204813; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Liu JK, 2004, CHEM BIODIVERS, V1, P601, DOI 10.1002/cbdv.200490050; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; ZHOU W, 1994, BIOCHEMISTRY-US, V33, P14926, DOI 10.1021/bi00253a032	30	337	340	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					108	113		10.1038/nature03314	http://dx.doi.org/10.1038/nature03314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744309				2022-12-28	WOS:000227334600053
J	Karassa, FB; Matsagas, MI; Schmidt, WA; Ioannidis, JPA				Karassa, FB; Matsagas, MI; Schmidt, WA; Ioannidis, JPA			Meta-analysis: Test performance of ultrasonography for giant-cell arteritis	ANNALS OF INTERNAL MEDICINE			English	Review							COLOR DOPPLER ULTRASONOGRAPHY; TEMPORAL ARTERITIS; DUPLEX ULTRASONOGRAPHY; POLYMYALGIA-RHEUMATICA; DIAGNOSTIC-TEST; CLASSIFICATION CRITERIA; GLUCOCORTICOID THERAPY; BIOPSY; ULTRASOUND; SONOGRAPHY	Background: Giant-cell arteritis is a diagnostic challenge. Purpose: To determine the diagnostic performance of ultrasonography for giant-cell arteritis. Data Sources: Studies published up to April 2004 in the MEDLINE, EMBASE, and Cochrane databases; reference lists; and direct contact with investigators. Study Selection: Studies in any language that examined temporal artery ultrasonography for diagnosis of giant-cell arteritis, enrolled at least 5 patients, and used biopsy or the American College of Rheumatology (ACR) criteria as the reference standard. Data Extraction: Two reviewers independently graded methodologic quality and abstracted data on sensitivity and specificity of ultrasonography for giant-cell arteritis. Diagnostic performance was determined for the halo sign, stenosis, or occlusion and for any of these ultrasonographic abnormalities. Data Synthesis: Weighted sensitivity and specificity estimates and summary receiver-operating characteristic (ROC) curve analysis were used. Twenty-three studies, involving a total of 2036 patients, met the inclusion criteria. The weighted sensitivity and specificity of the halo sign were 69% (95% Cl, 57% to 79%) and 82% (Cl, 75% to 87%), respectively, compared with biopsy and 55% (Cl, 36% to 73%) and 94% (Cl, 82% to 98%), respectively, compared with ACR criteria. Stenosis or occlusion was an almost equally sensitive marker compared with either biopsy (sensitivity, 68% [Cl, 49% to 82%]) or ACR criteria (sensitivity, 66% [Cl, 32% to 89%]). Consideration of any vessel abnormality nonsignificantly improved diagnostic performance compared with ACR criteria. Between-study heterogeneity was significant, but summary ROC curves were consistent with weighted estimates. When the pretest probability of giant-cell arteritis is 10%, negative results on ultrasonography practically exclude the disease (post-test probability, 2% to 5% for various analyses). Limitations: The primary studies were small and of modest quality and had considerable heterogeneity. Conclusion: Ultrasonography may be helpful in diagnosing giant-cell arteritis, but cautious interpretation of the test results based on clinical presentation and pretest probability of the disease is imperative.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Fdn Res & Technol, Ioannina, Greece; Med Ctr Rheumatol Berlin, Berlin, Germany; Tufts Univ, Sch Med, Tufts New England Med Ctr, Boston, MA USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Schmidt, Wolfgang/W-5599-2019; Karassa, Fotini/AAG-5040-2020	Schmidt, Wolfgang/0000-0001-7831-8738				Aburahma AF, 1996, AM SURGEON, V62, P449; ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; BARRIER J, 1982, JAMA-J AM MED ASSOC, V248, P2158, DOI 10.1001/jama.248.17.2158; Bhatti MT, 2001, DERMATOL SURG, V27, P15, DOI 10.1046/j.1524-4725.2001.00258.x; BRUNHOLZL C, 1988, ULTRASCHALL MED, V9, P232, DOI 10.1055/s-2007-1011633; DANY F, 1989, J MAL VASCUL, V14, P104; Deville WLJM, 2000, J CLIN EPIDEMIOL, V53, P65, DOI 10.1016/S0895-4356(99)00144-4; DORNBERGER V, 1987, MED WELT, V38, P1302; FISHER CM, 1971, T AM NEUROL ASSOC, V96, P12; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Forsberg F, 2004, ULTRASONICS, V42, P17, DOI [10.1016/j.ultras.2003.12.027, 10.1016/j.ultras.2004.12.027]; FRIEDMAN G, 1988, ISRAEL J MED SCI, V24, P686; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gould MK, 2003, ANN INTERN MED, V139, P879, DOI 10.7326/0003-4819-139-11-200311180-00013; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; HAIST SA, 1985, MAYO CLIN PROC, V60, P538, DOI 10.1016/S0025-6196(12)60572-2; HALL S, 1983, LANCET, V2, P1217; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Ihara M, 1999, Rinsho Shinkeigaku, V39, P1001; IKARD RW, 1988, SOUTHERN MED J, V81, P1222, DOI 10.1097/00007611-198810000-00005; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; Kelsey JL., 1996, METHODS OBSERVATIONA; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Lauwerys BR, 1997, J RHEUMATOL, V24, P1570; LeSar CJ, 2002, J VASC SURG, V36, P1154, DOI 10.1067/mva.2002.129648; LIE JT, 1990, ARTHRITIS RHEUM-US, V33, P1074; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mondavio M, 1990, Minerva Med, V81, P1; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Murgatroyd H, 2003, EYE, V17, P415, DOI 10.1038/sj.eye.6700350; Nesher G, 2002, J RHEUMATOL, V29, P1224; Owens DK, 1996, ANN INTERN MED, V124, P803, DOI 10.7326/0003-4819-124-9-199605010-00004; Pfadenhauer K, 2003, J RHEUMATOL, V30, P2177; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; PUECHAL X, 1995, LANCET, V345, P1437, DOI 10.1016/S0140-6736(95)92626-7; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; Reinhard M, 2004, RHEUMATOL INT, V24, P340, DOI 10.1007/s00296-003-0372-6; Roters S, 2001, BRIT J OPHTHALMOL, V85, P946, DOI 10.1136/bjo.85.8.946; Salvarani C, 2002, ANN INTERN MED, V137, P232, DOI 10.7326/0003-4819-137-4-200208200-00006; Schmid Rudenz, 2002, Ophthalmologica, V216, P16, DOI 10.1159/000048291; Schmidt WA, 2003, ANN INTERN MED, V138, P609, DOI 10.7326/0003-4819-138-7-200304010-00026; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; Schmidt WA, 2002, RHEUMATOLOGY, V41, P46, DOI 10.1093/rheumatology/41.1.46; Schmidt WA, 2000, CLIN EXP RHEUMATOL, V18, pS40; SIEMSSEN SJ, 1987, BRIT J PLAST SURG, V40, P73, DOI 10.1016/0007-1226(87)90015-4; SLAVIN ML, 1986, ARCH OPHTHALMOL-CHIC, V104, P1127; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Stammler F, 2000, DEUT MED WOCHENSCHR, V125, P1250, DOI 10.1055/s-2000-7853; Sudlow C, 1997, BRIT MED J, V315, P549, DOI 10.1136/bmj.315.7107.549; Venz S, 1998, ROFO-FORTSCHR RONTG, V169, P605, DOI 10.1055/s-2007-1015349; VINCKIER L, 1989, J MAL VASCUL, V14, P116; Wenkel H, 1997, KLIN MONATSBL AUGENH, V210, P48, DOI 10.1055/s-2008-1035013; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483	56	266	272	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					359	369		10.7326/0003-4819-142-5-200503010-00011	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738455				2022-12-28	WOS:000227325100006
J	Sarnak, MJ; Greene, T; Wang, XL; Beck, G; Kusek, JW; Collins, AJ; Levey, AS				Sarnak, MJ; Greene, T; Wang, XL; Beck, G; Kusek, JW; Collins, AJ; Levey, AS			The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the modification of diet in renal disease study	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITION; PROTEIN RESTRICTION; DESIGN	Background: Hypertension is a risk factor for progression of chronic kidney disease. The optimal blood pressure to slow progression is unknown. Objective: To evaluate the effects of a low target blood pressure on kidney failure and all-cause mortality. Design: Long-term follow-up of the Modification of Diet in Renal Disease Study, a randomized, controlled trial conducted from 1989 to 1993. Setting: 15 outpatient nephrology practices. Participants: 840 persons with predominantly nondiabetic kidney disease and a glomerular filtration rate of 13 to 55 mL/min per 1.73 m(2). Intervention: A low target blood pressure (mean arterial pressure < 92 mm Hg) or a usual target blood pressure (mean arterial pressure < 107 mm Hg). Measurements: After the randomized trial was completed, kidney failure (defined as initiation of dialysis or kidney transplantation) and a composite outcome of kidney failure or all-cause mortality were ascertained through 31 December 2000. Results: Kidney failure occurred in 554 participants (66%), and the composite outcome occurred in 624 participants (74%). After Cox proportional hazards modeling and intention-to-treat analysis, the adjusted hazard ratios were 0.68 (95% Cl, 0.57 to 0.82; P < 0.001) for kidney failure and 0.77 (Cl, 0.65 to 0.91; P = 0.0024) for the composite outcome in the low target blood pressure group compared with the usual target blood pressure group. Evidence was insufficient to conclude that the benefit of a low target blood pressure differed according to the cause of kidney disease, baseline glomerular filtration rate, or degree of proteinuria. Limitations: The exact mechanism underlying the benefit of a low target blood pressure is unknown. Conclusions: Assignment to a low target blood pressure slowed the progression of nondiabetic kidney disease in patients with a moderately to severely decreased glomerular filtration rate.	Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; NIH, Bethesda, MD 20892 USA; US Renal Data Syst, Minneapolis, MN USA	Tufts Medical Center; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA	Sarnak, MJ (corresponding author), Tufts Univ New England Med Ctr, Div Nephrol, Box 391,750 Washington St, Boston, MA 02111 USA.	msarnak@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK035073, K23DK002904] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2004, AM J KIDNEY DIS, V43, pS1; Appel LJ, 2003, J AM SOC NEPHROL, V14, pS166, DOI 10.1097/01.ASN.0000070081.15137.C0; BECK GJ, 1991, CONTROL CLIN TRIALS, V12, P566, DOI 10.1016/0197-2456(91)90069-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; KLAHR S, 1995, J AM SOC NEPHROL, V5, P2037; KLAHR S, 1989, NEW ENGL J MED, V320, P864, DOI 10.1056/NEJM198903303201310; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	13	370	385	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					342	351		10.7326/0003-4819-142-5-200503010-00009	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738453				2022-12-28	WOS:000227325100004
J	Wade, DT				Wade, DT			Ethics, audit, and research: all shades of grey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL AUDIT; COMMITTEES		Oxford Ctr Enablement, Oxford OX3 7LD, England	University of Oxford	Wade, DT (corresponding author), Oxford Ctr Enablement, Oxford OX3 7LD, England.	derick.wade@dsl.pipex.com		Wade, Derick/0000-0002-1188-8442				Carr ECJ, 1999, J ADV NURS, V29, P194, DOI 10.1046/j.1365-2648.1999.00875.x; Choo V, 1998, LANCET, V352, P337, DOI 10.1016/S0140-6736(05)60461-8; *CHRISTCH SCH MED, IS ETH APPR REQ CANT; Edwards SJL, 2004, BIOETHICS, V18, P408, DOI 10.1111/j.1467-8519.2004.00407.x; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Jamrozik K, 2004, BRIT MED J, V329, P286, DOI 10.1136/bmj.329.7460.286; Jamrozik K, 2000, J MED ETHICS, V26, P334, DOI 10.1136/jme.26.5.334; Kinn S, 1997, J MED ETHICS, V23, P250, DOI 10.1136/jme.23.4.250; McWilliams R, 2003, JAMA-J AM MED ASSOC, V290, P360, DOI 10.1001/jama.290.3.360; *NX RES DEV OFF, DIST RES AUD; O'Neill O, 2004, CLIN MED, V4, P269, DOI 10.7861/clinmedicine.4-3-269; Rix G, 1996, Int J Health Care Qual Assur, V9, P18, DOI 10.1108/09526869610128223; SADLER JZ, 1992, AM J PSYCHIAT, V149, P1315; SMITH R, 1992, BRIT MED J, V305, P905, DOI 10.1136/bmj.305.6859.905; Sulch D, 2002, STROKE, V33, P1600, DOI 10.1161/01.STR.0000017144.04043.87; *THAM VALL RES DEV, RES ETH; *UN BRIST HEALTHC, 2000, TELL DIFF AUD RES; Warlow C, 2004, BRIT MED J, V329, P241, DOI 10.1136/bmj.329.7460.241; WHILE AE, 1995, BRIT MED J, V311, P661, DOI 10.1136/bmj.311.7006.661; Wilson A, 1999, BRIT MED J, V319, P1235, DOI 10.1136/bmj.319.7219.1235; Yentis SM, 2004, ANAESTHESIA, V59, P316, DOI 10.1111/j.1365-2044.2004.03749.x	21	56	57	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2005	330	7489					468	471		10.1136/bmj.330.7489.468	http://dx.doi.org/10.1136/bmj.330.7489.468			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731146	Green Published			2022-12-28	WOS:000227315400025
J	McDermott, R; Simmonds, RW; Steffen, M; Cooper, KB; Cicak, K; Osborn, KD; Oh, S; Pappas, DP; Martinis, JM				McDermott, R; Simmonds, RW; Steffen, M; Cooper, KB; Cicak, K; Osborn, KD; Oh, S; Pappas, DP; Martinis, JM			Simultaneous state measurement of coupled Josephson phase qubits	SCIENCE			English	Article							CHARGE QUBITS	One of the many challenges of building a scalable quantum computer is single-shot measurement of all the quantum bits (qubits). We have used simultaneous single-shot measurement of coupled Josephson phase qubits to directly probe interaction of the qubits in the time domain. The concept of measurement crosstalk is introduced, and we show that its effects are minimized by careful adjustment of the timing of the measurements. We observe the antiphase oscillation of the two-qubit 101) and 110) states, consistent with quantum mechanical entanglement of these states, thereby opening the possibility for full characterization of multiqubit gates and elementary quantum algorithms.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Natl Inst Stand & Technol, Boulder, CO 80305 USA	University of California System; University of California Santa Barbara; National Institute of Standards & Technology (NIST) - USA	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Osborn, Kevin/AAJ-2872-2020	Simmonds, Raymond/0000-0003-2217-2965				Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cooper KB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180401; Johnson PR, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020509; Kempe J, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052330; MARTINIS JM, 1985, PHYS REV LETT, V55, P1543, DOI 10.1103/PhysRevLett.55.1543; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pashkin YA, 2003, NATURE, V421, P823, DOI 10.1038/nature01365; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	13	259	265	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1299	1302		10.1126/science.1107572	http://dx.doi.org/10.1126/science.1107572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731451				2022-12-28	WOS:000227313200055
J	Guimera, R; Amaral, LAN				Guimera, R; Amaral, LAN			Functional cartography of complex metabolic networks	NATURE			English	Article							SMALL-WORLD; ORGANIZATION; MODULARITY	High-throughput techniques are leading to an explosive growth in the size of biological databases and creating the opportunity to revolutionize our understanding of life and disease. Interpretation of these data remains, however, a major scientific challenge. Here, we propose a methodology that enables us to extract and display information contained in complex networks(1-3). Specifically, we demonstrate that we can find functional modules(4,5) in complex networks, and classify nodes into universal roles according to their pattern of intra- and inter-module connections. The method thus yields a 'cartographic representation' of complex networks. Metabolic networks(6-8) are among the most challenging biological networks and, arguably, the ones with most potential for immediate applicability(9). We use our method to analyse the metabolic networks of twelve organisms from three different superkingdoms. We find that, typically, 80% of the nodes are only connected to other nodes within their respective modules, and that nodes with different roles are affected by different evolutionary constraints and pressures. Remarkably, we find that metabolites that participate in only a few reactions but that connect different modules are more conserved than hubs whose links are mostly within a single module.	Northwestern Univ, NICO, Evanston, IL 60208 USA; Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, NICO, Evanston, IL 60208 USA.	amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Guimera, Roger/C-1727-2008; Guimera, Roger/M-9808-2019; Amaral, Luis N./C-5485-2009	Amaral, LAN/0000-0002-3762-789X; Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM069546] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Arenas A, 2004, EUR PHYS J B, V38, P373, DOI 10.1140/epjb/e2004-00130-1; Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; WASSERMAN S, 1994, SOCIAL NETWORK ANAL, pCH12	29	2232	2380	42	440	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					895	900		10.1038/nature03288	http://dx.doi.org/10.1038/nature03288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729348	Green Submitted, Green Accepted			2022-12-28	WOS:000227174600050
J	Gwatkin, DR				Gwatkin, DR			How much would poor people gain from faster progress towards the Millennium Development Goals for health?	LANCET			English	Editorial Material											Gwatkin, DR (corresponding author), 6483 Wishbone Terrace, Cabin John, MD 20818 USA.	dgwatkin@comcast.net						[Anonymous], 2001, ROAD MAP IMPL UN MIL; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2002, WORLD BANK RES OBSER, V17, P47, DOI 10.1093/wbro/17.1.47; FILMER D, FEVER ITS TREATMENT; Gwatkin D.R., 2002, OXFORD TXB PUBLIC HL, V3, P1581; Gwatkin DR, 2001, INT J EPIDEMIOL, V30, P720, DOI 10.1093/ije/30.4.720; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; VICTORA CG, 2004, REACH POOR C WASH 18; WAGSTAFF A, INEQUALITIES HLTH DE; WATERS H, 2004, REACHING POOR REV CO; *WORLD BANK GROUP, 2004, ROUND 2 COUNTR REP H	13	78	78	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					813	817						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733726				2022-12-28	WOS:000227285300032
J	Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB				Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB			Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor	NATURE			English	Article							PHOSPHOLIPASE-C; CATION CHANNELS; AXON GUIDANCE; CELLS; RECEPTORS; ACTIVATION; INHIBITOR; CURRENTS; FAMILY; BDNF	Brain-derived neurotrophic factor ( BDNF) is known to promote neuronal survival and differentiation(1) and to guide axon extension both in vitro(2,3) and in vivo(4). The BDNF-induced chemoattraction of axonal growth cones requires Ca2+ signalling(3), but how Ca2+ is regulated by BDNF at the growth cone remains largely unclear. Extracellular application of BDNF triggers membrane currents resembling those through TRPC ( transient receptor potential canonical) channels in rat pontine neurons(5) and in Xenopus spinal neurons(6). Here, we report that in cultured cerebellar granule cells, TRPC channels contribute to the BDNF-induced elevation of Ca2+ at the growth cone and are required for BDNF-induced chemo-attractive turning. Several members of the TRPC family are highly expressed in these neurons, and both Ca2+ elevation and growth-cone turning induced by BDNF are abolished by pharmacological inhibition of TRPC channels, overexpression of a dominant-negative form of TRPC3 or TRPC6, or downregulation of TRPC3 expression via short interfering RNA. Thus, TRPC channel activity is essential for nerve-growth-cone guidance by BDNF.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn; yuanxb@ion.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460; Jia, Yichang/0000-0002-7767-5714				Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TAPLEY P, 1992, ONCOGENE, V7, P371; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	29	352	379	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					894	898		10.1038/nature03477	http://dx.doi.org/10.1038/nature03477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758952				2022-12-28	WOS:000228327600040
J	Markowitz, M; Mohri, H; Mehandru, S; Shet, A; Berry, L; Kalyanaraman, R; Kim, A; Chung, C; Jean-Pierre, P; Horowitz, A; La Mar, M; Wrin, T; Parkin, N; Poles, M; Petropoulos, C; Mullen, M; Boden, D; Ho, DD				Markowitz, M; Mohri, H; Mehandru, S; Shet, A; Berry, L; Kalyanaraman, R; Kim, A; Chung, C; Jean-Pierre, P; Horowitz, A; La Mar, M; Wrin, T; Parkin, N; Poles, M; Petropoulos, C; Mullen, M; Boden, D; Ho, DD			Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHENOTYPIC DRUG SUSCEPTIBILITY; SYNCYTIUM-INDUCING PHENOTYPE; DISEASE PROGRESSION; ANTIRETROVIRAL AGENTS; REVERSE-TRANSCRIPTASE; PROTEASE INHIBITORS; SEXUAL TRANSMISSION; TYPE-1 INFECTION; PROGNOSTIC VALUE	Background Rapid progression to AIDS after acute HIV-1 infection, though uncommon, has been noted, as has the transmission of multidrug resistant viruses. Here, we describe a patient in whom these two factors arose concomitantly and assess the effects. Methods We did a case study of a patient with HIV-1 seroconversion. We genotyped the virus and host genetic markers by PCR and nucleotide sequencing. To ascertain the drug susceptibility of our patient's HIV-1 we did phenotypic studies with the PhenoSense assay. We assessed viral coreceptor use via syncytium formation in vitro and with a modified PhenoSense assay. Findings Our patient seems to have been recently infected by a viral variant of HIV-1 resistant to multiple classes of antiretroviral drugs. Furthermore, his virus population is dual tropic for cells that express CCR5 or CXCR4 coreceptor. The infection has resulted in progression to symptomatic AIDS in 4-20 months. Interpretation The intersection of multidrug resistance and rapid development of AIDS in this patient is of concern, especially in view of his case history, which includes high-risk sexual contacts and use of metamfetamine. The public health ramifications of such a case are great.	Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; ViroLogic, San Francisco, CA USA; NYU, Sch Med, New York, NY USA; Cabrini Med Ctr, New York, NY USA	Rockefeller University; New York University	Markowitz, M (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave,7th Floor, New York, NY 10016 USA.	mmarkowitz@adarc.org	Parkin, Neil/P-2724-2019	Poles, Michael/0000-0002-7993-6156; Shet, Anita/0000-0002-7204-8164	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041534, R01AI047033, R44AI048990, P30AI042848] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00102] Funding Source: Medline; NIAID NIH HHS [R44-AI048990, R01-AI47033, AI41534, P30-AI042848] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Balotta C, 1997, AIDS, V11, pF67, DOI 10.1097/00002030-199710000-00001; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Brenner BG, 2002, J VIROL, V76, P1753, DOI 10.1128/JVI.76.4.1753-1761.2002; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chan KCW, 2003, AIDS, V17, P1256, DOI 10.1097/00002030-200305230-00020; Colson P, 2002, AIDS, V16, P507, DOI 10.1097/00002030-200202150-00034; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DOLAN M, 2005, 12 ANN C RETR OPP IN; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; GANGE S, 2005, 12 ANN C RETR OPP IN; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hogan CM, 2001, ANN INTERN MED, V134, P978, DOI 10.7326/0003-4819-134-10-200105150-00012; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Johnson Victoria A, 2004, Top HIV Med, V12, P119; KEET IPM, 1993, AIDS, V7, P51, DOI 10.1097/00002030-199301000-00008; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Kozal M, 2004, AIDS PATIENT CARE ST, V18, P199, DOI 10.1089/108729104323038874; KURITZKES DR, 1994, AIDS, V8, P1017, DOI 10.1097/00002030-199407000-00026; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Michael NL, 1998, J VIROL, V72, P6040, DOI 10.1128/JVI.72.7.6040-6047.1998; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; *NY CIT DEP HLTH M, 2005, NYC HLTH AL NY CIT R; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Sheppard HW, 2002, J ACQ IMMUN DEF SYND, V29, P307, DOI 10.1097/00126334-200203010-00013; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Yu XF, 1998, J INFECT DIS, V178, P388, DOI 10.1086/515646; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	46	128	134	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1031	1038		10.1016/S0140-6736(05)71139-9	http://dx.doi.org/10.1016/S0140-6736(05)71139-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781098				2022-12-28	WOS:000227731800027
J	Wilson, T; Buck, D; Ham, C				Wilson, T; Buck, D; Ham, C			Rising to the challenge: will the NHS support people with long term conditions?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; MANAGEMENT	The NHS is waking to the challenge of chronic diseases. Three researchers who have worked in the Department of Health discuss how the NHS might rise to the challenge of better supporting people with long term conditions.	Mill Stream Surg, Wallingford OX10 6RL, Oxon, England; Dept Hlth, London SW1A 2NL, England; Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Wilson, T (corresponding author), Mill Stream Surg, Wallingford OX10 6RL, Oxon, England.	tim.wilson@gp-k84036.nhs.uk						Berwick DM, 2002, BRIT MED J, V324, P142; Caminal J, 2004, EUR J PUBLIC HEALTH, V14, P246, DOI 10.1093/eurpub/14.3.246; *CLIN SERV COMM CH, 2004, REP JOINT WORK PART; Grumbach Kevin, 2003, Ann Fam Med, V1, P4, DOI 10.1370/afm.47; *HM TREAS, 2005, PUBL SERV PERF; Hutt R, 2004, CASE MANAGING LONG T; Johri M, 2003, INT J GERIATR PSYCH, V18, P222, DOI 10.1002/gps.819; KENNEDY A, 2004, NAT EV EXP PAT PROGR; LAWRENCE S, 2004, E WEEK          0803; Maynard A, 2003, BRIT J GEN PRACT, V53, P754; MEADS G, 2003, PRIMARY CARE REPORT, V5, P10; *NAT PRIM CAR TRUS, CASTL HLTH CTR CHRON; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; *SECR STAT HLTH, 2004, NHS IMPR PLAN 2004; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Smith R, 2003, BRIT MED J, V327, P1239, DOI 10.1136/bmj.327.7426.1239; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37; Stuteley H, 2002, BRIT J GEN PRACT, V52, pS44; 2002, IMPROVING CHRONIC IL	20	61	61	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					657	661		10.1136/bmj.330.7492.657	http://dx.doi.org/10.1136/bmj.330.7492.657			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15775000	Green Published			2022-12-28	WOS:000227861700033
J	Pahnke, K; Zahn, R				Pahnke, K; Zahn, R			Southern hemisphere water mass conversion linked with North Atlantic climate variability	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; ANTARCTIC MODE WATER; VOSTOK ICE CORE; THERMOHALINE CIRCULATION; INTERMEDIATE WATER; OCEAN CIRCULATION; SEA-LEVEL; LABRADOR SEA; TIME SCALES; DEEP-WATER	Intermediate water variability at multicentennial scales is documented by 340,000-year-long isotope time series from bottom-dwelling foraminifers at a mid-depth core site in the southwest Pacific. Periods of sudden increases in intermediate water production are linked with transient Southern Hemisphere warm episodes, which implies direct control of climate warming on intermediate water conversion at high southern latitudes. Coincidence with episodes of climate cooling and minimum or halted deepwater convection in the North Atlantic provides striking evidence for interdependence of water mass conversion in both hemispheres, with implications for interhemispheric forcing of ocean thermohaline circulation and climate instability.	Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, S Glam, Wales; ICREA, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, ICTA, E-08193 Barcelona, Spain	Cardiff University; ICREA; Autonomous University of Barcelona	Pahnke, K (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	kpahnke@mit.edu; rainer.zahn@icrea.es		Pahnke, Katharina/0000-0001-9114-8411	ICREA Funding Source: Custom	ICREA(ICREA)		Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bostock HC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001047; Broecker WS, 1992, GLOBAL BIOGEOCHEM CY, V6, P315, DOI 10.1029/92GB01672; Chapman MR, 1999, GEOLOGY, V27, P795, DOI 10.1130/0091-7613(1999)027<0795:GIVFNA>2.3.CO;2; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; Cortese G, 2002, PALAEOGEOGR PALAEOCL, V182, P259, DOI 10.1016/S0031-0182(01)00499-0; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; Gersonde R, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000809; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; Hiscott RN, 2001, GLOBAL PLANET CHANGE, V28, P227, DOI 10.1016/S0921-8181(00)00075-8; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Mortyn PG, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000475; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; PIOLA AR, 1982, DEEP-SEA RES, V29, P687, DOI 10.1016/0198-0149(82)90002-4; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Ribbe J, 2001, GEOPHYS RES LETT, V28, P535, DOI 10.1029/2000GL012242; Rintoul SR, 2002, J PHYS OCEANOGR, V32, P1308, DOI 10.1175/1520-0485(2002)032<1308:ETDLAS>2.0.CO;2; Rohling EJ, 2004, NATURE, V430, P1016, DOI 10.1038/nature02859; Saenko OA, 2003, J CLIMATE, V16, P2797, DOI 10.1175/1520-0442(2003)016<2797:OTLBTT>2.0.CO;2; Schlitzer R., 2000, EOS T AGU, V81, P45, DOI DOI 10.1029/00E000028; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Seidov D, 2001, GLOBAL PLANET CHANGE, V30, P257, DOI 10.1016/S0921-8181(00)00087-4; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; SHACKLETON NJ, 2001, PANGAEA, DOI DOI 10.1594/PANGAEA.58229; SHEMESH A, 1994, SCIENCE, V266, P1542, DOI 10.1126/science.266.5190.1542; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P1005, DOI 10.1175/1520-0485(2001)031<1005:CRAMOA>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Talley LD, 1999, GEOPH MONOG SERIES, V112, P1; vanKreveld SA, 1996, MAR GEOL, V131, P21, DOI 10.1016/0025-3227(95)00143-3; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Wong APS, 1999, NATURE, V400, P440, DOI 10.1038/22733; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581	48	180	184	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1741	1746		10.1126/science.1102163	http://dx.doi.org/10.1126/science.1102163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774752				2022-12-28	WOS:000227883900036
J	Boyer, EW; Shannon, M				Boyer, EW; Shannon, M			The serotonin syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							REUPTAKE INHIBITORS; ANIMAL-MODEL; HYPERTHERMIA; RECEPTORS; TOXICITY; ASSOCIATION; ANTAGONIST; MONOAMINE; EXPOSURE; ECSTASY		Childrens Hosp, Div Emergency Med, Program Med Toxicol, Boston, MA 02115 USA; Univ Massachusetts, Dept Emergency Med, Div Med Toxicol, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Boyer, EW (corresponding author), Childrens Hosp, Div Emergency Med, Program Med Toxicol, IC Smith Bldg,300 Longwood Ave, Boston, MA 02115 USA.	edward.boyer@tch.harvard.edu	Boyer, Edward/AAF-3609-2020		NIDA NIH HHS [DA-14929] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014929] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ali Syed Z, 2003, Best Pract Res Clin Anaesthesiol, V17, P519, DOI 10.1016/j.bpa.2003.09.012; ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; BALOH RW, 1982, ANN NEUROL, V11, P95, DOI 10.1002/ana.410110117; Boddy R, 2004, J TOXICOL-CLIN TOXIC, V42, P725; Callaway JC, 1998, J PSYCHOACTIVE DRUGS, V30, P367; Demirkiran M, 1996, CLIN NEUROPHARMACOL, V19, P157, DOI 10.1097/00002826-199619020-00004; DeSilva KE, 2001, AIDS, V15, P1281, DOI 10.1097/00002030-200107060-00010; DONE CJG, 1994, NEUROPHARMACOLOGY, V33, P411, DOI 10.1016/0028-3908(94)90071-X; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Fink M, 1996, PHARMACOPSYCHIATRY, V29, P159; Gardner DM, 1998, ANN PHARMACOTHER, V32, P33, DOI 10.1345/aph.17204; Giese SY, 2001, PLAST RECONSTR SURG, V107, P293, DOI 10.1097/00006534-200101000-00069; Gill M, 1999, ANN EMERG MED, V33, P457, DOI 10.1016/S0196-0644(99)70313-6; Gillman PK, 1999, J PSYCHOPHARMACOL, V13, P100, DOI 10.1177/026988119901300111; Gillman PK, 1997, MED J AUSTRALIA, V167, P109; Graudins A, 1998, J Emerg Med, V16, P615, DOI 10.1016/S0736-4679(98)00057-2; GUZE BH, 1985, NEW ENGL J MED, V313, P163, DOI 10.1056/NEJM198507183130306; Hegerl U, 1998, EUR ARCH PSY CLIN N, V248, P96, DOI 10.1007/s004060050024; Hick JL, 1999, ACAD EMERG MED, V6, P239, DOI 10.1111/j.1553-2712.1999.tb00164.x; HOYER D, 1994, PHARMACOL REV, V46, P157; Isbister GK, 2004, J TOXICOL-CLIN TOXIC, V42, P277, DOI 10.1081/CLT-120037428; Isbister GK, 2002, BRIT J ANAESTH, V88, P603; Isbister GK, 2001, ANN PHARMACOTHER, V35, P1672; Isbister GK, 2001, ARCH DIS CHILD-FETAL, V85, pF147; Izzo AA, 2001, DRUGS, V61, P2163, DOI 10.2165/00003495-200161150-00002; Kaneda Y, 2002, INT J NEUROPSYCHOPH, V5, P105, DOI 10.1017/S1461145701002723; Kaneda Y, 2001, PSYCHIAT RES, V105, P135, DOI 10.1016/S0165-1781(01)00340-7; Kapur S, 1997, AM J PSYCHIAT, V154, P884; KLINE SS, 1989, CLIN PHARMACY, V8, P510; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lange-Asschenfeldt C, 2002, J CLIN PSYCHOPHARM, V22, P440, DOI 10.1097/00004714-200208000-00022; Lee DO, 1999, PHARMACOTHERAPY, V19, P894, DOI 10.1592/phco.19.10.894.31561; Mackay FJ, 1999, BRIT J GEN PRACT, V49, P871; Martin TG, 1996, ANN EMERG MED, V28, P520, DOI 10.1016/S0196-0644(96)70116-6; Mason PJ, 2000, MEDICINE, V79, P201, DOI 10.1097/00005792-200007000-00001; Mitchell PB, 1997, DRUG SAFETY, V17, P390, DOI 10.2165/00002018-199717060-00005; Nisijima K, 2001, BRAIN RES, V890, P23, DOI 10.1016/S0006-8993(00)03020-1; Nisijima K, 2004, PHARMACOPSYCHIATRY, V37, P57; Nisijima K, 2003, NEUROCHEM INT, V43, P155, DOI 10.1016/S0197-0186(02)00213-9; OATES JA, 1960, NEUROLOGY, V10, P1076, DOI 10.1212/WNL.10.12.1076; Olsen D, 2004, J TOXICOL-CLIN TOXIC, V42, P744; Parrott AC, 2002, PHARMACOL BIOCHEM BE, V71, P837, DOI 10.1016/S0091-3057(01)00711-0; Sampson E, 1999, BRIT J GEN PRACT, V49, P867; Saper C.B., 2000, PRINCIPLES NEURAL SC, V4th, P896; SNIDER SR, 1975, NEUROSCI LETT, V1, P237, DOI 10.1016/0304-3940(75)90067-1; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Turkel SB, 2001, PSYCHOSOMATICS, V42, P258, DOI 10.1176/appi.psy.42.3.258; Van Oekelen D, 2003, J NEUROCHEM, V85, P1087, DOI 10.1046/j.1471-4159.2003.01738.x; Watson WA, 2003, AM J EMERG MED, V21, P353, DOI 10.1016/S0735-6757(03)00088-3; Whyte I. M., 2002, Journal of Toxicology Clinical Toxicology, V40, P668	50	996	1029	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1112	1120		10.1056/NEJMra041867	http://dx.doi.org/10.1056/NEJMra041867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784664				2022-12-28	WOS:000227655000008
J	De Jong, PE; de Zeeuw, D				De Jong, PE; de Zeeuw, D			Renoprotective therapy: is it blood pressure or albuminuria that matters?	LANCET			English	Editorial Material							DIABETIC-NEPHROPATHY; PROTEINURIA; PROGRESSION; DISEASE		Univ Groningen, Univ Med Ctr Groningen, Dept Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands	University of Groningen	De Jong, PE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands.	p.e.dejong@int.umcg.nl	de Zeeuw, Dick/E-9080-2014	de Zeeuw, Dick/0000-0003-3434-7777				Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; De Jong PE, 1999, LANCET, V354, P352, DOI 10.1016/S0140-6736(99)90122-8; de Jong PE, 2004, KIDNEY INT, V66, P2109, DOI 10.1111/j.1523-1755.2004.66001.x; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Remuzzi G, 2005, LANCET, V365, P556; Remuzzi G, 2004, KIDNEY INT, V66, pS90, DOI 10.1111/j.1523-1755.2004.09221.x; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167	11	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					913	914		10.1016/S0140-6736(05)71055-2	http://dx.doi.org/10.1016/S0140-6736(05)71055-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766975				2022-12-28	WOS:000227559800003
J	Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P				Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P			AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HERMANSKY-PUDLAK-SYNDROME; ENVELOPE GLYCOPROTEIN; PATHWAY REQUIRES; PLASMA-MEMBRANE; PROTEIN COMPLEX; DOMAIN; TRANSPORT; BINDING; TSG101	Gag proteins direct the process of retroviral particle assembly and form the major protein constituents of the viral core. The matrix region of the HIV-1 Gag polyprotein plays a critical role in the transport of Gag to the plasma membrane assembly site. Recent evidence indicates that Gag trafficking to late endosomal compartments, including multivesicular bodies, occurs prior to viral particle budding from the plasma membrane. Here we demonstrate that the matrix region of HIV-1 Gag interacts directly with the 6 subunit of the AP-3 complex, and that this interaction plays an important functional role in particle assembly. Disruption of this interaction eliminated Gag trafficking to multivesicular bodies and diminished HIV particle formation. These studies illuminate an early step in retroviral particle assembly and provide evidence that the trafficking of Gag to late endosomes is part of a productive particle assembly pathway.	Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Fu Jen Catholic Univ, Dept Cell Biol, Taipei, Taiwan	Vanderbilt University; Vanderbilt University; Fu Jen Catholic University	Spearman, P (corresponding author), Vanderbilt Univ, Dept Pediat, 221 Kirkland Hall, Nashville, TN 37232 USA.	paul.spearman@vanderbilt.edu		Burnett, Atuhani/0000-0003-3276-3697	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040338, R01AI032539, R21AI055441, P30AI054999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NIAID NIH HHS [P30 AI054999, R21 AI055441, R01 AI40338, R01 AI32539] Funding Source: Medline; NICHD NIH HHS [HD15052] Funding Source: Medline; NIDDK NIH HHS [DK58404, DK20593] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; FACKE M, 1993, J VIROL, V67, P4972; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Freedman BI, 1998, AM J HYPERTENS, V11, P251, DOI 10.1016/S0895-7061(97)00481-0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lindwasser OW, 2004, J VIROL, V78, P6013, DOI 10.1128/JVI.78.11.6013-6023.2004; Luban J, 2001, NAT MED, V7, P1278, DOI 10.1038/nm1201-1278; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; PEVSNER J, 1994, GENE, V146, P279, DOI 10.1016/0378-1119(94)90306-9; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang JJ, 2001, APPL IMMUNOHISTO M M, V9, P371, DOI 10.1097/00022744-200112000-00014; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	52	187	201	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					663	674		10.1016/j.cell.2004.12.023	http://dx.doi.org/10.1016/j.cell.2004.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766529	Bronze			2022-12-28	WOS:000227771400012
J	Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R				Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R			MGMT gene silencing and benefit from temozolomide in glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; MALIGNANT GLIOMA; MISMATCH REPAIR; ALKYLTRANSFERASE; METHYLATION; SURVIVAL; CANCER; PROGRESSION; CARMUSTINE	BACKGROUND: Epigenetic silencing of the MGMT (O(sup 6)-methylguanine-DNA methyltransferase) DNA-repair gene by promoter methylation compromises DNA repair and has been associated with longer survival in patients with glioblastoma who receive alkylating agents. METHODS: We tested the relationship between MGMT silencing in the tumor and the survival of patients who were enrolled in a randomized trial comparing radiotherapy alone with radiotherapy combined with concomitant and adjuvant treatment with temozolomide. The methylation status of the MGMT promoter was determined by methylation-specific polymerase-chain-reaction analysis. RESULTS: The MGMT promoter was methylated in 45 percent of 206 assessable cases. Irrespective of treatment, MGMT promoter methylation was an independent favorable prognostic factor (P<0.001 by the log-rank test; hazard ratio, 0.45; 95 percent confidence interval, 0.32 to 0.61). Among patients whose tumor contained a methylated MGMT promoter, a survival benefit was observed in patients treated with temozolomide and radiotherapy; their median survival was 21.7 months (95 percent confidence interval, 17.4 to 30.4), as compared with 15.3 months (95 percent confidence interval, 13.0 to 20.9) among those who were assigned to only radiotherapy (P=0.007 by the log-rank test). In the absence of methylation of the MGMT promoter, there was a smaller and statistically insignificant difference in survival between the treatment groups. CONCLUSIONS: Patients with glioblastoma containing a methylated MGMT promoter benefited from temozolomide, whereas those who did not have a methylated MGMT promoter did not have such a benefit.	Univ Lausanne Hosp, Dept Neurosurg, Lab Tumor Biol & Genet, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Radiotherapy, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Neuropathol, Lausanne, Switzerland; Univ Lausanne Hosp, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, CH-1066 Epalinges, Switzerland; Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; European Org Res Treatment Canc, Ctr Data, Brussels, Belgium; Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany; Univ Regensburg, Dept Neurol, D-8400 Regensburg, Germany; Univ Rotterdam Hosp, Div Neuropathol, Rotterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Med Univ Vienna, Inst Neurol, Vienna, Austria; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Univ Calgary, Calgary, AB, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Swiss Institute Experimental Cancer Research; University of Bern; University Hospital of Bern; European Organisation for Research & Treatment of Cancer; Eberhard Karls University of Tubingen; University of Regensburg; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Medical University of Vienna; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Calgary	Hegi, ME (corresponding author), CHU Vaudois, Dept Neurosurg, Lab Tumor Biol & Genet, BH19-110, CH-1011 Lausanne, Switzerland.	monika.hegi@chuv.hospvd.ch	Hegi, Monika/O-4796-2015; Mariani, Luigi/AAB-9464-2019; Stupp, Roger/L-3303-2019	Hegi, Monika/0000-0003-0855-6495; Weller, Michael/0000-0002-1748-174X				Belanich M, 1996, CANCER RES, V56, P783; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 1999, CANCER RES, V59, P793; Friedman HS, 2000, J CLIN ONCOL, V18, P3522, DOI 10.1200/JCO.2000.18.20.3522; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gorlia T, 2004, J CLIN ONCOL, V22, p859S; Grombacher T, 1996, CARCINOGENESIS, V17, P2329, DOI 10.1093/carcin/17.11.2329; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOTTA T, 1994, J NEURO-ONCOL, V21, P135, DOI 10.1007/BF01052897; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Komine C, 2003, BRAIN PATHOL, V13, P176; Liu LL, 1996, CANCER RES, V56, P5375; Ochs K, 2000, CANCER RES, V60, P5815; Palmisano WA, 2000, CANCER RES, V60, P5954; Qian XLC, 1997, CANCER RES, V57, P3672; QUINN J, 2003, P AN M AM SOC CLIN, V22, P103; Silber JR, 1999, CLIN CANCER RES, V5, P807; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612	22	4821	5026	9	399	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					997	1003		10.1056/NEJMoa043331	http://dx.doi.org/10.1056/NEJMoa043331			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758010	Green Published			2022-12-28	WOS:000227491200008
J	Garg, AX; Adhikari, NKJ; McDonald, H; Rosas-Arellano, MP; Devereaux, PJ; Beyene, J; Sam, J; Haynes, RB				Garg, AX; Adhikari, NKJ; McDonald, H; Rosas-Arellano, MP; Devereaux, PJ; Beyene, J; Sam, J; Haynes, RB			Effects of computerized clinical decision support systems on practitioner performance and patient outcomes - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; PROMOTING SCREENING MAMMOGRAPHY; ORAL ANTICOAGULATION MANAGEMENT; INNER-CITY SETTINGS; PRIMARY-CARE; PREVENTIVE CARE; PREDICTIVE INSTRUMENT; WARFARIN THERAPY; GENERAL-PRACTITIONERS; PHYSICIAN PERFORMANCE	Context Developers of health care software have attributed improvements in patient care to these applications. As with any health care intervention, such claims require confirmation in clinical trials. Objectives To review controlled trials assessing the effects of computerized clinical decision support systems (CDSSs) and to identify study characteristics predicting benefit. DataSources We updated our earlier reviews by searching the MEDLINE, EMBASE, Cochrane Library, Inspec, and ISI databases and consulting reference lists through September 2004. Authors of 64 primary studies confirmed data or provided additional information. Study Selection We included randomized and non randomized controlled trials that evaluated the effect of a CDSS compared with care provided without a CDSS on practitioner performance or patient outcomes. Data Extraction Teams of 2 reviewers independently abstracted data on methods, setting, CDSS and patient characteristics, and outcomes. Data Synthesis One hundred studies met our inclusion criteria. The number and methodologic quality of studies improved over time. The CDSS improved practitioner performance in 62 (64%) of the 97 studies assessing this outcome, including 4 (40%) of 10 diagnostic systems, 16 (76%) of 21 reminder systems, 23 (62%) of 37 disease management systems, and 19 (66%) of 29 drug-dosing or prescribing systems. Fifty-two trials assessed 1 or more patient outcomes, of which 7 trials (13%) reported improvements. Improved practitioner performance was associated with CDSSs that automatically prompted users compared with requiring users to activate the system (success in 73% of trials vs 47%; P=.02) and studies in which the authors also developed the CDSS software compared with studies in which the authors were not the developers (74% success vs 28%; respectively, P=.001). Conclusions Many CDSSs improve practitioner performance. To date, the effects on patient outcomes remain understudied and, when studied, inconsistent.	McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Western Ontario, Div Nephrol, London, ON, Canada; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Interdept Div Crit Care, Toronto, ON M5G 1X8, Canada	McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Haynes, RB (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, 1200 Main St W,Room 2C10B, Hamilton, ON L8N 3Z5, Canada.	bhaynes@mcmaster.ca	Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021; Garg, Amit X/G-3295-2011	Devereaux, PJ/0000-0003-2935-637X; Haynes, Robert Brian/0000-0002-1453-3196				ABBRECHT PH, 1982, CLIN PHARMACOL THER, V32, P129, DOI 10.1038/clpt.1982.136; Ageno W, 1998, THROMB RES, V91, P237, DOI 10.1016/S0049-3848(98)00092-9; Ansari M, 2003, CIRCULATION, V107, P2799, DOI 10.1161/01.CIR.0000070952.08969.5B; BARNETT GO, 1983, MED CARE, V21, P400, DOI 10.1097/00005650-198304000-00003; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; BEGG EJ, 1989, BRIT J CLIN PHARMACO, V28, P137, DOI 10.1111/j.1365-2125.1989.tb05405.x; Berlin A, 2004, ST HEAL T, V107, P578; Bogusevicius A, 2002, EUR J SURG, V168, P78; Bonevski B, 1999, PREV MED, V29, P478, DOI 10.1006/pmed.1999.0567; BROWNBRIDGE G, 1986, J ROY COLL GEN PRACT, V36, P198; BURACK RC, 1994, MED CARE, V32, P609, DOI 10.1097/00005650-199406000-00006; Burack RC, 2003, PREV MED, V36, P547, DOI 10.1016/S0091-7435(02)00062-2; Burack RC, 1996, CANCER, V78, P1708, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1708::AID-CNCR11>3.3.CO;2-9; Burack RC, 1997, MED CARE, V35, P921, DOI 10.1097/00005650-199709000-00005; BURTON ME, 1991, CLIN PHARMACOL THER, V49, P685, DOI 10.1038/clpt.1991.86; Cannon DS, 2000, J AM MED INFORM ASSN, V7, P196, DOI 10.1136/jamia.2000.0070196; CARTER BL, 1987, CLIN PHARMACY, V6, P37; CASNER PR, 1993, CLIN PHARMACOL THER, V53, P684, DOI 10.1038/clpt.1993.90; Chambers C V, 1991, J Am Board Fam Pract, V4, P19; Christakis DA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.2.e15; Chuang JH, 2002, J AM MED INFORM ASSN, V9, P230, DOI 10.1197/jamia.M0997; COE FL, 1977, J CHRON DIS, V30, P81, DOI 10.1016/0021-9681(77)90077-7; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; East TD, 1999, J AM MED INFORM ASSN, P251; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; FIHN SD, 1994, J GEN INTERN MED, V9, P131, DOI 10.1007/BF02600026; Filippi A, 2003, DIABETES CARE, V26, P1497, DOI 10.2337/diacare.26.5.1497; Fitzmaurice DA, 2000, ARCH INTERN MED, V160, P2343, DOI 10.1001/archinte.160.15.2343; Fitzmaurice DA, 1996, BRIT J GEN PRACT, V46, P533; Flanagan JR, 1999, J AM MED INFORM ASSN, P755; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fox J, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P265; Frame P S, 1994, Arch Fam Med, V3, P581, DOI 10.1001/archfami.3.7.581; GONZALEZ ER, 1989, AM J EMERG MED, V7, P395, DOI 10.1016/0735-6757(89)90046-6; Gordon RB, 1998, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001096, DOI 10.1002/14651858.CD001096]; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Hales J W, 1995, Proc Annu Symp Comput Appl Med Care, P728; HAYNES RB, 1987, ARCH INTERN MED, V147, P1297, DOI 10.1001/archinte.147.7.1297; Hetlevik I, 2000, INT J TECHNOL ASSESS, V16, P210, DOI 10.1017/S0266462300161185; Hetlevik I, 1999, SCAND J PRIM HEALTH, V17, P35; Hetlevik Irene, 1998, Blood Pressure, V7, P270; HICKLING K, 1989, INTENS CARE MED, V15, P233, DOI 10.1007/BF00271057; Holbrook Anne, 2003, AMIA Annu Symp Proc, P862; Horn W, 2002, ARTIF INTELL MED, V24, P217, DOI 10.1016/S0933-3657(01)00105-1; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; HURLEY SF, 1986, AM REV RESPIR DIS, V134, P1219; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Kaplan B, 2001, INT J MED INFORM, V64, P15, DOI 10.1016/S1386-5056(01)00183-6; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kawamoto Kensaku, 2003, AMIA Annu Symp Proc, P361; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; Lees KR, 2003, QJM-INT J MED, V96, P143, DOI 10.1093/qjmed/hcg019; Lesourd F, 2002, FERTIL STERIL, V77, P456, DOI 10.1016/S0015-0282(01)03231-9; Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120; Lobach DF, 1997, AM J MED, V102, P89, DOI 10.1016/S0002-9343(96)00382-8; Lowensteyn I, 1998, PREV MED, V27, P730, DOI 10.1006/pmed.1998.0351; Manotti C, 2001, HAEMATOLOGICA, V86, P1060; MAZZUCA SA, 1990, AM EDUC RES J, V27, P473, DOI 10.3102/00028312027003473; MCALISTER NH, 1986, BRIT MED J, V293, P670, DOI 10.1136/bmj.293.6548.670; McCowan C, 2001, MED INFORM INTERNET, V26, P191, DOI 10.1080/14639230110067890; MCDONALD CJ, 1992, M D COMPUT, V9, P304; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1976, ANN INTERN MED, V84, P162, DOI 10.7326/0003-4819-84-2-162; MCDONALD CJ, 1980, JAMA-J AM MED ASSOC, V244, P1579, DOI 10.1001/jama.244.14.1579; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; McKinley BA, 2001, J TRAUMA, V50, P415, DOI 10.1097/00005373-200103000-00004; MCPHEE SJ, 1989, ARCH INTERN MED, V149, P1866, DOI 10.1001/archinte.149.8.1866; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; Meigs JB, 2003, DIABETES CARE, V26, P750, DOI 10.2337/diacare.26.3.750; Mitchell E, 2001, BMJ-BRIT MED J, V322, P279, DOI 10.1136/bmj.322.7281.279; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; Montori VM, 2002, DIABETES CARE, V25, P1952, DOI 10.2337/diacare.25.11.1952; MUNGALL DR, 1994, CLIN PHARMACOL THER, V55, P591, DOI 10.1038/clpt.1994.73; Murray MD, 2004, PHARMACOTHERAPY, V24, P324, DOI 10.1592/phco.24.4.324.33173; Nilasena D S, 1995, Proc Annu Symp Comput Appl Med Care, P640; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; ORNSTEIN SM, 1991, J FAM PRACTICE, V32, P82; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Overhage JM, 1996, ARCH INTERN MED, V156, P1551, DOI 10.1001/archinte.156.14.1551; Payne TH, 2000, CHEST, V118, p47S, DOI 10.1378/chest.118.2_suppl.47S; PECK CC, 1973, NEW ENGL J MED, V289, P441, DOI 10.1056/NEJM197308302890902; Petrucci K, 1991, Proc Annu Symp Comput Appl Med Care, P43; POLLER L, 1993, J CLIN PATHOL, V46, P299, DOI 10.1136/jcp.46.4.299; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Reisman Y, 1996, MED INFORM, V21, P179, DOI 10.3109/14639239609025356; RODMAN JH, 1984, ARCH INTERN MED, V144, P703, DOI 10.1001/archinte.144.4.703; Rogers J L, 1984, QRB Qual Rev Bull, V10, P65; ROGERS JL, 1979, MED CARE, V17, P618, DOI 10.1097/00005650-197906000-00006; ROGERS JL, 1982, MED CARE, V20, P63, DOI 10.1097/00005650-198201000-00005; Rollman BL, 2002, J GEN INTERN MED, V17, P493, DOI 10.1046/j.1525-1497.2002.10421.x; ROSSER WW, 1991, CAN MED ASSOC J, V145, P807; Rossi RA, 1997, J GEN INTERN MED, V12, P672, DOI 10.1046/j.1525-1497.1997.07140.x; Rotman BL, 1996, J AM MED INFORM ASSN, V3, P340, DOI 10.1136/jamia.1996.97035025; RUBENSTEIN LV, 1995, J GEN INTERN MED, V10, P607, DOI 10.1007/BF02602744; RYFFDELECHE A, 1992, DIABETES RES CLIN EX, V19, P97; SAFRAN C, 1995, LANCET, V346, P341, DOI 10.1016/S0140-6736(95)92226-1; Schriger DL, 2001, ANN EMERG MED, V37, P132, DOI 10.1067/mem.2001.112255; Selker HP, 2002, ANN INTERN MED, V137, P87, DOI 10.7326/0003-4819-137-2-200207160-00006; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; SHEA S, 1995, J AM MED INFORM ASSN, V2, P58, DOI 10.1136/jamia.1995.95202549; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Tang PC, 1999, J AM MED INFORM ASSN, V6, P115, DOI 10.1136/jamia.1999.0060115; TAPE TG, 1993, AM J MED, V94, P619, DOI 10.1016/0002-9343(93)90214-A; Thomas J C, 1983, J Med Syst, V7, P307, DOI 10.1007/BF00993294; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; Tierney WM, 2003, J GEN INTERN MED, V18, P967, DOI 10.1111/j.1525-1497.2003.30635.x; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; TURNER BJ, 1989, J GEN INTERN MED, V4, P403, DOI 10.1007/BF02599691; TURNER RC, 1994, ARCH INTERN MED, V154, P1957, DOI 10.1001/archinte.154.17.1957; Vadher B, 1997, BMJ-BRIT MED J, V314, P1252, DOI 10.1136/bmj.314.7089.1252; Vadher BD, 1997, CLIN LAB HAEMATOL, V19, P203; VERNER D, 1992, EUR J CLIN PHARMACOL, V43, P29, DOI 10.1007/BF02280750; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WELLWOOD J, 1992, ANN ROY COLL SURG, V74, P40; WEXLER JR, 1975, AM J DIS CHILD, V129, P203, DOI 10.1001/archpedi.1975.02120390037008; WHITE KS, 1984, J AM COLL CARDIOL, V4, P571, DOI 10.1016/S0735-1097(84)80104-7; WHITE RH, 1987, J GEN INTERN MED, V2, P141, DOI 10.1007/BF02596140; WHITE RH, 1991, THER DRUG MONIT, V13, P46, DOI 10.1097/00007691-199101000-00006; WYATT J, 1990, MED INFORM, V15, P205, DOI 10.3109/14639239009025268; WYATT J, 1989, P 6 WORLD C MED INF, P111; YOUNG DW, 1981, MED INFORM, V6, P13, DOI 10.3109/14639238109017764	128	1951	1979	4	224	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1223	1238		10.1001/jama.293.10.1223	http://dx.doi.org/10.1001/jama.293.10.1223			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755945				2022-12-28	WOS:000227498400023
J	Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A				Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A			Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin	SCIENCE			English	Article							ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; THERMAL HYPERALGESIA; NERVE-FIBERS; RECEPTOR; KERATINOCYTES; ACTIVATION; SENSATION; EPIDERMIS	Environmental temperature is thought to be directly sensed by neurons through their projections in the skin. A subset of the mammalian transient receptor potential (TRP) family of ion channels has been implicated in this process. These "thermoTRPs" are activated at distinct temperature thresholds and are typically expressed in sensory neurons. TRPV3 is activated by heat (>33degreesC) and, unlike most thermoTRPs, is expressed in mouse keratinocytes. We found that TRPV3 null mice have strong deficits in responses to innocuous and noxious heat but not in other sensory modalities; hence, TRPV3 has a specific role in thermosensation. The natural compound camphor, which modulates sensations of warmth in humans, proved to be a specific activator of TRPV3. Camphor activated cultured primary keratinocytes but not sensory neurons, and this activity was abolished in TRPV3 null mice. Therefore, heat-activated receptors in keratinocytes are important for mammalian thermosensation.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480; moqrich, aziz/0000-0002-1937-1675				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CAUNA N, 1973, J ANAT, V115, P277; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; GREEN BG, 1990, J INVEST DERMATOL, V94, P662, DOI 10.1111/1523-1747.ep12876242; Guler AD, 2002, J NEUROSCI, V22, P6408; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	23	506	547	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1468	1472		10.1126/science.1108609	http://dx.doi.org/10.1126/science.1108609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746429				2022-12-28	WOS:000227503100048
J	Ligi, M; Bonatti, E; Cipriani, A; Ottolini, L				Ligi, M; Bonatti, E; Cipriani, A; Ottolini, L			Water-rich basalts at mid-ocean-ridge cold spots	NATURE			English	Article							MIDOCEAN RIDGE; UPPER-MANTLE; BENEATH; GENERATION; ELEMENTS; FLOW; H2O	Although water is only present in trace amounts in the suboceanic upper mantle, it is thought to play a significant role in affecting mantle viscosity, melting and the generation of crust at mid-ocean ridges. The concentration of water in oceanic basalts(1,2) has been observed to stay below 0.2 wt%, except for water-rich basalts sampled near hotspots and generated by 'wet' mantle plumes(3-5). Here, however, we report unusually high water content in basaltic glasses from a cold region of the mid-ocean-ridge system in the equatorial Atlantic Ocean. These basalts are sodium-rich, having been generated by low degrees of melting of the mantle, and contain unusually high ratios of light versus heavy rare-earth elements, implying the presence of garnet in the melting region. We infer that water-rich basalts from such regions of thermal minima derive from low degrees of 'wet' melting greater than 60 km deep in the mantle, with minor dilution by melts produced by shallower 'dry' melting - a view supported by numerical modelling. We therefore conclude that oceanic basalts are water-rich not only near hotspots, but also at 'cold spots'.	CNR, Ist Sci Marine, I-40129 Bologna, Italy; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Roma La Sapienza, Dipartimento Sci Terra, I-00187 Rome, Italy; CNR, Sez Pavia, Ist Geosci & Georisorse, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Columbia University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR)	Bonatti, E (corresponding author), CNR, Ist Sci Marine, Via Gobetti 101, I-40129 Bologna, Italy.	enrico.bonatti@bo.ismar.cnr.it	Cipriani, Anna/A-2797-2012; Ligi, Marco/G-4853-2012; CNR, Ismar/P-1247-2014	Cipriani, Anna/0000-0001-8457-0147; Ligi, Marco/0000-0002-5098-5907; CNR, Ismar/0000-0001-5351-1486; Bonatti, Enrico/0000-0001-6162-9572				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Asimow PD, 2003, NATURE, V421, P815, DOI 10.1038/nature01429; Asimow PD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000568; BONATTI E, 1993, SCIENCE, V261, P315, DOI 10.1126/science.261.5119.315; Bonatti E, 2001, GEOLOGY, V29, P979, DOI 10.1130/0091-7613(2001)029<0979:SSCOCF>2.0.CO;2; BONATTI E, 1990, SCIENCE, V250, P107, DOI 10.1126/science.250.4977.107; Braun MG, 2000, EARTH PLANET SC LETT, V176, P339, DOI 10.1016/S0012-821X(00)00015-7; Christie DM, 1998, NATURE, V394, P637, DOI 10.1038/29226; Danyushevsky LV, 2001, J VOLCANOL GEOTH RES, V110, P265, DOI 10.1016/S0377-0273(01)00213-X; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Dixon JE, 1995, J PETROL, V36, P1633; Dixon JE, 2001, J PETROL, V42, P627, DOI 10.1093/petrology/42.3.627; ELLAM RM, 1992, GEOLOGY, V20, P153, DOI 10.1130/0091-7613(1992)020<0153:LTAACO>2.3.CO;2; FOX PJ, 1984, TECTONOPHYSICS, V104, P205, DOI 10.1016/0040-1951(84)90124-0; GAST PW, 1968, GEOCHIM COSMOCHIM AC, V32, P1057, DOI 10.1016/0016-7037(68)90108-7; Hellebrand E, 2002, J PETROL, V43, P2305, DOI 10.1093/petrology/43.12.2305; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; MCKENZIE D, 1991, J PETROL, V32, P1021, DOI 10.1093/petrology/32.5.1021; MICHAEL PJ, 1988, GEOCHIM COSMOCHIM AC, V52, P555, DOI 10.1016/0016-7037(88)90110-X; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; Nichols ARL, 2002, EARTH PLANET SC LETT, V202, P77, DOI 10.1016/S0012-821X(02)00758-6; OTTOLINI L, 1995, ANALYST, V120, P1309, DOI 10.1039/an9952001309; Phipps Morgan J., 1988, Journal of Geophysical Research, V93, P2955, DOI 10.1029/JB093iB04p02955; SCHILLING JG, 1995, J GEOPHYS RES-SOL EA, V100, P10057, DOI 10.1029/95JB00668; SCHILLING JG, 1975, EARTH PLANET SC LETT, V25, P103, DOI 10.1016/0012-821X(75)90186-7; SHEN Y, 1995, J GEOPHYS RES-SOL EA, V100, P2211, DOI 10.1029/94JB02768; Taylor B, 2003, EARTH PLANET SC LETT, V210, P481, DOI 10.1016/S0012-821X(03)-00167-5	30	40	41	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					66	69		10.1038/nature03264	http://dx.doi.org/10.1038/nature03264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744299	Green Published			2022-12-28	WOS:000227334600043
J	Scholes, RJ; Biggs, R				Scholes, RJ; Biggs, R			A biodiversity intactness index	NATURE			English	Article							PINUS-RADIATA; ASSEMBLAGES; AFFORESTATION; SAVANNA; LOWVELD	The nations of the world have set themselves a target of reducing the rate of biodiversity loss by 2010. Here, we propose a biodiversity intactness index (BII) for assessing progress towards this target that is simple and practical - but sensitive to important factors that influence biodiversity status - and which satisfies the criteria for policy relevance set by the Convention on Biological Diversity. Application of the BII is demonstrated on a large region ( 4 3 10 6 km 2) of southern Africa. The BII score in the year 2000 is about 84%: in other words, averaged across all plant and vertebrate species in the region, populations have declined to 84% of their presumed pre-modern levels. The taxonomic group with the greatest loss is mammals, at 71% of pre-modern levels, and the ecosystem type with the greatest loss is grassland, with 74% of its former populations remaining. During the 1990s, a population decline of 0.8% is estimated to have occurred.	CSIR Environmentek, ZA-0001 Pretoria, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR Environmentek, POB 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za	Biggs, Reinette/A-5155-2010	Biggs, Reinette/0000-0003-0300-4149; Scholes, Robert/0000-0001-5537-6935				ANDERSON JA, 2001, GONDWANA ALIVE PROMO; ARMSTRONG AJ, 1994, S AFR J WILDL RES, V24, P48; *CBD, 2003, MON IND DES NAT LEV; *CBD, 2003, PROP BIOD IND REL 20; *CIESIN IFPRI CIAT, 2004, GLOB RUR URB MAPP PR; *CSIR, 2002, SADC LANDC DAT; *CSIR, 2003, PROT AR S AFR; *CSIR, 1996, NAT LAND COV S AFR; Dean WRJ, 2002, J ARID ENVIRON, V51, P1, DOI 10.1006/jare.2001.0910; *EC, 2003, GLOB LAND COV 2000 G; Fabricius C, 2003, J APPL ECOL, V40, P392, DOI 10.1046/j.1365-2664.2003.00793.x; *FAO, 2004, FAOSTAT AGR DAT; FAO, 2001, GLOB FOR RES ASS 200; Friedmann Y, 2004, RED DATA BOOK MAMMAL; Herremans M, 1998, BIOL CONSERV, V86, P139, DOI 10.1016/S0006-3207(98)00016-0; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Houghton J.T., 1997, CH4 EMISSIONS COAL M; *IUCN UNEP, 2003, WORLD DAT PROT AR; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson R, 2002, J MAMMAL, V83, P290, DOI 10.1644/1545-1542(2002)083&lt;0290:DROSMA&gt;2.0.CO;2; Joubert DF, 1999, J ARID ENVIRON, V43, P287, DOI 10.1006/jare.1999.0553; Le Roux J, 2002, BIODIVERSITY S AFRIC; LOH J, 2002, LIVING PLANET REPORT; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Meik JM, 2002, BIOL CONSERV, V106, P29, DOI 10.1016/S0006-3207(01)00226-9; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parsons DAB, 1997, J ARID ENVIRON, V37, P319, DOI 10.1006/jare.1997.0283; Reid WV, 1993, BIODIVERSITY INDICAT; RICHARDSON DM, 1986, S AFR J BOT, V52, P309, DOI 10.1016/S0254-6299(16)31526-5; *ROYAL SOC, 2003, MEAS BIOD CONS; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Smart R, 2005, BIOL CONSERV, V122, P23, DOI 10.1016/j.biocon.2004.06.016; TENBRINK BJE, 2002, TECHNISCH ONTWERP NA, V2; United Nations, 2002, WORLD SUMMIT SUSTAIN; World Conservation Monitoring Centre (WCMC), 2000, GLOB BIOD EARTHS LIV; *WWF US, 2003, SPEC DAT AFR EC	38	279	299	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					45	49		10.1038/nature03289	http://dx.doi.org/10.1038/nature03289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744293				2022-12-28	WOS:000227334600037
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Phoebe and Iapetus	SCIENCE			English	Article							DARK SIDE; IRREGULAR SATELLITES; EVOLUTION; ASTEROIDS; LAPETUS; ORIGIN	The Cassini Imaging Science Subsystem acquired high-resolution imaging data on the outer Saturnian moon, Phoebe, during Cassini's close flyby on 11 June 2004 and on lapetus during a flyby on 31 December 2004. Phoebe has a heavily cratered and ancient surface, shows evidence of ice near the surface, has distinct layering of different materials, and has a mean density that is indicative of an ice-rock mixture. lapetus's dark leading side (Cassini Regio) is ancient, heavily cratered terrain bisected by an equatorial ridge system that reaches 20 kilometers relief. Local albedo variations within and bordering Cassini Regio suggest mass wasting of ballistically deposited material, the origin of which remains unknown.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carotyn@ciclops.org	Tiscareno, Matthew/D-6963-2011; Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012; Evans, Michael W/AAG-4117-2020	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				Bauer JM, 2004, ASTROPHYS J, V610, pL57, DOI 10.1086/423131; BELL JF, 1985, ICARUS, V61, P192, DOI 10.1016/0019-1035(85)90101-0; Brown ME, 2000, ASTRON J, V119, P977, DOI 10.1086/301202; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; BURNS JA, 1986, SATELLITES, P117; CLARK RN, 2005, IN PRESS NATURE; COLVIN TR, 1989, N2934NASA NASA STI; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; Denk T., 2000, LUN PLAN SCI C, V31, P1596; DENK T, 2000, LUNAR PLANET SCI C, V31, P1660; Gladman B, 2001, NATURE, V412, P163, DOI 10.1038/35084032; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; JACOBSON RA, 2004, B AM AST SOC, V35; Lee P, 1996, ICARUS, V120, P87, DOI 10.1006/icar.1996.0039; MCKINNON WB, 1996, NEPTUNE TRITON, P807; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MORRISON D, 1975, ICARUS, V24, P17; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; NEUKUM BA, 1994, HAZARDS DUE COMETS A, P359; Neukum G, 1997, THREE GALILEOS: THE MAN, THE SPACECRAFT, THE TELESCOPE, P201; NEUKUM G, 1971, EARTH PLANET SC LETT, V12, P59, DOI 10.1016/0012-821X(71)90055-0; NEUKUM G, 2001, CHRONOLOGY EVOLUTION, P53; NEUKUM G, 1998, LUNAR PLANET SCI, V29, P1742; Owen TC, 1999, ICARUS, V139, P379, DOI 10.1006/icar.1999.6116; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; Peale S. J., 1977, IAU C, P87; PECHMANN JB, 1979, ICARUS, V38, P243, DOI 10.1016/0019-1035(79)90181-7; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Schubert G., 1986, SATELLITES, P224; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; TABAK RG, 1989, EARTH MOON PLANETS, V44, P251, DOI 10.1007/BF00054241; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111	34	141	141	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1237	1242		10.1126/science.1107981	http://dx.doi.org/10.1126/science.1107981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731440				2022-12-28	WOS:000227313200039
J	Oerlemans, J				Oerlemans, J			Extracting a climate signal from 169 glacier records	SCIENCE			English	Article							MASS-BALANCE; LENGTH; SENSITIVITY	I constructed a temperature history for different parts of the world from 169 glacier length records. Using a first-order theory of glacier dynamics, I related changes in glacier length to changes in temperature. The derived temperature histories are fully independent of proxy and instrumental data used in earlier reconstructions. Moderate global warming started in the middle of the 19th century. The reconstructed warming in the first half of the 20th century is 0.5 kelvin. This warming was notably coherent over the globe. The warming signals from glaciers at low and high elevations appear to be very similar.	Univ Utrecht, Inst Marine & Atmospher Res, NL-3584 CC Utrecht, Netherlands	Utrecht University	Oerlemans, J (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res, Princetonpl 5, NL-3584 CC Utrecht, Netherlands.	j.oerlemans@phys.uu.nl	Oerlemans, Johannes/G-3802-2011					Anda E., 1985, Polar Research, V3, P129, DOI 10.1111/j.1751-8369.1985.tb00501.x; ANIYA M, 2001, B GLACIOL RES, V18, P55; BOGEN J, 1989, GLACIER FLUCTUATIONS, P305; Braithwaite RJ, 2000, J GLACIOL, V46, P7, DOI 10.3189/172756500781833511; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Christy JR, 2000, J ATMOS OCEAN TECH, V17, P1153, DOI 10.1175/1520-0426(2000)017<1153:MTTDCA>2.0.CO;2; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; Dyurgerov MB, 1997, ARCTIC ALPINE RES, V29, P379, DOI 10.2307/1551986; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; *GLAC COMM SWISS A, 1993, 1 GLAC COMM SWISS AC; Greuell W, 2001, J GEOPHYS RES-ATMOS, V106, P31717, DOI 10.1029/2001JD900127; Haeberli W, 1998, STUD HYDROL, V56, P35; Klok EJ, 2003, HOLOCENE, V13, P343, DOI 10.1191/0959683603hl627rp; Lanzante JR, 2003, J CLIMATE, V16, P224, DOI 10.1175/1520-0442(2003)016<0224:THOMRT>2.0.CO;2; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; MEIER MF, 1984, SCIENCE, V226, P1418, DOI 10.1126/science.226.4681.1418; Oerlemans J, 1997, ANN GLACIOL, V24, P382, DOI 10.3189/S0260305500012489; Oerlemans J, 1999, BOUND-LAY METEOROL, V92, P3, DOI 10.1023/A:1001856114941; OERLEMANS J, 1994, SCIENCE, V264, P243, DOI 10.1126/science.264.5156.243; Oerlemans J, 1998, CLIM DYNAM, V14, P267, DOI 10.1007/s003820050222; Oerlemans J., 2001, GLACIERS CLIMATE CHA; Ostrem G., 1976, NOR GEOGR TIDSSKR, V30, P187; Schmeits MJ, 1997, J GLACIOL, V43, P152, DOI 10.3189/S0022143000002914; Sigurethsson O, 1998, J KULL, V45, P3; Stroeven AP, 1996, GEOGR ANN A, V78A, P133, DOI 10.2307/520975; Vincent C, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003857; Wallinga J, 1998, J GLACIOL, V44, P383, DOI 10.3189/S0022143000002719; WEIDICK A, 1988, GLETSCHERE SYDGRONLA, P47; WILLIAMS RJ, 1989, SATELLITE IMAGE ATLA, V1; Zumbuhl HJ, 1980, SCHWANKUNGEN GRINDEL, V92	30	700	765	8	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					675	677		10.1126/science.1107046	http://dx.doi.org/10.1126/science.1107046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15746388	Green Submitted			2022-12-28	WOS:000228810900044
J	Daiger, SP				Daiger, SP			Was the human genome project worth the effort?	SCIENCE			English	Editorial Material							MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; SCAN; DISEASE; LINKAGE; REGIONS; GENE		Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Daiger, SP (corresponding author), Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA.	stephen.p.daiger@uth.tmc.edu			NEI NIH HHS [R01 EY005235, R01 EY007142-12A2, R01 EY007142] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005235, R01EY007142] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hyman Leslie, 2002, Curr Opin Ophthalmol, V13, P171; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476	17	46	54	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					362	364		10.1126/science.1111655	http://dx.doi.org/10.1126/science.1111655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15769856	Green Accepted			2022-12-28	WOS:000228492000036
J	LaRosa, JC; Grundy, SM; Waters, DD; Shear, C; Barter, P; Fruchart, J; Gotto, AM; Greten, H; Kastelein, JJP; Shepherd, J; Wenger, NK				LaRosa, JC; Grundy, SM; Waters, DD; Shear, C; Barter, P; Fruchart, J; Gotto, AM; Greten, H; Kastelein, JJP; Shepherd, J; Wenger, NK		TNT Investigators	Intensive lipid lowering with atorvastatin in patients with stable coronary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTION; GUIDELINES; OUTCOMES; AVERAGE; EVENTS	BACKGROUND: Previous trials have demonstrated that lowering low-density lipoprotein (LDL) cholesterol levels below currently recommended levels is beneficial in patients with acute coronary syndromes. We prospectively assessed the efficacy and safety of lowering LDL cholesterol levels below 100 mg per deciliter (2.6 mmol per liter) in patients with stable coronary heart disease (CHD). METHODS: A total of 10,001 patients with clinically evident CHD and LDL cholesterol levels of less than 130 mg per deciliter (3.4 mmol per liter) were randomly assigned to double-blind therapy and received either 10 mg or 80 mg of atorvastatin per day. Patients were followed for a median of 4.9 years. The primary end point was the occurrence of a first major cardiovascular event, defined as death from CHD, nonfatal non-procedure-related myocardial infarction, resuscitation after cardiac arrest, or fatal or nonfatal stroke. RESULTS: The mean LDL cholesterol levels were 77 mg per deciliter (2.0 mmol per liter) during treatment with 80 mg of atorvastatin and 101 mg per deciliter (2.6 mmol per liter) during treatment with 10 mg of atorvastatin. The incidence of persistent elevations in liver aminotransferase levels was 0.2 percent in the group given 10 mg of atorvastatin and 1.2 percent in the group given 80 mg of atorvastatin (P<0.001). A primary event occurred in 434 patients (8.7 percent) receiving 80 mg of atorvastatin, as compared with 548 patients (10.9 percent) receiving 10 mg of atorvastatin, representing an absolute reduction in the rate of major cardiovascular events of 2.2 percent and a 22 percent relative reduction in risk (hazard ratio, 0.78; 95 percent confidence interval, 0.69 to 0.89; P<0.001). There was no difference between the two treatment groups in overall mortality. CONCLUSIONS: Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond that afforded by treatment with 10 mg of atorvastatin per day. This occurred with a greater incidence of elevated aminotransferase levels.	SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Pfizer, Groton, CT USA; Heart Res Inst, Sydney, NSW, Australia; Inst Pasteur, F-59019 Lille, France; Cornell Univ, Weill Med Coll, New York, NY USA; Univ Hamburg, Klinikum Eppendorf, Hamburg, Germany; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Glasgow, Glasgow, Lanark, Scotland; Emory Univ, Sch Med, Atlanta, GA USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; San Francisco General Hospital Medical Center; Pfizer; University of Sydney; Heart Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Cornell University; University of Hamburg; University of Amsterdam; Academic Medical Center Amsterdam; University of Glasgow; Emory University	LaRosa, JC (corresponding author), SUNY Hlth Sci Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	jclarosa@downstate.edu	Kastelein, John/AAF-7950-2020					Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; PEDERSEN TR, 1994, LANCET, V344, P1383; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Waters DD, 2004, AM J CARDIOL, V93, P154, DOI 10.1016/j.amjcard.2003.09.031	13	2529	2686	2	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1425	1435		10.1056/NEJMoa050461	http://dx.doi.org/10.1056/NEJMoa050461			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15755765	Green Published, Bronze			2022-12-28	WOS:000228145200006
J	Campbell, C; McGauley, G				Campbell, C; McGauley, G			Doctor-patient relationships in chronic illness: insights from forensic psychiatry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-STUDENTS; CHRONIC DISEASE; CARE; MANAGEMENT; ILL; ATTITUDES	Collaborative management of chronic illness is undermined by neglect of emotional and psychological factors in both the patient and doctor.	Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	St Georges University London	McGauley, G (corresponding author), Univ London St Georges Hosp, Sch Med, London SW17 0RE, England.	gmcgaule@sghms.ac.uk						Beaglehole R., 2003, WORLD HLTH REPORT 20; Butwell M, 2000, BRIT J PSYCHIAT, V176, P260, DOI 10.1192/bjp.176.3.260; Collinson S, 2002, MED TEACH, V24, P327, DOI 10.1080/01421590220134187; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Davis BE, 2001, ACAD MED, V76, P815, DOI 10.1097/00001888-200108000-00015; Edwards M, 1999, MED EDUC, V33, P704, DOI 10.1046/j.1365-2923.1999.00501.x; General Medical Council, 1993, TOM DOCT; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Lewis R, 2004, BMJ-BRIT MED J, V328, P220, DOI 10.1136/bmj.328.7433.220; Lloyd-Williams M, 2004, POSTGRAD MED J, V80, P31, DOI 10.1136/pmj.2003.009571; MAIN TF, 1957, BRIT J MED PSYCHOL, V30, P129, DOI 10.1111/j.2044-8341.1957.tb01193.x; MALAN DH, 1990, INDIVIDUAL PSYCHOTHE, P1; Nair BR, 2003, MED J AUSTRALIA, V179, P257, DOI 10.5694/j.1326-5377.2003.tb05533.x; Pham HH, 2004, ACAD MED, V79, P32, DOI 10.1097/00001888-200401000-00009; SAMUEL O, 2004, WORK BASED LEARNING, V2, P26; Sollod RN, 2002, J CLIN PSYCHOL, V58, P1397, DOI 10.1002/jclp.10087; Turner J, 2000, WESTERN J MED, V172, P124, DOI 10.1136/ewjm.172.2.124; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; WATTS D, 1994, BRIT J PSYCHIAT, V164, P11, DOI 10.1192/bjp.164.1.11	22	31	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2005	330	7492					667	670		10.1136/bmj.330.7492.667	http://dx.doi.org/10.1136/bmj.330.7492.667			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15775003	Green Published			2022-12-28	WOS:000227861700036
J	Cayley, WE				Cayley, WE			10-minute consultation - Irritable bowel syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Wisconsin, Dept Family Med, Eau Claire Family Med Residency, Eau Claire, WI 54701 USA	University of Wisconsin System	Cayley, WE (corresponding author), Univ Wisconsin, Dept Family Med, Eau Claire Family Med Residency, 617 W Clairemont, Eau Claire, WI 54701 USA.	bcayley@yahoo.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					632	632		10.1136/bmj.330.7492.632	http://dx.doi.org/10.1136/bmj.330.7492.632			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774992	Bronze, Green Published			2022-12-28	WOS:000227861700022
J	Spiliotis, ET; Kinoshita, M; Nelson, WJ				Spiliotis, ET; Kinoshita, M; Nelson, WJ			A mitotic septin scaffold required for mammalian chromosome congression and segregation	SCIENCE			English	Article							CENP-E; MICROTUBULE CAPTURE; BUDDING YEAST; PROTEIN-E; CHECKPOINT; CYTOKINESIS; COMPONENT; ACTIN; KINETOCHORES; ORGANIZATION	Coordination of cytokinesis with chromosome congression and segregation is critical for proper cell division, but the mechanism is unknown. Here, septins, a conserved family of polymerizing guanosine triphosphate-binding proteins, localized to the metaphase plate during mitosis. Septin depletion resulted in chromosome loss from the metaphase plate, lack of chromosome segregation and spindle elongation, and incomplete cytokinesis upon delayed mitotic exit. These defects correlated with loss of the mitotic motor and the checkpoint regulator centromere-associated protein E (CENP-E) from the kinetochores of congressing chromosomes. Mammalian septins may thus form a mitotic scaffold for CENP-E and other effectors to coordinate cytokinesis with chromosome congression and segregation.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, Horizontal Med Res Org, Kyoto 6068501, Japan	Stanford University; Kyoto University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu			NIGMS NIH HHS [R37 GM035527, GM35527, R01 GM035527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	27	188	197	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1781	1785		10.1126/science.1106823	http://dx.doi.org/10.1126/science.1106823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774761	Green Accepted			2022-12-28	WOS:000227883900047
J	Forbes, P				Forbes, P			Poetry and science: greatness in little	NATURE			English	Article													Forbes, Patricia BC/AFM-0683-2022	Forbes, Patricia BC/0000-0003-3453-9162				Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Register RA, 2003, NATURE, V424, P378, DOI 10.1038/424378a; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307	3	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					320	323		10.1038/434320a	http://dx.doi.org/10.1038/434320a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	907KG	15772650				2022-12-28	WOS:000227715100039
J	Ozonoff, D; Pepper, L				Ozonoff, D; Pepper, L			Ticket to ride: spreading germs a mile high	LANCET			English	Editorial Material							AIRCRAFT		Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University	Ozonoff, D (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.	dozonoff@bu.edu		Ozonoff, David/0000-0002-4281-4171				[Anonymous], 2013, WHOCDSCSRGAR2003; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Gammaitoni L, 1997, EMERG INFECT DIS, V3, P335, DOI 10.3201/eid0303.970310; Hocking MB, 1998, AM IND HYG ASSOC J, V59, P446, DOI 10.1080/15428119891010181; *INT CIV AV ORG, SEV AC RESP SYNDR SA; Miller JD, 2002, ASHRAE J, V44, P18; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; *UK PARL SEL COMM, 2000, 5 UK PARL SEL COMM S; *US GEN ACC OFF, 2004, AV SAF MOR RES NEED; Watts D.J., 2003, 6 DEGREES SCI CONNEC	10	11	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					917	919		10.1016/S0140-6736(05)71058-8	http://dx.doi.org/10.1016/S0140-6736(05)71058-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766978	Bronze, Green Published			2022-12-28	WOS:000227559800006
J	Resnick, MA				Resnick, MA			Reduced replication: A call to ARMS	CELL			English	Editorial Material							COMMON FRAGILE SITES; SACCHAROMYCES-CEREVISIAE; REARRANGEMENTS; REPAIR; BREAKS	In this issue of Cell, Lemoine et al. (2005) monitor chromosome instability in yeast cells with reduced levels of an essential replicative DNA polymerase. The authors identify a hotspot for chromosome aberrations reminiscent of fragile sites in human cells. This hotspot is composed of inverted Ty elements, which lead to a double-strand break under conditions of limited replication.	NIEHS, Chromosome Stabil Sect, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Chromosome Stabil Sect, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		resnick, Michael/F-1668-2019	resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021016, ZIAES021016] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1	8	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					569	570		10.1016/j.cell.2005.02.028	http://dx.doi.org/10.1016/j.cell.2005.02.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766518	Bronze			2022-12-28	WOS:000227771400001
J	Grubb, BP				Grubb, BP			Neurocardiogenic syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEURALLY-MEDIATED SYNCOPE; VASOVAGAL SYNCOPE; DOUBLE-BLIND; BETA-BLOCKERS; PREVENTION; PLACEBO; MANAGEMENT; MIDODRINE; THERAPY; TRIAL		Med Coll Ohio, Div Cardiol, Dept Med, Toledo, OH 43614 USA		Grubb, BP (corresponding author), Med Coll Ohio, Div Cardiol, Dept Med, 3000 Arlington Ave, Toledo, OH 43614 USA.	bgrubb@mco.edu						Ammirati F, 2001, CIRCULATION, V104, P52, DOI 10.1161/hc2601.091708; Benditt DG, 1996, J AM COLL CARDIOL, V28, P263, DOI 10.1016/0735-1097(96)00236-7; Bloomfield DM, 1999, AM J CARDIOL, V84, p33Q; BRIGNOLE M, 1992, AM J CARDIOL, V70, P339, DOI 10.1016/0002-9149(92)90615-6; Brignole M, 2003, J CARDIOVASC ELECTR, V14, pS64, DOI 10.1046/j.1540-8167.14.s9.7.x; Brignole M, 2002, J AM COLL CARDIOL, V40, P2053, DOI 10.1016/S0735-1097(02)02683-9; Brignole M, 2001, EUR HEART J, V22, P1256, DOI 10.1053/euhj.2001.2739; Connolly SJ, 2003, JAMA-J AM MED ASSOC, V289, P2224, DOI 10.1001/jama.289.17.2224; Connolly SJ, 1999, J AM COLL CARDIOL, V33, P16, DOI 10.1016/S0735-1097(98)00549-X; Di Girolamo E, 1999, J AM COLL CARDIOL, V33, P1227, DOI 10.1016/S0735-1097(98)00694-9; Ector H, 1998, PACE, V21, P193, DOI 10.1111/j.1540-8159.1998.tb01087.x; ElSayed H, 1996, HEART, V75, P134, DOI 10.1136/hrt.75.2.134; Fitzpatrick AP, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P63; Flevari P, 2002, J AM COLL CARDIOL, V40, P499, DOI 10.1016/S0735-1097(02)01974-5; Foglia-Manzillo G, 2004, EUROPACE, V6, P199, DOI 10.1016/j.eupc.2004.01.002; GIADA F, 2003, PACING CLIN ELECTROP, V26, P1016; Goldschlager N, 2003, ARCH INTERN MED, V163, P151, DOI 10.1001/archinte.163.2.151; Grubb BP, 1998, J INTERV CARD ELECTR, V2, P325, DOI 10.1023/A:1009792000490; Grubb BP, 1999, PACE, V22, P798, DOI 10.1111/j.1540-8159.1999.tb00546.x; Grubb BP, 1996, PACE, V19, P836, DOI 10.1111/j.1540-8159.1996.tb03367.x; GRUBB BP, 1993, PACE, V16, P458, DOI 10.1111/j.1540-8159.1993.tb01608.x; Grubb BP, 1997, PACE, V20, P781, DOI 10.1111/j.1540-8159.1997.tb03904.x; GRUBB BP, IN PRESS SYNCOPE MEC; Kaufmann H, 2002, ANN NEUROL, V52, P342, DOI 10.1002/ana.10293; KOSINSKI D, 1995, PACE, V18, P716, DOI 10.1111/j.1540-8159.1995.tb04666.x; Krahn AD, 2001, CIRCULATION, V104, P46, DOI 10.1161/01.CIR.104.1.46; Krediet CTP, 2002, CIRCULATION, V106, P1684, DOI 10.1161/01.CIR.0000030939.12646.8F; KUHN DM, 1980, HYPERTENSION, V2, P243, DOI 10.1161/01.HYP.2.3.243; Lee TM, 1996, AM J CARDIOL, V78, P480, DOI 10.1016/S0002-9149(96)00342-6; LINZER M, 1991, J CLIN EPIDEMIOL, V44, P1037, DOI 10.1016/0895-4356(91)90005-T; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; Low PA, 1997, JAMA-J AM MED ASSOC, V277, P1046, DOI 10.1001/jama.277.13.1046; Low PA, 1997, JAMA-J AM MED ASSOC, V278, P388; Lurie KG, 1996, J CARDIOVASC ELECTR, V7, P760, DOI 10.1111/j.1540-8167.1996.tb00582.x; Madrid AH, 2001, J AM COLL CARDIOL, V37, P554, DOI 10.1016/S0735-1097(00)01155-4; MCGRADY AV, 1986, J BEHAV THER EXP PSY, V17, P23, DOI 10.1016/0005-7916(86)90006-6; McGrady AV, 1997, APPL PSYCHOPHYS BIOF, V22, P63, DOI 10.1023/A:1026241826589; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; NATALE A, 1995, CIRCULATION, V92, P54, DOI 10.1161/01.CIR.92.1.54; Parry SW, 1999, QJM-MON J ASSOC PHYS, V92, P697, DOI 10.1093/qjmed/92.12.697; Perez-Lugones A, 2001, J CARDIOVASC ELECTR, V12, P935, DOI 10.1046/j.1540-8167.2001.00935.x; Raviele A, 1999, CIRCULATION, V99, P1452, DOI 10.1161/01.CIR.99.11.1452; SCOTT WA, 1995, AM J CARDIOL, V76, P400, DOI 10.1016/S0002-9149(99)80110-6; Sheldon R, 1996, AM J CARDIOL, V78, P536, DOI 10.1016/S0002-9149(96)00359-1; SHELDON R, 2004, LAT BREAK CLIN TRIAL; Shepherd R, 1999, AUTONOMIC FAILURE TX, P72; Sutton R, 2000, CIRCULATION, V102, P294; Sutton R, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P71; Sutton R, 2003, J INTERV CARD ELECTR, V9, P145, DOI 10.1023/A:1026272004709; Ventura R, 2002, PACE, V25, P816, DOI 10.1046/j.1460-9592.2002.t01-1-00816.x; Ward CR, 1998, HEART, V79, P45, DOI 10.1136/hrt.79.1.45; Wieling W, 1997, CLIN AUTONOMIC DISOR, P73; Younoszai AK, 1998, ARCH PEDIAT ADOL MED, V152, P165; [No title captured]	54	134	147	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					1004	1010		10.1056/NEJMcp042601	http://dx.doi.org/10.1056/NEJMcp042601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758011				2022-12-28	WOS:000227491200009
J	Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI				Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI			The global distribution of clinical episodes of Plasmodium falciparum malaria	NATURE			English	Article							MORTALITY; AFRICA; BURDEN; TRANSMISSION; POPULATION; MORBIDITY; CHILDREN; ABSENCE; DISEASE; WORLD	Interest in mapping the global distribution of malaria is motivated by a need to define populations at risk for appropriate resource allocation(1,2) and to provide a robust framework for evaluating its global economic impact(3,4). Comparison of older(5-7) and more recent(1,4) malaria maps shows how the disease has been geographically restricted, but it remains entrenched in poor areas of the world with climates suitable for transmission. Here we provide an empirical approach to estimating the number of clinical events caused by Plasmodium falciparum worldwide, by using a combination of epidemiological, geographical and demographic data. We estimate that there were 515 ( range 300 - 660) million episodes of clinical P. falciparum malaria in 2002. These global estimates are up to 50% higher than those reported by the World Health Organization ( WHO) and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries. Without an informed understanding of the cartography of malaria risk, the global extent of clinical disease caused by P. falciparum will continue to be underestimated.	KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi 00100, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	University of Oxford; University of Oxford; Mahidol University	Snow, RW (corresponding author), KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, POB 43640, Nairobi 00100, Kenya.	rsnow@wtnairobi.mimcom.net	Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022	Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [058992, 081829, 069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alles HK, 1998, PARASITOL TODAY, V14, P369, DOI 10.1016/S0169-4758(98)01296-4; [Anonymous], ITOGI NAUKI MEDICINS; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; *INT ASS MED ASS T, 2004, WORLD MAL RISK CHART; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; MAYFONG M, 2004, TRENDS PARASITOL, V20, P233; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Prusty SKR, 2001, ANN TROP MED PARASIT, V95, P133, DOI 10.1080/00034980120041080; RUSSELL PF, 1956, AM J TROP MED HYG, V5, P937, DOI 10.4269/ajtmh.1956.5.937; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; *WHO, 2003, INT TRAV HLTH SIT 1; *WO, 1999, WORLD HLTH REP 1999	23	1988	2067	5	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					214	217		10.1038/nature03342	http://dx.doi.org/10.1038/nature03342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759000	Green Accepted			2022-12-28	WOS:000227494500045
J	Maskell, NA; Davies, CWH; Nunn, AJ; Hedley, EL; Gleeson, FV; Miller, R; Gabe, R; Rees, GL; Peto, TEA; Woodhead, MA; Lane, DJ; Darbyshire, JH; Davies, RJO				Maskell, NA; Davies, CWH; Nunn, AJ; Hedley, EL; Gleeson, FV; Miller, R; Gabe, R; Rees, GL; Peto, TEA; Woodhead, MA; Lane, DJ; Darbyshire, JH; Davies, RJO		MIST1 Grp	UK controlled trial of intrapleural streptokinase for pleural infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLICATED PARAPNEUMONIC EFFUSIONS; COMMUNITY-ACQUIRED PNEUMONIA; EMPYEMA; UROKINASE; MANAGEMENT	BACKGROUND Intrapleural fibrinolytic agents are used in the drainage of infected pleural-fluid collections. This use is based on small trials that did not have the statistical power to evaluate accurately important clinical outcomes, including safety. We conducted a trial to clarify the therapeutic role of intrapleural streptokinase. METHODS In this double-blind trial, 454 patients with pleural infection (defined by the presence of purulent pleural fluid or pleural fluid with a pH below 7.2 with signs of infection or by proven bacterial invasion of the pleural space) were randomly assigned to receive either intrapleural streptokinase (250,000 IU twice daily for three days) or placebo. Patients received antibiotics and underwent chest-tube drainage, surgery, and other treatment as part of routine care. The number of patients in the two groups who had died or needed surgical drainage at three months was compared (the primary end point); secondary end points were the rates of death and of surgery (analyzed separately), the radiographic outcome, and the length of the hospital stay. RESULTS The groups were well matched at baseline. Among the 427 patients who received streptokinase or placebo, there was no significant difference between the groups in the proportion of patients who died or needed surgery (with streptokinase: 64 of 206 patients [31 percent]; with placebo: 60 of 221 [27 percent]; relative risk, 1.14 [95 percent confidence interval, 0.85 to 1.54; P=0.43), a result that excluded a clinically significant benefit of streptokinase. There was no benefit to streptokinase in terms of mortality, rate of surgery, radiographic outcomes, or length of the hospital stay. Serious adverse events (chest pain, fever, or allergy) were more common with streptokinase (7 percent, vs. 3 percent with placebo; relative risk, 2.49 [95 percent confidence interval, 0.98 to 6.36]; P=0.08). CONCLUSIONS The intrapleural administration of streptokinase does not improve mortality, the rate of surgery, or the length of the hospital stay among patients with pleural infection.	Oxford Radcliffe Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; Royal Berkshire Hosp, Dept Resp Med, Reading RG1 5AN, Berks, England; MRC, Clin Trials Unit, London, England; UCL, Dept Populat Sci & Primary Care, London, England; Manchester Royal Infirm, Dept Resp Med, Manchester M13 9WL, Lancs, England	University of Oxford; Royal Berkshire Hospital; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Manchester	Davies, RJO (corresponding author), Oxford Radcliffe Hosp, Oxford Ctr Resp Med, Churchill Hosp Site, Oxford OX3 7LJ, England.	robert.davies@ndm.ox.ac.uk		Miller, Robert/0000-0003-2067-4291; maskell, nick/0000-0002-1276-6500; peto, tim/0000-0003-3477-8307; Gabe, Rhian/0000-0002-0273-3094; Nunn, Andrew/0000-0002-9158-4595	Medical Research Council [MC_U122888468] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bouros D, 1999, AM J RESP CRIT CARE, V159, P37, DOI 10.1164/ajrccm.159.1.9803094; Bouros D, 1997, AM J RESP CRIT CARE, V155, P291, DOI 10.1164/ajrccm.155.1.9001327; Chin NK, 1997, CHEST, V111, P275, DOI 10.1378/chest.111.2.275; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Colice, 2001, CHEST, V119, P319; Davies CWH, 1999, CHEST, V115, P729, DOI 10.1378/chest.115.3.729; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; DAVIES CWH, 2003, THORAX S2, V58, P18; Davies RJO, 1997, THORAX, V52, P416, DOI 10.1136/thx.52.5.416; Diacon AH, 2004, AM J RESP CRIT CARE, V170, P49, DOI 10.1164/rccm.200312-1740OC; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Lee YCG, 2004, AM J RESP CRIT CARE, V170, P1, DOI 10.1164/rccm.2404013; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Light RW, 2000, LUNG, V178, P13, DOI 10.1007/s004080000002; Lim TK, 1999, EUR RESPIR J, V13, P514, DOI 10.1183/09031936.99.13351499; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Maskell NA, 2003, NEW ENGL J MED, V348, pE4, DOI 10.1056/ENEJMicm020531; MASKELL NA, 2003, TXB PLEURAL DIS, P310; Simpson G, 2000, CHEST, V117, P1728, DOI 10.1378/chest.117.6.1728; Simpson G, 2003, THORAX, V58, P365, DOI 10.1136/thorax.58.4.365; *STAT, 2003, STAT STAT SOFTW REL; Thomson AH, 2002, THORAX, V57, P343, DOI 10.1136/thorax.57.4.343	23	492	506	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					865	874		10.1056/NEJMoa042473	http://dx.doi.org/10.1056/NEJMoa042473			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745977	Green Published, Bronze			2022-12-28	WOS:000227310700005
J	McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS				McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS			Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up	ANNALS OF INTERNAL MEDICINE			English	Article							YUPIK ESKIMO POPULATION; HEALTH-CARE WORKERS; LONG-TERM EFFICACY; VIRUS-INFECTION; SURFACE-ANTIGEN; CHILDHOOD VACCINATION; ALASKA NATIVES; CHILDREN; IMMUNOGENICITY; INFANTS	Background: The duration of protection afforded by hepatitis B vaccination is unknown. Objective: To determine antibody persistence and protection from hepatitis B virus (HBV) infection. Design: Prospective cohort study. Setting: 15 villages in southwest Alaska. Participants: 1578 Alaska Natives vaccinated at age 6 months or older. Intervention: During 1981-1982, participants received 3 doses of plasma-derived hepatitis 8 vaccine. This cohort was followed annually over the first 11 years, and 841 (53%) persons were tested at 15 years. Measurements: Antibody to hepatitis B surface antigen (anti-HBs), markers of HBV infection, and testing to identify HBV variants. Results: Levels of anti-HBs in the cohort decreased from a geometric mean concentration of 822 mIU/mL after vaccination to 27 mIU/mL at 15 years. Initial anti-HBs level, older age at vaccination, and male sex were associated with persistence of higher anti-HBs levels at 15 years when analyzed by a longitudinal linear mixed model. After adjustment for initial anti-HBs level and sex, those vaccinated at age 6 months to 4 years had the lowest anti-HBs level at 15 years. Asymptomatic breakthrough infections were detected in 16 participants and occurred more frequently in persons who did not respond to vaccination than those who responded (P = 0.01). Among infected persons with viremia, 2 were infected with wild-type HBV and 4 had HBV surface glycoprotein variants, generally accompanied by wild-type HBV. Limitations: The loss of participants to follow-up at 15 years was 47%. However, characteristics of persons tested were similar to those of persons lost to follow-up. Conclusions: Hepatitis B vaccination strongly protected against infection for at least 15 years in all age groups. Antibody levels decreased the most among persons immunized at 4 years of age or younger.	Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Alaska Native Med Ctr, Anchorage, AK USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Alaska Native Medical Center; Centers for Disease Control & Prevention - USA	McMahon, BJ (corresponding author), Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	bdm9@cdc.gov			ODCDC CDC HHS [U50/CCU022279] Funding Source: Medline	ODCDC CDC HHS		Barash C, 1999, ARCH INTERN MED, V159, P1481, DOI 10.1001/archinte.159.13.1481; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Bulkow LR, 1998, CLIN INFECT DIS, V26, P933, DOI 10.1086/513939; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DING LM, 1993, CLIN INFECT DIS, V17, P475; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; GOH KT, 1992, B WORLD HEALTH ORGAN, V70, P233; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HADLER SC, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P766; Harpaz R, 2000, J INFECT DIS, V181, P413, DOI 10.1086/315259; HEYWARD WL, 1985, AM J EPIDEMIOL, V121, P914, DOI 10.1093/oxfordjournals.aje.a114061; Hino K, 1999, HEPATOLOGY, V30, p300A; Hsu HY, 1997, HEPATOLOGY, V26, P786, DOI 10.1053/jhep.1997.v26.pm0009303514; Huang LM, 1999, HEPATOLOGY, V29, P954, DOI 10.1002/hep.510290349; LAI CL, 1993, HEPATOLOGY, V18, P763, DOI 10.1002/hep.1840180403; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MCMAHON BJ, 1993, AM J EPIDEMIOL, V138, P544; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; McMahon BJ, 2000, VIRAL HEPATITIS REV, V6, P229; MILNE A, 1994, J MED VIROL, V44, P113, DOI 10.1002/jmv.1890440202; Nainan OV, 1996, J VIROL METHODS, V61, P127, DOI 10.1016/0166-0934(96)02077-0; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009; Ogata N, 1999, HEPATOLOGY, V30, P779, DOI 10.1002/hep.510300309; PASKO MT, 1990, AM J PUBLIC HEALTH, V80, P590, DOI 10.2105/AJPH.80.5.590; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; STEVENS CE, 1992, PEDIATRICS, V90, P170; TABOR E, 1993, J MED VIROL, V40, P204, DOI 10.1002/jmv.1890400307; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wainwright RB, 1997, J INFECT DIS, V175, P674, DOI 10.1093/infdis/175.3.674; WAINWRIGHT RB, 1991, ARCH INTERN MED, V151, P1634, DOI 10.1001/archinte.151.8.1634; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; Williams JL, 2001, VACCINE, V19, P4081, DOI 10.1016/S0264-410X(01)00112-8; Wu JS, 1999, J INFECT DIS, V179, P1319, DOI 10.1086/314768; XU ZY, 1995, J INFECT DIS, V171, P54, DOI 10.1093/infdis/171.1.54; Yotsuyanagi H, 1998, HEPATOLOGY, V27, P1377, DOI 10.1002/hep.510270526; YVONNET B, 1987, J MED VIROL, V22, P315, DOI 10.1002/jmv.1890220404	38	215	227	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					333	341		10.7326/0003-4819-142-5-200503010-00008	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738452				2022-12-28	WOS:000227325100003
J	Alexander, J				Alexander, J			Commentary: Research ethics committees deserve support	BRITISH MEDICAL JOURNAL			English	Editorial Material									S W Multictr Res Eth Comm, Lescaze Off, Dartington TQ9 6JE, England		Alexander, J (corresponding author), S W Multictr Res Eth Comm, Lescaze Off, Dartington TQ9 6JE, England.	jialexander@macunlimited.net						LAURENCE J, 2000, INDEPENDENT     0508; *NAT I CLIN EXC, CLIN AUD; STONE TJ, 2004, THESIS U BRISTOL; *UN BRIST HEALTHC, 2000, TELL DIFF AUD RES; Wade DT, 2005, BMJ-BRIT MED J, V330, P468, DOI 10.1136/bmj.330.7489.468	5	2	2	2	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					472	473		10.1136/bmj.330.7489.472	http://dx.doi.org/10.1136/bmj.330.7489.472			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15731148	Green Published			2022-12-28	WOS:000227315400027
J	Head, MW; Ironside, JW				Head, MW; Ironside, JW			Mad cows and monkey business: the end of vCJD?	LANCET			English	Editorial Material							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE		Univ Edinburgh, Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	james.ironside@ed.ac.uk		Ironside, James/0000-0001-5869-2108				Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Carrell RW, 2004, SCIENCE, V306, P1692, DOI 10.1126/science.1106679; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Cooper JD, 2003, INT J EPIDEMIOL, V32, P784, DOI 10.1093/ije/dyg248; Goldfarb LG, 2004, CURR MOL MED, V4, P375, DOI 10.2174/1566524043360627; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; *NAT CRUTZF DIS SU, 2004, 12 NAT CREUTZF DIS S; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; *WORK GROUP PRION, BSE TRANSM FOOD BLOO	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					730	731						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733699				2022-12-28	WOS:000227285300004
J	Kaufman, FR				Kaufman, FR			Intensive management of type 1 diabetes in young children	LANCET			English	Editorial Material							MELLITUS		Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California	Kaufman, FR (corresponding author), Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA.	fkaufman@chla.usc.edu						Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Kaufman FR, 1999, DIABETES-METAB RES, V15, P338, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<338::AID-DMRR57>3.3.CO;2-P; Kaufman FR, 2003, PEDIATR REV, V24, P291, DOI 10.1542/pir.24-9-291; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Kaufman Francine Ratner, 2002, Pediatr Diabetes, V3, P179, DOI 10.1034/j.1399-5448.2002.30402.x; Ryan CM, 1999, ENDOCRIN METAB CLIN, V28, P883, DOI 10.1016/S0889-8529(05)70107-9; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weinzimer SA, 2004, PEDIATRICS, V114, P1601, DOI 10.1542/peds.2004-0092	9	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					737	738						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733703				2022-12-28	WOS:000227285300008
J	Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM				Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM			Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANZANIAN CHILDREN; SEVERE ANEMIA; RISK-FACTORS; 2 AREAS; MORTALITY; MORBIDITY; PARASITE; ADMISSION; ALTITUDE; INFANTS	Context There are concerns that malaria control measures such as use of insecticide-treated bed nets, by delaying acquisition of immunity, might result in an increase in the more severe manifestations of malaria. An understanding of the relationships among the level of exposure to Plasmodium falciparum, age, and severity of malaria can provide evidence of whether this is likely. Objective To describe the clinical manifestations and case fatality of severe P falciparum malaria at varying altitudes resulting in varying levels of transmission. Design, Setting, and Patients A total of 1984 patients admitted for severe malaria to 10 hospitals serving populations living at levels of transmission varying from very low (altitude >1200 m) to very high (altitude <600 m) in a defined area of northeastern Tanzania, studied prospectively from February 2002 to February 2003. Data were analyzed in a logistic regression model and adjusted for potential clustering within hospitals. Main Outcome Measures Specific syndromes of severe malaria; mortality. Results The median age of patients was 1 year in high transmission, 3 years in moderate transmission, and 5 years in low transmission areas. The odds of severe malarial anemia (hemoglobin <5 g/dL) peaked at 1 year of age at high transmission and at 2 years at moderate and low transmission intensities and then decreased with increasing age (P=.002). Odds were highest in infants (0-1 year: referent; 2-4 years: odds ratio [OR], 0.83; 95% confidence interval [0], 0.72-0.96), 5 to <15 years: OR, 0.44; 95% Cl, 0.27-0.72; >= 15 years: OR, 0.44; 95% Cl, 0.27-0.73; P<.001) and high transmission intensity areas (altitude <600 in: referent; 600 In to 1200 in: OR, 0.55; 95% Cl, 0.35-0.84; >1200 in: OR, 0.55; 95% Cl, 0.26-1.15; P for trend =.03). The odds of cerebral malaria were significantly higher in low transmission intensity areas (altitude of residence <600 in: referent; 600 in to 1200 m: OR, 3.17; 95% Cl, 1.32-7.60; >1200 in: OR, 3.76; 95% Cl, 1.96-7.18; P for trend=.003) and with age 5 years and older (0-1 year: referent; 2-4 years: OR, 1.57; 95% Cl, 0.82-2.99; 5 to <15 years: OR, 6.07; 95% Cl, 2.98-12.38; >= 15 years: OR, 6.24; 95% Cl, 3.47-11.21; P<.001). The overall case-fatality rate of 7% (139 deaths) was similar at high and moderate levels of transmission but increased to 13% in low transmission areas (P=.03), an increase explained by the increase in the proportion of cases with cerebral malaria. Conclusions Age and level of exposure independently influence the clinical presentation of severe malaria. Our study suggests that an increase in the proportion of cases with more fatal manifestations of severe malaria is likely to occur only after transmission has been reduced to low levels where the overall incidence is likely to be low.	Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Natl Inst Med Res, Amani, Tanzania	Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Reyburn, H (corresponding author), Kilimanjaro Christian Med Ctr, Joint Malaria Programme, POB 2228, Moshi, Tanzania.	hugh.reyburn@lshtm.ac.uk; eleanor.riley@lshtm.ac.uk	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570				[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; DRAKELEY C, IN PRESS J INFECT DI; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Kahigwa E, 2002, TROP MED INT HEALTH, V7, P823, DOI 10.1046/j.1365-3156.2002.00938.x; Lengeler C, 1997, PARASITOL TODAY, V13, P123, DOI 10.1016/S0169-4758(97)84870-3; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; *MIN HLTH, 2001, 16 HIVAIDSSTI MIN HL; Ministry of Health, 2000, NAT GUID MAL DIAGN T; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Molineaux L, 1996, ANN TROP MED PARASIT, V90, P379, DOI 10.1080/00034983.1996.11813067; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Riley EM, 1999, IMMUNOL TODAY, V20, P228, DOI 10.1016/S0167-5699(99)01456-5; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1994, INT J EPIDEMIOL, V23, P1013, DOI 10.1093/ije/23.5.1013; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; *WHO, 2003, PUBL WHO, P1093	40	211	212	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1461	1470		10.1001/jama.293.12.1461	http://dx.doi.org/10.1001/jama.293.12.1461			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784869	Green Accepted, Bronze			2022-12-28	WOS:000227784700025
J	Greenhalgh, T; Collard, A; Begum, N				Greenhalgh, T; Collard, A; Begum, N			Sharing stories: complex intervention for diabetes education in minority ethnic groups who do not speak English	BRITISH MEDICAL JOURNAL			English	Article							SELF-MANAGEMENT; QUALITATIVE RESEARCH; HEALTH	Objective To develop and refine a complex intervention for diabetes support and education in minority ethnic groups, delivered through bilingual health advocates. Design Action research framework-a variety of methods used in an emergent and developmental manner, in partnership with clinicians, managers, and service users, drawing especially but not exclusively on narrative methods. Setting Deprived inner London district. Interventions Development and evaluation of three components of the complex intervention: a group based learning set for bilingual health advocates, in which stories about clients with diabetes formed the basis for action learning; advocate led support and education groups for people with diabetes, which used personal stories as the raw material for learning and action; organisational support to help to develop these new models and embed them within existing services. Results Both advocate groups and user groups were popular and well evaluated. Through storytelling, advocates identified and met their own educational needs in relation to diabetes and the unmet needs of service users. In the advocate led user groups, story fragments were exchanged in a seemingly chaotic way that the research team initially found difficult to facilitate or follow. Stories were not so much told as enacted and were often centred on discussion of "what to do." Whereas some organisations welcomed, successfully implemented, and sustained the advocate led groups, others failed to do so. A key component of the complex intervention was organisational support. Conclusions An action research approach allowed engagement with an underserved group of health service staff and with hard to reach service users. ne study produced subjective benefits to these groups locally as well as a worked-up complex intervention that will now be formally tested in a randomised controlled trial.	UCL, Sch Med, Dept Primary Care & Populat, London N19 5LW, England	University of London; University College London; UCL Medical School	Greenhalgh, T (corresponding author), UCL, Sch Med, Dept Primary Care & Populat, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				BLAXTER M, 1994, BLACK MINORITY ETHNI; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Denning S., 2000, SPRINGBOARD STORYTEL; ELWYN G, 2000, GROUPS HANDS ON GUID; EVE R, 2000, ED GEN PRACTICE, V11, P79; Fraser SW, 2001, BRIT MED J, V323, P799, DOI 10.1136/bmj.323.7316.799; Friere P., 1974, ED CRITICAL CONSCIOU; Glaser B.G., 1965, AWARENESS DYING; Greenhalgh T, 2002, ENDOCRIN METAB CLIN, V31, P583, DOI 10.1016/S0889-8529(02)00009-9; Greenhalgh T, 2001, MED EDUC, V35, P818, DOI 10.1046/j.1365-2923.2001.01027.x; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; GREENHALGH T, 2005, IN PRESS PRACT DIABE; Greenhalgh T, 2003, SHARING STORIES NEW; GREENHALGH T, 2001, REDUCING INEQUALITIE; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Kolb D. A., 1993, CULTURE PROCESSES AD, P138; Krichbaum K, 2003, DIABETES EDUCATOR, V29, P653, DOI 10.1177/014572170302900411; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; Meyer J, 2000, BMJ-BRIT MED J, V320, P178, DOI 10.1136/bmj.320.7228.178; NAZROO NY, 1997, HLTH BRITAINS ETHNIC; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6; Waterman H, 1998, J ADV NURS, V28, P101, DOI 10.1046/j.1365-2648.1998.00763.x; Waterman H, 2001, HEALTH TECHNOL ASSES, V5, pIII	24	74	77	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					628	631		10.1136/bmj.330.7492.628	http://dx.doi.org/10.1136/bmj.330.7492.628			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	909LP	15774990	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000227861700020
J	Mawer, S				Mawer, S			Science in literature	NATURE			English	Article									Field Museum Nat Hist, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Mawer, S (corresponding author), Field Museum Nat Hist, Chicago, IL 60605 USA.							Frayn Michael, 1998, COPENHAGEN; MAWER S, 1997, MENDELS DWARF; MCEWAN I, 2001, ENDURING LOVE; NABOKOV V, 1967, SPEAK MEMORY; Updike John, 1968, COUPLES	5	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					297	299		10.1038/434297a	http://dx.doi.org/10.1038/434297a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772643				2022-12-28	WOS:000227715100032
J	Wang, LC; Bushey, S				Wang, LC; Bushey, S			Acquired acrodermatitis enteropathica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Chicago, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; University of Chicago	Wang, LC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	15	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1121	1121		10.1056/NEJMicm030844	http://dx.doi.org/10.1056/NEJMicm030844			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784665				2022-12-28	WOS:000227655000009
J	Safdar, N; Fine, JP; Maki, DG				Safdar, N; Fine, JP; Maki, DG			Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection	ANNALS OF INTERNAL MEDICINE			English	Review							CENTRAL VENOUS CATHETERS; CRITICALLY-ILL PATIENTS; SEMIQUANTITATIVE CULTURE METHOD; IN-SITU DIAGNOSIS; RAPID DIAGNOSIS; SHORT-TERM; SURVEILLANCE CULTURES; INTRAVENOUS CATHETERS; QUANTITATIVE CULTURE; LABORATORY DIAGNOSIS	Background: No consensus exists on the best methods for diagnosis of intravascular device (IVD-relatecl bloodstream infection. Purpose: To identify the most accurate methods for diagnosis of lVD-related bloodstream infection. Data Sources: 51 English-language studies published from 1966 to 31 July 2004. Study Selection: Studies of diagnostic tests for lVD-related bloodstream infection that described a reference standard and provided sufficient data to calculate sensitivity and specificity. Data Extraction: Study quality, diagnostic tests examined, patient characteristics, prevalence, sensitivity, and specificity. Data Synthesis: Pooled sensitivity and specificity were calculated for 8 diagnostic methods. Summary measures of accuracy were Q* (the upper leftmost point on the summary receiver-operating characteristic curve) and mean D (a log odds ratio). Subgroup analyses were used to assess heterogeneity. Overall, the most accurate test was paired quantitative blood culture (Q* = 0.94 [95% CI, 0.88 to 1.01), followed by IVD-drawn qualitative blood culture (Q* = 0.89 [CI, 0.79 to 0.99]) and the acridine orange leukocyte cytospin test (Q* = 0.89 [CI, 0.79 to 0.91]). The most accurate catheter segment culture test was quantitative culture (Q* = 0.87 [CI, 0.81 to 0.931), followed by semi-quantitative culture (Q* = 0.84 [CI, 0.80 to 0.88]). Significant heterogeneity in pooled sensitivity and specificity was observed across all test categories. Limitations: The limited number of studies of some of the diagnostic methods precludes precise estimates of accuracy. Conclusions: Paired quantitative blood culture is the most accurate test for diagnosis of lVD-related bloodstream infection. However, most other methods studied showed acceptable sensitivity and specificity (both > 0.75) and negative predictive value (> 99%). The positive predictive value of all tests increased greatly with high pretest clinical probability. Catheters should not be cultured routinely but rather only if lVD-related bloodstream infection is suspected clinically.	Univ Wisconsin, Sch Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin Hosp & Clin, 600 Highland Ave,H5-574, Madison, WI 53792 USA.	dgmaki@facstaff.wisc.edu						ALVAREZ CA, 2001, 39 ANN M INF DIS SOC, P232; ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778; Atela I, 1997, J CLIN MICROBIOL, V35, P1784, DOI 10.1128/JCM.35.7.1784-1790.1997; AUFWERBER E, 1991, APMIS, V99, P627, DOI 10.1111/j.1699-0463.1991.tb01237.x; BANERJEE SN, 1991, AM J MED S3B, V0091, P00086; Bean C A, 1998, Crit Care Nurs Clin North Am, V10, P287; BJORNSON HS, 1982, SURGERY, V92, P720; Blot F, 1998, J CLIN MICROBIOL, V36, P105, DOI 10.1128/JCM.36.1.105-109.1998; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; Bong JJ, 2003, JPEN-PARENTER ENTER, V27, P146, DOI 10.1177/0148607103027002146; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BOZZETTI F, 1984, JPEN-PARENTER ENTER, V8, P396, DOI 10.1177/0148607184008004396; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Calfee, 1999, Curr Infect Dis Rep, V1, P238, DOI 10.1007/s11908-999-0025-3; CAPDEVILA JA, 1992, EUR J CLIN MICROBIOL, V11, P403, DOI 10.1007/BF01961854; CATTON J, 2002, 26 CLIN C NUTR PRACT; CERCENADO E, 1990, ARCH INTERN MED, V150, P1417, DOI 10.1001/archinte.150.7.1417; Chatzinikolaou I, 2000, Semin Respir Infect, V15, P264; CLERI DJ, 1980, J INFECT DIS, V141, P781, DOI 10.1093/infdis/141.6.781; COLLIGNON P, 1987, ARCH INTERN MED, V147, P2214, DOI 10.1001/archinte.1987.00370120150029; COLLIGNON P, 1987, ARCH INTERN MED, V147, P1609, DOI 10.1001/archinte.147.9.1609; COLLIGNON PJ, 1989, EUR J CLIN MICROBIOL, V8, P807, DOI 10.1007/BF02185853; COLLIGNON PJ, 1986, J CLIN MICROBIOL, V24, P532, DOI 10.1128/JCM.24.4.532-535.1986; COOPER GL, 1985, NEW ENGL J MED, V312, P1142, DOI 10.1056/NEJM198505023121802; COUTLEE F, 1988, J CLIN MICROBIOL, V26, P1088; Crnich Christopher J., 2001, Curr Infect Dis Rep, V3, P496, DOI 10.1007/s11908-001-0086-4; Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863; Crnich CJ, 2002, CLIN INFECT DIS, V34, P1362, DOI 10.1086/340105; Darouiche RO, 1999, NETH J MED, V55, P92, DOI 10.1016/S0300-2977(99)00032-7; DesJardin JA, 1999, ANN INTERN MED, V131, P641, DOI 10.7326/0003-4819-131-9-199911020-00002; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; DOUARD MC, 1991, INTENS CARE MED, V17, P30, DOI 10.1007/BF01708406; Douard MC, 1999, CLIN INFECT DIS, V29, P1197, DOI 10.1086/313444; DOUARD MC, 1994, NUTRITION, V10, P397; DRUSKIN MS, 1963, JAMA-J AM MED ASSOC, V185, P966, DOI 10.1001/jama.1963.03060120076031; FAN ST, 1988, J HOSP INFECT, V12, P191, DOI 10.1016/0195-6701(88)90006-0; Farr B M, 1995, Surg Oncol Clin N Am, V4, P493; Farr BM, 2001, CLIN INFECT DIS, V33, P1733, DOI 10.1086/323402; Farr BM, 2000, INFECT CONT HOSP EP, V21, P278, DOI 10.1086/501760; FLYNN PM, 1988, J CLIN MICROBIOL, V26, P1045, DOI 10.1128/JCM.26.5.1045-1046.1988; Fortun J, 2000, JPEN-PARENTER ENTER, V24, P210, DOI 10.1177/0148607100024004210; Franklin JA, 2004, PEDIATR INFECT DIS J, V23, P614, DOI 10.1097/01.inf.0000128779.34716.ee; FREEMAN R, 1975, BRIT J SURG, V62, P404, DOI 10.1002/bjs.1800620519; Gaur AH, 2003, CLIN INFECT DIS, V37, P469, DOI 10.1086/376904; Gowardman JR, 1998, INTENS CARE MED, V24, P1034, DOI 10.1007/s001340050712; GUTIERREZ J, 1992, DIAGN MICR INFEC DIS, V15, P575, DOI 10.1016/0732-8893(90)90033-R; HEISELMAN D, 1994, JAMA-J AM MED ASSOC, V272, P1819, DOI 10.1001/jama.272.23.1819; Jarvis WR, 1998, CLIN INFECT DIS, V26, P1200, DOI 10.1086/520284; JOHNSON A, 1992, J HOSP INFECT, V20, P67, DOI 10.1016/0195-6701(92)90108-X; JONES PG, 1986, DIAGN MICR INFEC DIS, V4, P299, DOI 10.1016/0732-8893(86)90070-2; Juste RN, 2000, INTENS CARE MED, V26, P1373, DOI 10.1007/s001340000582; Kelly M, 1996, AM J CLIN PATHOL, V105, P210; Kite P, 1997, J CLIN PATHOL, V50, P278, DOI 10.1136/jcp.50.4.278; Kite P, 1999, LANCET, V354, P1504, DOI 10.1016/S0140-6736(99)04070-2; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3; MAKI DG, 1973, ANN INTERN MED, V79, P867, DOI 10.7326/0003-4819-79-6-867; MAKI DG, 1977, J SURG RES, V22, P513, DOI 10.1016/0022-4804(77)90034-8; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; MAKI DG, 1989, INFECTIONS ASS INDWE, P161; MAKI DG, 1996, 36 ANN M INT SCI C A; MAKI DG, 1998, HOSP INFECT, P689; Malgrange VB, 2001, J CLIN MICROBIOL, V39, P274, DOI 10.1128/JCM.39.1.274-278.2001; Martinez JA, 2002, CRIT CARE MED, V30, P7, DOI 10.1097/00003246-200201000-00002; Mermel L A, 2001, J Intraven Nurs, V24, P180; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Mermel LA, 1998, 38 INT C ANT AG CHEM, P500; MOONENS F, 1994, J CLIN MICROBIOL, V32, P1578, DOI 10.1128/JCM.32.6.1578-1579.1994; MOSCA R, 1987, SURGERY, V102, P718; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MOYER MA, 1983, ARCH INTERN MED, V143, P66, DOI 10.1001/archinte.143.1.66; NAHASS RG, 1990, DIAGN MICR INFEC DIS, V13, P223, DOI 10.1016/0732-8893(90)90063-2; Nielsen J, 1998, SCAND J INFECT DIS, V30, P569, DOI 10.1080/00365549850161115; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PAYA CV, 1989, J CLIN MICROBIOL, V27, P1431, DOI 10.1128/JCM.27.7.1431-1433.1989; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; PITTET D, 1992, 32 INT C ANT AG CHEM, P411; Raad I, 2004, ANN INTERN MED, V140, P18, DOI 10.7326/0003-4819-140-1-200401060-00007; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; RAAD II, 1992, DIAGN MICR INFEC DIS, V15, P13, DOI 10.1016/0732-8893(92)90052-U; RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197; RAAD II, 1995, CLIN INFECT DIS, V20, P593, DOI 10.1093/clinids/20.3.593; RANCHER HS, 1984, J PEDIATR, V104, P29; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rello J, 1989, Clin Nephrol, V31, P118; RELLO J, 1991, SCAND J INFECT DIS, V23, P583, DOI 10.3109/00365549109105182; RELLO J, 1989, EUR J CLIN MICROBIOL, V8, P620, DOI 10.1007/BF01968140; Rijnders BJA, 2001, CRIT CARE MED, V29, P1399, DOI 10.1097/00003246-200107000-00016; RUSHFORTH JA, 1993, LANCET, V342, P402, DOI 10.1016/0140-6736(93)92815-B; RYDER MA, 1993, NURS CLIN N AM, V28, P937; Safdar N, 2002, CRIT CARE MED, V30, P2632, DOI 10.1097/00003246-200212000-00003; Salzman M B, 1995, Adv Pediatr Infect Dis, V10, P337; SANCHEZCONDE M, 2003, 43 INT C ANT AG CHEM; Schierholz JM, 2000, J HOSP INFECT, V44, P141, DOI 10.1053/jhin.1999.0678; Schmitt SK, 1996, J CLIN MICROBIOL, V34, P508, DOI 10.1128/JCM.34.3.508-511.1996; Seifert H, 2003, J CLIN MICROBIOL, V41, P118, DOI 10.1128/JCM.41.1.118-123.2003; SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76, DOI 10.1128/JCM.28.1.76-82.1990; SiegmanIgra Y, 1997, J CLIN MICROBIOL, V35, P928, DOI 10.1128/JCM.35.4.928-936.1997; SMITH RL, 1991, CHEST, V100, P164, DOI 10.1378/chest.100.1.164; SNYDMAN DR, 1982, AM J MED, V73, P695, DOI 10.1016/0002-9343(82)90412-0; SNYDMAN DR, 1982, LANCET, V2, P1385; Tacconelli E, 1997, EUR J CLIN MICROBIOL, V16, P203, DOI 10.1007/BF01709582; TELENTI A, 1991, MAYO CLIN PROC, V66, P1120, DOI 10.1016/S0025-6196(12)65791-7; Tighe MJ, 1996, BRIT MED J, V313, P1528, DOI 10.1136/bmj.313.7071.1528; Tighe MJ, 1996, JPEN-PARENTER ENTER, V20, P215, DOI 10.1177/0148607196020003215; vanHeerden PV, 1996, ANAESTH INTENS CARE, V24, P330, DOI 10.1177/0310057X9602400305; VELEZ LA, 1992, INFECT CONT HOSP EP, V13, P562; von Baum H, 1998, ZBL BAKT-INT J MED M, V287, P117; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; WHITMAN ED, 1995, AM J SURG, V170, P665, DOI 10.1016/S0002-9610(99)80038-5; WIDMER AF, 1992, ARCH INTERN MED, V152, P1299, DOI 10.1001/archinte.152.6.1299; WIDMER AF, 2003, 43 INT C ANT AG CHEM; Zhou XH, 1999, STAT MED, V18, P557, DOI 10.1002/(SICI)1097-0258(19990315)18:5<557::AID-SIM53>3.0.CO;2-F	113	181	192	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					451	466		10.7326/0003-4819-142-6-200503150-00011	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00011			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767623				2022-12-28	WOS:000227621100006
J	Holmes, W; Toole, M				Holmes, W; Toole, M			Micronutrient supplements in pregnant Nepalese women	LANCET			English	Editorial Material							LOW-BIRTH-WEIGHT		Burnet Inst, Melbourne, Vic 3001, Australia	Burnet Institute	Holmes, W (corresponding author), Burnet Inst, Melbourne, Vic 3001, Australia.	toole@burnet.edu.au						BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Brems S, 1988, ADVISORY GROUP NUTR; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Ruel MT, 2001, FOOD BASED STRATEGIE; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Zlotkin SH, 2005, PLOS MED, V2, P24, DOI 10.1371/journal.pmed.0020001	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2005	365	9463					916	917		10.1016/S0140-6736(05)71057-6	http://dx.doi.org/10.1016/S0140-6736(05)71057-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766977				2022-12-28	WOS:000227559800005
J	Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y				Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y			Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats	CELL			English	Article							PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; PROMOTES APOPTOSIS; GENETIC MOSAICS; GROWTH-CONTROL; HUMAN HOMOLOG; CYCLE EXIT; HIPPO; DEATH; FAMILY	Appropriate cell number and organ size in a multicellular organism are determined by coordinated cell growth, proliferation, and apoptosis. Disruption of these processes can cause cancer. Recent studies have identified the Large tumor suppressor (Lats)/ Warts (Wts) protein kinase as a key component of a pathway that controls the coordination between cell proliferation and apoptosis. Here we describe growth inhibitory functions for a Mob superfamily protein, termed Mats (Mob as tumor suppressor), in Drosophila. Loss of Mats function results in increased cell proliferation, defective apoptosis, and induction of tissue overgrowth. We show that mats and wts function in a common pathway. Mats physically associates with Wts to stimulate the catalytic activity of the Wts kinase. A human Mats ortholog (Mats1) can rescue the lethality associated with loss of Mats function in Drosophila. As Mats1 is mutated in human tumors, Mats-mediated growth inhibition and tumor suppression is likely conserved in humans.	Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Intercoll Program Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Integrat Biosci Grad Degree Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lai, ZC (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	zcl1@psu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20293] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Komarnitsky SI, 1998, MOL CELL BIOL, V18, P2100, DOI 10.1128/MCB.18.4.2100; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li YY, 2003, COMMUN PUR APPL ANAL, V2, P1; Luca FC, 1998, MOL BIOL CELL, V9, P29, DOI 10.1091/mbc.9.1.29; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Rothenberg ME, 2003, NATURE, V425, P469, DOI 10.1038/425469a; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stavridi ES, 2003, STRUCTURE, V11, P1163, DOI 10.1016/S0969-2126(03)00182-5; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Wolff Tanya, 1993, P1277; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	47	433	460	1	50	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					675	685		10.1016/j.cell.2004.12.036	http://dx.doi.org/10.1016/j.cell.2004.12.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766530	Bronze			2022-12-28	WOS:000227771400013
J	Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A				Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A			Worldwide phylogeography of wild boar reveals multiple centers of pig domestication	SCIENCE			English	Article							MITOCHONDRIAL-DNA; GENETIC-EVIDENCE; ORIGINS; PHYLOGENIES; SULAWESI	Mitochondrial DNA (mtDNA) sequences from 686 wild and domestic pig specimens place the origin of wild boar in island Southeast Asia (ISEA), where they dispersed across Eurasia. Previous morphological and genetic evidence suggested pig domestication took place in a limited number of locations (principally the Near East and Far East). in contrast, new genetic data reveal multiple centers of domestication across Eurasia and that European, rather than Near Eastern, wild boar are the principal source of modern European domestic pigs.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Durham, Dept Archaeol, Durham DH1 3L, England; Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Jurox Pty Ltd, Rutherford, NSW 2320, Australia; Roslin Inst, Dept Genom & Bioinformat, Roslin EH25 9PS, Midlothian, Scotland; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen O, Denmark	University of Oxford; Durham University; University of Sheffield; Uppsala University; Swedish University of Agricultural Sciences; University of Auckland; Massey University; University of Auckland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Copenhagen	Larson, G (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	greger.larson@zoo.ox.ac.uk; alan.cooper@adelaide.edu.au	Willerslev, Eske/AAA-5686-2019; Cooper, Alan/E-8171-2012; Willerslev, Eske/A-9619-2011	Cooper, Alan/0000-0002-7738-7851; Willerslev, Eske/0000-0002-7081-6748; Dobney, Keith/0000-0001-9036-4681; Matisoo-Smith, Elizabeth/0000-0002-3500-8307				APOLLONIO M, 1988, B ZOOL, V3, P213; B?k?nyi S., 1974, HIST DOMESTIC MAMMAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benecke N, 1993, EXPLOITATION ANIMAUX, P233; BULMER S, 1975, J SOC OCEANISTES, V31, P7, DOI DOI 10.3406/JSO.1975.2688; EPSTEIN J, 1984, EVOLUTION DOMESTICAT, P145; Ervynck A, 2002, PALEORIENT, V27, P47, DOI DOI 10.3406/paleo.2001.4731; Evans BJ, 1999, BIOL J LINN SOC, V66, P539, DOI 10.1006/bijl.1998.0292; Giuffra E, 2000, GENETICS, V154, P1785; Golson J., 1976, J SOC OCEAN, V36, P294; GROVES CP, 1981, TECH B DEP PREHISTOR, V3; Heise-Pavlov PM, 2003, WILDLIFE BIOL, V9, P21, DOI 10.2981/wlb.2003.060; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; KAKOI H, 1994, Z ZOOL SYST EVOL, V32, P1; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Peters Joris, 2000, Paleorient, V25, P27; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley-Conwy P., 2003, WIDENING HARVEST NEO, P99; Ruedi M, 1996, BIOL J LINN SOC, V58, P197, DOI 10.1111/j.1095-8312.1996.tb01431.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; VIGNE JD, 1988, GALLIA PREHISTORIE S, V26	27	578	625	7	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1618	1621		10.1126/science.1106927	http://dx.doi.org/10.1126/science.1106927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761152				2022-12-28	WOS:000227622400046
J	Bais, HP; Prithiviraj, B; Jha, AK; Ausubel, FM; Vivanco, JM				Bais, HP; Prithiviraj, B; Jha, AK; Ausubel, FM; Vivanco, JM			Mediation of pathogen resistance by exudation of antimicrobials from roots	NATURE			English	Article							PSEUDOMONAS-SYRINGAE STRAINS; ARABIDOPSIS; IDENTIFICATION; AVIRULENCE; GENES; HRP; PHASEOLICOLA; PLANTS; HOST	Most plant species are resistant to most potential pathogens. It is not known why most plant - microbe interactions do not lead to disease, although recent work indicates that this basic disease resistance is multi-factorial(1,2). Here we show that the exudation of root-derived antimicrobial metabolites by Arabidopsis thaliana confers tissue-specific resistance to a wide range of bacterial pathogens. However, a Pseudomonas syringae strain that is both at least partly resistant to these compounds and capable of blocking their synthesis/exudation is able to infect the roots and cause disease. We also show that the ability of this P. syringae strain to block antimicrobial exudation is dependent on the type III secretory system.	Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Colorado State University; Colorado State University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ausubel, FM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA.	ausubel@molbio.mgh.harvard.edu; j.vivanco@colostate.edu	Rechsteiner, Cynthia/C-5894-2011	Prithiviraj, Balakrishnan/0000-0002-9822-5261				Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bouarab K, 2002, NATURE, V418, P889, DOI 10.1038/nature00950; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; DAVIS KR, 1991, MOL PLANT MICROBE IN, V4, P477, DOI 10.1094/MPMI-4-477; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; FILLINGHAM AJ, 1992, PHYSIOL MOL PLANT P, V40, P1, DOI 10.1016/0885-5765(92)90066-5; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Haralampidis K, 2001, P NATL ACAD SCI USA, V98, P13431, DOI 10.1073/pnas.231324698; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NCCLS, 2003, M7A6 NCCLS; Nikaido H, 1998, CURR OPIN MICROBIOL, V1, P516, DOI 10.1016/S1369-5274(98)80083-0; Nishimura M, 2002, SCIENCE, V295, P2032, DOI 10.1126/science.1070443; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; REIMMANN C, 1994, GENE, V146, P221, DOI 10.1016/0378-1119(94)90296-8; RICH JJ, 1992, APPL ENVIRON MICROB, V58, P1440, DOI 10.1128/AEM.58.5.1440-1446.1992; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Walker TS, 2003, J AGR FOOD CHEM, V51, P2548, DOI 10.1021/jf021166h; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; YU GL, 1993, MOL PLANT MICROBE IN, V6, P434, DOI 10.1094/MPMI-6-434; Zwiesler-Vollick J, 2002, MOL MICROBIOL, V45, P1207, DOI 10.1046/j.1365-2958.2002.02964.x	30	110	122	0	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					217	221		10.1038/nature03356	http://dx.doi.org/10.1038/nature03356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759001				2022-12-28	WOS:000227494500046
J	Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE				Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE			Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study	LANCET			English	Article							SKELETAL-MUSCLE; AEROBIC CONDITIONS; LACTIC-ACIDOSIS; HYPOXIA; TISSUE; MICRODIALYSIS; METABOLISM; GLYCOLYSIS; TRANSPORT; PERFUSION	Background Hyperlactataemia during septic shock is often viewed as evidence of tissue hypoxia. However this blood, disorder is not usually correlated with indicators of perfusion or diminished with increased oxygen delivery. Muscles can generate lactate under aerobic conditions in a process linking glycolytic ATP supply to stimulation of Na+K+ ATPase. Using in-vivo microdialysis, we tested whether inhibition of Na+K+ ATPase can reduce muscle lactate. Methods In 14 patients with septic shock, two microdialysis probes were inserted into the quadriceps muscles and infused with lactate-free Ringer's solution in the absence or presence of 10(-7) mol/L ouabain, a specific inhibitor of Na+K+ ATPase. We measured lactate and pyruvate concentrations in both the dialysate fluid and arterial blood samples. Findings All patients had increased blood lactate concentrations (mean 4.0 mmol/L; SD 2.1). Lactate and pyruvate concentrations were consistently higher in muscle than in arteries during the study period, with a mean positive gradient of 1.98 mmol/L (SD 0.2; p = 0.001) and 230 mumol/L (30; p = 0.01), respectively. Ouabain infusion stopped over production of muscle lactate and pyruvate (p = 0.0001). Muscle lactate to pyruvate ratios remained unchanged during ouabain infusion with no differences between blood and muscle. Interpretation Skeletal muscle could be a leading source of lactate formation as a result of exaggerated aerobic glycolysis through Na+K+ ATPase stimulation during septic shock. Lactate clearance as an end-point of resuscitation could therefore prove useful. Relevance to clinical practice In patients with septic shock, a high lactate concentration should be interpreted as a marker of disease, portending a bad outcome. The presence of hyperlactataemia in resuscitated septic patients should not be taken as proof of oxygen debt needing increases in systemic or regional oxygen transport to supranormal values. Lactate, instead of being regarded only as a marker of hypoxia, might be an important metabolic signal.	Hop Cent, Serv Reanimat Med, F-54035 Nancy, France; Hop Cent, Biochim Lab, F-54035 Nancy, France	CHU de Nancy; CHU de Nancy	Levy, B (corresponding author), Hop Cent, Serv Reanimat Med, F-54035 Nancy, France.	b.levy@chu-nancy.fr						Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Binnert C, 2002, CURR OPIN CLIN NUTR, V5, P185, DOI 10.1097/00075197-200203000-00011; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BROOKS GA, 1986, FASEB J, V45, P2924; Bundgaard H, 2003, AM J PHYSIOL-HEART C, V284, pH1028, DOI 10.1152/ajpheart.00639.2002; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; CLAUSEN T, 1980, BRIT J PHARMACOL, V68, P749, DOI 10.1111/j.1476-5381.1980.tb10868.x; CLUTTER WE, 1980, J CLIN INVEST, V66, P94, DOI 10.1172/JCI109840; DANIEL AM, 1978, SURG GYNECOL OBSTET, V147, P697; DIETZ MR, 1980, J BIOL CHEM, V255, P2301; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Gore DC, 1996, ANN SURG, V224, P97, DOI 10.1097/00000658-199607000-00015; GREEVER CJ, 1959, CIRC RES, V7, P192, DOI 10.1161/01.RES.7.2.192; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Henriksson J, 1999, P NUTR SOC, V58, P919, DOI 10.1017/S0029665199001226; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; James JH, 1996, J CLIN INVEST, V98, P2388, DOI 10.1172/JCI119052; Kemper WF, 2001, P NATL ACAD SCI USA, V98, P723, DOI 10.1073/pnas.011387598; Kline JA, 2000, SHOCK, V14, P215, DOI 10.1097/00024382-200014020-00023; Leverve XM, 2002, CRIT CARE, V6, P284; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Luchette FA, 2002, J TRAUMA, V52, P415, DOI 10.1097/00005373-200203000-00001; MAZZEO RS, 1989, J APPL PHYSIOL, V67, P1319, DOI 10.1152/jappl.1989.67.4.1319; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Sair M, 2001, CRIT CARE MED, V29, P1343, DOI 10.1097/00003246-200107000-00008; Schurr A, 1997, J NEUROCHEM, V69, P423	30	308	324	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					871	875		10.1016/S0140-6736(05)71045-X	http://dx.doi.org/10.1016/S0140-6736(05)71045-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752531				2022-12-28	WOS:000227444600029
J	Sclar, ED; Garau, P; Carolini, G				Sclar, ED; Garau, P; Carolini, G			The 21st century health challenge of slums and cities	LANCET			English	Article									UN Millennium Project, Task Force Improving Lives Slum Dwellers 8, New York, NY 10027 USA; Univ Roma La Sapienza, Rome, Italy; Columbia Univ, New York, NY USA	Sapienza University Rome; Columbia University	Sclar, ED (corresponding author), UN Millennium Project, Task Force Improving Lives Slum Dwellers 8, 413 Avery Hall,1172 Amsterdam Ave,MC 0354, New York, NY 10027 USA.	eds2@columbia.edu		/0000-0003-3668-4099				Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; BERKMAN A, IN PRESS AM J PUBLIC; Garau P, 2004, AM J PUBLIC HEALTH, V94, P1848, DOI 10.2105/AJPH.94.11.1848; MEHTA S, 2004, MAXIMUM CITY BOMBAY, P29; National Academy of Sciences, 2003, CIT TRANSF DEM CHANG; Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064; SATTERTHWAITE D, 1999, EARTHSCAN READER SUS, P137; *UN HABITAT, 2003, WAT SAN WORLDS CIT L; *UN HABITAT, SLUMS WORLD FAC URB; *UN HABITAT GLOB U, 2003, GUID MON TARG 11 IMP; *UN MILL DEV PROJ, 2005, HOM CIT TASK FORC IM; *UNAIDS, 2004, REP GLOB AIDS EP; United Nations Population Division, 2003, WORLD URB PROSP; Winton A, 2004, ENVIRON URBAN, V16, P165, DOI 10.1177/095624780401600208	14	123	124	1	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					901	903		10.1016/S0140-6736(05)71049-7	http://dx.doi.org/10.1016/S0140-6736(05)71049-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	903RZ	15752535				2022-12-28	WOS:000227444600033
J	Viner, R; Macfarlane, A				Viner, R; Macfarlane, A			ABC of adolescence - Health promotion	BRITISH MEDICAL JOURNAL			English	Review								Health can be defined as optimum physical, emotional, social, spiritual, and intellectual health. Health promotion is die science or art of helping people change their lifestyle to move towards a state of optimal health. Lifestyle change can be facilitated through a combination of efforts to increase awareness, change behaviour, and create environments that support good health practices.	UCL Hosp NHS Fdn Trust, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Oxford Hlth Author, Oxford, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Viner, R (corresponding author), UCL Hosp NHS Fdn Trust, London, England.	rviner@ich.ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247				Toumbourou J., 2000, EVIDENCE BASED HLTH	1	44	45	3	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 5	2005	330	7490					527	529		10.1136/bmj.330.7490.527	http://dx.doi.org/10.1136/bmj.330.7490.527			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746135	Green Published			2022-12-28	WOS:000227581400023
J	Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO				Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO			Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C-elegans	NATURE			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; CRKII/DOCK180/RAC PATHWAY; PROTEIN CED-6; ENGULFMENT; PHAGOCYTOSIS; MIGRATION; CLEARANCE; GENETICS	The removal of apoptotic cells is essential for the physiological well being of the organism(1-3). In Caenorhabditis elegans, two conserved, partially redundant genetic pathways regulate this process(4-6). In the first pathway, the proteins CED-2, CED-5 and CED-12 ( mammalian homologues CrkII, Dock180 and ELMO, respectively) function to activate CED-10 (Rac1)(7,8). In the second group, the candidate receptor CED-1 (CD91/LRP/SREC) probably recognizes an unknown ligand on the apoptotic cell(9) and signals via its cytoplasmic tail to the adaptor protein CED-6 (hCED-6/GULP)(10,11), whereas CED-7 (ABCA1) is thought to play a role in membrane dynamics(12). Molecular understanding of how the second pathway promotes engulfment of the apoptotic cell is lacking. Here, we show that CED-1, CED-6 and CED-7 are required for actin reorganization around the apoptotic cell corpse, and that CED-1 and CED-6 colocalize with each other and with actin around the dead cell. Furthermore, we find that the CED-10( Rac) GTPase acts genetically downstream of these proteins to mediate corpse removal, functionally linking the two engulfment pathways and identifying the CED-1, - 6 and - 7 signalling module as upstream regulators of Rac activation.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11743 USA; TU Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	University of Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Michael.Hengartner@molbio.unizh.ch	Kinchen, Jason/ABC-5663-2021; Cabello, Juan/AAM-1683-2020; Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011	Cabello, Juan/0000-0002-3835-0116; Hengartner, Michael/0000-0002-7584-596X; Kinchen, Jason/0000-0001-8430-2265				Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; BRENNER S, 1974, GENETICS, V77, P71; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conradt B, 2001, DEV CELL, V1, P445, DOI 10.1016/S1534-5807(01)00065-X; ELLIS RE, 1991, GENETICS, V129, P79; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hamon Y, 2002, BBA-MOL CELL BIOL L, V1585, P64, DOI 10.1016/S1388-1981(02)00325-6; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harris TW, 2003, NUCLEIC ACIDS RES, V31, P133, DOI 10.1093/nar/gkg053; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Praitis V, 2001, GENETICS, V157, P1217; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	206	228	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					93	99		10.1038/nature03263	http://dx.doi.org/10.1038/nature03263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744306				2022-12-28	WOS:000227334600050
J	Smith, GD; Bracha, Y; Svendsen, KH; Neaton, JD; Haffner, SM; Kuller, LH				Smith, GD; Bracha, Y; Svendsen, KH; Neaton, JD; Haffner, SM; Kuller, LH		Multiple Risk Factor Intervention	Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; BODY-FAT DISTRIBUTION; 10-YEAR FOLLOW-UP; INSULIN-RESISTANCE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; MEN; HEALTHY; DIET	Background: weight loss and increased physical exercise reduce the risk for diabetes in people with impaired glucose tolerance. Randomized trial evidence on the effect of these interventions on people without impaired glucose tolerance is lacking. Objective: To examine the influence of a comprehensive intervention program on the risk for developing diabetes in men without impaired glucose tolerance and in a post hoc subgroup analysis by baseline cigarette smoking status. Design: Randomized, controlled trial. Setting: 22 clinical centers for the Multiple Risk Factor Intervention Trial (MRFIT). Participants: 12 866 men age 35 to 57 years at risk for cardiovascular disease were randomly assigned to either a special intervention or usual care group and followed for 6 to 7 years; this report focuses on 11 827 men without diabetes or impaired glucose tolerance at entry for whom follow-up glucose measurements were available. Measurements: Cardiovascular disease risk factors, fasting blood glucose levels, and diabetes medication history were assessed before randomization and annually. Intervention: Men in the special intervention group were counseled to change diet (reduce saturated fat, cholesterol, and calorie intake), to stop smoking, and to increase physical activity. Blood pressure was treated more intensively in the special intervention group than in the usual care group. Results: 11.5% of the special intervention group and 10.8% of the usual care group developed diabetes over 6 years of follow-up (hazard ratio, 1.08 [95% Cl, 0.96 to 1.20]). The special intervention-usual care hazard ratio for diabetes was 1.26 (Cl, 1.10 to 1.45) among smokers (63%) and 0.82 (Cl, 0.68 to 0.98) among nonsmokers (37%). These estimates differed significantly (P = 0.0003). Weight gain after smoking cessation and the use of anti hypertensive drugs may have counterbalanced the beneficial effect of the lifestyle intervention for the special intervention group smokers, while the lifestyle intervention was beneficial among nonsmokers. Conclusions: In nonsmokers, an intervention program that included nutrition counseling to produce reductions in weight, serum cholesterol, and (along with anti hypertensive medication) blood pressure reduced the risk for diabetes.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Minneapolis Med Res Fdn Inc, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Pittsburgh, Pittsburgh, PA USA	University of Bristol; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	zetkin@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314	NHLBI NIH HHS [R01-HL68140] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; CAGGIULA AW, 1981, PREV MED, V10, P443, DOI 10.1016/0091-7435(81)90060-8; Cutler JA, 1997, AM J CLIN NUTR, V65, P184; DIGGLE PJ, 2001, ANAL LONGITUDINAL DA, V322, P226; Eberly LE, 2003, DIABETES CARE, V26, P848, DOI 10.2337/diacare.26.3.848; Eriksson J, 1997, DIABETOLOGIA, V40, P125; ERIKSSON KF, 1996, ANN MED, V28, P445; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; HELLENIUS ML, 1993, ATHEROSCLEROSIS, V103, P81, DOI 10.1016/0021-9150(93)90042-S; HELLENIUS MLB, 1995, J INTERN MED, V238, P121, DOI 10.1111/j.1365-2796.1995.tb00909.x; HJERMANN I, 1981, LANCET, V2, P1303; HJERMANN I, 1980, SCAND J CLIN LAB INV, V40, P89, DOI 10.3109/00365518009091532; Jarrett R J, 1984, Diabet Med, V1, P279; JARRETT RJ, 1987, J EPIDEMIOL COMMUN H, V41, P145, DOI 10.1136/jech.41.2.145; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KATZEL LI, 1995, JAMA-J AM MED ASSOC, V274, P1915, DOI 10.1001/jama.274.24.1915; KEEN H, 1982, DIABETOLOGIA, V22, P73, DOI 10.1007/BF00254832; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KNOWLER WC, 1995, DIABETES, V44, P483, DOI 10.2337/diabetes.44.5.483; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; LITHELL H, 1992, CLIN EXP HYPERTENS A, V14, P151, DOI 10.3109/10641969209036178; MANSON JE, 1994, AM J PREV MED, V10, P172, DOI 10.1016/S0749-3797(18)30615-9; MARSHALL JA, 1991, AM J EPIDEMIOL, V134, P590, DOI 10.1093/oxfordjournals.aje.a116132; Melander A, 1996, DIABETIC MED, V13, pS20; MIETTINEN TA, 1985, JAMA-J AM MED ASSOC, V254, P2097, DOI 10.1001/jama.254.15.2097; NEATON JD, 1987, CONTROL CLIN TRIALS, V8, pS41; ODEA K, 1991, MED J AUSTRALIA, V155, P258, DOI 10.5694/j.1326-5377.1991.tb142236.x; ODEA K, 1984, DIABETES, V33, P596, DOI 10.2337/diabetes.33.6.596; OHLSON LO, 1985, DIABETES, V34, P1055, DOI 10.2337/diabetes.34.10.1055; PAGE RCL, 1993, Q J MED, V86, P145; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; ROBERTS J, 1966, VITAL HLTH STAT SERI; SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41; SHATEN BJ, 1993, DIABETES CARE, V16, P1331, DOI 10.2337/diacare.16.10.1331; SHERWIN R, 1981, PREV MED, V10, P402, DOI 10.1016/0091-7435(81)90058-X; SHINTANI TT, 1991, AM J CLIN NUTR, V53, pS1647; Simpson RW, 2003, DIABETES RES CLIN PR, V59, P165, DOI 10.1016/S0168-8227(02)00275-9; STERN MP, 1991, DIABETES CARE, V14, P399, DOI 10.2337/diacare.14.5.399; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang XL, 1999, INT J MOL MED, V4, P537; WIDDOWSON GM, 1986, CONTROL CLIN TRIALS, V7, pS17; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313; YOUNG CM, 1981, COMMITTEE FOOD CONSU; ZIMMET PZ, 1995, DIABETES CARE, V18, P1050, DOI 10.2337/diacare.18.7.1050; ZIMMET PZ, 1992, DIABETES CARE, V15, P232, DOI 10.2337/diacare.15.2.232; 1977, J CHRONIC DIS, V30, P261	52	103	106	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					313	322		10.7326/0003-4819-142-5-200503010-00006	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738450				2022-12-28	WOS:000227325100001
J	Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP				Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP			Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice	SCIENCE			English	Article							COLORECTAL-CANCER; CELL-DIFFERENTIATION; STEM-CELL; GROWTH; GENE; MARKER; MOUSE; EXPRESSION; NEOPLASIA; DELETION	Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenetic alteration that results in a modest increase in IGF2 expression, and it is present in the normal colonic mucosa of about 30% of patients with colorectal cancer. To investigate its role in intestinal tumorigenesis, we created a mouse model of lgf2 LOI by crossing female H19(+/-) mice with mate Apc(+/min) mice. Mice with LOI developed twice as many intestinal tumors as did control littermates. Notably, these mice also showed a shift toward a less differentiated normal intestinal epithelium, reflected by an increase in crypt length and increased staining with progenitor,cell markers. A similar shift in differentiation was seen in the normal colonic mucosa of humans with LOI. Thus, altered maturation of nonneoplastic tissue may be one mechanism. by which epigenetic changes affect cancer risk.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Uppsala Univ, Dept Genet & Dev, S-75236 Uppsala, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University; Uppsala University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020; Longo, Dan L./F-6022-2011; Carter, Mark/B-5089-2010; Okano, Hideyuki/I-7584-2019; Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Feinberg, Andrew/0000-0002-8364-1991; Kaneda, Atsushi/0000-0002-6980-5515	NCI NIH HHS [R01CA65145, K08CA106610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA106610, R01CA065145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000656, Z01AG000662] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hassan AB, 2000, CANCER RES, V60, P1070; Howe LR, 2003, CANCER RES, V63, P1906; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; LIPKIN M, 1976, CANCER RES, V36, P2665; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; SEGAL GH, 1997, HISTOLOGY PATHOLOGIS, P495; SELL S, 1994, LAB INVEST, V70, P6; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; Woodson K, 2004, JNCI-J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042; Yang WC, 2003, CANCER RES, V63, P4990	28	252	268	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1976	1978		10.1126/science.1108080	http://dx.doi.org/10.1126/science.1108080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15731405				2022-12-28	WOS:000227957300061
J	Xie, XH; Lu, J; Kulbokas, EJ; Golub, TR; Mootha, V; Lindblad-Toh, K; Lander, ES; Kellis, M				Xie, XH; Lu, J; Kulbokas, EJ; Golub, TR; Mootha, V; Lindblad-Toh, K; Lander, ES; Kellis, M			Systematic discovery of regulatory motifs in human promoters and 3 ' UTRs by comparison of several mammals	NATURE			English	Article							MICRORNA TARGETS; GENOME SEQUENCE; MOUSE GENOME; ELEMENTS; GENES; PREDICTION; PROTEIN; 3'-UTR; BINDS; POWER	Comprehensive identification of all functional elements encoded in the human genome is a fundamental need in biomedical research. Here, we present a comparative analysis of the human, mouse, rat and dog genomes to create a systematic catalogue of common regulatory motifs in promoters and 30 untranslated regions ( 3 0 UTRs). The promoter analysis yields 174 candidate motifs, including most previously known transcription-factor binding sites and 105 new motifs. The 3'-UTR analysis yields 106 motifs likely to be involved in post-transcriptional regulation. Nearly one-half are associated with microRNAs ( miRNAs), leading to the discovery of many new miRNA genes and their likely target genes. Our results suggest that previous estimates of the number of human miRNA genes were low, and that miRNAs regulate at least 20% of human genes. The overall results provide a systematic view of gene regulation in the human, which will be refined as additional mammalian genomes become available.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard, Broad Inst, Cambridge, MA 02141 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	lander@broad.mit.edu; manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Xie, Xiaohui/0000-0002-5479-6345	NHGRI NIH HHS [R01 HG004037, R01 HG004037-01A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; FONTANA W, 1993, PHYS REV E, V47, P2083, DOI 10.1103/PhysRevE.47.2083; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; LIM LP, 2005, NATURE          0130, DOI DOI 10.1038/NATURE3315; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MARGULIES EH, IN PRESS P NATL ACAD; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	37	1466	1625	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					338	345		10.1038/nature03441	http://dx.doi.org/10.1038/nature03441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15735639	Green Accepted			2022-12-28	WOS:000227715100041
J	Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA				Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA			Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the Hsp90 chaperone	CELL			English	Article							ATPASE ACTIVITY; CRYSTAL-STRUCTURE; MOLECULAR CLAMP; GLOBAL ANALYSIS; PROTEIN; YEAST; COMPLEX; ACTIVATION; DOMAIN; CO	Physical, genetic, and chemical-genetic interactions centered on the conserved chaperone Hsp90 were mapped at high resolution in yeast using systematic proteomic and genomic methods. Physical interactions were identified using genome-wide two hybrid screens combined with large-scale affinity purification of Hsp90-containing protein complexes. Genetic interactions were uncovered using synthetic genetic array technology and by a microarray-based chemical-genetic screen of a set of about 4700 viable yeast gene deletion mutants for hypersensitivity to the Hsp90 inhibitor geldanamycin. An extended network, consisting of 198 putative physical interactions and 451 putative genetic and chemical-genetic interactions, was found to connect Hsp90 to cofactors; and substrates involved in a wide range of cellular functions. Two novel Hsp90 cofactors, Tah1 (YCR060W) and Pih1 (YHR034C), were also identified. These cofactors interact physically and functionally with the conserved AAA(+)-type DNA helicases Rvb1/Rvb2, which are key components of several chromatin remodeling factors, thereby linking Hsp90 to epigenetic gene regulation.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Emili, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5S 1A8, Canada.	andrew.emili@utoronto.ca; walid.houry@utoronto.ca	Cagney, Gerard/A-4648-2009	Zhao, Rongmin/0000-0003-1300-5882; Cagney, Gerard/0000-0001-7189-9496; Davey, Michael/0000-0002-1172-5934				BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CSERMELY P, 1994, BIOCHEM BIOPH RES CO, V202, P1657, DOI 10.1006/bbrc.1994.2124; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GUARENTE L, 1992, TRENDS GENET, V8, P27, DOI 10.1016/0168-9525(92)90021-U; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lan CG, 2004, J BIOL CHEM, V279, P27607, DOI 10.1074/jbc.M402777200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	56	617	642	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					715	727		10.1016/j.cell.2004.12.024	http://dx.doi.org/10.1016/j.cell.2004.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766533	Bronze			2022-12-28	WOS:000227771400016
J	Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP				Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP			The receptors and coding logic for bitter taste	NATURE			English	Article							MAMMALIAN SWEET; MICE; SACCHARIN; RESPONSES; PATHWAYS; STIMULI; FAMILY; MOUSE; CELLS	The sense of taste provides animals with valuable information about the nature and quality of food. Bitter taste detection functions as an important sensory input to warn against the ingestion of toxic and noxious substances. T2Rs are a family of approximately 30 highly divergent G-protein-coupled receptors (GPCRs)(1,2) that are selectively expressed in the tongue and palate epithelium(1) and are implicated in bitter taste sensing(1-8). Here we demonstrate, using a combination of genetic, behavioural and physiological studies, that T2R receptors are necessary and sufficient for the detection and perception of bitter compounds, and show that differences in T2Rs between species ( human and mouse) can determine the selectivity of bitter taste responses. In addition, we show that mice engineered to express a bitter taste receptor in 'sweet cells'(9) become strongly attracted to its cognate bitter tastants, whereas expression of the same receptor ( or even a novel GPCR) in T2R-expressing cells resulted in mice that are averse to the respective compounds. Together these results illustrate the fundamental principle of bitter taste coding at the periphery: dedicated cells act as broadly tuned bitter sensors that are wired to mediate behavioural aversion.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu; nick.ryba@nih.gov		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; FARBMAN AI, 1965, DEV BIOL, V11, P110, DOI 10.1016/0012-1606(65)90040-0; Franchini LF, 2003, NEUROSCIENCE, V121, P875, DOI 10.1016/S0306-4522(03)00485-8; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	21	354	384	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					225	229		10.1038/nature03352	http://dx.doi.org/10.1038/nature03352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759003				2022-12-28	WOS:000227494500048
J	Rohde, RA; Muller, RA				Rohde, RA; Muller, RA			Cycles in fossil diversity	NATURE			English	Article							MASS EXTINCTIONS; MARINE	It is well known that the diversity of life appears to fluctuate during the course of the Phanerozoic, the eon during which hard shells and skeletons left abundant fossils ( 0 - 542 million years ago). Here we show, using Sepkoski's compendium(1) of the first and last stratigraphic appearances of 36,380 marine genera, a strong 62 +/- 3-million-year cycle, which is particularly evident in the shorter-lived genera. The five great extinctions enumerated by Raup and Sepkoski(2) may be an aspect of this cycle. Because of the high statistical significance we also consider the contributions of environmental factors, and possible causes.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Muller, RA (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	ramuller@lbl.gov						AGER DV, 1977, P GEOL ASS, V87, P131; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bahcall J N, 1989, NEUTRINO ASTROPHYSIC; BAHCALL JN, 1985, NATURE, V316, P706, DOI 10.1038/316706a0; Fischer A.G., 1977, SOC EC PALEONTOLOGIS, V25, P19; Gradstein F., 2005, GEOLOGIC TIME SCALE, DOI [10.1017/CBO9780511536045, DOI 10.1017/CBO9780511536045]; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Matese JJ, 2001, ASTROPHYS SPACE SC L, V261, P91; Miller AI, 1998, SCIENCE, V281, P1157, DOI 10.1126/science.281.5380.1157; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Prokoph A, 2004, J GEOL, V112, P1, DOI 10.1086/379689; Rahmstorf Stefan., 2004, EOS, V85, P38; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Schaeffer N, 2001, GEOPHYS RES LETT, V28, P455, DOI 10.1029/2000GL012215; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Sepkoski J., 2002, B AM PALEONTOL, V363; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1990, GEOL S AM S, V247, P33; Shaviv NirJ., 2003, GSA TODAY, V137, P4, DOI DOI 10.1130/1052-5173(2003)013; Shaviv NJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.051102; THOMSON KS, 1976, NATURE, V261, P578, DOI 10.1038/261578a0; Thomson KS., 1977, DEV PALAEONTOLOGY ST, Vvol. 5, P377, DOI DOI 10.1016/S0920-5446(08)70332-7; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; WHITMIRE DP, 1985, NATURE, V313, P36, DOI 10.1038/313036a0	28	195	206	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					208	210		10.1038/nature03339	http://dx.doi.org/10.1038/nature03339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758998				2022-12-28	WOS:000227494500043
J	Koppel, R; Metlay, JP; Cohen, A; Abaluck, B; Localio, AR; Kimmel, SE; Strom, BL				Koppel, R; Metlay, JP; Cohen, A; Abaluck, B; Localio, AR; Kimmel, SE; Strom, BL			Role of computerized physician order entry systems in facilitating medication errors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT SAFETY; PRESCRIBING ERRORS; INFORMATION-SYSTEM; HEALTH-CARE; HOSPITALS	Context Hospital computerized physician order entry (CPOE) systems are widely regarded as the technical solution to medication ordering errors, the largest identified source of preventable hospital medical error. Published studies report that CPOE reduces medication errors up to 81%. Few researchers, however, have focused on the existence or types of medication errors facilitated by CPOE. Objective To identify and quantify the role of CPOE in facilitating prescription error risks. Design, Setting, and Participants We performed a qualitative and quantitative study of house staff interaction with a CPOE system at a tertiary-care teaching hospital (2002-2004). We surveyed house staff (N=261; 88% of CPOE users); conducted 5 focus groups and 32 intensive one-on-one interviews with house staff, information technology leaders, pharmacy leaders, attending physicians, and nurses; shadowed house staff and nurses; and observed them using CPOE. Participants included house staff, nurses, and hospital leaders. Main Outcome Measure Examples of medication errors caused or exacerbated by the CPOE system. Results We found that a widely used CPOE system facilitated 22 types of medication error risks. Examples include fragmented CPOE displays that prevent a coherent view of patients' medications, pharmacy inventory displays mistaken for dosage guidelines, ignored antibiotic renewal notices placed on paper charts rather than in the CPOE system, separation of functions that facilitate double dosing and incompatible orders, and inflexible ordering formats generating wrong orders. Three quarters of the house staff reported observing each of these error risks, indicating that they occur weekly or more often. Use of multiple qualitative and survey methods identified and quantified error risks not previously considered, offering many opportunities for error reduction. Conclusions In this study, we found that a leading CPOE system often facilitated medication error risks, with many reported to occur frequently. As CPOE systems are implemented, clinicians and hospitals must attend to errors that these systems cause in addition to errors that they prevent.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Sociol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Gen Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA; Dept Vet Affairs, Ctr Hlth Equit Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Koppel, R (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Room 106,Blockley Hall, Philadelphia, PA 19104 USA.	rkoppel@sas.upenn.edu	Tao, Youyou/D-2367-2014; Greiver, Michelle/N-8764-2015; Cohen, Abigail/K-9180-2013	Greiver, Michelle/0000-0001-8957-0285; Cohen, Abigail/0000-0002-7425-7218; Koppel, Ross/0000-0002-8235-9900	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS011530] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; [Anonymous], 1999, 43 ANN M HUM FACT ER; ASH J, 2001, MEDINFO 2, V10, P1107; Ash JS, 2004, J AM MED INFORM ASSN, V11, P95, DOI 10.1197/jamia.M1427; Ash JS, 2000, J AM MED INFORM ASSN, P27; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; ASH JS, 2004, J AM MED INFORM ASSN, V11, P207; Bates D W, 1994, Qual Manag Health Care, V2, P18; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Berger RG, 2004, J AM MED INFORM ASSN, V11, P100, DOI 10.1197/jamia.M1411; BERNARD F, 2004, BMJ-BRIT MED J, V328, P1171; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bobb A, 2004, ARCH INTERN MED, V164, P785, DOI 10.1001/archinte.164.7.785; BRODER C, LAWMAKERS PUSH HLTH; Cook RI, 1996, J CLIN ANESTH, V8, pS29, DOI 10.1016/S0952-8180(96)90009-4; Cook RI, 2000, BRIT MED J, V320, P791, DOI 10.1136/bmj.320.7237.791; COOK RI, 1999, ENHANCING PATIENT SA; Cook Richard I, 2002, Nurs Econ, V20, P80; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Feied CF, 2004, ACAD EMERG MED, V11, P1162, DOI 10.1197/j.aem.2004.08.010; Ferner RE, 2004, BRIT MED J, V328, P1172, DOI 10.1136/bmj.328.7449.1172; *FROST SULL, 2002, US COMP PHYS ORD ENT; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; GORDON S, 1997, LIFE SUPPORT; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; KAUSHAL R, 2001, AHRQ PUBLICATION; Kohn KT, 2000, ERR IS HUMAN BUILDIN; KUPERMAN G, 1997, ASS HLTH SERV RES, V14, P224; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; McNutt RA, 2002, JAMA-J AM MED ASSOC, V287, P1997, DOI 10.1001/jama.287.15.1997; Nightingale PG, 2000, BMJ-BRIT MED J, V320, P750, DOI 10.1136/bmj.320.7237.750; Ottino JM, 2004, NATURE, V427, P399, DOI 10.1038/427399a; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Ramsay J, 1997, BEHAV INFORM TECHNOL, V16, P17, DOI 10.1080/014492997119987; RASMUSSEN J, 1985, ERGONOMICS, V28, P1185, DOI 10.1080/00140138508963241; Sanders DL, 2001, J AM MED INFORM ASSN, P583; Sarter N. D., 1997, HDB HUMAN FACTORS ER; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Shane R, 2002, AM J HEALTH-SYST PH, V59, P286, DOI 10.1093/ajhp/59.3.286; SITTIG DF, 1994, J AM MED INFORM ASSN, V1, P108, DOI 10.1136/jamia.1994.95236142; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; Tucker AL, 2003, CALIF MANAGE REV, V45, P55, DOI 10.2307/41166165; *US PHARM, 2004, MEDMARX 5 ANN DAT RE; Woods D.D., 2002, COGN TECHNOL WORK, V4, P137, DOI DOI 10.1007/S101110200012; Woods D.D., 1994, HUMAN ERROR COGNITIV; WOODS DD, STEERING REVERBERATI	53	1340	1363	3	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1197	1203		10.1001/jama.293.10.1197	http://dx.doi.org/10.1001/jama.293.10.1197			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755942	Bronze			2022-12-28	WOS:000227498400020
J	Shen, FH; Samartzis, D				Shen, FH; Samartzis, D			Traumatic scoliosis	LANCET			English	Editorial Material							FLEXION-DISTRACTION INJURIES		Univ Virginia Hlth Syst, Dept Orthopaed Surg, Charlottesville, VA 22903 USA; Harvard Univ, Grad Div, Cambridge, MA 02138 USA	University of Virginia; Harvard University	Shen, FH (corresponding author), Univ Virginia Hlth Syst, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.	fhs2g@virginia.edu		Samartzis, Dino/0000-0002-7473-1311				GERTZBEIN SD, 1988, CLIN ORTHOP RELAT R, P52; GREENWALD TA, 1994, PARAPLEGIA, V32, P743, DOI 10.1038/sc.1994.120; Weinstein J N, 1987, J Orthop Trauma, V1, P152, DOI 10.1097/00005131-198702010-00005	3	4	4	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					910	910		10.1016/S0140-6736(05)71052-7	http://dx.doi.org/10.1016/S0140-6736(05)71052-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752538				2022-12-28	WOS:000227444600036
J	Didham, RK; Ewers, RM; Gemmell, NJ				Didham, RK; Ewers, RM; Gemmell, NJ			Comment on "Avian extinction and mammalian introductions on oceanic islands"	SCIENCE			English	Editorial Material							HABITAT LOSS; BIODIVERSITY; DEFORESTATION; BIRDS		Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; Smithsonian Trop Res Inst, Panama City, Panama	University of Canterbury; Smithsonian Institution; Smithsonian Tropical Research Institute	Didham, RK (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 1, New Zealand.	Raphael.Didham@canterbury.ac.nz	Didham, Raphael K/B-5953-2011; Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637				Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sokal RR, 1995, BIOMETRY	14	34	36	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2005	307	5714					1412	1412		10.1126/science.1107333	http://dx.doi.org/10.1126/science.1107333			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746412	Green Submitted			2022-12-28	WOS:000227503100025
J	Jones, RH; Flynn, KJ				Jones, RH; Flynn, KJ			Nutritional status and diet composition affect the value of diatoms as copepod prey	SCIENCE			English	Article							MARINE PLANKTONIC COPEPOD; EGG-PRODUCTION; ACARTIA-TONSA; FOOD QUALITY; REPRODUCTIVE SUCCESS; CALANUS-FINMARCHICUS; HATCHING SUCCESS; GROWTH; PHYTOPLANKTON; RECRUITMENT	The role of diatoms as key food for copepods at the base of pelagic food chains has been questioned recently on the grounds of toxicity. We show, using unialgal versus mixed algal diets of different nutritional status (i.e., nitrogen:carbon ratio) fed to Acartia tonsa, that diatoms per se are not toxic but that single-diatom diets are inadequate. Additionally, the nutritional state of the phytoplankton has a profound effect on copepod growth and growth efficiency. The ecological significance of laboratory demonstrations of diatom toxicity needs to be reconsidered.	Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales	Swansea University	Flynn, KJ (corresponding author), Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales.	k.j.flynn@swansea.ac.uk	Flynn, Kevin/AAA-3253-2021; Jones, Ruth/R-5773-2016	Flynn, Kevin/0000-0001-6913-5884; Jones, Ruth/0000-0001-5811-8827				Alonzo F, 2001, MAR ECOL PROG SER, V209, P231, DOI 10.3354/meps209231; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Carotenuto Y, 2002, J EXP MAR BIOL ECOL, V276, P49, DOI 10.1016/S0022-0981(02)00237-X; CHECKLEY DM, 1980, LIMNOL OCEANOGR, V25, P430, DOI 10.4319/lo.1980.25.3.0430; Colin SP, 2002, LIMNOL OCEANOGR, V47, P1430, DOI 10.4319/lo.2002.47.5.1430; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Irigoien X, 2000, LIMNOL OCEANOGR, V45, P44, DOI 10.4319/lo.2000.45.1.0044; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jonasdottir SH, 1996, MAR BIOL, V125, P743, DOI 10.1007/BF00349257; Jonasdottir SH, 1998, MAR ECOL PROG SER, V172, P305, DOI 10.3354/meps172305; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; Kuijper LDJ, 2004, J PLANKTON RES, V26, P213, DOI 10.1093/plankt/fbh020; Marshall S. M., 1955, BIOL MARINE COPEPOD; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; POULET SA, 1994, MAR ECOL PROG SER, V111, P79, DOI 10.3354/meps111079; REEVE MR, 1977, J EXP MAR BIOL ECOL, V29, P211, DOI 10.1016/0022-0981(77)90066-1; Roman MR, 1997, LIMNOL OCEANOGR, V42, P623, DOI 10.4319/lo.1997.42.4.0623; Shin K, 2003, PROG OCEANOGR, V57, P265, DOI 10.1016/S0079-6611(03)00101-0; Starr M, 1999, SARSIA, V84, P379, DOI 10.1080/00364827.1999.10807345	26	161	163	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1457	1459		10.1126/science.1107767	http://dx.doi.org/10.1126/science.1107767			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746424				2022-12-28	WOS:000227503100043
J	Hussain, NK; Sheng, M				Hussain, NK; Sheng, M			Neuroscience - Making synapses: A balancing act	SCIENCE			English	Editorial Material							INHIBITORY SYNAPSES; NEUROLIGIN; AUTISM; NEUREXINS; MUTATION; NLGN4		MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Hussain, NK (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.	natashah@mit.edu; msheng@mit.edu						Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Missler M, 1998, J NEUROCHEM, V71, P1339; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6	10	17	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1207	1208		10.1126/science.1110011	http://dx.doi.org/10.1126/science.1110011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731430				2022-12-28	WOS:000227313200029
J	Lombard, DB; Chua, KF; Mostoslavsky, R; Franco, S; Gostissa, M; Alt, FW				Lombard, DB; Chua, KF; Mostoslavsky, R; Franco, S; Gostissa, M; Alt, FW			DNA repair, genome stability, and aging	CELL			English	Review							STRAND BREAK REPAIR; END-JOINING FACTORS; WERNER-SYNDROME HELICASE; CAUSES EARLY-ONSET; LIFE-SPAN; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; MICE LACKING; CALORIE RESTRICTION; GROWTH-RETARDATION	Aging can be defined as progressive functional decline and increasing mortality over time. Here, we review evidence linking aging to nuclear DNA lesions: DNA damage accumulates with age, and DNA repair defects can cause phenotypes resembling premature aging. We discuss how cellular DNA damage responses may contribute to manifestations of aging. We review Sir2, a factor linking genomic stability, metabolism, and aging. We conclude with a general discussion of the role of mutant mice in aging research and avenues for future investigation.	Harvard Univ, Childrens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Brigham & Women's Hospital	Alt, FW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Lombard, David/0000-0002-4292-0185				Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Bergmann E, 2001, TRENDS GENET, V17, P279, DOI 10.1016/S0168-9525(01)02280-6; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169; Browne SE, 2004, FREE RADICAL BIO MED, V36, P938, DOI 10.1016/j.freeradbiomed.2004.01.003; Campisi J, 2002, MECH AGEING DEV, V123, P567, DOI 10.1016/S0047-6374(02)00006-4; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Davis T, 2003, J CELL SCI, V116, P1349, DOI 10.1242/jcs.00331; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Espejel S, 2002, EXP CELL RES, V276, P242, DOI 10.1006/excr.2002.5533; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARRISON DE, 1994, J GERONTOL, V49, pB245, DOI 10.1093/geronj/49.6.B245; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Karanjawala ZE, 2004, MECH AGEING DEV, V125, P405, DOI 10.1016/j.mad.2004.04.003; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Machwe A, 2004, ONCOGENE, V23, P149, DOI 10.1038/sj.onc.1206906; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 2004, AGING CELL, V3, P47, DOI 10.1111/j.1474-9728.2004.00081.x; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Rockwood LD, 2003, MUTAT RES-FUND MOL M, V529, P51, DOI 10.1016/S0027-5107(03)00108-8; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Schulz VP, 1996, HUM GENET, V97, P750; Scully R, 2004, CANCER BIOL THER, V3, P521, DOI 10.4161/cbt.3.6.842; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Singh NP, 2001, BIOGERONTOLOGY, V2, P261, DOI 10.1023/A:1013262327193; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tahara H, 1997, ONCOGENE, V15, P1911, DOI 10.1038/sj.onc.1201377; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385	115	662	693	3	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2005	120	4					497	512		10.1016/j.cell.2005.01.028	http://dx.doi.org/10.1016/j.cell.2005.01.028			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901GR	15734682	Bronze			2022-12-28	WOS:000227271500007
J	Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB				Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB			Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease	SCIENCE			English	Article							AMYLOID-PRECURSOR-PROTEIN; AXONAL-TRANSPORT; TRANSGENIC MICE; PLAQUE-FORMATION; NERVE-TERMINALS; BASAL FOREBRAIN; BETA-SECRETASE; PRESENILIN-1; BRAIN; ACCUMULATION	We identified axonal defects in mouse models of Alzheimer's disease that preceded known disease-related pathology by more than a year; we observed similar axonal defects in the early stages of Alzheimer's disease in humans. Axonal defects consisted of swellings that accumulated abnormal amounts of microtubule-associated and molecular motor proteins, organelles, and vesicles. Impairing axonal transport by reducing the dosage of a kinesin molecular motor protein enhanced the frequency of axonal defects and increased amyloid-beta peptide levels and amyloid deposition. Reductions in microtubule-dependent transport may stimulate proteolytic processing of beta-amyloid precursor protein, resulting in the development of senile plaques and Alzheimer's disease.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	Lillo, Concepcion/A-6321-2009; Stokin, Gorazd Bernard/D-9480-2015; Falzone, Tomás/W-2528-2019	Lillo, Concepcion/0000-0001-5814-9826; Stokin, Gorazd Bernard/0000-0001-8430-8755; Falzone, Tomas/0000-0002-7984-1149	NEI NIH HHS [R01 EY013408, R01 EY007042, EY12598, R01 EY007042-19, R01 EY013408-02, EY13408] Funding Source: Medline; NIA NIH HHS [P50 AG05131] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012598, R01EY013408, R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; DAVIES P, 1976, LANCET, V2, P1403; Dhaenens CM, 2004, NEUROSCI LETT, V368, P290, DOI 10.1016/j.neulet.2004.07.040; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hernandez D, 2001, NEUROREPORT, V12, P1377, DOI 10.1097/00001756-200105250-00018; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KAWARABAYASHI T, 1993, NEUROSCI LETT, V153, P73, DOI 10.1016/0304-3940(93)90080-5; KITT CA, 1984, SCIENCE, V226, P1443, DOI 10.1126/science.6505701; MASLIAH E, 1993, AM J PATHOL, V142, P871; MASLIAH E, 1993, J NEUROPATH EXP NEUR, V52, P619, DOI 10.1097/00005072-199311000-00009; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; TERRY RD, 1964, AM J PATHOL, V44, P269; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; UCHIHARA T, 1995, ACTA NEUROPATHOL, V90, P51; WEBSTER HDF, 1962, J CELL BIOL, V12, P361; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Wong TP, 1999, J NEUROSCI, V19, P2706; YAGISHITA S, 1978, VIRCHOWS ARCH A, V378, P181, DOI 10.1007/BF00427359	36	906	956	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1282	1288		10.1126/science.1105681	http://dx.doi.org/10.1126/science.1105681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731448				2022-12-28	WOS:000227313200051
J	Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C				Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C			Composition and dynamics of plasma in Saturn's magnetosphere	SCIENCE			English	Article							WATER ICE; MODEL; INJECTIONS; TRANSPORT	During Cassini's initial orbit, we observed a dynamic magnetosphere composed primarily of a complex mixture of water-derived atomic and molecular ions. We have identified four distinct regions characterized by differences in both bulk plasma properties and ion composition. Protons are the dominant species outside about 9 R-s (where R-s is the radial distance from the center of Saturn), whereas inside, the plasma consists primarily of a corotating comet-like mix of water-derived ions with similar to3% N+. Over the A and B rings, we found an ionosphere in which O-2(+) and O+ are dominant, which suggests the possible existence of a layer of O-2. gas similar to the atmospheres of Europa and Ganymede.	SW Res Inst, San Antonio, TX 78238 USA; Observ St Maur, Ctr Etud Environm Terr & Planetaires, F-94107 St Maur, France; Observ Midi Pyrenees, F-31400 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Univ Virginia, Charlottesville, VA USA; Univ Oulu, Dept Phys Sci, Oulu 90014, Finland; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Norwegian Def Res Estab, Div Elect, N-2027 Kjeller, Norway; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Los Alamos Natl Lab, Space & Atmospher Sci Grp, Los Alamos, NM 87545 USA; Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA	Southwest Research Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Rice University; University of Virginia; University of Oulu; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Norwegian Defence Research Establishment; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana	Young, DT (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	dyoung@swri.edu	Bolton, Scott/M-4392-2019; Reisenfeld, Daniel/F-7614-2015; Mursula, Kalevi/L-8952-2014; Grande, Manuel/C-2242-2013; dunlop, malcolm w/F-1347-2010; Coates, Andrew/C-2396-2008; McComas, David J/H-6202-2011; Smith, Howard/H-4662-2016	Mursula, Kalevi/0000-0003-4892-5056; Grande, Manuel/0000-0002-2233-2618; dunlop, malcolm w/0000-0002-8195-5137; Coates, Andrew/0000-0002-6185-3125; McComas, David J/0000-0001-6160-1158; Smith, Howard/0000-0003-3537-3360; Holmlund, Christer/0000-0002-6116-6632; bolton, scott/0000-0002-9115-0789				[Anonymous], 1984, SATURN; BALSIGER H, 1986, NATURE, V321, P330, DOI 10.1038/321330a0; BRIDGE HS, 1982, SCIENCE, V215, P563, DOI 10.1126/science.215.4532.563; BRIDGE HS, 1981, SCIENCE, V212, P217, DOI 10.1126/science.212.4491.217; CUMMINGS WD, 1967, J GEOPHYS RES, V72, P1007, DOI 10.1029/JZ072i003p01007; Delitsky ML, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001855; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; EVIATAR A, 1984, J GEOPHYS RES-SPACE, V89, P3821, DOI 10.1029/JA089iA06p03821; FRANK LA, 1980, J GEOPHYS RES-SPACE, V85, P5695, DOI 10.1029/JA085iA11p05695; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HASEGAWA A, 1978, J GEOPHYS RES-SPACE, V83, P1117, DOI 10.1029/JA083iA03p01117; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; Johnson RE, 1997, J GEOPHYS RES-PLANET, V102, P10985, DOI 10.1029/97JE00068; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Johnson RE, 2004, CAMB PLANET, P485; JOHNSON RE, 1989, ICARUS, V77, P311, DOI 10.1016/0019-1035(89)90092-4; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Jurac S, 2001, PLANET SPACE SCI, V49, P319, DOI 10.1016/S0032-0633(00)00153-7; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KNUDSEN DJ, 1992, J GEOPHYS RES-SPACE, V97, P77, DOI 10.1029/91JA02300; LAZARUS AJ, 1983, J GEOPHYS RES-SPACE, V88, P8831, DOI 10.1029/JA088iA11p08831; MAUK BH, 1983, J GEOPHYS RES-SPACE, V88, P11, DOI 10.1029/JA088iA12p10011; Mauk BH, 1997, GEOPHYS RES LETT, V24, P2949, DOI 10.1029/97GL03026; Maurice S, 1996, J GEOPHYS RES-SPACE, V101, P15211, DOI 10.1029/96JA00765; NISHIDA A, 1966, J GEOPHYS RES, V71, P5669, DOI 10.1029/JZ071i023p05669; PONTIUS DH, 1986, GEOPHYS RES LETT, V13, P1097, DOI 10.1029/GL013i011p01097; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; Richardson JD, 1998, J GEOPHYS RES-PLANET, V103, P20245, DOI 10.1029/98JE01127; RICHARDSON JD, 1995, GEOPHYS RES LETT, V22, P1177, DOI 10.1029/95GL01018; RICHARDSON JD, 1990, J GEOPHYS RES-SPACE, V95, P12019, DOI 10.1029/JA095iA08p12019; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; SITTLER EC, 1983, J GEOPHYS RES-SPACE, V88, P8847, DOI 10.1029/JA088iA11p08847; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	36	265	265	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1262	1266		10.1126/science.1106151	http://dx.doi.org/10.1126/science.1106151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731443				2022-12-28	WOS:000227313200045
J	Fraser, L				Fraser, L			Pre-eclampsia: a first hand account	LANCET			English	Editorial Material									Insurance Australia Grp, Sydney, NSW, Australia		Fraser, L (corresponding author), Insurance Australia Grp, Sydney, NSW, Australia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					800	800						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733722				2022-12-28	WOS:000227285300028
J	Dougan, S; Gilbart, VL; Sinka, K; Evans, BG				Dougan, S; Gilbart, VL; Sinka, K; Evans, BG			HIV infections acquired through heterosexual intercourse in the United Kingdom: findings from national surveillance	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England	Health Protection Agency	Dougan, S (corresponding author), Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England.	sarah.dougan@hpa.org.uk						Health Protection Agency Scottish Centre for Infection and Environmental Health National Public Health Service for Wales Communicable Disease Surveillance Centre Northern Ireland Unlinked Anonymous Surveys Steering Group, 2003, REN FOC HIV OTH SEX; *PUBL HLTH LAB SER, 2001, HIV AIDS UK EP REV 2; *UK COLL GROUP HIV, 2004, FOC PREV HIV OTH SEX	3	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1303	1304		10.1136/bmj.38393.572188.EB	http://dx.doi.org/10.1136/bmj.38393.572188.EB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933TL	15764624	Green Published, Bronze			2022-12-28	WOS:000229655700022
J	Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E				Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E			Ecology - Are US coral reefs on the slippery slope to slime?	SCIENCE			English	Article							RESILIENCE; ECOSYSTEMS		Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Earth Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Math, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Life Sci, St Lucia, Qld 4072, Australia; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Natl ctr Ecol Anal & Synth, Santa Barbara, CA USA; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; James Cook Univ N Queensland, Sch Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Florida Inst Oceanog, St Petersburg, FL 33701 USA	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; National Center for Ecological Analysis & Synthesis; Australian National University; James Cook University; Stanford University	Pandolfi, JM (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia.	j.pandolfi@uq.edu.au	Kappel, Carrie Vanessa/B-9534-2009; Hughes, Terry P/L-4721-2013; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Pandolfi, John M/A-3121-2009	Kappel, Carrie Vanessa/0000-0003-2507-8042; Hughes, Terry P/0000-0002-5257-5063; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Pandolfi, John M/0000-0003-3047-6694; Bradbury, Roger/0000-0002-0940-3493; Guzman, Hector M./0000-0001-9928-8523; Micheli, Fiorenza/0000-0002-6865-1438				Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bohnsack James A., 2003, Gulf and Caribbean Research, V14, P1; BRUMBAUGH DR, 2003, P FOR 2003 C NASS BA; Bryant D., 1998, REEFS RISK MAP BASED; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.1890/1540-9295(2003)001[0488:RDECAR]2.0.CO;2; ESTRADA R, 2003, SISTEMA NACL AREAS M; *FL KEYS NATL MAR, 1995, DRAFT MAN PLAN ENV I, V1, P1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; *INT UN CONS NAT N, RED LIST THREAT SPEC; JAAP WC, 2003, ENV PROTECTION AGENC; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JARAGOS J, 2002, CORAL REEF ECOSYSTEM; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter James W., 2002, P749; SAFINA C, 2003, EYE ALBATROSS; WILKINSON CR, IN PRESS STATUS CORA, V1; [No title captured]	22	345	364	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1725	1726		10.1126/science.1104258	http://dx.doi.org/10.1126/science.1104258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774744				2022-12-28	WOS:000227883900028
J	Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H				Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H			Genetic effects on sperm design in the zebra finch	NATURE			English	Article							EJACULATE QUALITY; COMPETITION; SELECTION; EVOLUTION; POPULATION; DETERMINES; MOBILITY; LENGTH	Sperm design and function are important determinants of male reproductive success and are expected to be under strong selection(1,2). The way that spermatozoa phenotypes evolve is poorly understood, because there have been few studies of the quantitative genetics of sperm(3-5). Here we show, in the zebra finch Taeniopygia guttata, an extraordinary degree of inter-male variation in sperm design that is independent of sperm swimming velocity. A quantitative genetics study using data from over 900 zebra finches in a complex breeding experiment showed that sperm head, mid-piece and flagellum length are heritable, that negative genetic correlations exist between sperm traits, and that significant indirect ( maternal) genetic effects exist. Selection on the zebra finch sperm phenotype may be low because sperm competition is infrequent in this species(6), and this, in combination with negative genetic correlations and maternal genetic effects, may account for the variation in sperm phenotype between males. These results have important implications for the evolution of sperm in other taxa.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Autonoma Metropolitana Xochimilco, Mexico City 04960, DF, Mexico	University of Sheffield; Universidad Autonoma Metropolitana - Mexico	Birkhead, TR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	T.R.Birkhead@sheffield.ac.uk		Castillo-Juarez, Hector/0000-0002-5550-4180				Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1995, NATURE, V377, P422, DOI 10.1038/377422a0; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Boldman K.G., 1995, MANUAL USE MTDFREML; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; CHEVERUD JM, 1983, GENET RES, V42, P65, DOI 10.1017/S0016672300021492; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; COHEN J, 1977, REPRODUCTION; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Froman DP, 1998, BIOL REPROD, V58, P379, DOI 10.1095/biolreprod58.2.379; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Jamieson BGM, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P303; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lynch M., 1998, GENETICS ANAL QUANTI; MCFARLANE RW, 1963, P 13 INT ORN C ITH N, P91; Morrow EH, 2001, HEREDITY, V87, P356, DOI 10.1046/j.1365-2540.2001.00921.x; Morrow EH, 2001, J ZOOL, V254, P147, DOI 10.1017/S0952836901000656; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Royle NJ, 2003, FUNCT ECOL, V17, P472, DOI 10.1046/j.1365-2435.2003.00752.x; SEH J, 2004, P R SOC LOND B S, V271, pS306; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Zann RA., 1996, ZEBRA FINCH SYNTHESI	30	156	158	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					383	387		10.1038/nature03374	http://dx.doi.org/10.1038/nature03374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772662				2022-12-28	WOS:000227715100052
J	Lindberg, DAB; Humphreys, BL				Lindberg, DAB; Humphreys, BL			2015 - The future of medical libraries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Lindberg, DAB (corresponding author), NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.							De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; *NIH, 2004, ENH PUBL ACC NIH RES; Shill HB, 2004, COLL RES LIBR, V65, P123, DOI 10.5860/crl.65.2.123	3	44	48	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1067	+		10.1056/NEJMp048190	http://dx.doi.org/10.1056/NEJMp048190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784661				2022-12-28	WOS:000227655000002
J	Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M				Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M			The first cleavage of the mouse zygote predicts the blastocyst axis	NATURE			English	Article							1ST CLEAVAGE; BLASTOMERES; DIVISION; EGG	One of the unanswered questions in mammalian development is how the embryonic - abembryonic axis of the blastocyst is first established. It is possible that the first cleavage division contributes to this process, because in most mouse embryos the progeny of one two-cell blastomere primarily populate the embryonic part of the blastocyst and the progeny of its sister populate the abembryonic part(1-4). However, it is not known whether the embryonic - abembryonic axis is set up by the first cleavage itself, by polarity in the oocyte that then sets the first cleavage plane with respect to the animal pole, or indeed whether it can be divorced entirely from the first cleavage and established in relation to the animal pole. Here we test the importance of the orientation of the first cleavage by imposing an elongated shape on the zygote so that the division no longer passes close to the animal pole, marked by the second polar body. Non-invasive lineage tracing shows that even when the first cleavage occurs along the short axis imposed by this experimental treatment, the progeny of the resulting two-cell blastomeres tend to populate the respective embryonic and abembryonic parts of the blastocyst. Thus, the first cleavage contributes to breaking the symmetry of the embryo, generating blastomeres with different developmental characteristics.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	University of Cambridge; University of Cambridge; Columbia University	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	mzg@mole.bio.cam.ac.uk		Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Plusa, Berenika/0000-0003-2214-5940; Papaioannou, Virginia/0000-0001-7558-8601; Zernicka-Goetz, Magdalena/0000-0002-7004-2471; Glover, David/0000-0003-0956-0103	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DONAHUE RP, 1972, J EXP ZOOL, V180, P305, DOI 10.1002/jez.1401800303; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; GARNER W, 1974, J EMBRYOL EXP MORPH, V32, P495; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860	14	107	119	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					391	395		10.1038/nature03388	http://dx.doi.org/10.1038/nature03388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772664				2022-12-28	WOS:000227715100054
J	Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB				Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB			Relative importance of borderline and elevated levels of coronary heart disease risk factors	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SERUM-CHOLESTEROL; TASK-FORCE; PREVENTION; POPULATION; PREDICTION; MORTALITY; SMOKING	Background: Clinical trials indicate that a sizable proportion of adults have multiple borderline coronary risk factors and may benefit from treatment. Objective: To estimate the relative and absolute contributions of borderline and elevated risk factors to the population burden of coronary heart disease (CHD) events. Design: A prospective cohort study and a national crosssectional survey. Setting: The Framingham Study and the Third National Health and Nutrition Examination Survey (NHANES III). Participants: White non-Hispanic persons in the Framingham Study and in NHANES III who were between 35 to 74 years of age and had no CHD. Measurements: Occurrence of first CHD events according to 5 major CHD risk factors: blood pressure, low-density lipoprotein and high-density lipoprotein cholesterol levels, glucose intolerance, and smoking. Three categories - optimal, borderline, and elevated-were defined for each risk factor per national guide-lines. Sex-specific 10-year CHD event rates from the Framingham Study were applied to numbers of at-risk individuals estimated from NHANES III and the 2000 U.S. Census. Results: Twenty-six percent of men and 41% of women had at least 1 borderline risk factor in NHANES III. According to estimates, more than 90% of CHD events will occur in individuals with at least 1 elevated risk factor, and approximately 8% will occur in people with only borderline levels of multiple risk factors. Absolute 10-year CHD risk exceeded 10% in men older than age 45 years who had 1 elevated risk factor and 4 or more borderline risk factors and in those who had at least 2 elevated risk factors. In women, absolute CHD risk exceeded 10% only in those older than age 55 years who had at least 3 elevated risk factors. Limitations: The generalizability of the findings to persons of other ethnic backgrounds is unknown. Conclusions: Borderline CHD risk factors alone account for a small proportion of CHD events.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Med Univ S Carolina, Charleston, SC 29425 USA; SUNY Buffalo, Buffalo, NY 14260 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Boston, MA 02215 USA	Framingham Heart Study; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayne Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Sundström, Johan/A-6286-2009; Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Sundstrom, Johan/R-2139-2019	Sundström, Johan/0000-0003-2247-8454; Levy, Daniel/0000-0003-1843-8724; Sundstrom, Johan/0000-0003-2247-8454; Sullivan, Lisa/0000-0003-0726-7149; Ramachandran, Vasan/0000-0001-7357-5970				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Benjamin EJ, 2002, J AM COLL CARDIOL, V40, P588, DOI 10.1016/S0735-1097(02)02082-X; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; *CDCP, 1996, NHANES 3 1988 94 REF; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P4; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 1999, CIRCULATION, V100, P988, DOI 10.1161/01.CIR.100.9.988; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; KANNEL WB, 1995, CIRCULATION, V92, P3350, DOI 10.1161/01.CIR.92.11.3350; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB., 1987, SECTION 34 SOME RISK; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT CTR HLTH STAT, 2003, HLTH US 2003 CHARTB, P95; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	36	142	151	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					393	402		10.7326/0003-4819-142-6-200503150-00005	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767617				2022-12-28	WOS:000227621100001
J	de Koning, H				de Koning, H			Errors in "family" practice	LANCET			English	Editorial Material									Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Koning, H (corresponding author), Erasmus MC, Rotterdam, Netherlands.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					1001	1001		10.1016/S0140-6736(05)71091-6	http://dx.doi.org/10.1016/S0140-6736(05)71091-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15767004				2022-12-28	WOS:000227559800035
J	Garrido, T; Jamieson, L; Zhou, Y; Wiesenthal, A; Liang, L				Garrido, T; Jamieson, L; Zhou, Y; Wiesenthal, A; Liang, L			Effect of electronic health records in ambulatory care: retrospective, serial, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY; INFORMATION	Objective To evaluate the effect of implementing comprehensive, integrated electronic health record systems on use and quality of ambulatory care Design Retrospective, serial, cross sectional study. Setting Colorado and Northwest regions of Kaiser Permanente, a US integrated healthcare delivery system. Population 367 795 members in the Colorado region and 449 728 members in the Northwest region. Intervention Implementation of electronic health record systems. Main outcome measures Total number of office visits and use of primary care, specialty care, clinical laboratory, radiology services, and telephone contact. Health Plan Employer Data and Information Set to assess quality. Results Two years after electronic health records were fully implemented, age adjusted rates of office visits fell by 9% in both regions. Age adjusted primary care visits decreased by 11% in both regions and specialty care visits decreased by 5% in Colorado and 6% in the Northwest. All these decreases were significant (P < 0.0001). The percentage of members making >= 3 visits a year decreased by 10% in Colorado and 11% in the Northwest, and the percentage of members with <= 2 visits a year increased. In the Northwest scheduled telephone contact increased from a baseline of 1.26 per member per year to 2.09 after two years. Use of clinical laboratory and radiology services did not change conclusively. Intermediate measures of quality of health care remained unchanged or improved slightly. Conclusions Readily available, comprehensive, integrated clinical information reduced use of ambulatory care while maintaining quality and allowed doctors to replace some office visits with telephone contacts. Shifting patterns of use suggest reduced numbers of ambulatory care visits that are inappropriate or marginally productive.	Kaiser Permanente, Clin Syst Planning & Consulting, Oakland, CA 94612 USA	Kaiser Permanente	Garrido, T (corresponding author), Kaiser Permanente, Clin Syst Planning & Consulting, 2101 Webster St, Oakland, CA 94612 USA.	terhilda.garrido@kp.org						Anderson JD, 1999, M D COMPUT, V16, P62; Bates DW, 2003, J AM MED INFORM ASSN, V10, P1, DOI 10.1197/jamia.M1097; BATES DW, 2000, P AMIA S, P964; BURNUM JF, 1989, ANN INTERN MED, V110, P482, DOI 10.7326/0003-4819-110-6-482; Carroll AE, 2003, PEDIATRICS, V111, P976, DOI 10.1542/peds.111.5.976; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Committee on Improving the Patient Record & Medicine, 1997, COMP BAS PAT REC ESS; Duffy SQ, 1995, PUBLIC HEALTH REP, V110, P674; *GEN ACC OFF, 1991, MED ADP SYST AUT MED; Hersh WR, 2002, JAMA-J AM MED ASSOC, V288, P1955, DOI 10.1001/jama.288.16.1955; *KAIS PERM, KAIS PERM WHO WE AR; Keshavjee K, 2001, J AM MED INFORM ASSN, P309; KRALL MA, 1995, ANN S COMP APPL MED, P708; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McNeil BJ, 2001, NEW ENGL J MED, V345, P1612, DOI 10.1056/NEJMsa011810; *NAT COMM QUAL ASS, 2003, STAT HLTH CAR QUAL 2; *NAT COMM QUAL ASS, HLTH PLAN REP CARD; Penrod LE, 2001, J AM MED INFORM ASSN, P528; PENROD LE, 2001, P AMIA S, V528, P32; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; van Wijk MAM, 2001, ANN INTERN MED, V134, P274, DOI 10.7326/0003-4819-134-4-200102200-00010; Woodwell David A, 2004, Adv Data, P1	23	98	99	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					581	584A		10.1136/bmj.330.7491.581	http://dx.doi.org/10.1136/bmj.330.7491.581			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760999	Bronze, Green Published			2022-12-28	WOS:000227622300020
J	Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL				Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL			High-throughput mapping of a dynamic signaling network in mammalian cells	SCIENCE			English	Article							GROWTH-FACTOR-BETA; PROTEIN INTERACTIONS; TRANSDUCTION; MAP	Signaling pathways transmit information through protein interaction networks that are dynamically regulated by complex extracellular cues. We developed LUMIER (for luminescence-based mammalian interactome mapping), an automated high-throughput technology, to map protein-protein interaction networks systematically in mammalian cells and applied it to the transforming growth factor-beta (TGFbeta) pathway. Analysis using self-organizing maps and k-means clustering identified links of the TGFbeta pathway to the p21 activated kinase (PAK) network, to the polarity complex, and to Occludin, a structural component of tight junctions. We show that Occludin regulates TGFbeta type I receptor localization for efficient TGFbeta-dependent dissolution of tight junctions during epithelial-to-mesenchymal transitions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 2M9, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; RIKEN Genom Sci Ctr, Yokohama Inst, Lab Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; Princess Margaret Hosp, Ontario Canc Inst, Div Canc Informat, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Robinson, Mark D/A-6432-2015; Suzuki, Harukazu/N-9553-2015; Przulj, Natasa/AAO-2850-2020; Wrana, Jeffrey/F-8857-2013; Bose, Rohit/O-9825-2018; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Suzuki, Harukazu/0000-0002-8087-0836; Bose, Rohit/0000-0002-6785-0697; Robinson, Mark D./0000-0002-3048-5518; Przulj, Natasa/0000-0002-1290-853X; Brown, Kevin/0000-0002-5514-2538	NIGMS NIH HHS [P50 GM-62413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BARRIOSRODILES M, UNPUB; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; OZDAMAR B, IN PRESS; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Sultan M, 2002, Bioinformatics, V18 Suppl 1, pS111; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	23	539	566	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1621	1625		10.1126/science.1105776	http://dx.doi.org/10.1126/science.1105776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761153				2022-12-28	WOS:000227622400047
J	Hewitt, SC; Deroo, BJ; Korach, KS				Hewitt, SC; Deroo, BJ; Korach, KS			A new mediator for an old hormone?	SCIENCE			English	Editorial Material							MEMBRANE ESTROGEN-RECEPTORS; G-PROTEIN; CELLS; ROLES		NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Korach, Kenneth/0000-0002-7765-418X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham IM, 2004, ENDOCRINOLOGY, V145, P3055, DOI 10.1210/en.2003-1676; Cato A., 2002, SCI STKE; Fugger HN, 2001, NEUROSCI LETT, V309, P207, DOI 10.1016/S0304-3940(01)02083-3; Jensen E, 1960, BIOL ACTIVITIES STER, P161; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; PAPPAS TC, 1994, ENDOCRINE, V2, P813; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064	12	54	59	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1572	1573		10.1126/science.1110345	http://dx.doi.org/10.1126/science.1110345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761144				2022-12-28	WOS:000227622400031
J	Shapiro, NM; Campillo, M; Stehly, L; Ritzwoller, MH				Shapiro, NM; Campillo, M; Stehly, L; Ritzwoller, MH			High-resolution surface-wave tomography from ambient seismic noise	SCIENCE			English	Article							EXCITATION; SCATTERING	Cross-correlation of 1 month of ambient seismic noise recorded at USArray stations in California yields hundreds of short-period surface-wave group-speed measurements on interstation paths. We used these measurements to construct tomographic images of the principal geological units of California, with low-speed anomalies corresponding to the main sedimentary basins and high-speed anomalies corresponding to the igneous cores of the major mountain ranges. This method can improve the resolution and fidelity of crustal images obtained from surface-wave analyses.	Univ Colorado, Dept Phys, Ctr Imaging Earths Interior, Boulder, CO 80309 USA; Univ Grenoble 1, Lab Geophys Interne & Tectonophys, Grenoble, France	University of Colorado System; University of Colorado Boulder; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Shapiro, NM (corresponding author), Univ Colorado, Dept Phys, Ctr Imaging Earths Interior, Boulder, CO 80309 USA.	nshapiro@ciei.colorado.edu	Campillo, Michel/AAC-5666-2019; Campillo, Michel/K-6231-2012; Shapiro, Nikolai M/G-1049-2010	Campillo, Michel/0000-0001-6971-4499; Campillo, Michel/0000-0001-6971-4499; Shapiro, Nikolai M/0000-0002-0144-723X				Barmin MP, 2001, PURE APPL GEOPHYS, V158, P1351, DOI 10.1007/PL00001225; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Derode A, 2003, J ACOUST SOC AM, V113, P2973, DOI 10.1121/1.1570436; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ekstrom G, 2001, J GEOPHYS RES-SOL EA, V106, P26483, DOI 10.1029/2000JB000086; Friedrich A, 1998, J SEISMOL, V2, P47, DOI 10.1023/A:1009788904007; Goldstein P., 1996, SEISMOL RES LETT, V67, P39; Hennino R, 2001, PHYS REV LETT, V86, P3447, DOI 10.1103/PhysRevLett.86.3447; JONES CH, 1994, J GEOPHYS RES-SOL EA, V99, P4567, DOI 10.1029/93JB01232; Kos S, 2004, NATURE, V431, P29, DOI 10.1038/431029a; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Larose E, 2004, J APPL PHYS, V95, P8393, DOI 10.1063/1.1739529; Levshin A.L., 1989, SEISMIC SURFACE WAVE; Lobkis OI, 2001, J ACOUST SOC AM, V110, P3011, DOI 10.1121/1.1417528; Malcolm AE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.015601; Nolet G, 2000, J GEOPHYS RES-SOL EA, V105, P19043, DOI 10.1029/2000JB900161; Rhie J, 2004, NATURE, V431, P552, DOI 10.1038/nature02942; Ritzwoller MH, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001777; Ritzwoller MH, 1998, J GEOPHYS RES-SOL EA, V103, P4839, DOI 10.1029/97JB02622; Roux P, 2004, J ACOUST SOC AM, V116, P1995, DOI 10.1121/1.1797754; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; Shapiro NM, 1999, B SEISMOL SOC AM, V89, P1138; Snieder R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046610; Spetzler J, 2002, GEOPHYS J INT, V149, P755, DOI 10.1046/j.1365-246X.2002.01683.x; Tanimoto T, 1999, GEOPHYS J INT, V136, P395, DOI 10.1046/j.1365-246x.1999.00763.x; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301; Wilson AM, 1999, GEOL SOC AM BULL, V111, P432, DOI 10.1130/0016-7606(1999)111<0432:POTSJB>2.3.CO;2	28	1498	1619	21	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1615	1618		10.1126/science.1108339	http://dx.doi.org/10.1126/science.1108339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761151	Green Submitted			2022-12-28	WOS:000227622400045
J	Tanenbaum, SJ				Tanenbaum, SJ			Commentary: Uncertainty, consultation, and the context of medical care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Ohio State Univ, Sch Publ Hlth, Columbus, OH 43210 USA	Ohio State University	Tanenbaum, SJ (corresponding author), Ohio State Univ, Sch Publ Hlth, 246 Atwell Hall,1583 Perry St, Columbus, OH 43210 USA.	tanenbaum.1@osu.edu						Griffiths F, 2005, BMJ-BRIT MED J, V330, P511, DOI 10.1136/bmj.38336.482720.8F	1	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2005	330	7490					515	515		10.1136/bmj.330.7490.515	http://dx.doi.org/10.1136/bmj.330.7490.515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905PM	15746132	Green Published			2022-12-28	WOS:000227581400018
J	Venkataraman, C; Habib, G; Eiguren-Fernandez, A; Miguel, AH; Friedlander, SK				Venkataraman, C; Habib, G; Eiguren-Fernandez, A; Miguel, AH; Friedlander, SK			Residential biofuels in south Asia: Carbonaceous aerosol emissions and climate impacts	SCIENCE			English	Article							BIOMASS	High concentrations of pollution particles, including "soot" or black carbon,,exist over the Indian Ocean, but their sources and geographical origins are not well understood. We measured emissions from the combustion of biofuets, used widely in south Asia for cooking, and found that large amounts of carbonaceous aerosols are emitted per kilogram of fuel burnt. We calculate that biofuel combustion is the largest source of black carbon emissions in India, and we suggest that its control is central to climate change mitigation in the south Asian region.	Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India; Univ Calif Los Angeles, Inst Environm, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, So Calif Particle Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Venkataraman, C (corresponding author), Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.	chandra@che.iitb.ac.in						Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Bond TC, 2001, GEOPHYS RES LETT, V28, P4075, DOI 10.1029/2001GL013652; Fine PM, 2001, ENVIRON SCI TECHNOL, V35, P2665, DOI 10.1021/es001466k; FRANKE K, 2003, J GEOPHYS RES-ATMOS, V108, P2473, DOI DOI 10.1029/2002JD002473; FRIEDLANDER SK, 1973, ENVIRON SCI TECHNOL, V7, P235, DOI 10.1021/es60075a005; Habib G, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002157; Hobbs PV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002352; International Institute for Population Sciences, 2001, NAT FAM HLTH SURV NF; Jacobson MZ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004945; Jacobson MZ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002044; Mayol-Bracero OL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000039; Menon S, 2002, SCIENCE, V297, P2250, DOI 10.1126/science.1075159; NAZAROFF W, COMMUNICATION; Neususs C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000514; OLIVIER JGJ, 2002, 773301001 NAT I PUBL; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; RAU JA, 1989, AEROSOL SCI TECH, V10, P181, DOI 10.1080/02786828908959233; Reddy MS, 2002, ATMOS ENVIRON, V36, P699, DOI 10.1016/S1352-2310(01)00464-2; Satheesh SK, 2000, NATURE, V405, P60, DOI 10.1038/35011039; Schauer JJ, 2003, ENVIRON SCI TECHNOL, V37, P993, DOI 10.1021/es020622f; Sheesley RJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002981; Smith K., 2000, GREENHOUSE GASES SMA; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; Trollope WSW, 1996, J GEOPHYS RES-ATMOS, V101, P23531, DOI 10.1029/96JD00691; Venkataraman C, 2001, ENVIRON SCI TECHNOL, V35, P2100, DOI 10.1021/es001603d; Yevich R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001952	28	467	482	4	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1454	1456		10.1126/science.1104359	http://dx.doi.org/10.1126/science.1104359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746423				2022-12-28	WOS:000227503100042
J	Gilman, SL; Glaze, FE				Gilman, SL; Glaze, FE			History of science - "How science survived" - Medieval manuscripts as fossils	SCIENCE			English	Editorial Material									Coastal Carolina Univ, Dept Biol, Conway, SC 29528 USA; Coastal Carolina Univ, Dept Hist, Conway, SC 29528 USA	Coastal Carolina University; Coastal Carolina University	Gilman, SL (corresponding author), Coastal Carolina Univ, Dept Biol, Conway, SC 29528 USA.	sgilman@coastal.edu; fglaze@coastal.edu						Cisne JL, 2005, SCIENCE, V307, P1305, DOI 10.1126/science.1104718; FRENCH R, 2003, MED SCI BUSINESS MED, pCH5; GLAZE FE, 2000, THESIS DUKE U; GLAZE FE, UNPUB MED MISSION PR, P500; Langslow D.R., 2000, MED LATIN ROMAN EMPI; Lindberg David C., 1992, BEGINNINGS W SCI; McCormick M, 2001, ORIGINS EUROPEAN EC; SABBAH G, 1987, BIBLIO TEXTES MED LA; SAVAGESMITH E, 2005, ISLAMIC MED MANUSCRI; STAHL WH, 1962, ROMAN SCI ORIGINS DE; Sylla Edith, 1997, TEXTS CONTEXTS ANCIE	11	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1208	1209		10.1126/science.1109679	http://dx.doi.org/10.1126/science.1109679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731431				2022-12-28	WOS:000227313200030
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Helfenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukurn, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Helfenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukurn, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Saturn's rings and small satellites	SCIENCE			English	Article							F-RING; PLANETARY RINGS; STELLAR OCCULTATION; MAIN RINGS; VOYAGER OBSERVATIONS; IRREGULAR STRUCTURE; PARTICLE SIZES; DENSITY WAVES; ENCKE GAP; B-RING	Images acquired of Saturn's rings and small moons by the Cassini Imaging Science Subsystem (ISS) during the first 9 months of Cassini operations at Saturn have produced many new findings. These include new saturnian moons; refined orbits of new and previously known moons; narrow diffuse rings in the F-ring region and embedded in gaps within the main rings; exceptionally fine-scale ring structure in moderate- to high-optical depth regions; new estimates for the masses of ring-region moons, as well as ring particle properties in the Cassini division, derived from the analysis of linear density waves; ring particle albedos in select ring regions; And never-before-seen phenomena within the rings.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Tiscareno, Matthew/D-6963-2011; Evans, Michael W/AAG-4117-2020; Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; BORDERIES N, 1986, ICARUS, V68, P522, DOI 10.1016/0019-1035(86)90054-0; BORDERIES N, 1989, ICARUS, V80, P344, DOI 10.1016/0019-1035(89)90145-0; BORDERIES N, 1985, ICARUS, V63, P406, DOI 10.1016/0019-1035(85)90054-5; Borderies N., 1984, PLANETARY RINGS, P713; Bosh AS, 2002, ICARUS, V157, P57, DOI 10.1006/icar.2002.6791; Brahic A., 1984, IAU C, V75, P513; Burns JA, 1998, PLANET SPACE SCI, V46, P1401, DOI 10.1016/S0032-0633(97)00147-5; CHANDRASEKHAR S, 1947, ASTROPHYS J, V106, P152, DOI 10.1086/144950; Chiang EI, 2000, ASTROPHYS J, V540, P1084, DOI 10.1086/309372; Cuzzi J.N., 1984, PLANETARY RINGS, V75, P73; CUZZI JN, 1985, ASTROPHYS J, V292, P276, DOI 10.1086/163158; Cuzzi JN, 2002, ICARUS, V158, P199, DOI 10.1006/icar.2002.6851; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; DERMOTT SF, 1979, ASTRON J, V84, P1225, DOI 10.1086/112533; DERMOTT SF, 1980, NATURE, V284, P309, DOI 10.1038/284309a0; DERMOTT SF, 1980, ICARUS, V48, P1; DOYLE LR, 1989, ICARUS, V80, P104, DOI 10.1016/0019-1035(89)90163-2; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; Estrada PR, 1996, ICARUS, V122, P251, DOI 10.1006/icar.1996.0124; Estrada PR, 2003, ICARUS, V166, P212, DOI 10.1016/j.icarus.2003.06.001; French RG, 2000, ICARUS, V145, P502, DOI 10.1006/icar.2000.6357; FRENCH RG, 1993, ICARUS, V103, P163, DOI 10.1006/icar.1993.1066; GOLDREICH P, 1987, ASTRON J, V93, P730, DOI 10.1086/114355; GOLDREICH P, 1978, ICARUS, V34, P227, DOI 10.1016/0019-1035(78)90164-1; Goldreich P, 2003, ASTROPHYS J, V585, P1024, DOI 10.1086/346202; Griv E, 2003, PLANET SPACE SCI, V51, P899, DOI 10.1016/j.pss.2003.05.003; Horn LJ, 1996, ICARUS, V119, P285, DOI 10.1006/icar.1996.0021; Horn LJ, 1996, ICARUS, V124, P663, DOI 10.1006/icar.1996.0240; Jacobson R.A., 2004, BAAS, V36, P1097; Jacobson RA, 2004, ICARUS, V172, P382, DOI 10.1016/j.icarus.2004.08.018; JULIAN WH, 1966, ASTROPHYS J, V146, P810, DOI 10.1086/148957; KARKOSCHKA E, 1994, ICARUS, V111, P174, DOI 10.1006/icar.1994.1139; KOLVOORD RA, 1990, NATURE, V345, P695, DOI 10.1038/345695a0; LEWIS MC, IN PRESS ICARUS; LUMME K, 1978, ICARUS, V33, P288, DOI 10.1016/0019-1035(78)90148-3; McGhee CA, 2001, ICARUS, V152, P282, DOI 10.1006/icar.2001.6635; MCGHEE CA, IN PRESS ICARUS; Murray CD, 1997, ICARUS, V129, P304, DOI 10.1006/icar.1997.5774; NAMOUNI F, 2002, B AM ASTRON SOC, V34, P884; NICHOLSON PD, 1990, ASTRON J, V100, P1339, DOI 10.1086/115601; NICHOLSON PD, 1992, ICARUS, V100, P464, DOI 10.1016/0019-1035(92)90111-J; Nitter T, 1998, J GEOPHYS RES-SPACE, V103, P6605, DOI 10.1029/97JA03523; NULL GW, 1981, ASTRON J, V86, P456, DOI 10.1086/112905; PAPALOIZOU JCB, 1988, ASTROPHYS J, V331, P838, DOI 10.1086/166604; PORCO C, 1984, ICARUS, V60, P1, DOI 10.1016/0019-1035(84)90134-9; PORCO C, 1984, ICARUS, V60, P17, DOI 10.1016/0019-1035(84)90135-0; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; PORCO CC, 1991, SCIENCE, V253, P995, DOI 10.1126/science.253.5023.995; PORCO CC, 1983, THESIS CALTECH; PORCO CC, 2004, 8432 IAU, P1; PORCO CC, 1990, ADV SPACE RES, V10, P221; Poulet F, 2003, ASTRON ASTROPHYS, V412, P305, DOI 10.1051/0004-6361:20031123; Poulet F, 2002, ICARUS, V160, P350, DOI 10.1006/icar.2002.6967; Poulet F, 2000, ICARUS, V144, P135, DOI 10.1006/icar.1999.6267; RENNER S, IN PRESS ICARUS; ROSEN PA, 1988, SCIENCE, V241, P690, DOI 10.1126/science.241.4866.690; SCARGLE J, 1993, B AM ASTRON SOC, V25, P1103; Schmidt J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.061102; SHOWALTER MR, 1986, ICARUS, V66, P297, DOI 10.1016/0019-1035(86)90160-0; SHOWALTER MR, 1982, ICARUS, V52, P526, DOI 10.1016/0019-1035(82)90013-6; SHU FH, 1985, ASTROPHYS J, V299, P542, DOI 10.1086/163722; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; Spilker LJ, 2004, ICARUS, V171, P372, DOI 10.1016/j.icarus.2004.05.016; THOMAS P, 1983, J GEOPHYS RES-SPACE, V88, P8743, DOI 10.1029/JA088iA11p08743; Tremaine S, 2003, ASTRON J, V125, P894, DOI 10.1086/345963; TURTLE E, 1991, BAAS, V23, P1179; Winter SMG, 2000, PLANET SPACE SCI, V48, P817, DOI 10.1016/S0032-0633(00)00009-X; ZEBKER HA, 1985, ICARUS, V64, P531, DOI 10.1016/0019-1035(85)90074-0	70	170	171	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1226	1236		10.1126/science.1108056	http://dx.doi.org/10.1126/science.1108056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731439				2022-12-28	WOS:000227313200038
J	Donnan, GA; Dewey, HM				Donnan, GA; Dewey, HM			Stroke and nutrition: FOOD for thought	LANCET			English	Editorial Material									Univ Melbourne, Austin Hosp, Natl Stroke Res Inst, Heidelberg West, Vic 3081, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Donnan, GA (corresponding author), Univ Melbourne, Austin Hosp, Natl Stroke Res Inst, Heidelberg West, Vic 3081, Australia.	gdonnan@unimelb.edu.au	DONNAN, GEOFFREY A/A-9947-2008	Donnan, Geoffrey/0000-0001-6324-3403				Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; Gariballa SE, 1998, AM J CLIN NUTR, V68, P275, DOI 10.1093/ajcn/68.2.275; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; *NAT STROK FDN AUS, 2003, NAT CLIN GUID AC STR; Toni D, 2004, CEREBROVASC DIS, V17, P30, DOI 10.1159/000074818	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					729	730						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733698				2022-12-28	WOS:000227285300003
